Identification of essential genes in prokaryotes

Abstract

The sequences of antisense nucleic acids which inhibit the proliferation of prokaryotes are disclosed. Cell-based assays which employ the antisense nucleic acids to identify and develop antibiotics are also disclosed. The antisense nucleic acids can also be used to identify proteins required for proliferation, express these proteins or portions thereof, obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous nucleic acids that are required for proliferation in cells other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms.

Description

SEQUENCE LISTING

[0002] The present application is being filed along with duplicate copies of a CD-ROM marked “Copy 1” and “Copy 2” containing a Sequence Listing in electronic format. The duplicate copies of the CD-ROM each contain a file entitled SEQLIST_FINAL—9PM created on Mar. 20, 2001 which is 37,487,912 bytes in size. The information on these duplicate CD-ROMs is incorporated herein by reference in its entirety.

BACKGROUND OF THE INVENTION

[0003] Since the discovery of penicillin, the use of antibiotics to treat the ravages of bacterial infections has saved millions of lives. With the advent of these “miracle drugs,” for a time it was popularly believed that humanity might, once and for all, be saved from the scourge of bacterial infections. In fact, during the 1980s and early 1990s, many large pharmaceutical companies cut back or eliminated antibiotics research and development. They believed that infectious disease caused by bacteria finally had been conquered and that markets for new drugs were limited. Unfortunately, this belief was overly optimistic.

[0004] The tide is beginning to turn in favor of the bacteria as reports of drug resistant bacteria become more frequent. The United States Centers for Disease Control announced that one of the most powerful known antibiotics, vancomycin, was unable to treat an infection of the common Staphylococcus aureus (staph). This organism is commonly found in our environment and is responsible for many nosocomial infections. The import of this announcement becomes clear when one considers that vancomycin was used for years to treat infections caused by Staphylococcus species as well as other stubborn strains of bacteria. In short, bacteria are becoming resistant to our most powerful antibiotics. If this trend continues, it is conceivable that we will return to a time when what are presently considered minor bacterial infections are fatal diseases.

[0005] Over-prescription and improper prescription habits by some physicians have caused an indiscriminate increase in the availability of antibiotics to the public. The patients are also partly responsible, since they will often improperly use the drug, thereby generating yet another population of bacteria that is resistant, in whole or in part, to traditional antibiotics.

[0006] The bacterial pathogens that have haunted humanity remain, in spite of the development of modern scientific practices to deal with the diseases that they cause. Drug resistant bacteria are now an increasing threat to the health of humanity. A new generation of antibiotics is needed to once again deal with the pending health threat that bacteria present.

Discovery of New Antibiotics

[0007] As more and more bacterial strains become resistant to the panel of available antibiotics, new antibiotics are required to treat infections. In the past, practitioners of pharmacology would have to rely upon traditional methods of drug discovery to generate novel, safe and efficacious compounds for the treatment of disease. Traditional drug discovery methods involve blindly testing potential drug candidate-molecules, often selected at random, in the hope that one might prove to be an effective treatment for some disease. The process is painstaking and laborious, with no guarantee of success. Today, the average cost to discover and develop a new drug exceeds US $500 million, and the average time from laboratory to patient is 15 years. Improving this process, even incrementally, would represent a huge advance in the generation of novel antimicrobial agents.

[0008] Newly emerging practices in drug discovery utilize a number of biochemical techniques to provide for directed approaches to creating new drugs, rather than discovering them at random. For example, gene sequences and proteins encoded thereby that are required for the proliferation of a cell or microorganism make excellent targets since exposure of bacteria to compounds active against these targets would result in the inactivation of the cell or microorganism. Once a target is identified, biochemical analysis of that target can be used to discover or to design molecules that interact with and alter the functions of the target. Use of physical and computational techniques to analyze structural and biochemical properties of targets in order to derive compounds that interact with such targets is called rational drug design and offers great potential. Thus, emerging drug discovery practices use molecular modeling techniques, combinatorial chemistry approaches, and other means to produce and screen and/or design large numbers of candidate compounds.

[0009] Nevertheless, while this approach to drug discovery is clearly the way of the future, problems remain. For example, the initial step of identifying molecular targets for investigation can be an extremely time consuming task. It may also be difficult to design molecules that interact with the target by using computer modeling techniques. Furthermore, in cases where the function of the target is not known or is poorly understood, it may be difficult to design assays to detect molecules that interact with and alter the functions of the target. To improve the rate of novel drug discovery and development, methods of identifying important molecular targets in pathogenic cells or microorganisms and methods for identifying molecules that interact with and alter the functions of such molecular targets are urgently required.

[0010] Staphylococcus aureus is a Gram positive microorganism which is the causative agent of many infectious diseases. Local infection by Staphylococcus aureus can cause abscesses on skin and cellulitis in subcutaneous tissues and can lead to toxin-related diseases such as toxic shock and scalded skin syndromes. Staphylococcus aureus can cause serious systemic infections such as osteomyelitis, endocarditis, pneumonia, and septicemia. Staphylococcus aureus is also a common cause of food poisoning, often arising from contact between prepared food and infected food industry workers. Antibiotic resistant strains of Staphylococcus aureus have recently been identified, including those that are now resistant to all available antibiotics, thereby severely limiting the options of care available to physicians.

[0011] Pseudomonas aerginosa is an important Gram-negative opportunistic pathogen. It is the most common Gram-negative found in nosocomial infections. P. aeruginosa is responsible for 16% of nosocomial pneumonia cases, 12% of hospital-acquired urinary tract infections, 8% of surgical wound infections, and 10% of bloodstream infections. Immunocompromised patients, such as neutropenic cancer and bone marrow transplant patients, are particular susceptible to opportunistic infections. In this group of patients, P. aeruginosa is responsible for pneumonia and septicemia with attributable deaths reaching 30%. P. aeruginosa is also one of the most common and lethal pathogens responsible for ventilator-associated pneumonia in intubated patients, with directly attributable death rates reaching 38%. Although P. aeruginosa outbreaks in bum patients are rare, it is associated with 60% death rates. In the AIDS population, P. aerginosa is associated with 50% of deaths. Cystic fibrosis patients are characteristically susceptible to chronic infection by P. aeruginosa, which is responsible for high rates of illness and death. Current antibiotics work poorly for CF infections (Van Delden & Igelwski. 1998. Emerging Infectious Diseases 4:551-560; references therein).

[0012] The gram-negative enteric bacterial genus, Salmonella, encompasses at least 2 species. One of these, S. enterica, is divided into multiple subspecies and thousands of serotypes or serovars (Brenner, et al. 2000 J. Clin. Microbiol. 38:2465-2467). The S. enterica human pathogens include serovars Typhi, Paratyphi, Typhimurium, Cholerasuis, and many others deemed so closely related that they are variants of a widespread species. Worldwide, disease in humans caused by Salmonella is a very serious problem. In many developing countries, S. enterica ser. Typhi still causes often-fatal typhoid fever. This problem has been reduced or eliminated in wealthy industrial states. However, enteritis induced by Salmonella is widespread and is the second most common disease caused by contaminated food in the United States (Edwards, B H 1999 “Salmonella and Shigella species” Clin. Lab Med. 19(3):469-487). Though usually self-limiting in healthy individuals, others such as children, seniors, and those with compromising illnesses can be at much greater risk of serious illness and death.

[0013] Some S. enterica serovars (e.g. Typhimurium) cause a localized infection in the gastrointestinal tract. Other serovars (i.e. Typhi and Paratyphi) cause a much more serious systemic infection. In animal models, these roles can be reversed which has allowed the use of the relatively safe S. enterica ser. Typhimurium as a surrogate in mice for the typhoid fever agent, S. enterica ser. Typhi. In mice, S. enterica ser Typhimurium causes a systemic infection similar in outcome to typhoid fever. Years of study of the Salmonella have led to the identification of many determinants of virulence in animals and humans. Salmonella is interesting in its ability to localize to and invade the intestinal epithelium, induce morphologic changes in target cells via injection of certain cell-remodeling proteins, and to reside intracellularly in membrane-bound vesicles (Wallis, T S and Galyov, EE 2000 “Molecular basis of Salmonella-induced enteritis.” Molec. Microb. 36:997-1005; Falkow, S “The evolution of pathogenicity in Escherichia, Shigella, and Salmonella,” Chap. 149 in Neidhardt, et al. eds pp 2723-2729; Gulig, P A “Pathogenesis of Systemic Disease,” Chap. 152 in Neidhardt, et al. ppp 2774-2787). The immediate infection often results in a severe watery diarrhea but Salmonella also can establish and maintain a subclinical carrier state in some individuals. Spread is via food contaminated with sewage.

[0014] The gene products implicated in Salmonella pathogenesis include type three secretion systems (TTSS), proteins affecting cytoplasmic structure of the target cells, many proteins carrying out functions necessary for survival and proliferation of Salmonella in the host, as well as “traditional” factors such as endotoxin and secreted exotoxins. Additionally, there must be factors mediating species-specific illnesses. Despite this most of the genomes of S. enterica ser. Typhi (see http://www.sanger.ac.uk/Proiects/S_typhi/ for the genome database) and S. enterica ser. Typhimurium (see http://genome.wustl.edu/gsc/bacterial/salmonella.shtml for the genome database) are highly conserved and are mutually useful for gene identification in multiple serovars. The Salmonella are a complex group of enteric bacteria causing disease similar to but distinct from other gram-negative enterics such as E. coli and have been a focus of biomedical research for the last century.

[0015] Enterococcus faecalis , a Gram-positive bacterium, is by far the most common member of the enterococci to cause infections in humans. Enterococcus faecium generally accounts for less than 20% of clinical isolates. Enterococci infections are mostly hospital-acquired though they are also associated with some community-acquired infections. Of nosocomial infections enterococci account for 12% of bacteremia, 15% of surgical wound infections, 14% of urinary tract infections, and 5 to 15% of endocarditis cases (Huycke, M. M., D. F., Sahm and M. S. Gilmore. 1998. Emerging Infectious Diseases 4:239-249). Additionally enterococci are frequently associated with intraabdominal and pelvic infections. Enterococci infections are often hard to treat because they are resistant to a vast array of antimicrobial drugs, including aminoglycosides, penicillin, ampicillin and vancomycin. The development of multiple-drug resistant (MDR) enterococci has made this bacteria a major concern for treating nosocomial infections.

[0016] These reasons underscore the urgency of developing new antibiotics that are effective against Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterococcus faecalis. Accordingly, there is an urgent need for more novel methods to identify and characterize bacterial genomic sequences that encode gene products involved in proliferation, and are thereby potential new targets for antibiotic development. Prior to the present invention, the discovery of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, and Pseudomonas aerginosa and Enterococcus faecalis genes required for proliferation of the microorganism was a painstaking and slow process. While the detection of new cellular drug targets within a Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis cell is key for novel antibiotic development, the current methods of drug target discovery available prior to this invention have required painstaking processes requiring years of effort.

SUMMARY OF THE INVENTION

[0017] Some aspects of the present invention are described in the numbered paragraphs below.

[0018] 1. A purified or isolated nucleic acid sequence comprising a nucleotide sequence consisting essentially of one of SEQ ID NOs: 8-3795, wherein expression of said nucleic acid inhibits proliferation of a cell.

[0019] 2. The nucleic acid sequence of Paragraph 1, wherein said nucleotide sequence is complementary to at least a portion of a coding sequence of a gene whose expression is required for proliferation of a cell.

[0020] 3. The nucleic acid of Paragraph 1, wherein said nucleic acid sequence is complementary to at least a portion of a nucleotide sequence of an RNA required for proliferation of a cell.

[0021] 4. The nucleic acid of Paragraph 3, wherein said RNA is an RNA comprising a sequence of nucleotides encoding more than one gene product.

[0022] 5. A purified or isolated nucleic acid comprising a fragment of one of SEQ ID NOs.: 8-3795, said fragment selected from the group consisting of fragments comprising at least 10, at least 20, at least 25, at least 30, at least 50 and more than 50 consecutive nucleotides of one of SEQ ID NOs: 8-3795.

[0023] 6. The fragment of Paragraph 5, wherein said fragment is included in a nucleic acid obtained from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0024] 7. The fragment of Paragraph 5, wherein said fragment is included in a nucleic acid obtained from an organism other than Escherichia coli.

[0025] 8. A vector comprising a promoter operably linked to the nucleic acid of any one of Paragraphs 1-7.

[0026] 9. The vector of Paragraph 8, wherein said promoter is active in a microorganism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0027] 10. A host cell containing the vector of Paragraph 8 or Paragraph 9.

[0028] 11. A purified or isolated antisense nucleic acid comprising a nucleotide sequence complementary to at least a portion of an intragenic sequence, intergenic sequence, sequences spanning at least a portion of two or more genes, 5′ noncoding region, or 3′ noncoding region within an operon comprising a proliferation-required gene whose activity or expression is inhibited by an antisense nucleic acid comprising the nucleotide sequence of one of SEQ ID NOs.: 8-3795.

[0029] 12. The purified or isolated antisense nucleic acid of Paragraph 11, wherein said antisense nucleic acid is complementary to a nucleic acid from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0030] 13. The purified or isolated antisense nucleic acid of Paragraph 11, wherein said nucleotide sequence is complementary to a nucleotide sequence of a nucleic acid from an organism other than E. coli.

[0031] 14. The purified or isolated antisense nucleic acid of Paragraph 11, wherein said proliferation-required gene comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0032] 15. A purified or isolated nucleic acid comprising a nucleotide sequence having at least 70% identity to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 8-3795, the nucleotide sequences complementary to SEQ ID NOs.: 8-3795 and the sequences complementary to fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 8-3795 as determined using BLASTN version 2.0 with the default parameters.

[0033] 16. The purified or isolated nucleic acid of Paragraph 15, wherein said nucleic acid is obtained from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0034] 17. The nucleic acid of Paragraph 15, wherein said nucleic acid is obtained from an organism other than E. coli.

[0035] 18. A vector comprising a promoter operably linked to a nucleic acid encoding a polypeptide whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of any one of SEQ ID NOs.: 8-3795.

[0036] 19. The vector of Paragraph 18, wherein said nucleic acid encoding said polypeptide is obtained from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0037] 20. The vector of Paragraph 18, wherein said nucleotide sequence encoding said polypeptide is obtained from an organism other than E. coli.

[0038] 21. A host cell containing the vector of Paragraph 18.

[0039] 22. The vector of Paragraph 18, wherein said polypeptide comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0040] 23. The vector of Paragraph 18, wherein said promoter is operably linked to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0041] 24. A purified or isolated polypeptide comprising a polypeptide whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of any one of SEQ ID NOs.: 8-3795, or a fragment selected from the group consisting of fragments comprising at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 60 or more than 60 consecutive amino acids of one of the said polypeptides.

[0042] 25. The polypeptide of Paragraph 24, wherein said polypeptide comprises an amino acid sequence of any one of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 or a fragment comprising at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 60 or more than 60 consecutive amino acids of a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0043] 26. The polypeptide of Paragraph 24, wherein said polypeptide is obtained from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0044] 27. The polypeptide of Paragraph 24, wherein said polypeptide is obtained from an organism other than E. coli.

[0045] 28. A purified or isolated polypeptide comprising a polypeptide having at least 25% amino acid identity to a polypeptide whose expression is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, or at least 25% amino acid identity to a fragment comprising at least 10, at least 20, at least 30, at least 40, at least 50, at least 60 or more than 60 consecutive amino acids of a polypeptide whose expression is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 as determined using FASTA version 3.0t78 with the default parameters.

[0046] 29. The polypeptide of Paragraph 28, wherein said polypeptide has at least 25% identity to a polypeptide comprising one of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110 or at least 25% identity to a fragment comprising at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 60 or more than 60 consecutive amino acids of a polypeptide comprising one of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 as determined using FASTA version 3.0t78 with the default parameters.

[0047] 30. The polypeptide of Paragraph 28, wherein said polypeptide is obtained from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0048] 31. The polypeptide of Paragraph 28, wherein said polypeptide is obtained from an organism other than E. coli.

[0049] 32. An antibody capable of specifically binding the polypeptide of one of Paragraphs 28-31.

[0050] 33. A method of producing a polypeptide, comprising introducing a vector comprising a promoter operably linked to a nucleic acid comprising a nucleotide sequence encoding a polypeptide whose expression is inhibited by an antisense nucleic acid comprising one of SEQ ID NOs.: 8-3795 into a cell.

[0051] 34. The method of Paragraph 33, further comprising the step of isolating said polypeptide.

[0052] 35. The method of Paragraph 33, wherein said polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0053] 36. The method of Paragraph 33, wherein said nucleic acid encoding said polypeptide is obtained from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0054] 37. The method of Paragraph 33, wherein said nucleic acid encoding said polypeptide is obtained from an organism other than E. coli.

[0055] 38. The method of Paragraph 33, wherein said promoter is operably linked to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0056] 39. A method of inhibiting proliferation of a cell in an individual comprising inhibiting the activity or reducing the amount of a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or inhibiting the activity or reducing the amount of a nucleic acid encoding said gene product.

[0057] 40. The method of Paragraph 39, wherein said method comprises inhibiting said activity or reducing said amount of a gene product in an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnet, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0058] 41. The method of Paragraph 39, wherein said method comprises inhibiting said activity or reducing said amount of a gene product in an organism other than E. coli.

[0059] 42. The method of Paragraph 39, wherein said gene product is present in an organism other than E. coli.

[0060] 43. The method of Paragraph 39, wherein said gene product comprises a polypeptide comprising a sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0061] 44. A method for identifying a compound which influences the activity of a gene product required for proliferation, said gene product comprising a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising:

[0062] contacting said gene product with a candidate compound; and

[0063] determining whether said compound influences the activity of said gene product.

[0064] 45. The method of Paragraph 44, wherein said gene product is from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0065] 46. The method of Paragraph 44, wherein said gene product is from an organism other than E coli.

[0066] 47. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is an enzymatic activity.

[0067] 48. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is a carbon compound catabolism activity.

[0068] 49. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is a biosynthetic activity.

[0069] 50. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is a transporter activity.

[0070] 51. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is a transcriptional activity.

[0071] 52. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is a DNA replication activity.

[0072] 53. The method of Paragraph 44, wherein said gene product is a polypeptide and said activity is a cell division activity.

[0073] 54. The method of Paragraph 44, wherein said gene product is an RNA.

[0074] 55. The method of Paragraph 44, wherein said gene product is a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0075] 56. A compound identified using the method of Paragraph 44.

[0076] 57. A method for identifying a compound or nucleic acid having the ability to reduce the activity or level of a gene product required for proliferation, said gene product comprising a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising:

[0077] (a) contacting a target gene or RNA encoding said gene product with a candidate compound or nucleic acid; and

[0078] (b) measuring an activity of said target.

[0079] 58. The method of Paragraph 57, wherein said target gene or RNA is from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0080] 59. The method of Paragraph 57, wherein said target gene or RNA is from an organism other than E. coli.

[0081] 60. The method of Paragraph 57, wherein said gene product is from an organism other than E. coli.

[0082] 61. The method of Paragraph 57, wherein said target is a messenger RNA molecule and said activity is translation of said messenger RNA.

[0083] 62. The method of Paragraph 57, wherein said target is a messenger RNA molecule and said activity is transcription of a gene encoding said messenger RNA.

[0084] 63. The method of Paragraph 57, wherein said target is a gene and said activity is transcription of said gene.

[0085] 64. The method of Paragraph 57, wherein said target is a nontranslated RNA and said activity is processing or folding of said nontranslated RNA or assembly of said nontranslated RNA into a protein/RNA complex.

[0086] 65. The method of Paragraph 57, wherein said target is a messenger RNA molecule encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0087] 66. The method of Paragraph 57, wherein said target comprises a nucleic acid selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0088] 67. A compound or nucleic acid identified using the method of Paragraph 57.

[0089] 68. A method for identifying a compound which reduces the activity or level of a gene product required for proliferation of a cell, wherein the activity or expression of said gene product is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising the steps of:

[0090] (a) providing a sublethal level of an antisense nucleic acid comprising a nucleotide sequence complementary to a nucleic acid comprising a nucleotide sequence encoding said gene product in a cell to reduce the activity or amount of said gene product in said cell, thereby producing a sensitized cell;

[0091] (b) contacting said sensitized cell with a compound; and

[0092] (c) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

[0093] 69. The method of Paragraph 68, wherein said determining step comprises determining whether said compound inhibits the growth of said sensitized cell to a greater extent than said compound inhibits the growth of a nonsensitized cell.

[0094] 70. The method of Paragraph 68, wherein said cell is a Gram positive bacterium.

[0095] 71. The method of Paragraph 68, wherein said Gram positive bacterium is selected from the group consisting of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0096] 72. The method of Paragraph 68, wherein said bacterium is Staphylococcus aureus.

[0097] 73. The method of Paragraph 72, wherein said Staphylococcus species is coagulase negative.

[0098] 74. The method of Paragraph 72, wherein said bacterium is selected from the group consisting of Staphylococcus aureus RN450 and Staphylococcus aureus RN4220.

[0099] 75. The method of Paragraph 68, wherein said cell is an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0100] 76. The method of Paragraph 68, wherein said cell is not an E. coli cell.

[0101] 77. The method of Paragraph 68, wherein said gene product is from an organism other than E. coli.

[0102] 78. The method of Paragraph 68, wherein said antisense nucleic acid is transcribed from an inducible promoter.

[0103] 79. The method of Paragraph 68, further comprising the step of contacting said cell with a concentration of inducer which induces transcription of said antisense nucleic acid to a sublethal level.

[0104] 80. The method of Paragraph 68, wherein growth inhibition is measured by monitoring optical density of a culture growth solution.

[0105] 81. The method of Paragraph 68, wherein said gene product is a polypeptide.

[0106] 82. The method of Paragraph 81, wherein said polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0107] 83. The method of Paragraph 68, wherein said gene product is an RNA.

[0108] 84. The method of Paragraph 68, wherein nucleic acid encoding said gene product comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0109] 85. A compound identified using the method of Paragraph 68.

[0110] 86. A method for inhibiting cellular proliferation comprising introducing an effective amount of a compound with activity against a gene whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a compound with activity against the product of said gene into a population of cells expressing said gene.

[0111] 87. The method of Paragraph 86, wherein said compound is an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, or a proliferation-inhibiting portion thereof.

[0112] 88. The method of Paragraph 86, wherein said proliferation inhibiting portion of one of SEQ ID NOs.: 8-3795 is a fragment comprising at least 10, at least 20, at least 25, at least 30, at least 50 or more than 51 consecutive nucleotides of one of SEQ ID NOs.: 8-3795.

[0113] 89. The method of Paragraph 86, wherein said population is a population of Gram positive bacteria.

[0114] 90. The method of Paragraph 89, wherein said population of Gram positive bacteria is selected from the group consisting of a population of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0115] 91. The method of Paragraph 86, wherein said population is a population of Staphylococcus aureus.

[0116] 92. The method of Paragraph 91, wherein said population is a population of a bacterium selected from the group consisting of Staphylococcus aureus RN450 and Staphylococcus aureus RN4220.

[0117] 93. The method of Paragraph 86, wherein said population is a population of a bacterium selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0118] 94. The method of Paragraph 86, wherein said population is a population of an organism other than E. coli.

[0119] 95. The method of Paragraph 86, wherein said product of said gene is from an organism other than E. coli.

[0120] 96. The method of Paragraph 86, wherein said gene encodes a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805,4861-5915, 10013-14110.

[0121] 97. The method of Paragraph 86, wherein said gene comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0122] 98. A composition comprising an effective concentration of an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, or a proliferation-inhibiting portion thereof in a pharmaceutically acceptable carrier.

[0123] 99. The composition of Paragraph 98, wherein said proliferation-inhibiting portion of one of SEQ ID NOs.: 8-3795 comprises at least 20, at least 25, at least 30, at least 50 or more than 50 consecutive nucleotides of one of SEQ ID NOs.: 8-3795.

[0124] 100. A method for inhibiting the activity or expression of a gene in an operon required for proliferation wherein the activity or expression of at least one gene in said operon is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising contacting a cell in a cell population with an antisense nucleic acid complementary to at least a portion of said operon.

[0125] 101. The method of Paragraph 100, wherein said antisense nucleic acid comprises a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a proliferation-inhibiting portion thereof.

[0126] 102. The method of Paragraph 100, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0127] 103. The method of Paragraph 100, wherein said cell is not an E. coli cell.

[0128] 104. The method of Paragraph 100, wherein said gene is from an organism other than E. coli.

[0129] 105. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by introducing a plasmid which expresses said antisense nucleic acid into said cell population.

[0130] 106. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by introducing a phage which encodes said antisense nucleic acid into said cell population.

[0131] 107. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by expressing said antisense nucleic acid from the chromosome of cells in said cell population.

[0132] 108. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by introducing a promoter adjacent to a chromosomal copy of said antisense nucleic acid such that said promoter directs the transcription of said antisense nucleic acid.

[0133] 109. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by introducing a retron which expresses said antisense nucleic acid into said cell population.

[0134] 110. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by introducing a ribozyme into said cell-population, wherein a binding portion of said ribozyme comprises said antisense nucleic acid.

[0135] 111. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by introducing a liposome comprising said antisense nucleic acid into said cell.

[0136] 112. The method of Paragraph 100, wherein said cell is contacted with said antisense nucleic acid by electroporation of said antisense nucleic acid into said cell.

[0137] 113. The method of Paragraph 100, wherein said antisense nucleic acid is a fragment comprising at least 10, at least 20, at least 25, at least 30, at least 50 or more than 50 consecutive nucleotides of one of SEQ ID NOs.: 8-3795.

[0138] 114. The method of Paragraph 100 wherein said antisense nucleic acid is a synthetic oligonucleotide.

[0139] 115. The method of Paragraph 100, wherein said gene comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0140] 116. A method for identifying a gene which is required for proliferation of a cell comprising:

[0141] (a) contacting a cell with an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, wherein said cell is a cell other than the organism from which said nucleic acid was obtained;

[0142] (b) determining whether said nucleic acid inhibits proliferation of said cell; and

[0143] (c) identifying the gene in said cell which encodes the mRNA which is complementary to said antisense nucleic acid or a portion thereof.

[0144] 117. The method of Paragraph 116, wherein said cell is selected from the group consisting of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0145] 118. The method of Paragraph 116 wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0146] 119. The method of Paragraph 116, wherein said cell is not E. coli.

[0147] 120. The method of Paragraph 116, further comprising operably linking said antisense nucleic acid to a promoter which is functional in said cell, said promoter being included in a vector, and introducing said vector into said cell.

[0148] 121. A method for identifying a compound having the ability to inhibit proliferation of a cell comprising:

[0149] (a) identifying a homolog of a gene or gene product whose activity or level is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 in a test cell, wherein said test cell is not the cell from which said nucleic acid was obtained;

[0150] (b) identifying an inhibitory nucleic acid sequence which inhibits the activity of said homolog in said test cell;

[0151] (c) contacting said test cell with a sublethal level of said inhibitory nucleic acid, thus sensitizing said cell;

[0152] (d) contacting the sensitized cell of step (c) with a compound; and

[0153] (e) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not contain said inhibitory nucleic acid.

[0154] 122. The method of Paragraph 121, wherein said determining step comprises determining whether said compound inhibits proliferation of said sensitized test cell to a greater extent than said compound inhibits proliferation of a nonsensitized test cell.

[0155] 123. The method of Paragraph 121, wherein step (a) comprises identifying a nucleic acid homologous to a gene or gene product whose activity or level is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs. 8-3795 or a nucleic acid encoding a homologous polypeptide to a polypeptide whose activity or level is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs. 8-3795 by using an algorithm selected from the group consisting of BLASTN version 2.0 with the default parameters and FASTA version 3.0t78 algorithm with the default parameters to identify said homologous nucleic acid or said nucleic acid encoding a homologous polypeptide in a database.

[0156] 124. The method of Paragraph 121 wherein said step (a) comprises identifying a homologous nucleic acid or a nucleic acid comprising a sequence of nucleotides encoding a homologous polypeptide by identifying nucleic acids which hybridize to said nucleic acid selected from the group consisting of SEQ ID NOs. 8-3795 or the complement of said nucleic acid selected from the group consisting of SEQ ID NOs. 8-3795.

[0157] 125. The method of Paragraph 121 wherein step (a) comprises expressing a nucleic acid selected from the group consisting of SEQ ID NOs. 8-3795 in said test cell.

[0158] 126. The method of Paragraph 121, wherein step (a) comprises identifying a homologous nucleic acid or a nucleic acid encoding a homologous polypeptide in a test cell selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0159] 127. The method of Paragraph 121, wherein step (a) comprises identifying a homologous nucleic acid or a nucleic acid encoding a homologous polypeptide in a test cell other than E coli.

[0160] 128. The method of Paragraph 121, wherein said inhibitory nucleic acid is an antisense nucleic acid.

[0161] 129. The method of Paragraph 121, wherein said inhibitory nucleic acid comprises an antisense nucleic acid to a portion of said homolog.

[0162] 130. The method of Paragraph 121, wherein said inhibitory nucleic acid comprises an antisense nucleic acid to a portion of the operon encoding said homolog.

[0163] 131. The method of Paragraph 121, wherein the step of contacting the cell with a sublethal level of said inhibitory nucleic acid comprises directly contacting the surface of said cell with said inhibitory nucleic acid.

[0164] 132. The method of Paragraph 121, wherein the step of contacting the cell with a sublethal level of said inhibitory nucleic acid comprises transcribing an antisense nucleic acid complementary to at least a portion of the RNA transcribed from said homolog in said cell.

[0165] 133. The method of Paragraph 121, wherein said gene product comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0166] 134. The method of Paragraph 121, wherein said gene comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0167] 135. A compound identified using the method of Paragraph 121.

[0168] 136. A method of identifying a compound having the ability to inhibit proliferation comprising:

[0169] (a) contacting a test cell with a sublethal level of a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 or a portion thereof which inhibits the proliferation of the cell from which said nucleic acid was obtained, thus sensitizing said test cell;

[0170] (b) contacting the sensitized test cell of step (a) with a compound; and

[0171] (c) determining the degree to which said compound inhibits proliferation of said sensitized test cell relative to a cell which does not contain said nucleic acid.

[0172] 137. The method of Paragraph 136, wherein said determining step comprises determining whether said compound inhibits proliferation of said sensitized test cell to a greater extent than said compound inhibits proliferation of a nonsensitized test cell.

[0173] 138. A compound identified using the method of Paragraph 136.

[0174] 139. The method of Paragraph 136, wherein said test cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0175] 140. The method of Paragraph 136, wherein the test cell is not E. coli.

[0176] 141. A method for identifying a compound having activity against a biological pathway required for proliferation comprising:

[0177] (a) sensitizing a cell by providing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding a gene product required for proliferation, wherein the activity or expression of said gene product is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, in said cell to reduce the activity or amount of said gene product;

[0178] (b) contacting the sensitized cell with a compound; and

[0179] (c) determining the degree to which said compound inhibits the growth of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

[0180] 142. The method of Paragraph 141, wherein said determining step comprises determining whether said compound inhibits the growth of said sensitized cell to a greater extent than said compound inhibits the growth of a nonsensitized cell.

[0181] 143. The method of Paragraph 141, wherein said cell is selected from the group consisting of bacterial cells, fungal cells, plant cells, and animal cells.

[0182] 144. The method of Paragraph 141, wherein said cell is a Gram positive bacterium.

[0183] 145. The method of Paragraph 144, wherein said Gram positive bacterium is selected from the group consisting of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0184] 146. The method of Paragraph 145, wherein said Gram positive bacterium is Staphylococcus aureus.

[0185] 147. The method of Paragraph 146, wherein said Gram positive bacterium is selected from the group consisting of Staphylococcus aureus RN450 and Staphylococcus aureus RN4220.

[0186] 148. The method of Paragraph 141, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnet, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0187] 149. The method of Paragraph 141, wherein said cell is not an E. coli cell.

[0188] 150. The method of Paragraph 141, wherein said gene product is from an organism other than E. coli.

[0189] 151. The method of Paragraph 141, wherein said antisense nucleic acid is transcribed from an inducible promoter.

[0190] 152. The method of Paragraph 141, further comprising contacting the cell with an agent which induces transcription of said antisense nucleic acid from said inducible promoter, wherein said antisense nucleic acid is transcribed at a sublethal level.

[0191] 153. The method of Paragraph 141, wherein inhibition of proliferation is measured by monitoring the optical density of a liquid culture.

[0192] 154. The method of Paragraph 141, wherein said gene product comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0193] 155. The method of Paragraph 141, wherein said nucleic acid encoding said gene product comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0194] 156. A compound identified using the method of Paragraph 141.

[0195] 157. A method for identifying a compound having the ability to inhibit cellular proliferation comprising:

[0196] (a) contacting a cell with an agent which reduces the activity or level of a gene product required for proliferation of said cell, wherein said gene product is a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795;

[0197] (b) contacting said cell with a compound; and

[0198] (c) determining whether said compound reduces proliferation of said contacted cell by acting on said gene product.

[0199] 158. The method of Paragraph 157, wherein said determining step comprises determining whether said compound reduces proliferation of said contacted cell to a greater extent than said compound reduces proliferation of cells which have not been contacted with said agent.

[0200] 159. The method of Paragraph 157, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0201] 160. The method of Paragraph 157, wherein said cell is not an E. coli cell.

[0202] 161. The method of Paragraph 157, wherein said gene product is from an organism other than E. coli.

[0203] 162. The method of Paragraph 157, wherein said agent which reduces the activity or level of a gene product required for proliferation of said cell comprises an antisense nucleic acid to a gene or operon required for proliferation.

[0204] 163. The method of Paragraph 157, wherein said agent which reduces the activity or level of a gene product required for proliferation of said cell comprises a compound known to inhibit growth or proliferation of a cell.

[0205] 164. The method of Paragraph 157, wherein said cell contains a mutation which reduces the activity or level of said gene product required for proliferation of said cell.

[0206] 165. The method of Paragraph 157, wherein said mutation is a temperature sensitive mutation.

[0207] 166. The method of Paragraph 157, wherein said gene product comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0208] 167. A compound identified using the method of Paragraph 157.

[0209] 168. A method for identifying the biological pathway in which a proliferation-required gene or its gene product lies, wherein said gene or gene product comprises a gene or gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising:

[0210] (a) providing a sublethal level of an antisense nucleic acid which inhibits the activity of said proliferation-required gene or gene product in a test cell;

[0211] (b) contacting said test cell with a compound known to inhibit growth or proliferation of a cell, wherein the biological pathway on which said compound acts is known; and

[0212] (c) determining the degree to which said proliferation of said test cell is inhibited relative to a cell which was not contacted with said compound.

[0213] 169. The method of Paragraph 168, wherein said determining step comprises determining whether said test cell has a substantially greater sensitivity to said compound than a cell which does not express said sublethal level of said antisense nucleic acid.

[0214] 170. The method of Paragraph 168, wherein said gene product comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0215] 171. The method of Paragraph 168, wherein said test cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0216] 172. The method of Paragraph 168, wherein said test cell is not an E. coli cell.

[0217] 173. The method of Paragraph 168, wherein said gene product is from an organism other than E. coli.

[0218] 174. A method for determining the biological pathway on which a test compound acts comprising:

[0219] (a) providing a sublethal level of an antisense nucleic acid complementary to a proliferation-required nucleic acid in a first cell, wherein the activity or expression of said proliferation-required nucleic acid is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795 and wherein the biological pathway in which said proliferation-required nucleic acid or a protein encoded by said proliferation-required nucleic acid lies is known,

[0220] (b) contacting said first cell with said test compound; and

[0221] (c) determining the degree to which said test compound inhibits proliferation of said first cell relative to a cell which does not contain said antisense nucleic acid.

[0222] 175. The method of Paragraph 174, wherein said determining step comprises determining whether said first cell has a substantially greater sensitivity to said test compound than a cell which does not express said sublethal level of said antisense nucleic acid.

[0223] 176. The method of Paragraph 174, further comprising:

[0224] (d) providing a sublethal level of a second antisense nucleic acid complementary to a second proliferation-required nucleic acid in a second cell, wherein said second proliferation-required nucleic acid is in a different biological pathway than said proliferation-required nucleic acid in step (a); and

[0225] (e) determining whether said second cell does not have a substantially greater sensitivity to said test compound than a cell which does not express said sublethal level of said second antisense nucleic acid, wherein said test compound is specific for the biological pathway against which the antisense nucleic acid of step (a) acts if said first cell has a substantially greater sensitivity to said test compound than said second cell.

[0226] 177. The method of Paragraph 174, wherein said first cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0227] 178. The method of Paragraph 174, wherein said first cell is not an E. coli cell.

[0228] 179. The method of Paragraph 174, wherein said proliferation-required nucleic acid is from an organism other than E. coli.

[0229] 180. A purified or isolated nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795.

[0230] 181. A compound which interacts with a gene eorgene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of one of SEQ ID NOs.: 8-3795 to inhibit proliferation.

[0231] 182. The compound of Paragraph 181, wherein said gene product is a polypeptide comprising one of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0232] 183. The compound of Paragraph 181, wherein said gene comprises a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0233] 184. A compound which interacts with a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of one of SEQ ID NOs.: 8-3795 to inhibit proliferation.

[0234] 185. A method for manufacturing an antibiotic comprising the steps of:

[0235] screening one or more candidate compounds to identify a compound that reduces the activity or level of a gene product required for proliferation, said gene product comprising a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795; and

[0236] manufacturing the compound so identified.

[0237] 186. The method of Paragraph 185, wherein said screening step comprises performing any one of the methods of Paragraphs 44, 68, 121, 136, 141, and 157.

[0238] 187. The method of Paragraph 185, wherein said gene product is a polypeptide comprising one of SEQ ID NOs:3801-3805, 4861-5915, 10013-14110.

[0239] 188. A method for inhibiting proliferation of a cell in a subject comprising administering an effective amount of a compound that reduces the activity or level of a gene product required for proliferation of said cell, said gene product comprising a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 to said subject.

[0240] 189. The method of Paragraph 188 wherein said subject is selected from the group consisting of vertebrates, mammals, avians, and human beings.

[0241] 190. The method of Paragraph 188, wherein said gene product comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0242] 191. The method of Paragraph 188, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0243] 192. The method of Paragraph 188, wherein said cell is not E. coli.

[0244] 193. The method of Paragraph 188, wherein said gene product is from an organism other than E. coli.

[0245] 194. A purified or isolated nucleic acid consisting essentially of the coding sequence of one of SEQ ID NOs: 3796-3800, 3806-4860, 5916-10012.

[0246] 195. A fragment of the nucleic acid of Paragraph 8, said fragment comprising at least 10, at least 20, at least 25, at least 30, at least 50 or more than 50 consecutive nucleotides of one of SEQ ID NOs: 3796-3800, 3806-4860, 5916-10012.

[0247] 196. A purified or isolated nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, the nucleotide sequences complementary to SEQ ID NOs.:3796-3800, 3806-4860, 5916-10012, and the nucleotide sequences complementary to fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 as determined using BLASTN version 2.0 with the default parameters.

[0248] 197. The nucleic acid of Paragraph 196, wherein said nucleic acid is from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0249] 198. The nucleic acid of Paragraph 196, wherein said nucleic acid is from an organism other than E. coli.

[0250] 199. A method of inhibiting proliferation of a cell comprising inhibiting the activity or reducing the amount of a gene product in said cell or inhibiting the activity or reducing the amount of a nucleic acid encoding said gene product in said cell, wherein said gene product is selected from the group consisting of a gene product having having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid which hybridizes to a nucleic acid comprising a nucleotide sequence selected from the croup consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid which hybridizes to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 8-3795.

[0251] 200. The method of Paragraph 199, wherein said method comprises inhibiting said activity or reducing said amount of said gene product or inhibiting the activity or reducing the amount of a nucleic acid encoding said gene product in an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0252] 201. The method of Paragraph 199, wherein said method comprises inhibiting said activity or reducing said amount of said gene product or inhibiting the activity or reducing the amount of a nucleic acid encoding said gene product in an organism other than E. coli.

[0253] 202. The method of Paragraph 199, wherein said gene product is from an organism other than E. coli.

[0254] 203. The method of Paragraph 199, wherein said gene product comprises a polypeptide selected from the group consisting of a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 to a polypeptide selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 and a polypeptide whose activity may be complemented by a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0255] 204. The method of Paragraph 199, wherein said gene product is encoded by a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid comprising a nucleotide sequence which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid comprising a nucloetide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0256] 205. A method for identifying a compound which influences the activity of a gene product required for proliferation comprising:

[0257] contacting a candidate compound with a gene product selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent ,conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; and

[0258] determining whether said candidate compound influences the activity of said gene product.

[0259] 206. The method of Paragraph 205, wherein said gene product is from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0260] 207. The method of Paragraph 205, wherein said gene product is from an organism other than E. coli.

[0261] 208. The method of Paragraph 205, wherein said gene product is a polypeptide selected from the group consisting of a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 to a polypeptide selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 and a polypeptide whose activity may be complemented by a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0262] 209. The method of Paragraph 205, wherein said gene product is encoded by a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0263] 210. A compound identified using the method of Paragraph 205.

[0264] 211. A method for identifying a compound or nucleic acid having the ability to reduce the activity or level of a gene product required for proliferation comprising:

[0265] (a) providing a target that is a gene or RNA, wherein said target comprises a nucleic acid that encodes a gene product selected from the group consisting of a gene product having having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleic acid identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795;

[0266] (b) contacting said target with a candidate compound or nucleic acid; and

[0267] (c) measuring an activity of said target.

[0268] 212. The method of Paragraph 211, wherein said target gene or RNA is from an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0269] 213. The method of Paragraph 211, wherein said target gene or RNA is from an organism other than E. coli.

[0270] 214. The method of Paragraph 211, wherein said gene product is from an organism other than E. coli.

[0271] 215. The method of Paragraph 211, wherein said target is a messenger RNA molecule and said activity is translation of said messenger RNA.

[0272] 216. The method of Paragraph 211, wherein said compound is a nucleic acid and said activity is translation of said gene product.

[0273] 217. The method of Paragraph 211, wherein said target is a gene and said activity is transcription of said gene.

[0274] 218. The method of Paragraph 211, wherein said target is a nontranslated RNA and said activity is processing or folding of said nontranslated RNA or assembly of said nontranslated RNA into a protein/RNA complex.

[0275] 219. The method of Paragraph 211, wherein said target gene is a messenger RNA molecule encoding a polypeptide selected from the group consisting of a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 to a polypeptide selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 and a polypeptide whose activity may be complemented by a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0276] 220. The method of Paragraph 11, wherein said target gene comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0277] 221. A compound or nucleic acid identified using the method of Paragraph 211.

[0278] 222. A method for identifying a compound which reduces the activity or level of a gene product required for proliferation of a cell comprising:

[0279] (a) providing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding said gene product in a cell to reduce the activity or amount of said gene product in said cell, thereby producing a sensitized cell, wherein said gene product is selected from the group consisting of a gene product having having at least 70% nucleic acid identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795;

[0280] (b) contacting said sensitized cell with a compound; and

[0281] (c) determining the degree to which said compound inhibits the growth of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

[0282] 223. The method of Paragraph 222, wherein said determining step comprises determining whether said compound inhibits the growth of said sensitized cell to a greater extent than said compound inhibits the growth of a nonsensitized cell.

[0283] 224. The method of Paragraph 222, wherein said sensitized cell is a Gram positive bacterium.

[0284] 225. The method of Paragraph 224, wherein said Gram positive bacterium is selected from the group consisting of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0285] 226. The method of Paragraph 225, wherein said bacterium is Staphylococcus aureus.

[0286] 227. The method of Paragraph 224, wherein said Staphylococcus species is coagulase negative.

[0287] 228. The method of Paragraph 226, wherein said bacterium is selected from the group consisting of Staphylococcus aureus RN450 and Staphylococcus aureus RN4220.

[0288] 229. The method of Paragraph 222, wherein said sensitized cell is an organism selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0289] 230. The method of Paragraph 222, wherein said cell is an organism other than E. coli.

[0290] 231. The method of Paragraph 222, wherein said gene product is from an organism other than E. coli.

[0291] 232. The method of Paragraph 222, wherein said antisense nucleic acid is transcribed from an inducible promoter.

[0292] 233. The method of Paragraph 222, further comprising the step of contacting said cell with a concentration of inducer which induces transcription of said antisense nucleic acid to a sublethal level.

[0293] 234. The method of Paragraph 222, wherein growth inhibition is measured by monitoring optical density of a culture medium.

[0294] 235. The method of Paragraph 222, wherein said gene product is a polypeptide.

[0295] 236. The method of Paragraph 235, wherein said polypeptide comprises a polypeptide selected from the group consisting of a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 to a polypeptide selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 and a polypeptide whose activity may be complemented by a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0296] 237. The method of Paragraph 222, wherein said gene product is an RNA.

[0297] 238. The method of Paragraph 222, wherein said nucleic acid encoding said gene product comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleic acid identity as determined using BLASTN version 2.0 with the default parameters to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0298] 239. A compound identified using the method of Paragraph 222.

[0299] 240. A method for inhibiting cellular proliferation comprising introducing a compound with activity against a gene product or a compound with activity against a gene encoding said gene product into a population of cells expressing said gene product, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

[0300] 241. The method of Paragraph 240, wherein said compound is an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, or a proliferation-inhibiting portion thereof.

[0301] 242. The method of Paragraph 240, wherein said proliferation inhibiting portion of one of SEQ ID NOs.: 8-3795 is a fragment comprising at least 10, at least 20, at least 25, at least 30, at least 50 or more than 51 consecutive nucleotides of one of SEQ ID NOs.: 8-3795.

[0302] 243. The method of Paragraph 240, wherein said population is a population of Gram positive bacteria.

[0303] 244. The method of Paragraph 243, wherein said population of Gram positive bacteria is selected from the group consisting of a population of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0304] 245. The method of Paragraph 243, wherein said population is a population of Staphylococcus aureus.

[0305] 246. The method of Paragraph 245, wherein said population is a population of a bacterium selected from the group consisting of Staphylococcus aureus RN450 and Staphylococcus aureus RN4220.

[0306] 247. The method of Paragraph 240, wherein said population is a population of a bacterium selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnet, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0307] 248. The method of Paragraph 240, wherein said population is a population of an organism other than E. coli.

[0308] 249. The method of Paragraph 240, wherein said product of said gene is from an organism other than E. coli.

[0309] 250. The method of Paragraph 240, wherein said gene product is selected from the group consisting of a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 to a polypeptide selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 and a polypeptide whose activity may be complemented by a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0310] 251. The method of Paragraph 240, wherein said gene comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0311] 252. A preparation comprising an effective concentration of an antisense nucleic acid in a pharmaceutically acceptable carrier wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid comprising a sequence having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a proliferation-inhibiting portion thereof, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions.

[0312] 253. The preparation of Paragraph 252, wherein said proliferation-inhibiting portion of one of SEQ ID NOs.: 8-3795 comprises at least 10, at least 20, at least 25, at least 30, at least 50 or more than 50 consecutive nucleotides of one of SEQ ID NOs.: 8-3795.

[0313] 254. A method for inhibiting the activity or expression of a gene in an operon which encodes a gene product required for proliferation comprising contacting a cell in a cell population with an antisense nucleic acid comprising at least a proliferation-inhibiting portion of said operon in an antisense orientation, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

[0314] 255. The method of Paragraph 254, wherein said antisense nucleic acid comprises a nucleotide sequence having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide seqence selected from the group consisting of SEQ ID NOs.: 8-3795, a proliferation inhibiting portion thereof, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid which comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions.

[0315] 256. The method of Paragraph 254, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnet, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0316] 257. The method of Paragraph 254, wherein said cell is not an E. coli cell.

[0317] 258. The method of Paragraph 254, wherein said gene is from an organism other than E. coli.

[0318] 259. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by introducing a plasmid which transcribes said antisense nucleic acid into said cell population.

[0319] 260. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by introducing a phage which transcribes said antisense nucleic acid into said cell population.

[0320] 261. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by transcribing said antisense nucleic acid from the chromosome of cells in said cell population.

[0321] 262. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by introducing a promoter adjacent to a chromosomal copy of said antisense nucleic acid such that said promoter directs the synthesis of said antisense nucleic acid.

[0322] 263. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by introducing a retron which expresses said antisense nucleic acid into said cell population.

[0323] 264. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by introducing a ribozyme into said cell-population, wherein a binding portion of said ribozyme is complementary to said antisense oligonucleotide.

[0324] 265. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by introducing a liposome comprising said antisense oligonucleotide into said cell.

[0325] 266. The method of Paragraph 254, wherein said cell is contacted with said antisense nucleic acid by electroporation of said antisense nucleic acid into said cell.

[0326] 267. The method of Paragraph 254, wherein said antisense nucleic acid has at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence comprising at least 10, at least 20, at least 25, at least 30, at least 50 or more than 50 consecutive nucleotides of one of SEQ ID NOs.: 8-3795.

[0327] 268. The method of Paragraph 254 wherein said antisense nucleic acid is a synthetic oligonucleotide.

[0328] 269. The method of Paragraph 254, wherein said gene comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid -comprising a nucleotide sequence which hybridizes to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0329] 270. A method for identifying a gene which is required for proliferation of a cell comprising:

[0330] (a) contacting a cell with an antisense nucleic acid selected from the group consisting of a nucleic acid at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a proliferation-inhibiting portion thereof, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, wherein said cell is a cell other than the organism from which said nucleic acid was obtained;

[0331] (b) determining whether said nucleic acid inhibits proliferation of said cell; and

[0332] (c) identifying the gene in said cell which encodes the mRNA which is complementary to said antisense nucleic acid or a portion thereof.

[0333] 271. The method of Paragraph 270, wherein said cell is selected from the group consisting of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0334] 272. The method of Paragraph 270 wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0335] 273. The method of Paragraph 270, wherein said cell is not E. coli.

[0336] 274. The method of Paragraph 270, further comprising operably linking said antisense nucleic acid to a promoter which is functional in said cell, said promoter being included in a vector, and introducing said vector into said cell.

[0337] 275. A method for identifying a compound having the ability to inhibit proliferation of a cell comprising:

[0338] (a) identifying a homolog of a gene or gene product whose activity or level is inhibited by an antisense nucleic acid in a test cell, wherein said test cell is not the microorgaism from which the antisense nucleic acid was obtained, wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions;

[0339] (b) identifying an inhibitory nucleic acid sequence which inhibits the activity of said homolog in said test cell;

[0340] (c) contacting said test cell with a sublethal level of said inhibitory nucleic acid, thus sensitizing said cell;

[0341] (d) contacting the sensitized cell of step (c) with a compound; and

[0342] (e) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not express said inhibitory nucleic acid.

[0343] 276. The method of Paragraph 275, wherein said determining step comprises determining whether said compound inhibits proliferation of said sensitized test cell to a greater extent than said compound inhibits proliferation of a nonsensitized test cell.

[0344] 277. The method of Paragraph 275, wherein step (a) comprises identifying a homologous nucleic acid to a gene or gene product whose activity or level is inhibited by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 or a nucleic acid encoding a homologous polypeptide to a polypeptide whose activity or level is inhibited by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 by using an algorithm selected from the group consisting of BLASTN version 2.0 with the default parameters and FASTA version 3.0t78 algorithm with the default parameters to identify said homologous nucleic acid or said nucleic acid encoding a homologous polypeptide in a database.

[0345] 278. The method of Paragraph 275 wherein said step (a) comprises identifying a homologous nucleic acid or a nucleic acid encoding a homologous polypeptide by identifying nucleic acids comprising nucleotide sequences which hybridize to said nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 or the complement of the nucleotide sequence of said nucleic acid selected from the group consisting of SEQ ID NOs. 8-3795.

[0346] 279. The method of Paragraph 275 wherein step (a) comprises expressing a nucleic acid having at least 70% nucleic acid identity as determined using BLASTN version 2.0 with the default parameters to a sequence selected from the group consisting of SEQ ID NOs. 8-3795 in said test cell.

[0347] 280. The method of Paragraph 275, wherein step (a) comprises identifying a homologous nucleic acid or a nucleic acid encoding a homologous polypeptide in an test cell selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0348] 281. The method of Paragraph 275, wherein step (a) comprises identifying a homologous nucleic acid or a nucleic acid encoding a homologous polypeptide in a test cell other than E. coli.

[0349] 282. The method of Paragraph 275, wherein said inhibitory nucleic acid is an antisense nucleic acid.

[0350] 283. The method of Paragraph 275, wherein said inhibitory nucleic acid comprises an antisense nucleic acid to a portion of said homolog.

[0351] 284. The method of Paragraph 275, wherein said inhibitory nucleic acid comprises an antisense nucleic acid to a portion of the operon encoding said homolog.

[0352] 285. The method of Paragraph 275, wherein the step of contacting the cell with a sublethal level of said inhibitory nucleic acid comprises directly contacting said cell with said inhibitory nucleic acid.

[0353] 286. The method of Paragraph 275, wherein the step of contacting the cell with a sublethal level of said inhibitory nucleic acid comprises expressing an antisense nucleic acid to said homolog in said cell.

[0354] 287. The method of Paragraph 275, wherein said gene product comprises a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0355] 288. The method of Paragraph 275, wherein said gene comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0356] 289. A compound identified using the method of Paragraph 275.

[0357] 290. A method of identifying a compound having the ability to inhibit proliferation comprising:

[0358] (a) sensitizing a test cell by contacting said test cell with a sublethal level of an antisense nucleic acid, wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 or a portion thereof which inhibits the proliferation of the cell from which said nucleic acid was obtained, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditionst;

[0359] (b) contacting the sensitized test cell of step (a) with a compound; and

[0360] (c) determining the degree to which said compound inhibits proliferation of said sensitized test cell relative to a cell which does not contain said antisense nucleic acid.

[0361] 291. The method of Paragraph 290, wherein said determining step comprises determining whether said compound inhibits proliferation of said sensitized test cell to a greater extent than said compound inhibits proliferation of a nonsensitized test cell.

[0362] 292. A compound identified using the method of Paragraph 290.

[0363] 293. The method of Paragraph 290, wherein said test cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0364] 294. The method of Paragraph 290, wherein the test cell is not E. coli.

[0365] 295. A method for identifying a compound having activity against a biological pathway required for proliferation comprising:

[0366] (a) sensitizing a cell by providing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding a gene product required for proliferation, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795;

[0367] (b) contacting the sensitized cell with a compound; and

[0368] (c) determining the extent to which said compound inhibits the growth of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

[0369] 296. The method of Paragraph 295, wherein said determining step comprises determining whether said compound inhibits the growth of said sensitized cell to a greater extent than said compound inhibits the growth of a nonsensitized cell.

[0370] 297. The method of Paragraph 295, wherein said cell is selected from the group consisting of bacterial cells, fungal cells, plant cells, and animal cells.

[0371] 298. The method of Paragraph 295, wherein said cell is a Gram positive bacterium.

[0372] 299. The method of Paragraph 298, wherein said Gram positive bacterium is selected from the group consisting of Staphylococcus species, Streptococcus species, Enterococcus species, Mycobacterium species, Clostridium species, and Bacillus species.

[0373] 300. The method of Paragraph 299, wherein said Gram positive bacterium is Staphylococcus aureus.

[0374] 301. The method of Paragraph 298, wherein said Gram positive bacterium is selected from the group consisting of Staphylococcus aureus RN450 and Staphylococcus aureus RN4220.

[0375] 302. The method of Paragraph 295, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0376] 303. The method of Paragraph 295, wherein said cell is not an E. coli cell.

[0377] 304. The method of Paragraph 295, wherein said gene product is from an organism other than E. coli.

[0378] 305. The method of Paragraph 295, wherein said antisense nucleic acid is transcribed from an inducible promoter.

[0379] 306. The method of Paragraph 305, further comprising contacting the cell with an agent which induces expression of said antisense nucleic acid from said inducible promoter, wherein said antisense nucleic acid is expressed at a sublethal level.

[0380] 307. The method of Paragraph 295, wherein inhibition of proliferation is measured by monitoring the optical density of a liquid culture.

[0381] 308. The method of Paragraph 295, wherein said gene product comprises a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0382] 309. The method of Paragraph 295, wherein said nucleic acid encoding said gene product comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0383] 310. A compound identified using the method of Paragraph 295.

[0384] 311. A method for identifying a compound having the ability to inhibit cellular proliferation comprising:

[0385] (a) contacting a cell with an agent which reduces the activity or level of a gene product required for proliferation of said cell, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795;

[0386] (b) contacting said cell with a compound; and

[0387] (c) determining the degree to which said compound reduces proliferation of said contacted cell relative to a cell which was not contacted with said agent.

[0388] 312. The method of Paragraph 311, wherein said determining step comprises determining whether said compound reduces proliferation of said contacted cell to a greater extent than said compound reduces proliferation of cells which have not been contacted with said agent.

[0389] 313. The method of Paragraph 311, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0390] 314. The method of Paragraph 311, wherein said cell is not an E. coli cell.

[0391] 315. The method of Paragraph 311, wherein said gene product is from an organism other than E. coli.

[0392] 316. The method of Paragraph 311, wherein said agent which reduces the activity or level of a gene product required for proliferation of said cell comprises an antisense nucleic acid to a gene or operon required for proliferation.

[0393] 317. The method of Paragraph 311, wherein said agent which reduces the activity or level of a gene product required for proliferation of said cell comprises a compound known to inhibit growth or proliferation of a cell.

[0394] 318. The method of Paragraph 311, wherein said cell contains a mutation which reduces the activity or level of said gene product required for proliferation of said cell.

[0395] 319. The method of Paragraph 311, wherein said mutation is a temperature sensitive mutation.

[0396] 320. The method of Paragraph 311, wherein said gene product comprises a gene product comprises a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0397] 321. A compound identified using the method of Paragraph 311.

[0398] 322. A method for identifying the biological pathway in which a proliferation-required gene product or a gene encoding a proliferation-required gene product lies comprising:

[0399] (a) providing a sublethal level of an antisense nucleic acid which inhibits the activity or reduces the level of said gene encoding a proliferation-required gene product or said said proliferation-required gene product in a test cell, wherein said proliferation-required gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795;

[0400] (b) contacting said test cell with a compound known to inhibit growth or proliferation of a cell, wherein the biological pathway on which said compound acts is known; and

[0401] (c) determining the degree to which said compound inhibits proliferation of said test cell relative to a cell which does not contain said antisense nucleic acid.

[0402] 323. The method of Paragraph 322, wherein said determining step comprises determining whether said test cell has a substantially greater sensitivity to said compound than a cell which does not express said sublethal level of said antisense nucleic acid.

[0403] 324. The method of Paragraph 322, wherein said gene product comprises a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0404] 325. The method of Paragraph 322, wherein said test cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0405] 326. The method of Paragraph 322, wherein said test cell is not an E. coli cell.

[0406] 327. The method of Paragraph 322, wherein said gene product is from an organism other than E. coli.

[0407] 328. A method for determining the biological pathway on which a test compound acts comprising:

[0408] (a) providing a sublethal level of an antisense nucleic acid complementary to a proliferation-required nucleic acid in a cell, thereby producing a sensitized cell, wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795 or a proliferation-inhibiting portion thereof a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions and wherein the biological pathway in which said proliferation-required nucleic acid or a protein encoded by said proliferation-required polypeptide lies is known,

[0409] (b) contacting said cell with said test compound; and

[0410] (c) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

[0411] 329. The method of Paragraph 328, wherein said determining step comprises determining whether said sensitized cell has a substantially greater sensitivity to said test compound than a cell which does not express said sublethal level of said antisense nucleic acid.

[0412] 330. The method of Paragraph 328, further comprising:

[0413] (d) providing a sublethal level of a second antisense nucleic acid complementary to a second proliferation-required nucleic acid in a second cell, wherein said second proliferation-required nucleic acid is in a different biological pathway than said proliferation-required nucleic acid in step (a); and

[0414] (e) determining whether said second cell does not have a substantially greater sensitivity to said test compound than a cell which does not express said sublethal level of said second antisense nucleic acid, wherein said test compound is specific for the biological pathway against which the antisense nucleic acid of step (a) acts if said sensitized cell has substantially greater sensitivity to said test compound than said second cell.

[0415] 331. The method of Paragraph 328, wherein said sensitized cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0416] 332. The method of Paragraph 328, wherein said sensitized cell is not an E. coli cell.

[0417] 333. The method of Paragraph 328, wherein said proliferation-required nucleic acid is from an organism other than E. coli.

[0418] 334. A compound which inhibits proliferation by interacting with a gene encoding a gene product required for proliferation or with a gene product required for proliferation, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

[0419] 335. The compound of Paragraph 334, wherein said gene product comprises a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0420] 336. The compound of Paragraph 334, wherein said gene comprises a nucleic acid selected from the group consisting of a nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 under moderate condtions.

[0421] 337. A method for manufacturing an antibiotic comprising the steps of:

[0422] screening one or more candidate compounds to identify a compound that reduces the activity or level of a gene product required for proliferation wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; and

[0423] manufacturing the compound so identified.

[0424] 338. The method of Paragraph 337, wherein said screening step comprises performing any one of the methods of Paragraphs 205, 211, 222, 275, 290, 295, 311.

[0425] 339. The method of Paragraph 337, wherein said gene product comprises a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0426] 340. A method for inhibiting proliferation of a cell in a subject comprising administering an effective amount of a compound that reduces the activity or level of a gene product required for proliferation of said cell, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

[0427] 341. The method of Paragraph 340 wherein said subject is selected from the group consisting of vertebrates, mammals, avians, and human beings.

[0428] 342. The method of Paragraph 340, wherein said gene product comprises a polypeptide having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to an amino acid sequence selected from the group consisting of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110.

[0429] 343. The method of Paragraph 340, wherein said cell is selected from the group consisting of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species.

[0430] 344. The method of Paragraph 340, wherein said cell is not E. coli.

[0431] 345. The method of Paragraph 340, wherein said gene product is from an organism other than E. coli.

Definitions

[0432] By “biological pathway” is meant any discrete cell function or process that is carried out by a gene product or a subset of gene products. Biological pathways include anabolic, catabolic, enzymatic, biochemical and metabolic pathways as well as pathways involved in the production of cellular structures such as cell walls. Biological pathways that are usually required for proliferation of cells or microorganisms include, but are not limited to, cell division, DNA synthesis and replication, RNA synthesis (transcription), protein synthesis (translation), protein processing, protein transport, fatty acid biosynthesis, electron transport chains, cell wall synthesis, cell membrane production, synthesis and maintenance, and the like.

[0433] By “inhibit activity of a gene or gene product” is meant having the ability to interfere with the function of a gene or gene product in such a way as to decrease expression of the gene, in such a way as to reduce the level or activity of a product of .the gene or in such a way as to inhibit the interaction of the gene or gene product with other biological molecules required for its activity. Agents which inhibit the activity of a gene include agents that inhibit transcription of the gene, agents that inhibit processing of the transcript of the gene, agents that reduce the stability of the transcript of the gene, and agents that inhibit translation of the mRNA transcribed from the gene. In microorganisms, agents which inhibit the activity of a gene can act to decrease expression of the operon in which the gene resides or alter the folding or processing of operon RNA so as to reduce the level or activity of the gene product. The gene product can be a non-translated RNA such as ribosomal RNA, a translated RNA (mRNA) or the protein product resulting from translation of the gene mRNA. Of particular utility to the present invention are antisense RNAs that have activities against the operons or genes to which they specifically hybridze.

[0434] By “activity against a gene product” is meant having the ability to inhibit the function or to reduce the level or activity of the gene product in a cell. This includes, but is not limited to, inhibiting the enzymatic activity of the gene product or the ability of the gene product to interact with other biological molecules required for its activity, including inhibiting the gene product's assembly into a multimeric structure.

[0435] By “activity against a protein” is meant having the ability to inhibit the function or to reduce the level or activity of the protein in a cell. This includes, but is not limited to, inhibiting the enzymatic activity of the protein or the ability of the protein to interact with other biological molecules required for its activity, including inhibiting the protein's assembly into a multimeric structure.

[0436] By “activity against a nucleic acid” is meant having the ability to inhibit the function or to reduce the level or activity of the nucleic acid in a cell. This includes, but is not limited to, inhibiting the ability of the nucleic acid interact with other biological molecules required for its activity, including inhibiting the nucleic acid's assembly into a multimeric structure.

[0437] By “activity against a gene” is meant having the ability to inhibit the function or expression of the gene in a cell. This includes, but is not limited to, inhibiting the ability of the gene to interact with other biological molecules required for its activity.

[0438] By “activity against an operon” is meant having the ability to inhibit the function or reduce the level of one or more products of the operon in a cell. This includes, but is not limited to, inhibiting the enzymatic activity of one or more products of the operon or the ability of one or more products of the operon to interact with other biological molecules required for its activity.

[0439] By “antibiotic” is meant an agent which inhibits the proliferation of a cell or microorganism.

[0440] By “E. coli or Escherichia coli” is meant Escherichia coli or any organism previously categorized as a species of Shigella including Shigella boydii, Shigella flexneri, Shigella dysenteriae, Shigella sonnei, Shigella 2A.

[0441] By “homologous coding nucleic acid” is meant a nucleic acid homologous to a nucleic acid encoding a gene product whose activity or level is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 or a portion thereof. In some embodiments, the homologous coding nucleic acid may have at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof. In other embodiments the homologous coding nucleic acids may have at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of the nucleotide sequences complementary to one of SEQ ID NOs.: 8-3795 and fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof. Identity may be measured using BLASTN version 2.0 with the default parameters or tBLASTX with the default parameters. (Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acid Res. 25: 3389-3402 (1997), the disclosure of which is incorporated herein by reference in its entirety) Alternatively a “homologuous coding nucleic acid” could be identified by membership of the gene of interest to a functional orthologue cluster. All other members of that orthologue cluster would be considered homologues. Such a library of functional orthologue clusters can be found at http://www.ncbi.nlm.nih.gov/COG. A gene can be classified into a cluster of orthologous groups or COG by using the COGNITOR program available at the above web site, or by direct BLASTP comparison of the gene of interest to the members of the COGs and analysis of these results as described by Tatusov, R. L., Galperin, M. Y., Natale, D. A. and Koonin, E. V. (2000) The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Research v. 28 n. 1, pp33-36.

[0442] The term “homologous coding nucleic acid” also includes nucleic acids comprising nucleotide sequences which encode polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% maino acid identity or similarity to a polypeptide comprising the amino acid sequence of one of SEQ IDNOs: 3801-3805, 4861-5915, 10013-14110 or to a polypeptpide whose expression is inhibited by a nucleic acid comprising a nucleotide sequence of one of SEQ ID NOs: 8-3795 or fragments comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids thereof as determined using the FASTA version 3.0t78 algorithm with the default parameters. Alternatively, protein identity or similarity may be identified using BLASTP with the default parameters, BLASTX with the default parameters, TBLASTN with the default parameters, or tBLASTX with the default parameters. (Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acid Res.

[0443] 25: 3389-3402 (1997), the disclosure of which is incorporated herein by reference in its entirety).

[0444] The term “homologous coding nucleic acid” also includes coding nucleic acids which hybridize under stringent conditions to a nucleic acid selected from the group consisting of the nucleotide sequences complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and coding nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequences complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 As used herein, “stringent conditions” means hybridization to filter-bound nucleic acid in 6× SSC at about 45° C. followed by one or more washes in 0.1× SSC/0.2% SDS at about 68° C. Other exemplary stringent conditions may refer, e.g., to washing in 6× SSC/0.05% sodium pyrophosphate at 37° C., 48° C., 55° C., and 60° C. as appropriate for the particular probe being used.

[0445] The term “homologous coding nucleic acid” also includes coding nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a nucleotide sequence selected from the group consisting of the sequences complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and coding nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequences complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012. As used herein, “moderate conditions” means hybridization to filter-bound DNA in 6× sodium chloride/sodium citrate (SSC) at about 45° C. followed by one or more washes in 0.2× SSC/0.1% SDS at about 42-65° C.

[0446] The term “homologous coding nucleic acids” also includes nucleic acids comprising nucleotide sequences which encode a gene product whose activity may be complemented by a gene encoding a gene product whose activity is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795. In some embodiments, the homologous coding nucleic acids may encode a gene product whose activity is complemented by the gene product encoded by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012. In other embodiments, the homologous coding nucleic acids may comprise a nucleotide sequence encode a gene product whose activity is complemented by one of the polypeptides of SEQ ID NOs. 3745-4773.

[0447] The term “homologous antisense nucleic acid” includes nucleic acids comprising a nucleotide sequence having at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of one of the sequences of SEQ ID NOS. 8-3795 and fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof. Homologous antisense nucleic acids may also comprising nucleotide sequences which have at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of the sequences complementary to one of sequences of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof. Nucleic acid identity may be determined as described above.

[0448] The term “homologous antisense nucleic acid” also includes antisense nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleotide sequence complementary to one of SEQ ID NOs.: 8-3795 and antisens nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequence complementary to one of SEQ ID NOs. 8-3795. Homologous antisense nucleic acids also include antisense nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and antisense nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20,25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0449] The term “homologous antisense nucleic acid” also includes antisense nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a nucleotide sequence complementary to one of SEQ ID NOs.: 8-3795 and antisens nucleic acids comprising nucleotide seuqences which hybridize under moderate conditions to a fragment comprising at least 10, 15,20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequence complementary to one of SEQ ID NOs. 8-3795. Homologous antisense nucleic acids also include antisense nucleic acids comprising nucleotide seuqences which hybridize under moderate conditions to a nucleotide sequence selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and antisense nucleic acids which comprising nucleotide sequences hybridize under moderate conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0450] By “homologous polypeptide” is meant a polypeptide homologous to a polypeptide whose activity or level is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or by a homologous antisense nucleic acid. The term “homologous polypeptide” includes polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% amino acid identity or similarity to a polypeptide whose activity or level is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795 or by a homologous antisense nucleic acid, or polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% amino acid identity or similarity to a polypeptide to a fragment comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids of a polypeptide whose activity or level is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 or by a homologous antisense nucleic acid. Identity or similarity may be determined using the FASTA version 3.0t78 algorithm with the default parameters. Alternatively, protein identity or similarity may be identified using BLASTP with the default parameters, BLASTX with the default parameters, or TBLASTN with the default parameters. (Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acid Res. 25: 3389-3402 (1997), the disclosure of which is incorporated herein by reference in its entirety).

[0451] The term homologous polypeptide also includes polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% amino acid identity or similarity to a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110 and polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% amino acid identity or similarity to a fragment comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids of a polypeptide selected from the group consisting of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110.

[0452] The invention also includes polynucleotides, preferably DNA molecules, that hybridize to one of the nucleic acids of SEQ ID NOs.: 8-3795, SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 or the complements of any of the preceding nucleic acids. Such hybridization may be under stringent or moderate conditions as defined above or under other conditions which permit specific hybridization. The nucleic acid molecules of the invention that hybridize to these DNA sequences include oligodeoxynucleotides (“oligos”) which hybridize to the target gene under highly stringent or stringent conditions. In general, for oligos between 14 and 70 nucleotides in length the melting temperature (Tm) is calculated using the formula:

Tm(° C.)=81.5+16.6(log[monovalent cations (molar)]+0.41 (% G+C)−(500/N)

[0453] where N is the length of the probe. If the hybridization is carried out in a solution containing formamide, the melting temperature may be calculated using the equation:

Tm(° C.)=81.5+16.6(log[monovalent cations (molar)]+0.41(% G+C)−(0.61) (% formamide)−(500/N)

[0454] where N is the length of the probe. In general, hybridization is carried out at about 20-25 degrees below Tm (for DNA-DNA hybrids) or about 10-15 degrees below Tm (for RNA-DNA hybrids).

[0455] Other hybridization conditions are apparent to those of skill in the art (see, for example, Ausubel, F. M. et al., eds., 1989, Current Protocols in Molecular Biology, Vol. I, Green Publishing Associates, Inc. and John Wiley & Sons, Inc., New York, at pp. 6.3.1-6.3.6 and 2.10.3, the disclosure of which is incorporated herein by reference in its entirety).

[0456] The term, Salmonella, is the generic name for a large group of gram-negative enteric bacteria that are closely related to Escherichia coli. The diseases caused by Salmonella are often due to contamination of foodstuffs or the water supply and affect millions of people each year. Traditional methods of Salmonella taxonomy were based on assigning a separate species name to each serologically distinguishable strain (Kauffmann, F 1966 The bacteriology of the Enterobacteriaceae. Munksgaard, Copenhagen). Serology of Salmonella is based on surface antigens (O [somatic] and H [flagellar]). Over 2,400 serotypes or serovars of Salmonella are known (Popoff, et al. 2000 Res. Microbiol. 151:63-65). Therefore, each serotype was considered to be a separate species and often given names, accordingly (e.g. S. paratyphi, S. typhimurium, S. typhi, S. enteriditis, etc.).

[0457] However, by the 1970s and 1980s it was recognized that this system was not only cumbersome, but also inaccurate. Then, many Salmonella species were lumped into a single species (all serotypes and subgenera I, II, and IV and all serotypes of Arizona) with a second subspecies, S. bongorii also recognized (Crosa, et al., 1973, J. Bacteriol. 115:307-315). Though species designations are based on the highly variable surface antigens, the Salmonella are very similar otherwise with a major exception being pathogenicity determinants.

[0458] There has been some debate on the correct name for the Salmonella species. Currently (Brenner, et al. 2000 J. Clin. Microbiol. 38:2465-2467), the accepted name is Salmonella enterica. S. enterica is divided into six subspecies (I, S. enterica subsp. enterica; II, S. enterica, subsp. salamae; IIIa, S. enterica subsp. arizonae; IIIb, S. enterica subsp. diarizonae; IV, S. enterica subsp. houtenae; and VI, S. enterica subsp. indica). Within subspecies I, serotypes are used to distinguish each of the serotypes or serovars (e.g. S. enterica serotype Enteriditis, S. enterica serotype Typhimurium, S. enterica serotype Typhi, and S. enterica serotype Choleraesuis, etc.). Current convention is to spell this out on first usage (Salmonella enterica ser. Typhimurium) and then use an abbreviated form (Salmonella Typhimurium or S. Typhimurium). Note, the genus and species names (Salmonella enterica) are italicized but not the serotype/serovar name (Typhimurium). Because the taxonomic committees have yet to officially approve of the actual species name, this latter system is what is employed by the CDC (Brenner, et al. 2000 J. Clin. Microbiol. 38:2465-2467). Due to the concerns of both taxonomic priority and medical importance, some of these serotypes might ultimately receive full species designations (S. typhi would be the most notable).

[0459] Therefore, as used herein “Salmonella enterica or S. enterica” includes serovars Typhi, Typhimurium, Paratyphi, Choleraesuis, etc.” However, appeals of the “official” name are in process and the taxonomic designations may change (S. choleraesuis is the species name that could replace S. enterica based solely on priority).

[0460] By “identifying a compound” is meant to screen one or more compounds in a collection of compounds such as a combinatorial chemical library or other library of chemical compounds or to characterize a single compound by testing the compound in a given assay and determining whether it exhibits the desired activity.

[0461] By “inducer” is meant an agent or solution which, when placed in contact with a cell or microorganism, increases transcription, or inhibitor and/or promoter clearance/fidelity, from a desired promoter.

[0462] As used herein, “nucleic acid” means DNA, RNA, or modified nucleic acids. Thus, the terminology “the nucleic acid of SEQ ID NO: X” or “the nucleic acid comprising the nucleotide sequence” includes both the DNA sequence of SEQ ID NO: X and an RNA sequence in which the thymidines in the DNA sequence have been substituted with uridines in the RNA sequence and in which the deoxyribose backbone of the DNA sequence has been substituted with a ribose backbone in the RNA sequence. Modified nucleic acids are nucleic acids having nucleotides or structures which do not occur in nature, such as nucleic acids in which the internucleotide phosphate residues with methylphosphonates, phosphorothioates, phosphoramidates, and phosphate esters. Nonphosphate internucleotide analogs such as siloxane bridges, carbonate brides, thioester bridges, as well as many others known in the art may also be used in modified nucleic acids. Modified nucleic acids may also comprise, (x-anomeric nucleotide units and modified nucleotides such as 1,2-dideoxy-d-ribofuranose, 1,2-dideoxy-1-phenylribofuranose, and N4, N4-ethano-5-methyl-cytosine are contemplated for use in the present invention. Modified nucleic acids may also be peptide nucleic acids in which the entire deoxyribose-phosphate backbone has been exchanged with a chemically completely different, but structurally homologous, polyamide (peptide) backbone containing 2-aminoethyl glycine units.

[0463] As used herein, “sub-lethal” means a concentration of an agent below the concentration required to inhibit all cell growth.

BRIEF DESCRIPTION OF THE DRAWINGS

[0464] FIG. 1 is an IPTG dose response curve in E. coli transformed with an IPTG-inducible plasmid containing either an antisense clone to the E. coli ribosomal protein rplW (AS-rplW) which is required for protein synthesis and essential for cell proliferation, or an antisense clone to the elaD (AS-elaD) gene which is not known to be involved in protein synthesis and which is also essential for proliferation.

[0465] FIG. 2A is a tetracycline dose response curve in E. coli transformed with an IPTG-inducible plasmid containing antisense to rplW (AS-rplW) in the absence (0) or presence of IPTG at concentrations that result in 20% and 50% growth inhibition.

[0466] FIG. 2B is a tetracycline dose response curve in E. coli transformed with an IPTG-inducible plasmid containing antisense to elaD (AS-elaD)in the absence (0) or presence of IPTG at concentrations that result in 20% and 50% growth inhibition.

[0467] FIG. 3 is a graph showing the fold increase in tetracycline sensitivity of E. coli transfected with antisense clones to essential ribosomal proteins L23 (AS-rplW) and L7/L12 and L10 (AS-rplLrplJ). Antisense clones to genes known to not be directly involved in protein synthesis, atpB/E (AS-atpB/E), visC (AS-visC), elaD (AS-elaD), yohH (AS-yohH), are much less sensitive to tetracycline.

[0468] FIG. 4 illustrates the results of an assay in which Staphylococcus aureus cells transcribing an antisense nucleic acid complementary to the gyrB gene encoding the β subunit of gyrase were contacted with several antibiotics whose targets were known.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0469] The present invention describes a group of prokaryotic genes and gene families required for cellular proliferation. Exemplary genes and gene families from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and Salmonella typhi are provided. A proliferation-required gene or gene family is one where, in the absence or substantial reduction of a gene transcript and/or gene product, growth or viability of the cell or microorganism is reduced or eliminated. Thus, as used herein, the terminology “proliferation-required” or “required for proliferation” encompasses instances where the absence or substantial reduction of a gene transcript and/or gene product completely eliminates cell growth as well as instances where the absence of a gene transcript and/or gene product merely reduces cell growth. These proliferation-required genes can be used as potential targets for the generation of new antimicrobial agents. To achieve that goal, the present invention also encompasses assays for analyzing proliferation-required genes and for identifying compounds which interact with the gene and/or gene products of the proliferation-required genes. In addition, the present invention contemplates the expression of genes and the purification of the proteins encoded by the nucleic acid sequences identified as required proliferation genes and reported herein. The purified proteins can be used to generate reagents and screen small molecule libraries or other candidate compound libraries for compounds that can be further developed to yield novel antimicrobial compounds.

[0470] The present invention also describes methods for identification of nucleotide sequences homologous to these genes and polypeptides described herein, including nucleic acids comprising nucleotide sequences homologous to the nucleic acids of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and polypeptides homologous to the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110. For example, these sequences may be used to identify homologous coding nucleic acids, homologous antisense nucleic acids, or homologous polypeptides in microorganisms such as Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments, the homologous coding nucleic acids, homologus antisense nucleic acids, or homologous polypeptides are identified in an organism other than E. coli.

[0471] The homologous coding nucleic acids, homologous antisense nucleic acids, or homologous polypeptides, may then be used in each of the methods described herein, including methods to identify compounds which inhibit the proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide, methods of inhibiting the growth of the organism containing the homologous coding nucleic acid, homologus antisense nucleic acid or homologous polypeptide, methods of identifying compounds which influence the activity or level of a gene product required for proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide, methods for identifying compounds or nucleic acids having the ability to reduce the level or activity of a gene product required for proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide, methods of inhibiting the activity or expression of a gene in an operon required for proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide, methods for identifying a gene required proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide, methods for identifying the biological pathway in which a gene or gene product required for proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide lies, methods for identifying compounds having activity against biological pathway required for proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide, methods for determining the biological pathway on which a test compound acts, and methods of inhibiting the proliferation of the organism containing the homologous coding nucleic acid, homologous antisense nucleic acid or homologous polypeptide in a subject. In some embodiments of the present invention, the methods are performed using an organism, other than E. coli or a gene or gene product from an organism other than E. coli.

[0472] The present invention utilizes a novel method to identify proliferation-required sequences. Generally, a library of nucleic acid sequences from a given source are subcloned or otherwise inserted immediately downstream of an inducible promoter on an appropriate vector, such as a Staphylococcus aureus/E. coli or Pseudomonas aeruginosa/E. coli shuttle vector, or a vector which will replicate in both Salmonella typhimurium and Klebsiella pneumoniae, or other vector or shuttle vector capable of functioning in the intended organism., thus forming an expression library. It is generally preferred that expression is directed by a regulatable promoter sequence such that expression level can be adjusted by addition of variable concentrations of an inducer molecule or of an inhibitor molecule to the medium. Temperature activated promoters, such as promoters regulated by temperature sensitive repressors, such as the lambda C1857 repressor, are also envisioned. Although the insert nucleic acids may be derived from the chromosome of the cell or microorganism into which the expression vector is to be introduced, because the insert is not in its natural chromosomal location, the insert nucleic acid is an exogenous nucleic acid for the purposes of the discussion herein. The term “expression” is defined as the production of a sense or antisense RNA molecule from a gene, gene fragment, genomic fragment, chromosome, operon or portion thereof. Expression can also be used to refer to the process of peptide or polypeptide synthesis. An expression vector is defined as a vehicle by which a ribonucleic acid (RNA) sequence is transcribed from a nucleic acid sequence carried within the expression vehicle. The expression vector can also contain features that permit translation of a protein product from the transcribed RNA message expressed from the exogenous nucleic acid sequence carried by the expression vector. Accordingly, an expression vector can produce an RNA molecule as its sole product or the expression vector can produce a RNA molecule that is ultimately translated into a protein product.

[0473] Once generated, the expression library containing the exogenous nucleic acid sequences is introduced into a population of cells (such as the organism from which the exogenous nucleic acid sequences were obtained) to search for genes that are required for bacterial proliferation. Because the library molecules are foreign, in context, to the population of cells, the expression vectors and the nucleic acid segments contained therein are considered exogenous nucleic acid.

[0474] Expression of the exogenous nucleic acid fragments in the test population of cells containing the expression library is then activated. Activation of the expression vectors consists of subjecting the cells containing the vectors to conditions that result in the expression of the exogenous nucleic acid sequences carried by the expression library. The test population of cells is then assayed to determine the effect of expressing the exogenous nucleic acid fragments on the test population of cells. Those expression vectors that negatively impacted the growth of the cells upon induction of expression of the random sequences contained therein were identified, isolated, and purified for further study.

[0475] A variety of assays are contemplated to identify nucleic acid sequences that negatively impact growth upon expression. In one embodiment, growth in cultures expressing exogenous nucleic acid sequences and growth in cultures not expressing these sequences is compared. Growth measurements are assayed by examining the extent of growth by measuring optical densities. Alternatively, enzymatic assays can be used to measure bacterial growth rates to identify exogenous nucleic acid sequences of interest. Colony size, colony morphology, and cell morphology are additional factors used to evaluate growth of the host cells. Those cultures that fail to grow or grow at a reduced rate under expression conditions are identified as containing an expression vector encoding a nucleic acid fragment that negatively affects a proliferation-required gene.

[0476] Once exogenous nucleic acids of interest are identified, they are analyzed. The first step of the analysis is to acquire the nucleotide sequence of the nucleic acid fragment of interest. To achieve this end, the insert in those expression vectors identified as containing a nucleotide sequence of interest is sequenced, using standard techniques well known in the art. The next step of the process is to determine the source of the nucleotide sequence. As used herein “source” means the genomic region containing the cloned fragment.

[0477] Determination of the gene(s) corresponding to the nucleotide sequence was achieved by comparing the obtained sequence data with databases containing known protein and nucleotide sequences from various microorganisms. Thus, initial gene identification was made on the basis of significant sequence similarity or identity to either characterized or predicted Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis genes or their encoded proteins and/or homologues in other species.

[0478] The number of nucleotide and protein sequences available in database systems has been growing exponentially for years. For example, the complete nucleotide sequences of Caenorhabditis elegans and several bacterial genomes, including E. coli, Aeropyrum pernix, Aquifex aeolicus, Archaeoglobus fulgidus, Bacillus subtilis, Borrelia burgdorferi, Chlamydia pneumoniae, Chlamydia trachomatis, Clostridium tetani, Corynebacterium diptheria, Deinococcus radiodurans, Haemophilus influenzae, Helicobacter pylori 26695, Helicobacter pylori J99, Methanobacterium thermoautotrophicum, Methanococcus jannaschii, Mycobacterium tuberculosis, Mycoplasma genitalium, Mycoplasma pneumoniae, Pseudomonas aeruginosa, Pyrococcus abyssi, Pyrococcus horikoshii, Rickettsia prowazekii, Synechocystis PCC6803, Thermotoga maritima, Treponema pallidum, Bordetella pertussis, Campylobacter jejuni, Clostridium acetobutylicum, Mycobacterium tuberculosis CSU#93, Neisseria gonorrhoeae, Neisseria meningitidis, Pseudomonas aeruginosa, Pyrobaculum aerophilum, Pyrococcus furiosus, Rhodobacter capsulatus, Salmonella typhimurium, Streptococcus mutans, Streptococcus pyogenes, Ureaplasma urealyticum and Vibrio cholera are available. This nucleotide sequence information is stored in a number of databanks, such as GenBank, the National Center for Biotechnology Information (NCBI), the Genome Sequencing Center (http:Hlgenome.wustl.edu/gsc/salmonella.shtml), and the Sanger Centre (http://www.sanger.ac.uk/projects/S_typhi) which are publicly available for searching.

[0479] A variety of computer programs are available to assist in the analysis of the sequences stored within these databases. FASTA, (W. R. Pearson (1990) “Rapid and Sensitive Sequence Comparison with FASTP and FASTA” Methods in Enzymology 183:63-98), Sequence Retrieval System (SRS), (Etzold & Argos, SRS an indexing and retrieval tool for flat file data libraries. Comput. Appl. Biosci. 9:49-57, 1993) are two examples of computer programs that can be used to analyze sequences of interest. In one embodiment of the present invention, the BLAST family of computer programs, which includes BLASTN version 2.0 with the default parameters, or BLASTX version 2.0 with the default parameters, is used to analyze nucleotide sequences.

[0480] BLAST, an acronym for “Basic Local Alignment Search Tool,” is a family of programs for database similarity searching. The BLAST family of programs includes: BLASTN, a nucleotide sequence database searching program, BLASTX, a protein database searching program where the input is a nucleic acid sequence; and BLASTP, a protein database searching program. BLAST programs embody a fast algorithm for sequence matching, rigorous statistical methods for judging the significance of matches, and various options for tailoring the program for special situations. Assistance in using the program can be obtained by e-mail at blastincbi.nlm.nih.gov. tBLASTX can be used to translate a nucleotide sequence in all three potential reading frames into an amino acid sequence.

[0481] Bacterial genes are often transcribed in polycistronic groups. These groups comprise operons, which are a collection of genes and intergenic sequences under common regulation. The genes of an operon are transcribed on the same MRNA and are often related functionally. Given the nature of the screening protocol, it is possible that the identified exogenous nucleic acid corresponds to a gene or portion thereof with or without adjacent noncoding sequences, an intragenic sequence (i.e. a sequence within a gene), an intergenic sequence (i.e. a sequence between genes), a nucleotide sequence spanning at least a portion of two or more genes, a 5′ noncoding region or a 3′ noncoding region located upstream or downstream from the actual nucleotide sequence that is required for bacterial proliferation. Accordingly, it is often desirable to determine which gene(s) that is encoded within the operon is individually required for proliferation.

[0482] In one embodiment of the present invention, an operon is identified and then dissected to determine which gene or genes are required for proliferation. Operons can be identified by a variety of means known to those in the art. For example, the RegulonDB DataBase described by Huerta et al. (Nucl. Acids Res. 26:55-59, 1998), which may also be found on the website http://www.cifn.unam.mx/Computational_Biology/regulondb/, the disclosures of which are incorporated herein by reference in their entireties, provides information about operons in Escherichia coli. The Subtilist database (http://bioweb.pasteur.fr/GenoList/SubtiList), (Moszer, I., Glaser, P. and Danchin, A. (1995) Microbiology 141: 261-268 and Moszer, 1 (1998) FEBS Letters 430: 28-36, the disclosures of which are incorporated herein in their entireties), may also be used to predict operons. This database lists genes from the fully sequenced, Gram-positive bacteria, Bacillus subtilis, together with predicted promoters and terminator sites. This information can be used in conjunction with the Staphylococcus aureus genomic sequence data to predict operons and thus produce a list of the genes affected by the antisense nucleic acids of the present invention. The Pseudomonas aerginosa web site (http://www.pseudomonas.com) can be used to help predict operon organization in this bacterium. The databases available from the Genome Sequencing Center (http:/Hgenome.wustl.edu/gsc/salmonella.shtml), and the Sanger Centre (http:/Hwww.sanger.ac.uk/projects/S typhi) may be used to predict operons in Salmonella typhimurium. The TIGR microbial database has an incomplete version of the E. faecalis genome http://www.tigr.org/cgi-bin/BlastSearch/blast.cai?organism=_e faecalis. One can take a nucleotide sequence and BLAST it for homologs.

[0483] A number of techniques that are well known in the art can be used to dissect the operon. Analysis of RNA transcripts by Northern blot or primer extension techniques are commonly used to analyze operon transcripts. In one aspect of this embodiment, gene disruption by homologous recombination is used to individually inactivate the genes of an operon that is thought to contain a gene required for proliferation.

[0484] Several gene disruption techniques have been described for the replacement of a functional gene with a mutated, non-functional (null) allele. These techniques generally involve the use of homologous recombination. One technique using homologous recombination in Staphylococcus aureus is described in Xia et a. 1999, Plasmid 42: 144-149, the disclosure of which is incorporated herein by reference in its entirety. This technique uses crossover PCR to create a null allele with an in-frame deletion of the coding region of a target gene. The null allele is constructed in such a way that nucleotide sequences adjacent to the wild type gene are retained. These homologous sequences surrounding the deletion null allele provide targets for homologous recombination so that the wild type gene on the Staphylococcus aureus chromosome can be replaced by the constructed null allele. This method can be used with other bacteria as well, including Salmonella and Klebsiella species. Similar gene disruption methods that employ the counter selectable marker sacb (Schweizer, H. P., Klassen, T. and Hoang, T. (1996) Mol. Biol. of Pseudomonas. ASM press, 229-237, the disclosure of which is incorporated herein by reference in its entirety) are available for Pseudomonas, Salmonella and Klebsiella species. E. faecalis genes can be disrupted by recombining in a non-replicating plasmid that contains an internal fragment to that gene (Leboeuf, C., L. Leblanc, Y. Auffray and A. Hartke. 2000. J. Bacteriol. 182:5799-5806, the disclosure of which is incorporated herein by reference in its entirety).

[0485] The crossover PCR amplification product is subcloned into a suitable vector having a selectable marker, such as a drug resistance marker. In some embodiments the vector may have an origin of replication which is functional in E. coli or another organism distinct from the organism in which homologous recombination is to occur, allowing the plasmid to be grown in E. coli or the organism other than that in which homologous recombination is to occur, but may lack an origin of replication functional in Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi such that selection of the selectable marker requires integration of the vector into the homologous region of the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi chromosome. Usually a single crossover event is responsible for this integration event such that the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi chromosome now contains a tandem duplication of the target gene consisting of one wild type allele and one deletion null allele separated by vector sequence. Subsequent resolution of the duplication results in both removal of the vector sequence and either restoration of the wild type gene or replacement by the in-frame deletion. The latter outcome will not occur if the gene should prove essential. A more detailed description of this method is provided in Example 5 below. It will be appreciated that this method may be practiced with any of the nucleic acids or organisms described herein.

[0486] Recombinant DNA techniques can be used to express the entire coding sequences of the gene identified as required for proliferation, or portions thereof. The over-expressed proteins can be used as reagents for further study. The identified exogenous sequences are isolated, purified, and cloned into a suitable expression vector using methods well known in the art. If desired, the nucleic acids can contain the nucleotide sequences encoding a signal peptide to facilitate secretion of the expressed protein.

[0487] Expression of fragments of the bacterial genes identified as required for proliferation is also contemplated by the present invention. The fragments of the identified genes can encode a polypeptide comprising at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 75, or more than 75 consecutive amino acids of a gene complementary to one of the identified sequences of the present invention. The nucleic acids inserted into the expression vectors can also contain endogenous sequences upstream and downstream of the coding sequence.

[0488] When expressing the encoded protien of the idnetified required for bacterial proliferation or a fragment thereof, the nucleotide sequence to be expressed is operably linked to a promoter in an expression vector using conventional cloning technology. The expression vector can be any of the bacterial, insect, yeast, or mammalian expression systems known in the art. Commercially available vectors and expression systems are available from a variety of suppliers including Genetics Institute (Cambridge, Mass.), Stratagene (La Jolla, Calif.), Promega (Madison, Wis.), and Invitrogen (San Diego, Calif.). If desired, to enhance expression and facilitate proper protein folding, the codon usage and codon bias of the sequence can be optimized for the particular expression organism in which the expression vector is introduced, as explained by Hatfield, et al., U.S. Pat. No. 5,082,767, incorporated herein by this reference. Fusion protein expression systems are also contemplated by the present invention.

[0489] Following expression of the protein encoded by the identified exogenous nucleic acid, the protein may be purified. Protein purification techniques are well known in the art. Proteins encoded and expressed from identified exogenous nucleic acids can be partially purified using precipitation techniques, such as precipitation with polyethylene glycol. Alternatively, epitope tagging of the protein can be used to allow simple one step purification of the protein. In addition, chromatographic methods such as ion-exchange chromatography, gel filtration, use of hydroxyapaptite columns, immobilized reactive dyes, chromatofocusing, and use of high-performance liquid chromatography, may also be used to purify the protein. Electrophoretic methods such as one-dimensional gel electrophoresis, high-resolution two-dimensional polyacrylamide electrophoresis, isoelectric focusing, and others are contemplated as purification methods. Also, affinity chromatographic methods, comprising antibody columns, ligand presenting columns and other affinity chromatographic matrices are contemplated as purification methods in the present invention.

[0490] The purified proteins produced from the gene coding sequences identified as required for proliferation can be used in a variety of protocols to generate useful antimicrobial reagents. In one embodiment of the present invention, antibodies are generated against the proteins expressed from the identified exogenous nucleic acids. Both monoclonal and polyclonal antibodies can be generated against the expressed proteins. Methods for generating monoclonal and polyclonal antibodies are well known in the art. Also, antibody fragment preparations prepared from the produced antibodies discussed above are contemplated.

[0491] In addition, the purified protein, fragments thereof, or derivatives thereof may be administered to an individual in a pharmaceutically acceptable carrier to induce an immune response against the protein. Preferably, the immune response is a protective immune response which protects the individual. Methods for determining appropriate dosages of the protein and pharmaceutically acceptable carriers may be determined empiracally and are familiar to those skilled in the art.

[0492] Another application for the purified proteins of the present invention is to screen small molecule libraries for candidate compounds active against the various target proteins of the present invention. Advances in the field of combinatorial chemistry provide methods, well known in the art, to produce large numbers of candidate compounds that can have a binding, or otherwise inhibitory effect on a target protein. Accordingly, the screening of small molecule libraries for compounds with binding affinity or inhibitory activity for a target protein produced from an identified gene is contemplated by the present invention.

[0493] The present invention further contemplates utility against a variety of other pathogenic microorganisms in addition to Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi. For example, homologous coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides from other pathogenic microorganisms (including nucleic acids homologous to the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, nucleic acids homologous to the antisense nucleic acids of SEQ ID NOs.: 8-3795, and polypeptides homologous to the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) may be identified using methods such as those described herein. The homologous coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides may be used to identify compounds which inhibit the proliferation of these other pathogenic microorganisms using methods such as those described herein.

[0494] For example, the proliferation-required nucleic acids, antisense nucleic acids, and polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi described herein (including the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, the antisense nucleic acids of SEQ ID NOs: 8-3795, and the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) may be used to identify homologous coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides required for proliferation in prokaryotes and eukaryotes. For example, nucleic acids or polypeptides required for the proliferation of protists, such as Plasmodium spp.; plants; animals, such as Entamoeba spp. and Contracaecum spp; and fungi including Candida spp., (e.g., Candida albicans), Cryptococcus neoformans, and Aspergillus fumigatus may be identified. In one embodiment of the present invention, monera, specifically bacteria, including both Gram positive and Gram negative bacteria, are probed in search of novel gene sequences required for proliferation. Likewise, homologous antisense nucleic acids which may be used to inhibit growth of these organisms or to identify antibiotics may also be identified. These embodiments are particularly important given the rise of drug resistant bacteria.

[0495] The number of bacterial species that are becoming resistant to existing antibiotics is growing. A partial list of these microorganisms includes: Escherichia spp., such as E. coli, Enterococcus spp, such as E. faecalis; Pseudomonas spp., such as P. aeruginosa, Clostridium spp., such as C. botulinum, Haemophilus spp., such as H. influenzae, Enterobacter spp., such as E. cloacae, Vibrio spp., such as V. cholera; Moraxala spp., such as M. catarrhalis; Streptococcus spp., such as S. pneumoniae, Neisseria spp., such as N. gonorrhoeae; Mycoplasma spp., such as Mycoplasma pneumoniae; Salmonella typhimurium; Helicobacter pylori; Escherichia coli; and Mycobacterium tuberculosis. The genes and polypeptides identified as required for the proliferation of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi (including the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, the sequences complementary to the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, and the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) can be used to identify homologous coding nucleic acids or homologous polypeptides required for proliferation from these and other organisms using methods such as nucleic acid hybridization and computer database analysis. Likewise, the antisense nucleic acids which inhibit proliferation of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi (including the antisense nucleic acids of SEQ ID NOs.: 8-3795 or the sequences complementary thereto) may also be used to identify antisense nucleic acids which inhibit proliferation of these and other microorganisms or cells using nucleic acid hybridization or computer database analysis.

[0496] In one embodiment of the present invention, the nucleic acid sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhii (including the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 and the antisense nucleic acids of SEQ ID NOs. 8-3795) are used to screen genomic libraries generated from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi and other bacterial species of interest. For example, the genomic library may be from Gram positive bacteria, Gram negative bacteria or other organisms including Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species, including coagulase negative species of Staphylococcus. In some embodiments, the genomic library may be from an organism other than E. coli. Standard molecular biology techniques are used to generate genomic libraries from various cells or microorganisms. In one aspect, the libraries are generated and bound to nitrocellulose paper. The identified exogenous nucleic acid sequences of the present invention can then be used as probes to screen the libraries for homologous sequences.

[0497] For example, the libraries may be screened to identify homologous coding nucleic acids or homologous antisense nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200,300, 400, or 500 consecutive nucleotides of one of SEQ ID .NOs. 8-3795, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleic acid complementary to one of SEQ ID NOs. 8-3795, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequence complementary to one of SEQ ID NOs. 8-3795, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleic acid selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleic acid complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300,400, or 500 consecutive nucleotides of the sequence complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a nucleic acid selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, and nucleic acids comprising nucleotide sequences which hybridize under stringent conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0498] The libraries may also be screened to identify homologous nucleic coding nucleic acids or homologous antisense nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795, nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of one of SEQ ID NOs. 8-3795, nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a nucleic acid complementary to one of SEQ ID NOs. 8-3795, nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequence complementary to one of SEQ ID NOs. 8-3795, nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a nucleic acid selected from the group consisting of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids comprising nucleic acid sequences which hybridize under moderate conditions to a fragment comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150,200, 300, 400, or 500 consecutive nucleotides of one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a nucleic acid complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 and nucleic acids comprising nucleotide sequences which hybridize under moderate conditions to a fragment comprising at least 10, 15, 20,25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides of the sequence complementary to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012.

[0499] The homologous nucleic coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides identified as above can then be used as targets or tools for the identification of new, antimicrobial compounds using methods such as those described herein. In some embodiments, the homologous coding nucleic acids, homologous antisense nucleic acids, or homologous polypeptides may be used to identify compounds with activity against more than one microorganism.

[0500] For example, the preceding methods may be used to isolate homologous coding nucleic acids or homologous antisense nucleic acids comprising a nucleotide sequence with at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of one of the sequences of SEQ ID NOS. 8-3795, fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof, and the sequences complementary thereto. The preceding methods may also be used to isolate homologous coding nucleic acids or homologous antisense nucleic acids comprising a nucleotide sequence with at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of one of the nucleotide sequences of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof, and the sequences complementary thereto. In some embodiments, the preceding methods may be used to isolate homologous coding nucleic acids or homologous antisense nucleic acids comprising a nucleotide sequence with at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleic acid sequence selected from the group consisting of one of the sequences of SEQ ID NOS. 3796-3800, 3806-4860, 5916-10012, fragments comprising at least 10, 15, 20,25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof, and the sequences complementary thereto. Identity may be measured using BLASTN version 2.0 with the default parameters. (Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acid Res. 25: 3389-3402 (1997), the disclosure of which is incorporated herein by reference in its entirety). For example, the homologous polynucleotides may comprise a coding sequence which is a naturally occurring allelic variant of one of the coding sequences described herein. Such allelic variants may have a substitution, deletion or addition of one or more nucleotides when compared to the nucleic acids of SEQ ID NOs: 8-3795, SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012 or the nucleotide sequences complementary thereto.

[0501] Additionally, the above procedures may be used to isolate homologous coding nucleic acids which encode polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% amino acid identity or similarity to a polypeptide comprising the sequence of one of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110 or to a polypeptpide whose expression is inhibited by a nucleic acid of one of SEQ ID NOs: 8-3795 or fragments comprising at least 5, 10, 15, 20,25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids thereof as determined using the FASTA version 3.0t78 algorithm with the default parameters. Alternatively, protein identity or similarity may be identified using BLASTP with the default parameters, BLASTX with the default parameters, or TBLASTN with the default parameters. (Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acid Res. 25: 3389-3402 (1997), the disclosure of which is incorporated herein by reference in its entirety).

[0502] Alternatively, homologous coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides may be identified by searching a database to identify sequences having a desired level of nucleotide or amino acid sequence homology to a nucleic acid or polypeptide involved in proliferation or an antisense nucleic acid to a nucleic acid involved in microbial proliferation. A variety of such databases are available to those skilled in the art, including GenBank and GenSeq. In some embodiments, the databases are screened to identify nucleic acids with at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 70% nucleotide sequence identity to a nucleic acid required for proliferation, an antisense nucleic acid which inhibits proliferation, or a portion of a nucleic acid required for proliferation or a portion of an antisense nucleic acid which inhibits proliferation. For example, homologous coding sequences may be identified by using a database to identify nucleic acids homologous to one of SEQ ID Nos. 8-3795, homologous to fragments comprising at least 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, 150, 200, 300, 400, or 500 consecutive nucleotides thereof, nucleic acids homologous to one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, homologous to fragments comprising at least 10, 15, 20, 25, 30, 35,40, 50, 75, 100, 150, 200, 300,400, or 500 consecutive nucleotides of one of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, nucleic acids homologous to one of SEQ ID Nos. 8-3795, homologous to fragments comprising at least 10, 15, 20,25,30, 35, 40, 50, 75, 100, 150,200, 300, 400, or 500 consecutive nucleotides thereof or nucleic acids homologous to the sequences complementary to any of the preceding nucleic acids. In other embodiments, the databases are screened to identify polypeptides having at least 99%, 95%, at least 90%, at least 85%, at least 80%, at least 70%, at least 60%, at least 50%, at least 40% or at least 25% amino acid sequence identity or similarity to a polypeptide involved in proliferation or a portion thereof. For example, the database may be screened to identify polypeptides homologous to a polypeptide comprising one of SEQ ID NOs: 3801-3805, 4861-5915, 10013-14110, a polypeptide whose expression is inhibited by a nucleic acid of one of SEQ ID NOs: 8-3795 or homologous to fragments comprising at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids of any of the preceding polypeptides. In some embodiments, the database may be screened to identify homologous coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides from cells or microorganisms other than the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi species from which they were obtained. For example the database may be screened to identify homologous coding nucleic acids, homologous antisense nucleic acids or homologous polypeptides from microorganisms such as Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species, including coagulase negative Staphylococcus. In some embodiments, the homologous coding nucleic acids, homologous antisense nucleic acids, or homologous polypeptides are from an organism other than E. coli.

[0503] In another embodiment, gene expression arrays and microarrays can be employed. Gene expression arrays are high density arrays of DNA samples deposited at specific locations on a glass chip, nylon membrane, or the like. Such arrays can be used by researchers to quantify relative gene expression under different conditions. Gene expression arrays are used by researchers to help identify optimal drug targets, profile new compounds, and determine disease pathways. An example of this technology is found in U.S. Pat. No. 5,807,522, which is hereby incorporated by reference.

[0504] It is possible to study the expression of all genes in the genome of a particular microbial organism using a single array. For example, the arrays may consist of 12×24 cm nylon filters containing PCR products corresponding to ORFs from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi (including the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012). 10 ngs of each PCR product are spotted every 1.5 mm on the filter. Single stranded labeled cDNAs are prepared for hybridization to the array (no second strand synthesis or amplification step is done) and placed in contact with the filter. Thus the labeled cDNAs are of “antisense” orientation. Quantitative analysis is done by phosphorimager.

[0505] Hybridization of cDNA made from a sample of total cell mRNA to such an array followed by detection of binding by one or more of various techniques known to those in the art results in a signal at each location on the array to which cDNA hybridized. The intensity of the hybridization signal obtained at each location in the array thus reflects the amount of mRNA for that specific gene that was present in the sample. Comparing the results obtained for mRNA isolated from cells grown under different conditions thus allows for a comparison of the relative amount of expression of each individual gene during growth under the different conditions.

[0506] Gene expression arrays may be used to analyze the total mRNA expression pattern at various time points after induction of an antisense nucleic acid complementary to a proliferation-required gene. Analysis of the expression pattern indicated by hybridization to the array provides information on other genes whose expression is influenced by antisense expression. For example, if the antisense is complementary to a gene for ribosomal protein L7/L12 in the 50S subunit, levels of other mRNAs may be observed to increase, decrease or stay the same following expression of antisense to the L7/L12 gene. If the antisense is complementary to a different 50S subunit ribosomal protein mRNA (e.g. L25), a different mRNA expression pattern may result. Thus, the mRNA expression pattern observed following expression of an antisense nucleic acid comprising a nucleotide sequence complementary to a proliferation required gene may identify other proliferation-required nucleic acids. In addition, the mRNA expression patterns observed when the bacteria are exposed to candidate drug compounds or known antibiotics may be compared to those observed with antisense nucleic acids comprising a nucleotide sequence complementary to a proliferation-required nucleic acid. If the mRNA expression pattern observed with the candidate drug compound is similar to that observed with the antisense nucleic acid, the drug compound may be a promising therapeutic candidate. Thus, the assay would be useful in assisting in the selection of promising candidate drug compounds for use in drug development.

[0507] In cases where the source of nucleic acid deposited on the array and the source of the nucleic acid being hybridized to the array are from two different cells or microorganisms, gene expression arrays can identify homologous nucleic acids in the two cells or microorganisms.

[0508] The present invention also contemplates additional methods for screening other microorganisms for proliferation-required genes. In one aspect of this embodiment, an antisense nucleic acid comprising a nucleotide sequence complementary to the proliferation-required sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi or a portion thereof is transcribed in an antisense orientation in such a way as to alter the level or activity of a nucleic acid required for proliferation of an autologous or heterologous cell or microorganism. For example, the antisense nucleic acid may be a homologous antisense nucleic acid such as an antisense nucleic acid homologous to the nucleotide sequence complementary to one of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, an antisense nucleic acid comprising a nucleotide sequence homologous to one of SEQ ID Nos.: 8-3795, or an antisense nucleic acid comprising a nucleotide sequence complementary to a portion of any of the preceding nucleic acids. The cell or microorganism transcribing the homologous antisense nucleic acid may be used in a cell-based assay, such as those described herein, to identify candidate antibiotic compounds. In another embodiment, the conserved portions of nucleotide sequences identified as proliferation-required can be used to generate degenerate primers for use in the polymerase chain reaction (PCR). The PCR technique is well known in the art. The successful production of a PCR product using degenerate probes generated from the nucleotide sequences identified herein indicates the presence of a homologous gene sequence in the species being screened. This homologous gene is then isolated, expressed, and used as a target for candidate antibiotic compounds. In another aspect of this embodiment, the homologous gene (for example a homologous coding nucleic acid )thus identified, or a portion thereof, is transcribed in an autologous cell or microorganism or in a heterologous cell or microorganism in an antisense orientation in such a way as to alter the level or activity of a homologous gene required for proliferation in the autologous or heterologous cell or microorganism. Alternatively, a homologous antisense nucleic acid may be transcribed in an autologous or heterologous cell or microorganism in such a way as to alter the level or activity of a gene product required for proliferation in the autologous or heterologous cell or microorganism.

[0509] The nucleic acids homologous to the genes required for the proliferation of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi or the sequences complementary thereto may be used to identify homologous coding nucleic acids or homologous antisense nucleic acids from cells or microorganisms other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi to inhibit the proliferation of cells or microorganisms other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi by inhibiting the activity or reducing the amount of the identified homologous coding nucleic acid or homologous polypeptide in the cell or microorganism other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or to identify compounds which inhibit the growth of cells or microorganisms other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi as described below. For example, the nucleic acids homologous to proliferation-required genes from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi or the sequences complementary thereto may be used to identify compounds which inhibit the growth of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species. In some embodiments of the present invention, the nucleic acids homologous to proliferation-required sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi (including nucleic acids homologous to one of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012) or the sequences complementary thereto (including nucleic acids homologous to one of SEQ ID NOs.: 8-3795) are used to identify proliferation-required sequences in an organism other than E. coli.

[0510] In another embodiment of the present invention, antisense nucleic acids complementary to the sequences identified as required for proliferation or portions thereof (including antisense nucleic acids comprising a nucleotide sequence complementary to one of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 or portions thereof, such as the nucleic acids of SEQ ID NOs.: 8-3795) are transferred to vectors capable of function within a species other than the species from which the sequences were obtained. For example, the vector may be functional in Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments of the present invention, the vector may be functional in an organism other than E. coli. As would be appreciated by one of ordinary skill in the art, vectors may contain certain elements that are species specific. These elements can include promoter sequences, operator sequences, repressor genes, origins of replication, ribosomal binding sequences, termination sequences, and others. To use the antisense nucleic acids, one of ordinary skill in the art would know to use standard molecular biology techniques to isolate vectors containing the sequences of interest from cultured bacterial cells, isolate and purify those sequences, and subclone those sequences into a vector adapted for use in the species of bacteria to be screened.

[0511] Vectors for a variety of other species are known in the art. For example, numerous vectors which function in E. coli are known in the art. Also, Pla et al. have reported an expression vector that is functional in a number of relevant hosts including: Salmonella typhimurium, Pseudomonas putida, and Pseudomonas aeruginosa. J. Bacteriol. 172(8):4448-55 (1990). Brunschwig and Darzins (Gene (1992) 111:35-4, the disclosure of which is incorporated herein by reference in its entirety) described a shuttle expression vector for Pseudomonas aeruginosa. Similarly many examples exist of expression vectors that are freely transferable among various Gram-positive microorganisms. Expression vectors for Enterococcus faecalis may be engineered by incorporating suitable promoters into a pAK80 backbone (Israelsen, H., S. M. Madsen, A. Vrang, E. B. Hansen and E. Johansen. 1995. Appl. Environ. Microbiol. 61:2540-2547, the disclosure of which is incorporated herein by reference in its entirety).

[0512] Following the subcloning of the antisense nucleic acids complementary to proliferation-required sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi or portions thereof into a vector functional in a second cell or microorganism of interest (i.e. a cell or microorganism other than the one from which the identified nucleic acids were obtained), the antisense nucleic acids are conditionally transcribed to test for bacterial growth inhibition. The nucleotide sequences of the nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi that, when transcribed, inhibit growth of the second cell or microorganism are compared to the known genomic sequence of the second cell or microorganism to identify the homologous gene from the second organism. If the homologous sequence from the second cell or microorganism is not known, it may be identified and isolated by hybridization to the proliferation-required Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi sequence of interest or by amplification using PCR primers based on the proliferation-required nucleotide sequence of interest as described above. In this way, sequences which may be required for the proliferation of the second cell or microorganism may be identified. For example, the second microorganism may be Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments of the present invention, the second microorganism is an organism other than E. coli.

[0513] The homologous nucleic acid sequences from the second cell or microorganism which are identified as described above may then be operably linked to a promoter, such as an inducible promoter, in an antisense orientation and introduced into the second cell or microorganism. The techniques described herein for identifying Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Salmonella typhi genes required for proliferation may thus be employed to determine whether the identified nucleotide sequences from a second cell or microorganism inhibit the proliferation of the second cell or microorganism. For example, the second microorganism may be Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments of the present invention, the second microorganism may be an organism other than E. coli.

[0514] Antisense nucleic acids required for the proliferation of microorganisms other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or the genes corresponding thereto, may also be hybridized to a microarray containing the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis ORFs, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, and Salmonella typhi (including the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012) to gauge the homology between the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi sequences and the proliferation-required nucleic acids from other cells or microorganisms. For example, the proliferation-required nucleic acid may be from Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments of the present invention, the proliferation-required nucleotide sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, Salmonella typhi or homologous nucleic acids are used to identify proliferation-required sequences in an organism other than E. coli. In some embodiments of the present invention, the proliferation-required sequences may be from an organism other than E. coli. The proliferation-required nucleic acids from a cell or microorganism other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi may be hybridized to the array under a variety of conditions which permit hybridization to occur when the probe has different levels of homology to the nucleotide sequence on the microarray. This would provide an indication of homology across the cells or microorganisms as well as clues to other possible essential genes in these cells or microorganisms.

[0515] In still another embodiment, the antisense nucleic acids of the present invention (including the antisense nucelic acids of SEQ ID NOs. 8-3795 or homologous antisense nucleic acids) that inhibit bacterial growth or proliferation can be used as antisense therapeutics for killing bacteria. The antisense sequences can be complementary to one of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, homologous nucleic acids, or portions thereof. Alternatively, antisense therapeutics can be complementary to operons in which proliferation-required genes reside (i.e. the antisense nucleic acid may hybridize to a nucleotide sequence of any gene in the operon in which the proliferation-required genes reside). Further, antisense therapeutics can be complementary to a proliferation-required gene or portion thereof with or without adjacent noncoding sequences, an intragenic sequence (i.e. a sequence within a gene), an intergenic sequence (i.e. a sequence between genes), a sequence spanning at least a portion of two or more genes, a 5′ noncoding region or a 3′ noncoding region located upstream or downstream from the actual sequence that is required for bacterial proliferation or an operon containing a proliferation-required gene.

[0516] In addition to therapeutic applications, the present invention encompasses the use of nucleic acids complementary to nucleic acids required for proliferation as diagnostic tools. For example, nucleic acid probes comprising nucleotide sequences complementary to proliferation-required sequences that are specific for particular species of cells or microorganisms can be used as probes to identify particular microorganism species or cells in clinical specimens. This utility provides a rapid and dependable method by which to identify the causative agent or agents of a bacterial infection. This utility would provide clinicians the ability to accurately identify the species responsible for the infection and amdminister a compound effective against it. In an extension of this utility, antibodies generated against proteins translated from mRNA transcribed from proliferation-required sequences can also be used to screen for specific cells or microorganisms that produce such proteins in a species-specific manner.

[0517] Other embodiments of the present invention include methods of identifying compounds which inhibit the activity of gene products required for cellular proliferation using rational drug design. As discussed in more detail below, in such methods, the structure of the gene product is determined using techniques such as x-ray crystallography or computer modeling. Compounds are screened to identify those which have a structure which would allow them to interact with the gene product or a portion thereof to inhibit its activity. The compounds may be obtained using any of a variety of methods familiar to those skilled in the art, including combinatorial chemistry. In some embodiments, the compounds may be obtained from a natural product library. In some embodiments, compounds having a structure which allows them to interact with the active site of a gene product, such as the active site of an enzyme, or with a portion of the gene product which interacts with another biomolecule to form a complex are identified. If desired, lead compounds may be identified and further optimized to provide compounds which are highly effective against the gene product.

[0518] The following examples teach the genes of the present invention and a subset of uses for the genes identified as required for proliferation. These examples are illustrative only and are not intended to limit the scope of the present invention.

EXAMPLES

[0519] The following examples are directed to the identification and exploitation of genes required for proliferation. Methods of gene identification are discussed as well as a variety of methods to utilize the identified sequences. It will be appreciated that any of the antisense nucleic acids, proliferartion-required genes or proliferation-required gene products described herein, or portions thereof, may be used in the procedures described below, including the antisense nucleic acids of SEQ ID NOs.: 8-3795, the nucleic acids of SEQ ID NOS.: 3796-3800, 3806-4860, 5916-10012, or the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110. Likewise, homologous coding nucleic acids or portions thereof, may be used in any of the procedures described below.

[0520] Genes Identified as Required for Proliferation of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis

[0521] Genomic fragments were operably linked to an inducible promoter in a vector and assayed for growth inhibition activity. Example 1 describes the examination of a library of genomic fragments cloned into vectors comprising inducible promoters. Upon induction with xylose or IPTG, the vectors produced an RNA molecule corresponding to the subcloned genomic fragments. In those instances where the genomic fragments were in an antisense orientation with respect to the promoter, the transcript produced was complementary to at least a portion of an MRNA (messenger RNA) encoding a Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis gene product such that they interacted with sense mRNA produced from various Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis genes and thereby decreased the translation efficiency or the level of the sense messenger RNA thus decreasing production of the protein encoded by these sense mRNA molecules. In cases where the sense mRNA encoded a protein required for proliferation, bacterial cells containing a vector from which transcription from the promoter had been induced failed to grow or grew at a substantially reduced rate. Additionally, in cases where the transcript produced was complementary to at least a portion of a non-translated RNA and where that non-translated RNA was required for proliferation, bacterial cells containing a vector from which transcription from the promoter had been induced also failed to grow or grew at a substantially reduced rate.

Example 1

Inhibition of Bacterial Proliferation after Induction of Antisense Expression

[0522] Nucleic acids involved in proliferation of Staphylococcus aureus, Salmonella typhimurium, and Klebsiella pneumoniae were identified as follows. Randomly generated fragments of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis genomic DNA were transcribed from inducible promoters.

[0523] In the case of Staphylococcus aureus, a novel inducible promoter system, XylT5, comprising a modified T5 promoter fused to the xylO operater from the xyla promoter of Staphylococcus aureus was used. The promoter is described in U.S. Provisional Patent Application Ser. No. 60/259,434, the disclosure of which is incorporated herein by reference in its entirety. Transcription from this hybrid promoter is inducible by xylose.

[0524] Randomly generated fragments of Salmonella typhimurium genomic DNA were transcribed from an IPTG inducible promoter in pLEX5BA (Krause et al., J. Mol. Biol.

[0525] 274: 365 (1997) or a derivative thereof. Randomly generated fragements of Klebsiella pneumoniae genomic DNA were expressed from an IPTG inducible promoter in pLEX5BA-Kan. To construct pLEX5BA-kan, pLEX5BA was digested to completion with ClaI in order to remove the bla gene. Then the plasmid was treated with a partial NotI digestion and blunted with T4 DNA polymerase. A 3.2 kbp fragment was then gel purified and ligated to a blunted 1.3 kbp kan gene from pKant. Kan resistant transformants were selected on Kan plates. Orientation of the kan gene was checked by SmaI digestion. A clone, which had the kan gene in the same orientation as the bla gene, was used to identify genes required for proliferation of Klebsiella pneumoniae.

[0526] Randomly generated fragments of Pseudomonas aeruginosa genomic DNA were trancribed from a two-component inducible promoter system. Integrated on the chromosome was the T7 RNA polymerase gene regulated by lacUV5/lacO (Brunschwig, E. and Darzins, A. 1992. Gene 1 11:35-41, the disclosure of which is incorporated herein by reference in its entirety). On a separate plasmid, a T7 gene 10 promoter, which is transcribed by T7 RNA polymerase, was fused with a lacO operator followed by a multiple cloning site.

[0527] Should the genomic DNA downstream of the promoter contain, in an antisense orientation, at least a portion of an MRNA or a non-translated RNA encoding a gene product involved in proliferation, then induction of transcription from the promoter will result in detectable inhibition of proliferation.

[0528] In the case of Staphylococcus aureus, a shotgun library of Staphylococcus aureus genomic fragments was cloned into the vector pXyIT5-P15a, which harbors the Xy1T5 inducible promoter. The vector was linearized at a unique BamHI site immediately downstream of the XyIT5 promoter/operator. The linearized vector was treated with shrimp alkaline phosphatase to prevent reclosure of the linearized ends. Genomic DNA isolated from Staphylococcus aureus strain RN450 was fully digested with the restriction enzyme Sau3A, or, alternatively, partially digested with DNase I and “blunt-ended” by incubating with T4 DNA polymerase. Random genomic fragments between 200 and 800 base pairs in length were selected by gel purification. The size-selected genomic fragments were added to the linearized and dephosphorylated vector at a molar ratio of 0.1 to 1, and ligated to form a shotgun library.

[0529] The ligated products were transformed into electrocompetent E. coli strain XL1-Blue MRF (Stratagene) and plated on LB medium with supplemented with carbenicillin at 100 μg/ml. Resulting colonies numbering 5×105 or greater were scraped and combined, and were then subjected to plasmid purification.

[0530] The purified library was then transformed into electrocompetent Staphylococcus aureus RN4220. Resulting transformants were plated on agar containing LB+0.2% glucose (LBG medium)+chloramphenicol at 15 μg/ml (LBG+CM15 medium) in order to generate 100 to 150 platings at 500 colonies per plating. The colonies were subjected to robotic picking and arrayed into wells of 384 well culture dishes. Each well contained 100 μl of LBG+CM15 liquid medium. Inoculated 384 well dishes were incubated 16 hours at 37° C., and each well was robotically gridded onto solid LBG+CM15 medium with or without 2% xylose. Gridded plates were incubated 16 hours at 37° C., and then manually scored for arrayed colonies that were growth-compromised in the presence of xylose.

[0531] Arrayed colonies that were growth-sensitive on medium containing 2% xylose, yet were able to grow on similar medium lacking xylose, were subjected to further growth sensitivity analysis as follows: Colonies from the plate lacking xylose were manually picked and inoculated into individual wells of a 96 well culture dish containing LBG+CM15, and were incubated for 16 hours at 37° C. These cultures were robotically diluted {fraction (1/100)} into fresh medium and allowed to incubate for 4 hours at 37° C., after which they were subjected to serial dilutions in a 384 well array and then gridded onto media containing 2% xylose or media lacking xylose. After growth for 16 hours at 37° C., the arrays that resulted on the two media were compared to each other. Clones that grew similarly at all dilutions on both media were scored as a negative and were no longer considered. Clones that grew on xylose medium but failed to grow at the same serial dilution on the non-xylose plate were given a score based on the differential, i.e. should the clone grow at a serial dilution of 104 or less on the xylose plate and grow at a serial dilution of 108 or less on the non-xylose plate, then the corresponding clone received a score of “4” representing the log difference in growth observed.

[0532] For Salmonella typhimurium and Klebsiella pneumoniae growth curves were carried out by back diluting cultures 1:200 into fresh media containing 1 mM IPTG or media lacking IPTG and measuring the OD450 every 30 minutes (min). To study the effects of transcriptional induction on solid medium, 102, 103, 104, 105, 106, 107 and 108 fold dilutions of overnight cultures were prepared. Aliquots of from 0.5 to 3 μl of these dilutions were spotted on selective agar plates with or without 1 mM IPTG. After overnight incubation, the plates were compared to assess the sensitivity of the clones to IPTG.

[0533] Nucleic acids involved in proliferation of Pseudomonas aeruginosa were identified as follows. Randomly generated fragments of Pseudomonas aeruginosa genomic DNA were transcribed from a two-component inducible promoter system. Integrated on the chromosome was the T7 RNA polymerase gene regulated by lacUV5/lacO (Brunschwig, E. and Darzins, A. 1992. Gene 111:35-41). On an expression plasmid there was a T7 gene 10 promoter, which is transcribed by T7 RNA polymerase, fused with a lacO operator followed by a multiple cloning site. Transcription from this hybrid promoter is inducible by IPTG. Should the genomic DNA downstream of the promoter contain, in an antisense orientation, at least a portion of an mRNA encoding a gene product involved in proliferation, then induction of expression from the promoter will result in detectable inhibition of proliferation.

[0534] A shotgun library of Pseudomonas aeruginosa genomic fragments was cloned into the vectors pEP5, pEP5S, or other similarly constructed vectors which harbor the T7lacO inducible promoter. The vector was linearized at a unique SmaI site immediately downstream of the T7lacO promoter/operator. The linearized vector was treated with shrimp alkaline phosphatase to prevent reclosure of the linearized ends. Genomic DNA isolated from Pseudomonas aeruginosa strain PAO1 was partially digested with DNase I and “blunt-ended” by incubating with T4 DNA polymerase. Random genomic fragments between 200 and 800 base pairs in length were selected by gel purification. The size-selected genomic fragments were added to the linearized and dephosphorylated vector at a molar ratio of 2 to 1, and ligated to form a shotgun library.

[0535] The ligated products were transformed into electrocompetent E. coli strain XL1-Blue MRF (Stratagene) and plated on LB medium with carbenicillin at 100 μg/ml or Streptomycin 100 μg/ml. Resulting colonies numbering 5×105 or greater were scraped and combined, and were then subjected to plasmid purification.

[0536] The purified library was then transformed into electrocompetent Pseudomonas aeruginosa strain PAO1. Resulting transformants were plated on LB agar with carbenicillin at 100 μg/ml or Streptomycin 40 μg/ml in order to generate 100 to 150 platings at 500 colonies per plating. The colonies were subjected to robotic picking and arrayed into wells of 384 well culture dishes. Each well contained 100 μl of LB+CB 100 or Streptomycin 40 liquid medium. Inoculated 384 well dishes were incubated 16 hours at room temperature, and each well was robotically gridded onto solid LB+CB100 or Streptomycin 40 medium with or without 1 mM IPTG. Gridded plates were incubated 16 hours at 37° C., and then manually scored for arrayed colonies that were growth-compromised in the presence of IPTG.

[0537] Arrayed colonies that were growth-sensitive on medium containing 1 mM IPTG, yet were able to grow on similar medium lacking IPTG, were subjected to further growth sensitivity analysis as follows: Colonies from the plate lacking IPTG were manually picked and inoculated into individual wells of a 96 well culture dish containing LB+CB100 or Streptomycin 40, and were incubated for 16 hours at 30° C. These cultures were robotically diluted {fraction (1/100)} into fresh medium and allowed to incubate for 4 hours at 37° C., after which they were subjected to serial dilutions in a 384 well array and then gridded onto media with and without 1 mM IPTG. After growth for 16 hours at 37° C., the arrays of serially diluted spots that resulted were compared between the two media. Clones that grew similarly at all dilutions on both media were scored as a negative and were no longer considered. Clones that grew on IPTG medium but failed to grow at the same serial dilution on the non-IPTG plate were given a score based on the differential, i.e. should the clone grow at a serial dilution of 104 or less on the IPTG plate and grow at a serial dilution of 108 or less on the IPTG plate, then the corresponding clone received a score of “4” representing the log difference in growth observed.

[0538] Following the identification of those vectors that, upon induction, negatively impacted Pseudomonas aeruginosa growth or proliferation, the inserts or nucleic acid fragments contained in those vectors were isolated for subsequent characterization. Vectors of interest were subjected to nucleic acid sequence determination.

[0539] Nucleic acids involved in proliferation of E. faecalis were identified as follows. Randomly generated fragments of genomic DNA were expressed from the vectors pEPEF3 or pEPEF14, which contain the CP25 or P59 promoter, respectively, regulated by the xy1 operator/repressor. Should the genomic DNA downstream of the promoter contain, in an antisense orientation, at least a portion of a mRNA encoding a gene product involved in proliferation, then induction of expression from the promoter will result in detectable inhibition of proliferation.

[0540] A shotgun library of E. faecalis genomic fragments was cloned into the vector pEPEF3 or pEPEF14, which harbor xylose inducible promoters. The vector was linearized at a unique SmaI site immediately downstream of the promoter/operator. The linearized vector was treated with alkaline phosphatase to prevent reclosure of the linearized ends. Genomic DNA isolated from E. faecalis strain OG1RF was partially digested with DNase I and “blunt-ended” by incubating with T4 DNA polymerase. Random genomic fragments between 200 and 800 base pairs in length were selected by gel purification. The size-selected genomic fragments were added to the linearized and dephosphorylated vector at a molar ratio of 2 to 1, and ligated to form a shotgun library.

[0541] The ligated products were transformed into electrocompetent E. coli strain TOP10 cells (Invitrogen) and plated on LB medium with erythromycin (Erm) at 150 μg/ml. Resulting colonies numbering 5×105 or greater were scraped and combined, and were then subjected to plasmid purification.

[0542] The purified library was then transformed into electrocompetent E. faecalis strain OGIRF. Resulting transformants were plated on Todd-Hewitt (TH) agar with erythromycin at 10 μg/ml in order to generate 100 to 150 platings at 500 colonies per plating. The colonies were subjected to robotic picking and arrayed into wells of 384 well culture dishes. Each well contained 100 μl of THB+Erm 10 μg/ml. Inoculated 384 well dishes were incubated 16 hours at room temperature, and each well was robotically gridded onto solid TH agar+Erm with or without 5% xylose. Gridded plates were incubated 16 hours at 37° C., and then manually scored for arrayed colonies that were growth-compromised in the presence of xylose.

[0543] Arrayed colonies that were growth-sensitive on medium containing 5% xylose, yet were able to grow on similar medium lacking xylose, were subjected to further growth sensitivity analysis. Colonies from the plate lacking xylose were manually picked and inoculated into individual wells of a 96 well culture dish containing THB+Erm 10, and were incubated for 16 hours at 30° C. These cultures were robotically diluted {fraction (1/100)} into fresh medium and allowed to incubate for 4 hours at 37° C., after which they were subjected to serial dilution on plates containing 5% xylose or plates lacking xylose. After growth for 16 hours at 37° C., the arrays of serially diluted spots that resulted were compared between the two media. Colonies that grew similarly on both media were scored as a negative and corresponding colonies were no longer considered. Colonies on xylose medium that failed to grow to the same serial dilution compared to those on the non-xylose plate were given a score based on the differential. For example, colonies on xylose medium that only grow to a serial dilution of −4 while they were able to grow to −8 on the non-xylose plate, then the corresponding transformant colony received a score of “4” representing the log difference in growth observed.

[0544] Following the identification of those vectors that, upon induction, negatively impacted E. faecalis growth or proliferation, the inserts or nucleic acid fragments contained in those expression vectors were isolated for subsequent characterization. The inserts in the vectors of interest were subjected to nucleotide sequence determination.

[0545] It will be appreciated that other restriction enzymes and other endonucleases or methodologies may be used to generate random genomic fragments. In addition, random genomic fragments may be generated by mechanical shearing. Sonication and nebulization are two such techniques commonly used for mechanical shearing of DNA.

Example 2

Nucleotide Sequence Determination of Identified Clones Transribing Nucleic Acid Fragments with Detrimental Effects on Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis Proliferation

[0546] Plasmids from clones that received a dilution plating score of “2” or greater were isolated to obtain the genomic DNA insert responsible for growth inhibition as follows. Staphylococcus aureus were grown in standard laboratory media (LB or TB with 15 ug/ml Chloramphenicol to select for the plasmid). Growth was carried out at 37° C. overnight in culture tubes or 2 ml deep well microtiter plates.

[0547] Lysis of Staphylococcus aureus was performed as follows. Cultures (2-5 ml) were centrifuged and the cell pellets resuspended in 1.5 mg/ml solution of lysostaphin (20 μl/ml of original culture) followed by addition of 250 μl of resuspension buffer (Qiagen). Alternatively, cell pellets were resuspended directly in 250 μl of resuspension buffer (Qiagen) to which 5-20 μl of a 1 mg/ml lysostaphin solution were added.

[0548] DNA was isolated using Qiagen miniprep kits or Wizard (Qiagen) miniprep kits according to the instructions provided by the manufacturer.

[0549] The genomic DNA inserts were amplified from the purified plasmids by PCR as follows.

[0550] 1 μl of Qiagen purified plasmid was put into a total reaction volume of 25 μl Qiagen Hot Start PCR mix. For Staphylococcus aureus, the following primers were used in the PCR reaction:

pXylT5F: CAGCAGTCTGAGTTATAAAATAG (SEQ ID NO: 1)
LexL TGTTTTATCAGACCGCTT          (SEQ ID NO: 2)

[0551] Similar methods were conducted for Salmonella typhimurium and Klebsiella pneumoniae. For Salmonella typhimurium and Klebsiella pneumoniae the following primers were used:

5′-TGTTTTATCAGACCGCTT-3′ (SEQ ID NO: 2)
and
5′-ACAATTTCACACAGCCTC-3′ (SEQ ID NO: 4)

[0552] PCR was carried out in a PE GenAmp with the following cycle times:

[0553] Step 1. 95° C. 15 min

[0554] Step 2. 94° C. 45sec

[0555] Step 3. 54° C. 45 sec

[0556] Step 4. 72° C. 1 minute

[0557] Step 5. Return to step 2, 29 times

[0558] Step 6. 72° C. 10 minutes

[0559] Step 7. 4° C. hold

[0560] The PCR products were cleaned using Qiagen Qiaquick PCR plates according to the manufacturer's instructions.

[0561] For Pseudomonas aeruginosa, plasmids from transformant colonies that received a dilution plating score of “2” or greater were isolated to obtain the genomic DNA insert responsible for growth inhibition as follows. Pseudomonas aeruginosa were grown in standard laboratory media (LB with carbenicillin at 100 μg/ml or Streptomycin 40 μg/ml to select for the plasmid). Growth was carried out at 30° C. overnight in 100 ul culture wells in microtiter plates. To amplify insert DNA 2 ul of culture were placed into 25 ul Qiagen Hot Start PCR mix. PCR reactions were in 96 well microtiter plates. For plasmid pEP5S the following primers were used in the PCR reaction:

T7L1+: GTCGGCGATATAGGCGCCAGCAACCG (SEQ ID NO: 5)
pStrA3: ATAATCGAGCATGAGTATCATACG (SEQ ID NO: 6)

[0562] PCR was carried out in a PE GenAmp with the following cycle times:

[0563] Step 1. 95° C. 15 min

[0564] Step 2. 94° C. 45 sec

[0565] Step 3. 54° C. 45 sec

[0566] Step 4. 72° C. 1 minute

[0567] Step 5. Return to step 2, 29 times

[0568] Step 6. 72° C. 10 minutes

[0569] Step 7. 4° C. hold

[0570] The PCR products were cleaned using Qiagen Qiaquick PCR plates according to the manufacturer's instructions.

[0571] The purified PCR products were then directly cycle sequenced with Qiagen Hot Start PCR mix. The following primers were used in the sequencing reaction:

T7/L2: ATGCGTCCGGCGTAGAGGAT (SEQ ID NO: 7)

[0572] PCR was carried out in a PE GenAmp with the following cycle times:

[0573] Step 1. 94° C. 15 min

[0574] Step 2. 96° C. 10 sec

[0575] Step 3. 50° C. 5 sec

[0576] Step 4. 60° C. 4 min

[0577] Step 5. Return to step 2, 24 times

[0578] Step 6. 4° C. hold

[0579] The PCR products were cleaned using Qiagen Qiaquick PCR plates according to the manufacturer's instructions.

[0580] For E. faecalis, plasmids from transformant colonies that received a dilution plating score of “2” or greater were isolated to obtain the genomic DNA insert responsible for growth inhibition as follows. E. faecalis were grown in THB 10 μg/ml Erm at 30° C. overnight in 100 ul culture wells in microtiter plates. To amplify insert DNA 2 ul of culture were placed into 25 μl Qiagen Hot Start PCR mix. PCR reactions were in 96 well microtiter plates. The following primers were used in the PCR reaction:

pXylT5: CAGCAGTCTGAGTTATAAAATAG (SEQ ID NO: 1)
and the

[0581] PCR was carried out in a PE GenAmp with the following cycle times:

[0582] Step 1. 95° C. 15 min

[0583] Step 2. 94° C. 45 sec

[0584] Step 3. 54° C. 45 sec

[0585] Step 4. 72° C. 1 minute

[0586] Step 5. Return to step 2, 29 times

[0587] Step 6. 72° C. 10 minutes

[0588] Step 7. 4° C. hold

[0589] The PCR products were cleaned using Qiagen Qiaquick PCR plates according to the manufacturer's instructions.

[0590] The purified PCR products were then directly cycle sequenced with Qiagen Hot Start PCR mix. The following primers were used in the PCR reaction:

pXylT5: CAGCAGTCTGAGTTATAAAATAG (SEQ ID NO: 1)

[0591] PCR was carried out in a PE GenAmp with the following cycle times:

[0592] Step 1. 94° C. 15 min

[0593] Step 2. 96° C. 10 sec

[0594] Step 3. 50° C. 5 sec

[0595] Step 4. 60° C. 4 min

[0596] Step 5. Return to step 2, 24 times

[0597] Step 6. 4° C. hold

[0598] The PCR products were cleaned using Qiagen Qiaquick PCR plates according to the manufacturer's instructions.

[0599] The amplified genomic DNA inserts from each of the above procedures were subjected to automated sequencing. Sequence identification numbers (SEQ ID NOs) and clone names for the identified inserts are listed in Table IA and discussed below.

Example 3

Comparison of Isolated Nucleic Acids to Known Sequences

[0600] The nucleotide sequences of the subcloned fragments from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis obtained from the expression vectors discussed above were compared to known sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis and other microorganisms as follows. First, to confirm that each clone originated from one location on the chromosome and was not chimeric, the nucleotide sequences of the selected clones were compared against the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis genomic sequences to align the clone to the correct position on the chromosome. The NCBI BLASTN v 2.0.9 program was used for this comparison, and the incomplete Staphylococcus aureus genomic sequences licensed from TIGR, as well as the NCBI nonredundant GenBank database were used as the source of genomic data. Salmonella typhimurium sequences were compared to sequences available from the Genome Sequencing Center (http://genome.wustl.edu/gsc/salmonella.shtml), and the Sanger Centre (http://www.sanger.ac.uk/projects/S_typhi). Pseudomonas aeruginosa sequences were compared to a proprietary database and the NCBI GenBank database. The E. faecalis sequences were compared to a proprietary database.

[0601] The BLASTN analysis was performed using the default parameters except that the filtering was turned off. No further analysis was performed on inserts which resulted from the ligation of multiple fragments.

[0602] In general, antisense molecules and their complementary genes are identified as follows. First, all possible full length open reading frames (ORFs) are extracted from available genomic databases. Such databases include the GenBank nonredundant (nr) database, the unfinished genome database available from TIGR and the PathoSeq database developed by Incyte Genomics. The latter database comprises over 40 annotated bacterial genomes including complete ORF analysis. If databases are incomplete with regard to the bacterial genome of interest, it is not necessary to extract all ORFs in the genome but only to extract the ORFs within the portions of the available genomic sequences which are complementary to the clones of interest. Computer algorithms for identifying ORFs, such as GeneMark, are available and well known to those in the art. Comparison of the clone DNA to the complementary ORF(s) allows determination of whether the clone is a sense or antisense clone. Furthermore, each ORF extracted from the database can be compared to sequences in well annotated databases including the GenBank (nr) protein database, SWISSPROT and the like. A description of the gene or of a closely related gene in a closely related microorganism is often available in these databases. Similar methods are used to identify antisense clones corresponding to genes encoding non-translated RNAs.

[0603] In order to generate the gene identification data compiled in Table IB, each of the cloned nucleic acid sequences discussed above corresponding to SEQ ID NO.s 8-3795 was used to identify the corresponding Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis ORFs in the PathoSeq v.4.1 (March 2000 release) database of microbial genomic sequences. For this purpose, the NCBI BLASTN 2.0.9 computer algorithm was used. The default parameters were used except that filtering was turned off. The default parameters for the BLASTN and BLASTX analyses were:

[0604] Expectation value (e)=10

[0605] Alignment view options: pairwise

[0606] Filter query sequence (DUST with BLASTN, SEG with others)=T

[0607] Cost to open a gap (zero invokes behavior)=0

[0608] Cost to extend a gap (zero invokes behavior)=0

[0609] X dropoff value for gapped alignment (in bits) (zero invokes behavior)=0

[0610] Show GI's in deflines=F

[0611] Penalty for a nucleotide mismatch (BLASTN only)=!3

[0612] Reward for a nucleotide match (BLASTN only)=1

[0613] Number of one-line descriptions (V)=500

[0614] Number of alignments to show (B)=250

[0615] Threshold for extending hits=default

[0616] Perform gapped alignment (not available with BLASTX)=T

[0617] Query Genetic code to use=1

[0618] DB Genetic code (for TBLAST[nx] only=1

[0619] Number of processors to use=1

[0620] SeqAlign file

[0621] Believe the query defline=F

[0622] Matrix=BLOSUM62

[0623] Word Size=default

[0624] Effective length of the database (use zero for the real size)=0

[0625] Number of best hits from a region to keep=100

[0626] Length of region used to judge hits=20

[0627] Effective length of the search space (use zero for the real size)=0

[0628] Query strands to search against database (for BLAST[nx] and TBLASTX), 3 is both, 1 is top, 2 is bottom=3

[0629] Produce HTML output=F

[0630] Alternatively, ORFs were identified and refined by conducting a survey of the public and private data sources. Full-length gene protein and nucleotide sequences for these organisms were assembled from various sources. For Pseudomonas aeruginosa, gene sequences were adopted from the Pseudomonas genome sequencing project (downloaded from http://www.pseudomonas.com). For Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pneumoniae and Salmonella typhi, genomic sequences from PathoSeq v 4.1 (Mar 2000 release) was reanalyzed for ORFs using the gene finding software GeneMark v 2.4a, which was purchased from GenePro Inc. 451 Bishop St., N. W., Suite B, Atlanta, Ga., 30318, USA.

[0631] Antisense clones were identified as those clones for which transcription from the inducible promoter would result in the expression of an RNA antisense to a complementary ORF, intergenic or intragenic sequence. Those clones containing single inserts and that caused growth sensitivity upon induction are listed in Table IA. ORFs complementary to the antisense nucleic acids, and their encoded polypeptides, are listed in Table IB.

[0632] The gene descriptions in the PathoSeq database derive from annotations available in the public sequence databases described above. Where a clone was found to share significant sequence identity to two or more adjacent ORFs, it was listed once for each ORF and the PathoSeq information for each ORF was compiled in Table IB.

[0633] Table IA lists the SEQ ID NOs. and clone names of the inserts which inhibited proliferation and the organism in which the clone was identified. This information was used to identify the ORFs (SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012) whose gene products (SEQ ID NOs. 3801-3805, 4861-5915, 10013-14110) were inhibited by the nucleic acids comprising the nucleotide sequences of SEQ ID NOs. 8-3795. Table IB lists the clone name, the SEQ ID NO. of the antisense clone (in the column labelled Clone SEQ ID), the PathoSeq Locus containing the clone, the SEQ ID of the ORF identified in PathoSeq (in the column labelled Gene Seq ID (protein), the refined full length gene (column labelled genemarked gene), and the SEQ ID NO of the protein encoded by the refined full length gene (column labelled full length ORF protein SEQ ID).

[0634] Table IC provides a cross reference between PathoSeq Gene Locus listed in Table IB, the SEQ ID NOs. of the PathoSeq proteins and the SEQ ID NOs. of the nucleic acids which encode them.

[0635] It will be appreciated that ORFs may also be identified using databases other than PathoSeq. For example, the ORFs may be identified using the methods described in U.S. Provisional Patent Application Ser. No. 60/191,078, filed Mar. 21, 2000, the disclosure of which is incorporated herein by reference in its entirety.

Example 4

Identification of Genes and their Corresponding Operons Affected by Antisense Inhibition

[0636] Once the genes involved in Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis proliferation are identified as described above, the operons in which these genes lie may be identified by comparison with known microbial genomes. Since bacterial genes are transcribed in a polycistronic manner, the antisense inhibition of a single gene in an operon might affect the expression of all the other genes on the operon or the genes downstream from the single gene identified. Accordingly, each of the genes contained within an operon may be analyzed for their effect on proliferation.

[0637] Operons are predicted by looking for all adjacent genes in a genomic region that lie in the same orientation with no large noncoding gaps in between. First, full-length ORFs complementary to the antisense molecules are identified as described above. Adjacent ORFs are then identified and their relative orientation determined either by directly analyzing the genomic sequences surrounding the ORFs complementary to the antisense clones or by extracting adjacent ORFs from the collection obtained through whole genome ORF analysis described above followed by ORF alignment. Operons predicted in this way may be confirmed by comparison to the arrangement of the homologous nucleic acids in the Bacillus subtilis complete genome sequence, as reported by the genome database compiled at Institut Pasteur Subtilist Release RI 5.1 (Jun. 24, 1999) which can be found at htt ://bioweb.pasteur.fr/GenoList/SubtiList/. The Bacillus subtilis genome is the only fully sequenced and annotated genome from a Gram-positive microorganism, and appears to have a high level of similarity to Staphylococcus aureus both at the level of conservation of gene sequence and genomic organization including operon structure. Operons for Salmonella typhimurium and Klebsiella pneumoniae may be identified by comparison with E. coli, Haemophilus, or Pseudomonas sequences. The Pseudomonas aeruginosa web site (http://www.pseudomonas.com) can also be used to help predict operon organization in this bacterium.

[0638] Extensive DNA sequences of Salmonella typhimurium are available through the Salmonella Genome Center (Washington University, St. Louis, Mo.) the Sanger Centre (United Kingdom) and the PathoSeq database (Incyte ). Annotation of some of the DNA sequences in some of the aforementioned databases is lacking, but comparisons may be made to E. coli using tools such as BLASTX.

[0639] Public or proprietary databases may be used to analyzed E. faecalis sequences as well as sequences from the organisms listed above.

[0640] The results of such an analysis as applied to clone number S1M10000001A05 from Staphylococcus aureus are listed in Table II. Table II lists the SEQ ID NOs. of the Staphylococcus aureus genes involved in proliferation, the SEQ ID NOs. of the proteins encoded by these genes, and the clone name containing the nucleic acid which inhibits Staphylococcus aureus proliferation. In addition, Table II lists those other genes located on the operon included in the Staphylococcus aureus genomic sequence determined as described above. For each of the genes described in Table II, the microoganism containing the most closely related homolog, identified in one of the public databases, is also indicated in Table II.

TABLE II
					Organism
					used for
DNA	Protein	Molecule			identification
Seq ID	Seq ID	number	Clone name	Gene	of gene
3796	3801	SaXA001	S1M10000001A05	ytmI	B. subtilis
3797	3802			nirR	S. carnosus
3798	3803			nirB	S. carnosus
3799	3804			nirD	S. carnosus
3800	3805			sirB	S. carnosus

[0641] The preceding analyses may be conducted for each of the sequences which are listed in Table IA which inhibit proliferation and the ORFs listed in Table IB and Table IC. Once the full length ORFs and/or the operons containing them have been identified using the methods described above, they can be obtained from a genomic library by performing a PCR amplification using primers at each end of the desired sequence. Those skilled in the art will appreciate that a comparison of the ORFs to homologous sequences in other cells or microorganisms will facilitate confirmation of the start and stop codons at the ends of the ORFs.

[0642] In some embodiments, the primers may contain restriction sites which facilitate the insertion of the gene or operon into a desired vector. For example, the gene may be inserted into an expression vector and used to produce the proliferation-required protein as described below. Other methods for obtaining the full length ORFs and/or operons are familiar to those skilled in the art. For exmaple, natural restriction sites may be employed to insert the full length ORFs and/or operons into a desired vector.

Example 5

Identification of Individual Genes within an Operon Required for Proliferation

[0643] The following example illustrates a method for determining if a targeted gene within an operon is required for cell proliferation by replacing the targeted allele in the chromosome with an in-frame deletion of the coding region of the targeted gene.

[0644] Deletion inactivation of a chromosomal copy of a gene in Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi can be accomplished by integrative gene replacement. The principles of this method were described in Xia, M., et al. 1999 Plasmid 42:144-149 and Hamilton, C. M., et al 1989. J Bacteriol. 171: 4617-4622, the disclosures of which are incorporated herein by reference in their entireties. A similar gene disruption method is available for Pseudomonas aeruginosa, except the counter selectable marker is sacB (Schweizer, H. P., Klassen, T. and Hoang, T. (1996) Mol. Biol. of Pseudomonas. ASM press, 229-237, the disclosure of which is incorporated herein by reference in its entirety). In this approach, a mutant allele of the targeted gene is constructed by way of an in-frame deletion and introduced into the chromosome using a suicide vector. This results in a tandem duplication comprising a deleted (null) allele and a wild type allele of the target gene. Cells in which the vector sequences have been deleted are isolated using a counter-selection technique. Removal of the vector sequence from the chromosomal insertion results in either restoration of the wild-type target sequence or replacement of the wild type sequence with the deletion (null) allele. E. faecalis genes can be disrupted using a suicide vector that contains an internal fragment to a gene of interest. With the appropriate selection this plasmid will homologously recombine into the chromosome (Nallapareddy, S. R., X. Qin, G. M. Weinstock, M. Hook, B. E. Murray. 2000. Infect. Immun. 68:5218-5224, the disclosure of which is incorporated herein by reference).

[0645] The resultant population of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi colonies can then be evaluated to determine whether the target sequence is required for proliferation by PCR amplification of the affected target sequence. If the targeted gene is not required for proliferation, then PCR analysis will show that roughly equal numbers of colonies have retained either the wild-type or the mutant allele. If the targeted gene is required for proliferation, then only wild-type alleles will be recovered in the PCR analysis.

[0646] The method of cross-over PCR is used to generate the mutant allele by amplification of nucleotide sequences flanking but not including the coding region of the gene of interest, using specifically designed primers such that overlap between the resulting two PCR amplification products allows them to hybridize. Further PCR amplification of this hybridization product using primers representing the extreme 5′ and 3′ ends can produce an amplification product containing an in-frame deletion of the coding region but retaining substantial flanking sequences.

[0647] For Staphylococcus aureus, this amplification product is subcloned into the suicide vector pSA3182 (Xia, M., et al. 1999 Plasmid 42:144-149, the disclosure of which is incorporated herein by reference in its entirety) which is host-dependent for autonomous replication. This vector includes a tetC tetracycline-resistance marker and the origin of replication of the well-known Staphylococcus aureus plasmid pT181 (Mojumdar, M and Kahn, S. A., Characterisation of the Tetracycline Resistance Gene of Plasmid pT181, J. Bacteriol. 170: 5522 (1988), the disclosure of which is incorporated herein by reference in its entirety). The vector lacks the repC gene which is required for autonomous replication of the vector at the pT181 origin. This vector can be propagated in a Staphylococcus aureus host strain such as SA3528, which expresses repC in trans. Once the amplified truncated target gene sequence is cloned and propagated in the pSA3182 vector, it can then be introduced into a repC minus strain such as RN4220 (Kreiswirth, B. N. et al., The Toxic Shock Syndrome Exotoxin Structural Gene is Not Detectably Transmitted by a Prophage, Nature 305:709-712 (1983), the disclosure of which is incorporated herein by reference in its entirety) by electroporation with selection for tetracycline resistance. In this strain, the vector must integrate by homologous recombination at the targeted gene in the chromosome to impart drug resistance. This results in a inserted truncated copy of the allele, followed by pSA3182 vector sequence, and finally an intact and functional allele of the targeted gene.

[0648] Once a tetracycline resistant Staphylococcus aureus strain is isolated using the above technique and shown to include truncated and wild-type alleles of the targeted gene as described above, a second plasmid, pSA7592 (Xia, M., et al. 1999 Plasmid 42:144-149, the disclosure of which is incorporated herein by reference in its entirety) is introduced into the strain by electroporation. This gene includes an erythromycin resistance gene and a repC gene that is expressed at high levels. Expression of repC in these transformants is toxic due to interference of normal chromosomal replication at the integrated pT181 origin of replication. This selects for strains that have removed the vector sequence by homologous recombination, resulting in either of two outcomes: The selected cells either possess a wild-type allele of the targeted gene or a gene in which the wild-type allele has been replaced by the engineered in-frame deletion of the truncated allele.

[0649] PCR amplification can be used to determine the genetic outcome of the above process in the resulting erythromycin resistant, tet sensitive transformant colonies. If the targeted gene is not required for cellular replication, then PCR evidence for both wild-type and mutant alleles will be found among the population of resultant transformants. However, if the targeted gene is required for cellular proliferation, then only the wild-type form of the gene will be evident among the resulting transformants.

[0650] Similarly, for Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi the PCR products containing the mutant allele of the target sequence may be introduced into an appropriate knockout vector and cells in which the wild type target has been disrupted are selected using the appropriate methodology.

[0651] The above methods have the advantage that insertion of an in-frame deletion mutation is far less likely to cause downstream polar effects on genes in the same operon as the targeted gene. However, it will be appreciated that other methods for disrupting Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi genes which are familiar to those skilled in the art may also be used.

[0652] Each gene in the operon may be disrupted using the methodology above to determine whether it is required for proliferation.

Example 6

Expression of the Proteins Encoded by Genes Identified as Required for Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi Proliferation

[0653] The following is provided as one exemplary method to express the proliferation-required proteins idenfied as described above. The proliferation-required proteins may be expressed using any of the bacterial, insect, yeast, or mammalian expression systems known in the art. In some embodiments, the proliferation-required proteins encoded by the identified nucleotide sequences described above (including the proteins of SEQ ID NOs.: 3801-3805,4861-5915, 10013-14110 encoded by the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 are expressed using expression systems designed either for E. coli or for Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi. First, the initiation and termination codons for the gene are identified. If desired, methods for improving translation or expression of the protein are well known in the art. For example, if the nucleic acid encoding the polypeptide to be expressed lacks a methionine codon to serve as the initiation site, a strong Shine-Delgarno sequence, or a stop codon, these nucleotide sequences can be added. Similarly, if the identified nucleic acid lacks a transcription termination signal, this nucleotide sequence can be added to the construct by, for example, splicing out such a sequence from an appropriate donor sequence. In addition, the coding sequence may be operably linked to a strong constitutive promoter or an inducible promoter if desired. The identified nucleic acid or portion thereof encoding the polypeptide to be expressed is obtained by, for example, PCR from the bacterial expression vector or genome using oligonucleotide primers complementary to the identified nucleic acid or portion thereof and containing restriction endonuclease sequences appropriate for inserting the coding sequences into the vector such that the coding sequences can be expressed from the vector's promoter. Alternatively, other conventional cloning techniques may be used to place the coding sequence under the control of the promoter. In some embodiments, a termination signal may be located downstream of the coding sequence such that transcription of the coding sequence ends at an appropriate position.

[0654] Several expression vector systems for protein expression in E. coli are well known and available to those knowledgeable in the art. The coding sequence may be inserted into any of these vectors and placed under the control of the promoter. The expression vector may then be transformed into DH5α or some other E. coli strain suitable for the over expression of proteins.

[0655] Alternatively, an expression vector encoding a protein required for proliferation of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi may be introduced into Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi. Protocols for introducing nucleic acids into these organisms are well known in the art. For example, the protocols described in J. C. Lee “Electroporation of Staphylococci” from Methods in Molecular Biology vol 47: Electroporation Protocols for Microorganisms Edited by: J. A. Nickoloff Humana Press Inc., Totowa, N.J. pp209-216, the disclosure of which is incorporated herein by reference in its entirety, may be used to introduce nucleic acids into Staphylococcus aureus. Nucleic acids may also be introduced into Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa or Enterococcus faecalis using methods familiar to those skilled in the art. Positive transformants are selected after growing the transformed cells on plates containing an antibiotic to which the vector confers resistance. In one embodiment, Staphylococcus aureus is transformed with an expression vector in which the coding sequence is operably linked to the T5 promoter containing a xylose operator such that expression of the encoded protein is inducible with xylose.

[0656] In one embodiment, the protein is expressed and maintained in the cytoplasm as the native sequence. In an alternate embodiment, the expressed protein can be modified to include a protein tag that allows for differential cellular targeting, such as to the periplasmic space of Gram-negative or Gram-positive expression hosts or to the exterior of the cell (i.e., into the culture medium). In some embodiments, the osmotic shock cell lysis method described in Chapter 16 of Current Protocols in Molecular Biology, Vol. 2, (Ausubel, et al., Eds.) John Wiley & Sons, Inc. (1997) may be used to liberate the polypeptide from the cell. In still another embodiment, such a protein tag could also facilitate purification of the protein from either fractionated cells or from the culture medium by affinity chromatography. Each of these procedures can be used to express a proliferation-required protein.

[0657] Expressed proteins, whether in the culture medium or liberated from the periplasmic space or the cytoplasm, are then purified or enriched from the supernatant using conventional techniques such as ammonium sulfate precipitation, standard chromatography, immunoprecipitation, immunochromatography, size exclusion chromatography, ion exchange chromatography, and HPLC. Alternatively, the polypeptide may be secreted from the host cell in a sufficiently enriched or pure state in the supernatant or growth media of the host cell to permit it to be used for its intended purpose without further enrichment. The purity of the protein product obtained can be assessed using techniques such as SDS PAGE, which is a protein resolving technique well known to those skilled in the art. Coomassie, silver staining or staining with an antibody are typical methods used to visualize the protein of interest.

[0658] Antibodies capable of specifically recognizing the protein of interest can be generated using synthetic peptides using methods well known in the art. See, Antibodies: A Laboratory Manual, (Harlow and Lane, Eds.) Cold Spring Harbor Laboratory (1988). For example, 15-mer peptides having an amino acid sequence encoded by the appropriate identified gene sequence of interest or portion thereof can be chemically synthesized. The synthetic peptides are injected into mice to generate antibodies to the polypeptide encoded by the identified nucleic acid sequence of interest or portion thereof. Alternatively, samples of the protein expressed from the expression vectors discussed above can be purified and subjected to amino acid sequencing analysis to confirm the identity of the recombinantly expressed protein and subsequently used to raise antibodies. An Example describing in detail the generation of monoclonal and polyclonal antibodies appears in Example 7.

[0659] The protein encoded by the identified nucleic acid of interest or portion thereof can be purified using standard immunochromatography techniques. In such procedures, a solution containing the secreted protein, such as the culture medium or a cell extract, is applied to a column having antibodies against the secreted protein attached to the chromatography matrix. The secreted protein is allowed to bind the immunochromatography column. Thereafter, the column is washed to remove non-specifically bound proteins. The specifically-bound secreted protein is then released from the column and recovered using standard techniques. These procedures are well known in the art.

[0660] In an alternative protein purification scheme, the identified nucleic acid of interest or portion thereof can be incorporated into expression vectors designed for use in purification schemes employing chimeric polypeptides. In such strategies the coding sequence of the identified nucleic acid of interest or portion thereof is inserted in-frame with the gene encoding the other half of the chimera. The other half of the chimera can be maltose binding protein (MBP) or a nickel binding polypeptide encoding sequence. A chromatography matrix having maltose or nickel attached thereto is then used to purify the chimeric protein. Protease cleavage sites can be engineered between the MBP gene or the nickel binding polypeptide and the identified expected gene of interest, or portion thereof. Thus, the two polypeptides of the chimera can be separated from one another by protease digestion.

[0661] One useful expression vector for generating maltose binding protein fuision proteins is pMAL (New England Biolabs), which encodes the malE gene. In the pMa1 protein fusion system, the cloned gene is inserted into a pMa1 vector downstream from the malE gene. This results in the expression of an MBP-fusion protein. The fusion protein is purified by affinity chromatography. These techniques as described are well known to those skilled in the art of molecular biology.

Example 7

Production of an Antibody to an Isolated Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi Protein

[0662] Substantially pure protein or polypeptide (including one of the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) is isolated from the transformed cells as described in Example 6. The concentration of protein in the final preparation is adjusted, for example, by concentration on a 10,000 molecular weight cut off AMICON filter device (Millipore, Bedford, Mass.), to the level of a few micrograms/ml. Monoclonal or polyclonal antibody to the protein can then be prepared as follows:

[0663] Monoclonal Antibody Production by Hybridoma Fusion

[0664] Monoclonal antibody to epitopes of any of the peptides identified and isolated as described can be prepared from murine hybridomas according to the classical method of Kohler, G. and Milstein, C., Nature 256:495 (1975) or any of the well-known derivative methods thereof. Briefly, a mouse is repetitively inoculated with a few micrograms of the selected protein or peptides derived therefrom over a period of a few weeks. The mouse is then sacrificed, and the antibody-producing cells of the spleen isolated. The spleen cells are fused by means of polyethylene glycol with mouse myeloma cells, and the excess unfused cells are destroyed by growth of the system on selective medium comprising aminopterin (HAT medium). The successfully-fused cells are diluted and aliquots of the dilution placed in wells of a microtiter plate where growth of the culture is continued. Antibody-producing clones are identified by detection of antibody in the supernatant fluid of the wells by immunoassay procedures, such as ELISA, as described by Engvall, E., “Enzyme immunoassay ELISA and EMIT,” Meth. Enzymol. 70:419 (1980), and derivative methods thereof. Selected positive clones can be expanded and their monoclonal antibody product harvested for use. Detailed procedures for monoclonal antibody production are described in Davis, L. et al. Basic Methods in Molecular Biology Elsevier, New York. Section 21-2.

[0665] Polyclonal Antibody Production by Immunization

[0666] Polyclonal antiserum containing antibodies to heterogeneous epitopes of a single protein or a peptide can be prepared by immunizing suitable animals with the expressed protein or peptides derived therefrom described above, which can be unmodified or modified to enhance immunogenicity. Effective polyclonal antibody production is affected by many factors related both to the antigen and the host species. For example, small molecules tend to be less immunogenic than larger molecules and can require the use of carriers and adjuvant. Also, host animals vary in response to site of inoculations and dose, with both inadequate or excessive doses of antigen resulting in low titer antisera. Small doses (ng level) of antigen administered at multiple intradermal sites appears to be most reliable. An effective immunization protocol for rabbits can be found in Vaitukaitis, J. et al. J. Clin. Endocrinol. Metab. 33:988-991 (1971).

[0667] Booster injections can be given at regular intervals, and antiserum harvested when antibody titer thereof, as determined semi-quantitatively, for example, by double immunodiffusion in agar against known concentrations of the antigen, begins to fall. See, for example, Ouchterlony, O. et al., Chap. 19 in: Handbook of Experimental Immunology D. Wier (ed) Blackwell (1973). Plateau concentration of antibody is usually in the range of 0.1 to 0.2 mg/ml of serum (about 12 EM). Affinity of the antisera for the antigen is determined by preparing competitive binding curves, as described, for example, by Fisher, D., Chap. 42 in: Manual of Clinical Immunology, 2d Ed. (Rose and Friedman, Eds.) Amer. Soc. For Microbiol., Washington, D.C. (1980).

[0668] Antibody preparations prepared according to either protocol are useful in quantitative immunoassays which determine concentrations of antigen-bearing substances in biological samples; they are also used semi-quantitatively or qualitatively to identify the presence of antigen in a biological sample. The antibodies can also be used in therapeutic compositions for killing bacterial cells expressing the protein.

Example 8

Screening Chemical Libraries

[0669] A. Protein-based Assays

[0670] Having isolated and expressed bacterial proteins shown to be required for bacterial proliferation, the present invention further contemplates the use of these expressed target proteins in assays to screen libraries of compounds for potential drug candidates. The generation of chemical libraries is well known in the art. For example, combinatorial chemistry can be used to generate a library of compounds to be screened in the assays described herein. A combinatorial chemical library is a collection of diverse chemical compounds generated by either chemical synthesis or biological synthesis by combining a number of chemical “building block” reagents. For example, a linear combinatorial chemical library such as a polypeptide library is formed by combining amino acids in every possible combination to yield peptides of a given length. Millions of chemical compounds theoretically can be synthesized through such combinatorial mixings of chemical building blocks. For example, one commentator observed that the systematic, combinatorial mixing of 100 interchangeable chemical building blocks results in the theoretical synthesis of 100 million tetrameric compounds or 10 billion pentameric compounds. (Gallop et al., “Applications of Combinatorial Technologies to Drug Discovery, Background and Peptide Combinatorial Libraries,” Journal of Medicinal Chemistry, Vol. 37, No. 9, 1233-1250 (1994). Other chemical libraries known to those in the art may also be used, including natural product libraries.

[0671] Once generated, combinatorial libraries can be screened for compounds that possess desirable biological properties. For example, compounds which may be useful as drugs or to develop drugs would likely have the ability to bind to the target protein identified, expressed and purified as discussed above. Further, if the identified target protein is an enzyme, candidate compounds would likely interfere with the enzymatic properties of the target protein. For example, the enzymatic function of a target protein may be to serve as a protease, nuclease, phosphatase, dehydrogenase, transporter protein, transcriptional enzyme, and any other type of enzyme known or unknown. Thus, the present invention contemplates using the protein products described above to screen combinatorial chemical libraries.

[0672] In one example, the target protein is a serine protease and the substrate of the enzyme is known. The present example is directed towards the analysis of libraries of compounds to identify compounds that function as inhibitors of the target enzyme. First, a library of small molecules is generated using methods of combinatorial library formation well known in the art. U.S. Pat. Nos. 5,463,564 and 5,574,656, to Agrafiotis, et al., entitled “System and Method of Automatically Generating Chemical Compounds with Desired Properties,” the disclosures of which are incorporated herein by reference in their entireties, are two such teachings. Then the library compounds are screened to identify those compounds that possess desired structural and functional properties. U.S. Pat. No. 5,684,711, the disclosure of which is incorporated herein by reference in its entirety, also discusses a method for screening libraries.

[0673] To illustrate the screening process, the target polypeptide and chemical compounds of the library are combined with one another and permitted to interact with one another. A labeled substrate is added to the incubation. The label on the substrate is such that a detectable signal is emitted from the products of the substrate molecules that result from the activity of the target polypeptide. The emission of this signal permits one to measure the effect of the combinatorial library compounds on the enzymatic activity of target enzymes by comparing it to the signal emitted in the absence of combinatorial library compounds. The characteristics of each library compound are encoded so that compounds demonstrating activity against the enzyme can be analyzed and features common to the various compounds identified can be isolated and combined into future iterations of libraries.

[0674] Once a library of compounds is screened, subsequent libraries are generated using those chemical building blocks that possess the features shown in the first round of screen to have activity against the target enzyme. Using this method, subsequent iterations of candidate compounds will possess more and more of those structural and functional features required to inhibit the function of the target enzyme, until a group of enzyme inhibitors with high specificity for the enzyme can be found. These compounds can then be further tested for their safety and efficacy as antibiotics for use in manmmals.

[0675] It will be readily appreciated that this particular screening methodology is exemplary only. Other methods are well known to those skilled in the art. For example, a wide variety of screening techniques are known for a large number of naturally-occurring targets when the biochemical function of the target protein is known. For example, some techniques involve the generation and use of small peptides to probe and analyze target proteins both biochemically and genetically in order to identify and develop drug leads. Such techniques include the methods described in PCT publications No. WO9935494, WO9819162, WO9954728, the disclosures of which are incorporated herein by reference in their entireties. Other techniques utilize natural product libraries or libraries of larger molecules such as proteins.

[0676] It will be appreciated that the above protein-based assays may be performed with any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) or portions thereof. In addition, the above protein-based assays may be performed with homologous polypeptides or portions thereof.

[0677] B. Cell-based Assays

[0678] Current cell-based assays used to identify or to characterize compounds for drug discovery and development frequently depend on detecting the ability of a test compound to modulate the activity of a target molecule located within a cell or located on the surface of a cell. An advantage of cell-based assays is that they allow the effect of a compound on a target molecule's activity to be detected within the physiologically relevant environment of the cell as opposed to an in vitro environment. Most often such target molecules are proteins such as enzymes, receptors and the like. However, target molecules may also include other molecules such as DNAs, lipids, carbohydrates and RNAs including messenger RNAs, ribosomal RNAs, tRNAs, regulatory RNAs and the like. A number of highly sensitive cell-based assay methods are available to those of skill in the art to detect binding and interaction of test compounds with specific target molecules. However, these methods are generally not highly effective when the test compound binds to or otherwise interacts with its target molecule with moderate or low affinity. In addition, the target molecule may not be readily accessible to a test compound in solution, such as when the target molecule is located inside the cell or within a cellular compartment. Thus, current cell-based assay methods are limited in that they are not effective in identifying or characterizing compounds that interact with their targets with moderate to low affinity or compounds that interact with targets that are not readily accessible.

[0679] The cell-based assay methods of the present invention have substantial advantages over current cell-based assays. These advantages derive from the use of sensitized cells in which the level or activity of at least one proliferation-required gene product (the target molecule) has been specifically reduced to the point where the presence or absence of its function becomes a rate-determining step for cellular proliferation. Bacterial, fungal, plant, or animal cells can all be used with the present method. Such sensitized cells become much more sensitive to compounds that are active against the affected target molecule. Thus, cell-based assays of the present invention are capable of detecting compounds exhibiting low or moderate potency against the target molecule of interest because such compounds are substantially more potent on sensitized cells than on non-sensitized cells. The effect may be such that a test compound may be two to several times more potent, at least 10 times more potent, at least 20 times more potent, at least 50 times more potent, at least 100 times more potent, at least 1000 times more potent, or even more than 1000 times more potent when tested on the sensitized cells as compared to the non-sensitized cells. The proliferation-required nucleic acids or polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or portions thereof, may be employed in any of the cell-based assays described herein. Similarly, homologous coding nucleic acids, homologous antisense nucleic acids, or homologous polypeptides or portions of the homologous nucleic acids or homologous polypeptides, may be employed in any of the cell-based assays described herein.

[0680] Due in part to the increased appearance of antibiotic resistance in pathogenic microorganisms and to the significant side-effects associated with some currently used antibiotics, novel antibiotics acting at new targets are highly sought after in the art. Yet, another limitation in the current art related to cell-based assays is the problem of repeatedly identifying hits against the same kinds of target molecules in the same limited set of biological pathways. This may occur when compounds acting at such new targets are discarded, ignored or fail to be detected because compounds acting at the “old” targets are encountered more frequently and are more potent than compounds acting at the new targets. As a result, the majority of antibiotics in use currently interact with a relatively small number of target molecules within an even more limited set of biological pathways.

[0681] The use of sensitized cells of the current invention provides a solution to the above problem in two ways. First, desired compounds acting at a target of interest, whether a new target or a previously known but poorly exploited target, can now be detected above the “noise” of compounds acting at the “old” targets due to the specific and substantial increase in potency of such desired compounds when tested on the sensitized cells of the current invention. Second, the methods used to sensitize cells to compounds acting at a target of interest may also sensitize these cells to compounds acting at other target molecules within the same biological pathway. For example, expression of an antisense molecule to a gene encoding a ribosomal protein is expected to sensitize the cell to compounds acting at that ribosomal protein and may also sensitize the cells to compounds acting at any of the ribosomal components (proteins or rRNA) or even to compounds acting at any target which is part of the protein synthesis pathway. Thus an important advantage of the present invention is the ability to reveal new targets and pathways that were previously not readily accessible to drug discovery methods.

[0682] Sensitized cells of the present invention are prepared by reducing the activity or level of a target molecule. The target molecule may be a gene product, such as an RNA or polypeptide produced from the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including a gene product produced from the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, such as the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) or from homologous nucleic acids. For example, the target molecule may be one of the polypeptides of SEQ ID NOs. 3801-3805, 4861-5915, 10013-14110 or a homologous polypeptide. Alternatively, the target may be a gene product such as an RNA or polypeptide which is produced from a sequence within the same operon as the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or from homologous nucleic acids. In addition, the target may be an RNA or polypeptide in the same biological pathway as the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or from homologous nucleic acids. Such biological pathways include, but are not limited to, enzymatic, biochemical and metabolic pathways as well as pathways involved in the production of cellular structures such the cell wall.

[0683] Current methods employed in the arts of medicinal and combinatorial chemistries are able to make use of structure-activity relationship information derived from testing compounds in various biological assays including direct binding assays and cell-based assays. Occasionally compounds are directly identified in such assays that are sufficiently potent to be developed as drugs. More often, initial hit compounds exhibit moderate or low potency. Once a hit compound is identified with low or moderate potency, directed libraries of compounds are synthesized and tested in order to identify more potent leads. Generally these directed libraries are combinatorial chemical libraries consisting of compounds with structures related to the hit compound but containing systematic variations including additions, subtractions and substitutions of various structural features. When tested for activity against the target molecule, structural features are identified that either alone or in combination with other features enhance or reduce activity. This information is used to design subsequent directed libraries containing compounds with enhanced activity against the target molecule. After one or several iterations of this process, compounds with substantially increased activity against the target molecule are identified and may be further developed as drugs. This process is facilitated by use of the sensitized cells of the present invention since compounds acting at the selected targets exhibit increased potency in such cell-based assays, thus; more compounds can now be characterized providing more useful information than would be obtained otherwise.

[0684] Thus, it is now possible using cell-based assays of the present invention to identify or characterize compounds that previously would not have been readily identified or characterized including compounds that act at targets that previously were not readily exploited using cell-based assays. The process of evolving potent drug leads from initial hit compounds is also substantially improved by the cell-based assays of the present invention because, for the same number of test compounds, more structure-function relationship information is likely to be revealed.

[0685] The method of sensitizing a cell entails selecting a suitable gene or operon. A suitable gene or operon is one whose transcription and/or expression is required for the proliferation of the cell to be sensitized. The next step is to introduce into the cells to be sensitized, an antisense RNA capable of hybridizing to the suitable gene or operon or to the RNA encoded by the suitable gene or operon. Introduction of the antisense RNA can be in the form of a vector in which antisense RNA is produced under the control of an inducible promoter. The amount of antisense RNA produced is modulated by varying an inducer concentration to which the cell is exposed and thereby varying the activity of the promoter driving transcription of the antisense RNA. Thus, cells are sensitized by exposing them to an inducer concentration that results in a sub-lethal level of antisense RNA expression. The requisite maount of inducer may be derived empiracally by one of skill in the art.

[0686] In one embodiment of the cell-based assays, antisense nucleic acids complementary to the identified Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi nucleotide sequences or portions thereof (including antisense nucleic acids comprising a nucleotide sequence complementary to one of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, and the antisense nucleic acids of SEQ ID NOs.: 8-3795 or antisense nucleic acids comprising a nucleotide sequence complementary to portions of the foregoing nucleic acids thereof), antisense nucleic complementary to homologous coding nucleic acids or portions thereof or homologous antisense nucleic acids are used to inhibit the production of a proliferation-required protein. Vectors producing antisense RNA complementary to identified genes required for proliferation, or portions thereof, are used to limit the concentration of a proliferation-required protein without severely inhibiting growth. The proliferation-required protein may be one of the proteins of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110 or a homologous polypeptide. To achieve that goal, a growth inhibition dose curve of inducer is calculated by plotting various doses of inducer against the corresponding growth inhibition caused by the antisense expression. From this curve, the concentration of inducer needed to achieve various percentages of antisense induced growth inhibition, from 1 to 100% can be determined.

[0687] A variety of different regulatable promoters may be used to produce the antisense nucleic acid. Transcription from the regulatable promoters may be modulated by controlling the activity of a transcription factor repressor which acts at the regulatable promoter. For example, if transcription is modulated by affecting the activity of a repressor, the choice of inducer to be used depends on the repressor/operator responsible for regulating transcription of the antisense nucleic acid. If the regulatable promoter comprises a T5 promoter fused to a xylO (xylose operator; e.g. derived from Staphylococcus xylosis (Schnappinger, D. et al., FEMS Microbiol. Let. 129: 121-128 (1995), the disclosure of which is incorporated herein by reference in its entirety) then transcription of the antisense nucleic acid may be regulated by a xylose repressor. The xylose repressor may be provided by ectoptic expression within an S. aureus cell of an exogenous xylose repressor gene, e.g. derived from S. xylosis DNA. In such cases transcription of antisense RNA from the promoter is inducible by adding xylose to the medium and the promoter is thus “xylose inducible.” Similarly, IPTG inducible promoters may be used. For example, the highest concentration of the inducer that does not reduce the growth rate significantly can be estimated from the curve. Cellular proliferation can be monitored by growth medium turbidity via OD measurements. In another example, the concentration of inducer that reduces growth by 25% can be predicted from the curve. In still another example, a concentration of inducer that reduces growth by 50% can be calculated. Additional parameters such as colony forming units (cfu) can be used to measure cellular viability.

[0688] Cells to be assayed are exposed to the above-determined concentrations of inducer. The presence of the inducer at this sub-lethal concentration reduces the amount of the proliferation required gene product to a sub-optimal amount in the cell that will still support growth. Cells grown in the presence of this concentration of inducer are therefore specifically more sensitive to inhibitors of the proliferation-required protein or RNA of interest or to inhibitors of proteins or RNAs in the same biological pathway as the proliferation-required protein or RNA of interest but not to inhibitors of unrelated proteins or RNAs.

[0689] Cells pretreated with sub-inhibitory concentrations of inducer and thus containing a reduced amount of proliferation-required target gene product are then used to screen for compounds that reduce cell growth. The sub-lethal concentration of inducer may be any concentration consistent with the intended use of the assay to identify candidate compounds to which the cells are more sensitive. For example, the sub-lethal concentration of the inducer may be such that growth inhibition is at least about 5%, at least about 8%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60% at least about 75%, or more. Cells which are pre-sensitized using the preceding method are more sensitive to inhibitors of the target protein because these cells contain less target protein to inhibit than do wild-type cells.

[0690] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids comprising a nucleotide sequence complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof or homologous antisense nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or homologous polypeptides.

[0691] In another embodiment of the cell-based assays of the present invention, the level or activity of a proliferation required gene product is reduced using a mutation, such as a temperature sensitive mutation, in the gene encoding a gene product required for proliferation and an antisense nucleic acid comprising a nucleotide sequence complementary to the gene encoding the gene product required for proliferation or a portion thereof. Growing the cells at an intermediate temperature between the permissive and restrictive temperatures of the temperature sensitive mutant where the mutation is in a proliferation-required gene produces cells with reduced activity of the proliferation-required gene product. The antisense RNA complementary to the proliferation-required sequence further reduces the activity of the proliferation required gene product. Drugs that may not have been found using either the temperature sensitive mutation or the antisense nucleic acid alone may be identified by determining whether cells in which transcription of the antisense nucleic acid has been induced and which are grown at a temperature between the permissive temperature and the restrictive temperature are substantially more sensitive to a test compound than cells in which expression of the antisense nucleic acid has not been induced and which are grown at a permissive temperature. Also drugs found previously from either the antisense nucleic acid alone or the temperature sensitive mutation alone may have a different sensitivity profile when used in cells combining the two approaches, and that sensitivity profile may indicate a more specific action of the drug in inhibiting one or more activities of the gene product.

[0692] Temperature sensitive mutations may be located at different sites within the gene and correspond to different domains of the protein. For example, the dnaB gene of Escherichia coli encodes the replication fork DNA helicase. DnaB has several domains, including domains for oligomerization, ATP hydrolysis, DNA binding, interaction with primase, interaction with DnaC, and interaction with DnaA [(Biswas, E. E. and Biswas, S. B. 1999. Mechanism and DnaB helicase of Escherichia coli: structural domains involved in ATP hydrolysis, DNA binding, and oligomerization. Biochem. 38:10919-10928; Hiasa, H. and Marians, K. J. 1999. Initiation of bidirectional replication at the chromosomal origin is directed by the interaction between helicase and primase. J. Biol. Chem. 274:27244-27248; San Martin, C., Radermacher, M., Wolpensinger, B., Engel, A., Miles, C. S., Dixon, N. E., and Carazo, J. M. 1998. Three-dimensional reconstructions from cryoelectron microscopy images reveal an intimate complex between helicase DnaB and its loading partner DnaC. Structure 6:501-9; Sutton, M. D., Carr, K. M., Vicente, M., and Kaguni, J. M. 1998. Escherichia coli DnaA protein. The N-terminal domain and loading of DnaB helicase at the E. coli chromosomal origin. J. Biol. Chem. 273:34255-62.), the disclosures of which are incorporated herein by reference in their entireties]. Temperature sensitive mutations in different domains of DnaB confer different phenotypes at the restrictive temperature, which include either an abrupt stop or slow stop in DNA replication with or without DNA breakdown (Wechsler, J. A. and Gross, J. D. 1971. Escherichia coli mutants temperature-sensitive for DNA synthesis. Mol. Gen. Genetics 113:273-284, the disclosure of which is incorporated herein by reference in its entirety) and termination of growth or cell death. Combining the use of temperature sensitive mutations in the dnaB gene that cause cell death at the restrictive temperature with an antisense to the dnaB gene could lead to the discovery of very specific and effective inhibitors of one or a subset of activities exhibited by DnaB.

[0693] It will be appreciated that the above method may be performed with any mutation which reduces but does not eliminate the activity or level of the gene product which is required for proliferation.

[0694] It will be appreciated that the above cell-based assays may be performed using mutations in, such as temperature sensitive mutations, and antisense nucleic acids comprising a nucleotide sequence complementary to any of the genes encoding proliferation-required gene products from from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or portions thereof (including the nucleic acids of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012), mutations in and antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof or homologous antisense nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110), or homologous polypeptides may be reduced.

[0695] When screening for antimicrobial agents against a gene product required for proliferation, growth inhibition of cells containing a limiting amount of that proliferation-required gene product can be assayed. Growth inhibition can be measured by directly comparing the amount of growth, measured by the optical density of the growth medium, between an experimental sample and a control sample. Alternative methods for assaying cell proliferation include measuring green fluorescent protein (GFP) reporter construct emissions, various enzymatic activity assays, and other methods well known in the art.

[0696] It will be appreciated that the above method may be performed in solid phase, liquid phase or a combination of the two. For example, cells grown on nutrient agar containing the inducer of the antisense construct may be exposed to compounds spotted onto the agar surface. If desired, the cells may be grown on agar containing varying concentrations of the inducer. A compound's effect may be judged from the diameter of the resulting killing zone, the area around the compound application point in which cells do not grow. Multiple compounds may be transferred to agar plates and simultaneously tested using automated and semi-automated equipment including but not restricted to multi-channel pipettes (for example the Beckman Multimek) and multi-channel spotters (for example the Genomic Solutions Flexys). In this way multiple plates and thousands to millions of compounds may be tested per day.

[0697] The compounds may also be tested entirely in liquid phase using microtiter plates as described below. Liquid phase screening may be performed in microtiter plates containing 96, 384, 1536 or more wells per microtiter plate to screen multiple plates and thousands to millions of compounds per day. Automated and semi-automated equipment may be used for addition of reagents (for example cells and compounds) and determination of cell density.

Example 9

Cell-based Assay Using Antisense Complementary to Genes Encoding Ribosomal Proteins

[0698] The effectiveness of the above cell-based assay was validated using constructs transribing antisense RNA to the proliferation required E. coli genes rplL, rplJ, and rplW encoding ribosomal proteins L7/L12, L10 and L23 respectively. These proteins are essential components of the protein synthesis apparatus of the cell and as such are required for proliferation. These constructs were used to test the effect of antisense transcription on cell sensitivity to antibiotics known to bind to the ribosome and thereby inhibit protein synthesis. Constructs transcribing antisense RNA to several other genes (elaD, visC, yohH, and atpE/B), the products of which are not involved in protein synthesis were used for comparison.

[0699] First, pLex5BA (Krause et al., J. Mol. Biol. 274: 365 (1997), the disclosure of which is incorporated herein by reference in its entirety) vectors containing antisense constructs to either rplW or to elaD were introduced into separate E. coli cell populations. Vector introduction is a technique well known to those of ordinary skill in the art. The vectors of this example contain IPTG inducible promoters that drive the transcription of the antisense RNA in the presence of the inducer. However, those skilled in the art will appreciate that other inducible promoters may also be used. Suitable vectors are also well known in the art. Antisense clones to genes encoding different ribosomal proteins or to genes encoding proteins that are not involved in protein synthesis were utilized to test the effect of antisense transcription on cell sensitivity to the antibiotics known to bind to ribosomal proteins and inhibit protein synthesis. Antisense nucleic acids comprising a nucleotide sequence complementarty to the elaD, atpB&atpE, visC and yohH genes are referred to as AS-elaD, AS-atpB/E, AS-visC, AS-yohH respectively. These genes are not known to be involved in protein synthesis. Antisense nucleic acids to the rplL, rplL&rplJ and rplW genes are referred to as AS-rplL, AS-rplL/J, and AS-rplW respectively. These genes encode ribosomal proteins L7/L12 (rplL) L10 (rplJ) and L23 (rplW). Vectors containing these antisense nucleic acids were introduced into separate E. coli cell populations.

[0700] The cell populations containing vectors producing AS-elaD or AS-rplW were exposed to a range of IPTG concentrations in liquid medium to obtain the growth inhibitory dose curve for each clone (FIG. 1). First, seed cultures were grown to a particular turbidity measured by the optical density (OD) of the growth solution. The OD of the solution is directly related to the number of bacterial cells contained therein. Subsequently, sixteen 200 μl liquid medium cultures were grown in a 96 well microtiter plate at 37° C. with a range of IPTG concentrations in duplicate two-fold serial dilutions from 1600 uM to 12.5 μM (final concentration). Additionally, control cells were grown in duplicate without IPTG. These cultures were started from an inoculum of equal amounts of cells derived from the same initial seed culture of a clone of interest. The cells were grown for up to 15 hours and the extent of growth was determined by measuring the optical density of the cultures at 600 nm. When the control culture reached mid-log phase the percent growth (relative to the control culture) for each of the IPTG containing cultures was plotted against the log concentrations of IPTG to produce a growth inhibitory dose response curve for the IPTG. The concentration of IPTG that inhibits cell growth to 50% (IC50) as compared to the 0 mM IPTG control (0% growth inhibition) was then calculated from the curve. Under these conditions, an amount of antisense RNA was produced that reduced the expression levels of rplW or elaD to a degree such that growth of cells containing their respective antisense vectors was inhibited by 50%.

[0701] Alternative methods of measuring growth are also contemplated. Examples of these methods include measurements of proteins, the expression of which is engineered into the cells being tested and can readily be measured. Examples of such proteins include green fluorescent protein (GFP), luciferase, and various enzymes.

[0702] Cells were pretreated with the selected concentration of IPTG and then used to test the sensitivity of cell populations to tetracycline, erythromycin and other known protein synthesis inhibitors. FIG. 1 is an IPTG dose response curve in E. coli transformed with an IPTG-inducible plasmid containing either an antisense clone to the E. coli rplW gene (AS-rplW) which encodes ribosomal protein L23 which is required for protein synthesis and essential for cell proliferation, or an antisense clone to the elaD (AS-elaD) gene which is not known to be involved in protein synthesis.

[0703] An example of a tetracycline dose response curve is shown in FIGS. 2A and 2B for the rplW and elaD genes, respectively. Cells were grown to log phase and then diluted into medium alone or medium containing IPTG at concentrations which give 20% and 50% growth inhibition as determined by IPTG dose response curves. After 2.5 hours, the cells were diluted to a final OD600 of 0.002 into 96 well plates containing (1) +/−IPTG at the same concentrations used for the 2.5 hour pre-incubation; and (2) serial two-fold dilutions of tetracycline such that the final concentrations of tetracycline range from 1 μg/ml to 15.6 ng/ml and 0 μg/ml. The 96 well plates were incubated at 37° C. and the OD600 was read by a plate reader every 5 minutes for up to 15 hours. For each IPTG concentration and the no IPTG control, tetracycline dose response curves were determined when the control (absence of tetracycline) reached 0.1 OD600.

[0704] To compare tetracycline sensitivity with and without IPTG, tetracycline IC50, were determined from the dose response curves (FIGS. 3A-B). Cells transcribing antisense nucleic acids AS-rplL or AS-rplW to genes encoding ribosomal proteins L7/L 12 and L23 respectively showed increased sensitivity to tetracycline (FIG. 2A) as compared to cells with reduced levels of the elaD gene product (AS-elaD) (FIG. 2B). FIG. 3 shows a summary bar chart in which the ratios of tetracycline IC50s determined in the presence of IPTG which gives 50% growth inhibition versus tetracycline IC50S determined without IPTG (fold increase in tetracycline sensitivity) were plotted. Cells with reduced levels of either L7/L 12 (encoded by genes rplL, rplJ) or L23 (encoded by the rplW gene) showed increased sensitivity to tetracycline (FIG. 3). Cells expressing antisense to genes not known to be involved in protein synthesis (AS-atpB/E, AS-visC, AS-elaD, AS-yohH) did not show the same increased sensitivity to tetracycline, validating the specificity of this assay (FIG. 3).

[0705] In addition to the above, it has been observed in initial experiments that clones transcribing antisense RNA to genes involved in protein synthesis (including genes encoding ribosomal proteins L7/L12 & L10, L7/L12 alone, L22, and L18, as well as genes encoding rRNA and Elongation Factor G) have increased sensitivity to the macrolide, erythromycin, whereas clones transcribing antisense to the non-protein synthesis genes elaD, atpB/E and visC do not. Furthermore, the clone transcribing antisense to rplL and rplJ (AS-rplL/J) does not show increased sensitivity to nalidixic acid and ofloxacin, antibiotics which do not inhibit protein synthesis.

[0706] The results with the ribosomal protein genes rplL, rplJ, and rplW as well as the initial results using various other antisense clones and antibiotics show that limiting the concentration of an antibiotic target makes cells more sensitive to the antimicrobial agents that specifically interact with that protein. The results also show that these cells are sensitized to antimicrobial agents that inhibit the overall function in which the protein target is involved but are not sensitized to antimicrobial agents that inhibit other functions. It will be appreciated that the cell-based assays described above may be implemented using the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi antisense nucleotide sequences which inhibit the activity of genes required for proliferation described herein (including the antisense nucleic acids of SEQ ID NOs.: 8-3795) or antisense nucleic acids comprising nucleotide sequences which are complementary to the sequences of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 or portions thereof.

[0707] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or homologous polypeptides may be reduced.

[0708] The cell-based assay described above may also be used to identify the biological pathway in which a proliferation-required nucleic acid or its gene product lies. In such methods, cells transcribing a sub-lethal level of antisense to a target proliferation-required nucleic acid and control cells in which transcription of the antisense has not been induced are contacted with a panel of antibiotics known to act in various pathways. If the antibiotic acts in the pathway in which the target proliferation-required nucleic acid or its gene product lies, cells in which transcription of the antisense has been induced will be more sensitive to the antibiotic than cells in which expression of the antisense has not been induced.

[0709] As a control, the results of the assay may be confirmed by contacting a panel of cells transcribing antisense nucleic acids to many different proliferation-required genes including the target proliferation-required gene. If the antibiotic is acting specifically, heightened sensitivity to the antibiotic will be observed only in the cells transcribing antisense to a target proliferation-required gene (or cells expressing antisense to other proliferation-required genes in the same pathway as the target proliferation-required gene) but will not be observed generally in all cells expressing antisense to proliferation-required genes.

[0710] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi , (including antisense nucleic acids complementary to SEQ ID NOs: 3796-3800, 3806-4860, 5916-10012, or the antisense nucleic acids of SEQ ID NOs.: 8-3795) or portions thereof, antisense nucleic acids comprising nucleotide sequences complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110), or homologous polypeptides may be reduced.

[0711] Similarly, the above method may be used to determine the pathway on which a test compound, such as a test antibiotic acts. A panel of cells, each of which transcribes an antisense to a proliferation-required nucleic acid in a known pathway, is contacted with a compound for which it is desired to determine the pathway on which it acts. The sensitivity of the panel of cells to the test compound is determined in cells in which transcription of the antisense has been induced and in control cells in which expression of the antisense has not been induced. If the test compound acts on the pathway on which an antisense nucleic acid acts, cells in which expression of the antisense has been induced will be more sensitive to the compound than cells in which expression of the antisense has not been induced. In addition, control cells in which expression of antisense to proliferation-required genes in other pathways has been induced will not exhibit heightened sensitivity to the compound. In this way, the pathway on which the test compound acts may be determined.

[0712] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids comprising nucleotide sequences complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including antisense nucleic acids complementary to SEQ ID NOs: 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs.: 8-3795) or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110) or homologous polypeptides may be reduced.

[0713] The Example below provides one method for performing such assays.

Example 10

Identification of the Pathway in which a Proliferation-Required Gene Lies or the Pathway on which an Antibiotic Acts

[0714] A. Preparation of Bacterial Stocks for Assay

[0715] To provide a consistent source of cells to screen, frozen stocks of host bacteria containing the desired antisense construct are prepared using standard microbiological techniques. For example, a single clone of the microorganism can be isolated by streaking out a sample of the original stock onto an agar plate containing nutrients for cell growth and an antibiotic for which the antisense construct contains a selectable marker which confers resistance. After overnight growth an isolated colony is picked from the plate with a sterile needle and transferred to an appropriate liquid growth medium containing the antibiotic required for maintenance of the plasmid. The cells are incubated at 30° C. to 37° C. with vigorous shaking for 4 to 6 hours to yield a culture in exponential growth. Sterile glycerol is added to 15% (volume to volume) and 100 μL to 500 μL aliquots are distributed into sterile cryotubes, snap frozen in liquid nitrogen, and stored at −80° C. for future assays.

[0716] B. Growth of Bacteria for Use in the Assay

[0717] A day prior to an assay, a stock vial is removed from the freezer, rapidly thawed (37° C. water bath) and a loop of culture is streaked out on an agar plate containing nutrients for cell growth and an antibiotic to which the selectable marker of the antisense construct confers resistance. After overnight growth at 37° C., ten randomly chosen, isolated colonies are transferred from the plate (sterile inoculum loop) to a sterile tube containing 5 mL of LB medium containing the antibiotic to which the antisense vector confers resistance. After vigorous mixing to form a homogeneous cell suspension, the optical density of the suspension is measured at 600 rm (OD600) and if necessary an aliquot of the suspension is diluted into a second tube of 5 mL, sterile, LB medium plus antibiotic to achieve an OD600≦0.02 absorbance units. The culture is then incubated at 37° C. for 1-2 hrs with shaking until the OD600 reaches OD 0.2-0.3. At this point the cells are ready to be used in the assay.

[0718] C. Selection of Media to be Used in Assay

[0719] Two-fold dilution series of the inducer are generated in culture media containing the appropriate antibiotic for maintenance of the antisense construct. Several media are tested side by side and three to four wells are used to evaluate the effects of the inducer at each concentration in each media. For example, LB broth, TBD broth and Muller-Hinton media may be tested with the inducer xylose at the following concentrations, 5 mM, 10 mM, 20 mM, 40 mM, 80 mM, 120 mM and 160 mM. Equal volumes of test media-inducer and cells are added to the wells of a 384 well microtiter plate and mixed. The cells are prepared as described above and diluted 1:100 in the appropriate media containing the test antibiotic immediately prior to addition to the microtiter plate wells. For a control, cells are also added to several wells of each media that do not contain inducer, for example 0 mM xylose. Cell growth is monitored continuously by incubation at 37° C. in a microtiter plate reader monitoring the OD600 of the wells over an 18-hour period. The percent inhibition of growth produced by each concentration of inducer is calculated by comparing the rates of logarithmic growth against that exhibited by cells growing in medium without inducer. The medium yielding greatest sensitivity to inducer is selected for use in the assays described below.

[0720] D. Measurement of Test Antibiotic Sensitivity in the Absence of Antisense Construct Induction

[0721] Two-fold dilution series of antibiotics of known mechanism of action are generated in the culture medium selected for further assay development that has been supplemented with the antibiotic used to maintain the construct. A panel of test antibiotics known to act on different pathways is tested side by side with three to four wells being used to evaluate the effect of a test antibiotic on cell growth at each concentration. Equal volumes of test antibiotic and cells are added to the wells of a 384 well microtiter plate and mixed. Cells are prepared as described above using the medium selected for assay development supplemented with the antibiotic required to maintain the antisense construct and are diluted 1:100 in identical medium immediately prior to addition to the microtiter plate wells. For a control, cells are also added to several wells that lack antibiotic, but contain the solvent used to dissolve the antibiotics. Cell growth is monitored continuously by incubation at 37° C. in a microtiter plate reader monitoring the OD600 of the wells over an 18-hour period. The percent inhibition of growth produced by each concentration of antibiotic is calculated by comparing the rates of logarithmic growth against that exhibited by cells growing in medium without antibiotic. A plot of percent inhibition against log[antibiotic concentration] allows extrapolation of an IC50 value for each antibiotic.

[0722] E. Measurement of Test Antibiotic Sensitivity in the Presence of Antisense Construct Inducer

[0723] The culture medium selected for use in the assay is supplemented with inducer at concentrations shown to inhibit cell growth by 50% and 80% as described above, as well as the antibiotic used to maintain the construct. Two-fold dilution series of the panel of test antibiotics used above are generated in each of these media. Several antibiotics are tested side by side in each medium with three to four wells being used to evaluate the effects of an antibiotic on cell growth at each concentration. Equal volumes of test antibiotic and cells are added to the wells of a 384 well microtiter plate and mixed. Cells are prepared as described above using the medium selected for use in the assay supplemented with the antibiotic required to maintain the antisense construct. The cells are diluted 1:100 into two 50 mL aliquots of identical medium containing concentrations of inducer that have been shown to inhibit cell growth by 50% and 80% respectively and incubated at 37° C. with shaking for 2.5 hours. Immediately prior to addition to the microtiter plate wells, the cultures are adjusted to an appropriate OD600 (typically 0.002) by dilution into warm (37° C.) sterile medium supplemented with identical concentrations of the inducer and antibiotic used to maintain the antisense construct. For a control, cells are also added to several wells that contain solvent used to dissolve test antibiotics but which contain no antibiotic. Cell growth is monitored continuously by incubation at 37° C. in a microtiter plate reader monitoring the OD600 of the wells over an 18-hour period. The percent inhibition of growth produced by each concentration of antibiotic is calculated by comparing the rates of logarithmic growth against that exhibited by cells growing in medium without antibiotic. A plot of percent inhibition against log[antibiotic concentration] allows extrapolation of an IC50 value for each antibiotic.

[0724] F. Determining the Specificity of the Test Antibiotics

[0725] A comparison of the IC50s generated by antibiotics of known mechanism of action under antisense induced and non-induced conditions allows the pathway in which a proliferation-required nucleic acid lies to be identified. If cells expressing an antisense nucleic acid comprising a nucleotide sequence complementary to a proliferation-required gene are selectively sensitive to an antibiotic acting via a particular pathway, then the gene against which the antisense acts is involved in the pathway on which the antibiotic acts.

[0726] G. Identification of Pathway in which a Test Antibiotic Acts

[0727] As discussed above, the cell-based assay may also be used to determine the pathway against which a test antibiotic acts. In such an analysis, the pathways against which each member of a panel of antisense nucleic acids acts are identified as described above. A panel of cells, each containing an inducible vector which transcribes an antisense nucleic acid comprising a nucleotide sequence complementary to a gene in a known proliferation-required pathway, is contacted with a test antibiotic for which it is desired to determine the pathway on which it acts under inducing and non-inducing conditions. If heightened sensitivity is observed in induced cells transcribing antisense complementary to a gene in a particular pathway but not in induced cells transcribing antisense nucleic acids comprising nucleotide sequences complementary to genes in other pathways, then the test antibiotic acts against the pathway for which heightened sensitivity was observed.

[0728] One skilled in the art will appreciate that further optimization of the assay conditions, such as the concentration of inducer used to induce antisense transcription and/or the growth conditions used for the assay (for example incubation temperature and medium components) may further increase the selectivity and/or magnitude of the antibiotic sensitization exhibited.

[0729] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids comprising nucleotide sequences complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, (including antisense nucleic acids comprising nucleotide sequences complemenatary to SEQ ID NOs: 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs.: 8-3795) or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof or homologous antisense nucleic acids In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110), or homologous polypeptides may be reduced.

[0730] The following example confirms the effectiveness of the methods described above.

Example 11

Identification of the Biological Pathway in which a Proliferation-Required Gene Lies

[0731] The effectiveness of the above assays was validated using proliferation-required genes from E. coli which were identified using procedures similar to those described above. Antibiotics of various chemical classes and modes of action were purchased from Sigma Chemicals (St. Louis, Mo.). Stock solutions were prepared by dissolving each antibiotic in an appropriate aqueous solution based on information provided by the manufacturer. The final working solution of each antibiotic contained no more than 0.2% (w/v) of any organic solvent. To determine their potency against a bacterial strain engineered for transcription of an antisense comprising a nucleotide sequence complementary to a proliferation-required 50S ribosomal protein, each antibiotic was serially diluted two- or three- fold in growth medium supplemented with the appropriate antibiotic for maintenance of the antisense construct. At least ten dilutions were prepared for each antibiotic. 25 μL aliquots of each dilution were transferred to discrete wells of a 384-well microplate (the assay plate) using a multi-channel pipette. Quadruplicate wells were used for each dilution of an antibiotic under each treatment condition (plus and minus inducer). Each assay plate contained twenty wells for cell growth controls (growth medium replacing antibiotic), ten wells for each treatment (plus and minus inducer, in this example IPTG). Assay plates were usually divided into the two treatments: half the plate containing induced cells and an appropriate concentrations of inducer (in this example IPTG) to maintain the state of induction, the other half containing non-induced cells in the absence of IPTG.

[0732] Cells for the assay were prepared as follows. Bacterial cells containing a construct, from which transcription of antisense nucleic acid comprising a nucleotide sequence complementary to rplL and rplJ (AS-rplL/J), which encode proliferation-required 50S ribosomal subunit proteins, is inducible in the presence of IPTG, were grown into exponential growth (OD600 0.2 to 0.3) and then diluted 1:100 into fresh medium containing either 400 μM or 0 μM inducer (IPTG). These cultures were incubated at 37° C. for 2.5 hr. After a 2.5 hr incubation, induced and non-induced cells were respectively diluted into an assay medium at a final OD600 value of 0.0004. The medium contained an appropriate concentration of the antibiotic for the maintenance of the antisense construct. In addition, the medium used to dilute induced cells was supplemented with 800 μM IPTG so that addition to the assay plate would result in a final IPTG concentration of 400 μM. Induced and non-induced cell suspensions were dispensed (25 μl/well) into the appropriate wells of the assay plate as discussed previously. The plate was then loaded into a plate reader, incubated at constant temperature, and cell growth was monitored in each well by the measurement of light scattering at 595 nm. Growth was monitored every 5 minutes until the cell culture attained a stationary growth phase. For each concentration of antibiotic, a percentage inhibition of growth was calculated at the time point corresponding to mid-exponential growth for the associated control wells (no antibiotic, plus or minus IPTG). For each antibiotic and condition (plus or minus IPTG), a plot of percent inhibition versus log of antibiotic concentration was generated and the IC50 determined. A comparison of the IC50 for each antibiotic in the presence and absence of IPTG revealed whether induction of the antisense construct sensitized the cell to the mechanism of action exhibited by the antibiotic. Cells which exhibited a statistically significant decrease in the IC50 value in the presence of inducer were considered to have an increased sensitivity to the test antibiotic.

[0733] The results are provided in the table below, which lists the classes and names of the antibiotics used in the analysis, the targets of the antibiotics, the IC50 in the absence of IPTG, the IC50 in the presence of IPTG, the concentration units for the IC50s, the fold increase in IC50 in the presence of IPTG, and whether increased sensitivity was observed in the presence of IPTG.

TABLE III
Effect of Expression of Antisense RINA to rylL and rplJ on Antibiotic Sensitivity
					Fold
		IC50	IC50	Conc.	Increase in	Sensitivity
ANTIBIOTIC CLASS /Names	TARGET	(−IPTG)	(+IPTG)	Unit	Sensitivity	Increased?
PROTEIN SYNTHESIS INHIBITOR
AMINOGLYCOSIDES
Gentamicin	30S ribosome function	2715	19.19	ng/ml	141	Yes
Streptomycin	30S ribosome function	11280	161	ng/ml	70	Yes
Spectinomycin	30S ribosome function	18050	<156	ng/ml	Yes
Tobramycin	30S ribosome function	3594	70.58	ng/ml	51	Yes
MACROLIDES	50S ribosome function	7467	187	ng/ml	40	Yes
Erythromycin
AROMATIC POYKETIDES
Tetracycline	30S ribosome function	199.7	1.83	ng/ml	109	Yes
Minocycline	30S ribosome function	668.4	3.897	ng/ml	172	Yes
Doxycycline	30S ribosome function	413.1	27.81	ng/ml	15	Yes
OTHER PROTEIN SYNTHESIS
INHIBITORS
Fusidic acid	Elongation Factor G function	59990	641	ng/ml	94	Yes
Chloramphenicol	30S ribosome function	465.4	1.516	ng/ml	307	Yes
Lincomycin	50S ribosome function	47150	324.2	ng/ml	145	Yes
OTHER ANTIBIOTIC MECHANISMS
B-LACTAMS
Cefoxitin	Cell wall biosynthesis	2782	2484	ng/ml	1	No
Cefotaxime	Cell wall biosynthesis	24.3	24.16	ng/ml	1	No
DNA SYNTHESIS INHIBITORS
Nalidixic acid	DNA Gyrase activity	6973	6025	ng/ml	1	No
Ofloxacin	DNA Gyrase activity	49.61	45.89	ng/ml	1	No
OTHER
Bacitracin	Cell membrane function	4077	4677	mg/ml	1	No
	Dihydrofolate Reductase
Trimethoprim	activity	128.9	181.97	ng/ml	1	No
Vancomycin	Cell wall biosynthesis	145400	72550	ng/ml	2	No

[0734] The above results demonstrate that induction of an antisense RNA complementary to genes encoding 50S ribosomal subunit proteins results in a selective and highly significant sensitization of cells to antibiotics that inhibit ribosomal function and protein synthesis. The above results further demonstrate that induction of an antisense to an essential gene sensitizes a cell or microorganism to compounds that interfere with that gene product's biological role. This sensitization is restricted to compounds that interfere with pathways associated with the targeted gene and its product.

[0735] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including antisense nucleic acids complementary to SEQ ID NOs. 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs.: 8-3795) or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof or homologous antisense nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110), or homologous polypeptides may be reduced.

[0736] Example 11A below describes an analysis performed in Staphylococcus aureus.

Example 11A

Identification of the Biological Pathway in which a Gene Required for Proliferation of Staphylococcus aureus Lies

[0737] Antibiotics of various chemical classes and modes of action were purchased from chemical suppliers, for example Sigma Chemicals (St. Louis, Mo.). Stock solutions were prepared by dissolving each antibiotic in an appropriate aqueous solution based on information provided by the manufacturer. The final working solution of each antibiotic contained no more than 0.2% (w/v) of any organic solvent.

[0738] To determine its potency against a bacterial strain containing an antisense nucleic acid comprising a nucleotide sequence complementary to the nucleotide sequence encoding the Beta subunit of DNA gyrase (which is required for proliferation) under the control of a xylose inducible promoter, each antibiotic was serially diluted two- or three- fold in growth medium supplemented with the appropriate antibiotic for maintenance of the antisense construct. At least ten dilutions were prepared for each antibiotic.

[0739] Aliquots (25 μL) of each dilution were transferred to discrete wells of a 384-well microplate (the assay plate) using a multi-channel pipette. Quadruplicate wells were used for each dilution of an antibiotic under each treatment condition (plus and minus inducer). Each assay plate contained twenty wells for cell growth controls (growth medium, no antibiotic), ten wells for each treatment (plus and minus inducer, xylose, in this example). Half the assay plate contained induced cells (in this example Staphylococcus aureus cells) and appropriate concentrations of inducer (xylose, in this example) to maintain the state of induction while the other half of the assay plate contained non-induced cells maintained in the absence of inducer.

[0740] Preparation of Bacterial Cells

[0741] Cells of a bacterial clone containing a construct in which transcription of antisense comprising a nucleotide sequence complementary to the sequence encoding the Beta subunit of DNA gyrase under the control of the xylose inducible promoter (S1M10000001F08) were grown into exponential growth (OD600 0.2 to 0.3) and then diluted 1:100 into fresh medium containing either 12 mM or 0 mM inducer (xylose). These cultures were incubated at 37° C. for 2.5 hr. The presence of inducer (xylose) in the medium initiates and maintains production of antisense RNA from the antisense construct. After a 2.5 hr incubation, induced and non-induced cells were respectively diluted into an assay medium containing an appropriate concentration of the antibiotic for the maintenance of the antisense construct. In addition, medium used to dilute induced cells was supplemented with 24 mM xylose so that addition to the assay plate would result in a final xylose concentration of 12 mM. The cells were diluted to a final OD600 value of 0.0004.

[0742] Induced and non-induced cell suspensions were dispensed (25 μl/well) into the appropriate wells of the assay plate as discussed previously. The plate was then loaded into a plate reader and incubated at constant temperature while cell growth was monitored in each well by the measurement of light scattering at 595 nm. Growth was monitored every 5 minutes until the cell culture attained a stationary growth phase. For each concentration of antibiotic, a percentage inhibition of growth was calculated at the time point corresponding to mid-exponential growth for the associated control wells (no antibiotic, plus or minus xylose). For each antibiotic and condition (plus or minus xylose), plots of percent inhibition versus Log of antibiotic concentration were generated and IC50s determined.

[0743] A comparison of each antibiotic's IC50 in the presence and absence of inducer ( xylose, in this example) reveals whether induction of the antisense construct sensitized the cell to the antibiotic's mechanism of action. If the antibiotic acts against the β subunit of DNA gyrase, the IC50 of induced cells will be significantly lower than the IC50 of uninduced cells.

[0744] FIG. 4 lists the antibiotics tested, their targets, and their fold increase in potency between induced cells and uninduced cells. As illustrated in FIG. 4, the potency of cefotaxime, cefoxitin, fusidic acid, lincomycin, tobramycin, trimethoprim and vancomycin, each of which act on targets other than the β subunit of gyrase, was not significantly different in induced cells as compared to uninduced cells. However, the potency of novobiocin, which is known to act against the Beta subunit of DNA gyrase, was significantly different between induced cells and uninduced cells.

[0745] Thus, induction of an antisense nucleic acid comprising a nucleotide sequence complementary to the sequence encoding the β subunit of gyrase results in a selective and significant sensitization of Staphylococcus aureus cells to an antibiotic which inhibits the activity of this protein. Furthermore, the results demonstrate that induction of an antisense construct to an essential gene sensitizes a cell or microorganism to compounds that interfere with that gene product's biological role. This sensitization is apparently restricted to compounds that interfere with the targeted gene and its product.

[0746] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including antisense nucleic acids complementary to SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs. 8-3795), or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or homologous polypeptides may be reduced.

[0747] Assays utilizing antisense constructs to essential genes or portions thereof can be used to identify compounds that interfere with the activity of those gene products. Such assays could be used to identify drug leads, for example antibiotics.

[0748] Panels of cells transcribing different antisense nucleic acids can be used to characterize the point of intervention of a compound affecting an essential biochemical pathway including antibiotics with no known mechanism of action.

[0749] Assays utilizing antisense constructs to essential genes can be used to identify compounds that specifically interfere with the activity of multiple targets in a pathway. Such constructs can be used to simultaneously screen a sample against multiple targets in one pathway in one reaction (Combinatorial HTS).

[0750] Furthermore, as discussed above, panels of antisense construct-containing cells may be used to characterize the point of intervention of any compound affecting an essential biological pathway including antibiotics with no known mechanism of action.

[0751] It will be appreciated that the above cell-based assays may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including antisense nucleic acids comprising nucleotide sequences complementary to SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs. 8-3795), or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or homologous polypeptides may be reduced.

[0752] Another embodiment of the present invention is a method for determining the pathway against which a test antibiotic compound is active, in which the activity of target proteins or nucleic acids involved in proliferation-required pathways is reduced by contacting cells with a sub-lethal concentration of a known antibiotic which acts against the target protein or nucleic acid. In one embodiment, the target protein or nucleic acid corresponds to a proliferation-required nucleic acid identified using the methods described above, such as the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110, or homologous polypeptides. The method is similar to those described above for determining which pathway a test antibiotic acts against, except that rather than reducing the activity or level of a proliferation-required gene product using a sub-lethal level of antisense to a proliferation-required nucleic acid, the sensitized cell is generated by reducing the activity or level of the proliferation-required gene product using a sub-lethal level of a known antibiotic which acts against the proliferation required gene product. Heightened sensitivity determines the pathway on which the test compound is active.

[0753] Interactions between drugs which affect the same biological pathway have been described in the literature. For example, Mecillinam (Amdinocillin) binds to and inactivates the penicillin binding protein 2 (PBP2, product of the mrdA in E. coli). This antibiotic interacts with other antibiotics that inhibit PBP2 as well as antibiotics that inhibit other penicillin binding proteins such as PBP3 [(Gutmann, L., Vincent, S., Billot-Klein, D., Acar, J. F., Mrena, E., and Williamson, R. (1986) Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam). Antimicrobial Agents & Chemotherapy, 30:906-912), the disclosure of which is incorporated herein by reference in its entirety]. Interactions between drugs could, therefore, involve two drugs that inhibit the same target protein or nucleic acid or inhibit different proteins or nucleic acids in the same pathway [(Fukuoka, T., Domon, H., Kakuta, M., Ishii, C., Hirasawa, A., Utsui, Y., Ohya, S., and Yasuda, H. (1997) Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus. Japan. J. Antibio. 50:411-419; Smith, C. E., Foleno, B. E., Barrett, J. F., and Frosc, M. B. (1997) Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods. Diagnos. Microbiol. Infect. Disease 27:85-92; den Hollander, J. G., Horrevorts, A. M., van Goor, M. L., Verbrugh, H. A., and Mouton, J. W. (1997) Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrobial Agents & Chemotherapy. 41:95-110), the disclosure of all of which are incorporated herein by reference in their entireties].

[0754] Two drugs may interact even though they inhibit different targets. For example, the proton pump inhibitor, Omeprazole, and the antibiotic, Amoxycillin, two synergistic compounds acting together, can cure Helicobacter pylori infection [(Gabryelewicz, A., Laszewicz, W., Dzieniszewski, J., Ciok, J., Marlicz, K., Bielecki, D., Popiela, T., Legutko, J., Knapik, Z., Poniewierka, E. (1997) Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation). J. Physiol. Pharmacol. 48 Suppl 4:93-105), the disclosure of which is incorporated herein by reference in its entirety].

[0755] The growth inhibition from the sub-lethal concentration of the known antibiotic may be at least about 5%, at least about 8%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, or at least about 75%, or more.

[0756] Alternatively, the sub-lethal concentration of the known antibiotic may be determined by measuring the activity of the target proliferation-required gene product rather than by measuring growth inhibition.

[0757] Cells are contacted with a combination of each member of a panel of known antibiotics at a sub-lethal level and varying concentrations of the test antibiotic. As a control, the cells are contacted with varying concentrations of the test antibiotic alone. The IC50 of the test antibiotic in the presence and absence of the known antibiotic is determined. If the IC50s in the presence and absence of the known drug are substantially similar, then the test drug and the known drug act on different pathways. If the IC50s are substantially different, then the test drug and the known drug act on the same pathway.

[0758] It will be appreciated that the above cell-based assays may be performed using a sub-lethal concentration of a known antibiotic which acts against the product of any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the products of SEQ ID NOs: 3796-3800, 3806-4860, 5916-10012, or portions thereof, or the products of homologous coding nucleic acids or portions thereof . In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including the polypeptides of SEQ ID NOs.: 3801-3805, 4861-5915, 10013-14110), or homologous polypeptides may be reduced.

[0759] Another embodiment of the present invention is a method for identifying a candidate compound for use as an antibiotic in which the activity of target proteins or nucleic acids involved in proliferation-required pathways is reduced by contacting cells with a sub-lethal concentration of a known antibiotic which acts against the target protein or nucleic acid. In one embodiment, the target protein or nucleic acid is a target protein or nucleic acid corresponding to a proliferation-required nucleic acid identified using the methods described above. The method is similar to those described previously herein for identifying candidate compounds for use as antibiotics except that rather than reducing the activity or level of a proliferation-required gene product using a sub-lethal level of antisense to a proliferation-required nucleic acid, the activity or level of the proliferation-required gene product is reduced using a sub-lethal level of a known antibiotic which acts against the proliferation required gene product.

[0760] The growth inhibition from the sub-lethal concentration of the known antibiotic may be at least about 5%, at least about 8%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, or at least about 75%, or more.

[0761] Alternatively, the sub-lethal concentration of the known antibiotic may be determined by measuring the activity of the target proliferation-required gene product rather than by measuring growth inhibition.

[0762] In order to characterize test compounds of interest, cells are contacted with a panel of known antibiotics at a sub-lethal level and one or more concentrations of the test compound. As a control, the cells are contacted with the same concentrations of the test compound alone. The IC50 of the test compound in the presence and absence of the known antibiotic is determined. If the IC50 of the test compound is substantially different in the presence and absence of the known drug then the test compound is a good candidate for use as an antibiotic. As discussed above, once a candidate compound is identified using the above methods its structure may be optimized using standard techniques such as combinatorial chemistry.

[0763] Representative known antibiotics which may be used in each of the above methods are provided in Table IV below. However, it will be appreciated that other antibiotics may also be used.

TABLE IV
Antibiotics and Their Targets
		RESISTANT
ANTIBIOTIC	INHIBITS/TARGET	MUTANTS
Inhibitors of Transcription
Rifamycin, Rifampicin	Inhibits initiation of transcription/β-	rpoB, crp, cyaA
Rifabutin Rifaximin	subunit RNA polymerase, rpoB
Streptolydigin	Accelerates transcription chain	rpoB
	termination/β-subunit RNA
	polymerase
Streptovaricin	an acyclic ansamycin, inhibits RNA	rpoB
	polymerase
Actinomycin D + EDTA	Intercalates between 2 successive G-	pldA
	C pairs, rpoB, inhibits RNA
	synthesis
Inhibitors of Nucleic
Acid Metabolism
Quinolones,	α subunit gyrase and/or	gyrAorB, icd, sloB
Nalidixic acid	topoisomerase IV, gyrA
Oxolinic acid
Fluoroquinolones	α subunit gyrase, gyrA and/or	gyrA
Ciprofloxacin,	topoisomerase IV (probable target in	norA (efflux in
Norfloxacin	Staph)	Staph)
		hipQ
Coumerins	Inhibits ATPase activity of β-subunit
Novobiocin	gyrase, gyrB	gyrB, cysB, cysE,
		nov, ompA
Coumermycin	Inhibits ATPase activity of β-subunit	gyrB, hisW
	gyrase, gyrB
Albicidin	DNA synthesis	tsx (nucleoside
		channel)
Metronidazole	Causes single-strand breaks in DNA	nar
Inhibitors of Metabolic
Pathways
Sulfonamides,	blocks synthesis of	folP, gpt, pabA,
Sulfanilamide	dihydrofolate,dihydro-pteroate	pabB, pabC
	synthesis, folP
Trimethoprim,	Inhibits dihydrofolate reductase,	folA, thyA
	folA
Showdomycin	Nucleoside analogue capable of	nupC, pnp
	alkylating sulfhydryl groups, inhibito
	of thymidylate synthetase
Thiolactomycin	type II fatty acid synthase inhibitor	emrB
		fadB, emrB due to
		gene dosage
Psicofuranine	Adenosine glycoside antibiotic,	guaA,B
	target is GMP synthetase
Triclosan	Inhibits fatty acid synthesis	fabI (envM)
Diazoborines Isoniazid,	heterocyclic, contain boron, inhibit	fabI (envM)
Ethionamide	fatty acid synthesis, enoyl-ACP
	reductase, fabI
Inhibitors of Translation
Phenylpropanoids	Binds to ribosomal peptidyl transfer
Chloramphenicol,	center preventing peptide	rrn, cm/A, marA,
	translocation/binds to S6, L3, L6,	ompF, ompR
	L14, L16, L25, L26, L27, but
	preferentially to L16
Tetracyclines, type II	Binding to 305 ribosomal subunit, “A	clmA (cmr), mar,
polyketides	site	ompF
Minocycline	on 30S subunit, blocks peptide
Doxycycline	elongation, strongest binding to S7
Macrolides (type I	Binding to 50 S ribosomal subunit,
polyketides)	23S rRNA, blocks peptide
Erythromycin,	translocation, L15, L4, L12	rrn, rplC, rplD,
Carbomycin,		rplV, mac
Spiramycin etc
Aminoglycosides	Irreversible binding to 30S
Streptomycin,	ribosomal subunit, prevents	rpsL, strC,M, ubiF
	translation or causes mistranslation	atpA-E, ecfB,
Neomycin	of mRNA/16S rRNA	hemAC,D,E,G,
		topA,
		rpsC,D,E, rrn, speB
Spectinomycin		atpA-atpE, cpxA,
Kanamycin		ecfB, hemA,B,L,
		topA
Kasugamycin		ksgA,B,C,D,
		rplB,K,
Gentamicin,		rpsI,N,M,R
Amikacin		rplF, ubiF
Paromycin		cpxA
		rpsL
Lincosamides	Binding to 50 S ribosomal subunit,
Lincomycin,	blocks peptide translocation	linB, rplN,O, rpsG
Clindamycin
Streptogramins	2 components, Streptogramins
Virginiamycin,	A&B, bind to the 50S ribosomal
Pristinamycin	subunit blocking peptide
Synercid: quinupristin/	translocation and peptide bond
dalfopristin	formation
Fusidanes	Inhibition of elongation factor G	fusA
Fusidic Acid	(EF-G) prevents peptide
	translocation
Kirromycin (Mocimycin)	Inhibition of elongation factor TU	tufA,B
	(EF-Tu), prevents peptide bond
	formation
Pulvomycin	Binds to and inhibits EF-TU
Thiopeptin	Sulfur-containing antibiotic, inhibits	rplE
	protein synthesis,EF-G
Tiamulin	Inhibits protein synthesis	rplC, rplD
Negamycin	Inhibits termination process of	prfB
	protein synthesis
Oxazolidinones Linezolid	23S rRNA
Isoniazid
		pdx
Nitrofurantoin	Inhibits protein synthesis,	nfnA, B
	nitroreductases convert
	nitrofurantoin to highly reactive
	electrophilic intermediates which
	attack bacterial ribosomal
	proteins non-specifically
Pseudomonic Acids	Inhibition of isoleucyl tRNA	ileS
Mupirocin (Bactroban)	synthetase-used for Staph, topical
	cream, nasal spray
Indolmycin	Inhibits tryptophanyl-tRNA	trpS
	synthetase
Viomycin		rrmA (23S rRNA
		methyltransferase;
		mutant has slow
		growth rate, slow
		chain elongation
		rate, and
		viomycin
		resistance)
Thiopeptides	Binds to L11-23S RNA complex
Thiostrepton	Inhibits GTP hydrolysis by EF-G
	Stimulates GTP hydrolysis by EF-G
Micrococcin
Inhibitors of
Cell Walls/Membranes
β-lactams	Inhibition of one or more cell wall
Penicillin, Ampicillin	transpeptidases, endopeptidases,
	and glycosidases (PBPs), of the 12	ampC, ampD,
Methicillin,	PBPs only 2 are essential: mrdA	ampE, envZ,
	(PBP2) and ftsI (pbpB, PBP3)	galU, hipA,
	hipQ, ompC,
	ompF, ompR,
Cephalosporins,		ptsI, rfa, tolD,
Mecillinam	Binds to and inactivates PBP2	tolE
(amdinocillin)	(mrdA)	tonB
	Inactivates PBP3 (ftsl)	alaS, argS, crp,
Aztreonam		cyaA, envB,
(Furazlocillin)	mrdA,B,
		mreB, C,D
Bacilysin, Tetaine	Dipeptide, inhib glucosamine	dppA
	synthase
Glycopeptides Vancomycin,	Inhib G+ cell wall syn, binds to
	terminal D-ala-D-ala of
	pentapeptide,
Polypeptides Bacitracin	Prevents dephosphorylation and
	regeneration of lipid carrier	rfa
Cyclic lipopeptide	Disrupts multiple aspects of
Daptomycin,	membrane function, including
	peptidoglycan synthesis,
	lipoteichoic acid synthesis, and the
	bacterial membrane potential
Cyclic polypeptides	Surfactant action disrupts cell	pmrA
Polymixin,	membrane lipids, binds lipid A
	mioety of LPS
Fosfomycin,	Analogue of P-enolpyruvate,	murA, crp, cyaA
	inhibits 1st step in peptidoglycan	glpT, hipA, ptsI,
	synthesis - UDP-N-	uhpT
	acetyiglucosamine enolpyruvyl
	transferase, murA. Also acts as
	Immunosuppressant
Cycloserine	Prevents formation of D-ala dimer,	hipA, cycA
	inhibits D-ala ligase, ddlA, B
Alafosfalin	phosphonodipeptide, cell wall	pepA, tpp
	synthesis inhibitor, potentiator of
	β-lactams
Inhibitors of Protein
Processing/Transport
Globomycin	Inhibits signal peptidase II	lpp, dnaE
	(cleaves prolipoproteins
	subsequent to lipid modification,
	lspA

[0764] It will be appreciated that the above cell-based assays may be performed using a sub-lethal concentration of a known antibiotic which acts against the product of any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or portions thereof, or homologous nucleic acids. In this way, the level or activity of a target, such as any of the proliferation-required polypeptides from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or homologous polypeptides may be reduced.

Example 12

Transfer of Exogenous Nucleic Acid Sequences to other Bacterial Species

[0765] The ability of an antisense molecule identified in a first organism to inhibit the proliferation of a second organism (thereby confirming that a gene in the second organism which is homologous to the gene from the first organism is required for proliferation of the second organism) was validated using antisense nucleic acids which inhibit the growth of E. coli which were identified using methods similar to those described above. Expression vectors which inhibited growth of E. coli upon induction of antisense RNA expression with IPTG were transformed directly into Enterobacter cloacae, Klebsiella pneumonia or Salmonella typhimurium. The transformed cells were then assayed for growth inhibition according to the method of Example 1. After growth in liquid culture, cells were plated at various serial dilutions and a score determined by calculating the log difference in growth for INDUCED vs. UNINDUCED antisense RNA expression as determined by the maximum 10 fold dilution at which a colony was observed. The results of these experiments are listed below in Table V. If there was no effect of antisense RNA expression in a microorganism, the clone is minus in Table V. In contrast, a positive in Table V means that at least 10 fold more cells were required to observe a colony on the induced plate than on the non-induced plate under the conditions used and in that microorganism.

TABLE V
Sensitivity of Other Microorganisms to Antisense Nucleic Acids
That Inhibit Proliferation in E. coli
	Mol. No.	S. typhimurium	E. cloacae	K. pneumoniae
	EcXA001	+	+	−
	EcXA004	+	−	−
	EcXA005	+	+	+
	EcXA006	−	−	−
	EcXA007	−	+	−
	EcXA008	+	−	+
	EcXA009	−	−	−
	EcXA010	+	+	+
	EcXA011	−	+	−
	EcXA012	−	+	−
	EcXA013	+	+	+
	EcXA014	+	+	−
	EcXA015	+	+	+
	EcXA016	+	+	+
	EcXA017	+	+	+
	EcXA018	+	+	+
	EcXA019	+	+	+
	EcXA020	+	+	+
	EcXA021	+	+	+
	EcXA023	+	+	+
	EcXA024	+	−	+
	EcXA025	−	−	−
	EcXA026	+	+	−
	EcXA027	+	+	−
	EcXA028	+	−	−
	EcXA029	−	−	−
	EcXA030	+	+	+
	EcXA031	+	−	−
	EcXA032	+	+	−
	EcXA033	+	+	+
	EcXA034	+	+	+
	EcXA035	−	−	−
	EcXA036	+	−	+
	EcXA037	+	+	−
	EcXA038	+	+	+
	EcXA039	+	−	−
	EcXA041	+	+	+
	EcXA042	−	+	+
	EcXA043	−	−	−
	EcXA044	−	−	−
	EcXA045	+	+	+
	EcXA046	−	−	−
	EcXA047	+	+	−
	EcXA048	−	−	−
	EcXA049	+	−	−
	EcXA050	−	−	−
	EcXA051	+	−	−
	EcXA052	+	−	−
	EcXA053	+	+	+
	EcXA054	−	−	+
	EcXA055	+	−	−
	EcXA056	+	−	+
	EcXA057	+	+	−
	EcXA058	−	−	−
	EcXA059	+	+	+
	EcXA060	−	−	−
	EcXA061	−	−	−
	EcXA062	−	−	−
	EcXA063	+	+	−
	EcXA064	−	−	−
	EcXA065	+	+	−
	EcXA066	−	−	−
	EcXA067	−	+	−
	EcXA068	−	−	−
	EcXA069	−	+	−
	EcXA070	−	−	−
	EcXA071	+	−	−
	EcXA072	+	−	+
	EcXA073	+	+	+
	EcXA074	+	+	+
	EcXA075	+	−	−
	EcXA076	−	+	−
	EcXA077	+	+	−
	EcXA079	+	+	+
	EcXA080	+	−	−
	EcXA082	−	+	−
	EcXA083	−	−	−
	EcXA084	−	+	−
	EcXA086	−	−	−
	EcXA087	−	−	−
	EcXA088	−	−	−
	EcXA089	−	−	−
	EcXA090	−	−	−
	EcXA091	−	−	−
	EcXA092	−	−	−
	EcXA093	−	−	−
	EcXA094	+	+	+
	EcXA095	+	+	−
	EcXA096	−	−	−
	EcXA097	+	−	−
	EcXA098	+	−	−
	EcXA099	−	−	−
	EcXA100	−	−	−
	EcXA101	−	−	−
	EcXA102	−	−	−
	EcXA103	−	+	−
	EcXA104	+	+	+
	EcXA106	+	+	−
	EcXA107	−	−	−
	EcXA108	−	−	−
	EcXA109	−	−	−
	EcXA110	+	+	−
	EcXA111	−	−	−
	EcXA112	−	+	−
	EcXA113	+	+	+
	EcXA114	−	+	−
	EcXA115	−	+	−
	EcXA116	+	+	−
	EcXA117	+	−	−
	EcXA118	−	−	−
	EcXA119	+	+	−
	EcXA120	−	−	−
	EcXA121	−	−	−
	EcXA122	+	−	+
	EcXA123	+	−	−
	EcXA124	−	−	−
	EcXA125	−	−	−
	EcXA126	−	−	−
	EcXA127	+	+	−
	EcXA128	−	−	−
	EcXA129	−	+	−
	EcXA130	+	+	−
	EcXA132	−	−	−
	EcXA133	−	−	−
	EcXA136	−	−	−
	EcXA137	−	−	−
	EcXA138	+	−	−
	EcXA139	−	−	−
	EcXA140	+	−	−
	EcXA141	+	−	−
	EcXA142	−	−	−
	EcXA143	−	+	−
	EcXA144	+	+	−
	EcXA145	−	−	−
	EcXA146	−	−	−
	EcXA147	−	−	−
	EcXA148	−	−	−
	EcXA149	+	+	+
	EcXA150	−	−	−
	EcXA151	+	−	−
	EcXA152	−	−	−
	EcXA153	+	+	−
	ExXA154	−	−	−
	EcXA155	−	−	ND
	EcXA156	−	+	−
	EcXA157	−	−	−
	EcXA158	−	−	−
	EcXA159	+	−	−
	EcXA160	+	−	−
	EcXA162	−	−	−
	EcXA163	−	−	−
	EcXA164	−	−	−
	EcXA165	−	−	−
	EcXA166	−	−	−
	EcXA167	−	−	−
	EcXA168	−	−	−
	EcXA169	−	+	−
	EcXA171	−	−	−
	EcXA172	−	−	−
	EcXA173	−	−	−
	EcXA174	−	−	−
	EcXA175	−	−	−
	EcXA176	−	−	−
	EcXA178	−	−	−
	EcXA179	−	−	−
	EcXA180	+	−	−
	EcXA181	−	−	−
	EcXA182	−	−	−
	EcXA183	−	−	−
	EcXA184	−	−	−
	EcXA185	−	−	−
	EcXA186	−	−	−
	EcXA187	+	+	+
	EcXA189	+	−	−
	EcXA190	+	+	+
	EcXA191	+	+	−
	EcXA192	−	+	−

[0766] Thus, the ability of an antisense nucleic acid which inhibits the proliferation of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi to inhibit the growth of other organims may be evaluated by transforming the antisense nucleic acid directly into species other than the organism from which they were obtained. In particular, the ability of the antisense nucleic acid to inhibit the growth of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. may be evaluated. In some embodiments of the present invention, the ability of the antisense nucleic acid to inhibit the growth of an organism other than E. coli may be evaluated. In such embodiments, the antisense nucleic acids are inserted into expression vectors functional in the organisms in which the antisense nucleic acids are evaluated.

[0767] It will be appreciated that the above methods for evaluating the ability of an antisense nucleic acid to inhibit the proliferation of a heterologous organism may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi (including antisense nucleic acids complementary to SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs.: 8-3795) or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids.

[0768] Those skilled in the art will appreciate that a negative result in a heterologous cell or microorganism does not mean that that cell or microorganism is missing that gene nor does it mean that the gene is unessential. However, a positive result means that the heterologous cell or microorganism contains a homologous gene which is required for proliferation of that cell or microorganism. The homologous gene may be obtained using the methods described herein. Those cells that are inhibited by antisense may be used in cell-based assays as described herein for the identification and characterization of compounds in order to develop antibiotics effective in these cells or microorganisms. Those skilled in the art will appreciate that an antisense molecule which works in the microorganism from which it was obtained will not always work in a heterologous cell or microorganism.

Example 12A

Transfer of Exogenous Nucleic Acid Sequences to other Bacterial Species Using the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi Expression Vectors or Expression Vectors Functional in Bacterial Species other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi.

[0769] The antisense nucleic acids that inhibit the growth of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, or portions thereof, may also be evaluated for their ability to inhibit the growth of cells or microorganisms other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi. For example, the antisense nucleic acids that inhibit the growth of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi may be evaluated for their ability to inhibit the growth of other organisms. In particular, the ability of the antisense nucleic acid to inhibit the growth of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species may be evaluated. In some embodiments of the present invention, the ability of the antisense nucleic acid to inhibit the growth of an organism other than E. coli may be evaluated.

[0770] In such methods, expression vectors in which the expression of an antisense nucleic acid that inhibits the growth of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi is under the control of an inducible promoter are introduced into the cells or microorganisms in which they are to be evaluated. In some embodiments, the antisense nucleic acids may be evaluated in cells or microorganisms which are closely related to Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi. The ability of these antisense nucleic acids to inhibit the growth of the related cells or microorganisms in the presence of the inducer is then measured.

[0771] For example, thirty-nine antisense nucleic acids which inhibited the growth of Staphylococcus aureus were identified using methods such as those described herein and were inserted into an expression vector such that their expression was under the control of a xylose-inducible Xyl-T5 promoter. A vector with Green Fluorescent Protein (GFP) under control of the Xyl-T5 promoter was used to show that expression from the Xyl-T5 promoter in Staphylococcus epidermidis was comparable to that in Staphylococcus aureus.

[0772] The vectors were introduced into Staphylococcus epidermidis by electroporation as follows: Staphylococcus epidermidis was grown in liquid culture to mid-log phase and then harvested by centrifugation. The cell pellet was resuspended in 1/3 culture volume of ice-cold EP buffer (0.625 M sucrose, 1 mM MgCl2, pH=4.0), and then harvested again by centrifugation. The cell pellet was then resuspended with {fraction (1/40)} volume EP buffer and allowed to incubate on ice for 1 hour. The cells were then frozen for storage at −80° C. For electroporation, 50 μl of thawed electrocompetent cells were combined with 0.5 μg plasmid DNA and then subjected to an electrical pulse of 10 kV/cm, 25 uFarads, 200 ohm using a biorad gene pulser electroporation device. The cells were immediately resuspended with 200 μl outgrowth medium and incubated for 2 hours prior to plating on solid growth medium with drug selection to maintain the plasmid vector. Colonies resulting from overnight growth of these platings were selected, cultured in liquid medium with drug selection, and then subjected to dilution plating analysis as described for Staphylococcus aureus in Example 10 above to test growth sensitivity in the presence of the inducer xylose.

[0773] The results are shown in Table VI below. The first column indicates the Molecule Number of the Staphylococcus aureus antisense nucleic acid which was introduced into Staphylococcus epidermidis. The second column indicates whether the antisense nucleic acid inhibited the growth of Staphylococcus epidermidis, with a indicating that growth was inhibited. Of the 39 Staphylococcus aureus antisense nucleic acids evaluated, 20 inhibited the growth of Staphylococcus epidermidis.

TABLE VI
Sensitivity of Other Microorganisms to Antisense Nucleic Acids
That Inhibit Proliferation of Staphylococcus aureus
Mol. No. S. epidermidis
SaXA005  +
SaXA007  +
SaXA008  +
SaXA009  +
SaXA010  −
SaXA011  −
SaXA012  −
SaXA013  −
SaXA015  +
SaXA017  −
SaXA022  +
SaXA023  −
SaXA024  −
SaXA025  +
SaXA026  +
SaXA027  −
SaXA027b −
SaXA02c  −
SaXA028  −
SaXA029  +
SaXA030  −
SaXA032  +
SaXA033  +
SaXA034  −
SaXA035  +
SaXA037  −
SaXA039  −
SaXA042  −
SaXA043  −
SaXA044  −
SaXA045  +
SaXA051  +
SaXA053  −
SaXA056b −
SaXA059a +
SaXA060  −
SaXA061  +
SaXA062  +
SaXA063  −
SaXA065  −

[0774] Although the results shown above were obtained using a subset of the nucleic acids of the present invention, it will be appreciated that similar analyses may be performed using the other nucleic acids of the present invention to determine whether they inhibit the proliferation of cells or microorganisms other than Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi.

[0775] Thus, it will be appreciated that the above methods for evaluating the ability of an antisense nucleic acid to inhibit the proliferation of a heterologous organism may be performed using antisense nucleic acids complementary to any of the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, (including antisense nucleic acids complementary to SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, such as the antisense nucleic acids of SEQ ID NOs.: 8-3795) or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids or portions thereof, or homologous antisense nucleic acids.

Example 12C

[0776] As a demonstration of the methodology required to find homologues to an essential gene, nine prokaryotic organisms were analyzed and compared in detail. First, the most reliable source of gene sequences for each organism was assessed by conducting a survey of the public and private data sources. The nine organisms studied are Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Salmonella typhi. Full-length gene protein and nucleotide sequences for these organisms were assembled from various sources. For Escherichia coli, Haemophilus influenzae and Helicobacter pylori, gene sequences were adopted from the public sequencing projects, and derived from the GenPept 115 database (available from NCBI). For Pseudomonas aeruginosa, gene sequences were adopted from the Pseudomonas genome sequencing project (downloaded from http://www.pseudomonas.com). For Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pneumoniae and Salmonella typhi, genomic sequences from PathoSeq v 4.1 (Mar 2000 release) was reanalyzed for ORFs using the gene finding software GeneMark v 2.4a, which was purchased from GenePro Inc. 451 Bishop St., N.W., Suite B, Atlanta, Ga., 30318, USA.

[0777] Subsequently, the essential genes found by the antisense methodology were compared to the derived proteomes of interest, in order to find all the homologous genes to a given gene. This comparison was done using the FASTA program v3.3. Genes were considered homologues if they were greater than 25% identical and the alignment between the two genes covered more than 70% of the length of one of the genes. The best homologue for each of the nine organisms, defined as the most significantly scoring match which also fulfilled the above criteria, was reported in Table VIIA. Table VIIA lists the best ORF identified as described above (column labelled LOCUSID), the SEQ ID, % identity, and the amount of the protein which aligns well with the query sequence (coverage) for the gene identified in each of the nine organisms evaluated as described above.

[0778] Table VIIB lists the PathoSeq cluster ID for genes identified as being required for proliferation in Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus using the methods described herein. As indicated in the column labelled PathoSeq cluster ID, these sequences share homology to one another and were consequently grouped within the same PathoSeq cluster. Thus, the methods described herein identified genes required for proliferation in several species which share homology.

TABLE VIIA
		Escherichia	Enterococcus	Haemophilus	Helicobacter	Klebsiella	Pseudomonas	Staphylococcus	Streptococcus	Salmonella
LOCUSID	Data	coli	faecalis	influenzae	pylori	pneumoniae	aeruginosa	aureus	pneumoniae	typhi
EFA100001	SeqID	10430	10618	10998	11603	11739		12309	13524	14040
	IDENTITY	27%	100%	28% 28%	29%		52%	55%	28%
	COVERAGE	99%	100%	101%	79%	77%		98%	98%	98%
EFA100023	SeqID		10505					12860	13392
	IDENTITY		100%					27%	39%
	COVERAGE		100%					95%	101%
EFA100065	SeqID	10322	10813	11177	11351		12018	12820	13186	13733
	IDENTITY	49%	100%	49%	44%		48%	59%	65%	48%
	COVERAGE	96%	100%	95%	96%		97%	97% 98%	96%
EFA100151	SeqID	10128	10516	11247	11340		11891	12529	13362
	IDENTITY	50%	100%	37%	46%		49%	54%	51%
	COVERAGE	99%	100%	100%	100%		100%	99%	100%
EFA100157	SeqID		10673		11448	12352	13176
	IDENTITY		100%		39%	64%	74%
	COVERAGE		100%		98%	98%	99%
EFA100165	SeqID	10031	10637	11189	11564		12009	12614	13399	14078
	IDENTITY	31%	100%	33%	28%		32%	29%	27%	29%
	COVERAGE	97%	100%	98%	100%		96%	90%	96%	97%
EFA100190	SeqID	10364	10480	11061	11408	11659	11996	12444	13232	13966
	IDENTITY	54%	100%	57%	55%	55%	54%	78%	80%	54%
	COVERAGE	100%	101%	100%	99%	90%	100%	101%	101%	101%
EFA100194	SeqID	10336	10540	11120	11426		11989	12230	13222	14096
	IDENTITY	60%	100%	62%	62%		60%	85%	86%	61%
	COVERAGE	100%	101%	100%	102%	100%	101%	92%	101%
EFA100200	SeqID	10323	10798	11193			12020	12527	13561	13731
	IDENTITY	39%	100%	38%			40%	50%	59%	39%
	COVERAGE	85%	100%	87%			85%	85%	88%	85%
EFA100210	SeqID	10352	10560	11104	11439		5171	12260	13204	13968
	IDENTITY	53%	100%	53%	53%		54%	74%	93%	53%
	COVERAGE	95%	101%	95%	94%		95%	101%	94%	95%
EFA100211	SeqID	10351	10523	11105	11438		11992	12214	13205
	IDENTITY	46%	100%	46%	39%		43%	69%	63%
	COVERAGE	87%	101%	87%	81%		87%	97%	81%	_______
EFA100289	SeqID	10284	10810				11827		13245
	IDENTITY	30%	100%				31%		25%
	COVERAGE	85%	100%				90%		84%
EFA100295	SeqID	10045	10517	11174	11601		11937	12390	13616	13911
	IDENTITY	43%	100%	41%	41%		45%	44%	45%	43%
	COVERAGE	92%	101%	95%	97%		97%	99%	94%	72%
EFA100312	SeqID		10641					12178
	IDENTITY		100%					33%
	COVERAGE		100%					88%
EFA100329	SeqID		10782
	IDENTITY		100%
	COVERAGE		100%
EFA100394	SeqID	10465	10675	11238	11563		11961	13003	13684	13853
	IDENTITY	43%	100%	43%	42%		44%	66%	72%	44%
	COVERAGE	108%	100%	109%	101%		108%	99%	100%	108%
EFA100397	SeqID	10027	10773	11185			12012	12396	13478	14074
	IDENTITY	31%	100%	29%			29%	43%	46%	31%
	COVERAGE	96%	100%	98%			93%	91%	97%	93%
EFA100399	SeqID	10295	10766	11196	11483		11791	12281	13413	13739
	IDENTITY	63%	100%	59%	59%		58%	72%	76%	63%
	COVERAGE	98%	100%	98%	99%		101%	99%	100%	98%
EFA100426	SeqID	10224	10702			11638		12139	13348	13957
	IDENTITY	28%	100%			29%		42%	41%	28%
	COVERAGE	99%	101%	99%		91%	109%	99%
EFA100478	SeqID	10486	11135	11338			12986	13184
	IDENTITY	100%	29%	31%			44%	43%
	COVERAGE	100%	72%	70%			99%	98%
EFA100615	SeqID	10501	11139			12028	12641	13331
	IDENTITY	100%	44%			47%	61%	78%
	COVERAGE	100%	82%			81%	100%	100%
EFA100617	SeqID	10314	10764	11216	11391		5198	12322	13381	13765
	IDENTITY	43%	100%	43%	44%		51%	63%	69%	44%
	COVERAGE	95%	100%	96%	78%		73%	84%	82%	93%
EFA100641	SeqID	10205	10793				11896	12862	13334
	IDENTITY	28%	100%				31%	50%	32%
	COVERAGE	79%	100%				74%	85%	82%
EFA100642	SeqID		10792	11520	12023	12493	13367
	IDENTITY		100%	46%	46%	73%	69%
	COVERAGE		100%	100%	101%	100%	100%
EFA100668	SeqID	10026	10679	11184	11613		12013	12891	13505	14073
	IDENTITY	28%	100%	28%	29%		28%	29%	50%	27%
	COVERAGE	83%	100%	76%	78%		92%	82%	99%	95%
EFA100689	SeqID		10717					12523	13698
	IDENTITY		100%		33%	33%
	COVERAGE		100%					100%	100%
EFA100704	SeqID	10362	10482	11059	11415		11995	12442	13171	13964
	IDENTITY 78%	100%	78%	77%		75%	90%	78%	77%
	COVERAGE	100%	100%	100%	101%		101%	100%	101%	100%
EFA100739	SeqID	10111	10537	11052	11429	11651	11876	12228	13220	14010
	IDENTITY 71%	100%	69%	63%	70%	71%	84%	84%	70%
	COVERAGE	83%	101%	83%	86%	87%	83%	87%	87%	87%
EFA100740	SeqID	10075	10536	11008	11348	11633	11942	12227	13219	13717
	IDENTITY 45%	100%	47%	30%	45%	48%	64%	60%	44%
	COVERAGE	94%	100%	94%	93%	94%	82%	94%	93%	94%
EFA100741	SeqID	10339	10535	11118	11430		11991	12226	13218	14098
	IDENTITY 40%	100%	37%	34%		39%	48%	60%	40%
	COVERAGE	103%	100%		102%	101%	102%	101%	100%	103%
EFA100742	SeqID	10340	10534	11116	11431		5160	12225	13217	14099
	IDENTITY 52%	100%	52%	39%		46%	79%	88%	52%
	COVERAGE	99%	101%	99%	92%		99%	101%	101%	99%
EFA100748	SeqID	10287	10483	11004	11523	11690	11944	12595		13868
	IDENTITY 41%	100%	39%	29%	42%	44%	52%		41%
	COVERAGE	99%	100%	99%	94%	98%	100%	100%		100%
EFA100756	SeqID	10112	10575		11396		11875	12327	13343	14009
	IDENTITY 49%	100%	43%		45%	64%	62%	47%
	COVERAGE	75%	102%		75%		81%	94%	94%	75%
EFA100757	SeqID	10155	10897
	IDENTITY	27%	100%
	COVERAGE	85%	100%
EFA100783	SeqID	10035	10811	10986		11543	11953	12738	13261	13914
	IDENTITY	32%	100%	34%	86%		37%	77%	75%	31%
	COVERAGE	104%	100%	83%	100%		78%	100%	99%	99%
EFA100795	SeqID	10863						13416
	IDENTITY	100%						50%
	COVERAGE	101%						101%
EFA100798	SeqID	10382	10818	11153	11550		11775		13641
	IDENTITY	62%	100%	61%	56%		63%		85%
	COVERAGE	95%	100%	95%	89%		92%		96%
EFA100811	SeqID		10546					12236	13439
	IDENTITY		100%					48%	58%
	COVERAGE		101%					98%	99%
EFA100870	SeqID	10439	10627	11036	11410		5179	12446	13646	14042
	IDENTITY	47%	100%	46%	52%		46%	72%	78%	46%
	COVERAGE	114%	100%	117%	79%		116%	99%	98%	114%
EFA100914	SeqID	10399	10579	11018	11617	11758	12111	12368	13230	14065
	IDENTITY	40%	100%	40%	34%	40%	40%	59%	63%	40%
	COVERAGE	102%	100%	102%	101%	102%	102%	101%	95%	102%
EFA100919	SeqID	10269	10491	11127	11419		11809	12556	13594	13874
	IDENTITY	44%	100%	45%	40%		46%	55%	63%	45%
	COVERAGE	101%	100%	101%	99%		101%	101%	100%	101%
EFA100955	SeqID	10333	10542	11123	11582	11627	5158	12232	13224	14093
	IDENTITY	48%	100%	48%	42%	49%	43%	65%	76%	48%
	COVERAGE	98%	101%	98%	98%	79%	98%	99%	101%	98%
EFA100970	SeqID		10906
	IDENTITY		100%
	COVERAGE		100%
EFA100978	SeqID	10334	10541	11122	11583		11987	12231	13223	14094
	IDENTITY	46%	100%	46%	35%		45%	71%	70%	46%
	COVERAGE	100%	100%	99%	98%		102%	101%	100%	100%
EFA100991	SeqID	10221	10681	11210	11607	11668	11801	12289	13191	14027
	IDENTITY	42%	100%	40%	29%	42%	39%	49%	56%	30%
	COVERAGE	91%	100%	93%	98%	94%	91%	93%	92%	93%
EFA101022	SeqID	10260	10875	10982	11401		11945	12715	13251	14086
	IDENTITY	59%	100%	58%	50%		61%	76%	86%	56%
	COVERAGE	85%	101%	85%	88%		85%	85%	89%	89%
EFA101060	SeqID		10722		11575	11646	11957	12504	13554
	IDENTITY		100%		35%	37%	34%	71%	67%
	COVERAGE		101%	83%	77%	97%	100%	101%
EFA101086	SeqID	10315	10763	11215	11454	11716	12052	12953	13662	13764
	IDENTITY	37%	100%	37%	27%	38%	35%	57%	55%	36%
	COVERAGE	91%	100%	89%	98%	91%	92%	98%	95%	93%
EFA101120	SeqID	10017	10687	11219	11331		12057	12505	13498	14012
	IDENTITY	30%	100%	31%	27%		29%	26%	64%	29%
	COVERAGE	102%	100%	102%	74%		103%	99%	98%	103%
EFA101121	SeqID		10686					12606	13600
	IDENTITY		100%		38%	50%
	COVERAGE		100%		98%	99%
EFA101123	SeqID	10420	10748	11131	11478	11629	11820	12674	13265	13783
	IDENTITY	43%	100%	39%	33%	43%	40%	70%	70%	42%
	COVERAGE	98%	100%	97%	97%	94%	96%	99%	100%	98%
EFA101141	SeqID	10436	10614	11071	11573		5181	12450	13246	14045
	IDENTITY	35%	100%	40%	35%		40%	60%	70%	31%
	COVERAGE	94%	101%	96%	95%	95%		98%	101%	96%
EFA101150	eqID	10174	10719	11221	11556		11880	12985	13385	13943
	IDENTITY	35%	100%	36%	26%		33%	45%	58%	36%
	COVERAGE	100%	100%	100%	102%	100%	100%	100%	73%
EFA101159	SeqID	10359	10543	11097	11442		5176	12235	13197	13974
	IDENTITY	55%	100%	52%	48%	49%	58%	89%	53%
	COVERAGE	100%	101%	100%	81%		101%	99%	99%	100%
EFA101160	SeqID	10358	10549	11098	11595		5175	12240	13198	13973
	IDENTITY	43%	100%	43%	33%		45%	62%	74%	43%
	COVERAGE	92%	100%	92%	96%		92%	100%	100%	93%
EFA101161	SeqID	10357	10551	11099			11994	12242	13199	13972
	IDENTITY	39%	100%	35%			37%	69%	66%	36%
	COVERAGE	86%	101%	99%			96%	93%	103%	100%
EFA101162	SeqID	10356	10555	11100	11441	11679	11993	12249	13200	13971
	IDENTITY	58%	100%	58%	59%	59%	57%	78%	84%	58%
	COVERAGE	100%	100%	100%	100%	100%	99%	100%	100%	100%
EFA101163	SeqID	10355	10557	11101	11594		5174	12255	13201
	IDENTITY	66%	100%	68%	60%		70%	84%	90%
	COVERAGE	100%	101%	99%	97%		100%	101%	100%
EFA101164	SeqID	10354	10558	11102	11593		5173	12258	13202	13970
	IDENTITY	55%	100%	58%	47%		57%	66%	81%	55%
	COVERAGE	91%	101%	91%	91%		85%	91%	97%	91%
EFA101165	SeqID	10353	10559	11103	11592		517212259	13203 13969
	IDENTITY	59%	100%	60%	52%		61%	78%	88%	59%
	COVERAGE	95%	100%	95%	99%		95%	100%	100%	95%
EFA101169	SeqID	10133	10574	11091			12025	12516		13849
	IDENTITY	27%	100%	28%			26%	41%		27%
	COVERAGE	93%	100%	97%			94%	100%		93%
EFA101253	SeqID	10389	10852	11065	11551		11838	13072	13457
	IDENTITY	43%	100%	42%	31%		39%	54%	67%
	COVERAGE	97%	100%	97%	96%		99%	97%	99%
EFA101257	SeqID	10124	10917	10976	11484		11914	12528	13357	14037
	IDENTITY	40%	100%	39%	39%		37%	39%	58%	38%
	COVERAGE	99%	100%	99%	101%	97%	97%	100%	101%
EFA101258	SeqID	10127	10918	10973	11513		11892	12802	13358	13871
	IDENTITY	40%	100%	40%	39%		36%	41%	66%	29%
	COVERAGE	97%	101%	96%	95%		96%	92%	95%	92%
EFA101322	SeqID		10620					12534	13328
	IDENTITY		100%		66%	65%
	COVERAGE		100%					86%	86%
EFA101339	SeqID		10743	11448			12326	13391
	IDENTITY		100%	33%			46%	60%
	COVERAGE		100%		97%			98%	98%
EFA101340	SeqID		10745
	IDENTITY		100%
	COVERAGE		102%
EFA101354	SeqID	10047	10648	11089	11608		11935	12617 13345	13913
	IDENTITY	33%	100%	33%	32%		34%	38%	36%	32%
	COVERAGE	101%	100%	104%	101%	104%	97%	100%	101%
EFA101370	SeqID		10738					13126
	IDENTITY		100%					31%
	COVERAGE		101%					98%
EFA101403	SeqID		10662					12941
	IDENTITY		100%					34%
	COVERAGE		100%					100%
EFA101404	SeqID	10210	10663	11214	11554		11921	12135 13418	13925
	IDENTITY	29%	100%	28%	39%		27%	59%	64%	30%
	COVERAGE	99%	100%	102%	98%		100%	99%	99%	99%
EFA101409	SeqID	10350	10524	11106	11437		5170	12215	13207
	IDENTITY	54%	100%	58%	44%		53%	81%	87%
	COVERAGE	83%	101%	80%	86%		91%	91%	91%	_______
EFA101410	SeqID	10349	10525	11107	11436		5169	12216	13208	14108
	IDENTITY	62%	100%	64%	63%		66%	90%	90%	62%
	COVERAGE	101%	101%	101%	100%	100%	101%	101%	102%
EFA101411	SeqID	10348	10526	11108			5168	12217	13209	14107
	IDENTITY	50%	100%	43%			49%	66%	71%	46%
	COVERAGE	97%	101%	97%			93%	96%	99%	97%
EFA101412	SeqID	10347	10527	11109	11589	11654	5167	12218	13210	14106
	IDENTITY	60%	100%	59%	52%	61%	58%	85%	83%	60%
COVERAGE	100%	101%	100%	98%	101%	99%	92%	100%	101%
EFA101414	SeqID	10345	10528	11111	11435		5165	12219	13212	14104
	IDENTITY	49%	100%	47%	42%		46%	79%	81%	49%
	COVERAGE	99%	101%	99%	99%		100%	101%	101%	101%
EFA101415	SeqID	10344	10529	11112	11434		5164	12220	13213	14103
IDENTITY	47%	100%	50%	39%		49%	63%	74%	47%
COVERAGE	98%	101%	98%	100%	98%	101%	101%	98%
EFA101416	SeqID	10343	10530	11113	11433		5163	12221	13214	14102
	IDENTITY	50%	100%	48%	42%		52%	68%	82%	51%
	COVERAGE	97%	101%	97%	91%		94%	99%	101%	98%
EFA101417	SeqID	10342	10531	11114	11432		5162	12222	13215	14101
	IDENTITY	55%	100%	56%	61%		52%	72%	85%	55%
	COVERAGE	100%	101%	95%	84%		92%	95%	94%	100%
EFA101424	SeqID	10220	10784	11276		11765	11950	12350	13280	13934
	IDENTITY	44%	100%	38%		34%	36%	65%	79%	41%
	COVERAGE	99%	101%	97%		73%	78%	101%	99%	99%
EFA101425	SeqID	10240	10785	11275			11925	12351 13281	13863
	IDENTITY	49%	100%	50%			39%	63%	78%	47%
	COVERAGE	99%	100%	99%			99%	100%	100%	84%
EFA101477	SeqID	10263	10861	10965	11562		11948	13066	13525	14089
	IDENTITY	52%	100%	50%	41%		49%	59%	72%	50%
	COVERAGE	91%	100%	95%	91%		95%	94%	91%	91%
EFA101536	SeqID	10281	10823
	IDENTITY	30%	100%
	COVERAGE	86%	100%
EFA101540	SeqID	10041	10487	11149	11456		11941	12314	13438	13907
	IDENTITY	51%	100%	50%	50%		49%	73%	76%	51%
	COVERAGE	92%	100%	90%	86%		92%	92%	99%	92%
EFA101541	SeqID	10042	10488	11150	11620		11940	12742	13437	13908
	IDENTITY	41%	100%	45%	35%		44%	63%	44%	41%
	COVERAGE	100%	100%	98%	121%		101%	100%	116%	100%
EFA101583	SeqID		10593
	IDENTITY		100%
	COVERAGE		100%
EFA101670	SeqID		10511
	IDENTITY		100%
	COVERAGE		100%
EFA101682	SeqID	10238	10789	11178	11517		11829	12811	13673	13864
	IDENTITY	45%	100%	45%	40%		44%	57%	57%	45%
	COVERAGE	97%	100%	98%	95%		91%	96%	95%	97%
EFA101685	SeqID		10791		11369		12022	12492	13368
	IDENTITY		100%		47%		51%	62%	69%
	COVERAGE		100%		92%		98%	97%	99%
EFA101686	SeqID	10237	10940	10999	11325		11901	12456	13455	13956
	IDENTITY	39%	100%	37%	37%		36%	64%	63%	38%
	COVERAGE	99%	100%	99%	99%		99%	99%	99%	99%
EFA101695	SeqID	10204	10629	11017	11479	11715	12106	12560	13284	13928
	IDENTITY	34%	100%	32%	34%	31%	35%	51%	75%	34%
	COVERAGE	104%	100%	106%	76%	93%	101%	100%	99%	105%
EFA101736	SeqID	10219	10775	11024			11924	12300	13340	13976
	IDENTITY	33%	100%	29%			27%	35%	32%	28%
	COVERAGE	100%	100%	100%			99%	98%	99%	100%
EFA101737	SeqID	10218	10778	11023			11923	12301	13341	13774
	IDENTITY	39%	100%	37%			42%	43%	43%	58%
	COVERAGE	98%	100%	98%			98%	100%	103%	96%
EFA101753	SeqID	10134	10552	11211			11895	12151	13693	13826
	IDENTITY	36%	100%	37%			36%	50%	50%	37%
	COVERAGE	91%	100%	89%			90%	94%	99%	91%
EFA101765	SeqID		10587					13010	13353
	IDENTITY		100%					28%	35%
	COVERAGE		100%		98%	97%
EFA101790	SeqID	10414	10803	11085			11915	12306		13747
	IDENTITY	42%	100%	41%			39%	46%		41%
	COVERAGE	101%	100%	101%	101%	101%		101%
EFA101791	SeqID	10804					12359
	IDENTITY	100%					37%
	COVERAGE	101%					77%
EFA101792	SeqID	10030	10805	11188	11458		5187	12360	13333	14077
	IDENTITY	31%	100%	32%	27%		33%	34%	47%	31%
	COVERAGE	98%	100%	96%	98%		99%	101%	100%	98%
EFA101795	SeqID	10329	10922	11159	11322		12062	12581	13363	13886
	IDENTITY	34%	100%	36%	36%		37%	36%	47%	32%
	COVERAGE	98%	101%	98%	99%		98%	98%	99%	97%
EFA101797	SeqID	10330	10924	11160	11321		12063	13127	13364	13885
	IDENTITY	53%	100%	52%	49%		55%	59%	74%	53%
	COVERAGE	98%	100%	98%	98%		98%	98%	99%	98%
EFA101799	SeqID	10048	10926	11014	11339		11934	12908	13366	13897
	IDENTITY	53%	100%	55%	49%		55%	54%	66%	54%
	COVERAGE	97%	100%	97%	94%		97%	97%	97%	97%
EFA101833	SeqID	10429	10720		11335		12039	12340	13451	14072
	IDENTITY	31%	100%		36%		35%	51%	59%	31%
	COVERAGE	79%	100%		92%		89%	92%	91%	79%
EFA101868	SeqID		10829
	IDENTITY		100%
	COVERAGE		100%
EFA101872	SeqID	10305	10815	11044	11343	11639	11797	12568	13288	13779
	IDENTITY	62%	100%	62%	38%	61%	60%	93%	92%	62%
	COVERAGE	86%	102%	86%	86%	79%	95%	97%	102%	86%
EFA101873	SeqID		10816				11796
	IDENTITY		100%				36%
	COVERAGE		101%				94%
EFA101892	SeqID	10454	10506	11048	11281		12005	12142	13190	14021
	IDENTITY	47%	100%	47%	41%		53%	49%	46%	47%
	COVERAGE	100%	101%	100%	97%		100%	101%	100% 100%
EFA101924	SeqID		10891		11532			12331	13463
	IDENTITY		100%		36%			65%	65%
	COVERAGE		100%		101%			100%	94%
EFA101925	SeqID		10893					12332
	IDENTITY		100%					59%
	COVERAGE		100%					99%
EFA101963	SeqID	10034	10848	11148	11536		12006	12552	13648	13901
	IDENTITY	48%	100%	47%	49%		47%	57%	69%	48%
	COVERAGE	105%	100%	105%	99%		108%	101%	100%	105%
EFA102006	SeqID		10580				11830	12804	13315
	IDENTITY		100%				33%	42%	43%
	COVERAGE		100%	84%	99%	95%
EFA102022	SeqID	10313	10881	11224	11502	11754	12051	12324	13485	13767
	IDENTITY	53%	100%	53%	51%	54%	55%	78%	78%	52%
	COVERAGE	88%	101%	88%	87%	89%	88%	89%	89%	89%
EFA102023	SeqID	10312	10882	10989	11576	11755	12050	12325	13699	13768
	IDENTITY	51%	100%	50%	38%	50%	50%	63%	70%	50%
	COVERAGE	98%	100%	99%	99%	84%	97%	99%	99%	97%
EFA102091	SeqID	10363	10481	11060	11568		11858	12443	13233	13965
	IDENTITY	60%	100%	61%	63%		62%	75%	86%	59%
	COVERAGE	101%	100%	101%	100%	101%	100%	100%	101%
EFA102110	SeqID	10193	10841	11255			12082		13430	13752
	IDENTITY	32%	100%	34%			34%		62%	32%
	COVERAGE	103%	100%	94%			100%		100%	99%
EFA102183	SeqID	10393	10952	11057	11330		11774	12695	13420	13920
	IDENTITY	55%	100%	54%	50%		54%	67%	78%	55%
	COVERAGE	84%	100%	86%	85%		86%	98%	100%	84%
EFA102185	SeqID	10458	10950	11051	11421	11632	12075	12413	13501	13858
	IDENTITY	27%	100%	29%	29%	28%	29%	63%	73%	27%
	COVERAGE	93%	101%	90%	94%	93%	91%	91%	96%	93%
EFA102186	SeqID	10448	10949	10995	11579			12412	13543	13817
	IDENTITY	29%	100%	29%	27%			53%	60%	30%
	COVERAGE	92%	101%	90%	94%			101%	92%	90%
EFA102205	SeqID	10108	10769	10985	11375				13375	13997
	IDENTITY	46%	100%	38%	56%				55%	37%
	COVERAGE	71%	102%	82%	73%				96%	104%
EFA102253	SeqID	10275	10727	11175	11320		11933	12372	13376	13865
	IDENTITY	53%	100%	55%	48%		53%	67%	80%	54%
	COVERAGE	100%	100%	101%	101%		101%	100%	99%	96%
EFA102282	SeqID		10729					12607	13424
	IDENTITY		100%					40%	46%
	COVERAGE		101%					81%	76%
EFA102338	SeqID	10250	10651	11012	11488		11954	12940	13272	13705
	IDENTITY	39%	100%	38%	35%		39%	42%	50%	38%
	COVERAGE	95%	100%	92%	86%		98%	99%	99%	99%
EFA102350	SeqID		10632
	IDENTITY		100%
	COVERAGE		101%
EFA102351	SeqID		10634					12795	13406
	IDENTITY		100%					33%	38%
	COVERAGE		100%					97%	101%
EFA102352	SeqID	10028	10635	11186	11328	11691	12011	12347	13409	14075
	IDENTITY	40%	100%	39%	35%	40%	39%	51%	55%	40%
	COVERAGE	101%	100%	101%	101%	101%	101%	99%	100%	101%
EFA102353	SeqID	10029	10636	11187	11329		12010	12348	13398	14076
	IDENTITY	32%	100%	34%	28%		32%	50%	61%	31%
	COVERAGE	99%	100%	99%	83%		98%	98%	99%	99%
EFA102389	SeqID	10378	10904	11094			11781	12126	13263
	IDENTITY	41%	100%	42%			40%	54%	52%
	COVERAGE	97%	100%	83%			98%	82%	100%
EFA102453	SeqID	10931	10995	11579	11762		12412	13502	13819
	IDENTITY	100%	29%	33%	33%		54%	54%	29%
	COVERAGE	101%	101%	88%	105%		101%	101%	96%
EFA102501	SeqID	10438	10626	11037	11410		11997	12447	13187	14043
	IDENTITY	45%	100%	44%	40%		44%	75%	76%	45%
	COVERAGE	112%	100%	111%	114%		113%	93%	96%	112%
EFA102502	SeqID	10439	10627	11036	11410		5179	12446	13646	14042
	IDENTITY	47%	100%	46%	52%		46%	72%	78%	46%
	COVERAGE	114%	100%	117%	79%		116%	99%	98%	114%
EFA102503	SeqID	10016	10643		11446		12027	12995	13481	13947
	IDENTITY	45%	100%		37%		43%	61%	65%	41%
	COVERAGE	99%	100%		101%		101%	98%	100%	85%
EFA102518	SeqID	10288	10647			11681		12248	13229	13881
	IDENTITY	33%	100%			50%		34%	54%	32%
	COVERAGE	105%	100%			71%		102%	100%	105%
EFA102541	SeqID	10327	10602	11241	11471		5188	12237	13356	13729
	IDENTITY	59%	100%	59%	49%		59%	69%	82%	56%
	COVERAGE	77%	101%	77%	73%		77%	77%	81%	77%
EFA102542	SeqID	10326	10603	11240	11288		12016	12238	13361	13732
	IDENTITY	75%	100%	70%	67%		75%	77%	100%	76%
	COVERAGE	95%	105%	95%	100%		95%	105%	100%	100%
EFA102549	SeqID	10338	10538	11117	11428		5159
	IDENTITY	63%	100%	63%	71%		68%
	COVERAGE	100%	103%	100%	100%		100%
EFA102551	SeqID	10337	10539	11119	11427	11688	11990	12229	13221	14097
	IDENTITY	59%	100%	61%	58%	30%	62%	75%	81%	58%
	COVERAGE	96%	101%	91%	99%	74%	96%	101%	101%	96%
EFA102554	SeqID	10341	10532	11115			5161	12223	13216
	IDENTITY	45%	100%	40%			42%	62%	63%
	COVERAGE	93%	102%	93%			97%	102%	100%
EFA102655	SeqID	10049	10733	11086	11305		11813	12952	13228	13898
	IDENTITY	47%	100%	47%	42%		48%	57%	60%	47%
	COVERAGE	97%	100%	99%	99%		99%	98%	108%	97%
EFA102656	SeqID		10734					12321	13668
	IDENTITY		100%					55%	55%
	COVERAGE		100%					100%	100%
EFA102698	SeqID	10082	10909	10956			11807			14011
	IDENTITY	56%	100%	60%			31%			55%
	COVERAGE	96%	100%	96%			96%			96%
EFA102728	SeqID	10459	10948	11050	11420		12074	12411	13503	13859
	IDENTITY	51%	100%	53%	52%		54%	76%	81%	52%
	COVERAGE	89%	101%	89%	73%		82%	96%	100%	90%
EFA102736	SeqID	10285	10556	11205	11300		11943		13401
	IDENTITY	53%	100%	52%	44%		51%		71%
	COVERAGE	98%	100%	100%	98%		100%		99%
EFA102764	SeqID	10201	10478	11054				12590	13425	13822
	IDENTITY	72%	100%	56%				68%	80%	71%
	COVERAGE	99%	100%	99%				99%	100%	99%
EFA102774	SeqID	10142	10896	11261	11362		12040	12150	13235	13978
	IDENTITY	50%	100%	52%	52%		51%	68%	74%	50%
	COVERAGE	96%	100%	96%	94%		95%	98%	97%	96%
EFA102780	SeqID	10395	10908	11167	11616		11772	12701	13552
	IDENTITY	49%	100%	46%	37%		51%	51%	46%
	COVERAGE	77%	100%	76%	77%		75%	101%	98%
EFA102788	SeqID	10176	10661	11223	11297		11882	12630	13303	13941
	IDENTITY	59%	100%	61%	54%		63%	70%	81%	59%
	COVERAGE	94%	101%	93%	97%		94%	93%	96%	94%
EFA102802	SeqID	10274	10854	11154	11298		11932	13128	13313	13866
	IDENTITY	66%	100%	64%	58%		64%	74%	83%	65%
	COVERAGE	99%	100%	100%	96%		100%	100%	100%	99%
EFA102813	SeqID	10191	10878	11005	11347		11815	12816	13492	13754
	IDENTITY	54%	100%	53%	51%		52%	64%	65%	53%
	COVERAGE	100%	100%	100%	99%		99%	99%	99%	100%
EFA102915	SeqID	10297	10640	10964	11323		11783	13090	13664	13737
	IDENTITY	27%	100%	32%	30%		31%	50%	52%	28%
	COVERAGE	100%	100%	100%	90%		100%	98%	99%	100%
EFA103021	SeqID	10434	10612	11039	11413		11999	12451	13517
	IDENTITY	65%	100%	66%	60%		62%	86%	86%
	COVERAGE	101%	101%	101%	99%		101%	101%	99%
EFA103033	SeqID	10221	10681	11210	11607	11668	11801	12289	13191	14027
	IDENTITY	42%	100%	40%	29%	42%	39%	49%	56%	30%
	COVERAGE	91%	100%	93%	98%	94%	91%	93%	92%	93%
EFA103038	SeqID	10435	10613	11038	11412		11998	12784	13397	14046
	IDENTITY	54%	100%	52%	56%		51%	73%	73%	53%
	COVERAGE	99%	100%	100%	99%		100%	100%	100%	99%
EFA103039	SeqID	10293	10850	11041	11482	11728	11793	12541	13377	13741
	IDENTITY	45%	100%	46%	44%	40%	46%	73%	69%	45%
	COVERAGE	99%	100%	101%	98%	99%	99%	102%	101%	99%
EFA103062	SeqID	10437	10615	11072	11572		5180	12449	13247	14044
	IDENTITY	59%	100%	64%	54%		65%	64%	68%	59%
	COVERAGE	101%	101%	102%	102%		101%	99%	101%	102%
EFA103081	SeqID	10262	10862	10984	11403		11947		13415	14090
	IDENTITY	41%	100%	41%	40%		41%		74%	40%
	COVERAGE	85%	101%	83%	82%		80%		95%	85%
EFA103174	SeqID	10251	10689	10969	11370		11955	12600	13518	13703
	IDENTITY	32%	100%	32%	37%		33%	63%	77%	33%
	COVERAGE	93%	100%	94%	95%		96%	100%	100%	92%
EFA103210	SeqID	10071	10688	11019	11371		11850	12601	13319	13945
	IDENTITY	56%	100%	63%	39%		57%	79%	76%	57%
	COVERAGE	97%	101%	98%	99%		97%	99%	101%	99%
EFA103268	SeqID	10365	10479	11062	11409		5178	12445	13231	13967
	IDENTITY	69%	100%	70%	68%		70%	83%	93%	70%
	COVERAGE	100%	101%	100%	100%	99%	101%	101%	101%
EFA103295	SeqID	10319	10633	11140	11493		12029	12640	13320	13771
	IDENTITY	66%	100%	58%	58%		70%	79%	86%	60%
	COVERAGE	77%	101%	85%	85%		77%	100%	96%	92%
EFA103348	SeqID		10873	10983	11402		11946
	IDENTITY		100%	39%	59%		39%
	COVERAGE		103%	82%	85%		82%
EFA103365	SeqID	10360	10533	11096	11443	11643	5177	12224	13196	13975
	IDENTITY	57%	100%	58%	53%	58%	58%	82%	82%	58%
	COVERAGE	100%	101%	100%	97%	100%	100%	88%	101%	100%
EFA103375	SeqID	10177	10660	11222	11296		5120	12628	13302
	IDENTITY	50%	100%	52%	36%		50%	66%	78%
	COVERAGE	82%	102%	82%	97%		94%	102%	102%
EFA103504	SeqID	10320	10671	11141	11492		12030	12638	13322	13766
	IDENTITY	42%	100%	45%	41%		48%	63%	81%	41%
	COVERAGE	97%	101%	97%	96%		97%	98%	100%	100%
EFA103508	SeqID		10672						13321
	IDENTITY		100%						30%
	COVERAGE		100%						80%
EFA103571	SeqID	10335	10879	11121	11425		11988	12578	13240	14095
	IDENTITY	45%	100%	47%	48%		47%	67%	68%	45%
	COVERAGE	102% 100%	102%	103%		102%	99%	100%	102%
EFA103786	SeqID		10806					12361
	IDENTITY		100%					59%
	COVERAGE		100%					94%
SAU100040	SeqID							12533
	IDENTITY							100%
	COVERAGE							101%
SAU100053	SeqID	10366	10504	11075	11376	11723	11855	12143	13318	13814
	IDENTITY	32%	46%	30%	32%	33%	33%	100%	48%	32%
	COVERAGE	97%	100%	99%	81%	84%	81%	100%	100%	97%
SAU100056	SeqID		10930					12577	13477
	IDENTITY		39%					100%	33%
	COVERAGE		98%					100%	100%
SAU100059	SeqID	10213	10598	11161	11528	11750	12064	12652	13433	13929
	IDENTITY	28%	70%	26%	26%	27%	28%	100%	25%	28%
	COVERAGE	71%	97%	95%	95%	71%	96%	100%	95%	71%
SAU100062	SeqID	10430	10618	10998	11603	11739		12309	13294	14040
	IDENTITY	27%	52%	29%	29%	31%		100%	53%	28%
	COVERAGE	103%	96%	103%	77%	76%		100%	97%	102%
SAU100077	SeqID		10565					12520	13464
	IDENTITY		64%					100%	62%
	COVERAGE		102%					100%	102%
SAU100112	SeqID	10059			11477	11702	12096	12634		13895
	IDENTITY	49%			52%	53%	46%	100%		49%
	COVERAGE	97%			100%	77%	100%	100%		97%
SAU100114	SeqID	10152	10515	11279	11302		11851	12535	13387	13824
	IDENTITY	44%	51%	43%	45%		43%	100%	25%	43%
	COVERAGE	98%	98%	98%	98%		98%	100%	102%	98%
SAU100118	SeqID		10903				11828	12125	13262
	IDENTITY		41%				27%	100%	37%
	COVERAGE		101%				100%	100%	101%
SAU100123	SeqID	10258	10628	11134	11489		5192	12526	13421	14088
	IDENTITY	52%	43%	53%	47%		52%	100%	45%	52%
	COVERAGE	98%	100%	97%	96%		98%	100%	82%	98%
SAU100131	SeqID	10466		11274			11960	12517		13854
	IDENTITY	35%		33%			40%	100%		35%
	COVERAGE	71%		97%			70%	100%		71%
SAU100133	SeqID	10311	10493	10990	11308	11703	11885	12574	13412	13769
	IDENTITY	34%	44%	34%	33%	30%	31%	100%	43%	34%
	COVERAGE	79%	99%	80%	78%	82%	79%	100%	99%	79%
SAU100139	SeqID	10355	10557	11101	11594		5174	12255	13201
	IDENTITY	65%	84%	66%	64%		63%	100%	86%
	COVERAGE	85%	86%	81%	83%		84%	101%	85%
SAU100140	SeqID	10354	10558	11102	11440		5173	12258	13202	13970
	IDENTITY	54%	66%	54%	40%		48%	100%	63%	54%
	COVERAGE	93%	91%	93%	94%		93%	101%	91%	93%
SAU100141	SeqID	10353	10559	11103	11592		5172	12259	13203	13969
	IDENTITY	55%	78%	58%	54%		57%	100%	74%	55%
	COVERAGE	96%	101%	96%	96%		96%	100%	100%	96%
SAU100157	SeqID	10364	10480	11061	11408	11659	11996	12444	13232	13966
	IDENTITY	60%	78%	60%	55%	62%	57%	100%	77%	60%
	COVERAGE	100%	101%	100%	99%	88%	100%	101%	101%	101%
SAU100158	SeqID	10363	10481	11060	11568		11858	12443	13233	13965
	IDENTITY	60%	75%	59%	63%		59%	100%	77%	58%
	COVERAGE	98%	97%	98%	97%		98%	100%	97%	99%
SAU100162	SeqID	10069	10630	11239	11382		11971	12583	13597	14084
	IDENTITY	43%	49%	44%	37%		43%	100%	46%	43%
	COVERAGE	92%	89%	88%	80%		83%	100%	89%	93%
SAU100175	SeqID	10250	10651	11012			11954	12582	13272	13705
	IDENTITY	34%	42%	38%			34%	100%	42%	35%
	COVERAGE	98%	100%	93%			93%	100%	102%	99%
SAU100182	SeqID							12362
	IDENTITY							100%
	COVERAGE							101%
SAU100186	SeqID	10043	10489	11124	11423		11939	12317	13355	13909
	IDENTITY	46%	61%	44%	46%		45%	100%	54%	45%
	COVERAGE	99%	99%	99%	98%		100%	101%	99%	101%
SAU100198	SeqID				11445			12120	13414
	IDENTITY				29%			100%	29%
	COVERAGE				78%			101%	79%
SAU100227	SeqID		10765					12525
	IDENTITY		36%					100%
	COVERAGE		100%					100%
SAU100242	SeqID	10097		11201			11836	12336		14056
	IDENTITY	65%		62%			65%	100%		65%
	COVERAGE	94%		96%			95%	100%	94%
SAU100246	SeqID		10821					12496	13490
	IDENTITY		35%					100%	38%
	COVERAGE		101%					101%	93%
SAU100251	SeqID						12363
	IDENTITY						100%
	COVERAGE							100%
SAU100265	SeqID	10469						12122
	IDENTITY	37%						100%
	COVERAGE	88%						100%
SAU100266	SeqID							12256
	IDENTITY							100%
	COVERAGE							101%
SAU100272	SeqID		10617					12141
	IDENTITY		26%					100%
	COVERAGE		104%					100%
SAU100275	SeqID	10041	10487	11149	11621		11941	12314	13438	13907
	IDENTITY	52%	73%	47%	51%		51%	100%	65%	51%
	COVERAGE	88%	94%	93%	98%		90%	100%	98%	88%
SAU100300	SeqID	10434	10612	11039	11413		11999	12451	13517
	IDENTITY	67%	86%	68%	63%		65%	100%	82%
	COVERAGE	99%	99%	99%	97%		99%	101%	97%
SAU100301	SeqID	10433	10624	11083	11414		12000	12452	13168
	IDENTITY	41%	58%	41%	35%		42%	100%	51%
	COVERAGE	99%	98%	102%	96%		98%	101%	97%
SAU100302	SeqID	10432		11082			12001	12453
	IDENTITY	25%		34%			31%	100%
	COVERAGE	92%		93%			103%	102%
SAU100305	SeqID	10311	10774	10990			11885	12397	13491	13769
	IDENTITY	40%	50%	38%			40%	100%	49%	40%
	COVERAGE	94%	99%	94%			92%	100%	101%	94%
SAU100307	SeqID	10392	10725	10954		11685		12313	13252	13919
	IDENTITY	28%	32%	29%		28%		100%	29%	28%
	COVERAGE	99%	100%	99%		99%		100%	99%	99%
SAU100308	SeqID	10013	10814	10963				12312	13244	13711
	IDENTITY	26%	44%	30%				100%	40%	27%
	COVERAGE	90%	86%	86%				100%	92%	90%
SAU100313	SeqID		10757					12661	13293
	IDENTITY		46%					100%	43%
	COVERAGE		99%					100%	100%
SAU100315	SeqID	10419	10802	11136	11326	11727	12087	12358	13521	13791
	IDENTITY	54%	73%	53%	53%	55%	53%	100%	74%	54%
	COVERAGE	96%	96%	96%	96%	82%	97%	100%	91%	96%
SAU100323	SeqID	10216	10855					12575		13933
	IDENTITY	32%	71%					100%		34%
	COVERAGE	88%	99%					100%		88%
SAU100347	SeqID	10895	10961			12077	12334	13206
	IDENTITY	44%	30%			30%	100%	42%
	COVERAGE	106%	84%			100%	100%	100%
SAU100355	SeqID		10683					12155	13300
	IDENTITY		42%					100%	31%
	COVERAGE		93%					_100%	109%
SAU100359	SeqID		10757					12239	13293
	IDENTITY		52%					100%	43%
	COVERAGE		97%					100%	99%
SAU100381	SeqID	10411	10674				11903	12276		14031
	IDENTITY	28%	29%	33%				100%		28%
	COVERAGE	101%	99%				92%	100%		101%
SAU100389	SeqID	10473	10737		11374			12279	13344
	IDENTITY	27%	50%		41%			100%	27%
	COVERAGE	75%	95%		99%			100%	71%
SAU100401	SeqID	10090	10706	10980		11641		12576		14053
	IDENTITY	31%	30%	27%		33%		100%		31%
	COVERAGE	95%	99%	95%		95%		101%		99%
SAU100412	SeqID	10102	10563	11194	11360		5150	12197	13468
	IDENTITY	31%	42%	30%	33%		35%	100%	40%
	COVERAGE	74%	100%	80%	74%		73%	100%	97%
SAU100414	SeqID	10453	10556	11205	11300		11943	12148	13401	13872
	IDENTITY	60%	80%	61%	60%		67%	100%	76%	60%
	COVERAGE	96%	99%	98%	99%		91%	101%	96%	96%
SAU100432	SeqID	10436	10614	11071	11411		5181	12450	13246	14045
	IDENTITY	34%	60%	33%	31%		39%	100%	55%	31%
	COVERAGE	98%	98%	100%	95%		99%	101%	98%	98%
SAU100433	SeqID	10437	10615	11072	11572		5180	12449	13247	14044
	IDENTITY	58%	64%	63%	57%		58%	100%	69%	58%
	COVERAGE	97%	99%	98%	99%		98%	101%	99%	98%
SAU100436	SeqID		10569					12154	13393
	IDENTITY		27%					100%	27%
	COVERAGE		100%					100%	100%
SAU100443	SeqID	10272	10894	11081			11930	12333	13515	13869
	IDENTITY	40%	52%	39%			38%	100%	45%	40%
	COVERAGE	92%	100%	96%			92%100%	100%	92%
SAU100444	SeqID	10440	10583	11016	11540		11967	12392	13403	14041
	IDENTITY	29%	30%	41%	41%		28%	100%	52%	29%
	COVERAGE	75%	88%	94%	90%		81%100%	91%	75%
SAU100475	SeqID		10927				11911	12337
	IDENTITY		33%				30%	100%
	COVERAGE		101%				101% 100%
SAU100478	SeqID			11273				12605
	IDENTITY			25%				100%
	COVERAGE			96%				100%
SAU100489	SeqID	10332	10685	11074	11580	11729	11778	12566	13298	14100
	IDENTITY	33%	33%	31%	34%	34%	29%	100%	34%	33%
	COVERAGE	101%	102%	99%	94%	101%	99%	100%	97%	94%
SAU100496	SeqID		10744					12484
	IDENTITY		40%					100%
	COVERAGE		80%					100%
SAU100497	SeqID	10245	10709	11171	11395		11792	12140		13740
	IDENTITY	46%	59%	49%	44%		48%	100%		45%
	COVERAGE	99%	101%	99%	100%		99%	100%		100%
SAU100514	SeqID	10215			11388		12036	12626		13932
	IDENTITY	52%			34%		51%	100%		51%
	COVERAGE	93%			95%		98%	100%		95%
SAU100521	SeqID	10251		10969	11370		11955	12600		13703
	IDENTITY	43%		39%	34%		39%	100%		42%
	COVERAGE	104%	108%	103%	103%		100%	104%
SAU100522	SeqID	10114		11206		11680	11904	12599		14007
	IDENTITY	36%		34%		30%	36%	100%		35%
	COVERAGE	91%		89%		80%	90%	100%		91%
SAU100527	SeqID	10298	10721	10996			11782	12341	13452	13736
	IDENTITY	44%	48%	42%			41%	100%	43%	45%
	COVERAGE	98%	97%	99%			98%	101%	98%	97%
SAU100528	SeqID		10521					12507	13470
	IDENTITY		30%					100%	33%
	COVERAGE		83%					101%	71%
SAU100532	SeqID	10235	10645	11128	11389			12580	13193	13744
	IDENTITY	39%	47%	29%	34%			100%	40%	31%
	COVERAGE	101%	100%	72%	90%			100%	97%	72%
SAU100542	SeqID	10371	11070	11422		12017	12532	13444	13806
	IDENTITY	52%	51%	46%		31%	100%	35%	52%
	COVERAGE	100%	98%	98%		102%	100%	102%	100%
SAU100546	SeqID	10359	11097	11596		5176	12235	13197	13974
	IDENTITY	43%	46%	34%		47%	100%	66%	46%
	COVERAGE	97%	97%	90%		99%	100%	99%	91%
SAU100547	SeqID	10358	10549	11098	11595		5175	12240	13198	13973
	IDENTITY	41%	62%	39%	40%		46%	100%	63%	41%
	COVERAGE	92%	100%	97%	96%		97%	100%	100%	93%
SAU100557	SeqID		10928					12565	13651
	IDENTITY		50%					100%	49%
	COVERAGE		99%					100%	99%
SAU100582	SeqID							12503
	IDENTITY							100%
	COVERAGE							100%
SAU100590	SeqID							12121
	IDENTITY							100%
	COVERAGE							100%
SAU100595	SeqID	10051	10832		11464		12109	12547	13174	13722
	IDENTITY	47%	66%		42%		50%	100%	46%	42%
	COVERAGE	88%	89%		89%		93%	100%	90%	91%
SAU100596	SeqID	10050	10833	11067	11624	11656	12110	12548	13173	13720
	IDENTITY	36%	50%	31%	41%	38%	42%	100%	30%	32%
	COVERAGE	99%	99%	100%	92%	89%	95%	100%	106%	95%
SAU100601	SeqID							12616
	IDENTITY							100%
	COVERAGE							100%
SAU100608	SeqID	10032	10870	11190	11349		12008	12293	13507	14079
	IDENTITY	30%	61%	29%	29%		34%	100%	50%	28%
	COVERAGE	102%	96%	100%	98%		87%	100%	96%	104%
SAU100610	SeqID							12294
	IDENTITY							100%
	COVERAGE							100%
SAU100613	SeqID	10378	10904	11094			11781	12126	13589
	IDENTITY	44%	54%	43%			46%	100%	49%
	COVERAGE	91%	88%	93%			73%	100%	89%
SAU100617	SeqID		10502					12295	13314
	IDENTITY		26%					100%	25%
	COVERAGE		91%					100%	91%
SAU100633	SeqID	10079	10589			11698	5107	12515	13644	13724
	IDENTITY	27%	42%			25%	29%	100%	35%	26%
	COVERAGE	92%	103%			89%	101%	100%	105%	103%
SAU100646	SeqID	10051	10570		11464		12109	12168	13174	14109
	IDENTITY	50%	48%		46%		49%	100%	42%	50%
	COVERAGE	95%	94%		97%		95%	100%	95%	96%
SAU100658	SeqID	10322	10813	11177	11351		12018	12388	13186	13733
	IDENTITY	49%	59%	49%	46%		48%	100%	58%	49%
	COVERAGE	100%	100%	100%	100%		100%	100%	100%	100%
SAU100659	SeqID	10045	10923	11174	11601		11937	12390	13616	13911
	IDENTITY	47%	54%	45%	40%		46%	100%	56%	44%
	COVERAGE	92%	92%	95%	103%		97%	101%	95%	81%
SAU100679	SeqID	10303		10997	11453	11713	11799	12137	13329	13757
	IDENTITY	32%		31%	32%	33%	35%	100%	42%	35%
	COVERAGE	96%		99%	106%	96%	97%	100%	104%	96%
SAU100684	SeqID	10412			11486		12097	12632		13749
	IDENTITY	46%			40%		46%	100%		46%
	COVERAGE	97%			99%		99%	100%		97%
SAU100685	SeqID							12633
	IDENTITY							100%
	COVERAGE							100%
SAU100689	SeqID		10694					12323	13311
	IDENTITY		55%					100%	46%
	COVERAGE		98%					100%	96%
SAU100702	SeqID		10655					12196	13671
	IDENTITY		46%					100%	41%
	COVERAGE		97%					100%	91%
SAU100710	SeqID						11908	12546
	IDENTITY						27%	100%
	COVERAGE						73%	101%
SAU100714	SeqID	10465	10675	11238	11563		11961	12635	13382	13853
	IDENTITY	48%	66%	41%	41%		44%	100%	60%	48%
	COVERAGE	108%	100%	110%	102%		108%	103%	101%	108%
SAU100731	SeqID	10071	10688	11019	11371		11850	12601	13319	13945
	IDENTITY	62%	79%	67%	40%		63%	100%	76%	60%
	COVERAGE	99%	100%	100%		101%	99%	101%	100%	101%
SAU100733	SeqID	10415			11611	11636	12084	12602		13746
	IDENTITY	41%			33%	42%	42%	100%		39%
	COVERAGE	95%			92%	74%	95%	100%		95%
SAU100734	SeqID	10321	10573	11142	11306		12031	12603	13273	13734
	IDENTITY	28%	36%	29%	27%		28%	100%	31%	29%
	COVERAGE	98%	95%	97%	90%		93%	100%	72%	101%
SAU100736	SeqID		10585					12391	13404
	IDENTITY		27%					100%	26%
	COVERAGE		97%					100%	97%
SAU100738	SeqID	10188	10847	10953	11600	11634	11907	12624	13169	13981
	IDENTITY	48%	45%	46%	42%	48%	51%	100%	45%	49%
	COVERAGE	97%	98%	98%	97%	94%	97%	100%	97%	97%
SAU100741	SeqID	10081	10591		11459		11776	12409		13714
	IDENTITY	65%	50%		35%		54%	100%		66%
	COVERAGE	100%	101%		82%		100%	101%		101%
SAU100745	SeqID	10442	10484	11202	11607	11733	11906	12596	13453	13847
	IDENTITY	34%	53%	35%	31%	35%	34%	100%	49%	35%
	COVERAGE	98%	97%	100%	99%	101%	98%	100%	98%	101%
SAU100747	SeqID		10749					12597	13266
	IDENTITY		32%					100%	31%
	COVERAGE		74%					100%	73%
SAU100751	SeqID	10425	10866	11080		11747	11927	12335	13431	13788
	IDENTITY	62%	64%	59%		62%	62%	100%	63%	61%
	COVERAGE	99%	99%	98%		87%	99%	100%	99%	99%
SAU100752	SeqID	10140					11976	12524		14022
	IDENTITY	31%					35%	100%		38%
	COVERAGE	71%					82%	100%	72%
SAU100767	SeqID	10290					12094	12579		13875
	IDENTITY	43%					42%	100%		42%
	COVERAGE	100%					90%	100%		100%
SAU100771	SeqID	10084					11821	12545	13306	13710
	IDENTITY	30%					29%	100%	28%	26%
	COVERAGE	88%					80%	101%	90%	94%
SAU100773	SeqID	10055	10758	11093	11336	11763	11928	12377	13250
	IDENTITY	47%	70%	41%	41%	46%	51%	100%	70%
	COVERAGE	94%	100%	98%	96%	94%	93%	101%	96%
SAU100776	SeqID							12482
	IDENTITY							100%
	COVERAGE							100%
SAU100778	SeqID	10083		10957			11970	12514		14062
	IDENTITY	52%		52%			45%	100%		47%
	COVERAGE	89%		89%			88%	100%		89%
SAU100793	SeqID							12188	13392
	IDENTITY							100%	27%
	COVERAGE							100%	103%
SAU100794	SeqID	10203						12189
	IDENTITY	25%						100%
	COVERAGE	101%					100%
SAU100799	SeqID							12682
	IDENTITY							100%
	COVERAGE							100%
SAU100808	SeqID							12345		14081
	IDENTITY							100%		35%
	COVERAGE							100%		70%
SAU100810	SeqID	10070					11824	12343		14080
	IDENTITY	51%					49%	100%		50%
	COVERAGE	94%					96%	100%		96%
SAU100813	SeqID	10314	10764	11216	11501		5198	12322	13381	13765
	IDENTITY	47%	63%	47%	45%		48%	100%	58%	50%
	COVERAGE	98%	94%	100%	91%		92%	100%	95%	92%
SAU100831	SeqID	10376	10741	11058			12093	12403	13349	13811
	IDENTITY	42%	58%	42%			42%	100%	51%	42%
	COVERAGE	97%	98%	102%			98%	100%	98%	101%
SAU100836	SeqID							12212
	IDENTITY							100%
	COVERAGE							100%
SAU100838	SeqID							12211
	IDENTITY							100%
	COVERAGE							100%
SAU100839	SeqID		10794					12210	13183
	IDENTITY		42%					100%	44%
	COVERAGE		100%				100%	100%
SAU100843	SeqID	10126	10921	10974	11342			12328	13601	14092
	IDENTITY	26%	28%	28%	28%			100%	26%	26%
	COVERAGE	101%	73%	101%	102%			100%	100%	104%
SAU100845	SeqID							12329
	IDENTITY							100%
	COVERAGE							100%
SAU100858	SeqID	10256	10776		11367	11719		12401	13472	13796
	IDENTITY	37%	48%		35%	37%		100%	39%	39%
	COVERAGE	106%	98%		103%	106%		101%	100%	106%
SAU100859	SeqID	10446	10777	11254	11548		12071	12402	13473	14026
	IDENTITY	33%	38%	33%	35%		34%	100%	38%	32%
	COVERAGE	94%	94%	95%	96%		94%	100%	92%	95%
SAU100865	SeqID	10252	10877	11010	11406		11956	12648	13506	13704
	IDENTITY	39%	49%	41%	28%		44%	100%	48%	38%
	COVERAGE	100%	99%	100%	101%	99%	100%	99%	100%
SAU100866	SeqID	10191	10878	11005	11347		11815	12553	13492	13754
	IDENTITY	54%	64%	51%	51%		53%	100%	57%	55%
	COVERAGE	100%	100%		100%	100%	100%	100%
SAU100879	SeqID							12483
	IDENTITY							100%
	COVERAGE							100%
SAU100880	SeqID	10429	10720		11335		12039	12340	13451	14072
	IDENTITY	31%	51%		35%		36%	100%	45%	32%
	COVERAGE	81%	95%		97%		81%	100%	99%	85%
SAU100882	SeqID	10322	10750	11177	11351		12018	12374	13330	13733
	IDENTITY	43%	54%	42%	40%		45%	100%	52%	43%
	COVERAGE	98%	98%	98%	99%		98%	100%	98%	98%
SAU100885	SeqID	10410	10754	11001	11509		12095	12376	14032
	IDENTITY	52%	67%	53%	52%		53%	100%	52%
	COVERAGE	93%	74%	94%	96%		92%	100%	93%
SAU100886	SeqID	10224	10701	11213	11357		11905	12139	13348	13957
	IDENTITY	38%	60%	38%	36%		36%	100%	52%	38%
	COVERAGE	97%	83%	93%	99%		104%	100%	102%	98%
SAU100887	SeqID	10393	10952	11057	11330		11774	12138	13342	13920
	IDENTITY	50%	51%	50%	49%		48%	100%	70%	50%
	COVERAGE	85%	96%	82%	83%		83%	100%	96%	85%
SAU100899	SeqID							12277
	IDENTITY							100%
	COVERAGE							100%
SAU100901	SeqID							12278
	IDENTITY							100%
	COVERAGE							100%
SAU100916	SeqID	10209	10887					12394		13876
	IDENTITY	32%	34%					100%		32%
	COVERAGE	75%	72%					101%		75%
SAU100920	SeqID	10060	10772	11191	11530	11756	11983	12395		13896
	IDENTITY	43%	48%	31%	28%	40%	30%	100%		43%
	COVERAGE	91%	86%	87%	91%	86%	90%	100%		91%
SAU100921	SeqID	10027	10773	11185		12012	12396	13478	14074
	IDENTITY	32%	43%	33%		33%	100%	34%	32%
	COVERAGE	101%	96%	96%			96%	100%	98%	101%
SAU100932	SeqID	10095		11271			11834	12615		14055
	IDENTITY	39%		36%			39%	100%		39%
	COVERAGE	101%		101%			102%	100%	101%
SAU100944	SeqID	10017	10687	11219	11506		12057	12505	13498	14012
	IDENTITY	37%	26%	36%	36%		39%	100%	27%	39%
	COVERAGE	80%	108%	79%	79%		83%	100%	83%	80%
SAU100952	SeqID		10717					12523	13312
	IDENTITY		33%					100%	31%
	COVERAGE		104%					100%	102%
SAU100959	SeqID		10704					12485	13504
	IDENTITY		58%					100%	49%
	COVERAGE		99%					100%	101%
SAU100961	SeqID	10320	10671	11141	11312		12030	12638	13322	13766
	IDENTITY	42%	63%	47%	40%		50%	100%	57%	42%
	COVERAGE	98%	99%	98%	97%		98%	101%	101%	99%
SAU100962	SeqID		11299			12639	13577
	IDENTITY		28%			100%	26%
	COVERAGE		80%			101%	92%
SAU100963	SeqID	10319	10633	11140	11493		12029	12640	13320	13771
	IDENTITY	60%	79%	59%	61%		63%	100%	81%	60%
	COVERAGE	84%	96%	81%	81%		84%	101%	92%	88%
SAU100964	SeqID		10501	11139			12028	12641	13331
	IDENTITY		61%	45%			47%	100%	60%
	COVERAGE		101%	76%			77%	100%	101%
SAU100965	SeqID							12642
	IDENTITY							100%
	COVERAGE							101%
SAU100970	SeqID	10128	10516	11247	11512		11891	12529	13362
	IDENTITY	52%	54%	39%	47%		52%	100%	46%
	COVERAGE	99%	99%	100%	100%	99%	100%	99%
SAU100996	SeqID		10686		11350			12606	13600
	IDENTITY		38%		34%			100%	39%
	COVERAGE		97%		73%			100%	96%
SAU101006	SeqID	10185	10572	11022	11473		5122	12190		13820
	IDENTITY	29%	40%	31%	26%		26%	100%		30%
	COVERAGE	84%	98%	87%	94%		79%	100%	91%
SAU101020	SeqID							12710
	IDENTITY							100%
	COVERAGE							100%
SAU101024	SeqID							12711
	IDENTITY							100%
	COVERAGE							101%
SAU101028	SeqID	10034	10848	11148	11364		12006	12552	13471	13901
	IDENTITY	46%	57%	43%	46%		46%	100%	55%	45%
	COVERAGE	106%	101%	107%	100%		108%	100%	100%	106%
SAU101034	SeqID		10578					12608	13654
	IDENTITY		36%					100%	37%
	COVERAGE		80%					100%	71%
SAU101038	SeqID		10716				11822	12521	13428
	IDENTITY		42%				35%	100%	36%
	COVERAGE		96%				78%	101%	103%
SAU101039	SeqID							12522
	IDENTITY							100%
	COVERAGE							100%
SAU101065	SeqID	10221	10681	11210	11607	11668	11801	12289	13191	14027
	IDENTITY	37%	49%	40%	28%	38%	36%	100%	46%	31%
	COVERAGE	98%	103%	100%	108%	97%	98%	100%	102%	98%
SAU101067	SeqID		10682					12290	13394
	IDENTITY		41%					100%	40%
	COVERAGE		100%					100%	99%
SAU101070	SeqID		10770					12291	13380
	IDENTITY		40%					100%	32%
	COVERAGE		89%					100%	82%
SAU101084	SeqID	10066		11156			11974	12283
	IDENTITY	36%		34%			35%	100%
	COVERAGE	90%		102%			92%	100%
SAU101085	SeqID	10170		11263	11462		11973	12284	13225	13993
	IDENTITY	37%		34%	37%		38%	100%	47%	32%
	COVERAGE	89%		88%	94%		94%	100%	101%	88%
SAU101086	SeqID				11366		11972	12285	13666
	IDENTITY				42%		34%	100%	49%
	COVERAGE				74%		94%	100%	101%
SAU101090	SeqID		10755					12191	13188
	IDENTITY		36%					100%	31%
	COVERAGE		97%					100%	97%
SAU101092	SeqID	10450	10567				11847	12192
	IDENTITY	35%	33%				30%	100%
	COVERAGE	71%	96%				72%	100%
SAU101104	SeqID	10135	10768	11248	11404	11732	11869	12195	13482	13827
	IDENTITY	38%	45%	39%	37%	37%	42%	100%	38%	37%
	COVERAGE	98%	100%	100%	92%	99%	99%	100%	96%	99%
SAU101143	SeqID	10040		11157	11315		11968	12502		13906
	IDENTITY	47%		27%	43%		44%	100%		47%
	COVERAGE	99%		82%	98%		100%	100%		99%
SAU101145	SeqID		10548				12070	12299
	IDENTITY		42%				43%	100%
	COVERAGE		98%				96%	101%
SAU101155	SeqID	10287	10697	11077	11352	11690	11944	12310	13549	13868
	IDENTITY	43%	49%	40%	30%	42%	42%	100%	37%	43%
	COVERAGE	95%	95%	95%	86%	95%	94%	100%	76%	95%
SAU101156	SeqID	10426	10698	11032	11333		12083	12311		13790
	IDENTITY	56%	63%	60%	52%		58%	100%		55%
	COVERAGE	96%	101%	96%	97%		96%	101%		96%
SAU101159	SeqID		10891		11532			12331	13463
	IDENTITY		65%		36%			100%	54%
	COVERAGE		100%		100%			100%	104%
SAU101175	SeqID							12213
	IDENTITY							100%
	COVERAGE							101%
SAU101180	SeqID	10061	10888				11910	12656
	IDENTITY	38%	50%				37%	100%
	COVERAGE	72%	89%				70%	100%
SAU101183	SeqID		10843					12304
	IDENTITY		42%					100%
	COVERAGE		102%				100%
SAU101184	SeqID	10477	10711	11218	11376	11735	12033	12305	13499	13709
	IDENTITY	37%	46%	36%	30%	38%	35%	100%	44%	38%
	COVERAGE	86%	100%	102%	85%	82%	85%	100%	98%	82%
SAU101189	SeqID							12264
	IDENTITY							100%
	COVERAGE							100%
SAU101197	SeqID	10180	10787	11024			11924	12300	13340	13976
	IDENTITY	31%	44%	31%			27%	100%	46%	30%
	COVERAGE	98%	98%	101%			100%	100%	98%	98%
SAU101198	SeqID	10218	10786	11023			11923	12301	13341
	IDENTITY	43%	50%	43%			41%	100%	46%
	COVERAGE	74%	98%	73%			75%	100%	102%
SAU101199	SeqID	10088	10742	10970			11949	12302	13178	14052
	IDENTITY	29%	40%	31%			36%	100%	37%	30%
	COVERAGE	97%	86%	94%			97%	100%	87%	98%
SAU101220	SeqID	10286	10864					12645	13390	13870
	IDENTITY	32%	37%					100%	39%	31%
	COVERAGE	74%	81%					100%	99%	74%
SAU101224	SeqID				11533			12647
	IDENTITY				28%			100%
	COVERAGE				77%			100%
SAU101226	SeqID		10837			11658	11825	12298	13296	13721
	IDENTITY		52%			28%	37%	100%	27%	27%
	COVERAGE		96%			75%	90%	100%	77%	77%
SAU101231	SeqID	10301	10513				12079	12303		13759
	IDENTITY	32%	61%				32%	100%		31%
	COVERAGE	101%	100%				73%	101%		106%
SAU101235	SeqID		10616	11087				12561	13486
	IDENTITY		37%	27%				100%		35%
	COVERAGE		84%	90%				100%		97%
SAU101236	SeqID	10089	10500			11673	11951	12564	13474
	IDENTITY	42%	55%			29%	39%	100%		35%
	COVERAGE	101%	77%			108%	100%	100%	103%
SAU101239	SeqID				11361			12570
	IDENTITY				33%			100%
	COVERAGE				98%			100%
SAU101240	SeqID							12573
	IDENTITY							100%
	COVERAGE							101%
SAU101242	SeqID	10335	10879	11121	11425		11988	12578	13240	14095
	IDENTITY	48%	67%	47%	48%		47%	100%	55%	47%
	COVERAGE	104%	101%	104%	105%		104%	101%	101%	105%
SAU101247	SeqID		10919				11984	12512	13359
	IDENTITY		32%				36%	100%		33%
	COVERAGE		91%				90%	100%	85%
SAU101262	SeqID	1013710735		11399		11922	12488	13238	13837
	IDENTITY	28%	70%		47%		33%	100%	67%	28%
	COVERAGE	73%	100%		101%		97%	100%	100%	73%
SAU101266	SeqID	10238	10789	11178	11517		11829	12490	13317	13864
	IDENTITY	45%	57%	46%	41%		43%	100%	51%	44%
	COVERAGE	100%	99%	100%	98%		89%	100%	98%	100%
SAU101267	SeqID							12364
	IDENTITY							100%
	COVERAGE							100%
SAU101270	SeqID	10175	10718	11220	11324		11881	12365	13383	13942
	IDENTITY	50%	62%	47%	45%		52%	100%	61%	50%
	COVERAGE	96%	99%	97%	93%		97%	100%	98%	96%
SAU101271	SeqID	10174	10719	11221	11556		11880	12366	13385	13943
	IDENTITY	37%	46%	36%	25%		35%	100%	46%	37%
	COVERAGE	100%	102%	100%	100%		100%	100%	101%	75%
SAU101275	SeqID	10232	10684	10981	11521	11708	11845	12604	13299	13954
	IDENTITY	35%	57%	38%	33%	34%	34%	100%	57%	35%
	COVERAGE	95%	101%	93%	98%	96%	94%	100%	101%	95%
SAU101286	SeqID		10884					12292	13189
	IDENTITY		47%					100%	40%
	COVERAGE		100%					101%	99%
SAU101293	SeqID							12631
	IDENTITY							100%
	COVERAGE							101%
SAU101300	SeqID		10751					12557	13194
	IDENTITY		57%					100%	54%
	COVERAGE		93%					101%	90%
SAU101301	SeqID		10752				11785	12558	13195
	IDENTITY		57%				27%	100%	54%
	COVERAGE		96%				94%	101%	99%
SAU101302	SeqID		10753		11317			12559	13611
	IDENTITY		49%		33%			100%	26%
	COVERAGE		101%		86%			101%	72%
SAU101310	SeqID	10330	10924	11160	11321		12063	12562	13364	13885
	IDENTITY	47%	52%	48%	43%		47%	100%	51%	47%
	COVERAGE	98%	98%	98%	98%		98%	100%	98%	98%
SAU101311	SeqID	10094		11278		11859	12563		13891
	IDENTITY	46%		46%		42%	100%		46%
	COVERAGE	98%		98%		96%	100%		95%
SAU101320	SeqID	10263	10861	10965	11562		11948	12128	13254	14089
	IDENTITY	50%	59%	49%	39%		51%	100%	56%	49%
	COVERAGE	100%	99%	99%	100%		99%	100%	97%	100%
SAU101327	SeqID	10018	10710	11147			11779	12612	13495	14014
	IDENTITY	35%	46%	43%			34%	100%	35%	35%
	COVERAGE	100%	97%	101%			92%	101%	99%	100%
SAU101339	SeqID	10093	10520		11365		11839	12399	13405	13888
	IDENTITY	55%	30%		26%		54%	100%	27%	45%
	COVERAGE	99%74%		74%		97%	100%	76%	99%
SAU101340	SeqID	10092					11840	12400		13889
	IDENTITY	37%					35%	100%		39%
	COVERAGE	106%					101%	101%		104%
SAU101341	SeqID	10230	10925	11212	11385		11898	12618	13365	13952
	IDENTITY	47%	55%	48%	48%		45%	100%	48%	47%
	COVERAGE	93%	92%	92%	98%		92%	100%	100%	93%
SAU101343	SeqID	10422	10649	11162		11721		12619	13346	13785
	IDENTITY	50%	55%	49%		50%		100%	58%	51%
	COVERAGE	99%	100%	99%		99%		100%	92%	99%
SAU101344	SeqID	10171	10650	11252			11826	12620	13347	13755
	IDENTITY	48%	62%	40%			37%	100%	44%	38%
	COVERAGE	81%	88%	79%			82%	100%	79%	81%
SAU101346	SeqID	10058			11282		11803	12621		13894
	IDENTITY	36%			35%		43%	100%		36%
	COVERAGE	99%			103%		99%	100%		99%
SAU101347	SeqID	10139		11163	11283		11877	12622	13259	13839
	IDENTITY	63%		29%	62%		62%	100%	30%	62%
	COVERAGE	100%		96%	101%		100%	100%	91%	100%
SAU101350	SeqID	10184	10508		11318		12069	12487	13286	13982
	IDENTITY	61%	56%		32%		46%	100%	55%	60%
	COVERAGE	95%	98%		81%		100%	100%	97%	97%
SAU101351	SeqID		10507					12486	13285
	IDENTITY		60%					100%	59%
	COVERAGE		96%					100%	96%
SAU101360	SeqID	10138	10571	10977	11598	11684	11878	12555	13175	13838
	IDENTITY	56%	70%	54%	35%	55%	58%	100%	71%	56%
	COVERAGE	98%	101%	98%	97%	88%	98%	100%	101%	98%
SAU101365	SeqID	10269	10491	11127	11577	11809	12556	13295	13874
	IDENTITY	45%	55%	44%	40%	45%	100%	50%	45%
	COVERAGE	101%	101%	101%	99%	101%	100%	100%	101%
SAU101366	SeqID	10147	10654					12266	13179	13843
	IDENTITY	49%	73%					100%	56%	48%
	COVERAGE	99%	98%					100%	99%	99%
SAU101369	SeqID							12274
	IDENTITY							100%
	COVERAGE							100%
SAU101371	SeqID				11372		11902	12275	13243
	IDENTITY				40%		32%	100%	34%
	COVERAGE				86%		79%	100%	77%
SAU101381	SeqID	10373						12145	13432
	IDENTITY	26%						100%	41%
	COVERAGE	98%						100%	99%
SAU101382	SeqID	10239	10707	11179	11292	11635	11879	12146	13657	13862
	IDENTITY	53%	60%	50%	42%	39%	53%	100%	63%	52%
	COVERAGE	98%	99%	97%	97%	79%	98%	100%	96%	98%
SAU101383	SeqID	10317	10625	11226	11418		12055	12147	13422	13761
	IDENTITY	37%	39%	36%	26%		38%	100%	37%	39%
	COVERAGE	102%	90%	97%	98%		94%	100%	112%	94%
SAU101385	SeqID	10403	10830	11030	11368	11640	12115	12385	13508	14067
	IDENTITY	33%	52%	31%	27%	32%	29%	100%	38%	32%
	COVERAGE	99%	90%	92%	89%	96%	98%	100%	92%	99%
SAU101387	SeqID	10402	10839		11549		12114	12386	13509	14068
	IDENTITY	27%	35%		27%		27%	100%	32%	27%
	COVERAGE	87%	88%		71%		87%	101%	90%	87%
SAU101389	SeqID	10401	10801	11029	11400		12113	12387	13510	14069
	IDENTITY	55%	72%	57%	60%		57%	100%	74%	55%
	COVERAGE	98%	99%	99%	100%		98%	100%	94%	98%
SAU101398	SeqID	10313	10881	11224	11502	11754	12051	12324	13485	13767
	IDENTITY	55%	78%	54%	51%	57%	56%	100%	68%	54%
	COVERAGE	100%	101%	100%	99%	101%	100%	101%	101%	101%
SAU101399	SeqID	10312	10882	10989	11416	11755	12050	12325	13699	13768
	IDENTITY	50%	63%	48%	38%	51%	51%	100%	58%	49%
	COVERAGE	99%	100%	98%	97%	85%	97%	100%	99%	99%
SAU101400	SeqID		10743		11448			12326	13391
	IDENTITY		46%		32%			100%	41%
	COVERAGE		96%		95%			100%	96%
SAU101408	SeqID	10267	10509					12308	13278	14050
	IDENTITY	37%	43%					100%	42%	39%
	COVERAGE	100%	99%					100%	101%	100%
SAU101421	SeqID		10676					12498
	IDENTITY		38%					100%
	COVERAGE		93%					100%
SAU101427	SeqID							12500	13234
	IDENTITY							100%	48%
	COVERAGE							100%	100%
SAU101432	SeqID			11046	11286	11744	12065	12184	13538
	IDENTITY			57%	60%	63%	68%	100%	26%
	COVERAGE			99%	100%	101%	99%	101%	73%
SAU101436	SeqID	10271		11045	11285		12067	12183		13873
	IDENTITY	27%		62%	61%		59%	100%		27%
	COVERAGE	90%		99%	97%		98%	100%		90%
SAU101438	SeqID	10146	10825	11042				12379	13337	13842
	IDENTITY	30%	29%	29%				100%	27%	30%
	COVERAGE	88%	94%	89%				100%	94%	88%
SAU101444	SeqID	10254	10827	11144	11301		12034	12381	13335	13792
	IDENTITY	60%	66%	57%	54%		60%	100%	61%	59%
	COVERAGE	100%	101%	100%	100%		100%	100%	99%	100%
SAU101445	SeqID	10248	10828	11207			12037	12382	13408	13949
	IDENTITY	52%	70%	52%			54%	100%	72%	51%
	COVERAGE	99%	100%	96%			99%	100%	100%	100%
SAU101446	SeqID	10411	10674				11903	12383		14031
	IDENTITY	50%	59%				33%	100%		50%
	COVERAGE	98%	100%				97%	100%		99%
SAU101447	SeqID							12683
	IDENTITY							100%
	COVERAGE							101%
SAU101452	SeqID							12684
	IDENTITY							100%
	COVERAGE							100%
SAU101455	SeqID							12686
	IDENTITY							100%
	COVERAGE							100%
SAU101461	SeqID		10705				11790	12680
	IDENTITY		54%				26%	100%
	COVERAGE		93%				86%	101%
SAU101463	SeqID	10268	10708				11919	12679	13584	14051
	IDENTITY	29%	45%				26%	100%	26%	29%
	COVERAGE	77%	98%				91%	101%	88%	77%
SAU101476	SeqID	10469	10905	12254	13454	13905
	IDENTITY	38%	29%	100%	25%	26%
	COVERAGE	84%	94%			100%	95%	73%
SAU101481	SeqID	10125	10920	10975	11290		11894	12130	13580
	IDENTITY	40%	39%	40%	32%		39%	100%	41%
	COVERAGE	93%	95%	96%	93%		96%	100%	96%
SAU101482	SeqID	10126	10921	10974	11342	11738	11893	12123	13360	14092
	IDENTITY	55%	51%	52%	44%	36%	52%	100%	48%	37%
	COVERAGE	98%	100%	98%	98%	77%	98%	100%	99%	101%
SAU101483	SeqID	10127	10918	10973	11341		11892	12124	13674	13871
	IDENTITY	65%	41%	59%	58%		61%	100%	51%	31%
	COVERAGE	88%	90%	90%	90%		87%	101%	92%	94%
SAU101488	SeqID		10730				11868	12164	13450	13799
	IDENTITY		28%				25%	100%	33%	28%
	COVERAGE		95%				74%	100%	98%	73%
SAU101491	SeqID		10580					12165	13315
	IDENTITY		42%					100%	42%
	COVERAGE		104%					100%	95%
SAU101492	SeqID	10073	10581	11020	11284		11831	12166	13323	13715
	IDENTITY	38%	52%	37%	29%		37%	100%	43%	38%
	COVERAGE	98%	101%	98%	78%		94%	101%	85%	98%
SAU101493	SeqID	10074		11021	11381		11832	12167	13564	13716
	IDENTITY	42%		41%	30%		43%	100%	64%	44%
	COVERAGE	96%		97%	94%		98%	101%	91%	96%
SAU101495	SeqID	1003010805	11188	11458		5187	12360	13333	14077
	IDENTITY	32%	34%	36%	29%		33%	100%	32%	32%
	COVERAGE	92%	92%	90%	86%		90%	100%	94%	92%
SAU101497	SeqID		10806					12361
	IDENTITY		59%					100%
	COVERAGE		100%					100%
SAU101509	SeqID	10121				11712		12418	13249
	IDENTITY	34%				36%		100%	49%
	COVERAGE	104%				104%		100%	83%
SAU101526	SeqID		10901					12179	13465
	IDENTITY		38%					100%	34%
	COVERAGE		88%					100%	89%
SAU101529	SeqID							12544
	IDENTITY							100%
	COVERAGE							100%
SAU101541	SeqID	10024	10631	11182	11526		12014	12344	13647	14019
	IDENTITY	41%	63%	42%	38%		42%	100%	59%	40%
	COVERAGE	101%	100%	101%	98%		101%	100%	101%	100%
SAU101543	SeqID	10025	10634	11183			11867	12346	13406	14091
	IDENTITY	26%	33%	27%			27%	100%	32%	28%
	COVERAGE	78%	97%	78%			73%	100%	96%	76%
SAU101545	SeqID	10029	10636	11187	11329		12010	12348	13633	14076
	IDENTITY	31%	50%	32%	27%		28%	100%	47%	30%
	COVERAGE	98%	99%	97%	83%		97%	100%	97%	98%
SAU101546	SeqID		10638					12349
	IDENTITY		27%					100%
	COVERAGE		80%					100%
SAU101549	SeqID	10443	10762	11228		11767	12049	12549	13460	14030
	IDENTITY	40%	38%	30%		38%	29%	100%	39%	38%
	COVERAGE	70%	95%	88%		70%	92%	102%	92%	70%
SAU101551	SeqID	10172	10490	11194	11360		12019	12550	13326	13939
	IDENTITY	52%	77%	26%	27%		26%	100%	76%	52%
	COVERAGE	97%	98%	98%	89%		96%	100%	98%	97%
SAU101554	SeqID		10485		11485			12551	13672
	IDENTITY		48%		26%			100%	46%
	COVERAGE		83%		81%			101%	91%
SAU101561	SeqID	10400	10937	11073	11355	11759	12112	12149	13307	14064
	IDENTITY	44%	57%	44%	38%	42%	44%	100%	49%	43%
	COVERAGE	99%	99%	99%	100%	99%	100%	100%	99%	99%
SAU101565	SeqID	10134	10552	11211			11895	12151	13448	13826
	IDENTITY	37%	50%	35%			36%	100%	44%	36%
	COVERAGE	93%	96%	94%			92%	100%	99%	92%
SAU101567	SeqID							12144
	IDENTITY							100%
	COVERAGE							100%
SAU101570	SeqID	10037	10690	11208		11700	11835	12584	13563	13900
	IDENTITY	32%	48%	31%		34%	33%	100%	37%	30%
	COVERAGE	100%	100%	99%		95%	102%	100%	100%	100%
SAU101571	SeqID		10691				11917	12585	13308
	IDENTITY		45%				33%	100%	31%
	COVERAGE		98%				94%	100%	97%
SAU101572	SeqID	10068	10692			11689	11864	12586	13309	14083
	IDENTITY	26%	56%			46%	43%	100%	45%	25%
	COVERAGE	75%	101%			89%	96%	100%	98%	75%
SAU101573	SeqID	10096	10693	11270			11865	12587		14054
	IDENTITY	31%	49%	35%			30%	100%		31%
	COVERAGE	98%	103%	98%			101%	100%		98%
SAU101574	SeqID							12588
	IDENTITY							100%
	COVERAGE							101%
SAU101575	SeqID		10869					12589	13638
	IDENTITY		31%					100%	27%
	COVERAGE		98%					100%	96%
SAU101576	SeqID		10762				12049	12554	13460
	IDENTITY		32%				29%	100%	39%
	COVERAGE		93%				98%	102%	98%
SAU101586	SeqID							12598	13487
	IDENTITY							100%	34%
	COVERAGE							101%	78%
SAU101592	SeqID	10249	10605	10987	11555	11741	11952	12406	13283	13950
	IDENTITY	51%	74%	53%	53%	51%	52%	100%	70%	51%
	COVERAGE	101%	100%	100%	100%	101%	101%	100%	100%	101%
SAU101599	SeqID							12478
	IDENTITY							100%
	COVERAGE							100%
SAU101610	SeqID	10449			11390		12048	12629		13816
	IDENTITY	38%			38%		40%	100%		38%
	COVERAGE	105%			101%		99%	100%		105%
SAU101612	SeqID							12637
	IDENTITY							100%
	COVERAGE							100%
SAU101614	SeqID	10167	10678	11262	11534		11978	12649	13462	13851
	IDENTITY	49%	55%	29%	29%		39%	100%	53%	48%
	COVERAGE	100%	98%	93%	94%		95%	100%	99%	100%
SAU101616	SeqID	10186	10667		11407	11695	11872	12432		13903
	IDENTITY	33%	28%		32%	29%	34%	100%		33%
	COVERAGE	102%	99%		88%	104%	96%		100%	100%
SAU101622	SeqID	10162			11619	11710	12104	12430		13832
	IDENTITY	69%			29%	67%	43%	100%		70%
	COVERAGE	100%			104%	78%	101%	100%		100%
SAU101624	SeqID	10193		11255	11316			12429	13430	13752
	IDENTITY	26%		27%	38%			100%	26%	26%
	COVERAGE	101%		106%	97%			100%	103%	107%
SAU101630	SeqID							12410
	IDENTITY							100%
	COVERAGE							100%
SAU101632	SeqID							12407
	IDENTITY							100%
	COVERAGE							100%
SAU101637	SeqID		10886					12201	13384
	IDENTITY		44%					100%	38%
	COVERAGE		99%					101%	98%
SAU101641	SeqID	10223					11918	12193
	IDENTITY	51%					53%	100%
	COVERAGE	92%					95%	100%
SAU101651	SeqID		10790		11552		12021	12491	13369
	IDENTITY		38%		28%		34%	100%	42%
	COVERAGE		97%		89%		90%	101%	100%
SAU101652	SeqID		10791		11369		12022	12492	13368
	IDENTITY		62%		49%		50%	100%	56%
	COVERAGE		97%		91%		95%	100%	98%
SAU101653	SeqID		10792		11520		12023	12493	13367
	IDENTITY		73%		46%		49%	100%	63%
	COVERAGE		100%		100%		100%	100%	100%
SAU101655	SeqID	10205	10793				11896	12494	13334
	IDENTITY	31%	50%				30%	100%	33%
	COVERAGE	84%	97%				83%	100%	93%
SAU101663	SeqID							12261
	IDENTITY							100%
	COVERAGE							100%
SAU101664	SeqID	10202	10512	11138			11863	12262	13685	13823
	IDENTITY	37%	41%	36%			38%	100%	38%	36%
	COVERAGE	98%	97%	108%			106%	101%	105%	98%
SAU101674	SeqID	10067					11846	12594		14082
	IDENTITY	27%					27%	100%		27%
	COVERAGE	103%					101%	100%		103%
SAU101679	SeqID	10190	10644	11055	11398		12105	12593	13264	13756
	IDENTITY	41%	53%	42%	36%		45%	100%	45%	40%
	COVERAGE	90%	100%	99%	86%		90%	100%	98%	90%
SAU101681	SeqID	10464	10746				11861	12592	13419	13987
	IDENTITY	39%	46%				31%	100%	44%	40%
	COVERAGE	100%	102%				95%	100%	102%	97%
SAU101682	SeqID	10156	10670	11265				12591	13488	13884
	IDENTITY	28%	30%	28%				100%	34%	26%
	COVERAGE	94%	96%	102%				100%	80%	94%
SAU101685	SeqID		10590				11920	12152	13396
	IDENTITY		26%				37%	100%	56%
	COVERAGE		88%				97%	100%	100%
SAU101717	SeqID	10129	10586	11027	11610		11890	12131	13352	14070
	IDENTITY	33%	51%	35%	31%		38%	100%	49%	34%
	COVERAGE	101%	100%	93%	70%		99%	100%	93%	101%
SAU101724	SeqID	10309	10588	11268	11337		12015	12136	13678	13772
	IDENTITY	44%	44%	41%	36%		43%	100%	45%	43%
	COVERAGE	97%	99%	97%	87%		80%	100%	98%	97%
SAU101726	SeqID	10130	10664	11026	11461		11889	12134	13550	14071
	IDENTITY	37%	50%	42%	36%		40%	100%	48%	41%
	COVERAGE	101%	100%	101%	101%		100%	100%	100%	77%
SAU101727	SeqID		10665					12133	13551
	IDENTITY		50%					100%	49%
	COVERAGE		101%					101%	101%
SAU101728	SeqID	10019	10666	11053		11734	11800	12132	13182	14015
	IDENTITY	34%	54%	35%		35%	34%	100%	53%	34%
	COVERAGE	86%	95%	88%		85%	90%	100%	94%	86%
SAU101736	SeqID	10225					11817	12519		13958
	IDENTITY	28%					38%	100%		29%
	COVERAGE	72%					99%					100%		72%
SAU101737	SeqID				11405		11817	12518
	IDENTITY				32%		30%	100%
	COVERAGE				78%		96%	101%
SAU101744	SeqID		10562					12367
	IDENTITY		44%					100%
	COVERAGE		101%					100%
SAU101751	SeqID	10474	10606			11671		12448	13165	13706
	IDENTITY	30%	46%			30%		100%	45%	31%
	COVERAGE	85%	100%			82%		100%	99%	79%
SAU101752	SeqID	10438	10626	11037	11410		11997	12447	13187	14043
	IDENTITY	46%	75%	47%	40%		45%	100%	69%	46%
	COVERAGE	115%	99%	114%	120%		116%	100%	99%	115%
SAU101754	SeqID	10439	10627	11036	11571		5179	12446	13646	14042
	IDENTITY	46%	72%	46%	53%		46%	100%	68%	46%
	COVERAGE	116%	100%	117%	80%		118%	100%	101%	116%
SAU101756	SeqID	10365	10479	11062	11409		5178	12445	13231	13967
	IDENTITY	65%	83%	66%	65%		68%	100%	82%	65%
	COVERAGE	91%	93%	91%	91%		91%	101%	93%	93%
SAU101771	SeqID	10220	10784	11276		11765	11950	12350	13280	13934
	IDENTITY	43%	65%	37%		35%	36%	100%	67%	41%
	COVERAGE	91%	101%	77%		82%	80%	101%	98%	91%
SAU101772	SeqID	10240	10785	11275	11294		11925	12351	13281	13863
	IDENTITY	50%	63%	51%	27%		38%	100%	61%	48%
	COVERAGE	100%	101%	100%	77%		100%	100%	101%	84%
SAU101777	SeqID		10673		11448			12352	13176
	IDENTITY		64%		43%			100%	62%
	COVERAGE		97%		88%			100%	98%
SAU101781	SeqID		10495				11917	12353	13308
	IDENTITY		67%				38%	100%	28%
	COVERAGE			99%				93%	100%	85%
SAU101782	SeqID		10496			11689	11916	12354	13309
	IDENTITY		75%			44%	41%	100%	40%
	COVERAGE		100%			89%	99%	100%	96%
SAU101784	SeqID	10037	10498	11208		11700	11866	12355	13563	13900
	IDENTITY	44%	65%	45%		35%	42%	100%	37%	44%
	COVERAGE	97%	100%	97%		92%	99%	100%	99%	97%
SAU101790	SeqID	10350	10524	11106	11437		5170	12215	13207
	IDENTITY	51%	81%	55%	48%		55%	100%	79%
	COVERAGE	86%	99%	86%	86%		90%	101%	99%
SAU101791	SeqID	10349	10525	11107	11436		5169	12216	13208	14108
	IDENTITY	67%	90%	69%	62%		66%	100%	89%	67%
	COVERAGE	101%	101%	101%	100%		100%	101%	101%	102%
SAU101792	SeqID	10348	10526	11108			5168	12217	13209	14107
	IDENTITY	53%	66%	52%			49%	100%	68%	50%
	COVERAGE	96%	94%	95%			97%	101%	94%	96%
SAU101793	SeqID	10347	10527	11109	11589	11654	5167	12218	13210	14106
	IDENTITY	64%	85%	65%	51%	64%	63%	100%	79%	64%
	COVERAGE	100%	101%	99%	99%	101%	99%	101%	100%	101%
SAU101795	SeqID	10345	10528	11111	11435		5165	12219	13212	14104
	IDENTITY	51%	79%	47%	44%		44%	100%	76%	51%
	COVERAGE	99%	101%	99%	98%		100%	101%	101%	101%
SAU101797	SeqID	10343	10530	11113	11433		5163	12221	13214	14102
	IDENTITY	45%	68%	41%	41%		48%	100%	66%	46%
	COVERAGE	100%	101%	99%	93%		96%	101%	101%	101%
SAU101798	SeqID	10342	10531	11114	11432		5162	12222	13215	14101
	IDENTITY	55%	72%	55%	62%		52%	100%	66%	55%
	COVERAGE	99%	95%	99%	87%		99%	101%	96%	99%
SAU101799	SeqID	10341	10532	11115			5161	12223	13216
	IDENTITY	51%	62%	42%			42%	100%	69%
	COVERAGE	100%	102%	100%			97%	102%	98%
SAU101800	SeqID	10340	10534	11116	11431		5160	12225	13217	14099
	IDENTITY	47%	79%	46%	40%		42%	100%	84%	47%
	COVERAGE	99%	101%	99%	90%		99%	101%	101%	99%
SAU101802	SeqID	10075	10536	11008	11348	11633	11942	12227	13219	13717
	IDENTITY	48%	64%	52%	31%	47%	53%	100%	56%	47%
	COVERAGE	97%	97%	97%	93%	97%	84%	100%	96%	97%
SAU101803	SeqID	10111	10537	11052	11429	11651	11876	12228	13220	14010
	IDENTITY	71%	84%	71%	60%	70%	71%	100%	82%	70%
	COVERAGE	97%	101%	97%	100%	101%	97%	101%	101%	101%
SAU101805	SeqID	10337	10539	11119	11427		11990	12229	13221	14097
	IDENTITY	53%	75%	52%	58%		60%	100%	74%	52%
	COVERAGE	96%	101%	99%	99%		96%	101%	101%	96%
SAU101806	SeqID	10336	10540	11120	11426		11989	12230	13222	14096
	IDENTITY	62%	85%	64%	60%		61%	100%	85%	63%
	COVERAGE	100%	101%	100%	102%		100%	101%	92%	101%
SAU101807	SeqID	10334	10541	11122	11583		11987	12231	13223	14094
	IDENTITY	42%	71%	42%	37%		42%	100%	58%	42%
	COVERAGE	99%	100%	99%	94%		99%	100%	99%	99%
SAU101808	SeqID	10333	10542	11123	11582	11627	5158	12232	13224	14093
	IDENTITY	48%	65%	49%	46%	48%	45%	100%	67%	48%
	COVERAGE	98%	103%	98%	99%	78%	98%	101%	106%	98%
SAU101810	SeqID	10053	10544	11229	11625	11666	11909	12233	13441	14110
	IDENTITY	35%	52%	34%	32%	36%	33%	100%	47%	36%
	COVERAGE	76%	88%	78%	77%	73%	72%	100%	88%	73%
SAU101811	SeqID	10196	10545	11068	11463	11666	11888	12234	13440	13721
	IDENTITY	38%	49%	33%	32%	33%	32%	100%	45%	34%
	COVERAGE	78%	87%	82%	82%	83%	82%	100%	87%	76%
SAU101814	SeqID	10327	10602	11241	11471	11655	5188	12237	13356	13729
	IDENTITY	58%	69%	57%	47%	56%	55%	100%	65%	56%
	COVERAGE	94%	96%	94%	92%	71%	97%	101%	99%	94%
SAU101815	SeqID	10326		11240	11288		12016	12238	13361	13732
	IDENTITY	49%		48%	46%		53%	100%	69%	51%
	COVERAGE	98%		98%	93%		93%	101%	99%	99%
SAU101818	SeqID			11231	11307		11814	12369	13494
	IDENTITY			32%	33%		31%	100%	35%
	COVERAGE			95%	90%		96%	101%	93%
SAU101824	SeqID	10158					12004	12371
	IDENTITY	33%					28%	100%
	COVERAGE	71%					75%	100%
SAU101833	SeqID	10207	10747	11040	11481		11794	12373	13388	13775
	IDENTITY	42%	49%	28%	44%		35%	100%	46%	44%
	COVERAGE	100%	102%	95%	107%		117%	100%	103%	89%
SAU101839	SeqID	10398	10849	11236			12100	12495	13291	13924
	IDENTITY	30%	33%	32%			25%	100%	32%	28%
	COVERAGE	94%	78%	90%			98%	100%	83%	94%
SAU101842	SeqID	10105	10942	11075	11376	11723	11855	12510	13445	13999
	IDENTITY	45%	70%	33%	48%	33%	47%	100%	65%	45%
	COVERAGE	98%	95%	95%	99%	94%	97%	100%	82%	99%
SAU101845	SeqID	10231	10739		11567		11899	12506	13544	13953
	IDENTITY	30%	47%		40%		26%	100%	43%	28%
	COVERAGE	101%	102%		102%		101%	100%	102%	101%
SAU101849	SeqID	10015	10740	11209	11472		12058	12567	13379	13713
	IDENTITY	56%	77%	54%	56%		56%	100%	75%	56%
	COVERAGE	103%	99%	103%	101%		103%	100%	98%	104%
SAU101857	SeqID							12569
	IDENTITY							100%
	COVERAGE							100%
SAU101862	SeqID	10257	10817	10955	11334		11802	12571	13305	13797
	IDENTITY	40%	63%	40%	33%		39%	100%	62%	39%
	COVERAGE	98%	100%	98%	101%		98%	100%	99%	98%
SAU101864	SeqID							12572
	IDENTITY							100%
	COVERAGE							100%
SAU101865	SeqID	10044	10834	11151	11417		11938	12318	13227	13910
	IDENTITY	43%	58%	45%	40%		40%	100%	54%	41%
	COVERAGE	85%	88%	88%	87%		87%	100%	88%	88%
SAU101866	SeqID		10835				11873	12319	13586
	IDENTITY		42%				29%	100%	40%
	COVERAGE		102%				99%	100%	100%
SAU101868	SeqID	10049	10733	11086	11305		11813	12320	13228	13898
	IDENTITY	45%	56%	45%	42%		48%	100%	49%	45%
	COVERAGE	101%	99%	101%	96%		100%	100%	108%	99%
SAU101869	SeqID		10734					12321	13668
	IDENTITY		55%					100%	49%
	COVERAGE		100%					100%	101%
SAU101876	SeqID							12169
	IDENTITY							100%
	COVERAGE							101%
SAU101881	SeqID	10325					12081	12162		13728
	IDENTITY	42%					41%	100%		42%
	COVERAGE	98%					97%	100%		98%
SAU101882	SeqID	10246	10824			11743	12080	12163		13727
	IDENTITY	33%	30%			31%	31%	100%		33%
	COVERAGE	96%	89%			73%	94%	100%		95%
SAU101890	SeqID	10374		11125			12091	12280		13809
	IDENTITY	53%		49%			47%	100%		53%
	COVERAGE	91%		92%			93%	100%		91%
SAU101891	SeqID	10295	10766	11196	11483		11791	12281	13413	13739
	IDENTITY	63%	72%	62%	60%		58%	100%	67%	64%
	COVERAGE	91%	91%	90%	90%		93%	100%	92%	91%
SAU101893	SeqID	10300	10724			11748	11981	12282	13290	13825
	IDENTITY	46%	47%			41%	35%	100%	40%	43%
	COVERAGE	87%	100%			78%	93%	100%	95%	96%
SAU101904	SeqID	10047	10648	11089	11451		11935	12617	13345	13913
	IDENTITY	34%	38%	33%	31%		31%	100%	34%	33%
	COVERAGE	98%	101%	102%	105%		104%	100%	93%	98%
SAU101907	SeqID	10362	10482	11059	11415		11995	12442	13171	13964
	IDENTITY	75%	90%	76%	74%		73%	100%	75%	74%
	COVERAGE	100%	101%	100%	101%		101%	100%	101%	100%
SAU101909	SeqID	10390		11249	11346		11789	12441		14063
	IDENTITY	41%		32%	29%		36%	100%		32%
	COVERAGE	99%		88%	90%		93%	100%		73%
SAU101910	SeqID	10199					11818	12440
	IDENTITY	56%					60%	100%
	COVERAGE	97%					97%	100%
SAU101915	SeqID		10838					12439
	IDENTITY		26%					100%
	COVERAGE		90%					100%
SAU101922	SeqID							12438
	IDENTITY							100%
	COVERAGE							100%
SAU101948	SeqID							12709
	IDENTITY							100%
	COVERAGE							100%
SAU101966	SeqID	10101	10561	11007	11538	11705	11897	12186		14003
	IDENTITY	45%	31%	32%	37%	43%	45%	100%		45%
	COVERAGE	88%	91%	92%	86%	88%	88%	101%		88%
SAU101968	SeqID	10106	10568	11242	11480		11965	12187		13998
	IDENTITY	30%	31%	33%	27%		30%	100%		31%
	COVERAGE	90%	92%	90%	88%		83%	100%		76%
SAU101991	SeqID		10938					12454	13500
	IDENTITY		40%					100%	25%
	COVERAGE		101%					101%	80%
SAU101995	SeqID	10388	10939	11066	11575	11646	11957	12455	13386
	IDENTITY	46%	47%	49%	58%	46%	57%	100%	51%
	COVERAGE	72%	78%	73%	72%	72%	76%	100%	74%
SAU101996	SeqID	10237	10940	10999	11325		11901	12456	13455	13956
	IDENTITY	38%	64%	36%	38%		35%	100%	58%	37%
	COVERAGE	98%	99%	98%	98%		99%	100%	100%	98%
SAU101999	SeqID	10476	10941	11259	11304		12035	12423	13241	13708
	IDENTITY	48%	61%	46%	49%		51%	100%	64%	48%
	COVERAGE	97%	98%	98%	91%		96%	100%	97%	97%
SAU102001	SeqID	10258	10628	11134	11489		11787	12424	13636	14088
	IDENTITY	47%	58%	47%	43%		49%	100%	46%	47%
	COVERAGE	105%	98%	106%	105%		98%	100%	98%	105%
SAU102002	SeqID							12425
	IDENTITY							100%
	COVERAGE							100%
SAU102003	SeqID							12426
	IDENTITY							100%
	COVERAGE							101%
SAU102006	SeqID			11267	11555			12427	13260
	IDENTITY			44%	28%			100%	47%
	COVERAGE			92%	74%			101%	105%
SAU102007	SeqID			11266				12428	13258
	IDENTITY			60%				100%	61%
	COVERAGE			97%				100%	97%
SAU102032	SeqID						12086	12198		13989
	IDENTITY						62%	100%		58%
	COVERAGE						99%	100%		75%
SAU102035	SeqID	10299	10933	10974	11514		11860	12199	13360	13763
	IDENTITY	60%	50%	26%	29%		41%	100%	31%	56%
	COVERAGE	98%	99%	85%	84%		97%	100%	86%	99%
SAU102044	SeqID	10141	10916	11011	11344		12041	12414	13447	13977
	IDENTITY	56%	67%	59%	50%		58%	100%	69%	56%
	COVERAGE	100%	102%	100%	101%		101%	100%	102%	100%
SAU102046	SeqID	10103	10723				12089	12415		14001
	IDENTITY	32%	28%				29%	100%		29%
	COVERAGE	74%	86%				90%	100%		89%
SAU102049	SeqID	10427	10518	10962	11291		11784	12416	13652	13781
	IDENTITY	36%	39%	49%	40%		41%	100%	46%	36%
	COVERAGE	101%	99%	97%	99%		100%	100%	98%	101%
SAU102054	SeqID	10280	10494	11095	11356	11676	11856	12417		13877
	IDENTITY	53%	50%	55%	51%	53%	55%	100%		53%
	COVERAGE	100%	79%	100%	100%	70%	100%	100%		100%
SAU102059	SeqID	10085	10771	11152	11622		11969	12286	13226	14059
	IDENTITY	43%	72%	43%	40%		41%	100%	72%	40%
	COVERAGE	107%	100%	107%	102%		109%	100%	71%	89%
SAU102067	SeqID	10380	10564	11155			11795	12287	13407	13798
	IDENTITY	32%	52%	31%			28%	100%	44%	31%
	COVERAGE	95%	98%	98%			97%	100%	98%	94%
SAU102068	SeqID		10680					12288
	IDENTITY		29%					100%
	COVERAGE		101%					100%
SAU102102	SeqID							12696
	IDENTITY							100%
	COVERAGE							100%
SAU102113	SeqID		10641					12178
	IDENTITY		34%					100%
	COVERAGE		110%					101%
SAU102116	SeqID		10642					12180	13480
	IDENTITY		29%					100%	31%
	COVERAGE		85%					100%	81%
SAU102117	SeqID	10016	10643		11604		12027	12181	13481	13947
	IDENTITY	43%	61%		38%		42%	100%	55%	41%
	COVERAGE	101%	100%		102%		103%	100%	100%	85%
SAU102129	SeqID		10859					12176	13400
	IDENTITY		60%					100%	56%
	COVERAGE		98%					100%	99%
SAU102132	SeqID		10760					12177	13304
	IDENTITY		39%					100%	41%
	COVERAGE		101%					100%	101%
SAU102142	SeqID	10154						12457
	IDENTITY	37%						100%
	COVERAGE	99%						100%
SAU102143	SeqID	10154						12458
	IDENTITY	32%						100%
	COVERAGE	100%						100%
SAU102144	SeqID							12459
	IDENTITY							100%
	COVERAGE							100%
SAU102162	SeqID							12462
	IDENTITY							100%
	COVERAGE							100%
SAU102165	SeqID							12460
	IDENTITY							100%
	COVERAGE							100%
SAU102200	SeqID							12665
	IDENTITY							100%
	COVERAGE								101%
SAU102201	SeqID							12666
	IDENTITY							100%
	COVERAGE							101%
SAU102222	SeqID	10447	10797	10994	11358		11986	12511	13192	13818
	IDENTITY	58%	68%	58%	52%		59%	100%	67%	58%
	COVERAGE	99%	99%	99%	99%		99%	100%	99%	99%
SAU102231	SeqID	10323	10798	11193			12020	12527	13561	13731
	IDENTITY	41%	50%	42%			38%	100%	46%	41%
	COVERAGE	94%	93%	89%			94%	100%	99%	94%
SAU102232	SeqID	10100	10799			11687		12530	13562	14004
	IDENTITY	36%	40%			35%		100%	42%	34%
	COVERAGE	75%	79%			74%		100%	79%	75%
SAU102233	SeqID		10800					12531	13496
	IDENTITY		61%					100%	45%
	COVERAGE		98%					100%	91%
SAU102241	SeqID	10163	10845					12539
	IDENTITY	28%	43%					100%
	COVERAGE	74%	99%					100%
SAU102242	SeqID	10188	10847	10953	11600	11634	11907	12540	13593	13981
	IDENTITY	47%	72%	44%	38%	47%	47%	100%	70%	47%
	COVERAGE	100%	99%	101%	100%	98%	100%	100%	100%	100%
SAU102246	SeqID	10274	10854	11154	11476		11932	12542	13313	13866
	IDENTITY	59%	74%	60%	54%		62%	100%	81%	58%
	COVERAGE	99%	100%	97%	96%		100%	100%	101%	99%
SAU102247	SeqID							12543	13180
	IDENTITY							100%	28%
	COVERAGE							101%	74%
SAU102252	SeqID	10300	10677			11748	11981	12241	13290	13825
	IDENTITY	39%	48%			39%	37%	100%	43%	41%
	COVERAGE	79%	93%			73%	91%	100%	95%	98%
SAU102256	SeqID	10451			11515			12243	13531
	IDENTITY	33%			32%			100%	75%
	COVERAGE	97%			97%			101%	101%
SAU102257	SeqID	10451			11515			12244	13274
	IDENTITY	38%			29%			100%	85%
	COVERAGE	81%			75%			101%	101%
SAU102259	SeqID		10844					12245	13519	13782
	IDENTITY		65%					100%	72%	25%
	COVERAGE		97%					100%	97%	87%
SAU102260	SeqID	10182	10646			11682		12246	13275	13984
	IDENTITY	34%	37%			32%		100%	83%	32%
	COVERAGE	96%	87%			96%		101%	100%	87%
SAU102261	SeqID	10183	10731					12247	13276	13983
	IDENTITY	25%	30%					100%	74%	26%
	COVERAGE	79%	80%					100%	99%	79%
SAU102262	SeqID	10270	10759			11724		12248	13277	13881
	IDENTITY	35%	39%			31%		100%	82%	34%
	COVERAGE	104%	103%				84%		100%	100%	104%
SAU102264	SeqID	10160					5103	12250		13830
	IDENTITY	45%					44%	100%		43%
	COVERAGE	100%					100%	100%		101%
SAU102265	SeqID						11926	12251
	IDENTITY						37%	100%
	COVERAGE						100%	100%
SAU102268	SeqID							12252
	IDENTITY							100%
	COVERAGE							101%
SAU102270	SeqID							12253
	IDENTITY							100%
	COVERAGE							100%
SAU102280	SeqID							12378
	IDENTITY							100%
	COVERAGE							100%
SAU102281	SeqID	10316		11227	11469		12054	12384	13497	13762
	IDENTITY	45%		48%	39%		45%	100%	61%	44%
	COVERAGE	99%		99%	100%		99%	100%	100%	99%
SAU102283	SeqID	10260	10875	10982	11560		11945	12119	13251	14086
	IDENTITY	41%	59%	43%	41%		41%	100%	54%	41%
	COVERAGE	88%	88%	88%	92%		95%	102%	88%	88%
SAU102284	SeqID							12389
	IDENTITY							100%
	COVERAGE							100%
SAU102286	SeqID	10385	10595					12393	13688
	IDENTITY	37%	42%					100%	39%
	COVERAGE	104%	99%					100%	101%
SAU102287	SeqID	10220	10594	11025		11663	11925	12398	13427	13934
	IDENTITY	42%	45%	40%		39%	41%	100%	41%	39%
	COVERAGE	81%	95%	88%		89%	84%	101%	94%	83%
SAU102292	SeqID	10399	10579	11018	11455	11758	12111	12368	13230	14065
	IDENTITY	41%	59%	40%	37%	41%	42%	100%	57%	41%
	COVERAGE	101%	100%	101%	100%	101%	101%	100%	94%	101%
SAU102294	SeqID							12610
	IDENTITY							100%
	COVERAGE							100%
SAU102297	SeqID	10405	10912	11063	11303		12117	12704	13686	14066
	IDENTITY	52%	66%	51%	46%		50%	100%	64%	48%
	COVERAGE	99%	100%	100%	99%		98%	100%	100%	77%
SAU102298	SeqID	10404	10914	11031		11686	12116	12705	13255
	IDENTITY	36%	62%	33%		35%	28%	100%	54%
	COVERAGE	72%	99%	87%	89%	87%		100%	100%
SAU102308	SeqID	10077	10577	11248	11625	11732	12032	12706	13350	13995
	IDENTITY	38%	46%	37%	33%	39%	38%	100%	45%	39%
	COVERAGE	88%	100%	86%	87%	88%	90%	100%	100%	95%
SAU102318	SeqID	10122	10795				11806	12707	13242	14039
	IDENTITY	32%	75%				37%	100%	63%	31%
	COVERAGE	90%	97%				72%	100%	97%	89%
SAU102333	SeqID	10057	10550				12102	12657	13316	13829
	IDENTITY	41%	43%				40%	100%	31%	38%
	COVERAGE	96%	97%				96%	100%	90%	95%
SAU102334	SeqID	10056					12101	12658
	IDENTITY	50%					50%	100%
	COVERAGE	91%					92%	100%
SAU102336	SeqID							12659
	IDENTITY							100%
	COVERAGE							101%
SAU102340	SeqID							12660
	IDENTITY							100%
	COVERAGE							100%
SAU102345	SeqID						11843	12655
	IDENTITY						37%	100%
	COVERAGE	86%						101%
SAU102350	SeqID							12433
	IDENTITY							100%
	COVERAGE							101%
SAU102352	SeqID		10657					12434	13426
	IDENTITY		55%					100%	39%
	COVERAGE		100%					100%	91%
SAU102355	SeqID		10726					12435
	IDENTITY		39%					100%
	COVERAGE		87%					100%
SAU102356	SeqID	10227	10669	11203	11546		11805	12436	13324	13960
	IDENTITY	43%	60%	45%	48%		43%	100%	56%	43%
	COVERAGE	95%	100%	95%	98%		95%	100%	99%	95%
SAU102378	SeqID							12437
	IDENTITY							100%
	COVERAGE							100%
SAU102380	SeqID						11870	12265
	IDENTITY						32%	100%
	COVERAGE						71%	100%
SAU102388	SeqID	10367		11157	11386		11808	12267		13802
	IDENTITY	36%		33%	27%		39%	100%		36%
	COVERAGE	96%		90%	101%		99%	100%		96%
SAU102389	SeqID	10063	10547	10988			11837	12268	13395	13917
	IDENTITY	33%	59%	31%			36%	100%	35%	33%
	COVERAGE	99%	97%	97%			95%	100%	98%	99%
SAU102390	SeqID	10192				11678		12269		13753
	IDENTITY	41%				26%		100%		42%
	COVERAGE	100%				97%		101%		100%
SAU102392	SeqID	10131	10500			11673	11951	12270	13474
	IDENTITY	50%	42%			32%	42%	100%	42%
	COVERAGE	73%	80%			80%	74%	100%	76%
SAU102394	SeqID		10807					12271
	IDENTITY		32%					100%
	COVERAGE		102%					100%
SAU102396	SeqID	10243	10809					12272	13467	13794
	IDENTITY	37%	62%					100%	27%	37%
	COVERAGE	101%	99%					100%	98%	98%
SAU102401	SeqID							12209
	IDENTITY							100%
	COVERAGE								100%
SAU102417	SeqID		10934				12068	12204
	IDENTITY		31%				25%	100%
	COVERAGE		79%				72%	100%
SAU102418	SeqID					11760		12205
	IDENTITY					25%		100%
	COVERAGE					89%		100%
SAU102420	SeqID							12206
	IDENTITY							100%
	COVERAGE							100%
SAU102422	SeqID	10308				11665	11977	12207		13776
	IDENTITY	30%				30%	27%	100%		31%
	COVERAGE	92%				72%	93%	100%		92%
SAU102423	SeqID			11084	11491		12099	12208
	IDENTITY			27%	25%		27%	100%
	COVERAGE			94%	92%		93%	100%
SAU102433	SeqID	10395	10908	11167	11616		11772	12701	13552
	IDENTITY	42%	51%	39%	37%		52%	100%	44%
	COVERAGE	101%	100%	100%	73%		72%	100%	98%
SAU102434	SeqID	10394	10907	11166			11773	12700	13446	13921
	IDENTITY	26%	44%	28%			26%	100%	40%	27%
	COVERAGE	99%	100%	99%			100%	100%	101%	99%
SAU102437	SeqID	10393	10952	11057	11330		11774	12695	13420	13920
	IDENTITY	55%	67%	57%	51%		55%	100%	64%	56%
	COVERAGE	86%	99%	88%	86%		87%	100%	99%	86%
SAU102440	SeqID					12085	12692		13990
	IDENTITY					41%	100%		39%
	COVERAGE					98%	100%		99%
SAU102447	SeqID		10947					12685	13436
	IDENTITY		38%					100%	32%
	COVERAGE		98%					100%	98%
SAU102448	SeqID	10460	10946	11049	11332		12073	12681	13435	13860
	IDENTITY	32%	55%	31%	35%		34%	100%	46%	32%
	COVERAGE	101%	102%	101%	101%		101%	101%	102%	102%
SAU102449	SeqID	10445	10945	11253	11444	11731	12072	12677	13434	14028
	IDENTITY	45%	55%	43%	35%	43%	44%	100%	51%	45%
	COVERAGE	97%	98%	98%	99%	76%	97%	100%	100%	97%
SAU102450	SeqID	10456	10943	11264	11487		12076	12675	13237	13857
	IDENTITY	47%	70%	46%	43%		47%	100%	68%	47%
	COVERAGE	100%	100%	100%		99%	99%	100%	100%	100%
SAU102452	SeqID	10420	10748	11143	11478	11629	11820	12674	13265	13783
	IDENTITY	41%	70%	37%	32%	40%	40%	100%	62%	38%
	COVERAGE	97%	98%	97%	97%	94%	97%	100%	100%	99%
SAU102453	SeqID		10749				12107	12669	13266
	IDENTITY		43%				29%	100%	41%
	COVERAGE		101%				70%	100%	71%
SAU102460	SeqID	10063	10547	10988			11837	12171	13395	13917
	IDENTITY	34%	35%	34%			34%	100%	34%	34%
	COVERAGE	98%	100%	100%			100%	100%	101%	98%
SAU102469	SeqID	10217					12172
	IDENTITY	58%					100%
	COVERAGE	98%					100%
SAU102473	SeqID		10868					12173	13475
	IDENTITY		28%					100%	35%
	COVERAGE		88%					100%	83%
SAU102474	SeqID		10713	10971				12174	13476	14025
	IDENTITY		26%	26%				100%	26%	27%
	COVERAGE		96%	105%				100%	89%	97%
SAU102476	SeqID							12175
	IDENTITY							100%
	COVERAGE							100%
SAU102479	SeqID	10306						12405
	IDENTITY	26%						100%
	COVERAGE	84%						100%
SAU102480	SeqID	10310	10935				11871	12404		13770
	IDENTITY	28%	33%				30%	100%		27%
	COVERAGE	100%	88%				100%	100%		100%
SAU102481	SeqID	10289	10831					12422		13879
	IDENTITY	26%	29%					100%		26%
	COVERAGE	102%	94%					101%		102%
SAU102485	SeqID	10457	10890					12421	13512	13961
	IDENTITY	28%	53%					100%	56%	60%
	COVERAGE	86%	100%					100%	99%	93%
SAU102486	SeqID	10294	10889	11025				12420	13513	13962
	IDENTITY	36%	38%	27%				100%	42%	37%
	COVERAGE	95%	97%	95%				101%	93%	95%
SAU102487	SeqID							12419
	IDENTITY							100%
	COVERAGE							100%
SAU102498	SeqID	10241	10597	10974	11342	11706	11842	12688	13387	14092
	IDENTITY	36%	35%	35%	33%	37%	38%	100%	35%	36%
	COVERAGE	93%	94%	93%	92%	94%	94%	100%	93%	93%
SAU102502	SeqID						12060	12689
	IDENTITY						26%	100%
	COVERAGE						85%	100%
SAU102503	SeqID						12059	12690
	IDENTITY						32%	100%
	COVERAGE						92%	100%
SAU102526	SeqID							12691
	IDENTITY							100%
	COVERAGE							100%
SAU102527	SeqID	10352	10560	11104	11439		5171	12260	13204	13968
	IDENTITY	54%	74%	55%	56%		58%	100%	75%	54%
	COVERAGE	93%	101%	93%	94%		93%	101%	94%	93%
SAU102531	SeqID						10765	12667
	IDENTITY		34%					100%
	COVERAGE		102%					100%
SAU102541	SeqID	10076	10520	11000	11498		11966	12668	13405	13718
	IDENTITY	41%	49%	38%	37%		44%	100%	45%	41%
	COVERAGE	93%	102%	91%	93%		100%	100%	81%	93%
SAU102551	SeqID			11013	11353		11816	12672	13271
	IDENTITY			47%	38%		39%	100%	41%
	COVERAGE			87%	84%		84%	101%	95%
SAU102554	SeqID		10494					12673	13466
	IDENTITY		47%					100%	44%
	COVERAGE		99%					100%	98%
SAU102575	SeqID	10166		11232	11618		11777	12609		13836
	IDENTITY	28%		29%	35%		30%	100%		27%
	COVERAGE	98%		91%	99%		96%	100%		98%
SAU102578	SeqID	1045910948	11050	11420		12074	12411	13503	13859
	IDENTITY	59%	76%	60%	51%		65%	100%	73%	59%
	COVERAGE	88%	95%	88%	89%		81%	101%	94%	89%
SAU102584	SeqID							12537
	IDENTITY							100%
	COVERAGE							100%
SAU102585	SeqID							12611
	IDENTITY							100%
	COVERAGE							100%
SAU102593	SeqID		10889					12463	13513
	IDENTITY		27%					100%	27%
	COVERAGE		87%					100%	88%
SAU102598	SeqID	10187		10958		11710	11979	12464		13833
	IDENTITY	30%		32%		27%	31%	100%		31%
	COVERAGE	102%		85%		75%	92%	100%		86%
SAU102599	SeqID	10206	10944	10958	11619		11975	12466	13653	13773
	IDENTITY	36%	26%	30%	30%		33%	100%	32%	32%
	COVERAGE	89%	76%	93%	73%		79%	100%	77%	101%
SAU102601	SeqID	10273		11076		11722	11931	12467	13256	13867
	IDENTITY	27%		30%		28%	28%	100%	51%	27%
	COVERAGE	95%		93%		95%	93%	100%	97%	92%
SAU102602	SeqID	10356	10555	11100	11441	11679	11993	12249	13200	13971
	IDENTITY	58%	78%	61%	57%	59%	60%	100%	77%	58%
	COVERAGE	100%	100%	100%	100%	100%	99%	100%	100%	99%
SAU102603	SeqID							12469
	IDENTITY							100%
	COVERAGE							100%
SAU102605	SeqID		10836					12470
	IDENTITY		47%					100%
	COVERAGE		96%					100%
SAU102606	SeqID	10273		11076		11722	11931	12471	13256	13867
	IDENTITY	27%		30%		27%	25%	100%	50%	26%
	COVERAGE	95%		92%		95%	93%	100%	97%	94%
SAU102607	SeqID							12472	13579
	IDENTITY							100%	43%
	COVERAGE							100%	98%
SAU102609	SeqID							12473
	IDENTITY							100%
	COVERAGE							100%
SAU102610	SeqID							12474
	IDENTITY							100%
	COVERAGE							100%
SAU102613	SeqID	10461		11272				12475		13988
	IDENTITY	26%		28%				100%		26%
	COVERAGE	97%		95%				100%		97%
SAU102614	SeqID	10211	10600					12476		13927
	IDENTITY	33%	55%					100%		32%
	COVERAGE	89%	100%					100%		89%
SAU102615	SeqID	10234	10601			11720	12098	12477		13926
	IDENTITY	32%	40%			32%	26%	100%		31%
	COVERAGE	98%	100%			92%	87%	100%		100%
SAU102620	SeqID							12479
	IDENTITY							100%
	COVERAGE							100%
SAU102621	SeqID	10288	10519			11724		12480	13370	13881
	IDENTITY	61%	62%			58%		100%	59%	61%
	COVERAGE	100%	101%			81%		100%	101%	100%
SAU102629	SeqID		10885					12481
	IDENTITY		26%					100%
	COVERAGE		108%					100%
SAU102631	SeqID		10522			11657	11841	12712
	IDENTITY		27%			44%	32%	100%
	COVERAGE		83%			83%	81%	100%
SAU102636	SeqID							12650	13696
	IDENTITY							100%	29%
	COVERAGE							100%	102%
SAU102637	SeqID							12651	13697
	IDENTITY							100%	39%
	COVERAGE							100%	98%
SAU102652	SeqID							12653
	IDENTITY							100%
	COVERAGE							101%
SAU102658	SeqID	10283	10910	11064			12090	12654	13514	13855
	IDENTITY	45%	54%	42%			39%	100%	49%	41%
	COVERAGE	97%	92%	97%			97%	100%	96%	100%
SAU102663	SeqID	10304	10840	11043	11626		11798	12158	13172	13780
	IDENTITY	43%	58%	44%	34%		45%	100%	56%	41%
	COVERAGE	99%	99%	96%	95%		91%	100%	97%	99%
SAU102669	SeqID	10022	10756	11257			12045	12160	13371	14035
	IDENTITY	42%	26%	43%			41%	100%	54%	41%
	COVERAGE	96%	91%	95%			94%	100%	95%	93%
SAU102671	SeqID	10409		11079	11319	11683	12043	12161	13373	14033
	IDENTITY	34%		32%	44%	35%	56%	100%	69%	33%
	COVERAGE	91%		91%	96%	74%	99%	100%	96%	91%
SAU102674	SeqID	10020		11164		11648	5127	12156		14016
	IDENTITY	55%		54%		46%	55%	100%		53%
	COVERAGE	102%		103%		101%	105%	101%		102%
SAU102693	SeqID	10178	10659		11474		11883	12627	13301	13940
	IDENTITY	53%	74%		38%		49%	100%	61%	49%
	COVERAGE	82%	87%		86%		86%	101%	90%	72%
SAU102694	SeqID	10177	10660	11222	11296		5120	12628	13302
	IDENTITY	48%	66%	50%	44%		55%	100%	60%
	COVERAGE	97%	102%	97%	94%		94%	102%	102%
SAU102725	SeqID	10418	10514	11137	11507		12088	12338	13378	13789
	IDENTITY	40%	72%	39%	38%		37%	100%	66%	40%
	COVERAGE	96%	100%	96%	103%		104%	100%	100%	96%
SAU102764	SeqID	10179	10929	11234	11295		11884	12625	13484	13938
	IDENTITY	44%	67%	42%	41%		42%	100%	63%	43%
	COVERAGE	99%	99%	99%	90%		97%	100%	99%	99%
SAU102812	SeqID		10860				12127	13253
	IDENTITY		48%				100%	49%
	COVERAGE		100%				101%	96%
SAU102870	SeqID	10113	10880					12170	13270	14008
	IDENTITY	29%	35%					100%	29%	28%
	COVERAGE	92%	83%					100%	93%	87%
SAU102880	SeqID	10360	10533	11096	11443	11643	5177	12224	13196	13975
	IDENTITY	60%	82%	61%	57%	61%	58%	100%	85%	61%
	COVERAGE	100%	101%	100%	97%	100%	100%	101%	101%	100%
SAU102881	SeqID	10357	10551	11099			11994	12242	13199	13972
	IDENTITY	38%	69%	37%			38%	100%	54%	38%
	COVERAGE	89%	98%	89%			89%	101%	102%	89%
SAU102883	SeqID	10396		11168	11449		12118	12702	13181
	IDENTITY	63%		70%	60%		65%	100%	76%
	COVERAGE	86%		88%	86%		86%	102%	90%
SAU102905	SeqID		10732	11217	11373			12273
	IDENTITY		31%	26%	38%			100%
	COVERAGE		92%	80%	87%			100%
SAU102909	SeqID	10042	10488	11150	11457	11637	11940	12315	13437	13908
	IDENTITY	59%	68%	60%	69%	59%	60%	100%	73%	59%
	COVERAGE	95%	95%	95%	130%	95%	98%	101%	124%	95%
SAU102933	SeqID	10448	10949	10995	11579	11762	11985	12412	13502	13817
	IDENTITY	33%	53%	35%	32%	31%	29%	100%	50%	31%
	COVERAGE	104%	113%	101%	108%	107%	101%	101%	101%	103%
SAU102936	SeqID	10236	10872				11804	12356		13955
	IDENTITY	33%	66%				60%	100%		33%
	COVERAGE	97%	100%				96%	101%		98%
SAU102942	SeqID	10136	10492	11230		11696		12296	13339	13834
	IDENTITY	52%	55%	43%		50%		100%	51%	51%
	COVERAGE	100%	100%	99%		99%		100%	99%	99%
SAU102944	SeqID							12468	13257
	IDENTITY							100%	42%
	COVERAGE							100%	99%
SAU102979	SeqID	10014		10979	11384		11936	12536	13429	13712
	IDENTITY	33%		37%	32%		41%	100%	33%	33%
	COVERAGE	88%		87%	87%		87%	100%	87%	90%
SAU102983	SeqID		10883					12676	13269
	IDENTITY		28%					100%	27%
	COVERAGE		70%					100%	76%
SAU102992	SeqID	10176	10661	11223	11297		11882	12630	13303	13941
	IDENTITY	62%	70%	62%	48%		59%	100%	63%	61%
	COVERAGE	99%	92%	99%	97%		99%	101%	99%	101%
SAU103010	SeqID							12194
	IDENTITY							100%
	COVERAGE							100%
SAU103024	SeqID					11670	12042	12200
	IDENTITY					44%	26%	100%
	COVERAGE					89%	72%	101%
SAU103025	SeqID							12202
	IDENTITY							100%
	COVERAGE							100%
SAU103037	SeqID		10867					12613	13267
	IDENTITY		27%					100%	26%
	COVERAGE		99%					101%	86%
SAU103077	SeqID							12408
	IDENTITY							100%
	COVERAGE							100%
SAU103115	SeqID							12508	13469
	IDENTITY							100%	32%
	COVERAGE							101%	101%
SAU103	144	SeqID		10936					12663
	IDENTITY		42%					100%
	COVERAGE		84%					100%
SAU103159	SeqID	10110	10783	11134	11489		11787	12670	13411	13994
	IDENTITY	43%	48%	38%	48%		48%	100%	63%	43%
	COVERAGE	115%	100%	112%	117%		98%	100%	101%	116%
SAU103169	SeqID							12678	13239
	IDENTITY							100%	34%
	COVERAGE							100%	84%
SAU103175	SeqID	10157						12687
	IDENTITY	36%						100%
	COVERAGE	96%						100%
SAU103191	SeqID							12465	13332
	IDENTITY							100%	42%
	COVERAGE							102%	75%
SAU103204	SeqID							12499
	IDENTITY							100%
	COVERAGE							101%
SAU103226	SeqID							12713
	IDENTITY							100%
	COVERAGE							100%
SAU103232	SeqID	10368				11704	11848	12697		13803
	IDENTITY	36%				35%	48%	100%		35%
	COVERAGE	102%				98%	101%	101%		102%
SAU200006	SeqID	10033	10639	11192	11553		12007	12723	13479
	IDENTITY	53%	70%	47%	43%		50%	100%	65%
	COVERAGE	78%	80%	84%	82%		89%	100%	77%
SAU200028	SeqID							12694
	IDENTITY							100%
	COVERAGE							100%
SAU200030	SeqID	10372	10553	11056	11447	11672	12092	12745	13449	13807
	IDENTITY	42%	74%	39%	43%	41%	35%	100%	73%	42%
	COVERAGE	84%	98%	84%	93%	86%	93%	102%	95%	84%
SAU200058	SeqID		10621					12719	13327
	IDENTITY		39%					100%	37%
	COVERAGE		79%					101%	78%
SAU200059	SeqID	10259	10622	10978			12026	12720	13325	14087
	IDENTITY	31%	33%	32%			36%	100%	40%	31%
	COVERAGE	73%	97%	73%			74%	100%	96%	73%
SAU200088	SeqID	10262		10984	11403		11947	12724	13415	14090
	IDENTITY	51%		56%	57%		45%	100%	68%	49%
	COVERAGE	82%		91%	93%		93%	102%	100%	82%
SAU200242	SeqID		10712					12734
	IDENTITY		28%					100%
	COVERAGE		99%					100%
SAU200297	SeqID	10109	10756	11257			11982	12739	13371	13996
	IDENTITY	33%	64%	34%			33%	100%	33%	32%
	COVERAGE	95%	100%	98%			95%	100%	95%	95%
SAU200345	SeqID							12751
	IDENTITY							100%
	COVERAGE							100%
SAU200392	SeqID	10164	10584	10968	11566		11912	12755		13892
	IDENTITY	26%	30%	25%	27%		33%	100%		26%
	COVERAGE	97%	80%	96%	98%		93%	100%		98%
SAU200468	SeqID	10201	10478	11054		12061	12937	13425	13822
	IDENTITY	78%	75%	62%		36%	100%	76%	78%
	COVERAGE	74%	75%	74%		81%	101%	75%	74%
SAU200558	SeqID	10039	10728	11277			12046	12777	13423	13904
	IDENTITY	28%	31%	26%			30%	100%	32%	29%
	COVERAGE	72%	102%	80%			75%	100%	99%	72%
SAU200561	SeqID							12693
	IDENTITY							100%
	COVERAGE							100%
SAU200564	SeqID	10099		11170	11602	11645	11788	12780		13992
	IDENTITY	33%		31%	31%	34%	32%	100%		34%
	COVERAGE	87%		87%	82%	86%	93%	100%		87%
SAU200565	SeqID	10098		11250	11386		11786	12781		13991
	IDENTITY	32%		34%	35%		39%	100%		33%
	COVERAGE	97%		96%	98%		97%	100%		97%
SAU200593	SeqID	10435	10613	11038	11412		11998	12784	13397	14046
	IDENTITY	53%	73%	50%	53%		52%	100%	64%	52%
	COVERAGE	99%	100%	99%	98%		100%	100%	99%	99%
SAU200628	SeqID	10173	10856					12790	13297	13937
	IDENTITY	32%	31%					100%	29%	34%
	COVERAGE	92%	97%					100%	97%	94%
SAU200685	SeqID							12801	13185
	IDENTITY							100%	31%
	COVERAGE							100%	94%
SAU200721	SeqID	10208	10582	11015	11541			12797	13681	13922
	IDENTITY	40%	33%	41%	36%			100%	42%	41%
	COVERAGE	92%	79%	99%	94%			100%	100%	94%
SAU200725	SeqID	10118	10761	10966			11780	12933	13632	14020
	IDENTITY	30%	46%	30%			25%	100%	47%	29%
	COVERAGE	98%	100%	97%			98%	100%	100%	98%
SAU200731	SeqID	10283	10822	11064			12090	12342	13514	13855
	IDENTITY	55%	54%	44%			43%	100%	51%	46%
	COVERAGE	99%	100%	98%			98%	100%	100%	99%
SAU200740	SeqID	10318	10554	11225	11393		12056	12798	13695	13760
	IDENTITY	48%	56%	48%	49%		50%	100%	55%	48%
	COVERAGE	86%	102%	86%	73%		87%	100%	93%	86%
SAU200752	SeqID							12809
	IDENTITY							100%
	COVERAGE							100%
SAU200914	SeqID	10383	10714			11747	11927	12837	13431	13788
	IDENTITY	26%	28%			27%	27%	100%	25%	25%
	COVERAGE	96%	98%			79%	90%	100%	91%	90%
SAU200916	SeqID							12838
	IDENTITY							100%
	COVERAGE							100%
SAU200928	SeqID	10439	10627	11036	11571		5179	12815	13646	14042
	IDENTITY	54%	73%	55%	53%		49%	100%	69%	54%
	COVERAGE	86%	99%	87%	86%		102%	100%	100%	86%
SAU200934	SeqID	10212	10780				11964	12842		13835
	IDENTITY	44%	60%				42%	100%		42%
	COVERAGE	72%	93%				82%	100%		88%
SAU200949	SeqID							12846
	IDENTITY							100%
	COVERAGE							100%
SAU200960	SeqID				11500		11886	12431
	IDENTITY				42%		33%	100%
	COVERAGE				70%		91%	102%
SAU200994	SeqID	10036	10497	11270			11865	12935	13310	14054
	IDENTITY	36%	62%	32%			37%	100%	35%	33%
	COVERAGE	100%	101%	100%			102%	100%	73%	99%
SAU201	167	SeqID		10779					12887
	IDENTITY		37%					100%
	COVERAGE		98%					100%
SAU201168	SeqID		10819					12889	13626
	IDENTITY		53%					100%	56%
	COVERAGE		102%					100%	100%
SAU201184	SeqID	10448	10715	10995	11579		11985	12807	13502	13819
	IDENTITY	40%	52%	35%	37%		37%	100%	53%	32%
	COVERAGE	70%	108%	97%	82%		70%	101%	111%	111%
SAU201197	SeqID	10330	10924	11160	11321		5215	12938	13364	13885
	IDENTITY	58%	66%	60%	53%		58%	100%	63%	58%
	COVERAGE	99%	99%	99%	98%		99%	101%	96%	99%
SAU201225	SeqID		10812	11090				12896	13170
	IDENTITY		41%	33%				100%	38%
	COVERAGE		93%	80%				100%	87%
SAU201236	SeqID	10026	10679	11184	11613		12013	12891	13505	14073
	IDENTITY	32%	29%	33%	33%		34%	100%	30%	32%
	COVERAGE	92%	96%	93%	89%		95%	100%	95%	90%
SAU201301	SeqID							12899
	IDENTITY							100%
	COVERAGE							100%
SAU201333	SeqID	10192				11678		12905		13753
	IDENTITY	41%				28%		100%		41%
	COVERAGE	100%				96%		101%		100%
SAU201375	SeqID						11929	12926
	IDENTITY						36%	100%
	COVERAGE						95%	100%
SAU201380	SeqID	10379	10499		11313		12024	12922		13801
	IDENTITY	34%	25%		26%		25%	100%		25%
	COVERAGE	94%	93%		95%		89%	100%		101%
SAU201381	SeqID	10241	10597	10974	11387	11706	11833	12923	13387	13878
	IDENTITY	68%	59%	46%	44%	56%	57%	100%	52%	64%
	COVERAGE	89%	96%	90%	91%	89%	100%	104%	92%	89%
SAU201403	SeqID							12913
	IDENTITY							100%
	COVERAGE							100%
SAU201469	SeqID							12967
	IDENTITY							100%
	COVERAGE							100%
SAU201486	SeqID							13023
	IDENTITY							100%
	COVERAGE							100%
SAU201506	SeqID	10145					11963	12946		13841
	IDENTITY	49%					49%	100%		50%
	COVERAGE	101%					102%	100%		100%
SAU201508	SeqID	10370					11874	12947		13805
	IDENTITY	37%					42%	100%		36%
	COVERAGE	73%					72%	100%		73%
SAU201513	SeqID	10229						12944
	IDENTITY	29%						100%
	COVERAGE	71%						101%
SAU201539	SeqID	10109		11257			5099	12943	13625	13996
	IDENTITY	33%		28%			34%	100%	32%	33%
	COVERAGE	95%		96%			96%	100%	97%	95%
SAU201541	SeqID	10131	10500			11673	11951	12942	13474
	IDENTITY	50%	39%			33%	41%	100%	41%
	COVERAGE	71%	74%			77%	73%	100%	73%
SAU201558	SeqID	10112		11258	11396		11875	12954	13598	14009
	IDENTITY	51%		51%	43%		49%	100%	46%	51%
	COVERAGE	96%		94%	94%		99%	101%	96%	96%
SAU201571	SeqID	10224	10951	11213	11357		11905	12997	13268	13957
	IDENTITY	50%	61%	47%	50%		45%	100%	54%	49%
	COVERAGE	98%	94%	99%	92%		103%	100%	70%	98%
SAU201611	SeqID				11539		11902	12973	13243
	IDENTITY				38%		48%	100%	58%
	COVERAGE				73%		99%	100%	95%
SAU201615	SeqID						11962	12972
	IDENTITY						40%	100%
	COVERAGE						72%	100%
SAU201621	SeqID	10038	10842		11392	11707	12047	12662		13902
	IDENTITY	49%	53%		42%	49%	47%	100%		46%
	COVERAGE	91%	91%		91%	91%	91%	101%		91%
SAU201654	SeqID							12982
	IDENTITY							100%
	COVERAGE							101%
SAU201666	SeqID	10291	10900	11028	11557	11761	11811	12981		13743
	IDENTITY	33%	29%	35%	31%	32%	34%	100%		33%
	COVERAGE	71%	80%	71%	76%	79%	73%	100%		71%
SAU201752	SeqID		10623					12963	13689
	IDENTITY		45%					100%	40%
	COVERAGE		89%					100%	92%
SAU201765	SeqID							12770
	IDENTITY							100%
	COVERAGE							100%
SAU20	1773	SeqID							12996
	IDENTITY							100%
	COVERAGE							100%
SAU20	1775	SeqID							12996
	IDENTITY							100%
	COVERAGE							100%
SAU201810	SeqID							12769
	IDENTITY							100%
	COVERAGE							100%
SAU201827	SeqID	10258	10783	11134	11310		11787	13002	13411	14088
	IDENTITY	38%	46%	41%	41%		45%	100%	63%	39%
	COVERAGE	108%	100%	100%	104%		88%	100%	101%	108%
SAU201929	SeqID							13008
	IDENTITY							100%
	COVERAGE							100%
SAU20	1952	SeqID							13020
	IDENTITY							100%
	COVERAGE							100%
SAU201971	SeqID							13015
	IDENTITY							100%
	COVERAGE							101%
SAU202006	SeqID							13018
	IDENTITY							100%
	COVERAGE							100%
SAU202039	SeqID				11359			13009	13374
	IDENTITY				44%			100%	48%
	COVERAGE				96%			101%	98%
SAU202126	SeqID	10261	10874	10983	11561		11946	12714	13417	14085
	IDENTITY	51%	50%	52%	33%		46%	100%	58%	52%
	COVERAGE	94%	94%	91%	84%		93%	101%	94%	94%
SAU202174	SeqID							12895
	IDENTITY							100%
	COVERAGE							101%
SAU202	176	SeqID							12895
	IDENTITY							100%
	COVERAGE							101%
SAU202186	SeqID	10062						12731
	IDENTITY	28%						100%
	COVERAGE	73%						101%
SAU202267	SeqID							12727
	IDENTITY							100%
	COVERAGE							100%
SAU202708	SeqID	10428	10913					12855		13735
	IDENTITY	25%	28%					100%		25%
	COVERAGE	86%	84%					100%		86%
SAU202736	SeqID	10148	10902	11181	11494	11677	11857	12927	13248	13844
	IDENTITY	39%	40%	37%	40%	37%	38%	100%	38%	39%
	COVERAGE	95%	93%	98%	91%	80%	93%	100%	103%	95%
SAU202756	SeqID	10436	10614	11071			5181	13027	13246	14045
	IDENTITY	44%	63%	47%			44%	100%	53%	40%
	COVERAGE	97%	92%	86%			92%	100%	91%	97%
SAU202781	SeqID							12718
	IDENTITY							100%
	COVERAGE							100%
SAU202872	SeqID		10656					12866	13670
	IDENTITY		45%					100%	28%
	COVERAGE		101%					100%	98%
SAU202882	SeqID							12848
	IDENTITY							100%
	COVERAGE							101%
SAU202930	SeqID							12871
	IDENTITY							100%
	COVERAGE							100%
SAU202945	SeqID							12868
	IDENTITY							100%
	COVERAGE							100%
SAU202968	SeqID							12886
	IDENTITY							100%
	COVERAGE							100%
SAU203001	SeqID							12894
	IDENTITY							100%
	COVERAGE							100%
SAU203007	SeqID							12893
	IDENTITY							100%
	COVERAGE	100%
SAU203196	SeqID							12945
	IDENTITY							100%
	COVERAGE								101%
SAU203293	SeqID							12979
	IDENTITY							100%
	COVERAGE							101%
SAU203296	SeqID				11330			12263
	IDENTITY				29%			100%
	COVERAGE				88%			101%
SAU203524	SeqID							12957
	IDENTITY							100%
	COVERAGE							100%
SAU300110	SeqID	10054	10544			11662		13031	13441
	IDENTITY	33%	38%			33%		100%	30%
	COVERAGE	82%	109%			73%		102%	109%
SAU300131	SeqID	10344	10529	11112	11434		5164	13034	13213	14103
	IDENTITY	45%	71%	44%	52%		47%	100%	60%	44%
	COVERAGE	100%	99%	100%	99%		99%	101%	99%	100%
SAU300156	SeqID							13036
	IDENTITY							100%
	COVERAGE							100%
SAU300191	SeqID		10562		11519		11844	12367	13522
	IDENTITY		43%		39%		32%	100%	41%
	COVERAGE		103%		91%		72%	101%	104%
SAU300572	SeqID				11522			12717
	IDENTITY				32%			100%
	COVERAGE				108%			100%
SAU300617	SeqID		10851					12513	13289
	IDENTITY		50%					100%	49%
	COVERAGE		97%					100%	97%
SAU300713	SeqID		10767				11823	13058
	IDENTITY		26%				30%	100%
	COVERAGE		83%				93%	100%
SAU300719	SeqID	10468	10611	11246	11380	11644	11887	12987	13456	13726
	IDENTITY	46%	34%	34%	30%	30%	40%	100%	33%	34%
	COVERAGE	100%	87%	101%	94%	101%	100%	101%	96%	100%
SAU300732	SeqID	10282	10682					13061	13394
	IDENTITY	26%	51%					100%	49%
	COVERAGE	71%	88%					100%	86%
SAU300825	SeqID		10655					13068	13671
	IDENTITY		52%					100%	41%
	COVERAGE		97%					100%	97%
SAU300975	SeqID		10604					12203
	IDENTITY		30%					100%
	COVERAGE		72%					102%
SAU300998	SeqID		10820					13077	13489
	IDENTITY		40%					100%	40%
	COVERAGE		99%					102%	99%
SAU301004	SeqID		10744					13079
	IDENTITY		40%					100%
	COVERAGE		101%					100%
SAU301030	SeqID							13080
	IDENTITY							100%
	COVERAGE							100%
SAU301080	SeqID							13083
	IDENTITY							100%
	COVERAGE							100%
SAU301118	SeqID	10242	10808	11092		11653		12904		13795
	IDENTITY	47%	58%	48%		53%		100%		48%
	COVERAGE	98%	98%	91%		78%		100%		96%
SAU301133	SeqID		10898					13087	13443
	IDENTITY		39%					100%	30%
	COVERAGE		96%						100%	93%
SAU301223	SeqID	10297	10640	10964	11323		11783	13090	13664	13737
	IDENTITY	31%	50%	31%	32%		34%	100%	48%	32%
	COVERAGE	104%	99%	102%	90%		102%	100%	98%	104%
SAU301230	SeqID	10252	10877	11010		11669	11956	13092	13506	13704
	IDENTITY	52%	52%	63%		52%	59%	100%	59%	52%
	COVERAGE	95%	92%	74%		95%	77%	100%	92%	95%
SAU301268	SeqID							13102
	IDENTITY							100%
	COVERAGE							100%
SAU301275	SeqID	10048	10926	11014	11511		11934	13103	13366	13897
	IDENTITY	54%	47%	55%	50%		53%	100%	46%	54%
	COVERAGE	99%	84%	97%	97%		97%	101%	84%	99%
SAU301357	SeqID		10696	11063		11766		12859	13354
	IDENTITY		74%	32%		33%		100%	76%
	COVERAGE		98%	80%		93%		101%	100%
SAU301433	SeqID							12845	13393
	IDENTITY							100%	26%
	COVERAGE							100%	91%
SAU301465	SeqID	10210	10663	11214	11554		11921	13013	13418	13925
	IDENTITY	29%	54%	32%	37%		28%	100%	52%	29%
	COVERAGE	100%	104%	104%	100%		101%	100%	103%	102%
SAU301472	SeqID	10157						12925
	IDENTITY	36%						100%
	COVERAGE	85%						100%
SAU301592	SeqID							13137
	IDENTITY							100%
	COVERAGE							100%
SAU301620	SeqID							13140
	IDENTITY							100%
	COVERAGE							100%
SAU301758	SeqID							13156
	IDENTITY							100%
	COVERAGE							100%
SAU301773	SeqID							12729
	IDENTITY							100%
	COVERAGE							100%
SAU301829	SeqID	10107			11309		11857	13162	13248	13935
	IDENTITY	45%			40%		42%	100%	38%	41%
	COVERAGE	98%			97%		96%	100%	106%	99%
SAU301869	SeqID		10732		11373			12903
	IDENTITY		30%		36%			100%
	COVERAGE		80%		95%			100%
SAU301898	SeqID		10932					13057
	IDENTITY		27%					100%
	COVERAGE		71%					100%
SAU302060	SeqID							13042
	IDENTITY							100%
	COVERAGE							100%
SAU302513	SeqID							12851
	IDENTITY							100%
	COVERAGE							100%
SAU302626	SeqID							13105
	IDENTITY							100%
	COVERAGE							100%
SAU302685	SeqID							13113
	IDENTITY							100%
	COVERAGE							100%
SAU302698	SeqID							12725
	IDENTITY							100%
	COVERAGE							100%
SAU302699	SeqID							13115
	IDENTITY							100%
	COVERAGE							100%
SAU302805	SeqID				11345		13133
	IDENTITY				33%		100%
	COVERAGE				75%		101%
SAU302901	SeqID							12872
	IDENTITY							100%
	COVERAGE							100%
SAU30293	1	SeqID							13155
	IDENTITY							100%
	COVERAGE							100%
SAU302950	SeqID							12664
	IDENTITY							100%
	COVERAGE							101%
SAU302956	SeqID	10023		11256		11742	12044	12930	13372	14018
	IDENTITY	32%		28%		31%	26%	100%	31%	32%
	COVERAGE	88%		88%		88%	86%	101%	88%	88%
ECO100078	SeqID	10023		11256		11742	12044		13595	14018
	IDENTITY	100%		66%		95%	65%		41%	97%
	COVERAGE	100%		98%		100%	99%		97%	100%
ECO100252	SeqID	10052			11503		12078	12626		13932
	IDENTITY	100%			41%		48%	38%		40%
	COVERAGE	100%			99%		96%	93%		93%
ECO100397	SeqID	10064	10781	10993	11499		11959	12884	13614	13915
	IDENTITY	100%	50%	71%	38%		71%	45%	47%	94%
	COVERAGE	100%	96%	100%	97%		97%	97%	97%	99%
ECO100398	SeqID	10065	10653	10992	11311		11958	12883	13177	13916
	IDENTITY	100%	53%	81%	46%		71%	57%	50%	98%
	COVERAGE	100%	95%	101%	98%		99%	95%	95%	100%
ECO100990	SeqID	10120				11768
	IDENTITY	100%				72%
	COVERAGE	100%				82%
ECO102108	SeqID	10214	10608	11129		11757	11852		13627	13931
	IDENTITY	100%	36%	74%		94%	36%		36%	96%
	COVERAGE	100%	96%	100%		100%	97%		97%	73%
ECO102262	SeqID	10228		11204		11631	12038	13132		13963
	IDENTITY	100%		42%		86%	51%	35%		87%
	COVERAGE	100%		100%		81%	100%	100%		100%
ECO102447	SeqID	10247					11812			13948
	IDENTITY	100%					47%			99%
	COVERAGE	100%					93%			96%
ECO102539	SeqID	10258	10628	11134	11489		5192	12526	13636	14088
	IDENTITY	100%	46%	77%	48%		71%	52%	47%	97%
	COVERAGE	100%	101%	100%		100%	100%	100%	82%	100%
ECO102620	SeqID	10266	10510	11269	11524		11819	12915	13279	14049
	IDENTITY	100%	51%	26%	30%		28%	42%	49%	89%
	COVERAGE	100%	93%	80%	94%		91%	96%	101%	99%
ECO103101	SeqID	10315	10763	11215	11615	11716	12052		13662	13764
	IDENTITY	100%	37%	73%	26%	96%	64%		33%	94%
	COVERAGE	100%	74%	100%	76%	100%	100%		74%	101%
ECO104120	SeqID	10462	10609	11034		11726	11853			13887
	IDENTITY	100%	29%	34%		87%	28%			37%
	COVERAGE	100%	79%	89%		100%	89%			92%
ECO104268	SeqID	10475	10607					12370	13166	13707
	IDENTITY	100%	43%					43%	38%	95%
	COVERAGE	100%	92%					99%	92%100%
KPN100432	SeqID	10258	10736	11134	11310	11628	5192	12789	13636	14088
	IDENTITY	90%	37%	62%	37%	100%	62%	41%	47%	92%
	COVERAGE	100%	97%	100%	93%	101% 97%	86%	87%101%
KPN100854	SeqID	10086	10652	11197	11565	11630	11862		13389	14060
	IDENTITY	35%	29%	26%	27%	100%	42%		32%	35%
	COVERAGE	74%	72%	72%	85%	100% 77%		71%	74%
KPN101022	SeqID	10475	10607			11642		12370	13166	13707
	IDENTITY	90%	29%			100%		27%	26%	91%
	COVERAGE	100%	77%			101%		101%	79%101%
KPN101026	SeqID	10228		11204		11631	12038	13132		13963
	IDENTITY	86%		44%		100%	54%	37%		85%
	COVERAGE	99%		97%		100% 98%	99%		99%
KPN101729	SeqID	11045	11467	11647	12067	13032
	IDENTITY	50%	50%	100%	63%	63%
	COVERAGE	96%	96%	102% 96%	96%
KPN101750	SeqID	10052			11503	11652	12078	12626		13918
	IDENTITY	94%			38%	100%	47%	37%		34%
	COVERAGE	100%			103%	100% 100%	96%		100%
KPN102057	SeqID	10406	10892	11035		11661	11854	13153		13883
	IDENTITY	29%	30%	30%		100%	27%	28%		29%
	COVERAGE	96%	96%	84%		100%	97%	85%		96%
KPN102638	SeqID	10266	10510		11524	11667		12915	13557	14049
	IDENTITY	77%	51%		29%	100%		44%	50%	77%
	COVERAGE	79%	79%		83%	100%		80%	79%	79%
KPN103882	SeqID	10315	10763	11215	11454	11716	12052		13662	13764
	IDENTITY	96%	38%	73%	26%	100%	65%		33%	93%
	COVERAGE	100%	74%	100%	77%	100%	100%		74%	101%
KPN104183	SeqID	10065	10653	10992	11490	11650	11958	12883	13177	13916
	IDENTITY	97%	56%	80%	46%	100%	80%	60%	55%	98%
	COVERAGE	85%	74%	89%	86%	100%	85%	74%	74%	85%
KPN104281	SeqID	10023		11256		11742	12044		13595	14018
	IDENTITY	95%		68%		100%	66%		41%	95%
	COVERAGE	94%		92%		101%	94%		91%	101%
KPN104538	SeqID	10462	10609	11034		11726	11853			13887
	IDENTITY	87%	27%	35%		100%	29%			38%
	COVERAGE	100%	87%	89%		100%	89%			94%
KPN104716	SeqID	10214	10608	11129		1175711852		13627	13931
	IDENTITY	94%	36%	75%		100%	36%		35%	94%
	COVERAGE	100%	96%	100%		100%	97%		97%	73%
KPN105779	SeqID					11770	12103
	IDENTITY					100%	28%
	COVERAGE					101%	99%
KPN106659	SeqID	10064	10781	10993		116491	1959	12884	13614	13915
	IDENTITY	90%	58%	72%		100%	74%	51%	58%	91%
	COVERAGE	80%	70%	75%		101%	74%	72%	70%	81%
KPN106840	SeqID	10259	10857	10978		11664	12026	12182	13691	14087
	IDENTITY	91%	44%	74%		100%	55%	38%	42%	91%
	COVERAGE	100%	101%	98%		100%	99%	94%	92%	100%
KPN107776	SeqID	10222		11132		11771	11810			13936
	IDENTITY	78%		37%		100%	35%			80%
	COVERAGE	98%		89%		102%	87%			98%
SAU100968	SeqID	10064	10781	10993	11499		11959	12643	13614	13915
	IDENTITY	45%	62%	44%	36%		46%	100%	62%	46%
	COVERAGE	97%	97%	100%	99%		97%	100%	98%	97%
SAU201145	SeqID	10064	10781	10993	11499		11959	12884	13614	13915
	IDENTITY	45%	62%	44%	36%		46%	100%	62%	46%
	COVERAGE	97%	97%	100%	99%		97%	100%	98%	97%
SPN101971	SeqID	10064	10781	10993	11499		11959	12884	13287	13915
	IDENTITY	46%	77%	42%	36%		48%	62%	100%	46%
	COVERAGE	100%	99%	102%	100%		100%	99%	100%	100%
SPN201024	SeqID	10064	10781	10993	11499		11959	12884	13614	13915
	IDENTITY	46%	77%	43%	36%		49%	62%	100%	46%
	COVERAGE	99%	99%	102%	101%		99%	99%	100%	99%
STY000277	SeqID	10475	10607					1237013166	13707
	IDENTITY	95%	44%					42%	38%	100%
	COVERAGE	100%	91%					99%	96%100%
STY000625	SeqID	10421								13784
	IDENTITY	93%								100%
	COVERAGE	100%								101%
STY000773	SeqID	10315	10763	11215	11454	11716	12052		13662	13764
	IDENTITY	94%	36%	71%	26%	93%	62%		31%	100%
	COVERAGE	100%	74%	100%	77%	100%	100%		74%	100%
STY001430	SeqID	10064	10781	10993	11499		11959	1288413614	13915
	IDENTITY	94%	49%	70%	37%		70%	46%	47%	100%
	COVERAGE	100%	96%	101%	98%		98%	97%	98%	100%
STY001433	SeqID	10065	10653	10992	11311		11958	12883	13177	13916
	IDENTITY	98%	53%	82%	46%		72%	58%	50%	100%
	COVERAGE	99%	94%	100%	97%		99%	94%	94%	100%
STY001867	SeqID	10247					11812			13948
	IDENTITY	99%					47%			100%
	COVERAGE	98%					96%			100%
STY002995	SeqID	10023		11256		11742	12044		13595	14018
	IDENTITY	97%		67%		95%	65%		40%	100%
	COVERAGE	94%		92%		101%	94%		91%	101%
STY003357	SeqID	10228		11204		11631	12038	13132		13963
	IDENTITY	87%		42%		85%	49%	36%		100%
	COVERAGE	100%		100%		81%	101%	100%		100%
PA0028	SeqID						5053
	COVERAGE						100%
	IDENTITY						100%
PA0120	SeqID	10386		10959			5054			13899
	COVERAGE	96%		94%			100%			95%
	IDENTITY	28%		28%			100%			28%
PA0129	SeqID	10265			11388		5055	12844		14048
	COVERAGE	93%			91%		100%	94%		91%
	IDENTITY	67%			32%		100%	36%		67%
PA0141	SeqID						5056
	COVERAGE						100%
	IDENTITY						100%
PA0221	SeqID			11250	11386	11701	5057	12781		13778
	COVERAGE			73%	77%	83%	100%	96%		77%
	IDENTITY			32%	26%	28%	100%	28%		29%
PA0265	SeqID	10264	10550		11466		5058	12375	13316	14047
	COVERAGE	100%	97%		99%		100%	96%	91%	100%
	IDENTITY	81%	35%		26%		100%	38%	34%	80%
PA0321	SeqID						5059
	COVERAGE						100%
	IDENTITY						100%
PA0337	SeqID	10278	10785	11275			5060	12351	13281	13880
	COVERAGE	99%	73%	72%			100%	72%	73%	99%
	IDENTITY	43%	35%	37%			100%	36%	35%	42%
PA0353	SeqID	10408	11088		11397	11749	5061	12159	13511	14034
	COVERAGE	97%		100%	88%	101%	100%	100%	96%	101%
	IDENTITY	74%		75%	28%	74%100%	45%	38%	74%
PA0378	SeqID	10324		11130			5062			13730
	COVERAGE	94%		80%			100%			95%
	IDENTITY	52%		49%			100%			53%
PA0401	SeqID	10078	10858				5063	12993	13560	13723
	COVERAGE	99%	100%				100%	96%	100%	99%
	IDENTITY	26%	31%				100%	33%	33%	26%
PA0413	SeqID						5064
	COVERAGE						100%
	IDENTITY						100%
PA0414	SeqID						5065
	COVERAGE						100%
	IDENTITY						100%
PA0419	SeqID	10296	10871	11003		11660	5066	12971	13461	13738
	COVERAGE	100%	93%	102%		78%	100%	100%	91%	100%
	IDENTITY	46%	29%	45%		47%	100%	27%	29%	47%
PA0423	SeqID	10123			11424		5067	12708		14038
	COVERAGE	99%			97%		100%	75%		99%
	IDENTITY	75%			32%		100%	32%		76%
PA0469	SeqID						5068
	COVERAGE						100%
	IDENTITY						100%
PA0472	SeqID	10471					5069
	COVERAGE	88%					100%
	IDENTITY	47%					100%
PA0506	SeqID						5070
	COVERAGE						100%
	IDENTITY						100%
PA0600	SeqID						5071
	COVERAGE						100%
	IDENTITY						100%
PA0642	SeqID						5072
	COVERAGE						100%
	IDENTITY						100%
PA0650	SeqID	10150		11237	11581		5073	12153	13459	13846
	COVERAGE	95%		83%	93%		100%	76%	95%	95%
	IDENTITY	38%		38%	35%		100%	34%	38%	39%
PA0715	SeqID						5074
	COVERAGE						100%
	IDENTITY						100%
PA0788	SeqID						5075
	COVERAGE						100%
	IDENTITY							100%
PA0882	SeqID	10233					5076			14013
	COVERAGE	85%					100%			101%
	IDENTITY	33%					100%			28%
PA0934	SeqID	10276	10876	11006		11753	5077	12646	13483
	COVERAGE	101%	93%	101%		80%	100%	92%	94%
	IDENTITY	47%	40%	46%		37%	100%	39%	38%
PA0938	SeqID						5078
	COVERAGE						100%
	IDENTITY							100%
PA1019	SeqID	10467	10592	11180			5079
	COVERAGE	88%	84%	88%			100%
	IDENTITY	26%	25%	28%			100%
PA1072	SeqID	10377					5080		13410	13813
	COVERAGE	100%					100%		71%	100%
	IDENTITY	62%					100%		36%	61%
PA1115	SeqID						5081
	COVERAGE						100%
	IDENTITY						100%
PA1270	SeqID	10328				11751	5082			13946
	COVERAGE	76%				79%	100%			76%
	IDENTITY	26%				25%	100%			26%
PA1301	SeqID	10470					5083
	COVERAGE	96%					100%
	IDENTITY	28%					100%
PA1360	SeqID	10104					5084		13282	14000
	COVERAGE	92%					100%		97%	92%
	IDENTITY	63%					100%		25%	63%
PA1365	SeqID						5085
	COVERAGE						100%
	IDENTITY						100%
PA1398	SeqID						5086
	COVERAGE						100%
	IDENTITY						100%
PA1462	SeqID		10915		11559		5087
	COVERAGE		98%		101%		100%
	IDENTITY			29%		30%		100%
PA1493	SeqID	110423				11718	5088			13786
	COVERAGE	92%				97%	100%			92%
	IDENTITY	56%				49%	100%			56%
PA1547SeqID				11377		5089
	COVERAGE				88%		100%
	IDENTITY				28%		100%
SeqID	110091					5090	12990		13890
	COVERAGE	101%					100%	96%		81%
	IDENTITY	37%					100%	26%		32%
PA1684	SeqID					11693	5091
	COVERAGE					99%	100%
	IDENTITY					59%	100%
PA1868	SeqID	10361					5092
	COVERAGE	82%					100%
	IDENTITY	35%					100%
PA1876	SeqID					11746	5093		14036
	COVERAGE					76%	100%		93%
	IDENTITY					40%	100%		39%
PA1918	SeqID	10153		11033			5094			13745
	COVERAGE	79%		82%			100%			79%
	IDENTITY	31%		28%			100%			28%
PA1986	SeqID						5095
	COVERAGE						100%
	IDENTITY						100%
PA2009	SeqID						5096
	COVERAGE						100%
	IDENTITY						100%
PA2083	SeqID	10253				11692	5097
	COVERAGE	87%				85%	100%
	IDENTITY	31%				35%	100%
PA2101	SeqID	10198					5098		13282	13861
	COVERAGE	92%					100%		88%	95%
	IDENTITY	30%					100%		25%	28%
PA2108	SeqID	10109		11257			5099	12943	13625	13996
	COVERAGE	96%		95%			100%	94%	90%	96%
	IDENTITY	37%		27%			100%	34%	29%	37%
PA2128	SeqID	10472	10865			11752	5100		13683	13893
	COVERAGE	97%	96%			86%	100%		80%	97%
	IDENTITY	27%	26%			25%	100%		27%	33%
PA2147	SeqID	10181					5101			13985
	COVERAGE	98%					100%			98%
	IDENTITY	60%					100%			59%
PA2196	SeqID	10169					5102		13852
	COVERAGE	99%					100%		99%
	IDENTITY	43%					100%		43%
PA2197	SeqID	10160					5103	12917		13830
	COVERAGE	100%					100%	97%		100%
	IDENTITY	74%					100%	44%		73%
PA2222	SeqID						5104
	COVERAGE						100%
	IDENTITY						100%
PA2313	SeqID						5105
	COVERAGE						100%
	IDENTITY						100%
PA2398	SeqID	10132					5106
	COVERAGE	86%					100%
	IDENTITY	35%					100%
PA2424	SeqID						5107
	COVERAGE						100%
	IDENTITY						100%
PA2461	SeqID						5108
	COVERAGE						100%
	IDENTITY						100%
PA2470	SeqID						5109	13930
	COVERAGE						100%	98%
	IDENTITY						100%	60%
PA2488	SeqID	10189		11172			5110			13980
	COVERAGE	89%		70%			100%			87%
	IDENTITY	32%		28%			100%			29%
PA2494	SeqID	10331		11145	11516		5111			13719
	COVERAGE	99%		98%	100%		100%			98%
	IDENTITY	42%		31%	26%		100%			41%
PA2584	SeqID	10195	10899	10967	11504		5112	12330	13442	14058
	COVERAGE	94%	99%	94%	97%		100%	99%	92%	94%
	IDENTITY	60%	37%	57%	38%		100%	41%	42%	58%
PA2594	SeqID	10116				11714	5113
	COVERAGE	97%				80%	100%
	IDENTITY	41%				45%	100%
PA2634	SeqID	10441					5114
	COVERAGE	74%					100%
	IDENTITY	28%					100%
PA2641	SeqID	10226	10566				5115			13959
	COVERAGE	95%	89%				100%			95%
	IDENTITY	80%	37%				100%			80%
PA2671	SeqID						5116
	COVERAGE						100%
	IDENTITY						100%
PA2680	SeqID	10444	10703			11730	5117			14029
	COVERAGE	101%	74%			90%	100%			101%
	IDENTITY	42%	30%			43%	100%			42%
PA2684	SeqID	10384					5118
	COVERAGE	99%					100%
	IDENTITY	33%					100%
PA2726	SeqID						5119
	COVERAGE						100%
	IDENTITY							100%
PA2742	SeqID	10177	10660	11222	11296		5120	12628	13302
	COVERAGE	91%	97%	84%	89%		100%	97%	97%
	IDENTITY	64%	50%	67%	47%		100%	55%	45%
PA3006	SeqID						5121
	COVERAGE						100%
	IDENTITY						100%
PA3011	SeqID	10151	10695	11233	11293		5122	12339		13848
	COVERAGE	100%	79%	100%	86%		100%	75%		100%
	IDENTITY	68%	40%	64%	39%		100%	42%		66%
PA3013	SeqID	10416	10494	11095	11525		5123	12461		13750
	COVERAGE	98%	80%	102%	102%		100%	102%		98%
	IDENTITY	64%	39%	43%	41%		100%	40%		64%
PA3041	SeqID	10307					5124			13777
	COVERAGE	88%					100%			88%
	IDENTITY	32%					100%			32%
PA3048	SeqID	10117		10966			5125			14005
	COVERAGE	99%		75%			100%			99%
	IDENTITY	47%		45%			100%			47%
PA3068	SeqID						5126
	COVERAGE						100%
	IDENTITY						100%
PA3121	SeqID	10021		11164	11363		5127	12156		14017
	COVERAGE	99%		99%	81%		100%	99%		99%
	IDENTITY	63%		59%	26%		100%	56%		62%
PA3153	SeqID						5128
	COVERAGE						100%
	IDENTITY						100%
PA3154	SeqID						5129
	COVERAGE						100%
	IDENTITY						100%
PA3160	SeqID						5130
	COVERAGE						100%
	IDENTITY						100%
PA3279	SeqID						5131
	COVERAGE						100%
	IDENTITY						100%
PA3280	SeqID						5132
	COVERAGE						100%
	IDENTITY						100%
PA3374	SeqID	10452					5133
	COVERAGE	99%					100%
	IDENTITY	55%						100%
PA3479	SeqID						5134
	COVERAGE						100%
	IDENTITY						100%
PA3484	SeqID						5135
	COVERAGE						100%
	IDENTITY						100%
PA3522	SeqID	10331		11145	11516		5136			13719
	COVERAGE	98%		99%	99%		100%			99%
	IDENTITY	41%		30%	26%		100%			40%
PA3643	SeqID	10046		11173	11378		5137			13912
	COVERAGE	99%		100%	79%		100%			99%
	IDENTITY	53%		51%	30%		100%			52%
PA3703	SeqID	10194					5138			13751
	COVERAGE	100%					100%			100%
	IDENTITY	30%					100%			31%
PA3709	SeqID						5139
	COVERAGE						100%
	IDENTITY						100%
PA3716	SeqID						5140
	COVERAGE						100%
	IDENTITY						100%
PA3764	SeqID	10255		10991			5141			13793
	COVERAGE	94%		91%			100%			82%
	IDENTITY	38%		41%			100%			39%
PA3845	SeqID	10277		11200			5142			13882
	COVERAGE	98%		98%			100%			98%
	IDENTITY	34%		30%			100%			35%
PA3866	SeqID						5143
	COVERAGE						100%
	IDENTITY						100%
PA3876	SeqID	10144					5144			13840
	COVERAGE	97%					100%			97%
	IDENTITY	61%					100%			58%
PA3877	SeqID	10161					5145	12699		13831
	COVERAGE	98%					100%	92%		98%
	IDENTITY	28%					100%	27%		27%
PA3931	SeqID	10050	10833	11067	11460	11656	5146	12548	13173	13720
	COVERAGE	82%	92%	103%	92%	82%	100%	96%	109%	95%
	IDENTITY	50%	43%	41%	49%	48%	100%	44%	36%	35%
PA3984	SeqID	10087		11002		11674	5147			14061
	COVERAGE	97%		98%		91%	100%			99%
	IDENTITY	40%		37%		39%	100%			40%
PA4024	SeqID	10244	10700			11736	5148			13951
	COVERAGE	95%	95%			71%	100%			95%
	IDENTITY	50%	50%			72%	100%			50%
PA4027	SeqID						5149
	COVERAGE						100%
	IDENTITY						100%
PA4037	SeqID	10102	10563	11194	11527	11725	5150	12958	13296	14002
	COVERAGE	72%	83%	72%	72%	72%	100%	70%	71%	72%
	IDENTITY	35%	30%	33%	34%	33%	100%	35%	31%	34%
PA4067	SeqID	10149					5151			13845
	COVERAGE	98%					100%			99%
	IDENTITY	44%					100%			43%
PA4070	SeqID	10159					5152
	COVERAGE	96%					100%
	IDENTITY	28%					100%
PA408	1	SeqID						5153
	COVERAGE						100%
	IDENTITY						100%
PA4105	SeqID						5154
	COVERAGE						100%
	IDENTITY						100%
PA4124	SeqID						5155			14023
	COVERAGE						100%			93%
	IDENTITY						100%			64%
PA4125	SeqID						5156			14024
	COVERAGE						100%			94%
	IDENTITY						100%			67%
PA4158	SeqID	10080	10610	11009	11379	11769	5157	12297		13725
	COVERAGE	98%	95%	88%	83%	74%	100%	96%		97%
	IDENTITY	61%	38%	31%	28%	61%	100%	50%		61%
PA4237	SeqID	10333	10542	11123	11582		5158	12232	13224	14093
	COVERAGE	91%	97%	98%	90%		100%	92%	97%	91%
	IDENTITY	79%	43%	76%	43%		100%	45%	42%	79%
PA4242	SeqID	10338	10538	11117	11428		5159
	COVERAGE	100%	100%	100%		100%	100%
	IDENTITY	87%	68%	76%	74%		100%
PA4244	SeqID	10340	10534	11116			5160	12225	13217	14099
	COVERAGE	100%	100%	100%	100%			100%	100%	100%
	IDENTITY	65%	46%	63%			100%	42%	43%	65%
PA4245	SeqID	10341	10532	11115			5161	12223	13216	13812
	COVERAGE	95%	98%	95%			100%	98%	98%	78%
	IDENTITY	56%	42%	58%			100%	42%	40%	33%
PA4246	SeqID	10342	10531	11114	11432		5162	12222	13215	14101
	COVERAGE	100%	92%	99%	88%		100%	99%	92%	100%
	IDENTITY	77%	52%	74%	49%		100%	52%	53%	77%
PA4247	SeqID	10343	10530	11113	11433		5163	12221	13214	14102
	COVERAGE	99%	98%	99%	97%		100%	98%	98%	99%
	IDENTITY	59%	52%	63%	37%		100%	48%	54%	59%
PA4248	SeqID	10344	10529	11112	11434		5164	12220	13571	14103
	COVERAGE	100%	99%	100%	99%		100%	99%	99%	100%
	IDENTITY	62%	49%	66%	50%		100%	43%	47%	62%
PA4249	SeqID	10345	10528	11111	11435		5165	13033	13212	14104
	COVERAGE	99%	102%	99%	100%		100%	102%	102%	99%
	IDENTITY	64%	46%	64%	40%		100%	44%	47%	64%
PA4250	SeqID	10346	10599	11110			5166	12737	13211	14105
	COVERAGE	100%	100%	100%			100%	100%	100%	100%
	IDENTITY	69%	43%	63%			100%	46%	53%	67%
PA4251	SeqID	10347	10527	11109	11589	11654	5167	12218	13210	14106
	COVERAGE	99%	99%	99%	99%	99%	100%	90%	98%	99%
	IDENTITY	69%	58%	68%	48%	69%	100%	63%	61%	68%
PA4252	SeqID	10348	10526	11108			5168	12217	13209	14107
	COVERAGE	97%	92%	94%			100%	98%	92%	96%
	IDENTITY	65%	49%	62%			100%	49%	46%	64%
PA4253	SeqID	10349	10525	11107	11436		5169	12216	13208	14108
	COVERAGE	101%	100%	101%	100%		100%	100%	100%	101%
	IDENTITY	85%	66%	85%	65%		100%	66%	66%	84%
PA4254	SeqID	10350	10524	11106	11437		5170	12215	13207
	COVERAGE	90%	98%	90%	84%		100%	89%	89%
	IDENTITY	71%	53%	62%	45%		100%	55%	56%
PA4256	SeqID	10352	10560	11104	11439		5171	12260	13204	13968
	COVERAGE	100%	100%	100%	96%		100%	98%	98%	100%
	IDENTITY	77%	54%	77%	65%		100%	58%	57%	77%
PA4257	SeqID	10353	10559	11103	11592		5172	12259	13203	13969
	COVERAGE	99%	91%	100%	99%		100%	91%	93%	99%
	IDENTITY	74%	61%	72%	55%		100%	57%	59%	74%
PA4258	SeqID	10354	10558	11102	11593		5173	12258	13202	13970
	COVERAGE	100%	91%	100%	95%		100%	99%	91%	100%
	IDENTITY	69%	57%	70%	41%		100%	48%	58%	69%
PA4259	SeqID	10355	10557	11101	11594		5174	12255	13201
	COVERAGE	100%	101%	100%	99%		100%	100%	100%
	IDENTITY	82%	70%	84%	61%		100%	63%	67%
PA4262	SeqID	10358	10549	11098	11595		5175	12240	13198	13973
	COVERAGE	100%	95%	100%	96%		100%	101%	97%	100%
	IDENTITY	68%	45%	72%	36%		100%	46%	44%	68%
PA4263	SeqID	10359		11097	11442		5176	12235	13197	13974
	COVERAGE	99%		98%	91%		100%	103%	99%	99%
	IDENTITY	75%		73%	35%		100%	46%	51%	75%
PA4264	SeqID	10360	10533	11096	11443	11643	5177		13196	13975
	COVERAGE	100%	75%	100%	95%	100%	100%		99%	100%
	IDENTITY	90%	58%	92%	57%	92%	100%		61%	91%
PA4268	SeqID	10365	10479	11062	11409		5178	12445	13231	13967
	COVERAGE	100%	111%	100%	100%		100%	111%	111%	100%
	IDENTITY	89%	70%	89%	75%		100%	68%	70%	89%
PA4269	SeqID	10439	10627	11036	11410		5179	12446	13646	14042
	COVERAGE	100%	100%	100%	109%		100%	101%	99%	100%
	IDENTITY	76%	46%	73%	47%		100%	46%	45%	75%
PA4271	SeqID	10437	10615	11072	11572		5180	12449	13247	14044
	COVERAGE	100%	101%	101%	102%		100%	98%	100%	100%
	IDENTITY	66%	65%	66%	54%		100%	58%	58%	64%
PA4272	SeqID	10436	10614	11071			5181	12450	13246	14045
	COVERAGE	99%	95%	100%			100%	99%	95%	99%
	IDENTITY	68%	40%	66%			100%	39%	42%	65%
PA4316	SeqID	10200		11235			5182			13821
	COVERAGE	88%		90%			100%			91%
	IDENTITY	51%		47%			100%			51%
PA4332	SeqID						5183
	COVERAGE						100%
	IDENTITY	1						100%
PA4347	SeqID					11699	5184
	COVERAGE					86%	100%
	IDENTITY					27%	100%
PA4363	SeqID	10292				11740	5185			13742
	COVERAGE	95%				81%	100%			95%
	IDENTITY	40%				36%	100%			41%
PA4375	SeqID	10072		11145	11516		5186			13719
	COVERAGE	101%		100%	100%		100%			101%
	IDENTITY	33%		45%	28%		100%			33%
PA4413	SeqID	10030	10805	11188	11458		5187	12360	13333	14077
	COVERAGE	90%	94%	92%	93%		100%	93%	98%	90%
	IDENTITY	45%	33%	41%	30%		100%	33%	32%	44%
PA4433	SeqID	10327	10602	11241	11289	11655	5188	12237	13356	13729
	COVERAGE	100%	99%	100%	94%	72%	100%	99%	99%	100%
	IDENTITY	75%	59%	73%	54%	76%	100%	55%	56%	72%
PA4473	SeqID	10463		11195			5189			13986
	COVERAGE	84%		81%			100%			84%
	IDENTITY	39%		37%			100%			39%
PA4506	SeqID	10381	10658	11198	11314	11717	5190	12850	13248	13800
	COVERAGE	99%	77%	98%	79%	91%	100%	99%	81%	99%
	IDENTITY	58%	48%	60%	51%	59%	100%	46%	42%	58%
PA4512	SeqID						5191			13815
	COVERAGE	100%								99%
	IDENTITY						100%			57%
PA4542	SeqID	10258	10628	11134	11489		5192	12526	13421	14088
	COVERAGE	100%	101%	100%	100%		100%	101%	80%	100%
	IDENTITY	71%	47%	70%	49%		100%	52%	46%	71%
PA4576	SeqID						5193
	COVERAGE						100%
	IDENTITY						100%
PA4598	SeqID	10072		11145	11516		5194			13719
	COVERAGE	100%		100%	99%		100%			100%
	IDENTITY	50%		29%	28%		100%			50%
PA4665	SeqID	10143	10826	11251	11287	11675	5195	12380	13336	13979
	COVERAGE	100%	97%	101%	97%	100%	100%	98%	99%	100%
	IDENTITY	66%	54%	64%	52%	65%	100%	53%	50%	66%
PA4681	SeqID						5196
	COVERAGE						100%
	IDENTITY						100%
PA4709	SeqID						5197
	COVERAGE						100%
	IDENTITY						100%
PA4744	SeqID	10314		11216	11501		5198	12322	13663	13765
	COVERAGE	107%		98%	93%		100%	78%	91%	107%
	IDENTITY	58%		58%	39%		100%	48%	43%	58%
PA4771	SeqID	10387	11280	5199			13402	13828
	COVERAGE	100%		99%			100%		96%	97%
	IDENTITY	87%		75%			100%		33%	33%
PA4888	SeqID						5200
	COVERAGE						100%
	IDENTITY						100%
PA4942	SeqID	10455		10972			5201			13856
	COVERAGE	93%		91%			100%			95%
	IDENTITY	48%		41%			100%			48%
PA4997	SeqID	10115	10619	10960	11394		5202	12501	13458	14006
	COVERAGE	86%	82%	97%	83%		100%	96%	97%	86%
	IDENTITY	43%	36%	44%	31%		100%	37%	32%	44%
PA5030	SeqID	10165					5203
	COVERAGE	90%					100%
	IDENTITY	64%					100%
PA5076	SeqID	10197	10796	11176	11383	11694	5204		13292	14057
	COVERAGE	94%	82%	97%	97%	90%	100%		98%	94%
	IDENTITY	29%	33%	27%	26%	29%	100%		30%	30%
PA5088	SeqID						5205
	COVERAGE						100%
	IDENTITY						100%
PA5193	SeqID	10373		11126		11709	5206			13808
	COVERAGE	100%		96%		77%	100%			100%
	IDENTITY	41%		39%		42%	100%			41%
PA5199	SeqID	10375	10596			11711	5207			13810
	COVERAGE	102%	71%			102%	100%			103%
	IDENTITY	33%	26%			34%	100%			32%
PA5207	SeqID			11260	11612		5208	12730
	COVERAGE			100%	88%		100%	100%
	IDENTITY			54%	39%		100%	28%
PA5209	SeqID	10302					5209			13758
	COVERAGE	90%					100%			89%
	IDENTITY	29%					100%			28%
PA5248	SeqID						5210
	COVERAGE						100%
	IDENTITY						100%
PA5299	SeqID						5211
	COVERAGE						100%
	IDENTITY						100%
PA5316	SeqID	10391		11158	11327		5212	12129
	COVERAGE	100%		99%	78%		100%	73%
	IDENTITY	82%		79%	39%		100%	40%
PA5388	SeqID		10503				5213
	COVERAGE		85%				100%
	IDENTITY		28%				100%
PA5393	SeqID						5214
	COVERAGE						100%
	IDENTITY						100%
PA5436	SeqID	10330	10924	11160	11321		5215	13127	13617	13885
	COVERAGE	94%	94%	94%	94%		100%	94%	94%	94%
	IDENTITY	52%	51%	52%	46%		100%	55%	54%	52%
PA5443	SeqID	10413	10788	11199	11452		5216	12489	13643	13748
	COVERAGE	100%	103%	100%	96%		100%	100%	105%	100%
	IDENTITY	64%	38%	56%	35%		100%	38%	39%	64%
PA5490	SeqID						5217
	COVERAGE						100%
	IDENTITY						100%
PA5493	SeqID	10417	10668	11133	11609		5218	12623	13236
	COVERAGE	102%	102%	102%	102%		100%	100%	101%
	IDENTITY	62%	37%	58%	31%		100%	38%	37%
PA5507	SeqID	10119					5219
	COVERAGE	99%					100%
	IDENTITY	31%					100%
PA5567	SeqID	10397	10911	11169	11450		5220	12703	13338	13923
	COVERAGE	99%	103%	99%	100%		100%	102%	101%	99%
	IDENTITY	67%	39%	64%	33%		100%	34%	37%	67%

[0779]

TABLE VIIB
				Staphyl -
PathoSeq	Enterococcus	Escherichia	Pseudomonas	ococcus
Cluster ID	faecalis	coli	aeruginosa	aureus
15	EFA102326	ECO101796	PAE100280	SAU102515
55	EFA100151	ECO104157	PAE100416	SAU100633
57	EFA100617	ECO102690	PAE105434	SAU100158
1443	EFA100689	ECO103692	PAE101987	SAU100952
1861	EFA101412	ECO103231	PAE104331	SAU101793
2286	EFA103268	ECO103265	PAE104314	SAU101756
2362	EFA101425	ECO100662	PAE101537	SAU101236
2367	EFA101417	ECO103226	PAE103206	SAU101798
2549	EFA101410	ECO103233	PAE104329	SAU101791
3816	EFA101159	ECO103243	PAE104319	SAU100546
3857	EFA101415	ECO103228	PAE103204	SAU101796
4322	EFA101165	ECO103237	PAE104325	SAU100141
4569	EFA100955	ECO103217	PAE103215	SAU101808
4948	EFA101160	ECO103242	PAE104320	SAU100547
5818	EFA100742	ECO103224	PAE103208	SAU101800
8159	EFA101163	ECO103239	PAE104323	SAU100139
8296	EFA101164	ECO103238	PAE104324	SAU100140
8316	EFA101409	ECO103234	PAE104328	SAU101790
8494	EFA103062	ECO103884	PAE104311	SAU100433
8498	EFA101411	ECO103232	PAE104330	SAU101792
8499	EFA101416	ECO103227	PAE103205	SAU101797
7		ECO100071	PAE100837	SAU102674
8	EFA101340		PAE106580	SAU100118
28	EFA101403		PAE102647	SAU100514
41	EFA101753	ECO100148		SAU101565
63	EFA101685		PAE103857	SAU100331
147		ECO100645	PAE100543	SAU100053
548		ECO100377	PAE100604	SAU100747
730		ECO103592	PAE103108	SAU100061
1721	EFA101686	ECO100663		SAU101996
1749	EFA101477	ECO102557		SAU100613
2153	EFA102656	ECO100184	SAU101869
2790	EFA102764	ECO100500	SAU101578
3164	EFA101162	ECO103240		SAU102602
3312	EFA103174		PAE105008	SAU100521
3926	EFA100194	ECO103220		SAU101806
4441	EFA102541		PAE105364	SAU101814
5685	EFA100190	ECO103264		SAU100157
7417	EFA102788	ECO101684		SAU102992
7437	EFA102351	ECO100084		SAU100056
7579		ECO102470	PAE102641	SAU100607
7726	EFA102551	ECO103221		SAU101805
7727	EFA100978	ECO103218		SAU101807
8092		ECO102035	PAE102964	SAU100794
8158	EFA103365		PAE104318	SAU102880
8161	EFA100210		PAE104326	SAU102527
8162	EFA101414		PAE103203	SAU101795
8164	EFA100741	ECO103223		SAU101801
8493	EFA101141		PAE104310	SAU100432
10185	EFA102728	ECO104092		SAU102578
35		ECO102870		SAU100497
44			PAE101061	SAU101143
54			PAE100225	SAU100123
85		ECO101104		SAU101262
184			PAE104901	SAU101366
362	EFA102736			SAU 100414
575	EFA101790			SAU100133
579	EFA102110			SAU101624
911			PAE105432	SAU102054
941		ECO101365		SAU102162
952	EFA100615			SAU100964
1084	EFA100289	ECO102819
1141		ECO102255		SAU102356
1232		ECO100703		SAU101346
1274			PAE103655	SAU102264
1337		ECO102562		SAU100567
1350		ECO100930	PAE103901
1374		ECO103659		SAU101385
1427	EFA100394			SAU100714
1535		ECO101207		SAU101561
1653	EFA102655			SAU101868
1849	EFA100642			SAU101653
1932	EFA100919			SAU101365
2156	EFA101150			SAU101271
2189		ECO102827	PAE100476
2238		ECO101436		SAU101092
2338	EFA103038			SAU100518
2411	EFA102802			SAU102246
2501	EFA101121			SAU100996
2974			PAE102537	SAU102125
3027		ECO103959		SAU200242
3239	EFA103021			SAU100300
3244	EFA100399			SAU101891
3386	EFA100426			SAU100886
3447	EFA102915			SAU102112
3460	EFA102023			SAU101399
3682	EFA100740			SAU101802
3771	EFA101540			SAU100275
4424	EFA102542			SAU101815
4654		ECO100488	PAE106184
5148	EFA100065			SAU100658
7227	EFA100023			SAU100436
7240		ECO103672		SAU101682
7278			PAE101620	SAU301370
7374			PAE106765	SAU103042
7375	EFA102051			SAU103038
7402		ECO103572	PAE106044
7419		ECO101686		SAU102693
7436	EFA101792			SAU101495
7504	EFA101670			SAU102603
7653	EFA100397			SAU100246
7660	EFA102352	ECO103698
7719	EFA100756			SAU100496
7725	EFA100739			SAU101803
8040	EFA101736			SAU101197
8058	EFA103571			SAU101242
8077	EFA100200			SAU102231
8082	EFA101080			SAU100199
8116	EFA101963			SAU101028
8122	EFA101737			SAU101198
8141	EFA102780			SAU102433
8177	EFA103348			SAU202126
8178	EFA101022			SAU102283
8181	EFA101541			SAU102909
8191	EFA102022			SAU101398
8234	EFA103033			SAU100745
8237	EFA101682			SAU101266
8238	EFA103295			SAU100963
8251			PAE100662	SAU100596
8300	EFA101120			SAU100944
8539	EFA101339			SAU101400
8610		ECO103661		SAU102298
8874	EFA100748			SAU101155
9028	EFA103210			SAU100731
9996	EFA102338			SAU100175
10234	EFA102186			SAU102933
10248		ECO102828		SAU101220
10297			PAE105229	SAU101381
10328	EFA101079			SAU101547
10345	EFA100298			SAU100659
10365	EFA100641			SAU101655
10393	EFA103504			SAU100961
10402	EFA101833			SAU100880
12426	EFA101413			SAU101794
14277	EFA103081			SAU200088
14330	EFA101161			SAU102881
14455	EFA101424			SAU101771
14520	EFA100211			SAU101789
15660	EFA103375			SAU102694

Example 13

Use of Identified Nucleic Acid Sequences as Probes

[0780] The sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi described herein, homologous coding nucleic acids, or homologous antisense nucleic acids can be used as probes to obtain the sequence of additional genes of interest from a second cell or microorganism. For example, probes to genes encoding potential bacterial target proteins may be hybridized to nucleic acids from other organisms including other bacteria and higher organisms, to identify homologous sequences in these other organisms. For example, the identified sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi, homologous coding nucleic acids, or homologous antisense nucleic acids may be used to identify homologous sequences in Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis and any species falling within the genera of any of the above species. In some embodiments of the present invention, the nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi described herein, homologous coding nucleic acids, or homologous antisense nucleic acids may be used to identify homologous nucleic acids from a heterologous organism other than E. coli.

[0781] Hybridization between the nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi described herein, homologous coding nucleic acids, or homologous antisense nucleic acids and nucleic acids from humans might indicate that the protein encoded by the gene to which the probe corresponds is found in humans and therefore not necessarily an optimal drug target. Alternatively, the gene can be conserved only in bacteria and therefore would be a good drug target for a broad spectrum antibiotic or antimicrobial. These probes can also be used in a known manner to isolate homologous nucleic acids from Staphylococcus, Salmonella, Klebsiella, Pseudomonas, Enterococcus or other cells or microorganisms, e.g. by screening a genomic or cDNA library.

[0782] Probes derived from the nucleic acid sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi described herein, homologous coding nucleic acids, or homologous antisense nucleic acids, or portions thereof, can be labeled with detectable labels familiar to those skilled in the art, including radioisotopes and non-radioactive labels, to provide a detectable probe. The detectable probe can be single stranded or double stranded and can be made using techniques known in the art, including in vitro transcription, nick translation, or kinase reactions. A nucleic acid sample containing a sequence capable of hybridizing to the labeled probe is contacted with the labeled probe. If the nucleic acid in the sample is double stranded, it can be denatured prior to contacting the probe. In some applications, the nucleic acid sample can be immobilized on a surface such as a nitrocellulose or nylon membrane. The nucleic acid sample can comprise nucleic acids obtained from a variety of sources, including genomic DNA, cDNA libraries, RNA, or tissue samples.

[0783] Procedures used to detect the presence of nucleic acids capable of hybridizing to the detectable probe include well known techniques such as Southern blotting, Northern blotting, dot blotting, colony hybridization, and plaque hybridization. In some applications, the nucleic acid capable of hybridizing to the labeled probe can be cloned into vectors such as expression vectors, sequencing vectors, or in vitro transcription vectors to facilitate the characterization and expression of the hybridizing nucleic acids in the sample. For example, such techniques can be used to isolate, purify and clone sequences from a genomic library, made from a variety of bacterial species, which are capable of hybridizing to probes made from the sequences identified in Examples 5 and 6.

Example 14

Preparation of PCR Primers and Amplification of DNA

[0784] The identified Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi genes corresponding directly to or located within the operon of nucleic acid sequences required for proliferation, homologous coding nucleic acids, or homologous antisense nucleic acids or portions thereof can be used to prepare PCR primers for a variety of applications, including the identification or isolation of homologous sequences from other species. For example, the Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi genes may be used to prepare PCR primers to identify or isolate homologous sequences from Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis; Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments of the present invention, the PCR primers may be used to identify or isolate homologous nucleic acids from an organism other than E. coli.

[0785] The identified or isolated nucleic acids obtained using the PCR primers may contain part or all of the homologous nucleic acids. Because homologous nucleic acids are related but not identical in sequence, those skilled in the art will often employ degenerate sequence PCR primers. Such degenerate sequence primers are designed based on sequence regions that are either known to be conserved or suspected to be conserved such as conserved coding regions. The successful production of a PCR product using degenerate probes generated from the sequences identified herein would indicate the presence of a homologous gene sequence in the species being screened. The PCR primers are at least 10 nucleotides, and preferably at least 20 nucleotides in length. More preferably, the PCR primers are at least 20-30 nucleotides in length. In some embodiments, the PCR primers can be more than 30 nucleotides in length. It is preferred that the primer pairs have approximately the same G/C ratio, so that melting temperatures are approximately the same. A variety of PCR techniques are familiar to those skilled in the art. For a review of PCR technology, see Molecular Cloning to Genetic Engineering White, B. A. Ed. in Methods in Molecular Biology 67: Humana Press, Totowa 1997. When the entire coding sequence of the target gene is known, the 5′ and 3′ regions of the target gene can be used as the sequence source for PCR probe generation. In each of these PCR procedures, PCR primers on either side of the nucleic acid sequences to be amplified are added to a suitably prepared nucleic acid sample along with dNTPs and a thermostable polymerase such as Taq polymerase, Pfu polymerase, or Vent polymerase. The nucleic acid in the sample is denatured and the PCR primers are specifically hybridized to complementary nucleic acid sequences in the sample. The hybridized primers are extended. Thereafter, another cycle of denaturation, hybridization, and extension is initiated. The cycles are repeated multiple times to produce an amplified fragment containing the nucleic acid sequence between the primer sites.

Example 15

Inverse PCR

[0786] The technique of inverse polymerase chain reaction can be used to extend the known nucleic acid sequence identified in Examples 5 and 6. The inverse PCR reaction is described generally by Ochman et al., in Ch. 10 of PCR Technology: Principles and Applications for DNA Amplification, (Henry A. Erlich, Ed.) W.H. Freeman and Co. (1992). Traditional PCR requires two primers that are used to prime the synthesis of complementary strands of DNA. In inverse PCR, only a core sequence need be known.

[0787] Using the sequences identified as relevant from the techniques taught in Examples 5 and 6 and applied to other species of bacteria, a subset of nucleic sequences are identified that correspond to genes or operons that are required for bacterial proliferation. In species for which a genome sequence is not known, the technique of inverse PCR provides a method for obtaining the gene in order to determine the sequence or to place the probe sequences in full context to the target sequence to which the identified nucleic acid sequence binds.

[0788] To practice this technique, the genome of the target organism is digested with an appropriate restriction enzyme so as to create fragments of nucleic acid that contain the identified sequence as well as unknown sequences that flank the identified sequence. These fragments are then circularized and become the template for the PCR reaction. PCR primers are designed in accordance with the teachings of Example 15 and directed to the ends of the identified sequence. The primers direct nucleic acid synthesis away from the known sequence and toward the unknown sequence contained within the circularized template. After the PCR reaction is complete, the resulting PCR products can be sequenced so as to extend the sequence of the identified gene past the core sequence of the identified exogenous nucleic acid sequence identified. In this manner, the full sequence of each novel gene can be identified. Additionally the sequences of adjacent coding and noncoding regions can be identified.

Example 16

Identification of Genes Required for Escherichia coli Proliferation

[0789] Genes required for proliferation in Escherichia coli are identified according to the methods described above.

Example 17

Identification of Genes Required for Neisseria gonorrhoeae Proliferation

[0790] Genes required for proliferation in Neisseria gonorrhoeae are identified according to the methods described above.

Example 18

Identification of Genes Required for Salmonella enterica Proliferation

[0791] Genes required for proliferation in Salmonella enterica are identified according to the methods described above.

Example 19

Identification of Genes Required for Enterococcus faecium Proliferation

[0792] Genes required for proliferation in Enterococcus faecium are identified according to the methods described above.

Example 20

Identification of Genes Required for Haemophilus influenzae Proliferation

[0793] Genes required for proliferation in Haemophilus influenzae are identified according to the methods described above.

Example 21

Identification of Genes Required for Aspergillus fumigatus Proliferation

[0794] Genes required for proliferation in Aspergillus fumigatus are identified according to the methods described above.

Example 22

Identification of Genes Required for Helicobacter pylori Proliferation

[0795] Genes required for proliferation in Helicobacter pylori are identified according to the methods described above.

Example 23

Identification of Genes Required for Mycoplasma pneumoniae Proliferation

[0796] Genes required for proliferation in Mycoplasma pneumoniae are identified according to the methods described above.

Example 24

Identification of Genes Required for Plasmodium ovale Proliferation

[0797] Genes required for proliferation in Plasmodium ovale are identified according to the methods described above.

Example 25

Identification of Genes Required for Entamoeba histolytica Proliferation

[0798] Genes required for proliferation in Entamoeba histolytica are identified according to the methods described above.

Example 26

Identification of Genes Required for Candida albicans Proliferation

[0799] Genes required for proliferation in Candida albicans are identified according to the methods described above.

Example 27

Identification of Genes Required for Histoplasma capsulatum Proliferation

[0800] Genes required for proliferation in Histoplasma capsulatum are identified according to the methods described above.

Example 28

Identification of Genes Required for Salmonella typhi Proliferation

[0801] Genes required for proliferation in Salmonella typhi are identified according to the methods described above.

Example 29

Identification of Genes Required for Salmonella paratyphi Proliferation

[0802] Genes required for proliferation in Salmonella paratyphi are identified according to the methods described above.

Example 30

Identification of Genes Required for Salmonella cholerasuis Proliferation

[0803] Genes required for proliferation in Salmonella cholerasuis are identified according to the methods described above.

Example 31

Identification of Genes Required for Staphylococcus epidermis Proliferation

[0804] Genes required for proliferation in Staphylococcus epidermis are identified according to the methods described above.

Example 32

Identification of Genes Required for Mycobacterium tuberculosis Proliferation

[0805] Genes required for proliferation in Mycobacterium tuberculosis are identified according to the methods described above.

Example 33

Identification of Genes Required for Mycobacterium leprae Proliferation

[0806] Genes required for proliferation in Mycobacterium leprae are identified according to the methods described above.

Example 34

Identification of Genes Required for Treponema pallidum Proliferation

[0807] Genes required for proliferation in Treponema pallidum are identified according to the methods described above.

Example 35

Identification of Genes Required for Bacillus anthracis Proliferation

[0808] Genes required for proliferation in Bacillus anthracis are identified according to the methods described above.

Example 36

Identification of Genes Required for Yersinia pestis Proliferation

[0809] Genes required for proliferation in Yersinia pestis are identified according to the methods described above.

Example 37

Identification of Genes Required for Clostridium botulinum Proliferation

[0810] Genes required for proliferation in Clostridium botulinum are identified according to the methods described above.

Example 38

Identification of Genes Required for Campylobacter jejuni Proliferation

[0811] Genes required for proliferation in Campylobacter jejuni are identified according to the methods described above.

Example 39

Identification of Genes Required for Chlamydia trachomatis Proliferation

[0812] Genes required for proliferation in Chlamydia trachomatis are identified according to the methods described above.

Example 40

Identification of Genes Required for Staphylococcus aureus Proliferation

[0813] Genes required for proliferation in Staphylococcus aureus are identified according to the methods described above.

Example 41

Identification of Genes Required for Salmonella typhimurium Proliferation

[0814] Genes required for proliferation in Salmonella typhimurium are identified according to the methods described above.

Example 42

Identification of Genes Required for Klebsiella Pneumoniae Proliferation

[0815] Genes required for proliferation in Klebsiella Pneumoniae are identified according to the methods described above.

Example 43

Identification of Genes Required for Pseudomonas aeruginosa Proliferation

[0816] Genes required for proliferation in Pseudomonas aeruginosa are identified according to the methods described above.

Example 44

Identification of Genes Required for Enterococcus faecalis Proliferation

[0817] Genes required for proliferation in Enterococcus faecalis are identified according to the methods described above.

[0818] Use of Isolated Exogenous Nucleic Acid Fragments as Antisense Antibiotics

[0819] In addition to using the identified sequences to enable screening of molecule libraries to identify compounds useful to identify antibiotics, antisense nucleic acids complementary to the proliferation-required sequences or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids, or homologous antisense nucleic acids can be used as therapeutic agents. Specifically, the proliferation-required sequences or homolgous coding nucleic acids, or portions therof, in an antisense orientation or homologous antisense nucleic acids can be provided to an individual to inhibit the translation of a bacterial target gene or the processing, folding, or assembly into a protein/RNA complex of a nontranslated RNA.

Example 45

Generation of Antisense Therapeutics from Identified Exogenous Sequences

[0820] Antisense nucleic acids complementary to the proliferation-required sequences described herein, or portions thereof, antisense nucleic acids complementary to homologous coding nucleic acids, or portions thereof, or homologous antisense nucleic acids or portions thereof can be used as antisense therapeutics for the treatment of bacterial infections or simply for inhibition of bacterial growth in vitro or in vivo. For example, the antisense therapeutics may be used to treat bacterial infections caused by Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or to inhibit the growth of these organisms. The antisense therapeutics may also be used to treat infections caused by or to inhibit the growth of Anaplasma marginale, Aspergillus fumigatus, Bacillus anthracis, Bacterioides fragilis Bordetella pertussis, Burkholderia cepacia, Campylobacter jejuni, Candida albicans, Candida glabrata (also called Torulopsis glabrata), Candida tropicalis, Candida parapsilosis, Candida guilliermondii, Candida krusei, Candida kefyr (also called Candida pseudotropicalis), Candida dubliniensis, Chlamydia pneumoniae, Chlamydia trachomatus, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Coccidiodes immitis, Corynebacterium diptheriae, Cryptococcus neoformans, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia colt, Haemophilus influenzae, Helicobacter pylori, Histoplasma capsulatum, Klebsiella pneumoniae, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Pasteurella haemolytica, Pasteurella multocida, Pneumocystis carinii, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella bongori, Salmonella cholerasuis, Salmonella enterica, Salmonella paratyphi, Salmonella typhi, Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Moxarella catarrhalis, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus mutans, Treponema pallidum, Yersinia enterocolitica, Yersinia pestis or any species falling within the genera of any of the above species. In some embodiments of the present invention, the antisense therapuetics may be used to treat infection by or inhibit the growth of an organism other than E. coli.

[0821] The therapy exploits the biological process in cells where genes are transcribed into messenger RNA (mRNA) that is then translated into proteins. Antisense RNA technology contemplates the use of antisense nucleic acids, including antisense oligonucleotides, complementary to a target gene that will bind to its target nucleic acid and decrease or inhibit the expression of the target gene. For example, the antisense nucleic acid may inhibit the translation or transcription of the target nucleic acid. In one embodiment, antisense oligonucleotides can be used to treat and control a bacterial infection of a cell culture containing a population of desired cells contaminated with bacteria. In another embodiment, the antisense oligonucleotides can be used to treat an organism with a bacterial infection.

[0822] Antisense oligonucleotides can be synthesized from any of the sequences of the present invention using methods well known in the art. In a preferred embodiment, antisense oligonucleotides are synthesized using artificial means. Uhlmann & Peymann, Chemical Rev. 90:543-584 (1990) review antisense oligonucleotide technology in detail. Modified or unmodified antisense oligonucleotides can be used as therapeutic agents. Modified antisense oligonucleotides are preferred. Modification of the phosphate backbones of the antisense oligonucleotides can be achieved by substituting the intemucleotide phosphate residues with methylphosphonates, phosphorothioates, phosphoramidates, and phosphate esters. Nonphosphate internucleotide analogs such as siloxane bridges, carbonate brides, thioester bridges, as well as many others known in the art may also be used. The preparation of certain antisense oligonucleotides with modified internucleotide linkages is described in U.S. Pat. No. 5,142,047, hereby incorporated by reference.

[0823] Modifications to the nucleoside units of the antisense oligonucleotides are also contemplated. These modifications can increase the half-life and increase cellular rates of uptake for the oligonucleotides in vivo. For example, α-anomeric nucleotide units and modified nucleotides such as 1,2-dideoxy-d-ribofaranose, 1,2-dideoxy-1-phenylribofuranose, and N4, N4-ethano-5-methyl-cytosine are contemplated for use in the present invention.

[0824] An additional form of modified antisense molecules is found in peptide nucleic acids. Peptide nucleic acids (PNA) have been developed to hybridize to single and double stranded nucleic acids. PNA are nucleic acid analogs in which the entire deoxyribose-phosphate backbone has been exchanged with a chemically different, but structurally homologous, polyamide (peptide) backbone containing 2-aminoethyl glycine units. Unlike DNA, which is highly negatively charged, the PNA backbone is neutral. Therefore, there is much less repulsive energy between complementary strands in a PNA-DNA hybrid than in the comparable DNA-DNA hybrid, and consequently they are much more stable. PNA can hybridize to DNA in either a Watson/Crick or Hoogsteen fashion (Demidov et al., Proc. Natl. Acad. Sci. U.S.A. 92:2637-2641, 1995; Egholm, Nature 365:566-568, 1993; Nielsen et al., Science 254:1497-1500, 1991; Dueholm et al., New J. Chem. 21:19-31, 1997).

[0825] Molecules called PNA “clamps” have been synthesized which have two identical PNA sequences joined by a flexible hairpin linker containing three 8-amino-3,6-dioxaoctanoic acid units. When a PNA clamp is mixed with a complementary homopurine or homopyrimidine DNA target sequence, a PNA-DNA-PNA triplex hybrid can form which has been shown to be extremely stable (Bentin et al., Biochemistry 35:8863-8869, 1996; Egholm et al., Nucleic Acids Res. 23:217-222, 1995; Griffith et al., J. Am. Chem. Soc. 117:831-832, 1995).

[0826] The sequence-specific and high affinity duplex and triplex binding of PNA have been extensively described (Nielsen et al., Science 254:1497-1500, 1991; Egholm et al., J. Am. Chem. Soc. 114:9677-9678, 1992; Egholm et al., Nature 365:566-568, 1993; Almarsson et al., Proc. Natl. Acad. Sci. USA. 90:9542-9546, 1993; Demidov et al., Proc. Natl. Acad. Sci. USA. 92:2637-2641, 1995). They have also been shown to be resistant to nuclease and protease digestion (Demidov et al., Biochem. Pharm. 48:1010-1313, 1994). PNA has been used to inhibit gene expression (Hanvey et al., Science 258:1481-1485,1992; Nielsen et al., Nucl. Acids. Res., 21:197-200, 1993; Nielsen et al., Gene 149:139-145, 1994; Good & Nielsen, Science, 95: 2073-2076, 1998; all of which are hereby incorporated by reference), to block restriction enzyme activity (Nielsen et al., supra., 1993), to act as an artificial transcription promoter (Mollegaard, Proc. Natl. Acad Sci. U.S.A. 91:3892-3895, 1994) and as a pseudo restriction endonuclease (Demidov et al., Nucl. Acids. Res. 21:2103-2107, 1993). Recently, PNA has also been shown to have antiviral and antitumoral activity mediated through an antisense mechanism (Norton, Nature Biotechnol., 14:615-619, 1996; Hirschman et al., J. Investig. Med. 44:347-351, 1996). PNAs have been linked to various peptides in order to promote PNA entry into cells (Basu et al., Bioconj. Chem. 8:481-488, 1997; Pardridge et al., Proc. Natl. Acad. Sci. U.S.A. 92:5592-5596, 1995).

[0827] The antisense oligonucleotides contemplated by the present invention can be administered by direct application of oligonucleotides to a target using standard techniques well known in the art. The antisense oligonucleotides can be generated within the target using a plasmid, or a phage. Alternatively, the antisense nucleic acid may be expressed from a sequence in the chromosome of the target cell. For example, a promoter may be introduced into the chromosome of the target cell near the target gene such that the promoter directs the transcription of the antisense nucleic acid. Alternatively, a nucleic acid containing the antisense sequence operably linked to a promoter may be introduced into the chromosome of the target cell. It is further contemplated that the antisense oligonucleotides are incorporated in a ribozyme sequence to enable the antisense to specifically bind and cleave its target mRNA. For technical applications of ribozyme and antisense oligonucleotides see Rossi et al., Pharmacol. Ther. 50(2):245-254, (1991), which is hereby incorporated by reference. The present invention also contemplates using a retron to introduce an antisense oligonucleotide to a cell. Retron technology is exemplified by U.S. Pat. No. 5,405,775, which is hereby incorporated by reference. Antisense oligonucleotides can also be delivered using liposomes or by electroporation techniques which are well known in the art.

[0828] The antisense nucleic acids described above can also be used to design antibiotic compounds comprising nucleic acids which function by intracellular triple helix formation. Triple helix oligonucleotides are used to inhibit transcription from a genome. The antisense nucleic acids can be used to inhibit cell or microorganism gene expression in individuals infected with such microorganisms or containing such cells. Traditionally, homopurine sequences were considered the most useful for triple helix strategies. However, homopyrimidine sequences can also inhibit gene expression. Such homopyrimidine oligonucleotides bind to the major groove at homopurine:homopyrimidine sequences. Thus, both types of sequences based on the sequences from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia colt, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or homologous nucleic acids that are required for proliferation are contemplated for use as antibiotic compound templates.

[0829] The antisense nucleic acids, such as antisense oligonucleotides, which are complementary to the proliferation-required nucleic acids from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or to homologous coding nucleic acids, or portions thereof, may be used to induce bacterial cell death or at least bacterial stasis by inhibiting target nucleic acid transcription or translation. Antisense oligonucleotides complementary to about 8 to 40 nucleotides of the proliferation-required nucleic acids described herein or homologous coding nucleic acids have sufficient complementarity to form a duplex with the target sequence under physiological conditions.

[0830] To kill bacterial cells or inhibit their growth, the antisense oligonucleotides are applied to the bacteria or to the target cells under conditions that facilitate their uptake. These conditions include sufficient incubation times of cells and oligonucleotides so that the antisense oligonucleotides are taken up by the cells. In one embodiment, an incubation period of 7-10 days is sufficient to kill bacteria in a sample. An optimum concentration of antisense oligonucleotides is selected for use.

[0831] The concentration of antisense oligonucleotides to be used can vary depending on the type of bacteria sought to be controlled, the nature of the antisense oligonucleotide to be used, and the relative toxicity of the antisense oligonucleotide to the desired cells in the treated culture. Antisense oligonucleotides can be introduced to cell samples at a number of different concentrations preferably between 1×10−10M to 1×10−4M. Once the minimum concentration that can adequately control gene expression is identified, the optimized dose is translated into a dosage suitable for use in vivo. For example, an inhibiting concentration in culture of 1×10−7 translates into a dose of approximately 0.6 mg/kg body weight. Levels of oligonucleotide approaching 100 mg/kg body weight or higher may be possible after testing the toxicity of the oligonucleotide in laboratory animals. It is additionally contemplated that cells from the subject are removed, treated with the antisense oligonucleotide, and reintroduced into the subject. This range is merely illustrative and one of skill in the art are able to determine the optimal concentration to be used in a given case.

[0832] After the bacterial cells have been killed or controlled in a desired culture, the desired cell population may be used for other purposes.

Example 46

Use of Antisense Oligonucleotides to Treat Contaminated Cell Cultures

[0833] The following example demonstrates the ability of an Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi antisense oligonucleotide or an antisense oligonucleotide complementary to a homologous coding nucleic acid, or portions thereof, to act as a bacteriocidal or bacteriostatic agent to treat a contaminated cell culture system. The application of the antisense oligonucleotides of the present invention are thought to inhibit the translation of bacterial gene products required for proliferation. The antisense nucleic acids may also inhibit the transcription, folding or processing of the target RNA.

[0834] In one embodiment of the present invention, the antisense oligonucleotide may comprise a phosphorothioate modified nucleic acid comprising at least about 15, at least about 20, at least about 25, at least about 30, at least about 35, at least about 40, or more than 40 consecutive nucleotides of an antisense nucleic acid listed in Table IA. A sense oligodeoxynucleotide complementary to the antisense sequence is synthesized and used as a control. The oligonucleotides are synthesized and purified according to the procedures of Matsukura, et al., Gene 72:343 (1988). The test oligonucleotides are dissolved in a small volume of autoclaved water and added to culture medium to make a 100 micromolar stock solution.

[0835] Human bone marrow cells are obtained from the peripheral blood of two patients and cultured according standard procedures well known in the art. The culture is contaminated with Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or an organism containing a homologous nucleic acid and incubated at 37° C. overnight to establish bacterial infection.

[0836] The control and antisense oligonucleotide containing solutions are added to the contaminated cultures and monitored for bacterial growth. After a 10 hour incubation of culture and oligonucleotides, samples from the control and experimental cultures are drawn and analyzed for the translation of the target bacterial gene using standard microbiological techniques well known in the art. The target Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi gene or an organism containing the homologous coding nucleic acid is found to be translated in the control culture treated with the control oligonucleotide, however, translation of the target gene in the experimental culture treated with the antisense oligonucleotide of the present invention is not detected or reduced, indicating that the culture is no longer contaminated or is contaminated at a reduced level.

Example 47

Use of Antisense Oligonucleotides to Treat Infections

[0837] A subject suffering from a Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi infection or an infection with an organism containing a homologous coding nucleic acid is treated with the antisense oligonucleotide preparation above. The antisense oligonucleotide is provided in a pharmaceutically acceptable carrier at a concentration effective to inhibit the transcription or translation of the target nucleic acid. The present subject is treated with a concentration of antisense oligonucleotide sufficient to achieve a blood concentration of about 0.1-100 micromolar. The patient receives daily injections of antisense oligonucleotide to maintain this concentration for a period of 1 week. At the end of the week a blood sample is drawn and analyzed for the presence or absence of the organism using standard techniques well known in the art. There is no detectable evidence of Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or an organim containing a homologous coding nucleic acid and the treatment is terminated.

[0838] Antisense nucleic acids complementary to a homologous coding nucleic acid or a portion thereof may be used in the preceding method to treat individuals infected with an organism containing the homologous coding nucleic acid.

Example 48

Preparation and Use of Triple Helix Forming Oligonucleotides

[0839] The sequences of proliferation-required nucleic acids, homologous coding nucleic acids, or homologous antisense nucleic acids are scanned to identify 10-mer to 20-mer homopyrimidine or homopurine stretches that could be used in triple-helix based strategies for inhibiting gene expression. Following identification of candidate homopyrimidine or homopurine stretches, their efficiency in inhibiting gene expression is assessed by introducing varying amounts of oligonucleotides containing the candidate sequences into a population of bacterial cells that normally express the target gene. The oligonucleotides may be prepared on an oligonucleotide synthesizer or they may be purchased commercially from a company specializing in custom oligonucleotide synthesis.

[0840] The oligonucleotides can be introduced into the cells using a variety of methods known to those skilled in the art, including but not limited to calcium phosphate precipitation, DEAE-Dextran, electroporation, liposome-mediated transfection or native uptake.

[0841] Treated cells are monitored for a reduction in proliferation using techniques such as monitoring growth levels as compared to untreated cells using optical density measurements. The oligonucleotides that are effective in inhibiting gene expression in cultured cells can then be introduced in vivo using the techniques well known in that art at a dosage level shown to be effective.

[0842] In some embodiments, the natural (beta) anomers of the oligonucleotide units can be replaced with alpha anomers to render the oligonucleotide more resistant to nucleases. Further, an intercalating agent such as ethidium bromide, or the like, can be attached to the 3′ end of the alpha oligonucleotide to stabilize the triple helix. For information on the generation of oligonucleotides suitable for triple helix formation see Griffin et al. (Science 245:967-971 (1989), which is hereby incorporated by this reference).

Example 49

Identification of Bacterial Strains from Isolated Specimens by PCR

[0843] Classical bacteriological methods for the detection of various bacterial species are time consuming and costly. These methods include growing the bacteria isolated from a subject in specialized medium, cultivation on selective agar medium, followed by a set of confirmation assays that can take from 8 to 10 days or longer to complete. Use of the identified sequences of the present invention provides a method to dramatically reduce the time necessary to detect and identify specific bacterial species present in a sample.

[0844] In one exemplary method, bacteria are grown in enriched medium and DNA samples are isolated from specimens of, for example, blood, urine, stool, saliva or central nervous system fluid by conventional methods. A panel of PCR primers based on identified sequences unique to various species or types of cells or microorganisms are then utilized in accordance with Example 12 to amplify DNA of approximately 100-200 nucleotides in length from the specimen. A separate PCR reaction is set up for each pair of PCR primers and after the PCR reaction is complete, the reaction mixtures are assayed for the presence of PCR product. The presence or absence of bacteria from the species to which the PCR primer pairs belong is determined by the presence or absence of a PCR product in the various test PCR reaction tubes.

[0845] Although the PCR reaction is used to assay the isolated sample for the presence of various bacterial species, other assays such as the Southern blot hybridization are also contemplated.

[0846] Compounds which inhibit the activity or reduce the amount of gene products required for proliferation may be identified using rational drug design. These methods may be used with the proliferation-required polypeptides described herein or homologous polypeptides. In such methods, the structure of the gene product is determined using methods such as x-ray crystallography, NMR, or computer modelling. Compounds are screened to identify those which have a structure which allows them to interact with the gene product. In some embodiments, the compounds are screened to identify those which have structures which allow them to interact with regions of the gene product which are important for its activity. For example, the compounds may be screened to identify those which have structures which allow them to bind to the active site of the gene product to inhibit its activity. For example, the compound may be a suicide substrate which binds to the active site with high affinity, thereby preventing the gene product from acting on its natural substrate. Alternatively, the compound may bind to a region of the gene product which is involved in complex formation with other biomolecules. In such instances, the activity of the gene product is inhibited by blocking the interaction between the gene product and other members of the complex.

[0847] Thus, one embodiment of the present invention comprises a method of using a crystal of the gene products of the present invention and/or a dataset comprising the three-dimensional coordinates obtained from the crystal in a drug-screening assay. The present invention also includes agents (modulators or drugs) that are identified by the methods of the present invention, along with the method of using agents (modulators or drugs) identified by a method of the present invention, for inhibiting the activity of or modulating the amount of an essential gene product. The present invention also includes crystals comprising the gene products of the present invention or portions thereof.

[0848] In some embodiments of the present invention, the three-dimensional structure of the polypeptides required for proliferation is determined using X-ray crystallography or NMR. The coordinates of the determined structure are used in computer-assisted modeling programs to identify compounds that bind to and/or modulate the activity or amount of the encoded polypeptide. The method may include the following steps: 1) the generation of high-purity crystals of the encoded recombinant (or endogenous) polypeptide for analysis; 2) determination of the three-dimensional structure of the polypeptide; and, 3) the use of computer-assisted “docking” programs to analyze the molecular interaction of compound structure and the polypeptide (i.e., drug screening).

[0849] General methods for performing each of the above steps are described below and are also well known to those of skill in the art. Any method known to those of skill in the art, including those described herein, may be employed for generating the three-dimensional structure for each identified essential gene product and its use in the drug-screening assays.

[0850] Crystals of the gene products required for proliferation may be obtained as follows. Under certain conditions, molecules condense from solution into a highly-ordered crystalline lattice, which is defined by a unit cell, the smallest repeating volume of the crystalline array. The contents of such a cell can interact with and diffract certain electromagnetic and particle waves (e.g., X-rays, neutron beams, electron beams etc.). Due to the symmetry of the lattice, the diffracted waves interact to create a diffraction pattern. By measuring the diffraction pattern, crystallographers are able to reconstruct the three-dimensional structure of the atoms in the crystal.

[0851] Any method known to those of skill in the art, including those set forth below, may be employed to prepare high-purity crystals. For example, crystals of the product of the identified essential gene can be grown by a number of techniques including batch crystallization, vapor diffusion (either by sitting drop or hanging drop) and by microdialysis. Seeding of the crystals in some instances is required to obtain X-ray quality crystals. Standard micro and/or macro seeding of crystals may therefore be used. Exemplified below is the hanging-drop vapor diffusion procedure. Hanging drops of an essential gene product (2.5 μl, 10 mg/ml) in 20 mM Tris, pH=8.0, 100 mM NaCl are mixed with an equal amount of reservoir buffer containing 2.7-3.2 M sodium formate and 100 mM Tris buffer, pH=8.0, and kept at 4° C. Crystal showers may appear after 1-2 days with large single crystals growing to full size (0.3×0.3×0.15 mmd) within 2-3 weeks. Crystals are harvested in 3.5 M sodium formate and 100 mM Tris buffer, pH=8.0 and cryoprotected in 3.5 M sodium formate, 100 mM Tris buffer, pH=8.0, 10% (w/v) sucrose, and 10% (v/v) ethylene glycol before flash freezing in liquid propane.

[0852] In some embodiments, the crystal may be obtained using the methods described in U.S. Pat. No. 5,869,604, the disclosure of which is incorporated herein by reference in its entirety. The method involves (a) contacting a mixture containing uncrystallized polypeptides with an exogenous nucleating agent that has an areal lattice match of at least 90.4% to the polypeptide,(b) crystallizing the polypeptides, thereby forming at least one crystal of the polypeptide attached to the nucleating agent, the attached crystal being of a high purity, and at least one polypeptide crystal unattached to the nucleating agent, the unattached crystal being of a lower purity than the attached crystal, and (c) separating the crystal attached to the nucleating agent from the crystal unattached to the nucleating agent. The crystallized polypeptide may also be purified from contaminants by (a) contacting a mixture containing uncrystallized polypeptides and a contaminant with an exogenous nucleating agent that has an areal lattice match of at least 90.4% to the polypeptide, (b) crystallizing the polypeptides, thereby forming at least one crystal of the polypeptide attached to the nucleating agent, the attached crystal being of a high purity and produced in a high yield, and at least one crystal unattached to the nucleating agent, the unattached crystal being of a lower purity than the attached crystal, and (c) separating the crystal attached to the nucleating agent from the crystal unattached to the nucleating agent.

[0853] Once a crystal of the present invention is grown, X-ray diffraction data can be collected using methods familiar to those skilled in the art. Therefore, any person with skill in the art of protein crystallization having the present teachings and without undue experimentation can crystallize a large number of alternative forms of the essential gene products from a variety of different organisms, or polypeptides having conservative substitutions in their amino acid sequence.

[0854] A crystal lattice is defined by the symmetry of its unit cell and any structural motifs the unit cell contains. For example, there are 230 possible symmetry groups for an arbitrary crystal lattice, while the unit cell of the crystal lattice group may have an arbitrary dimension that depends on the molecules making up the lattice. Biological macromolecules, however, have asymmetric centers and are limited to 65 of the 230 symmetry groups. See Cantor et al., Biophysical Chemistry, Vol. III, W. H. Freeman & Company (1980), the disclosure of which is incorporated herein by reference in its entirety.

[0855] A crystal lattice interacts with electromagnetic or particle waves, such as X-rays or electron beams respectively, that have a wavelength with the same order of magnitude as the spacing between atoms in the unit cell. The diffracted waves are measured as an array of spots on a detection surface positioned adjacent to the crystal. Each spot has a three-dimensional position, hkl, and an intensity, I(hkl), both of which are used to reconstruct the three-dimensional electron density of the crystal with the so-called Electron Density Equation. The Electron Density Equation states that the three-dimensional electron density of the unit cell is the Fourier transform of the structure factors. Thus, in theory, if the structure factors are known for a sufficient number of spots in the detection space, then the three-dimensional electron density of the unit cell could be calculated using the Electron Density Equation.

[0856] In some embodiments of the present invention, an image of a crystal of a gene product required for proliferation or a portion thereof is obtained with the aid of a digital computer and the crystal's diffraction pattern as described in U.S. Pat. No. 5,353,236, the disclosure of which is incorporated herein by reference in its entirety. The diffraction pattern contains a plurality of reflections, each having an associated resolution. The image is obtained by (a) converting the diffraction pattern of the crystal into computer usable normalized amplitudes, the pattern being produced with a diffractometer; (b) determining from the diffraction pattern a dimension of a unit cell of the crystal; (c) providing an envelope defining the region of the unit cell occupied by the gene product or portion thereof in the crystal; (d) distributing a collection of scattering bodies within said envelope, the collection of scattering bodies having various arrangements, each of which has an associated pattern of Fourier amplitudes; (e) condensing the collection of scattering bodies to a condensed arrangement that results in a high correlation between a diffraction pattern and the pattern of Fourier amplitudes for said collection of scattering bodies; (f) determining the phase associated with at least one of the reflections of said diffraction pattern from the condensed arrangement of scattering bodies; (g) calculating an electron density distribution of the gene product or portion thereof within the unit cell from the phase determined in procedure f; and (h) displaying a graphical image of the gene product or portion thereof constructed from said electron density distribution.

[0857] The crystals of the gene products required for proliferation may be used in drug screening methods such as those described in U.S. Pat. No. 6,156,526, the disclosure of which is incorporated herein by reference in its entirety. Briefly, in such methods, a compound which inhibits the formation of a complex comprising the gene product or a portion thereof is identified as follows. A set of atomic coordinates defining the three-dimensional structure of a complex including the gene product of interest or a portion thereof are determined. A potential compound that binds to the gene product or a portion thereof involved in complex formation is selected using the atomic coordinates obtained above. The compound is contacted with the gene product or portion thereof and its binding partner(s) in the complex under conditions which would permit the complex to form in the absence of the potential compound. The binding affinity of the gene product or portion thereof for its binding partner(s) is determined and a potential compound is identified as a compound that inhibits the formation of the complex when there is a decrease in the binding affinity of the gene product or portion thereof for its binding partner(s).

[0858] In some embodiments of the present invention, the three dimensional structure of the essential gene product is determined and potential agonists and/or potential antagonists are designed with the aid of computer modeling [Bugg et al., Scientific American, Dec.:92-98 (1993); West et al., TIPS, 16:67-74 (1995); Dunbrack et al., Folding & Design, 2:27-42 (1997), the disclosures of which are incorporated herein by reference in their entireties].

[0859] Computer analysis may be performed with one or more of the computer programs including: QUANTA, CHARMM, INSIGHT, SYBYL, MACROMODEL and ICM [Dunbrack et al., Folding & Design, 2:27-42 (1997), the disclosure of which is incorporated herein by reference in its entirety]. In a further embodiment of this aspect of the invention, an initial drug-screening assay is performed using the three-dimensional structure so obtained, preferably along with a docking computer program. Such computer modeling can be performed with one or more Docking programs such as FlexX, DOC, GRAM and AUTO DOCK [Dunbrack et al., Folding & Design, 2:27-42 (1997)].

[0860] It should be understood that for each drug screening assay provided herein, a number of iterative cycles of any or all of the steps may be performed to optimize the selection. The drug screening assays of the present invention may use any of a number of means for determining the interaction between an agent or drug and an essential gene product.

[0861] In some embodiments of the present invention, a drug can be specifically designed to bind to an essential gene product of the present invention through NMR based methodology. [Shuker et al., pi Science 274:1531-1534 (1996) the disclosure of which is incorporated herein by reference herein in its entirety.] NMR spectra may be recorded using devices familiar to those skilled in the art, such as the Varian Unity Plus 500 and unity 600 spectrometers, each equipped with a pulsed-field gradient triple resonance probe as analyzed as described in Bagby et al., [Cell 82:857-867 (1995), the disclosure of which is incorporated herein by reference in its entirety]. Sequential resonance assignments of backbone 1H, .15 N, and .13C atoms may be made using a combination of triple resonance experiments similar to those previously described [Bagby et al., Biochemistry, 33:2409-2421 (1994a), the disclosure of which is incorporated herein by reference in its entirety], except with enhanced sensitivity [Muhandiram and Kay, J. Magn. Reson., 103: 203-216 (1994), the disclosure of which is incorporated herein by reference in its entirety] and minimal H2O saturation [Kay et al., J. Magn. Reson., 109:129-133 (1994), the disclosure of which is incorporated herein by reference in its entirety]. Side chain 1H and 13 C assignments may be made using HCCH-TOCSY [Bax et al., J. Magn. Reson., 87:620-627 (1990), the disclosure of which is incorporated herein by reference in its entirety] experiments with mixing times of 8 ms and 16 ms.in solution but need not be included in structure calculations. Nuclear Overhauser effect (NOE) cross peaks in two-dimensional 1H-1H NOE spectroscopy (NOESY), three-dimensional 15N-edited NOESY-HSQC [Zhang et al., J. Biomol, NMR, 4:845-858 (1994), the disclosure of which is incorporated herein by reference in its entirety] and three-dimensional simultaneous acquisition 15N/13C-edited NOE [Pascal et al., J. Magn. Reson., 103:197-201 (1994), the disclosure of which is incorporated herein by reference in its entirety] spectra may be obtained with 100 ms NOE mixing times. Standard pseudo-atom distance corrections [Wuthrich et al., J. Mol. Biol., 169:949-961 (1983), the disclosure of which is incorporated herein by reference in its entirety] may be incorporated to account for center averaging. An additional 0.5 .ANG. may be added to the upper limits for distances involving methyl groups [Wagner et al., J. Mol. Biol., 196:611-639 (1987); Clore et al., Biochemistry, 26:8012-8023 (1987), the disclosures of which are incorporated herein by reference in their entireties].

[0862] The structures can be calculated using a simulated annealing protocol [Nilges et al., In computational Aspects of the Study of Biological Macromolecules by Nuclear Magnetic Resonance Spectroscopy, J. C. Hoch, F. M. Poulsen, and C. Redfield, eds., New York: Plenum Press, pp. 451-455 (1991, the disclosures of which are incorporated herein by reference in their entireties] within X-PLOR [Brunger, X-PLOR Manual, Version 3.1, New Haven, Conn.: Department of Molecular Biophysics and Biochemistry, Yale University (1993), the disclosure of which is incorporated herein by reference in its entirety] using the previously described strategy [Bagby et al., Structure, 2:107-122 (1994b), the disclosure of which is incorporated herein by reference in its entirety]. Interhelical anges may be calculated using a program written by K. Yap. Accessible surface areas were calculated using the program Naccess, available from Prof. J. Thornton, University College, London.

[0863] Compounds capable of reducing the activity or amount of gene products required for cellular proliferation may be identified using the methods described in U.S. Pat. No. 6,077,682, the disclosure of which is incorporated herein by reference in its entirety. Briefly, the three-dimensional structure of the gene product or portion thereof may be used in a drug screening assay by (a) selecting a potential drug by performing rational drug design with the three-dimensional structure determined from one or more sets of atomic coordinates of the gene product or portion thereof in conjunction with computer modeling; (b) contacting the potential drug with a polypeptide comprising the gene product or portion thereof and (c) detecting the binding of the potential drug with said polypeptide; wherein a potential drug is selected as a drug if the potential drug binds to the polypeptide. In some methods, the three-dimensional structure of the gene product or portion thereof is used in a drug screening assay involving (a) selecting a potential drug by performing structural based rotational drug design with the three-dimensional structure of the gene product or portion thereof; wherein said selecting is performed in conjunction with computer modeling; (b) contacting the potential drug with a polypeptide comprising the gene product or portion thereof in the presence of a substrate of the gene product; wherein in the absence of the potential drug the substrate is acted upon by the gene product; and (c) determining the extent to which the gene product acted upon the substrate; wherein a drug is selected when a decrease in the action of the gene product on the substrate is determined in the presence of the potential drug relative to in its absence. In some embodiments, the preceding method further involves(d) contacting the potential drug with the gene product or portion thereof for NMR analysis; wherein a binding complex forms between the potential drug and said gene product or portion thereof for NMR analysis; wherein the gene product or portion thereof for NMR analysis comprises a conservative amino acid substitution; (e) determining the three-dimensional structure of the binding complex by NMR; and (f) selecting a candidate drug by performing structural based rational drug design with the three-dimensional structure determined for the binding complex; wherein said selecting is performed in conjunction with computer modeling; (g) contacting the candidate drug with a second polypeptide comprising the gene product or portion thereof in the presence of a substrate of the gene product or portion thereof; wherein in the absence of the candidate drug the substrate is acted upon by the second polypeptide; and (h) determining the amount of action of the second polypeptide on the substrate; wherein a drug is selected when a decrease in the amount of action of the second polypeptide is determined in the presence of the candidate drug relative to in its absence.

[0864] Once the three-dimensional structure of a crystal comprising an essential gene product is determined, a potential modulator of its activity, can be examined through the use of computer modeling using a docking program such as FlexX, GRAM, DOCK, or AUTODOCK [Dunbrack et al., 1997, supra], to identify potential modulators. This procedure can include computer fitting of potential modulators to the polypeptide or fragments thereof to ascertain how well the shape and the chemical structure of the potential modulator will bind. Computer programs can also be employed to estimate the attraction, repulsion, and steric hindrance of the two binding partners (e.g., the essential gene product and a potential modulator). Generally the tighter the fit, the lower the steric hindrances, and the greater the attractive forces, the more potent the potential modulator since these properties are consistent with a tighter binding constant. Furthermore, the more specificity in the design of a potential drug the more likely that the drug will not interact as well with other proteins. This will minimize potential side-effects due to unwanted interactions with other proteins.

[0865] Compound and compound analogs can be systematically modified by computer modeling programs until one or more promising potential analogs is identified. In addition systematic modification of selected analogs can then be systematically modified by computer modeling programs until one or more potential analogs are identified. Such analysis has been shown to be effective in the development of HIV protease inhibitors [Lam et al., Science 263:380-384 (1994); Wlodawer et al., Ann. Rev. Biochem. 62:543-585 (1993); Appelt, Perspectives in Drug Discovery and Design 1:23-48 (1993); Erickson, Perspectives in Drug Discovery and Design 1:109-128 (1993), the disclosures of which are incorporated herein by reference in their entireties]. Alternatively a potential modulator could be obtained by initially screening a random peptide library produced by recombinant bacteriophage for example, [Scott and Smith, Science, 249:386-390 (1990); Cwirla et al., Proc. Natl. Acad. Sci., 87:6378-6382 (1990); Devlin et al., Science, 249:404-406 (1990), the disclosures of which are incorporated herein by reference in their entireties]. A peptide selected in this manner would then be systematically modified by computer modeling programs as described above, and then treated analogously to a structural analog.

[0866] Example 45 describes computer modelling of the structures of gene products required for proliferation.

Example 50

Determination of the Structure of Gene Products Required for Proliferation Using Computer Modelling

[0867] Three dimensional models were built by applying computer modelling methods to some of the gene products required for proliferation of Staphylococcus aureus using the amino acid sequences of the encoded proteins as follows. Sir Tom Blundell's program COMPOSER as provided by Tripos Associates in their BIOPOLYMER module to SYBYL was used to build the models. Skolnik's method of topology fingerprinting as implemented in Matchmaker was used to score the average mutation free energy. This number is in Boltzmans (units of kT) and should be negative (the more negative, the better the model.

[0868] Composer uses a Needleman Wunsch alignment with jumbling to find significant alignments. The reported parameters are percent identity and significance as measured from the jumbling. Those matches which were 30% identical and had a significance greater that 4 on the scale were judged to be good candidates for model building templates. If no three dimensional structures met these criteria, then a BLAST search was conducted against the most recent PDB sequence database. Any significant hits discovered in this manner were then added to the binary protein structure database and the candidate search was repeated in the manner discussed above.

[0869] In the next phase, Composer assigned structurally conserved and structurally variable regions and built the backbone structure and then searched the database for structures of the variable loops. These were then spliced in and a model of the protein resulted. Any loops (variable regions) which were unassignable were manually built and refined with a combination of dynamics.

[0870] The structure was then refined. Hydrogen atoms were added and a non-active aggregate was defined. 1000 pS of dynamics using AMBER ALL-ATOM and Kollman charges are performed. Next a minimization cycle of up 5000 steepest decent steps were performed and then the aggregate was thawed and the process was repeated on the entire protein.

[0871] The resulting structure was then validated in MATCHMAKER. The topologicaly scanned free energy determined from empirically derived protein topologies was computed and the average energy/residue is reported in Boltzamans was reported. As this number represents a free energy the more negative it is the more favorable it is.

[0872] Sixty six proteins required for the proliferation of Staphylococcus aureus were modelled as described above. MATCHMAKER energies were computed for these.

[0873] The distribution of the models built by class is shown in the table below.

TABLE 1
Distribution of models built with their MATCHMAKER energies in kT
		Average Matchmaker
Classification	Number of Models	Energy
Acylases	1	−0.10
Dehydrogenases	3	−0.12
DNA Related	3	−0.12
Heat Shock Protein	2	−0.16
Hydrolases	3	−0.16
Isomerases	1	−0.05
Ligases	7	−0.07
Lyases	1	−0.09
Membrane Anchored	1	−0.12
Misc	18	−0.21
Oxidoreductases	6	−0.09
Proteases	1	−0.03
Ribosome	3	−0.11
Synthases	4	−0.14
Transferases	6	−0.12

[0874] The validity of the above method was confirmed using FtsZ. In the case of FtsZ, a crystal structure from M. Janeschi was available. Examination of the gross structural features determined using the above modelling showed all of the folds in the 20 correct place, although there were some minor differences from the structure determined by x-ray crystallography.

Example 51

Functional Complementation

[0875] In another embodiment, gene products whose activities may be complemented by a proliferation-required gene product from Staphylococcus aureus, Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Enterococcus faecalis, Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Helicobacter pylori, or Salmonella typhi or homologous polypeptides are identified using merodiploids, created by introducing a plasmid or Bacterial Artificial Chromosome into an organism having a mutation in the essential gene which reduces or eliminates the activity of the gene product. In some embodiments, the mutation may be a conditional mutation, such as a temperature sensitive mutation, such that the organism proliferates under permissive conditions but is unable to proliferate under non-permissive conditions in the absence of complementation by the gene on the plasmid or Bacterial Artificial Chromosome. Alternatively, duplications may be constructed as described in Roth et al. (1987) Biosynthesis of Aromatic Amino Acids in Escherichia coli and Salmonella typhimurium, F. C. Neidhardt, ed., American Society for Microbiology, publisher, pp. 2269-2270, the disclosure of which is incorporated herein by reference in its entirety. Such methods are familiar to those skilled in the art.

[0876] Table VIII provides a cross reference for SEQ ID NOs. of the nucleotide sequences discussed herein and the SEQ ID NOs. of the polypeptides encoded by these nucleotide.

[0877] All documents cited herein are incorporated herein by reference in their entireties.

TABLE VIII
Nucleotide SeqID	Protein SeqID	Nucleotide SeqID	Protein SeqID
5916	10013	5961	10058
5917	10014	5962	10059
5918	10015	5963	10060
5919	10016	5964	10061
5920	10017	5965	10062
5921	10018	5966	10063
5922	10019	5967	10064
5923	10020	5968	10065
5924	10021	5969	10066
5925	10022	5970	10067
5926	10023	5971	10068
5927	10024	5972	10069
5928	10025	5973	10070
5929	10026	5974	10071
5930	10027	5975	10072
5931	10028	5976	10073
5932	10029	5977	10074
5933	10030	5978	10075
5934	10031	5979	10076
5935	10032	5980	10077
5936	10033	5981	10078
5937	10034	5982	10079
5938	10035	5983	10080
5939	10036	5984	10081
5940	10037	5985	10082
5941	10038	5986	10083
5942	10039	5987	10084
5943	10040	5988	10085
5944	10041	5989	10086
5945	10042	5990	10087
5946	10043	5991	10088
5947	10044	5992	10089
5948	10045	5993	10090
5949	10046	5994	10091
5950	10047	5995	10092
5951	10048	5996	10093
5952	10049	5997	10094
5953	10050	5998	10095
5954	10051	5999	10096
5955	10052	6000	10097
5956	10053	6001	10098
5957	10054	6002	10099
5958	10055	6003	10100
5959	10056	6004	10101
5960	10057	6005	10102
6006	10103	6053	10150
6007	10104	6054	10151
6008	10105	6055	10152
6009	10106	6056	10153
6010	10107	6057	10154
6011	10108	6058	10155
6012	10109	6059	10156
6013	10110	6060	10157
6014	10111	6061	10158
6015	10112	6062	10159
6016	10113	6063	10160
6017	10114	6064	10161
6018	10115	6065	10162
6019	10116	6066	10163
6020	10117	6067	10164
6021	10118	6068	10165
6022	10119	6069	10166
6023	10120	6070	10167
6024	10121	6071	10168
6025	10122	6072	10169
6026	10123	6073	10170
6027	10124	6074	10171
6028	10125	6075	10172
6029	10126	6076	10173
6030	10127	6077	10174
6031	10128	6078	10175
6032	10129	6079	10176
6033	10130	6080	10177
6034	10131	6081	10178
6035	10132	6082	10179
6036	10133	6083	10180
6037	10134	6084	10181
6038	10135	6085	10182
6039	10136	6086	10183
6040	10137	6087	10184
6041	10138	6088	10185
6042	10139	6089	10186
6043	10140	6090	10187
6044	10141	6091	10188
6045	10142	6092	10189
6046	10143	6093	10190
6047	10144	6094	10191
6048	10145	6095	10192
6049	10146	6096	10193
6050	10147	6097	10194
6051	10148	6098	10195
6052	10149	6099	10196
6100	10197	6147	10244
6101	10198	6148	10245
6102	10199	6149	10246
6103	10200	6150	10247
6104	10201	6151	10248
6105	10202	6152	10249
6106	10203	6153	10250
6107	10204	6154	10251
6108	10205	6155	10252
6109	10206	6156	10253
6110	10207	6157	10254
6111	10208	6158	10255
6112	10209	6159	10256
6113	10210	6160	10257
6114	10211	6161	10258
6115	10212	6162	10259
6116	10213	6163	10260
6117	10214	6164	10261
6118	10215	6165	10262
6119	10216	6166	10263
6120	10217	6167	10264
6121	10218	6168	10265
6122	10219	6169	10266
6123	10220	6170	10267
6124	10221	6171	10268
6125	10222	6172	10269
6126	10223	6173	10270
6127	10224	6174	10271
6128	10225	6175	10272
6129	10226	6176	10273
6130	10227	6177	10274
6131	10228	6178	10275
6132	10229	6179	10276
6133	10230	6180	10277
6134	10231	6181	10278
6135	10232	6182	10279
6136	10233	6183	10280
6137	10234	6184	10281
6138	10235	6185	10282
6139	10236	6186	10283
6140	10237	6187	10284
6141	10238	6188	10285
6142	10239	6189	10286
6143	10240	6190	10287
6144	10241	6191	10288
6145	10242	6192	10289
6146	10243	6193	10290
6194	10291	6241	10338
6195	10292	6242	10339
6196	10293	6243	10340
6197	10294	6244	10341
6198	10295	6245	10342
6199	10296	6246	10343
6200	10297	6247	10344
6201	10298	6248	10345
6202	10299	6249	10346
6203	10300	6250	10347
6204	10301	6251	10348
6205	10302	6252	10349
6206	10303	6253	10350
6207	10304	6254	10351
6208	10305	6255	10352
6209	10306	6256	10353
6210	10307	6257	10354
6211	10308	6258	10355
6212	10309	6259	10356
6213	10310	6260	10357
6214	10311	6261	10358
6215	10312	6262	10359
6216	10313	6263	10360
6217	10314	6264	10361
6218	10315	6265	10362
6219	10316	6266	10363
6220	10317	6267	10364
6221	10318	6268	10365
6222	10319	6269	10366
6223	10320	6270	10367
6224	10321	6271	10368
6225	10322	6272	10369
6226	10323	6273	10370
6227	10324	6274	10371
6228	10325	6275	10372
6229	10326	6276	10373
6230	10327	6277	10374
6231	10328	6278	10375
6232	10329	6279	10376
6233	10330	6280	10377
6234	10331	6281	10378
6235	10332	6282	10379
6236	10333	6283	10380
6237	10334	6284	10381
6238	10335	6285	10382
6239	10336	6286	10383
6240	10337	6287	10384
6288	10385	6335	10432
6289	10386	6336	10433
6290	10387	6337	10434
6291	10388	6338	10435
6292	10389	6339	10436
6293	10390	6340	10437
6294	10391	6341	10438
6295	10392	6342	10439
6296	10393	6343	10440
6297	10394	6344	10441
6298	10395	6345	10442
6299	10396	6346	10443
6300	10397	6347	10444
6301	10398	6348	10445
6302	10399	6349	10446
6303	10400	6350	10447
6304	10401	6351	10448
6305	10402	6352	10449
6306	10403	6353	10450
6307	10404	6354	10451
6308	10405	6355	10452
6309	10406	6356	10453
6310	10407	6357	10454
6311	10408	6358	10455
6312	10409	6359	10456
6313	10410	6360	10457
6314	10411	6361	10458
6315	10412	6362	10459
6316	10413	6363	10460
6317	10414	6364	10461
6318	10415	6365	10462
6319	10416	6366	10463
6320	10417	6367	10464
6321	10418	6368	10465
6322	10419	6369	10466
6323	10420	6370	10467
6324	10421	6371	10468
6325	10422	6372	10469
6326	10423	6373	10470
6327	10424	6374	10471
6328	10425	6375	10472
6329	10426	6376	10473
6330	10427	6377	10474
6331	10428	6378	10475
6332	10429	6379	10476
6333	10430	6380	10477
6334	10431	6381	10478
6382	10479	6429	10526
6383	10480	6430	10527
6384	10481	6431	10528
6385	10482	6432	10529
6386	10483	6433	10530
6387	10484	6434	10531
6388	10485	6435	10532
6389	10486	6436	10533
6390	10487	6437	10534
6391	10488	6438	10535
6392	10489	6439	10536
6393	10490	6440	10537
6394	10491	6441	10538
6395	10492	6442	10539
6396	10493	6443	10540
6397	10494	6444	10541
6398	10495	6445	10542
6399	10496	6446	10543
6400	10497	6447	10544
6401	10498	6448	10545
6402	10499	6449	10546
6403	10500	6450	10547
6404	10501	6451	10548
6405	10502	6452	10549
6406	10503	6453	10550
6407	10504	6454	10551
6408	10505	6455	10552
6409	10506	6456	10553
6410	10507	6457	10554
6411	10508	6458	10555
6412	10509	6459	10556
6413	10510	6460	10557
6414	10511	6461	10558
6415	10512	6462	10559
6416	10513	6463	10560
6417	10514	6464	10561
6418	10515	6465	10562
6419	10516	6466	10563
6420	10517	6467	10564
6421	10518	6468	10565
6422	10519	6469	10566
6423	10520	6470	10567
6424	10521	6471	10568
6425	10522	6472	10569
6426	10523	6473	10570
6427	10524	6474	10571
6428	10525	6475	10572
6476	10573	6523	10620
6477	10574	6524	10621
6478	10575	6525	10622
6479	10576	6526	10623
6480	10577	6527	10624
6481	10578	6528	10625
6482	10579	6529	10626
6483	10580	6530	10627
6484	10581	6531	10628
6485	10582	6532	10629
6486	10583	6533	10630
6487	10584	6534	10631
6488	10585	6535	10632
6489	10586	6536	10633
6490	10587	6537	10634
6491	10588	6538	10635
6492	10589	6539	10636
6493	10590	6540	10637
6494	10591	6541	10638
6495	10592	6542	10639
6496	10593	6543	10640
6497	10594	6544	10641
6498	10595	6545	10642
6499	10596	6546	10643
6500	10597	6547	10644
6501	10598	6548	10645
6502	10599	6549	10646
6503	10600	6550	10647
6504	10601	6551	10648
6505	10602	6552	10649
6506	10603	6553	10650
6507	10604	6554	10651
6508	10605	6555	10652
6509	10606	6556	10653
6510	10607	6557	10654
6511	10608	6558	10655
6512	10609	6559	10656
6513	10610	6560	10657
6514	10611	6561	10658
6515	10612	6562	10659
6516	10613	6563	10660
6517	10614	6564	10661
6518	10615	6565	10662
6519	10616	6566	10663
6520	10617	6567	10664
6521	10618	6568	10665
6522	10619	6569	10666
6570	10667	6617	10714
6571	10668	6618	10715
6572	10669	6619	10716
6573	10670	6620	10717
6574	10671	6621	10718
6575	10672	6622	10719
6576	10673	6623	10720
6577	10674	6624	10721
6578	10675	6625	10722
6579	10676	6626	10723
6580	10677	6627	10724
6581	10678	6628	10725
6582	10679	6629	10726
6583	10680	6630	10727
6584	10681	6631	10728
6585	10682	6632	10729
6586	10683	6633	10730
6587	10684	6634	10731
6588	10685	6635	10732
6589	10686	6636	10733
6590	10687	6637	10734
6591	10688	6638	10735
6592	10689	6639	10736
6593	10690	6640	10737
6594	10691	6641	10738
6595	10692	6642	10739
6596	10693	6643	10740
6597	10694	6644	10741
6598	10695	6645	10742
6599	10696	6646	10743
6600	10697	6647	10744
6601	10698	6648	10745
6602	10699	6649	10746
6603	10700	6650	10747
6604	10701	6651	10748
6605	10702	6652	10749
6606	10703	6653	10750
6607	10704	6654	10751
6608	10705	6655	10752
6609	10706	6656	10753
6610	10707	6657	10754
6611	10708	6658	10755
6612	10709	6659	10756
6613	10710	6660	10757
6614	10711	6661	10758
6615	10712	6662	10759
6616	10713	6663	10760
6664	10761	6711	10808
6665	10762	6712	10809
6666	10763	6713	10810
6667	10764	6714	10811
6668	10765	6715	10812
6669	10766	6716	10813
6670	10767	6717	10814
6671	10768	6718	10815
6672	10769	6719	10816
6673	10770	6720	10817
6674	10771	6721	10818
6675	10772	6722	10819
6676	10773	6723	10820
6677	10774	6724	10821
6678	10775	6725	10822
6679	10776	6726	10823
6680	10777	6727	10824
6681	10778	6728	10825
6682	10779	6729	10826
6683	10780	6730	10827
6684	10781	6731	10828
6685	10782	6732	10829
6686	10783	6733	10830
6687	10784	6734	10831
6688	10785	6735	10832
6689	10786	6736	10833
6690	10787	6737	10834
6691	10788	6738	10835
6692	10789	6739	10836
6693	10790	6740	10837
6694	10791	6741	10838
6695	10792	6742	10839
6696	10793	6743	10840
6697	10794	6744	10841
6698	10795	6745	10842
6699	10796	6746	10843
6700	10797	6747	10844
6701	10798	6748	10845
6702	10799	6749	10846
6703	10800	6750	10847
6704	10801	6751	10848
6705	10802	6752	10849
6706	10803	6753	10850
6707	10804	6754	10851
6708	10805	6755	10852
6709	10806	6756	10853
6710	10807	6757	10854
6758	10855	6805	10902
6759	10856	6806	10903
6760	10857	6807	10904
6761	10858	6808	10905
6762	10859	6809	10906
6763	10860	6810	10907
6764	10861	6811	10908
6765	10862	6812	10909
6766	10863	6813	10910
6767	10864	6814	10911
6768	10865	6815	10912
6769	10866	6816	10913
6770	10867	6817	10914
6771	10868	6818	10915
6772	10869	6819	10916
6773	10870	6820	10917
6774	10871	6821	10918
6775	10872	6822	10919
6776	10873	6823	10920
6777	10874	6824	10921
6778	10875	6825	10922
6779	10876	6826	10923
6780	10877	6827	10924
6781	10878	6828	10925
6782	10879	6829	10926
6783	10880	6830	10927
6784	10881	6831	10928
6785	10882	6832	10929
6786	10883	6833	10930
6787	10884	6834	10931
6788	10885	6835	10932
6789	10886	6836	10933
6790	10887	6837	10934
6791	10888	6838	10935
6792	10889	6839	10936
6793	10890	6840	10937
6794	10891	6841	10938
6795	10892	6842	10939
6796	10893	6843	10940
6797	10894	6844	10941
6798	10895	6845	10942
6799	10896	6846	10943
6800	10897	6847	10944
6801	10898	6848	10945
6802	10899	6849	10946
6803	10900	6850	10947
6804	10901	6851	10948
6852	10949	6899	10996
6853	10950	6900	10997
6854	10951	6901	10998
6855	10952	6902	10999
6856	10953	6903	11000
6857	10954	6904	11001
6858	10955	6905	11002
6859	10956	6906	11003
6860	10957	6907	11004
6861	10958	6908	11005
6862	10959	6909	11006
6863	10960	6910	11007
6864	10961	6911	11008
6865	10962	6912	11009
6866	10963	6913	11010
6867	10964	6914	11011
6868	10965	6915	11012
6869	10966	6916	11013
6870	10967	6917	11014
6871	10968	6918	11015
6872	10969	6919	11016
6873	10970	6920	11017
6874	10971	6921	11018
6875	10972	6922	11019
6876	10973	6923	11020
6877	10974	6924	11021
6878	10975	6925	11022
6879	10976	6926	11023
6880	10977	6927	11024
6881	10978	6928	11025
6882	10979	6929	11026
6883	10980	6930	11027
6884	10981	6931	11028
6885	10982	6932	11029
6886	10983	6933	11030
6887	10984	6934	11031
6888	10985	6935	11032
6889	10986	6936	11033
6890	10987	6937	11034
6891	10988	6938	11035
6892	10989	6939	11036
6893	10990	6940	11037
6894	10991	6941	11038
6895	10992	6942	11039
6896	10993	6943	11040
6897	10994	6944	11041
6898	10995	6945	11042
6946	11043	6993	11090
6947	11044	6994	11091
6948	11045	6995	11092
6949	11046	6996	11093
6950	11047	6997	11094
6951	11048	6998	11095
6952	11049	6999	11096
6953	11050	7000	11097
6954	11051	7001	11098
6955	11052	7002	11099
6956	11053	7003	11100
6957	11054	7004	11101
6958	11055	7005	11102
6959	11056	7006	11103
6960	11057	7007	11104
6961	11058	7008	11105
6962	11059	7009	11106
6963	11060	7010	11107
6964	11061	7011	11108
6965	11062	7012	11109
6966	11063	7013	11110
6967	11064	7014	11111
6968	11065	7015	11112
6969	11066	7016	11113
6970	11067	7017	11114
6971	11068	7018	11115
6972	11069	7019	11116
6973	11070	7020	11117
6974	11071	7021	11118
6975	11072	7022	11119
6976	11073	7023	11120
6977	11074	7024	11121
6978	11075	7025	11122
6979	11076	7026	11123
6980	11077	7027	11124
6981	11078	7028	11125
6982	11079	7029	11126
6983	11080	7030	11127
6984	11081	7031	11128
6985	11082	7032	11129
6986	11083	7033	11130
6987	11084	7034	11131
6988	11085	7035	11132
6989	11086	7036	11133
6990	11087	7037	11134
6991	11088	7038	11135
6992	11089	7039	11136
7040	11137	7087	11184
7041	11138	7088	11185
7042	11139	7089	11186
7043	11140	7090	11187
7044	11141	7091	11188
7045	11142	7092	11189
7046	11143	7093	11190
7047	11144	7094	11191
7048	11145	7095	11192
7049	11146	7096	11193
7050	11147	7097	11194
7051	11148	7098	11195
7052	11149	7099	11196
7053	11150	7100	11197
7054	11151	7101	11198
7055	11152	7102	11199
7056	11153	7103	11200
7057	11154	7104	11201
7058	11155	7105	11202
7059	11156	7106	11203
7060	11157	7107	11204
7061	11158	7108	11205
7062	11159	7109	11206
7063	11160	7110	11207
7064	11161	7111	11208
7065	11162	7112	11209
7066	11163	7113	11210
7067	11164	7114	11211
7068	11165	7115	11212
7069	11166	7116	11213
7070	11167	7117	11214
7071	11168	7118	11215
7072	11169	7119	11216
7073	11170	7120	11217
7074	11171	7121	11218
7075	11172	7122	11219
7076	11173	7123	11220
7077	11174	7124	11221
7078	11175	7125	11222
7079	11176	7126	11223
7080	11177	7127	11224
7081	11178	7128	11225
7082	11179	7129	11226
7083	11180	7130	11227
7084	11181	7131	11228
7085	11182	7132	11229
7086	11183	7133	11230
7134	11231	7181	11278
7135	11232	7182	11279
7136	11233	7183	11280
7137	11234	7184	11281
7138	11235	7185	11282
7139	11236	7186	11283
7140	11237	7187	11284
7141	11238	7188	11285
7142	11239	7189	11286
7143	11240	7190	11287
7144	11241	7191	11288
7145	11242	7192	11289
7146	11243	7193	11290
7147	11244	7194	11291
7148	11245	7195	11292
7149	11246	7196	11293
7150	11247	7197	11294
7151	11248	7198	11295
7152	11249	7199	11296
7153	11250	7200	11297
7154	11251	7201	11298
7155	11252	7202	11299
7156	11253	7203	11300
7157	11254	7204	11301
7158	11255	7205	11302
7159	11256	7206	11303
7160	11257	7207	11304
7161	11258	7208	11305
7162	11259	7209	11306
7163	11260	7210	11307
7164	11261	7211	11308
7165	11262	7212	11309
7166	11263	7213	11310
7167	11264	7214	11311
7168	11265	7215	11312
7169	11266	7216	11313
7170	11267	7217	11314
7171	11268	7218	11315
7172	11269	7219	11316
7173	11270	7220	11317
7174	11271	7221	11318
7175	11272	7222	11319
7176	11273	7223	11320
7177	11274	7224	11321
7178	11275	7225	11322
7179	11276	7226	11323
7180	11277	7227	11324
7228	11325	7275	11372
7229	11326	7276	11373
7230	11327	7277	11374
7231	11328	7278	11375
7232	11329	7279	11376
7233	11330	7280	11377
7234	11331	7281	11378
7235	11332	7282	11379
7236	11333	7283	11380
7237	11334	7284	11381
7238	11335	7285	11382
7239	11336	7286	11383
7240	11337	7287	11384
7241	11338	7288	11385
7242	11339	7289	11386
7243	11340	7290	11387
7244	11341	7291	11388
7245	11342	7292	11389
7246	11343	7293	11390
7247	11344	7294	11391
7248	11345	7295	11392
7249	11346	7296	11393
7250	11347	7297	11394
7251	11348	7298	11395
7252	11349	7299	11396
7253	11350	7300	11397
7254	11351	7301	11398
7255	11352	7302	11399
7256	11353	7303	11400
7257	11354	7304	11401
7258	11355	7305	11402
7259	11356	7306	11403
7260	11357	7307	11404
7261	11358	7308	11405
7262	11359	7309	11406
7263	11360	7310	11407
7264	11361	7311	11408
7265	11362	7312	11409
7266	11363	7313	11410
7267	11364	7314	11411
7268	11365	7315	11412
7269	11366	7316	11413
7270	11367	7317	11414
7271	11368	7318	11415
7272	11369	7319	11416
7273	11370	7320	11417
7274	11371	7321	11418
7322	11419	7369	11466
7323	11420	7370	11467
7324	11421	7371	11468
7325	11422	7372	11469
7326	11423	7373	11470
7327	11424	7374	11471
7328	11425	7375	11472
7329	11426	7376	11473
7330	11427	7377	11474
7331	11428	7378	11475
7332	11429	7379	11476
7333	11430	7380	11477
7334	11431	7381	11478
7335	11432	7382	11479
7336	11433	7383	11480
7337	11434	7384	11481
7338	11435	7385	11482
7339	11436	7386	11483
7340	11437	7387	11484
7341	11438	7388	11485
7342	11439	7389	11486
7343	11440	7390	11487
7344	11441	7391	11488
7345	11442	7392	11489
7346	11443	7393	11490
7347	11444	7394	11491
7348	11445	7395	11492
7349	11446	7396	11493
7350	11447	7397	11494
7351	11448	7398	11495
7352	11449	7399	11496
7353	11450	7400	11497
7354	11451	7401	11498
7355	11452	7402	11499
7356	11453	7403	11500
7357	11454	7404	11501
7358	11455	7405	11502
7359	11456	7406	11503
7360	11457	7407	11504
7361	11458	7408	11505
7362	11459	7409	11506
7363	11460	7410	11507
7364	11461	7411	11508
7365	11462	7412	11509
7366	11463	7413	11510
7367	11464	7414	11511
7368	11465	7415	11512
7416	11513	7463	11560
7417	11514	7464	11561
7418	11515	7465	11562
7419	11516	7466	11563
7420	11517	7467	11564
7421	11518	7468	11565
7422	11519	7469	11566
7423	11520	7470	11567
7424	11521	7471	11568
7425	11522	7472	11569
7426	11523	7473	11570
7427	11524	7474	11571
7428	11525	7475	11572
7429	11526	7476	11573
7430	11527	7477	11574
7431	11528	7478	11575
7432	11529	7479	11576
7433	11530	7480	11577
7434	11531	7481	11578
7435	11532	7482	11579
7436	11533	7483	11580
7437	11534	7484	11581
7438	11535	7485	11582
7439	11536	7486	11583
7440	11537	7487	11584
7441	11538	7488	11585
7442	11539	7489	11586
7443	11540	7490	11587
7444	11541	7491	11588
7445	11542	7492	11589
7446	11543	7493	11590
7447	11544	7494	11591
7448	11545	7495	11592
7449	11546	7496	11593
7450	11547	7497	11594
7451	11548	7498	11595
7452	11549	7499	11596
7453	11550	7500	11597
7454	11551	7501	11598
7455	11552	7502	11599
7456	11553	7503	11600
7457	11554	7504	11601
7458	11555	7505	11602
7459	11556	7506	11603
7460	11557	7507	11604
7461	11558	7508	11605
7462	11559	7509	11606
7510	11607	7557	11654
7511	11608	7558	11655
7512	11609	7559	11656
7513	11610	7560	11657
7514	11611	7561	11658
7515	11612	7562	11659
7516	11613	7563	11660
7517	11614	7564	11661
7518	11615	7565	11662
7519	11616	7566	11663
7520	11617	7567	11664
7521	11618	7568	11665
7522	11619	7569	11666
7523	11620	7570	11667
7524	11621	7571	11668
7525	11622	7572	11669
7526	11623	7573	11670
7527	11624	7574	11671
7528	11625	7575	11672
7529	11626	7576	11673
7530	11627	7577	11674
7531	11628	7578	11675
7532	11629	7579	11676
7533	11630	7580	11677
7534	11631	7581	11678
7535	11632	7582	11679
7536	11633	7583	11680
7537	11634	7584	11681
7538	11635	7585	11682
7539	11636	7586	11683
7540	11637	7587	11684
7541	11638	7588	11685
7542	11639	7589	11686
7543	11640	7590	11687
7544	11641	7591	11688
7545	11642	7592	11689
7546	11643	7593	11690
7547	11644	7594	11691
7548	11645	7595	11692
7549	11646	7596	11693
7550	11647	7597	11694
7551	11648	7598	11695
7552	11649	7599	11696
7553	11650	7600	11697
7554	11651	7601	11698
7555	11652	7602	11699
7556	11653	7603	11700
7604	11701	7651	11748
7605	11702	7652	11749
7606	11703	7653	11750
7607	11704	7654	11751
7608	11705	7655	11752
7609	11706	7656	11753
7610	11707	7657	11754
7611	11708	7658	11755
7612	11709	7659	11756
7613	11710	7660	11757
7614	11711	7661	11758
7615	11712	7662	11759
7616	11713	7663	11760
7617	11714	7664	11761
7618	11715	7665	11762
7619	11716	7666	11763
7620	11717	7667	11764
7621	11718	7668	11765
7622	11719	7669	11766
7623	11720	7670	11767
7624	11721	7671	11768
7625	11722	7672	11769
7626	11723	7673	11770
7627	11724	7674	11771
7628	11725	4052	5107
7629	11726	4053	5108
7630	11727	4054	5109
7631	11728	4055	5110
7632	11729	4056	5111
7633	11730	4057	5112
7634	11731	4058	5113
7635	11732	4059	5114
7636	11733	4060	5115
7637	11734	4061	5116
7638	11735	4062	5117
7639	11736	4063	5118
7640	11737	4064	5119
7641	11738	4065	5120
7642	11739	4066	5121
7643	11740	4067	5122
7644	11741	4068	5123
7645	11742	4069	5124
7646	11743	4070	5125
7647	11744	4071	5126
7648	11745	4072	5127
7649	11746	4073	5128
7650	11747	4074	5129
4075	5130	4122	5177
4076	5131	4123	5178
4077	5132	4124	5179
4078	5133	4125	5180
4079	5134	4126	5181
4080	5135	4127	5182
4081	5136	4128	5183
4082	5137	4129	5184
4083	5138	4130	5185
4084	5139	4131	5186
4085	5140	4132	5187
4086	5141	4133	5188
4087	5142	4134	5189
4088	5143	4135	5190
4089	5144	4136	5191
4090	5145	4137	5192
4091	5146	4138	5193
4092	5147	4139	5194
4093	5148	4140	5195
4094	5149	4141	5196
4095	5150	4142	5197
4096	5151	4143	5198
4097	5152	4144	5199
4098	5153	4145	5200
4099	5154	4146	5201
4100	5155	4147	5202
4101	5156	4148	5203
4102	5157	4149	5204
4103	5158	4150	5205
4104	5159	4151	5206
4105	5160	4152	5207
4106	5161	4153	5208
4107	5162	4154	5209
4108	5163	4155	5210
4109	5164	4156	5211
4110	5165	4157	5212
4111	5166	4158	5213
4112	5167	4159	5214
4113	5168	4160	5215
4114	5169	4161	5216
4115	5170	4162	5217
4116	5171	4163	5218
4117	5172	4164	5219
4118	5173	4165	5220
4119	5174	3998	5053
4120	5175	3999	5054
4121	5176	4000	5055
4001	5056	4048	5103
4002	5057	4049	5104
4003	5058	4050	5105
4004	5059	4051	5106
4005	5060	7675	11772
4006	5061	7676	11773
4007	5062	7677	11774
4008	5063	7678	11775
4009	5064	7676	11776
4010	5065	7679	11777
4011	5066	7680	11778
4012	5067	7681	11779
4013	5068	7682	11780
4014	5069	7683	11781
4015	5070	7684	11782
4016	5071	7685	11783
4017	5072	7686	11784
4018	5073	7687	11785
4019	5074	7688	11786
4020	5075	7689	11787
4021	5076	7690	11788
4022	5077	7691	11789
4023	5078	7692	11790
4024	5079	7693	11791
4025	5080	7694	11792
4026	5081	7695	11793
4027	5082	7696	11794
4028	5083	7697	11795
4029	5084	7698	11796
4030	5085	7699	11797
4031	5086	7700	11798
4032	5087	7701	11799
4033	5088	7702	11800
4034	5089	7703	11801
4035	5090	7704	11802
4036	5091	7705	11803
4037	5092	7706	11804
4038	5093	7707	11805
4039	5094	7708	11806
4040	5095	7709	11807
4041	5096	7710	11808
4042	5097	7711	11809
4043	5098	7712	11810
4044	5099	7713	11811
4045	5100	7714	11812
4046	5101	7715	11813
4047	5102	7716	11814
7717	11815	7764	11862
7718	11816	7765	11863
7719	11817	7766	11864
7720	11818	7767	11865
7721	11819	7768	11866
7722	11820	7769	11867
7723	11821	7770	11868
7724	11822	7771	11869
7725	11823	7772	11870
7726	11824	7773	11871
7727	11825	7774	11872
7728	11826	7775	11873
7729	11827	7776	11874
7730	11828	7777	11875
7731	11829	7778	11876
7732	11830	7779	11877
7733	11831	7780	11878
7734	11832	7781	11879
7735	11833	7782	11880
7736	11834	7783	11881
7737	11835	7784	11882
7738	11836	7785	11883
7739	11837	7786	11884
7740	11838	7787	11885
7741	11839	7788	11886
7742	11840	7789	11887
7743	11841	7790	11888
7744	11842	7791	11889
7745	11843	7792	11890
7746	11844	7793	11891
7747	11845	7794	11892
7748	11846	7795	11893
7749	11847	7796	11894
7750	11848	7797	11895
7751	11849	7798	11896
7752	11850	7799	11897
7753	11851	7800	11898
7754	11852	7801	11899
7755	11853	7802	11900
7756	11854	7803	11901
7757	11855	7804	11902
7758	11856	7805	11903
7759	11857	7806	11904
7760	11858	7807	11905
7761	11859	7808	11906
7762	11860	7809	11907
7763	11861	7810	11908
7811	11909	7858	11956
7812	11910	7859	11957
7813	11911	7860	11958
7814	11912	7861	11959
7815	11913	7862	11960
7816	11914	7863	11961
7817	11915	7864	11962
7818	11916	7865	11963
7819	11917	7866	11964
7820	11918	7867	11965
7821	11919	7868	11966
7822	11920	7869	11967
7823	11921	7870	11968
7824	11922	7871	11969
7825	11923	7872	11970
7826	11924	7873	11971
7827	11925	7874	11972
7828	11926	7875	11973
7829	11927	7876	11974
7830	11928	7877	11975
7831	11929	7878	11976
7832	11930	7879	11977
7833	11931	7880	11978
7834	11932	7881	11979
7835	11933	7882	11980
7836	11934	7883	11981
7837	11935	7884	11982
7838	11936	7885	11983
7839	11937	7886	11984
7840	11938	7887	11985
7841	11939	7888	11986
7842	11940	7889	11987
7843	11941	7890	11988
7844	11942	7891	11989
7845	11943	7892	11990
7846	11944	7893	11991
7847	11945	7894	11992
7848	11946	7895	11993
7849	11947	7896	11994
7850	11948	7897	11995
7851	11949	7898	11996
7852	11950	7899	11997
7853	11951	7900	11998
7854	11952	7901	11999
7855	11953	7902	12000
7856	11954	7903	12001
7857	11955	7904	12002
7905	12003	7952	12050
7906	12004	7953	12051
7907	12005	7954	12052
7908	12006	7955	12053
7909	12007	7956	12054
7910	12008	7957	12055
7911	12009	7958	12056
7912	12010	7959	12057
7913	12011	7960	12058
7914	12012	7961	12059
7915	12013	7962	12060
7916	12014	7963	12061
7917	12015	7964	12062
7918	12016	7965	12063
7919	12017	7966	12064
7920	12018	7967	12065
7921	12019	7968	12066
7922	12020	7969	12067
7923	12021	7970	12068
7924	12022	7971	12069
7925	12023	7972	12070
7926	12024	7973	12071
7927	12025	7974	12072
7928	12026	7975	12073
7929	12027	7976	12074
7930	12028	7977	12075
7931	12029	7978	12076
7932	12030	7979	12077
7933	12031	7980	12078
7934	12032	7981	12079
7935	12033	7982	12080
7936	12034	7983	12081
7937	12035	7984	12082
7938	12036	7985	12083
7939	12037	7986	12084
7940	12038	7987	12085
7941	12039	7988	12086
7942	12040	7989	12087
7943	12041	7990	12088
7944	12042	7991	12089
7945	12043	7992	12090
7946	12044	7993	12091
7947	12045	7994	12092
7948	12046	7995	12093
7949	12047	7996	12094
7950	12048	7997	12095
7951	12049	7998	12096
7999	12097	8046	12144
8000	12098	8047	12145
8001	12099	8048	12146
8002	12100	8049	12147
8003	12101	8050	12148
8004	12102	8051	12149
8005	12103	8052	12150
8006	12104	8053	12151
8007	12105	8054	12152
8008	12106	8055	12153
8009	12107	8056	12154
8010	12108	8057	12155
8011	12109	8058	12156
8012	12110	8059	12157
8013	12111	8060	12158
8014	12112	8061	12159
8015	12113	8062	12160
8016	12114	8063	12161
8017	12115	8064	12162
8018	12116	8065	12163
8019	12117	8066	12164
8020	12118	8067	12165
8021	12119	8068	12166
8022	12120	8069	12167
8023	12121	8070	12168
8024	12122	8071	12169
8025	12123	8072	12170
8026	12124	8073	12171
8027	12125	8074	12172
8028	12126	8075	12173
8029	12127	8076	12174
8030	12128	8077	12175
8031	12129	8078	12176
8032	12130	8079	12177
8033	12131	8080	12178
8034	12132	8081	12179
8035	12133	8082	12180
8036	12134	8083	12181
8037	12135	8084	12182
8038	12136	8085	12183
8039	12137	8086	12184
8040	12138	8087	12185
8041	12139	8088	12186
8042	12140	8089	12187
8043	12141	8090	12188
8044	12142	8091	12189
8045	12143	8092	12190
8093	12191	8140	12238
8094	12192	8141	12239
8095	12193	8142	12240
8096	12194	8143	12241
8097	12195	8144	12242
8098	12196	8145	12243
8099	12197	8146	12244
8100	12198	8147	12245
8101	12199	8148	12246
8102	12200	8149	12247
8103	12201	8150	12248
8104	12202	8151	12249
8105	12203	8152	12250
8106	12204	8153	12251
8107	12205	8154	12252
8108	12206	8155	12253
8109	12207	8156	12254
8110	12208	8157	12255
8111	12209	8158	12256
8112	12210	8159	12257
8113	12211	8160	12258
8114	12212	8161	12259
8115	12213	8162	12260
8116	12214	8163	12261
8117	12215	8164	12262
8118	12216	8165	12263
8119	12217	8166	12264
8120	12218	8167	12265
8121	12219	8168	12266
8122	12220	8169	12267
8123	12221	8170	12268
8124	12222	8171	12269
8125	12223	8172	12270
8126	12224	8173	12271
8127	12225	8174	12272
8128	12226	8175	12273
8129	12227	8176	12274
8130	12228	8177	12275
8131	12229	8178	12276
8132	12230	8179	12277
8133	12231	8180	12278
8134	12232	8181	12279
8135	12233	8182	12280
8136	12234	8183	12281
8137	12235	8184	12282
8138	12236	8185	12283
8139	12237	8186	12284
8187	12285	8234	12332
8188	12286	8235	12333
8189	12287	8236	12334
8190	12288	8237	12335
8191	12289	8238	12336
8192	12290	8239	12337
8193	12291	8240	12338
8194	12292	8241	12339
8195	12293	8242	12340
8196	12294	8243	12341
8197	12295	8244	12342
8198	12296	8245	12343
8199	12297	8246	12344
8200	12298	8247	12345
8201	12299	8248	12346
8202	12300	8249	12347
8203	12301	8250	12348
8204	12302	8251	12349
8205	12303	8252	12350
8206	12304	8253	12351
8207	12305	8254	12352
8208	12306	8255	12353
8209	12307	8256	12354
8210	12308	8257	12355
8211	12309	8258	12356
8212	12310	8259	12357
8213	12311	8260	12358
8214	12312	8261	12359
8215	12313	8262	12360
8216	12314	8263	12361
8217	12315	8264	12362
8218	12316	8265	12363
8219	12317	8266	12364
8220	12318	8267	12365
8221	12319	8268	12366
8222	12320	8269	12367
8223	12321	8270	12368
8224	12322	8271	12369
8225	12323	8272	12370
8226	12324	8273	12371
8227	12325	8274	12372
8228	12326	8275	12373
8229	12327	8276	12374
8230	12328	8277	12375
8231	12329	8278	12376
8232	12330	8279	12377
8233	12331	8280	12378
8281	12379	8328	12426
8282	12380	8329	12427
8283	12381	8330	12428
8284	12382	8331	12429
8285	12383	8332	12430
8286	12384	8333	12431
8287	12385	8334	12432
8288	12386	8335	12433
8289	12387	8336	12434
8290	12388	8337	12435
8291	12389	8338	12436
8292	12390	8339	12437
8293	12391	8340	12438
8294	12392	8341	12439
8295	12393	8342	12440
8296	12394	8343	12441
8297	12395	8344	12442
8298	12396	8345	12443
8299	12397	8346	12444
8300	12398	8347	12445
8301	12399	8348	12446
8302	12400	8349	12447
8303	12401	8350	12448
8304	12402	8351	12449
8305	12403	8352	12450
8306	12404	8353	12451
8307	12405	8354	12452
8308	12406	8355	12453
8309	12407	8356	12454
8310	12408	8357	12455
8311	12409	8358	12456
8312	12410	8359	12457
8313	12411	8360	12458
8314	12412	8361	12459
8315	12413	8362	12460
8316	12414	8363	12461
8317	12415	8364	12462
8318	12416	8365	12463
8319	12417	8366	12464
8320	12418	8367	12465
8321	12419	8368	12466
8322	12420	8369	12467
8323	12421	8370	12468
8324	12422	8371	12469
8325	12423	8372	12470
8326	12424	8373	12471
8327	12425	8374	12472
8375	12473	8422	12520
8376	12474	8423	12521
8377	12475	8424	12522
8378	12476	8425	12523
8379	12477	8426	12524
8380	12478	8427	12525
8381	12479	8428	12526
8382	12480	8429	12527
8383	12481	8430	12528
8384	12482	8431	12529
8385	12483	8432	12530
8386	12484	8433	12531
8387	12485	8434	12532
8388	12486	8435	12533
8389	12487	8436	12534
8390	12488	8437	12535
8391	12489	8438	12536
8392	12490	8439	12537
8393	12491	8440	12538
8394	12492	8441	12539
8395	12493	8442	12540
8396	12494	8443	12541
8397	12495	8444	12542
8398	12496	8445	12543
8399	12497	8446	12544
8400	12498	8447	12545
8401	12499	8448	12546
8402	12500	8449	12547
8403	12501	8450	12548
8404	12502	8451	12549
8405	12503	8452	12550
8406	12504	8453	12551
8407	12505	8454	12552
8408	12506	8455	12553
8409	12507	8456	12554
8410	12508	8457	12555
8411	12509	8458	12556
8412	12510	8459	12557
8413	12511	8460	12558
8414	12512	8461	12559
8415	12513	8462	12560
8416	12514	8463	12561
8417	12515	8464	12562
8418	12516	8465	12563
8419	12517	8466	12564
8420	12518	8467	12565
8421	12519	8468	12566
8469	12567	8516	12614
8470	12568	8517	12615
8471	12569	8518	12616
8472	12570	8519	12617
8473	12571	8520	12618
8474	12572	8521	12619
8475	12573	8522	12620
8476	12574	8523	12621
8477	12575	8524	12622
8478	12576	8525	12623
8479	12577	8526	12624
8480	12578	8527	12625
8481	12579	8528	12626
8482	12580	8529	12627
8483	12581	8530	12628
8484	12582	8531	12629
8485	12583	8532	12630
8486	12584	8533	12631
8487	12585	8534	12632
8488	12586	8535	12633
8489	12587	8536	12634
8490	12588	8537	12635
8491	12589	8538	12636
8492	12590	8539	12637
8493	12591	8540	12638
8494	12592	8541	12639
8495	12593	8542	12640
8496	12594	8543	12641
8497	12595	8544	12642
8498	12596	8545	12643
8499	12597	8546	12644
8500	12598	8547	12645
8501	12599	8548	12646
8502	12600	8549	12647
8503	12601	8550	12648
8504	12602	8551	12649
8505	12603	8552	12650
8506	12604	8553	12651
8507	12605	8554	12652
8508	12606	8555	12653
8509	12607	8556	12654
8510	12608	8557	12655
8511	12609	8558	12656
8512	12610	8559	12657
8513	12611	8560	12658
8514	12612	8561	12659
8515	12613	8562	12660
8563	12661	8610	12708
8564	12662	8611	12709
8565	12663	8612	12710
8566	12664	8613	12711
8567	12665	8614	12712
8568	12666	8615	12713
8569	12667	8616	12714
8570	12668	8617	12715
8571	12669	8618	12716
8572	12670	8619	12717
8573	12671	8620	12718
8574	12672	8621	12719
8575	12673	8622	12720
8576	12674	8623	12721
8577	12675	8624	12722
8578	12676	8625	12723
8579	12677	8626	12724
8580	12678	8627	12725
8581	12679	8628	12726
8582	12680	8629	12727
8583	12681	8630	12728
8584	12682	8631	12729
8585	12683	8632	12730
8586	12684	8633	12731
8587	12685	8634	12732
8588	12686	8635	12733
8589	12687	8636	12734
8590	12688	8637	12735
8591	12689	8638	12736
8592	12690	8639	12737
8593	12691	8640	12738
8594	12692	8641	12739
8595	12693	8642	12740
8596	12694	8643	12741
8597	12695	8644	12742
8598	12696	8645	12743
8599	12697	8646	12744
8600	12698	8647	12745
8601	12699	8648	12746
8602	12700	8649	12747
8603	12701	8650	12748
8604	12702	8651	12749
8605	12703	8652	12750
8606	12704	8653	12751
8607	12705	8654	12752
8608	12706	8655	12753
8609	12707	8656	12754
8657	12755	8704	12802
8658	12756	8705	12803
8659	12757	8706	12804
8660	12758	8707	12805
8661	12759	8708	12806
8662	12760	8709	12807
8663	12761	8710	12808
8664	12762	8711	12809
8665	12763	8712	12810
8666	12764	8713	12811
8667	12765	8714	12812
8668	12766	8715	12813
8669	12767	8716	12814
8670	12768	8717	12815
8671	12769	8718	12816
8672	12770	8719	12817
8673	12771	8720	12818
8674	12772	8721	12819
8675	12773	8722	12820
8676	12774	8723	12821
8677	12775	8724	12822
8678	12776	8725	12823
8679	12777	8726	12824
8680	12778	8727	12825
8681	12779	8728	12826
8682	12780	8729	12827
8683	12781	8730	12828
8684	12782	8731	12829
8685	12783	8732	12830
8686	12784	8733	12831
8687	12785	8734	12832
8688	12786	8735	12833
8689	12787	8736	12834
8690	12788	8737	12835
8691	12789	8738	12836
8692	12790	8739	12837
8693	12791	8740	12838
8694	12792	8741	12839
8695	12793	8742	12840
8696	12794	8743	12841
8697	12795	8744	12842
8698	12796	8745	12843
8699	12797	8746	12844
8700	12798	8747	12845
8701	12799	8748	12846
8702	12800	8749	12847
8703	12801	8750	12848
8751	12849	8798	12896
8752	12850	8799	12897
8753	12851	8800	12898
8754	12852	8801	12899
8755	12853	8802	12900
8756	12854	8803	12901
8757	12855	8804	12902
8758	12856	8805	12903
8759	12857	8806	12904
8760	12858	8807	12905
8761	12859	8808	12906
8762	12860	8809	12907
8763	12861	8810	12908
8764	12862	8811	12909
8765	12863	8812	12910
8766	12864	8813	12911
8767	12865	8814	12912
8768	12866	8815	12913
8769	12867	8816	12914
8770	12868	8817	12915
8771	12869	8818	12916
8772	12870	8819	12917
8773	12871	8820	12918
8774	12872	8821	12919
8775	12873	8822	12920
8776	12874	8823	12921
8777	12875	8824	12922
8778	12876	8825	12923
8779	12877	8826	12924
8780	12878	8827	12925
8781	12879	8828	12926
8782	12880	8829	12927
8783	12881	8830	12928
8784	12882	8831	12929
8785	12883	8832	12930
8786	12884	8833	12931
8787	12885	8834	12932
8788	12886	8835	12933
8789	12887	8836	12934
8790	12888	8837	12935
8791	12889	8838	12936
8792	12890	8839	12937
8793	12891	8840	12938
8794	12892	8841	12939
8795	12893	8842	12940
8796	12894	8843	12941
8797	12895	8844	12942
8845	12943	8892	12990
8846	12944	8893	12991
8847	12945	8894	12992
8848	12946	8895	12993
8849	12947	8896	12994
8850	12948	8897	12995
8851	12949	8898	12996
8852	12950	8899	12997
8853	12951	8900	12998
8854	12952	8901	12999
8855	12953	8902	13000
8856	12954	8903	13001
8857	12955	8904	13002
8858	12956	8905	13003
8859	12957	8906	13004
8860	12958	8907	13005
8861	12959	8908	13006
8862	12960	8909	13007
8863	12961	8910	13008
8864	12962	8911	13009
8865	12963	8912	13010
8866	12964	8913	13011
8867	12965	8914	13012
8868	12966	8915	13013
8869	12967	8916	13014
8870	12968	8917	13015
8871	12969	8918	13016
8872	12970	8919	13017
8873	12971	8920	13018
8874	12972	8921	13019
8875	12973	8922	13020
8876	12974	8923	13021
8877	12975	8924	13022
8878	12976	8925	13023
8879	12977	8926	13024
8880	12978	8927	13025
8881	12979	8928	13026
8882	12980	8929	13027
8883	12981	8930	13028
8884	12982	8931	13029
8885	12983	8932	13030
8886	12984	8933	13031
8887	12985	8934	13032
8888	12986	8935	13033
8889	12987	8936	13034
8890	12988	8937	13035
8891	12989	8938	13036
8939	13037	8986	13084
8940	13038	8987	13085
8941	13039	8988	13086
8942	13040	8989	13087
8943	13041	8990	13088
8944	13042	8991	13089
8945	13043	8992	13090
8946	13044	8993	13091
8947	13045	8994	13092
8948	13046	8995	13093
8949	13047	8996	13094
8950	13048	8997	13095
8951	13049	8998	13096
8952	13050	8999	13097
8953	13051	9000	13098
8954	13052	9001	13099
8955	13053	9002	13100
8956	13054	9003	13101
8957	13055	9004	13102
8958	13056	9005	13103
8959	13057	9006	13104
8960	13058	9007	13105
8961	13059	9008	13106
8962	13060	9009	13107
8963	13061	9010	13108
8964	13062	9011	13109
8965	13063	9012	13110
8966	13064	9013	13111
8967	13065	9014	13112
8968	13066	9015	13113
8969	13067	9016	13114
8970	13068	9017	13115
8971	13069	9018	13116
8972	13070	9019	13117
8973	13071	9020	13118
8974	13072	9021	13119
8975	13073	9022	13120
8976	13074	9023	13121
8977	13075	9024	13122
8978	13076	9025	13123
8979	13077	9026	13124
8980	13078	9027	13125
8981	13079	9028	13126
8982	13080	9029	13127
8983	13081	9030	13128
8984	13082	9031	13129
8985	13083	9032	13130
9033	13131	9080	13178
9034	13132	9081	13179
9035	13133	9082	13180
9036	13134	9083	13181
9037	13135	9084	13182
9038	13136	9085	13183
9039	13137	9086	13184
9040	13138	9087	13185
9041	13139	9088	13186
9042	13140	9089	13187
9043	13141	9090	13188
9044	13142	9091	13189
9045	13143	9092	13190
9046	13144	9093	13191
9047	13145	9094	13192
9048	13146	9095	13193
9049	13147	9096	13194
9050	13148	9097	13195
9051	13149	9098	13196
9052	13150	9099	13197
9053	13151	9100	13198
9054	13152	9101	13199
9055	13153	9102	13200
9056	13154	9103	13201
9057	13155	9104	13202
9058	13156	9105	13203
9059	13157	9106	13204
9060	13158	9107	13205
9061	13159	9108	13206
9062	13160	9109	13207
9063	13161	9110	13208
9064	13162	9111	13209
9065	13163	9112	13210
9066	13164	9113	13211
9067	13165	9114	13212
9068	13166	9115	13213
9069	13167	9116	13214
9070	13168	9117	13215
9071	13169	9118	13216
9072	13170	9119	13217
9073	13171	9120	13218
9074	13172	9121	13219
9075	13173	9122	13220
9076	13174	9123	13221
9077	13175	9124	13222
9078	13176	9125	13223
9079	13177	9126	13224
9127	13225	9174	13272
9128	13226	9175	13273
9129	13227	9176	13274
9130	13228	9177	13275
9131	13229	9178	13276
9132	13230	9179	13277
9133	13231	9180	13278
9134	13232	9181	13279
9135	13233	9182	13280
9136	13234	9183	13281
9137	13235	9184	13282
9138	13236	9185	13283
9139	13237	9186	13284
9140	13238	9187	13285
9141	13239	9188	13286
9142	13240	9189	13287
9143	13241	9190	13288
9144	13242	9191	13289
9145	13243	9192	13290
9146	13244	9193	13291
9147	13245	9194	13292
9148	13246	9195	13293
9149	13247	9196	13294
9150	13248	9197	13295
9151	13249	9198	13296
9152	13250	9199	13297
9153	13251	9200	13298
9154	13252	9201	13299
9155	13253	9202	13300
9156	13254	9203	13301
9157	13255	9204	13302
9158	13256	9205	13303
9159	13257	9206	13304
9160	13258	9207	13305
9161	13259	9208	13306
9162	13260	9209	13307
9163	13261	9210	13308
9164	13262	9211	13309
9165	13263	9212	13310
9166	13264	9213	13311
9167	13265	9214	13312
9168	13266	9215	13313
9169	13267	9216	13314
9170	13268	9217	13315
9171	13269	9218	13316
9172	13270	9219	13317
9173	13271	9220	13318
9221	13319	9268	13366
9222	13320	9269	13367
9223	13321	9270	13368
9224	13322	9271	13369
9225	13323	9272	13370
9226	13324	9273	13371
9227	13325	9274	13372
9228	13326	9275	13373
9229	13327	9276	13374
9230	13328	9277	13375
9231	13329	9278	13376
9232	13330	9279	13377
9233	13331	9280	13378
9234	13332	9281	13379
9235	13333	9282	13380
9236	13334	9283	13381
9237	13335	9284	13382
9238	13336	9285	13383
9239	13337	9286	13384
9240	13338	9287	13385
9241	13339	9288	13386
9242	13340	9289	13387
9243	13341	9290	13388
9244	13342	9291	13389
9245	13343	9292	13390
9246	13344	9293	13391
9247	13345	9294	13392
9248	13346	9295	13393
9249	13347	9296	13394
9250	13348	9297	13395
9251	13349	9298	13396
9252	13350	9299	13397
9253	13351	9300	13398
9254	13352	9301	13399
9255	13353	9302	13400
9256	13354	9303	13401
9257	13355	9304	13402
9258	13356	9305	13403
9259	13357	9306	13404
9260	13358	9307	13405
9261	13359	9308	13406
9262	13360	9309	13407
9263	13361	9310	13408
9264	13362	9311	13409
9265	13363	9312	13410
9266	13364	9313	13411
9267	13365	9314	13412
9315	13413	9362	13460
9316	13414	9363	13461
9317	13415	9364	13462
9318	13416	9365	13463
9319	13417	9366	13464
9320	13418	9367	13465
9321	13419	9368	13466
9322	13420	9369	13467
9323	13421	9370	13468
9324	13422	9371	13469
9325	13423	9372	13470
9326	13424	9373	13471
9327	13425	9374	13472
9328	13426	9375	13473
9329	13427	9376	13474
9330	13428	9377	13475
9331	13429	9378	13476
9332	13430	9379	13477
9333	13431	9380	13478
9334	13432	9381	13479
9335	13433	9382	13480
9336	13434	9383	13481
9337	13435	9384	13482
9338	13436	9385	13483
9339	13437	9386	13484
9340	13438	9387	13485
9341	13439	9388	13486
9342	13440	9389	13487
9343	13441	9390	13488
9344	13442	9391	13489
9345	13443	9392	13490
9346	13444	9393	13491
9347	13445	9394	13492
9348	13446	9395	13493
9349	13447	9396	13494
9350	13448	9397	13495
9351	13449	9398	13496
9352	13450	9399	13497
9353	13451	9400	13498
9354	13452	9401	13499
9355	13453	9402	13500
9356	13454	9403	13501
9357	13455	9404	13502
9358	13456	9405	13503
9359	13457	9406	13504
9360	13458	9407	13505
9361	13459	9408	13506
9409	13507	9456	13554
9410	13508	9457	13555
9411	13509	9458	13556
9412	13510	9459	13557
9413	13511	9460	13558
9414	13512	9461	13559
9415	13513	9462	13560
9416	13514	9463	13561
9417	13515	9464	13562
9418	13516	9465	13563
9419	13517	9466	13564
9420	13518	9467	13565
9421	13519	9468	13566
9422	13520	9469	13567
9423	13521	9470	13568
9424	13522	9471	13569
9425	13523	9472	13570
9426	13524	9473	13571
9427	13525	9474	13572
9428	13526	9475	13573
9429	13527	9476	13574
9430	13528	9477	13575
9431	13529	9478	13576
9432	13530	9479	13577
9433	13531	9480	13578
9434	13532	9481	13579
9435	13533	9482	13580
9436	13534	9483	13581
9437	13535	9484	13582
9438	13536	9485	13583
9439	13537	9486	13584
9440	13538	9487	13585
9441	13539	9488	13586
9442	13540	9489	13587
9443	13541	9490	13588
9444	13542	9491	13589
9445	13543	9492	13590
9446	13544	9493	13591
9447	13545	9494	13592
9448	13546	9495	13593
9449	13547	9496	13594
9450	13548	9497	13595
9451	13549	9498	13596
9452	13550	9499	13597
9453	13551	9500	13598
9454	13552	9501	13599
9455	13553	9502	13600
9503	13601	9550	13648
9504	13602	9551	13649
9505	13603	9552	13650
9506	13604	9553	13651
9507	13605	9554	13652
9508	13606	9555	13653
9509	13607	9556	13654
9510	13608	9557	13655
9511	13609	9558	13656
9512	13610	9559	13657
9513	13611	9560	13658
9514	13612	9561	13659
9515	13613	9562	13660
9516	13614	9563	13661
9517	13615	9564	13662
9518	13616	9565	13663
9519	13617	9566	13664
9520	13618	9567	13665
9521	13619	9568	13666
9522	13620	9569	13667
9523	13621	9570	13668
9524	13622	9571	13669
9525	13623	9572	13670
9526	13624	9573	13671
9527	13625	9574	13672
9528	13626	9575	13673
9529	13627	9576	13674
9530	13628	9577	13675
9531	13629	9578	13676
9532	13630	9579	13677
9533	13631	9580	13678
9534	13632	9581	13679
9535	13633	9582	13680
9536	13634	9583	13681
9537	13635	9584	13682
9538	13636	9585	13683
9539	13637	9586	13684
9540	13638	9587	13685
9541	13639	9588	13686
9542	13640	9589	13687
9543	13641	9590	13688
9544	13642	9591	13689
9545	13643	9592	13690
9546	13644	9593	13691
9547	13645	9594	13692
9548	13646	9595	13693
9549	13647	9596	13694
9597	13695	9644	13742
9598	13696	9645	13743
9599	13697	9646	13744
9600	13698	9647	13745
9601	13699	9648	13746
9602	13700	9649	13747
9603	13701	9650	13748
9604	13702	9651	13749
9605	13703	9652	13750
9606	13704	9653	13751
9607	13705	9654	13752
9608	13706	9655	13753
9609	13707	9656	13754
9610	13708	9657	13755
9611	13709	9658	13756
9612	13710	9659	13757
9613	13711	9660	13758
9614	13712	9661	13759
9615	13713	9662	13760
9616	13714	9663	13761
9617	13715	9664	13762
9618	13716	9665	13763
9619	13717	9666	13764
9620	13718	9667	13765
9621	13719	9668	13766
9622	13720	9669	13767
9623	13721	9670	13768
9624	13722	9671	13769
9625	13723	9672	13770
9626	13724	9673	13771
9627	13725	9674	13772
9628	13726	9675	13773
9629	13727	9676	13774
9630	13728	9677	13775
9631	13729	9678	13776
9632	13730	9679	13777
9633	13731	9680	13778
9634	13732	9681	13779
9635	13733	9682	13780
9636	13734	9683	13781
9637	13735	9684	13782
9638	13736	9685	13783
9639	13737	9686	13784
9640	13738	9687	13785
9641	13739	9688	13786
9642	13740	9689	13787
9643	13741	9690	13788
9691	13789	9738	13836
9692	13790	9739	13837
9693	13791	9740	13838
9694	13792	9741	13839
9695	13793	9742	13840
9696	13794	9743	13841
9697	13795	9744	13842
9698	13796	9745	13843
9699	13797	9746	13844
9700	13798	9747	13845
9701	13799	9748	13846
9702	13800	9749	13847
9703	13801	9750	13848
9704	13802	9751	13849
9705	13803	9752	13850
9706	13804	9753	13851
9707	13805	9754	13852
9708	13806	9755	13853
9709	13807	9756	13854
9710	13808	9757	13855
9711	13809	9758	13856
9712	13810	9759	13857
9713	13811	9760	13858
9714	13812	9761	13859
9715	13813	9762	13860
9716	13814	9763	13861
9717	13815	9764	13862
9718	13816	9765	13863
9719	13817	9766	13864
9720	13818	9767	13865
9721	13819	9768	13866
9722	13820	9769	13867
9723	13821	9770	13868
9724	13822	9771	13869
9725	13823	9772	13870
9726	13824	9773	13871
9727	13825	9774	13872
9728	13826	9775	13873
9729	13827	9776	13874
9730	13828	9777	13875
9731	13829	9778	13876
9732	13830	9779	13877
9733	13831	9780	13878
9734	13832	9781	13879
9735	13833	9782	13880
9736	13834	9783	13881
9737	13835	9784	13882
9785	13883	9832	13930
9786	13884	9833	13931
9787	13885	9834	13932
9788	13886	9835	13933
9789	13887	9836	13934
9790	13888	9837	13935
9791	13889	9838	13936
9792	13890	9839	13937
9793	13891	9840	13938
9794	13892	9841	13939
9795	13893	9842	13940
9796	13894	9843	13941
9797	13895	9844	13942
9798	13896	9845	13943
9799	13897	9846	13944
9800	13898	9847	13945
9801	13899	9848	13946
9802	13900	9849	13947
9803	13901	9850	13948
9804	13902	9851	13949
9805	13903	9852	13950
9806	13904	9853	13951
9807	13905	9854	13952
9808	13906	9855	13953
9809	13907	9856	13954
9810	13908	9857	13955
9811	13909	9858	13956
9812	13910	9859	13957
9813	13911	9860	13958
9814	13912	9861	13959
9815	13913	9862	13960
9816	13914	9863	13961
9817	13915	9864	13962
9818	13916	9865	13963
9819	13917	9866	13964
9820	13918	9867	13965
9821	13919	9868	13966
9822	13920	9869	13967
9823	13921	9870	13968
9824	13922	9871	13969
9825	13923	9872	13970
9826	13924	9873	13971
9827	13925	9874	13972
9828	13926	9875	13973
9829	13927	9876	13974
9830	13928	9877	13975
9831	13929	9878	13976
9879	13977	9926	14024
9880	13978	9927	14025
9881	13979	9928	14026
9882	13980	9929	14027
9883	13981	9930	14028
9884	13982	9931	14029
9885	13983	9932	14030
9886	13984	9933	14031
9887	13985	9934	14032
9888	13986	9935	14033
9889	13987	9936	14034
9890	13988	9937	14035
9891	13989	9938	14036
9892	13990	9939	14037
9893	13991	9940	14038
9894	13992	9941	14039
9895	13993	9942	14040
9896	13994	9943	14041
9897	13995	9944	14042
9898	13996	9945	14043
9899	13997	9946	14044
9900	13998	9947	14045
9901	13999	9948	14046
9902	14000	9949	14047
9903	14001	9950	14048
9904	14002	9951	14049
9905	14003	9952	14050
9906	14004	9953	14051
9907	14005	9954	14052
9908	14006	9955	14053
9909	14007	9956	14054
9910	14008	9957	14055
9911	14009	9958	14056
9912	14010	9959	14057
9913	14011	9960	14058
9914	14012	9961	14059
9915	14013	9962	14060
9916	14014	9963	14061
9917	14015	9964	14062
9918	14016	9965	14063
9919	14017	9966	14064
9920	14018	9967	14065
9921	14019	9968	14066
9922	14020	9969	14067
9923	14021	9970	14068
9924	14022	9971	14069
9925	14023	9972	14070
9973	14071
9974	14072
9975	14073
9976	14074
9977	14075
9978	14076
9979	14077
9980	14078
9981	14079
9982	14080
9983	14081
9984	14082
9985	14083
9986	14084
9987	14085
9988	14086
9989	14087
9990	14088
9991	14089
9992	14090
9993	14091
9994	14092
9995	14093
9996	14094
9997	14095
9998	14096
9999	14097
10000	14098
10001	14099
10002	14100
10003	14101
10004	14102
10005	14103
10006	14104
10007	14105
10008	14106
10009	14107
10010	14108
10011	14109
10012	14110

[0878]

TABLE IA
SeqID	Clone name	Organism
8	E3M10000001A02	Enterococcus faecalis
9	E3M10000001A06	Enterococcus faecalis
10	E3M10000001B01	Enterococcus faecalis
11	E3M10000001B02	Enterococcus faecalis
12	E3M10000001B05	Enterococcus faecalis
13	E3M10000001B06	Enterococcus faecalis
14	E3M10000001B08	Enterococcus faecalis
15	E3M10000001B10	Enterococcus faecalis
16	E3M10000001C02	Enterococcus faecalis
17	E3M10000001C09	Enterococcus faecalis
18	E3M10000001D02	Enterococcus faecalis
19	E3M10000001D04	Enterococcus faecalis
20	E3M10000001D05	Enterococcus faecalis
21	E3M10000001D09	Enterococcus faecalis
22	E3M10000001E01	Enterococcus faecalis
23	E3M10000001E02	Enterococcus faecalis
24	E3M10000001E03	Enterococcus faecalis
25	E3M10000001E04	Enterococcus faecalis
26	E3M10000001E08	Enterococcus faecalis
27	E3M10000001E09	Enterococcus faecalis
28	E3M10000001F02	Enterococcus faecalis
29	E3M10000001F04	Enterococcus faecalis
30	E3M10000001F06	Enterococcus faecalis
31	E3M10000001F07	Enterococcus faecalis
32	E3M10000001G02	Enterococcus faecalis
33	E3M10000001G03	Enterococcus faecalis
34	E3M10000001G04	Enterococcus faecalis
35	E3M10000001G05	Enterococcus faecalis
36	E3M10000001H02	Enterococcus faecalis
37	E3M10000001H03	Enterococcus faecalis
38	E3M10000001H04	Enterococcus faecalis
39	E3M10000004A04	Enterococcus faecalis
40	E3M10000004C03	Enterococcus faecalis
41	E3M10000004D01	Enterococcus faecalis
42	E3M10000004D02	Enterococcus faecalis
43	E3M10000004D10	Enterococcus faecalis
44	E3M10000004E11	Enterococcus faecalis
45	E3M10000004F08	Enterococcus faecalis
46	E3M10000004F10	Enterococcus faecalis
47	E3M10000004G01	Enterococcus faecalis
48	E3M10000004H11	Enterococcus faecalis
49	E3M10000005A07	Enterococcus faecalis
50	E3M10000005B01	Enterococcus faecalis
51	E3M10000005B08	Enterococcus faecalis
52	E3M10000005C01	Enterococcus faecalis
53	E3M10000005C03	Enterococcus faecalis
54	E3M10000005C04	Enterococcus faecalis
55	E3M10000005D03	Enterococcus faecalis
56	E3M10000005D04	Enterococcus faecalis
57	E3M10000005D10	Enterococcus faecalis
58	E3M10000005E01	Enterococcus faecalis
59	E3M10000005E02	Enterococcus faecalis
60	E3M10000005E03	Enterococcus faecalis
61	E3M10000005E08	Enterococcus faecalis
62	E3M10000005F07	Enterococcus faecalis
63	E3M10000005F10	Enterococcus faecalis
64	E3M10000005G05	Enterococcus faecalis
65	E3M10000005H04	Enterococcus faecalis
66	E3M10000006B03	Enterococcus faecalis
67	E3M10000006C01	Enterococcus faecalis
68	E3M10000006C12	Enterococcus faecalis
69	E3M10000006D03	Enterococcus faecalis
70	E3M10000006E11	Enterococcus faecalis
71	E3M10000006F04	Enterococcus faecalis
72	E3M10000006G04	Enterococcus faecalis
73	E3M10000006G12	Enterococcus faecalis
74	E3M10000006H09	Enterococcus faecalis
75	E3M10000007A02	Enterococcus faecalis
76	E3M10000007B02	Enterococcus faecalis
77	E3M10000007B03	Enterococcus faecalis
78	E3M10000007C03	Enterococcus faecalis
79	E3M10000007C04	Enterococcus faecalis
80	E3M10000007D03	Enterococcus faecalis
81	E3M10000007E05	Enterococcus faecalis
82	E3M10000007F01	Enterococcus faecalis
83	E3M10000007F06	Enterococcus faecalis
84	E3M10000007G01	Enterococcus faecalis
85	E3M10000008C03	Enterococcus faecalis
86	E3M10000008C08	Enterococcus faecalis
87	E3M10000008C09	Enterococcus faecalis
88	E3M10000008D08	Enterococcus faecalis
89	E3M10000008E02	Enterococcus faecalis
90	E3M10000008G05	Enterococcus faecalis
91	E3M10000008G09	Enterococcus faecalis
92	E3M10000008H02	Enterococcus faecalis
93	E3M10000009C07	Enterococcus faecalis
94	E3M10000009C09	Enterococcus faecalis
95	E3M10000009D01	Enterococcus faecalis
96	E3M10000009E02	Enterococcus faecalis
97	E3M10000009E03	Enterococcus faecalis
98	E3M10000009E05	Enterococcus faecalis
99	E3M10000009G02	Enterococcus faecalis
100	E3M10000010C08	Enterococcus faecalis
101	E3M10000010D05	Enterococcus faecalis
102	E3M10000010F01	Enterococcus faecalis
103	E3M10000010G05	Enterococcus faecalis
104	E3M10000010G07	Enterococcus faecalis
105	E3M10000010G09	Enterococcus faecalis
106	E3M10000010G10	Enterococcus faecalis
107	E3M10000010H02	Enterococcus faecalis
108	E3M10000011A09	Enterococcus faecalis
109	E3M10000011B03	Enterococcus faecalis
110	E3M10000011B09	Enterococcus faecalis
111	E3M10000011C07	Enterococcus faecalis
112	E3M10000011D03	Enterococcus faecalis
113	E3M10000011H02	Enterococcus faecalis
114	E3M10000011H05	Enterococcus faecalis
115	E3M10000012B01	Enterococcus faecalis
116	E3M10000012B02	Enterococcus faecalis
117	E3M10000012B07	Enterococcus faecalis
118	E3M10000012B08	Enterococcus faecalis
119	E3M10000012C01	Enterococcus faecalis
120	E3M10000012D10	Enterococcus faecalis
121	E3M10000012E08	Enterococcus faecalis
122	E3M10000012F05	Enterococcus faecalis
123	E3M10000012F06	Enterococcus faecalis
124	E3M10000012F07	Enterococcus faecalis
125	E3M10000012F10	Enterococcus faecalis
126	E3M10000012G02	Enterococcus faecalis
127	E3M10000012G07	Enterococcus faecalis
128	E3M10000013A06	Enterococcus faecalis
129	E3M10000013A07	Enterococcus faecalis
130	E3M10000013C05	Enterococcus faecalis
131	E3M10000013D02	Enterococcus faecalis
132	E3M10000013D08	Enterococcus faecalis
133	E3M10000013D10	Enterococcus faecalis
134	E3M10000013E02	Enterococcus faecalis
135	E3M10000013E08	Enterococcus faecalis
136	E3M10000013F05	Enterococcus faecalis
137	E3M10000013F12	Enterococcus faecalis
138	E3M10000013G10	Enterococcus faecalis
139	E3M10000013H03	Enterococcus faecalis
140	E3M10000013H05	Enterococcus faecalis
141	E3M10000013H10	Enterococcus faecalis
142	E3M10000014B12	Enterococcus faecalis
143	E3M10000014E12	Enterococcus faecalis
144	E3M10000014G09	Enterococcus faecalis
145	E3M10000015B04	Enterococcus faecalis
146	E3M10000015B12	Enterococcus faecalis
147	E3M10000015E12	Enterococcus faecalis
148	E3M10000016A03	Enterococcus faecalis
149	E3M10000016A04	Enterococcus faecalis
150	E3M10000016C11	Enterococcus faecalis
151	E3M10000016D03	Enterococcus faecalis
152	E3M10000016F06	Enterococcus faecalis
153	E3M10000016F10	Enterococcus faecalis
154	E3M10000016H05	Enterococcus faecalis
155	E3M10000016H10	Enterococcus faecalis
156	E3M10000017A09	Enterococcus faecalis
157	E3M10000017D09	Enterococcus faecalis
158	E3M10000018A07	Enterococcus faecalis
159	E3M10000018C02	Enterococcus faecalis
160	E3M10000018E01	Enterococcus faecalis
161	E3M10000018G09	Enterococcus faecalis
162	E3M10000018H06	Enterococcus faecalis
163	E3M10000019B06	Enterococcus faecalis
164	E3M10000019D02	Enterococcus faecalis
165	E3M10000019E03	Enterococcus faecalis
166	E3M10000019E04	Enterococcus faecalis
167	E3M10000020G04	Enterococcus faecalis
168	E3M10000020H05	Enterococcus faecalis
169	E3M10000021A08	Enterococcus faecalis
170	E3M10000021A11	Enterococcus faecalis
171	E3M10000021B10	Enterococcus faecalis
172	E3M10000021C03	Enterococcus faecalis
173	E3M10000021C04	Enterococcus faecalis
174	E3M10000021C08	Enterococcus faecalis
175	E3M10000021D04	Enterococcus faecalis
176	E3M10000021E10	Enterococcus faecalis
177	E3M10000021G04	Enterococcus faecalis
178	E3M10000021G10	Enterococcus faecalis
179	E3M10000021G11	Enterococcus faecalis
180	E3M10000021H11	Enterococcus faecalis
181	E3M10000022A04	Enterococcus faecalis
182	E3M10000022A11	Enterococcus faecalis
183	E3M10000022B04	Enterococcus faecalis
184	E3M10000022B05	Enterococcus faecalis
185	E3M10000022B07	Enterococcus faecalis
186	E3M10000022C05	Enterococcus faecalis
187	E3M10000022C06	Enterococcus faecalis
188	E3M10000022C09	Enterococcus faecalis
189	E3M10000022D04	Enterococcus faecalis
190	E3M10000022F05	Enterococcus faecalis
191	E3M10000022F06	Enterococcus faecalis
192	E3M10000022F08	Enterococcus faecalis
193	E3M10000022G02	Enterococcus faecalis
194	E3M10000022G12	Enterococcus faecalis
195	E3M10000023A03	Enterococcus faecalis
196	E3M10000023A06	Enterococcus faecalis
197	E3M10000023A07	Enterococcus faecalis
198	E3M10000023A09	Enterococcus faecalis
199	E3M10000023B02	Enterococcus faecalis
200	E3M10000023B06	Enterococcus faecalis
201	E3M10000023C03	Enterococcus faecalis
202	E3M10000023C04	Enterococcus faecalis
203	E3M10000023C06	Enterococcus faecalis
204	E3M10000023C08	Enterococcus faecalis
205	E3M10000023C09	Enterococcus faecalis
206	E3M10000023D02	Enterococcus faecalis
207	E3M10000023D04	Enterococcus faecalis
208	E3M10000023D10	Enterococcus faecalis
209	E3M10000023E04	Enterococcus faecalis
210	E3M10000023E07	Enterococcus faecalis
211	E3M10000023E09	Enterococcus faecalis
212	E3M10000023F02	Enterococcus faecalis
213	E3M10000023F10	Enterococcus faecalis
214	E3M10000023G02	Enterococcus faecalis
215	E3M10000023G04	Enterococcus faecalis
216	E3M10000023G10	Enterococcus faecalis
217	E3M10000023H08	Enterococcus faecalis
218	E3M10000024A03	Enterococcus faecalis
219	E3M10000024A04	Enterococcus faecalis
220	E3M10000024A08	Enterococcus faecalis
221	E3M10000024C06	Enterococcus faecalis
222	E3M10000025A06	Enterococcus faecalis
223	E3M10000025B01	Enterococcus faecalis
224	E3M10000025B03	Enterococcus faecalis
225	E3M10000025B05	Enterococcus faecalis
226	E3M10000025B10	Enterococcus faecalis
227	E3M10000025C01	Enterococcus faecalis
228	E3M10000025C04	Enterococcus faecalis
229	E3M10000025C05	Enterococcus faecalis
230	E3M10000025C07	Enterococcus faecalis
231	E3M10000025C08	Enterococcus faecalis
232	E3M10000025C09	Enterococcus faecalis
233	E3M10000025C11	Enterococcus faecalis
234	E3M10000025D0I	Enterococcus faecalis
235	E3M10000025D10	Enterococcus faecalis
236	E3M10000025E07	Enterococcus faecalis
237	E3M10000025E08	Enterococcus faecalis
238	E3M10000025E12	Enterococcus faecalis
239	E3M10000025F04	Enterococcus faecalis
240	E3M10000025F06	Enterococcus faecalis
241	E3M10000025F08	Enterococcus faecalis
242	E3M10000025F09	Enterococcus faecalis
243	E3M10000025F10	Enterococcus faecalis
244	E3M10000025F11	Enterococcus faecalis
245	E3M10000025F12	Enterococcus faecalis
246	E3M10000025G02	Enterococcus faecalis
247	E3M10000025G07	Enterococcus faecalis
248	E3M10000025G09	Enterococcus faecalis
249	E3M10000027A02	Enterococcus faecalis
250	F3M10000027A07	Enterococcus faecalis
251	E3M10000027A09	Enterococcus faecalis
252	E3M10000027B07	Enterococcus faecalis
253	E3M10000027B08	Enterococcus faecalis
254	E3M10000027B09	Enterococcus faecalis
255	E3M10000027C02	Enterococcus faecalis
256	E3M10000027C03	Enterococcus faecalis
257	E3M10000027C08	Enterococcus faecalis
258	E3M10000027D03	Enterococcus faecalis
259	E3M10000027D05	Enterococcus faecalis
260	E3M10000027D08	Enterococcus faecalis
261	E3M10000027D10	Enterococcus faecalis
262	E3M10000027G01	Enterococcus faecalis
263	E3M10000027G08	Enterococcus faecalis
264	E3M10000027H04	Enterococcus faecalis
265	E3M10000027H07	Enterococcus faecalis
266	E3M10000028A02	Enterococcus faecalis
267	E3M10000028A03	Enterococcus faecalis
268	E3M10000028A04	Enterococcus faecalis
269	E3M10000028A05	Enterococcus faecalis
270	E3M10000028A06	Enterococcus faecalis
271	E3M10000028A08	Enterococcus faecalis
272	E3M10000028B01	Enterococcus faecalis
273	E3M10000028B02	Enterococcus faecalis
274	E3M10000028B03	Enterococcus faecalis
275	E3M10000028B04	Enterococcus faecalis
276	E3M10000028B05	Enterococcus faecalis
277	E3M10000028B06	Enterococcus faecalis
278	E3M10000028B07	Enterococcus faecalis
279	E3M10000028B08	Enterococcus faecalis
280	E3M10000028C01	Enterococcus faecalis
281	E3M10000028C02	Enterococcus faecalis
282	E3M10000028C04	Enterococcus faecalis
283	E3M10000028C05	Enterococcus faecalis
284	E3M10000028C06	Enterococcus faecalis
285	E3M10000028C07	Enterococcus faecalis
286	E3M10000028C08	Enterococcus faecalis
287	E3M10000028D01	Enterococcus faecalis
288	E3M10000028D02	Enterococcus faecalis
289	E3M10000028D05	Enterococcus faecalis
290	E3M10000028D06	Enterococcus faecalis
291	E3M10000028D08	Enterococcus faecalis
292	E3M10000028E01	Enterococcus faecalis
293	E3M10000028E04	Enterococcus faecalis
294	E3M10000028E07	Enterococcus faecalis
295	E3M10000028F02	Enterococcus faecalis
296	E3M10000028F03	Enterococcus faecalis
297	E3M10000028F04	Enterococcus faecalis
298	E3M10000028F05	Enterococcus faecalis
299	E3M10000028F06	Enterococcus faecalis
300	E3M10000028F07	Enterococcus faecalis
301	E3M10000028G05	Enterococcus faecalis
302	E3M10000028G06	Enterococcus faecalis
303	E3M10000028G07	Enterococcus faecalis
304	E3M10000028H04	Enterococcus faecalis
305	E3M10000028H07	Enterococcus faecalis
306	E3M10000029A02	Enterococcus faecalis
307	E3M10000029A04	Enterococcus faecalis
308	E3M10000029A05	Enterococcus faecalis
309	E3M10000029A10	Enterococcus faecalis
310	E3M10000029A11	Enterococcus faecalis
311	E3M10000029B01	Enterococcus faecalis
312	E3M10000029B02	Enterococcus faecalis
313	E3M10000029B05	Enterococcus faecalis
314	E3M10000029B06	Enterococcus faecalis
315	E3M10000029B08	Enterococcus faecalis
316	E3M10000029B11	Enterococcus faecalis
317	E3M10000029B12	Enterococcus faecalis
318	E3M10000029C01	Enterococcus faecalis
319	E3M10000029C02	Enterococcus faecalis
320	E3M10000029C03	Enterococcus faecalis
321	E3M10000029C04	Enterococcus faecalis
322	E3M10000029C05	Enterococcus faecalis
323	E3M10000029C06	Enterococcus faecalis
324	E3M10000029C07	Enterococcus faecalis
325	E3M10000029C08	Enterococcus faecalis
326	E3M10000029C09	Enterococcus faecalis
327	E3M10000029C10	Enterococcus faecalis
328	E3M10000029C12	Enterococcus faecalis
329	E3M10000029D01	Enterococcus faecalis
330	E3M10000029D03	Enterococcus faecalis
331	E3M10000029D04	Enterococcus faecalis
332	E3M10000029D05	Enterococcus faecalis
333	E3M10000029D06	Enterococcus faecalis
334	E3M10000029D08	Enterococcus faecalis
335	E3M10000029D12	Enterococcus faecalis
336	E3M10000029E01	Enterococcus faecalis
337	E3M10000029E02	Enterococcus faecalis
338	E3M10000029E03	Enterococcus faecalis
339	E3M10000029E05	Enterococcus faecalis
340	E3M10000029E07	Enterococcus faecalis
341	E3M10000029E08	Enterococcus faecalis
342	E3M10000029E09	Enterococcus faecalis
343	E3M10000029E12	Enterococcus faecalis
344	E3M10000029F01	Enterococcus faecalis
345	E3M10000029F05	Enterococcus faecalis
346	E3M10000029F06	Enterococcus faecalis
347	E3M10000029F09	Enterococcus faecalis
348	E3M10000029F10	Enterococcus faecalis
349	E3M10000029F11	Enterococcus faecalis
350	E3M10000029F12	Enterococcus faecalis
351	E3M10000029G01	Enterococcus faecalis
352	E3M10000029G04	Enterococcus faecalis
353	E3M10000029G05	Enterococcus faecalis
354	E3M10000029G07	Enterococcus faecalis
355	E3M10000029G08	Enterococcus faecalis
356	E3M10000029G09	Enterococcus faecalis
357	E3M10000029G10	Enterococcus faecalis
358	E3M10000029G11	Enterococcus faecalis
359	E3M10000029G12	Enterococcus faecalis
360	E3M10000029H02	Enterococcus faecalis
361	E3M10000029H04	Enterococcus faecalis
362	E3M10000029H05	Enterococcus faecalis
363	E3M10000029H07	Enterococcus faecalis
364	E3M10000029H08	Enterococcus faecalis
365	E3M10000029H11	Enterococcus faecalis
366	E3M10000030A05	Enterococcus faecalis
367	E3M10000030A08	Enterococcus faecalis
368	E3M10000030A09	Enterococcus faecalis
369	E3M10000030A11	Enterococcus faecalis
370	E3M10000030B03	Enterococcus faecalis
371	E3M10000030B04	Enterococcus faecalis
372	E3M10000030B05	Enterococcus faecalis
373	E3M10000030B06	Enterococcus faecalis
374	E3M10000030B07	Enterococcus faecalis
375	E3M10000030B08	Enterococcus faecalis
376	E3M10000030B10	Enterococcus faecalis
377	E3M10000030B11	Enterococcus faecalis
378	E3M10000030B12	Enterococcus faecalis
379	E3M10000030C03	Enterococcus faecalis
380	E3M10000030C04	Enterococcus faecalis
381	E3M10000030C12	Enterococcus faecalis
382	E3M10000030D02	Enterococcus faecalis
383	E3M10000030D05	Enterococcus faecalis
384	E3M10000030D08	Enterococcus faecalis
385	E3M10000030D09	Enterococcus faecalis
386	E3M10000030D10	Enterococcus faecalis
387	E3M10000030D12	Enterococcus faecalis
388	E3M10000030E01	Enterococcus faecalis
389	E3M10000030E02	Enterococcus faecalis
390	E3M10000030E04	Enterococcus faecalis
391	E3M10000030E08	Enterococcus faecalis
392	E3M10000030E09	Enterococcus faecalis
393	E3M10000030E10	Enterococcus faecalis
394	E3M10000030F01	Enterococcus faecalis
395	E3M10000030F04	Enterococcus faecalis
396	E3M10000030F06	Enterococcus faecalis
397	E3M10000030F07	Enterococcus faecalis
398	E3M10000030F10	Enterococcus faecalis
399	E3M10000030F12	Enterococcus faecalis
400	E3M10000030G01	Enterococcus faecalis
401	E3M10000030G03	Enterococcus faecalis
402	E3M10000030G06	Enterococcus faecalis
403	E3M10000030G08	Enterococcus faecalis
404	E3M10000030G09	Enterococcus faecalis
405	E3M10000030G12	Enterococcus faecalis
406	E3M10000030H03	Enterococcus faecalis
407	E3M10000030H04	Enterococcus faecalis
408	E3M10000030H06	Enterococcus faecalis
409	E3M10000030H07	Enterococcus faecalis
410	E3M10000030H08	Enterococcus faecalis
411	E3M10000030H10	Enterococcus faecalis
412	E3M10000030H11	Enterococcus faecalis
413	E3M10000031A02	Enterococcus faecalis
414	E3M10000031A06	Enterococcus faecalis
415	E3M10000031A07	Enterococcus faecalis
416	E3M10000031A08	Enterococcus faecalis
417	E3M10000031B02	Enterococcus faecalis
418	E3M10000031B03	Enterococcus faecalis
419	E3M10000031B04	Enterococcus faecalis
420	E3M10000031B09	Enterococcus faecalis
421	E3M10000031B10	Enterococcus faecalis
422	E3M10000031B11	Enterococcus faecalis
423	E3M10000031B12	Enterococcus faecalis
424	E3M10000031C01	Enterococcus faecalis
425	E3M10000031C04	Enterococcus faecalis
426	E3M10000031C06	Enterococcus faecalis
427	E3M10000031C10	Enterococcus faecalis
428	E3M10000031C11	Enterococcus faecalis
429	E3M10000031C12	Enterococcus faecalis
430	E3M10000031D03	Enterococcus faecalis
431	E3M10000031D04	Enterococcus faecalis
432	E3M10000031D08	Enterococcus faecalis
433	E3M10000031E03	Enterococcus faecalis
434	E3M10000031E09	Enterococcus faecalis
435	E3M10000031F02	Enterococcus faecalis
436	E3M10000031F04	Enterococcus faecalis
437	E3M10000031F07	Enterococcus faecalis
438	E3M10000031F09	Enterococcus faecalis
439	E3M10000031F11	Enterococcus faecalis
440	E3M10000031G03	Enterococcus faecalis
441	E3M10000031G04	Enterococcus faecalis
442	E3M10000031G05	Enterococcus faecalis
443	E3M10000031G06	Enterococcus faecalis
444	E3M10000031G07	Enterococcus faecalis
445	E3M10000031G08	Enterococcus faecalis
446	E3M10000031G11	Enterococcus faecalis
447	E3M10000031H05	Enterococcus faecalis
448	E3M10000031H06	Enterococcus faecalis
449	E3M10000031H07	Enterococcus faecalis
450	E3M10000031H08	Enterococcus faecalis
451	E3M10000031H10	Enterococcus faecalis
452	E3M10000031H11	Enterococcus faecalis
453	E3M10000032A02	Enterococcus faecalis
454	E3M10000032A04	Enterococcus faecalis
455	E3M10000032A06	Enterococcus faecalis
456	E3M10000032A07	Enterococcus faecalis
457	E3M10000032A08	Enterococcus faecalis
458	E3M10000032A09	Enterococcus faecalis
459	E3M10000032A10	Enterococcus faecalis
460	E3M10000032A11	Enterococcus faecalis
461	E3M10000032B03	Enterococcus faecalis
462	E3M10000032B04	Enterococcus faecalis
463	E3M10000032B07	Enterococcus faecalis
464	E3M10000032B08	Enterococcus faecalis
465	E3M10000032B09	Enterococcus faecalis
466	E3M10000032B11	Enterococcus faecalis
467	E3M10000032B12	Enterococcus faecalis
468	E3M10000032C01	Enterococcus faecalis
469	E3M10000032C02	Enterococcus faecalis
470	E3M10000032C03	Enterococcus faecalis
471	E3M10000032C04	Enterococcus faecalis
472	E3M10000032C06	Enterococcus faecalis
473	E3M10000032C09	Enterococcus faecalis
474	E3M10000032C11	Enterococcus faecalis
475	E3M10000032C12	Enterococcus faecalis
476	E3M10000032D01	Enterococcus faecalis
477	E3M10000032D02	Enterococcus faecalis
478	E3M10000032D03	Enterococcus faecalis
479	E3M10000032D06	Enterococcus faecalis
480	E3M10000032D09	Enterococcus faecalis
481	E3M10000032D12	Enterococcus faecalis
482	E3M10000032E04	Enterococcus faecalis
483	E3M10000032E05	Enterococcus faecalis
484	E3M10000032E08	Enterococcus faecalis
485	E3M10000032E10	Enterococcus faecalis
486	E3M10000032E11	Enterococcus faecalis
487	E3M10000032E12	Enterococcus faecalis
488	E3M10000032F02	Enterococcus faecalis
489	E3M10000032F03	Enterococcus faecalis
490	E3M10000032F05	Enterococcus faecalis
491	E3M10000032F07	Enterococcus faecalis
492	E3M10000032F08	Enterococcus faecalis
493	E3M10000032F11	Enterococcus faecalis
494	E3M10000032F12	Enterococcus faecalis
495	E3M10000032G01	Enterococcus faecalis
496	E3M10000032G02	Enterococcus faecalis
497	E3M10000032G04	Enterococcus faecalis
498	E3M10000032G05	Enterococcus faecalis
499	E3M10000032G06	Enterococcus faecalis
500	E3M10000032G07	Enterococcus faecalis
501	E3M10000032H05	Enterococcus faecalis
502	E3M10000032H06	Enterococcus faecalis
503	E3M10000032H08	Enterococcus faecalis
504	E3M10000032H09	Enterococcus faecalis
505	E3M10000032H10	Enterococcus faecalis
506	E3M10000033A03	Enterococcus faecalis
507	E3M10000033A04	Enterococcus faecalis
508	E3M10000033A05	Enterococcus faecalis
509	E3M10000033A06	Enterococcus faecalis
510	E3M10000033A07	Enterococcus faecalis
511	E3M10000033A08	Enterococcus faecalis
512	E3M10000033A11	Enterococcus faecalis
513	E3M10000033B01	Enterococcus faecalis
514	E3M10000033B02	Enterococcus faecalis
515	E3M10000033B04	Enterococcus faecalis
516	E3M10000033B05	Enterococcus faecalis
517	E3M10000033B06	Enterococcus faecalis
518	E3M10000033B08	Enterococcus faecalis
519	E3M10000033B09	Enterococcus faecalis
520	E3M10000033C01	Enterococcus faecalis
521	E3M10000033C02	Enterococcus faecalis
522	E3M10000033C05	Enterococcus faecalis
523	E3M10000033C09	Enterococcus faecalis
524	E3M10000033C10	Enterococcus faecalis
525	E3M10000033C11	Enterococcus faecalis
526	E3M10000033C12	Enterococcus faecalis
527	E3M10000033D01	Enterococcus faecalis
528	E3M10000033D04	Enterococcus faecalis
529	E3M10000033D05	Enterococcus faecalis
530	E3M10000033D06	Enterococcus faecalis
531	E3M10000033D09	Enterococcus faecalis
532	E3M10000033D10	Enterococcus faecalis
533	E3M10000033D11	Enterococcus faecalis
534	E3M10000033E02	Enterococcus faecalis
535	E3M10000033E03	Enterococcus faecalis
536	E3M10000033E04	Enterococcus faecalis
537	E3M10000033E05	Enterococcus faecalis
538	E3M10000033E07	Enterococcus faecalis
539	E3M10000033E08	Enterococcus faecalis
540	E3M10000033E09	Enterococcus faecalis
541	E3M10000033E11	Enterococcus faecalis
542	E3M10000033F01	Enterococcus faecalis
543	E3M10000033F03	Enterococcus faecalis
544	E3M10000033F04	Enterococcus faecalis
545	E3M10000033F05	Enterococcus faecalis
546	E3M10000033F07	Enterococcus faecalis
547	E3M10000033F08	Enterococcus faecalis
548	E3M10000033F10	Enterococcus faecalis
549	E3M10000033F12	Enterococcus faecalis
550	E3M10000033G01	Enterococcus faecalis
551	E3M10000033G02	Enterococcus faecalis
552	E3M10000033G03	Enterococcus faecalis
553	E3M10000033G04	Enterococcus faecalis
554	E3M10000033G06	Enterococcus faecalis
555	E3M10000033G07	Enterococcus faecalis
556	E3M10000033G08	Enterococcus faecalis
557	E3M10000033G09	Enterococcus faecalis
558	E3M10000033G12	Enterococcus faecalis
559	E3M10000033H02	Enterococcus faecalis
560	E3M10000033H04	Enterococcus faecalis
561	E3M10000033H05	Enterococcus faecalis
562	E3M10000033H07	Enterococcus faecalis
563	E3M10000033H08	Enterococcus faecalis
564	E3M10000033H09	Enterococcus faecalis
565	E3M10000033H10	Enterococcus faecalis
566	E3M10000033H11	Enterococcus faecalis
567	E3M10000034A02	Enterococcus faecalis
568	E3M10000034A03	Enterococcus faecalis
569	E3M10000034A04	Enterococcus faecalis
570	E3M10000034B02	Enterococcus faecalis
571	E3M10000034B04	Enterococcus faecalis
572	E3M10000034C04	Enterococcus faecalis
573	E3M10000034D01	Enterococcus faecalis
574	E3M10000034D02	Enterococcus faecalis
575	E3M10000034E01	Enterococcus faecalis
576	E3M10000034E04	Enterococcus faecalis
577	E3M10000034F02	Enterococcus faecalis
578	E3M10000034F03	Enterococcus faecalis
579	E3M10000034F04	Enterococcus faecalis
580	E3M10000034G02	Enterococcus faecalis
581	E3M10000034G03	Enterococcus faecalis
582	E3M10000034H02	Enterococcus faecalis
583	E3M10000034H03	Enterococcus faecalis
584	E3M10000035A02	Enterococcus faecalis
585	E3M10000035A04	Enterococcus faecalis
586	E3M10000035A05	Enterococcus faecalis
587	E3M10000035A06	Enterococcus faecalis
588	E3M10000035A08	Enterococcus faecalis
589	E3M10000035A09	Enterococcus faecalis
590	E3M1000003SA11	Enterococcus faecalis
591	E3M10000035B01	Enterococcus faecalis
592	E3M10000035B03	Enterococcus faecalis
593	E3M10000035B06	Enterococcus faecalis
594	E3M10000035B07	Enterococcus faecalis
595	E3M10000035B08	Enterococcus faecalis
596	E3M10000035B10	Enterococcus faecalis
597	E3M1000003SB11	Enterococcus faecalis
598	E3M10000035B12	Enterococcus faecalis
599	E3M10000035C01	Enterococcus faecalis
600	E3M10000035C03	Enterococcus faecalis
601	E3M10000035C04	Enterococcus faecalis
602	E3M1000003SC05	Enterococcus faecalis
603	E3M10000035C06	Enterococcus faecalis
604	E3M10000035C07	Enterococcus faecalis
605	E3M10000035C08	Enterococcus faecalis
606	E3M10000035C09	Enterococcus faecalis
607	E3M10000035C11	Enterococcus faecalis
608	E3M10000035C12	Enterococcus faecalis
609	E3M10000035D02	Enterococcus faecalis
610	E3M10000035D03	Enterococcus faecalis
611	E3M10000035D04	Enterococcus faecalis
612	E3M10000035D05	Enterococcus faecalis
613	E3M10000035D10	Enterococcus faecalis
614	E3M10000035D11	Enterococcus faecalis
615	E3M10000035E03	Enterococcus faecalis
616	E3M10000035E04	Enterococcus faecalis
617	E3M10000035E05	Enterococcus faecalis
618	E3M10000035E07	Enterococcus faecalis
619	E3M10000035E08	Enterococcus faecalis
620	E3M10000035E09	Enterococcus faecalis
621	E3M10000035E10	Enterococcus faecalis
622	E3M10000035E11	Enterococcus faecalis
623	E3M10000035E12	Enterococcus faecalis
624	E3M10000035F01	Enterococcus faecalis
625	E3M10000035F02	Enterococcus faecalis
626	E3M10000035F03	Enterococcus faecalis
627	E3M10000035F06	Enterococcus faecalis
628	E3M10000035F07	Enterococcus faecalis
629	E3M10000035F08	Enterococcus faecalis
630	E3M10000035F09	Enterococcus faecalis
631	E3M10000035F11	Enterococcus faecalis
632	E3M10000035F12	Enterococcus faecalis
633	E3M10000035G02	Enterococcus faecalis
634	E3M10000035G04	Enterococcus faecalis
635	E3M10000035G05	Enterococcus faecalis
636	E3M10000035G08	Enterococcus faecalis
637	E3M10000035G09	Enterococcus faecalis
638	E3M10000035G10	Enterococcus faecalis
639	E3M10000035G11	Enterococcus faecalis
640	E3M10000035H03	Enterococcus faecalis
641	E3M10000035H06	Enterococcus faecalis
642	E3M10000035H09	Enterococcus faecalis
643	E3M10000035H11	Enterococcus faecalis
644	E3M10000036A03	Enterococcus faecalis
645	E3M10000036A04	Enterococcus faecalis
646	E3M10000036A05	Enterococcus faecalis
647	E3M10000036A06	Enterococcus faecalis
648	E3M10000036A07	Enterococcus faecalis
649	E3M10000036A08	Enterococcus faecalis
650	E3M10000036A09	Enterococcus faecalis
651	E3M10000036A10	Enterococcus faecalis
652	E3M10000036B01	Enterococcus faecalis
653	E3M10000036B03	Enterococcus faecalis
654	E3M10000036B06	Enterococcus faecalis
655	E3M10000036B07	Enterococcus faecalis
656	E3M10000036B08	Enterococcus faecalis
657	E3M10000036B09	Enterococcus faecalis
658	E3M10000036B11	Enterococcus faecalis
659	E3M10000036B12	Enterococcus faecalis
660	E3M10000036C01	Enterococcus faecalis
661	E3M10000036C03	Enterococcus faecalis
662	E3M10000036C06	Enterococcus faecalis
663	E3M10000036C07	Enterococcus faecalis
664	E3M10000036C08	Enterococcus faecalis
665	E3M10000036C09	Enterococcus faecalis
666	E3M10000036C10	Enterococcus faecalis
667	E3M10000036C11	Enterococcus faecalis
668	E3M10000036D03	Enterococcus faecalis
669	E3M10000036D04	Enterococcus faecalis
670	E3M10000036D06	Enterococcus faecalis
671	E3M10000036D08	Enterococcus faecalis
672	E3M10000036D09	Enterococcus faecalis
673	E3M10000036D10	Enterococcus faecalis
674	E3M10000036D11	Enterococcus faecalis
675	E3M10000036D12	Enterococcus faecalis
676	E3M10000036E01	Enterococcus faecalis
677	E3M10000036E04	Enterococcus faecalis
678	E3M10000036E05	Enterococcus faecalis
679	E3M10000036E07	Enterococcus faecalis
680	E3M10000036E08	Enterococcus faecalis
681	E3M10000036F03	Enterococcus faecalis
682	E3M10000036F04	Enterococcus faecalis
683	E3M10000036F05	Enterococcus faecalis
684	E3M10000036F08	Enterococcus faecalis
685	E3M10000036F09	Enterococcus faecalis
686	E3M10000036F10	Enterococcus faecalis
687	E3M10000036F12	Enterococcus faecalis
688	E3M10000036G01	Enterococcus faecalis
689	E3M10000036G02	Enterococcus faecalis
690	E3M10000036G03	Enterococcus faecalis
691	E3M10000036G04	Enterococcus faecalis
692	E3M10000036G06	Enterococcus faecalis
693	E3M10000036G10	Enterococcus faecalis
694	E3M10000036H02	Enterococcus faecalis
695	E3M10000036H03	Enterococcus faecalis
696	E3M10000036H04	Enterococcus faecalis
697	E3M10000036H05	Enterococcus faecalis
698	E3M10000036H06	Enterococcus faecalis
699	E3M10000036H07	Enterococcus faecalis
700	E3M10000036H08	Enterococcus faecalis
701	E3M10000036H09	Enterococcus faecalis
702	E3M10000036H10	Enterococcus faecalis
703	E3M10000037A03	Enterococcus faecalis
704	E3M10000037A06	Enterococcus faecalis
705	E3M10000037A08	Enterococcus faecalis
706	E3M10000037A09	Enterococcus faecalis
707	E3M10000037A10	Enterococcus faecalis
708	E3M10000037B02	Enterococcus faecalis
709	E3M10000037B07	Enterococcus faecalis
710	E3M10000037B08	Enterococcus faecalis
711	E3M10000037B11	Enterococcus faecalis
712	E3M10000037C01	Enterococcus faecalis
713	E3M10000037C02	Enterococcus faecalis
714	E3M10000037C04	Enterococcus faecalis
715	E3M10000037C05	Enterococcus faecalis
716	E3M10000037C07	Enterococcus faecalis
717	E3M10000037C11	Enterococcus faecalis
718	E3M10000037C12	Enterococcus faecalis
719	E3M10000037D02	Enterococcus faecalis
720	E3M10000037D03	Enterococcus faecalis
721	E3M10000037D04	Enterococcus faecalis
722	E3M10000037D05	Enterococcus faecalis
723	E3M10000037D06	Enterococcus faecalis
724	E3M10000037D09	Enterococcus faecalis
725	E3M10000037D11	Enterococcus faecalis
726	E3M10000037E01	Enterococcus faecalis
727	E3M10000037E02	Enterococcus faecalis
728	E3M10000037E03	Enterococcus faecalis
729	E3M10000037E05	Enterococcus faecalis
730	E3M10000037E07	Enterococcus faecalis
731	E3M10000037E08	Enterococcus faecalis
732	E3M10000037E10	Enterococcus faecalis
733	E3M10000037E12	Enterococcus faecalis
734	E3M10000037F01	Enterococcus faecalis
735	E3M10000037F02	Enterococcus faecalis
736	E3M10000037F06	Enterococcus faecalis
737	E3M10000037F07	Enterococcus faecalis
738	E3M10000037F12	Enterococcus faecalis
739	E3M10000037G01	Enterococcus faecalis
740	E3M10000037G02	Enterococcus faecalis
741	E3M10000037G03	Enterococcus faecalis
742	E3M10000037G05	Enterococcus faecalis
743	E3M10000037G06	Enterococcus faecalis
744	E3M10000037G07	Enterococcus faecalis
745	E3M10000037G08	Enterococcus faecalis
746	E3M10000037G10	Enterococcus faecalis
747	E3M10000037G11	Enterococcus faecalis
748	E3M10000037H02	Enterococcus faecalis
749	E3M10000037H05	Enterococcus faecalis
750	E3M10000037H07	Enterococcus faecalis
751	E3M10000037H10	Enterococcus faecalis
752	E3M10000037H11	Enterococcus faecalis
753	E3M10000038A02	Enterococcus faecalis
754	E3M10000038A03	Enterococcus faecalis
755	E3M10000038A05	Enterococcus faecalis
756	E3M10000038A06	Enterococcus faecalis
757	E3M10000038A07	Enterococcus faecalis
758	E3M10000038A09	Enterococcus faecalis
759	E3M10000038A10	Enterococcus faecalis
760	E3M10000038A11	Enterococcus faecalis
761	E3M10000038B02	Enterococcus faecalis
762	E3M10000038B03	Enterococcus faecalis
763	E3M10000038B04	Enterococcus faecalis
764	E3M10000038B05	Enterococcus faecalis
765	E3M10000038B07	Enterococcus faecalis
766	E3M10000038B08	Enterococcus faecalis
767	E3M10000038B09	Enterococcus faecalis
768	E3M10000038B11	Enterococcus faecalis
769	E3M10000038C02	Enterococcus faecalis
770	E3M10000038C03	Enterococcus faecalis
771	E3M10000038C05	Enterococcus faecalis
772	E3M10000038C07	Enterococcus faecalis
773	E3M10000038C10	Enterococcus faecalis
774	E3M10000038C12	Enterococcus faecalis
775	E3M10000038D01	Enterococcus faecalis
776	E3M10000038D02	Enterococcus faecalis
777	E3M10000038D04	Enterococcus faecalis
778	E3M10000038D08	Enterococcus faecalis
779	E3M10000038D10	Enterococcus faecalis
780	E3M10000038D11	Enterococcus faecalis
781	E3M10000038D12	Enterococcus faecalis
782	E3M10000038E02	Enterococcus faecalis
783	E3M10000038E03	Enterococcus faecalis
784	E3M10000038E04	Enterococcus faecalis
785	E3M10000038E05	Enterococcus faecalis
786	E3M10000038E07	Enterococcus faecalis
787	E3M10000038E08	Enterococcus faecalis
788	E3M10000038E11	Enterococcus faecalis
789	E3M10000038F02	Enterococcus faecalis
790	E3M10000038F04	Enterococcus faecalis
791	E3M10000038F05	Enterococcus faecalis
792	E3M10000038F06	Enterococcus faecalis
793	E3M10000038F07	Enterococcus faecalis
794	E3M10000038F09	Enterococcus faecalis
795	E3M10000038F10	Enterococcus faecalis
796	E3M10000038F11	Enterococcus faecalis
797	E3M10000038G02	Enterococcus faecalis
798	E3M10000038G03	Enterococcus faecalis
799	E3M10000038G06	Enterococcus faecalis
800	E3M10000038G07	Enterococcus faecalis
801	E3M10000038G11	Enterococcus faecalis
802	E3M10000038H02	Enterococcus faecalis
803	E3M10000038H05	Enterococcus faecalis
804	E3M10000038H06	Enterococcus faecalis
805	E3M10000038H07	Enterococcus faecalis
806	E3M10000038H08	Enterococcus faecalis
807	E3M10000038H09	Enterococcus faecalis
808	E3M10000038H10	Enterococcus faecalis
809	E3M10000039A02	Enterococcus faecalis
810	E3M10000039A06	Enterococcus faecalis
811	E3M10000039A07	Enterococcus faecalis
812	E3M10000039A08	Enterococcus faecalis
813	E3M10000039A10	Enterococcus faecalis
814	E3M10000039A11	Enterococcus faecalis
815	E3M10000039B01	Enterococcus faecalis
816	E3M10000039B03	Enterococcus faecalis
817	E3M10000039B04	Enterococcus faecalis
818	E3M10000039B06	Enterococcus faecalis
819	E3M10000039B07	Enterococcus faecalis
820	E3M10000039B08	Enterococcus faecalis
821	E3M10000039B09	Enterococcus faecalis
822	E3M10000039B11	Enterococcus faecalis
823	E3M10000039C02	Enterococcus faecalis
824	E3M10000039C04	Enterococcus faecalis
825	E3M10000039C05	Enterococcus faecalis
826	E3M10000039C06	Enterococcus faecalis
827	E3M10000039C07	Enterococcus faecalis
828	E3M10000039C08	Enterococcus faecalis
829	E3M10000039C09	Enterococcus faecalis
830	E3M10000039C10	Enterococcus faecalis
831	E3M10000039D02	Enterococcus faecalis
832	E3M10000039D03	Enterococcus faecalis
833	E3M10000039D04	Enterococcus faecalis
834	E3M10000039D06	Enterococcus faecalis
835	E3M10000039E01	Enterococcus faecalis
836	E3M10000039E02	Enterococcus faecalis
837	E3M10000039E03	Enterococcus faecalis
838	E3M10000039E05	Enterococcus faecalis
839	E3M10000039E07	Enterococcus faecalis
840	E3M10000039E08	Enterococcus faecalis
841	E3M10000039F01	Enterococcus faecalis
842	E3M10000039F02	Enterococcus faecalis
843	E3M10000039F03	Enterococcus faecalis
844	E3M10000039F06	Enterococcus faecalis
845	E3M10000039F07	Enterococcus faecalis
846	E3M10000039F08	Enterococcus faecalis
847	E3M10000039G01	Enterococcus faecalis
848	E3M10000039G02	Enterococcus faecalis
849	E3M10000039G05	Enterococcus faecalis
850	E3M10000039G07	Enterococcus faecalis
851	E3M10000039G09	Enterococcus faecalis
852	E3M10000039G10	Enterococcus faecalis
853	E3M10000039H02	Enterococcus faecalis
854	E3M10000039H07	Enterococcus faecalis
855	E3M10000039H08	Enterococcus faecalis
856	E3M10000039H10	Enterococcus faecalis
857	E3M10000039H11	Enterococcus faecalis
858	E3M10000040A03	Enterococcus faecalis
859	E3M10000040A05	Enterococcus faecalis
860	E3M10000040A07	Enterococcus faecalis
861	E3M10000040A09	Enterococcus faecalis
862	E3M10000040A10	Enterococcus faecalis
863	E3M10000040A11	Enterococcus faecalis
864	E3M10000040B01	Enterococcus faecalis
865	E3M10000040B02	Enterococcus faecalis
866	E3M10000040B05	Enterococcus faecalis
867	E3M10000040B06	Enterococcus faecalis
868	E3M10000040B08	Enterococcus faecalis
869	E3M10000040B09	Enterococcus faecalis
870	E3M1000004GB10	Enterococcus faecalis
871	E3M1000004GB11	Enterococcus faecalis
872	E3M1000004GB12	Enterococcus faecalis
873	E3M10000040C02	Enterococcus faecalis
874	E3M10000040C05	Enterococcus faecalis
875	E3M10000040C06	Enterococcus faecalis
876	E3M10000040C07	Enterococcus faecalis
877	E3M10000040C08	Enterococcus faecalis
878	E3M10000040C09	Enterococcus faecalis
879	E3M10000040C10	Enterococcus faecalis
880	E3M10000040C11	Enterococcus faecalis
881	E3M10000040C12	Enterococcus faecalis
882	E3M10000040D03	Enterococcus faecalis
883	E3M10000040D04	Enterococcus faecalis
884	E3M10000040D08	Enterococcus faecalis
885	E3M10000040D12	Enterococcus faecalis
886	E3M10000040E02	Enterococcus faecalis
887	E3M10000040E10	Enterococcus faecalis
888	E3M10000040E11	Enterococcus faecalis
889	E3M10000040E12	Enterococcus faecalis
890	E3M10000040F01	Enterococcus faecalis
891	E3M10000040F03	Enterococcus faecalis
892	E3M10000040F08	Enterococcus faecalis
893	E3M10000040F09	Enterococcus faecalis
894	E3M10000040F10	Enterococcus faecalis
895	E3M10000040G01	Enterococcus faecalis
896	E3M10000040G02	Enterococcus faecalis
897	E3M10000040G04	Enterococcus faecalis
898	E3M10000040G05	Enterococcus faecalis
899	E3M10000040G07	Enterococcus faecalis
900	E3M10000040G08	Enterococcus faecalis
901	E3M10000040G09	Enterococcus faecalis
902	E3M10000040G11	Enterococcus faecalis
903	E3M10000040H02	Enterococcus faecalis
904	E3M10000040H03	Enterococcus faecalis
905	E3M10000040H04	Enterococcus faecalis
906	E3M10000040H05	Enterococcus faecalis
907	E3M10000040H09	Enterococcus faecalis
908	E3M10000041A03	Enterococcus faecalis
909	E3M10000041A05	Enterococcus faecalis
910	E3M10000041A08	Enterococcus faecalis
911	E3M10000041A09	Enterococcus faecalis
912	E3M10000041A10	Enterococcus faecalis
913	E3M10000041A11	Enterococcus faecalis
914	E3M10000041B02	Enterococcus faecalis
915	E3M10000041B03	Enterococcus faecalis
916	E3M10000041B05	Enterococcus faecalis
917	E3M10000041B06	Enterococcus faecalis
918	E3M10000041B08	Enterococcus faecalis
919	E3M10000041B09	Enterococcus faecalis
920	E3M10000041B10	Enterococcus faecalis
921	E3M10000041B11	Enterococcus faecalis
922	E3M10000041B12	Enterococcus faecalis
923	E3M10000041C01	Enterococcus faecalis
924	E3M10000041C07	Enterococcus faecalis
925	E3M10000041C08	Enterococcus faecalis
926	E3M10000041C09	Enterococcus faecalis
927	E3M10000041C10	Enterococcus faecalis
928	E3M10000041C11	Enterococcus faecalis
929	E3M10000041C12	Enterococcus faecalis
930	E3M10000041D02	Enterococcus faecalis
931	E3M10000041D03	Enterococcus faecalis
932	E3M10000041D04	Enterococcus faecalis
933	E3M10000041D05	Enterococcus faecalis
934	E3M10000041D06	Enterococcus faecalis
935	E3M10000041D08	Enterococcus faecalis
936	E3M10000041D09	Enterococcus faecalis
937	E3M10000041D10	Enterococcus faecalis
938	E3M10000041D11	Enterococcus faecalis
939	E3M10000041D12	Enterococcus faecalis
940	E3M10000041E02	Enterococcus faecalis
941	E3M10000041E03	Enterococcus faecalis
942	E3M10000041EO5	Enterococcus faecalis
943	E3M10000041E07	Enterococcus faecalis
944	E3M10000041E10	Enterococcus faecalis
945	E3M1000004IE11	Enterococcus faecalis
946	E3M10000041F03	Enterococcus faecalis
947	E3M10000041F05	Enterococcus faecalis
948	E3M10000041F06	Enterococcus faecalis
949	E3M10000041F07	Enterococcus faecalis
950	E3M10000041F08	Enterococcus faecalis
951	E3M10000041F09	Enterococcus faecalis
952	E3M10000041F10	Enterococcus faecalis
953	E3M10000041F11	Enterococcus faecalis
954	E3M10000041G02	Enterococcus faecalis
955	E3M10000041G03	Enterococcus faecalis
956	E3M10000041G04	Enterococcus faecalis
957	E3M10000041G06	Enterococcus faecalis
958	E3M10000041G07	Enterococcus faecalis
959	E3M10000041G08	Enterococcus faecalis
960	E3M10000041G09	Enterococcus faecalis
961	E3M10000041G10	Enterococcus faecalis
962	E3M10000041G12	Enterococcus faecalis
963	E3M10000041H04	Enterococcus faecalis
964	E3M10000041H05	Enterococcus faecalis
965	E3M10000041H06	Enterococcus faecalis
966	E3M10000041H07	Enterococcus faecalis
967	E3M10000041H08	Enterococcus faecalis
968	E3M10000041H09	Enterococcus faecalis
969	E3M10000041H10	Enterococcus faecalis
970	E3M10000041H11	Enterococcus faecalis
971	E3M10000042A03	Enterococcus faecalis
972	E3M10000042A08	Enterococcus faecalis
973	E3M10000042A10	Enterococcus faecalis
974	E3M10000042B01	Enterococcus faecalis
975	E3M10000042B02	Enterococcus faecalis
976	E3M10000042B04	Enterococcus faecalis
977	E3M10000042B08	Enterococcus faecalis
978	E3M10000042B09	Enterococcus faecalis
979	E3M10000042B10	Enterococcus faecalis
980	E3M10000042B11	Enterococcus faecalis
981	E3M10000042C02	Enterococcus faecalis
982	E3M10000042C03	Enterococcus faecalis
983	E3M10000042C04	Enterococcus faecalis
984	E3M10000042C10	Enterococcus faecalis
985	E3M10000042D01	Enterococcus faecalis
986	E3M10000042D02	Enterococcus faecalis
987	E3M10000042D03	Enterococcus faecalis
988	E3M10000042D06	Enterococcus faecalis
989	E3M10000042D09	Enterococcus faecalis
990	E3M10000042D11	Enterococcus faecalis
991	E3M10000042D12	Enterococcus faecalis
992	E3M10000042E05	Enterococcus faecalis
993	E3M10000042E12	Enterococcus faecalis
994	E3M10000042F11	Enterococcus faecalis
995	E3M10000042G01	Enterococcus faecalis
996	E3M10000042G05	Enterococcus faecalis
997	E3M10000042G07	Enterococcus faecalis
998	E3M10000042G08	Enterococcus faecalis
999	E3M10000042G11	Enterococcus faecalis
1000	E3M10000042G12	Enterococcus faecalis
1001	E3M10000042H06	Enterococcus faecalis
1002	E3M10000042H08	Enterococcus faecalis
1003	E3M10000042H11	Enterococcus faecalis
1004	E3M10000043A02	Enterococcus faecalis
1005	E3M10000043A03	Enterococcus faecalis
1006	E3M10000043A05	Enterococcus faecalis
1007	E3M10000043A08	Enterococcus faecalis
1008	E3M10000043A09	Enterococcus faecalis
1009	E3M10000043A10	Enterococcus faecalis
1010	E3M10000043A11	Enterococcus faecalis
1011	E3M10000043B01	Enterococcus faecalis
1012	E3M10000043B02	Enterococcus faecalis
1013	E3M10000043B03	Enterococcus faecalis
1014	E3M10000043B06	Enterococcus faecalis
1015	E3M10000043B08	Enterococcus faecalis
1016	E3M10000043B09	Enterococcus faecalis
1017	E3M10000043B10	Enterococcus faecalis
1018	E3M10000043B11	Enterococcus faecalis
1019	E3M10000043B12	Enterococcus faecalis
1020	E3M10000043C01	Enterococcus faecalis
1021	E3M10000043C08	Enterococcus faecalis
1022	E3M10000043C09	Enterococcus faecalis
1023	E3M10000043D01	Enterococcus faecalis
1024	E3M10000043D02	Enterococcus faecalis
1025	E3M10000043D09	Enterococcus faecalis
1026	E3M10000043D10	Enterococcus faecalis
1027	E3M10000043D12	Enterococcus faecalis
1028	E3M10000043E03	Enterococcus faecalis
1029	E3M10000043E07	Enterococcus faecalis
1030	E3M10000043E08	Enterococcus faecalis
1031	E3M10000043E10	Enterococcus faecalis
1032	E3M10000043E11	Enterococcus faecalis
1033	E3M10000043F03	Enterococcus faecalis
1034	E3M10000043F04	Enterococcus faecalis
1035	E3M10000043F06	Enterococcus faecalis
1036	E3M10000043F08	Enterococcus faecalis
1037	E3M10000043F10	Enterococcus faecalis
1038	E3M10000043F12	Enterococcus faecalis
1039	E3M10000043G03	Enterococcus faecalis
1040	E3M10000043G04	Enterococcus faecalis
1041	E3M10000043G05	Enterococcus faecalis
1042	E3M10000043G07	Enterococcus faecalis
1043	E3M10000043G08	Enterococcus faecalis
1044	E3M10000043G10	Enterococcus faecalis
1045	E3M10000043G11	Enterococcus faecalis
1046	E3M10000043G12	Enterococcus faecalis
1047	E3M10000043H02	Enterococcus faecalis
1048	E3M10000043H05	Enterococcus faecalis
1049	E3M10000043H08	Enterococcus faecalis
1050	E3M10000043H09	Enterococcus faecalis
1051	E3M10000043H11	Enterococcus faecalis
1052	E3M10000044C02	Enterococcus faecalis
1053	E3M10000044E01	Enterococcus faecalis
1054	K1M10000002F02	Klebsiella pneumoniae
1055	K1M10000003C01	Klebsiella pneumoniae
1056	K1M10000004F06	Klebsiella pneumoniae
1057	K1M10000007F01	Klebsiella pneumoniae
1058	K1M10000008C02	Klebsiella pneumoniae
1059	K1M10000008C10	Klebsiella pneumoniae
1060	K1M10000008G10	Klebsiella pneumoniae
1061	K1M10000009D04	Klebsiella pneumoniae
1062	K1M10000013E04	Klebsiella pneumoniae
1063	K1M10000013E06	Klebsiella pneumoniae
1064	K1M10000019D06	Klebsiella pneumoniae
1065	K1M10000020B02	Klebsiella pneumoniae
1066	K1M10000021HO6	Klebsiella pneumoniae
1067	K1M10000022C10	Klebsiella pneumoniae
1068	K1M10000023E09	Klebsiella pneumoniae
1069	K1M10000023E10	Klebsiella pneumoniae
1070	K1M10000030C07	Klebsiella pneumoniae
1071	K1M10000030E07	Klebsiella pneumoniae
1072	K1M10000031B11	Klebsiella pneumoniae
1073	K1M10000032E11	Klebsiella pneumoniae
1074	K1M10000033B02	Klebsiella pneumoniae
1075	K1M10000033E01	Klebsiella pneumoniae
1076	K1M10000036G08	Klebsiella pneumoniae
1077	K1M10000037D10	Klebsiella pneumoniae
1078	K1M10000038H09	Klebsiella pneumoniae
1079	K1M10000039H03	Klebsiella pneumoniae
1080	K1M10000043C01	Klebsiella pneumoniae
1081	K1M10000043D05	Klebsiella pneumoniae
1082	K1M10000043H10	Klebsiella pneumoniae
1083	K1M10000044D05	Klebsiella pneumoniae
1084	K1M10000044D08	Klebsiella pneumoniae
1085	K1M10000044E05	Klebsiella pneumoniae
1086	K1M10000044G05	Klebsiella pneumoniae
1087	K1M10000045A07	Klebsiella pneumoniae
1088	K1M10000045D10	Klebsiella pneumoniae
1089	K1M10000003D03	Klebsiella pneumoniae
1090	K1M10000010C02	Klebsiella pneumoniae
1091	K1M10000021H10	Klebsiella pneumoniae
1092	P1M10000008C06	Pseudomonas aeruginosa
1093	P1M10000008G04	Pseudomonas aeruginosa
1094	P1M10000010C03	Pseudomonas aeruginosa
1095	P1M10000014H10	Pseudomonas aeruginosa
1096	P1M10000015C06	Pseudomonas aeruginosa
1097	P1M10000015C09	Pseudomonas aeruginosa
1098	P1M10000016C04	Pseudomonas aeruginosa
1099	P1M10000018B01	Pseudomonas aeruginosa
1100	P1M10000018C01	Pseudomonas aeruginosa
1101	P1M10000018E01	Pseudomonas aeruginosa
1102	P1M10000018G01	Pseudomonas aeruginosa
1103	P1M10000019F01	Pseudomonas aeruginosa
1104	P1M10000021G03	Pseudomonas aeruginosa
1105	P1M10000021G05	Pseudomonas aeruginosa
1106	P1M10000022D09	Pseudomonas aeruginosa
1107	P1M10000024D06	Pseudomonas aeruginosa
1108	P1M10000024E06	Pseudomonas aeruginosa
1109	P1M10000024H03	Pseudomonas aeruginosa
1110	P1M10000025A06	Pseudomonas aeruginosa
1111	P1M10000025G07	Pseudomonas aeruginosa
1112	P1M10000025H07	Pseudomonas aeruginosa
1113	P1M10000026E06	Pseudomonas aeruginosa
1114	P1M10000026F04	Pseudomonas aeruginosa
1115	P1M10000026G09	Pseudomonas aeruginosa
1116	P1M10000026H02	Pseudomonas aeruginosa
1117	P1M10000026H05	Pseudomonas aeruginosa
1118	P1M10000027A06	Pseudomonas aeruginosa
1119	P1M10000027B02	Pseudomonas aeruginosa
1120	P1M10000027G05	Pseudomonas aeruginosa
1121	P1M10000028A08	Pseudomonas aeruginosa
1122	P1M10000028B01	Pseudomonas aeruginosa
1123	P1M10000028E02	Pseudomonas aeruginosa
1124	P1M10000029A09	Pseudomonas aeruginosa
1125	P1M10000029G03	Pseudomonas aeruginosa
1126	P1M10000029H05	Pseudomonas aeruginosa
1127	P1M10000032F04	Pseudomonas aeruginosa
1128	P1M10000033A02	Pseudomonas aeruginosa
1129	P1M10000033B08	Pseudomonas aeruginosa
1130	P1M10000033E03	Pseudomonas aeruginosa
1131	P1M10000033F01	Pseudomonas aeruginosa
1132	P1M10000033G08	Pseudomonas aeruginosa
1133	P1M10000035A06	Pseudomonas aeruginosa
1134	P1M10000037B12	Pseudomonas aeruginosa
1135	P1M10000037G12	Pseudomonas aeruginosa
1136	P1M10000038B08	Pseudomonas aeruginosa
1137	P1M10000038C03	Pseudomonas aeruginosa
1138	P1M10000038C06	Pseudomonas aeruginosa
1139	P1M10000038F04	Pseudomonas aeruginosa
1140	P1M10000038G02	Pseudomonas aeruginosa
1141	P1M10000039G05	Pseudomonas aeruginosa
1142	P1M10000039G12	Pseudomonas aeruginosa
1143	PIM10000040C01	Pseudomonas aeruginosa
1144	P1M10000040C04	Pseudomonas aeruginosa
1145	P1M10000040D04	Pseudomonas aeruginosa
1146	P1M10000040D05	Pseudomonas aeruginosa
1147	P1M10000040E10	Pseudomonas aeruginosa
1148	P1M10000040H03	Pseudomonas aeruginosa
1149	P1M1OOOOO41A12	Pseudomonas aeruginosa
1150	P1M10000041B02	Pseudomonas aeruginosa
1151	P1M10000041E01	Pseudomonas aeruginosa
1152	P1M10000041F01	Pseudomonas aeruginosa
1153	P1M10000042B12	Pseudomonas aeruginosa
1154	P1M10000042E08	Pseudomonas aeruginosa
1155	P1M10000043A03	Pseudomonas aeruginosa
1156	P1M10000043D06	Pseudomonas aeruginosa
1157	P1M10000044F07	Pseudomonas aeruginosa
1158	P1M10000046B03	Pseudomonas aeruginosa
1159	P1M10000046C07	Pseudomonas aeruginosa
1160	P1M10000046C08	Pseudomonas aeruginosa
1161	P1M10000046C09	Pseudomonas aeruginosa
1162	P1M10000046G11	Pseudomonas aeruginosa
1163	P1M10000047B04	Pseudomonas aeruginosa
1164	P1M10000047E11	Pseudomonas aeruginosa
1165	P1M10000047F07	Pseudomonas aeruginosa
1166	P1M10000047G10	Pseudomonas aeruginosa
1167	P1M10000048A03	Pseudomonas aeruginosa
1168	P1M10000049E08	Pseudomonas aeruginosa
1169	P1M10000049G10	Pseudomonas aeruginosa
1170	P1M10000050G11	Pseudomonas aeruginosa
1171	P1M10000051D11	Pseudomonas aeruginosa
1172	P1M10000051F01	Pseudomonas aeruginosa
1173	P1M10000052C03	Pseudomonas aeruginosa
1174	P1M10000052C12	Pseudomonas aeruginosa
1175	P1M10000052E04	Pseudomonas aeruginosa
1176	P1M10000053B12	Pseudomonas aeruginosa
1177	P1M10000053C02	Pseudomonas aeruginosa
1178	P1M10000053E07	Pseudomonas aeruginosa
1179	P1M10000053F08	Pseudomonas aeruginosa
1180	P1M10000055A11	Pseudomonas aeruginosa
1181	P1M10000055C08	Pseudomonas aeruginosa
1182	P1M10000055E05	Pseudomonas aeruginosa
1183	P1M10000056C07	Pseudomonas aeruginosa
1184	P1M10000056F05	Pseudomonas aeruginosa
1185	P1M10000056F06	Pseudomonas aeruginosa
1186	P1M10000056G01	Pseudomonas aeruginosa
1187	P1M10000058B07	Pseudomonas aeruginosa
1188	P1M10000059B04	Pseudomonas aeruginosa
1189	P1M10000059B10	Pseudomonas aeruginosa
1190	P1M10000059B11	Pseudomonas aeruginosa
1191	P1M10000059D11	Pseudomonas aeruginosa
1192	P1M10000059H08	Pseudomonas aeruginosa
1193	P1M10000059H09	Pseudomonas aeruginosa
1194	P1M10000060E03	Pseudomonas aeruginosa
1195	P1M10000060H02	Pseudomonas aeruginosa
1196	P1M10000060H04	Pseudomonas aeruginosa
1197	P1M10000061B04	Pseudomonas aeruginosa
1198	P1M10000061E04	Pseudomonas aeruginosa
1199	P1M10000061F04	Pseudomonas aeruginosa
1200	P1M10000062A12	Pseudomonas aeruginosa
1201	P1M10000062C03	Pseudomonas aeruginosa
1202	P1M10000062C04	Pseudomonas aeruginosa
1203	P1M10000062C07	Pseudomonas aeruginosa
1204	P1M10000062C12	Pseudomonas aeruginosa
1205	P1M10000062D07	Pseudomonas aeruginosa
1206	P1M10000062D08	Pseudomonas aeruginosa
1207	P1M10000062E08	Pseudomonas aeruginosa
1208	P1M10000062F06	Pseudomonas aeruginosa
1209	P1M10000062G11	Pseudomonas aeruginosa
1210	P1M10000062H01	Pseudomonas aeruginosa
1211	P1M10000062H04	Pseudomonas aeruginosa
1212	P1M10000063F02	Pseudomonas aeruginosa
1213	P1M10000063G02	Pseudomonas aeruginosa
1214	P1M10000063H02	Pseudomonas aeruginosa
1215	P1M10000064A10	Pseudomonas aeruginosa
1216	P1M10000064C02	Pseudomonas aeruginosa
1217	P1M10000064C03	Pseudomonas aeruginosa
1218	P1M10000064D03	Pseudomonas aeruginosa
1219	P1M10000064E05	Pseudomonas aeruginosa
1220	P1M10000064G12	Pseudomonas aeruginosa
1221	P1M10000064H07	Pseudomonas aeruginosa
1222	P1M10000065A04	Pseudomonas aeruginosa
1223	P1M10000065B07	Pseudomonas aeruginosa
1224	P1M10000065C03	Pseudomonas aeruginosa
1225	P1M10000065C05	Pseudomonas aeruginosa
1226	P1M10000065D06	Pseudomonas aeruginosa
1227	P1M10000065F01	Pseudomonas aeruginosa
1228	P1M10000065G06	Pseudomonas aeruginosa
1229	P1M10000065H07	Pseudomonas aeruginosa
1230	P1M10000066A10	Pseudomonas aeruginosa
1231	P1M10000066A11	Pseudomonas aeruginosa
1232	P1M10000066F04	Pseudomonas aeruginosa
1233	P1M10000067A05	Pseudomonas aeruginosa
1234	P1M10000067A06	Pseudomonas aeruginosa
1235	P1M10000067A08	Pseudomonas aeruginosa
1236	P1M10000067C04	Pseudomonas aeruginosa
1237	P1M10000067C06	Pseudomonas aeruginosa
1238	P1M10000067D05	Pseudomonas aeruginosa
1239	P1M10000067F05	Pseudomonas aeruginosa
1240	P1M10000067G05	Pseudomonas aeruginosa
1241	P1M10000068A09	Pseudomonas aeruginosa
1242	P1M10000068D04	Pseudomonas aeruginosa
1243	P1M10000068F04	Pseudomonas aeruginosa
1244	P1M10000068F08	Pseudomonas aeruginosa
1245	P1M10000068G01	Pseudomonas aeruginosa
1246	P1M10000068H05	Pseudomonas aeruginosa
1247	P1M10000069D09	Pseudomonas aeruginosa
1248	P1M10000069G06	Pseudomonas aeruginosa
1249	P1M10000069H02	Pseudomonas aeruginosa
1250	P1M10000070A05	Pseudomonas aeruginosa
1251	P1M10000070B10	Pseudomonas aeruginosa
1252	P1M10000070C06	Pseudomonas aeruginosa
1253	P1M10000070D08	Pseudomonas aeruginosa
1254	P1M10000070E03	Pseudomonas aeruginosa
1255	P1M10000070G06	Pseudomonas aeruginosa
1256	P1M10000070G12	Pseudomonas aeruginosa
1257	P1M10000070H06	Pseudomonas aeruginosa
1258	P1M10000071A03	Pseudomonas aeruginosa
1259	P1M10000071C01	Pseudomonas aeruginosa
1260	P1M10000071E04	Pseudomonas aeruginosa
1261	P1M10000071F01	Pseudomonas aeruginosa
1262	P1M10000073A06	Pseudomonas aeruginosa
1263	P1M10000073B10	Pseudomonas aeruginosa
1264	P1M10000073D04	Pseudomonas aeruginosa
1265	P1M10000073D09	Pseudomonas aeruginosa
1266	P1M10000073G03	Pseudomonas aeruginosa
1267	PIM10000074B01	Pseudomonas aeruginosa
1268	P1M10000074B04	Pseudomonas aeruginosa
1269	P1M10000074E04	Pseudomonas aeruginosa
1270	P1M10000074E09	Pseudomonas aeruginosa
1271	P1M10000074F10	Pseudomonas aeruginosa
1272	P1M10000074G12	Pseudomonas aeruginosa
1273	P1M10000075A04	Pseudomonas aeruginosa
1274	P1M10000075B03	Pseudomonas aeruginosa
1275	P1M10000075F02	Pseudomonas aeruginosa
1276	P1M10000075G05	Pseudomonas aeruginosa
1277	P1M10000076D05	Pseudomonas aeruginosa
1278	P1M10000076D10	Pseudomonas aeruginosa
1279	P1M10000077A08	Pseudomonas aeruginosa
1280	P1M10000077C08	Pseudomonas aeruginosa
1281	P1M10000077E04	Pseudomonas aeruginosa
1282	P1M10000077H05	Pseudomonas aeruginosa
1283	P1M10000079A10	Pseudomonas aeruginosa
1284	P1M10000079B10	Pseudomonas aeruginosa
1285	P1M10000079C10	Pseudomonas aeruginosa
1286	P1M10000079D01	Pseudomonas aeruginosa
1287	P1M10000079D10	Pseudomonas aeruginosa
1288	P1M10000079F06	Pseudomonas aeruginosa
1289	P1M10000080B01	Pseudomonas aeruginosa
1290	P1M10000080B06	Pseudomonas aeruginosa
1291	P1M10000080C01	Pseudomonas aeruginosa
1292	P1M10000080C06	Pseudomonas aeruginosa
1293	P1M10000080E04	Pseudomonas aeruginosa
1294	P1M10000081D12	Pseudomonas aeruginosa
1295	P1M10000081G05	Pseudomonas aeruginosa
1296	P1M10000081H05	Pseudomonas aeruginosa
1297	P1M10000082A05	Pseudomonas aeruginosa
1298	P1M10000082B04	Pseudomonas aeruginosa
1299	P1M10000082C05	Pseudomonas aeruginosa
1300	P1M10000082D05	Pseudomonas aeruginosa
1301	P1M10000082E05	Pseudomonas aeruginosa
1302	P1M10000083A11	Pseudomonas aeruginosa
1303	P1M10000083B01	Pseudomonas aeruginosa
1304	P1M10000083B12	Pseudomonas aeruginosa
1305	P1M10000083C11	Pseudomonas aeruginosa
1306	P1M10000083C12	Pseudomonas aeruginosa
1307	P1M10000084A04	Pseudomonas aeruginosa
1308	P1M10000084D03	Pseudomonas aeruginosa
1309	P1M10000084E04	Pseudomonas aeruginosa
1310	P1M10000084E11	Pseudomonas aeruginosa
1311	P1M10000084F08	Pseudomonas aeruginosa
1312	P1M10000085D06	Pseudomonas aeruginosa
1313	P1M10000086A02	Pseudomonas aeruginosa
1314	P1M10000086B01	Pseudomonas aeruginosa
1315	P1M10000086D02	Pseudomonas aeruginosa
1316	P1M10000086E05	Pseudomonas aeruginosa
1317	P1M10000087A11	Pseudomonas aeruginosa
1318	P1M10000087C09	Pseudomonas aeruginosa
1319	P1M10000087E04	Pseudomonas aeruginosa
1320	P1M10000087F04	Pseudomonas aeruginosa
1321	P1M10000087F09	Pseudomonas aeruginosa
1322	P1M10000088A07	Pseudomonas aeruginosa
1323	P1M10000088D06	Pseudomonas aeruginosa
1324	P1M10000089C08	Pseudomonas aeruginosa
1325	P1M10000089D11	Pseudomonas aeruginosa
1326	P1M10000089G08	Pseudomonas aeruginosa
1327	P1M10000090B11	Pseudomonas aeruginosa
1328	P1M10000090F06	Pseudomonas aeruginosa
1329	P1M10000090F08	Pseudomonas aeruginosa
1330	P1M10000091D02	Pseudomonas aeruginosa
1331	P1M10000091E09	Pseudomonas aeruginosa
1332	P1M10000091G10	Pseudomonas aeruginosa
1333	P1M10000092B02	Pseudomonas aeruginosa
1334	P1M10000092B10	Pseudomonas aeruginosa
1335	P1M10000092D09	Pseudomonas aeruginosa
1336	P1M10000092E02	Pseudomonas aeruginosa
1337	P1M10000092F05	Pseudomonas aeruginosa
1338	P1M10000093A03	Pseudomonas aeruginosa
1339	P1M10000093B09	Pseudomonas aeruginosa
1340	P1M10000093C08	Pseudomonas aeruginosa
1341	P1M10000093E09	Pseudomonas aeruginosa
1342	P1M10000093F03	Pseudomonas aeruginosa
1343	P1M10000093H07	Pseudomonas aeruginosa
1344	P1M10000094F04	Pseudomonas aeruginosa
1345	P1M10000094H03	Pseudomonas aeruginosa
1346	P1M10000095C01	Pseudomonas aeruginosa
1347	P1M10000095C09	Pseudomonas aeruginosa
1348	P1M10000095E04	Pseudomonas aeruginosa
1349	P1M10000095G04	Pseudomonas aeruginosa
1350	P1M10000096E04	Pseudomonas aeruginosa
1351	P1M10000096E12	Pseudomonas aeruginosa
1352	ID2	Pseudomonas aeruginosa
1353	4.1	Pseudomonas aeruginosa
1354	S1M10000001A05	Staphylococcus aureus
1355	S1M10000001A08	Staphylococcus aureus
1356	S1M10000001A09	Staphylococcus aureus
1357	S1M10000001A10	Staphylococcus aureus
1358	S1M10000001C06	Staphylococcus aureus
1359	S1M10000001D01	Staphylococcus aureus
1360	S1M1000000ID02	Staphylococcus aureus
1361	S1M1000000ID06	Staphylococcus aureus
1362	S1M10000001D07	Staphylococcus aureus
1363	S1M10000001E02	Staphylococcus aureus
1364	S1M10000001E04	Staphylococcus aureus
1365	S1M10000001E05	Staphylococcus aureus
1366	S1M10000001E09	Staphylococcus aureus
1367	S1M10000001E10	Staphylococcus aureus
1368	S1M10000001E11	Staphylococcus aureus
1369	S1M10000001F02	Staphylococcus aureus
1370	S1M10000001F04	Staphylococcus aureus
1371	S1M10000001F08	Staphylococcus aureus
1372	S1M10000001F09	Staphylococcus aureus
1373	S1M10000001F10	Staphylococcus aureus
1374	S1M10000001F11	Staphylococcus aureus
1375	S1M10000001G01	Staphylococcus aureus
1376	S1M10000001G07	Staphylococcus aureus
1377	S1M10000001G08	Staphylococcus aureus
1378	S1M10000001G10	Staphylococcus aureus
1379	S1M10000002A02	Staphylococcus aureus
1380	S1M10000002A09	Staphylococcus aureus
1381	S1M10000002A10	Staphylococcus aureus
1382	S1M10000002A12	Staphylococcus aureus
1383	S1M10000002B01	Staphylococcus aureus
1384	S1M10000002B03	Staphylococcus aureus
1385	S1M10000002B04	Staphylococcus aureus
1386	S1M10000002B05	Staphylococcus aureus
1387	S1M10000002B06	Staphylococcus aureus
1388	S1M10000002B07	Staphylococcus aureus
1389	S1M10000002B09	Staphylococcus aureus
1390	S1M10000002B11	Staphylococcus aureus
1391	S1M10000002C02	Staphylococcus aureus
1392	S1M10000002C09	Staphylococcus aureus
1393	S1M10000002C10	Staphylococcus aureus
1394	S1M10000002C11	Staphylococcus aureus
1395	S1M10000002C12	Staphylococcus aureus
1396	S1M10000002D01	Staphylococcus aureus
1397	S1M10000002D02	Staphylococcus aureus
1398	S1M10000002D03	Staphylococcus aureus
1399	S1M10000002D05	Staphylococcus aureus
1400	S1M10000002D07	Staphylococcus aureus
1401	S1M10000002D08	Staphylococcus aureus
1402	S1M10000002D10	Staphylococcus aureus
1403	S1M10000002D12	Staphylococcus aureus
1404	S1M10000002E01	Staphylococcus aureus
1405	S1M10000002E02	Staphylococcus aureus
1406	S1M10000002E07	Staphylococcus aureus
1407	S1M10000002E09	Staphylococcus aureus
1408	S1M10000002E11	Staphylococcus aureus
1409	S1M10000002E12	Staphylococcus aureus
1410	S1M10000002F01	Staphylococcus aureus
1411	S1M10000002F02	Staphylococcus aureus
1412	S1M10000002F04	Staphylococcus aureus
1413	S1M10000002F09	Staphylococcus aureus
1414	S1M10000002F12	Staphylococcus aureus
1415	S1M10000002G01	Staphylococcus aureus
1416	S1M10000002G03	Staphylococcus aureus
1417	S1M10000002G05	Staphylococcus aureus
1418	S1M10000002G06	Staphylococcus aureus
1419	S1M10000002G07	Staphylococcus aureus
1420	S1M10000002G08	Staphylococcus aureus
1421	S1M10000002G09	Staphylococcus aureus
1422	S1M10000002G10	Staphylococcus aureus
1423	S1M10000002G11	Staphylococcus aureus
1424	S1M10000002G12	Staphylococcus aureus
1425	S1M10000003A01	Staphylococcus aureus
1426	S1M10000003A02	Staphylococcus aureus
1427	S1M10000003A03	Staphylococcus aureus
1428	S1M10000003A04	Staphylococcus aureus
1429	S1M10000003A06	Staphylococcus aureus
1430	S1M10000003A07	Staphylococcus aureus
1431	S1M10000003A08	Staphylococcus aureus
1432	S1M10000003A10	Staphylococcus aureus
1433	S1M10000003A11	Staphylococcus aureus
1434	S1M10000003B06	Staphylococcus aureus
1435	S1M10000003B08	Staphylococcus aureus
1436	S1M10000003B09	Staphylococcus aureus
1437	S1M10000003B12	Staphylococcus aureus
1438	S1M10000003C06	Staphylococcus aureus
1439	S1M10000003C07	Staphylococcus aureus
1440	S1M10000003C10	Staphylococcus aureus
1441	S1M10000003C12	Staphylococcus aureus
1442	S1M10000003D05	Staphylococcus aureus
1443	S1M10000003D06	Staphylococcus aureus
1444	S1M10000003D08	Staphylococcus aureus
1445	S1M10000003D10	Staphylococcus aureus
1446	S1M10000003E07	Staphylococcus aureus
1447	S1M10000003E09	Staphylococcus aureus
1448	S1M10000003E10	Staphylococcus aureus
1449	S1M10000003E11	Staphylococcus aureus
1450	S1M10000003F02	Staphylococcus aureus
1451	S1M10000003F05	Staphylococcus aureus
1452	S1M10000003F06	Staphylococcus aureus
1453	S1M10000003F07	Staphylococcus aureus
1454	S1M10000003F08	Staphylococcus aureus
1455	S1M10000003F12	Staphylococcus aureus
1456	S1M10000003G03	Staphylococcus aureus
1457	S1M10000003G04	Staphylococcus aureus
1458	S1M10000003G08	Staphylococcus aureus
1459	S1M10000003G10	Staphylococcus aureus
1460	S1M10000004A04	Staphylococcus aureus
1461	S1M10000004A06	Staphylococcus aureus
1462	S1M10000004A07	Staphylococcus aureus
1463	S1M10000004A11	Staphylococcus aureus
1464	S1M10000004A12	Staphylococcus aureus
1465	S1M10000004B03	Staphylococcus aureus
1466	S1M10000004B04	Staphylococcus aureus
1467	S1M10000004B06	Staphylococcus aureus
1468	S1M10000004B08	Staphylococcus aureus
1469	S1M10000004B09	Staphylococcus aureus
1470	S1M10000004B11	Staphylococcus aureus
1471	S1M10000004C01	Staphylococcus aureus
1472	S1M10000004C02	Staphylococcus aureus
1473	S1M10000004C03	Staphylococcus aureus
1474	S1M10000004C06	Staphylococcus aureus
1475	S1M10000004C07	Staphylococcus aureus
1476	S1M10000004C08	Staphylococcus aureus
1477	S1M10000004C09	Staphylococcus aureus
1478	S1M10000004C10	Staphylococcus aureus
1479	S1M10000004C12	Staphylococcus aureus
1480	S1M10000004D01	Staphylococcus aureus
1481	S1M10000004D03	Staphylococcus aureus
1482	S1M10000004D04	Staphylococcus aureus
1483	S1M10000004D06	Staphylococcus aureus
1484	S1M10000004D07	Staphylococcus aureus
1485	S1M10000004D08	Staphylococcus aureus
1486	S1M10000004D10	Staphylococcus aureus
1487	S1M10000004D12	Staphylococcus aureus
1488	S1M10000004E03	Staphylococcus aureus
1489	S1M10000004E04	Staphylococcus aureus
1490	S1M10000004E06	Staphylococcus aureus
1491	S1M10000004E07	Staphylococcus aureus
1492	S1M10000004E11	Staphylococcus aureus
1493	S1M10000004E12	Staphylococcus aureus
1494	S1M10000004F01	Staphylococcus aureus
1495	S1M10000004F02	Staphylococcus aureus
1496	S1M10000004F06	Staphylococcus aureus
1497	S1M10000004F07	Staphylococcus aureus
1498	S1M10000004F08	Staphylococcus aureus
1499	S1M10000004F09	Staphylococcus aureus
1500	S1M10000004F12	Staphylococcus aureus
1501	S1M10000004G01	Staphylococcus aureus
1502	S1M10000004G02	Staphylococcus aureus
1503	S1M10000004G03	Staphylococcus aureus
1504	S1M10000004G05	Staphylococcus aureus
1505	S1M10000004G06	Staphylococcus aureus
1506	S1M10000004G07	Staphylococcus aureus
1507	S1M10000004G09	Staphylococcus aureus
1508	S1M10000004G12	Staphylococcus aureus
1509	S1M10000005A01	Staphylococcus aureus
1510	S1M10000005A03	Staphylococcus aureus
1511	S1M10000005A05	Staphylococcus aureus
1512	S1M10000005A06	Staphylococcus aureus
1513	S1M10000005A07	Staphylococcus aureus
1514	S1M10000005A08	Staphylococcus aureus
1515	S1M10000005A09	Staphylococcus aureus
1516	S1M10000005A10	Staphylococcus aureus
1517	S1M10000005A11	Staphylococcus aureus
1518	S1M10000005B02	Staphylococcus aureus
1519	S1M10000005B04	Staphylococcus aureus
1520	S1M10000005B07	Staphylococcus aureus
1521	S1M10000005B08	Staphylococcus aureus
1522	S1M10000005B09	Staphylococcus aureus
1523	S1M10000005B12	Staphylococcus aureus
1524	S1M10000005C01	Staphylococcus aureus
1525	S1M10000005C05	Staphylococcus aureus
1526	S1M10000005C06	Staphylococcus aureus
1527	S1M10000005C09	Staphylococcus aureus
1528	S1M10000005C11	Staphylococcus aureus
1529	S1M10000005D01	Staphylococcus aureus
1530	S1M10000005D02	Staphylococcus aureus
1531	S1M10000005D03	Staphylococcus aureus
1532	S1M10000005D04	Staphylococcus aureus
1533	S1M10000005D05	Staphylococcus aureus
1534	S1M10000005D06	Staphylococcus aureus
1535	S1M10000005D07	Staphylococcus aureus
1536	S1M10000005D08	Staphylococcus aureus
1537	S1M10000005D09	Staphylococcus aureus
1538	S1M10000005D11	Staphylococcus aureus
1539	S1M10000005D12	Staphylococcus aureus
1540	S1M10000005E01	Staphylococcus aureus
1541	S1M10000005E02	Staphylococcus aureus
1542	S1M10000005E05	Staphylococcus aureus
1543	S1M10000005E06	Staphylococcus aureus
1544	S1M10000005E07	Staphylococcus aureus
1545	S1M10000005E08	Staphylococcus aureus
1546	S1M10000005E10	Staphylococcus aureus
1547	S1M10000005E11	Staphylococcus aureus
1548	S1M10000005E12	Staphylococcus aureus
1549	S1M10000005F02	Staphylococcus aureus
1550	S1M10000005F03	Staphylococcus aureus
1551	S1M10000005F04	Staphylococcus aureus
1552	S1M10000006A03	Staphylococcus aureus
1553	S1M10000006A04	Staphylococcus aureus
1554	S1M10000006A05	Staphylococcus aureus
1555	S1M10000006A07	Staphylococcus aureus
1556	S1M10000006A08	Staphylococcus aureus
1557	S1M10000006A10	Staphylococcus aureus
1558	S1M10000006A12	Staphylococcus aureus
1559	S1M10000006B02	Staphylococcus aureus
1560	S1M10000006B03	Staphylococcus aureus
1561	S1M10000006B04	Staphylococcus aureus
1562	S1M10000006B07	Staphylococcus aureus
1563	S1M10000006B10	Staphylococcus aureus
1564	S1M10000006B11	Staphylococcus aureus
1565	S1M10000006C02	Staphylococcus aureus
1566	S1M10000006C04	Staphylococcus aureus
1567	S1M10000006C06	Staphylococcus aureus
1568	S1M10000006C07	Staphylococcus aureus
1569	S1M10000006C08	Staphylococcus aureus
1570	S1M10000006C10	Staphylococcus aureus
1571	S1M10000006D03	Staphylococcus aureus
1572	S1M10000006D05	Staphylococcus aureus
1573	S1M10000006D06	Staphylococcus aureus
1574	S1M10000006D07	Staphylococcus aureus
1575	S1M10000006D08	Staphylococcus aureus
1576	S1M10000006E02	Staphylococcus aureus
1577	S1M10000006E03	Staphylococcus aureus
1578	S1M10000006E04	Staphylococcus aureus
1579	S1M10000006E07	Staphylococcus aureus
1580	S1M10000006E08	Staphylococcus aureus
1581	S1M10000006F01	Staphylococcus aureus
1582	S1M10000006F02	Staphylococcus aureus
1583	S1M10000006F03	Staphylococcus aureus
1584	S1M10000006F04	Staphylococcus aureus
1585	S1M10000006F06	Staphylococcus aureus
1586	S1M10000006G02	Staphylococcus aureus
1587	S1M10000006G03	Staphylococcus aureus
1588	S1M10000006G05	Staphylococcus aureus
1589	S1M10000006G06	Staphylococcus aureus
1590	S1M10000006G07	Staphylococcus aureus
1591	S1M10000006G09	Staphylococcus aureus
1592	S1M10000006G10	Staphylococcus aureus
1593	S1M10000006G11	Staphylococcus aureus
1594	S1M10000007A02	Staphylococcus aureus
1595	S1M10000007A03	Staphylococcus aureus
1596	S1M10000007B02	Staphylococcus aureus
1597	S1M10000007B11	Staphylococcus aureus
1598	S1M10000007C02	Staphylococcus aureus
1599	S1M10000007C04	Staphylococcus aureus
1600	S1M10000007C05	Staphylococcus aureus
1601	S1M10000007CO6	Staphylococcus aureus
1602	S1M10000007C07	Staphylococcus aureus
1603	S1M10000007C08	Staphylococcus aureus
1604	S1M10000007C09	Staphylococcus aureus
1605	S1M10000007D03	Staphylococcus aureus
1606	S1M10000007D06	Staphylococcus aureus
1607	S1M10000007D08	Staphylococcus aureus
1608	S1M10000007D10	Staphylococcus aureus
1609	S1M10000007D11	Staphylococcus aureus
1610	S1M10000007E04	Staphylococcus aureus
1611	S1M10000007E06	Staphylococcus aureus
1612	S1M10000007E07	Staphylococcus aureus
1613	S1M10000007F01	Staphylococcus aureus
1614	S1M10000007F02	Staphylococcus aureus
1615	S1M10000007F04	Staphylococcus aureus
1616	S1M10000007F08	Staphylococcus aureus
1617	S1M10000007F09	Staphylococcus aureus
1618	S1M10000007F10	Staphylococcus aureus
1619	S1M10000007F11	Staphylococcus aureus
1620	S1M10000007F12	Staphylococcus aureus
1621	S1M10000007G02	Staphylococcus aureus
1622	S1M10000007G03	Staphylococcus aureus
1623	S1M10000007G05	Staphylococcus aureus
1624	S1M10000007G07	Staphylococcus aureus
1625	S1M10000007G08	Staphylococcus aureus
1626	S1M10000008A03	Staphylococcus aureus
1627	S1M10000008A04	Staphylococcus aureus
1628	S1M10000008A05	Staphylococcus aureus
1629	S1M10000008A08	Staphylococcus aureus
1630	S1M10000008A09	Staphylococcus aureus
1631	S1M10000008A12	Staphylococcus aureus
1632	S1M10000008B03	Staphylococcus aureus
1633	S1M10000008B04	Staphylococcus aureus
1634	S1M10000008B06	Staphylococcus aureus
1635	S1M10000008B08	Staphylococcus aureus
1636	S1M10000008B09	Staphylococcus aureus
1637	S1M10000008B10	Staphylococcus aureus
1638	S1M10000008C05	Staphylococcus aureus
1639	S1M10000008C06	Staphylococcus aureus
1640	S1M10000008C07	Staphylococcus aureus
1641	S1M10000008C08	Staphylococcus aureus
1642	S1M10000008C09	Staphylococcus aureus
1643	S1M10000008D05	Staphylococcus aureus
1644	S1M10000008D09	Staphylococcus aureus
1645	S1M10000008E05	Staphylococcus aureus
1646	S1M10000008E08	Staphylococcus aureus
1647	S1M10000008E09	Staphylococcus aureus
1648	S1M10000008E10	Staphylococcus aureus
1649	S1M10000008F01	Staphylococcus aureus
1650	S1M10000008F02	Staphylococcus aureus
1651	S1M10000008F03	Staphylococcus aureus
1652	S1M10000008F06	Staphylococcus aureus
1653	S1M10000008F08	Staphylococcus aureus
1654	S1M10000008F09	Staphylococcus aureus
1655	S1M10000008F10	Staphylococcus aureus
1656	S1M10000008F11	Staphylococcus aureus
1657	S1M10000008G02	Staphylococcus aureus
1658	S1M10000008G03	Staphylococcus aureus
1659	S1M10000008G05	Staphylococcus aureus
1660	S1M10000009A02	Staphylococcus aureus
1661	S1M10000009A04	Staphylococcus aureus
1662	S1M10000009A07	Staphylococcus aureus
1663	S1M10000009A08	Staphylococcus aureus
1664	S1M10000009A09	Staphylococcus aureus
1665	S1M10000009A10	Staphylococcus aureus
1666	S1M10000009A11	Staphylococcus aureus
1667	S1M10000009B01	Staphylococcus aureus
1668	S1M10000009B02	Staphylococcus aureus
1669	S1M10000009B03	Staphylococcus aureus
1670	S1M10000009B04	Staphylococcus aureus
1671	S1M10000009B05	Staphylococcus aureus
1672	S1M10000009B06	Staphylococcus aureus
1673	S1M10000009B07	Staphylococcus aureus
1674	S1M10000009B10	Staphylococcus aureus
1675	S1M10000009B11	Staphylococcus aureus
1676	S1M10000009B12	Staphylococcus aureus
1677	S1M10000009C01	Staphylococcus aureus
1678	S1M10000009C02	Staphylococcus aureus
1679	S1M10000009C05	Staphylococcus aureus
1680	S1M10000009C06	Staphylococcus aureus
1681	S1M10000009C07	Staphylococcus aureus
1682	S1M10000009C08	Staphylococcus aureus
1683	S1M10000009C09	Staphylococcus aureus
1684	S1M10000009C10	Staphylococcus aureus
1685	S1M10000009C11	Staphylococcus aureus
1686	S1M10000009D01	Staphylococcus aureus
1687	S1M10000009D02	Staphylococcus aureus
1688	S1M10000009D03	Staphylococcus aureus
1689	S1M10000009D04	Staphylococcus aureus
1690	S1M10000009D05	Staphylococcus aureus
1691	S1M10000009D07	Staphylococcus aureus
1692	S1M10000009D09	Staphylococcus aureus
1693	S1M10000009D11	Staphylococcus aureus
1694	S1M10000009E02	Staphylococcus aureus
1695	S1M10000009E06	Staphylococcus aureus
1696	S1M10000009E08	Staphylococcus aureus
1697	S1M10000009B09	Staphylococcus aureus
1698	S1M10000009E11	Staphylococcus aureus
1699	S1M10000009E12	Staphylococcus aureus
1700	S1M10000009F01	Staphylococcus aureus
1701	S1M10000009F02	Staphylococcus aureus
1702	S1M10000009F03	Staphylococcus aureus
1703	S1M10000009F05	Staphylococcus aureus
1704	S1M10000009F06	Staphylococcus aureus
1705	S1M10000009F07	Staphylococcus aureus
1706	S1M10000009F09	Staphylococcus aureus
1707	S1M10000009F10	Staphylococcus aureus
1708	S1M10000009G02	Staphylococcus aureus
1709	S1M10000009G03	Staphylococcus aureus
1710	S1M10000009G05	Staphylococcus aureus
1711	S1M10000009G06	Staphylococcus aureus
1712	S1M10000009G07	Staphylococcus aureus
1713	S1M10000009G09	Staphylococcus aureus
1714	S1M10000009G10	Staphylococcus aureus
1715	S1M10000009G11	Staphylococcus aureus
1716	S1M10000009H01	Staphylococcus aureus
1717	S1M10000009H02	Staphylococcus aureus
1718	S1M10000009H03	Staphylococcus aureus
1719	S1M10000009H05	Staphylococcus aureus
1720	S1M10000009H07	Staphylococcus aureus
1721	S1M10000009H09	Staphylococcus aureus
1722	S1M10000009H11	Staphylococcus aureus
1723	S1M10000011A02	Staphylococcus aureus
1724	S1M10000011A03	Staphylococcus aureus
1725	S1M10000011A04	Staphylococcus aureus
1726	S1M10000011A06	Staphylococcus aureus
1727	S1M10000011B01	Staphylococcus aureus
1728	S1M10000011B02	Staphylococcus aureus
1729	S1M10000011B03	Staphylococcus aureus
1730	S1M10000011B04	Staphylococcus aureus
1731	S1M10000011B05	Staphylococcus aureus
1732	S1M10000011C01	Staphylococcus aureus
1733	S1M10000011C05	Staphylococcus aureus
1734	S1M10000011C06	Staphylococcus aureus
1735	S1M10000011D01	Staphylococcus aureus
1736	S1M10000011D02	Staphylococcus aureus
1737	S1M10000011D04	Staphylococcus aureus
1738	S1M10000011D06	Staphylococcus aureus
1739	S1M10000011E02	Staphylococcus aureus
1740	S1M10000011E03	Staphylococcus aureus
1741	S1M10000011E04	Staphylococcus aureus
1742	S1M10000011F01	Staphylococcus aureus
1743	S1M10000011F03	Staphylococcus aureus
1744	S1M10000011F04	Staphylococcus aureus
1745	S1M10000011F06	Staphylococcus aureus
1746	S1M10000011G01	Staphylococcus aureus
1747	S1M10000011G03	Staphylococcus aureus
1748	S1M10000011G04	Staphylococcus aureus
1749	S1M10000011G05	Staphylococcus aureus
1750	S1M10000011G06	Staphylococcus aureus
1751	S1M10000011H01	Staphylococcus aureus
1752	S1M10000011H03	Staphylococcus aureus
1753	S1M10000011H04	Staphylococcus aureus
1754	S1M10000012A02	Staphylococcus aureus
1755	S1M10000012A06	Staphylococcus aureus
1756	S1M10000012A08	Staphylococcus aureus
1757	S1M10000012A09	Staphylococcus aureus
1758	S1M10000012A10	Staphylococcus aureus
1759	S1M10000012A11	Staphylococcus aureus
1760	S1M10000012B01	Staphylococcus aureus
1761	S1M10000012B05	Staphylococcus aureus
1762	S1M10000012B06	Staphylococcus aureus
1763	S1M10000012B07	Staphylococcus aureus
1764	S1M10000012B11	Staphylococcus aureus
1765	S1M10000012C01	Staphylococcus aureus
1766	S1M10000012C03	Staphylococcus aureus
1767	S1M10000012C04	Staphylococcus aureus
1768	S1M10000012C05	Staphylococcus aureus
1769	S1M10000012C06	Staphylococcus aureus
1770	S1M10000012C11	Staphylococcus aureus
1771	S1M10000012C12	Staphylococcus aureus
1772	S1M10000012D04	Staphylococcus aureus
1773	S1M10000012D06	Staphylococcus aureus
1774	S1M10000012D07	Staphylococcus aureus
1775	S1M10000012D08	Staphylococcus aureus
1776	S1M10000012D09	Staphylococcus aureus
1777	S1M10000012D12	Staphylococcus aureus
1778	S1M10000012E01	Staphylococcus aureus
1779	S1M10000012E02	Staphylococcus aureus
1780	S1M10000012E04	Staphylococcus aureus
1781	S1M10000012E07	Staphylococcus aureus
1782	S1M10000012E08	Staphylococcus aureus
1783	S1M10000012E12	Staphylococcus aureus
1784	S1M10000012F04	Staphylococcus aureus
1785	S1M10000012F07	Staphylococcus aureus
1786	S1M10000012F08	Staphylococcus aureus
1787	S1M10000012F09	Staphylococcus aureus
1788	S1M10000012F10	Staphylococcus aureus
1789	S1M10000012F11	Staphylococcus aureus
1790	S1M10000012F12	Staphylococcus aureus
1791	S1M10000012G01	Staphylococcus aureus
1792	S1M10000012G02	Staphylococcus aureus
1793	S1M10000012G03	Staphylococcus aureus
1794	S1M10000012G06	Staphylococcus aureus
1795	S1M10000012G07	Staphylococcus aureus
1796	S1M10000012G08	Staphylococcus aureus
1797	S1M10000012G10	Staphylococcus aureus
1798	S1M10000012H05	Staphylococcus aureus
1799	S1M10000012H08	Staphylococcus aureus
1800	S1M10000012H09	Staphylococcus aureus
1801	S1M10000012H10	Staphylococcus aureus
1802	S1M10000012H11	Staphylococcus aureus
1803	S1M10000013A02	Staphylococcus aureus
1804	S1M10000013A03	Staphylococcus aureus
1805	S1M10000013A05	Staphylococcus aureus
1806	S1M10000013A07	Staphylococcus aureus
1807	S1M10000013A08	Staphylococcus aureus
1808	S1M10000013A09	Staphylococcus aureus
1809	S1M10000013A10	Staphylococcus aureus
1810	S1M10000013A11	Staphylococcus aureus
1811	S1M10000013A12	Staphylococcus aureus
1812	S1M10000013B02	Staphylococcus aureus
1813	S1M10000013B03	Staphylococcus aureus
1814	S1M10000013B04	Staphylococcus aureus
1815	S1M10000013B05	Staphylococcus aureus
1816	S1M10000013B06	Staphylococcus aureus
1817	S1M10000013B07	Staphylococcus aureus
1818	S1M10000013B09	Staphylococcus aureus
1819	S1M10000013B11	Staphylococcus aureus
1820	S1M10000013C03	Staphylococcus aureus
1821	S1M10000013C05	Staphylococcus aureus
1822	S1M10000013C07	Staphylococcus aureus
1823	S1M10000013C08	Staphylococcus aureus
1824	S1M10000013C09	Staphylococcus aureus
1825	S1M10000013C10	Staphylococcus aureus
1826	S1M10000013C11	Staphylococcus aureus
1827	S1M10000013C12	Staphylococcus aureus
1828	S1M10000013D08	Staphylococcus aureus
1829	S1M10000013D09	Staphylococcus aureus
1830	S1M10000013D11	Staphylococcus aureus
1831	S1M10000013E01	Staphylococcus aureus
1832	S1M10000013E02	Staphylococcus aureus
1833	S1M10000013E04	Staphylococcus aureus
1834	S1M10000013E06	Staphylococcus aureus
1835	S1M10000013E08	Staphylococcus aureus
1836	S1M10000013E09	Staphylococcus aureus
1837	S1M10000013E10	Staphylococcus aureus
1838	S1M10000013F02	Staphylococcus aureus
1839	S1M10000013F03	Staphylococcus aureus
1840	S1M10000013F06	Staphylococcus aureus
1841	S1M10000013F07	Staphylococcus aureus
1842	S1M10000013F08	Staphylococcus aureus
1843	S1M10000013F09	Staphylococcus aureus
1844	S1M10000013F12	Staphylococcus aureus
1845	S1M10000013G01	Staphylococcus aureus
1846	S1M10000013G04	Staphylococcus aureus
1847	S1M10000013G05	Staphylococcus aureus
1848	S1M10000013G06	Staphylococcus aureus
1849	S1M10000013G07	Staphylococcus aureus
1850	S1M10000013G10	Staphylococcus aureus
1851	S1M10000013G11	Staphylococcus aureus
1852	S1M10000013G12	Staphylococcus aureus
1853	S1M10000013H03	Staphylococcus aureus
1854	S1M10000013H04	Staphylococcus aureus
1855	S1M10000013H05	Staphylococcus aureus
1856	S1M10000013H07	Staphylococcus aureus
1857	S1M10000013H09	Staphylococcus aureus
1858	S1M10000013H10	Staphylococcus aureus
1859	S1M10000013H11	Staphylococcus aureus
1860	S1M10000014A02	Staphylococcus aureus
1861	S1M10000014A03	Staphylococcus aureus
1862	S1M10000014A05	Staphylococcus aureus
1863	S1M10000014A07	Staphylococcus aureus
1864	S1M10000014A08	Staphylococcus aureus
1865	S1M10000014A11	Staphylococcus aureus
1866	S1M10000014A12	Staphylococcus aureus
1867	S1M10000014B01	Staphylococcus aureus
1868	S1M10000014B02	Staphylococcus aureus
1869	S1M10000014B03	Staphylococcus aureus
1870	S1M10000014B04	Staphylococcus aureus
1871	S1M10000014B05	Staphylococcus aureus
1872	S1M10000014B06	Staphylococcus aureus
1873	S1M10000014B07	Staphylococcus aureus
1874	S1M10000014B08	Staphylococcus aureus
1875	S1M10000014B10	Staphylococcus aureus
1876	S1M10000014B11	Staphylococcus aureus
1877	S1M10000014B12	Staphylococcus aureus
1878	S1M10000014C01	Staphylococcus aureus
1879	S1M10000014C05	Staphylococcus aureus
1880	S1M10000014C06	Staphylococcus aureus
1881	S1M10000014C07	Staphylococcus aureus
1882	S1M10000014C09	Staphylococcus aureus
1883	S1M10000014C10	Staphylococcus aureus
1884	S1M10000014C11	Staphylococcus aureus
1885	S1M10000014C12	Staphylococcus aureus
1886	S1M10000014D03	Staphylococcus aureus
1887	S1M10000014D06	Staphylococcus aureus
1888	S1M10000014D08	Staphylococcus aureus
1889	S1M10000014D09	Staphylococcus aureus
1890	S1M10000014D10	Staphylococcus aureus
1891	S1M10000014E01	Staphylococcus aureus
1892	S1M10000014E04	Staphylococcus aureus
1893	S1M10000014E05	Staphylococcus aureus
1894	S1M10000014E07	Staphylococcus aureus
1895	S1M10000014E08	Staphylococcus aureus
1896	S1M10000014E09	Staphylococcus aureus
1897	S1M10000014E10	Staphylococcus aureus
1898	S1M10000014E12	Staphylococcus aureus
1899	S1M10000014F02	Staphylococcus aureus
1900	S1M10000014F03	Staphylococcus aureus
1901	S1M10000014F04	Staphylococcus aureus
1902	S1M10000014F05	Staphylococcus aureus
1903	S1M10000014F08	Staphylococcus aureus
1904	S1M10000014F09	Staphylococcus aureus
1905	S1M10000014F10	Staphylococcus aureus
1906	S1M10000014G02	Staphylococcus aureus
1907	S1M10000014G04	Staphylococcus aureus
1908	S1M10000014G06	Staphylococcus aureus
1909	S1M10000014G07	Staphylococcus aureus
1910	S1M10000014G08	Staphylococcus aureus
1911	S1M10000014G12	Staphylococcus aureus
1912	S1M10000014H02	Staphylococcus aureus
1913	S1M10000014H03	Staphylococcus aureus
1914	S1M10000014H04	Staphylococcus aureus
1915	S1M10000014H05	Staphylococcus aureus
1916	S1M10000014H06	Staphylococcus aureus
1917	S1M10000014H07	Staphylococcus aureus
1918	S1M10000014HO8	Staphylococcus aureus
1919	S1M10000014H11	Staphylococcus aureus
1920	S1M10000015A02	Staphylococcus aureus
1921	S1M10000015A03	Staphylococcus aureus
1922	S1M10000015A05	Staphylococcus aureus
1923	S1M10000015A06	Staphylococcus aureus
1924	S1M10000015A09	Staphylococcus aureus
1925	S1M10000015A10	Staphylococcus aureus
1926	S1M10000015A11	Staphylococcus aureus
1927	S1M10000015A12	Staphylococcus aureus
1928	S1M10000015B02	Staphylococcus aureus
1929	S1M10000015B05	Staphylococcus aureus
1930	S1M10000015B08	Staphylococcus aureus
1931	S1M10000015B09	Staphylococcus aureus
1932	S1M10000015B10	Staphylococcus aureus
1933	S1M10000015C01	Staphylococcus aureus
1934	S1M10000015C02	Staphylococcus aureus
1935	S1M10000015C03	Staphylococcus aureus
1936	S1M10000015C05	Staphylococcus aureus
1937	S1M10000015C06	Staphylococcus aureus
1938	S1M10000015C08	Staphylococcus aureus
1939	S1M10000015C10	Staphylococcus aureus
1940	S1M10000015C12	Staphylococcus aureus
1941	S1M10000015D02	Staphylococcus aureus
1942	S1M10000015D03	Staphylococcus aureus
1943	S1M10000015D04	Staphylococcus aureus
1944	S1M10000015D05	Staphylococcus aureus
1945	S1M10000015D06	Staphylococcus aureus
1946	S1M10000015D12	Staphylococcus aureus
1947	S1M10000015E02	Staphylococcus aureus
1948	S1M10000015E03	Staphylococcus aureus
1949	S1M10000015E06	Staphylococcus aureus
1950	S1M10000015E07	Staphylococcus aureus
1951	S1M10000015E09	Staphylococcus aureus
1952	S1M10000015E10	Staphylococcus aureus
1953	S1M10000015E11	Staphylococcus aureus
1954	S1M10000015E12	Staphylococcus aureus
1955	S1M10000015F01	Staphylococcus aureus
1956	S1M10000015F02	Staphylococcus aureus
1957	S1M10000015F03	Staphylococcus aureus
1958	SIM10000015F04	Staphylococcus aureus
1959	S1M10000015F06	Staphylococcus aureus
1960	S1M10000015F07	Staphylococcus aureus
1961	S1M10000015F08	Staphylococcus aureus
1962	S1M10000015F09	Staphylococcus aureus
1963	S1M10000015F10	Staphylococcus aureus
1964	S1M10000015G01	Staphylococcus aureus
1965	S1M10000015G02	Staphylococcus aureus
1966	S1M10000015G03	Staphylococcus aureus
1967	S1M10000015G04	Staphylococcus aureus
1968	S1M10000015G05	Staphylococcus aureus
1969	S1M10000015G06	Staphylococcus aureus
1970	S1M10000015G07	Staphylococcus aureus
1971	S1M10000015G08	Staphylococcus aureus
1972	SIM10000015G09	Staphylococcus aureus
1973	S1M10000015G10	Staphylococcus aureus
1974	S1M10000015G11	Staphylococcus aureus
1975	S1M10000015H04	Staphylococcus aureus
1976	S1M10000015H06	Staphylococcus aureus
1977	S1M10000016A03	Staphylococcus aureus
1978	S1M10000016A04	Staphylococcus aureus
1979	S1M10000016A06	Staphylococcus aureus
1980	S1M10000016A07	Staphylococcus aureus
1981	S1M10000016A09	Staphylococcus aureus
1982	S1M10000016A10	Staphylococcus aureus
1983	S1M10000016A12	Staphylococcus aureus
1984	S1M10000016B02	Staphylococcus aureus
1985	S1M10000016B05	Staphylococcus aureus
1986	S1M10000016B06	Staphylococcus aureus
1987	S1M10000016B07	Staphylococcus aureus
1988	S1M10000016B08	Staphylococcus aureus
1989	S1M10000016B09	Staphylococcus aureus
1990	S1M10000016B10	Staphylococcus aureus
1991	S1M10000016B11	Staphylococcus aureus
1992	S1M10000016B12	Staphylococcus aureus
1993	S1M10000016C01	Staphylococcus aureus
1994	S1M10000016C02	Staphylococcus aureus
1995	S1M10000016C04	Staphylococcus aureus
1996	S1M10000016C05	Staphylococcus aureus
1997	S1M10000016C06	Staphylococcus aureus
1998	S1M10000016C08	Staphylococcus aureus
1999	S1M10000016C09	Staphylococcus aureus
2000	S1M10000016C10	Staphylococcus aureus
2001	S1M10000016C11	Staphylococcus aureus
2002	S1M10000016C12	Staphylococcus aureus
2003	S1M10000016D01	Staphylococcus aureus
2004	S1M10000016D02	Staphylococcus aureus
2005	S1M10000016D04	Staphylococcus aureus
2006	S1M10000016D05	Staphylococcus aureus
2007	S1M10000016D06	Staphylococcus aureus
2008	S1M10000016D08	Staphylococcus aureus
2009	S1M10000016D09	Staphylococcus aureus
2010	S1M10000016D10	Staphylococcus aureus
2011	S1M10000016D11	Staphylococcus aureus
2012	S1M10000016E04	Staphylococcus aureus
2013	S1M10000016E05	Staphylococcus aureus
2014	S1M10000016E06	Staphylococcus aureus
2015	S1M10000016E07	Staphylococcus aureus
2016	S1M10000016E08	Staphylococcus aureus
2017	S1M10000016E09	Staphylococcus aureus
2018	S1M10000016E10	Staphylococcus aureus
2019	S1M10000016E11	Staphylococcus aureus
2020	S1M10000016E12	Staphylococcus aureus
2021	S1M10000016F02	Staphylococcus aureus
2022	S1M10000016F03	Staphylococcus aureus
2023	S1M10000016F05	Staphylococcus aureus
2024	S1M10000016F06	Staphylococcus aureus
2025	S1M10000016F08	Staphylococcus aureus
2026	S1M10000016F09	Staphylococcus aureus
2027	S1M10000016F11	Staphylococcus aureus
2028	S1M10000016G01	Staphylococcus aureus
2029	S1M10000016G03	Staphylococcus aureus
2030	S1M10000016G04	Staphylococcus aureus
2031	S1M10000016G05	Staphylococcus aureus
2032	S1M10000016H03	Staphylococcus aureus
2033	S1M10000016H04	Staphylococcus aureus
2034	S1M10000016H08	Staphylococcus aureus
2035	S1M10000016H10	Staphylococcus aureus
2036	S1M10000017A02	Staphylococcus aureus
2037	S1M10000017A03	Staphylococcus aureus
2038	S1M10000017A04	Staphylococcus aureus
2039	S1M10000017A08	Staphylococcus aureus
2040	S1M1OOOOO17A11	Staphylococcus aureus
2041	S1M10000017A12	Staphylococcus aureus
2042	S1M10000017B02	Staphylococcus aureus
2043	S1M10000017B05	Staphylococcus aureus
2044	S1M10000017B07	Staphylococcus aureus
2045	S1M10000017B08	Staphylococcus aureus
2046	S1M10000017B09	Staphylococcus aureus
2047	S1M10000017B10	Staphylococcus aureus
2048	S1M10000017B11	Staphylococcus aureus
2049	S1M10000017B12	Staphylococcus aureus
2050	S1M10000017C01	Staphylococcus aureus
2051	S1M10000017C03	Staphylococcus aureus
2052	S1M10000017C05	Staphylococcus aureus
2053	S1M10000017C08	Staphylococcus aureus
2054	S1M10000017C09	Staphylococcus aureus
2055	S1M10000017C10	Staphylococcus aureus
2056	S1M10000017C11	Staphylococcus aureus
2057	S1M10000017C12	Staphylococcus aureus
2058	S1M10000017D03	Staphylococcus aureus
2059	S1M10000017D09	Staphylococcus aureus
2060	S1M10000017D10	Staphylococcus aureus
2061	S1M10000017E04	Staphylococcus aureus
2062	S1M10000017E05	Staphylococcus aureus
2063	S1M10000017E08	Staphylococcus aureus
2064	S1M10000017E11	Staphylococcus aureus
2065	S1M10000017F01	Staphylococcus aureus
2066	S1M10000017FO4	Staphylococcus aureus
2067	S1M10000017F05	Staphylococcus aureus
2068	S1M10000017F06	Staphylococcus aureus
2069	S1M10000017F11	Staphylococcus aureus
2070	S1M10000017G02	Staphylococcus aureus
2071	S1M10000017G05	Staphylococcus aureus
2072	S1M10000017G06	Staphylococcus aureus
2073	S1M10000018A03	Staphylococcus aureus
2074	S1M10000018A04	Staphylococcus aureus
2075	S1M10000018A05	Staphylococcus aureus
2076	S1M10000018A06	Staphylococcus aureus
2077	S1M10000018A08	Staphylococcus aureus
2078	S1M10000018A09	Staphylococcus aureus
2079	S1M10000018A10	Staphylococcus aureus
2080	S1M10000018A11	Staphylococcus aureus
2081	S1M10000018B02	Staphylococcus aureus
2082	S1M10000018BO3	Staphylococcus aureus
2083	S1M10000018B05	Staphylococcus aureus
2084	S1M10000018B09	Staphylococcus aureus
2085	S1M10000018B10	Staphylococcus aureus
2086	S1M10000018B11	Staphylococcus aureus
2087	S1M10000018C01	Staphylococcus aureus
2088	S1M10000018C02	Staphylococcus aureus
2089	S1M10000018C03	Staphylococcus aureus
2090	S1M10000018C04	Staphylococcus aureus
2091	S1M10000018C05	Staphylococcus aureus
2092	S1M10000018C06	Staphylococcus aureus
2093	S1M10000018C08	Staphylococcus aureus
2094	S1M10000018C09	Staphylococcus aureus
2095	S1M10000018C10	Staphylococcus aureus
2096	S1M10000018C11	Staphylococcus aureus
2097	S1M10000018C12	Staphylococcus aureus
2098	S1M10000018D01	Staphylococcus aureus
2099	S1M10000018D02	Staphylococcus aureus
2100	S1M10000018D03	Staphylococcus aureus
2101	S1M10000018D04	Staphylococcus aureus
2102	S1M10000018D09	Staphylococcus aureus
2103	S1M10000018D10	Staphylococcus aureus
2104	S1M10000018D11	Staphylococcus aureus
2105	S1M10000018D12	Staphylococcus aureus
2106	S1M10000018E01	Staphylococcus aureus
2107	S1M10000018E02	Staphylococcus aureus
2108	S1M10000018E03	Staphylococcus aureus
2109	S1M10000018E04	Staphylococcus aureus
2110	S1M10000018E05	Staphylococcus aureus
2111	S1M10000018E08	Staphylococcus aureus
2112	S1M10000018E09	Staphylococcus aureus
2113	S1M10000018E11	Staphylococcus aureus
2114	S1M10000018E12	Staphylococcus aureus
2115	S1M10000018F03	Staphylococcus aureus
2116	S1M10000018F04	Staphylococcus aureus
2117	S1M10000018F07	Staphylococcus aureus
2118	S1M10000018F09	Staphylococcus aureus
2119	SIM10000018F10	Staphylococcus aureus
2120	S1M10000018F12	Staphylococcus aureus
2121	S1M10000018G03	Staphylococcus aureus
2122	S1M10000018G05	Staphylococcus aureus
2123	S1M10000018G07	Staphylococcus aureus
2124	S1M10000018G08	Staphylococcus aureus
2125	S1M10000018G09	Staphylococcus aureus
2126	S1M10000018G10	Staphylococcus aureus
2127	S1M10000018G12	Staphylococcus aureus
2128	S1M10000018H01	Staphylococcus aureus
2129	S1M10000018H02	Staphylococcus aureus
2130	S1M10000018H07	Staphylococcus aureus
2131	S1M10000018H09	Staphylococcus aureus
2132	S1M10000018H10	Staphylococcus aureus
2133	S1M10000019A02	Staphylococcus aureus
2134	S1M10000019A03	Staphylococcus aureus
2135	S1M10000019A05	Staphylococcus aureus
2136	S1M10000019A06	Staphylococcus aureus
2137	S1M10000019A07	Staphylococcus aureus
2138	S1M10000019A09	Staphylococcus aureus
2139	S1M10000019A11	Staphylococcus aureus
2140	S1M10000019A12	Staphylococcus aureus
2141	S1M10000019B03	Staphylococcus aureus
2142	S1M10000019B04	Staphylococcus aureus
2143	S1M10000019B07	Staphylococcus aureus
2144	S1M10000019B08	Staphylococcus aureus
2145	S1M10000019B09	Staphylococcus aureus
2146	S1M10000019B10	Staphylococcus aureus
2147	S1M10000019B11	Staphylococcus aureus
2148	S1M10000019B12	Staphylococcus aureus
2149	S1M10000019C01	Staphylococcus aureus
2150	S1M10000019C04	Staphylococcus aureus
2151	S1M10000019C05	Staphylococcus aureus
2152	S1M10000019C06	Staphylococcus aureus
2153	S1M10000019C07	Staphylococcus aureus
2154	S1M10000019C08	Staphylococcus aureus
2155	S1M10000019C11	Staphylococcus aureus
2156	S1M10000019C12	Staphylococcus aureus
2157	S1M10000019D01	Staphylococcus aureus
2158	S1M10000019D02	Staphylococcus aureus
2159	S1M10000019D04	Staphylococcus aureus
2160	S1M10000019D05	Staphylococcus aureus
2161	S1M10000019D06	Staphylococcus aureus
2162	S1M10000019D07	Staphylococcus aureus
2163	S1M10000019D09	Staphylococcus aureus
2164	S1M10000019D12	Staphylococcus aureus
2165	S1M10000019E01	Staphylococcus aureus
2166	S1M10000019E02	Staphylococcus aureus
2167	S1M10000019E07	Staphylococcus aureus
2168	S1M10000019F01	Staphylococcus aureus
2169	S1M10000019F05	Staphylococcus aureus
2170	S1M10000019F06	Staphylococcus aureus
2171	S1M10000019F08	Staphylococcus aureus
2172	S1M10000019F09	Staphylococcus aureus
2173	S1M10000019F11	Staphylococcus aureus
2174	S1M10000019G04	Staphylococcus aureus
2175	S1M10000019G07	Staphylococcus aureus
2176	S1M10000019G09	Staphylococcus aureus
2177	S1M10000019G10	Staphylococcus aureus
2178	S1M10000019G11	Staphylococcus aureus
2179	S1M10000019H05	Staphylococcus aureus
2180	S1M10000019H08	Staphylococcus aureus
2181	S1M10000020A05	Staphylococcus aureus
2182	S1M10000020A06	Staphylococcus aureus
2183	S1M10000020A07	Staphylococcus aureus
2184	S1M10000020A11	Staphylococcus aureus
2185	S1M10000020A12	Staphylococcus aureus
2186	S1M10000020B02	Staphylococcus aureus
2187	S1M10000020B03	Staphylococcus aureus
2188	S1M10000020B05	Staphylococcus aureus
2189	S1M10000020B06	Staphylococcus aureus
2190	S1M10000020B07	Staphylococcus aureus
2191	S1M10000020B09	Staphylococcus aureus
2192	S1M10000020B12	Staphylococcus aureus
2193	S1M10000020C09	Staphylococcus aureus
2194	S1M10000020C10	Staphylococcus aureus
2195	S1M10000020C11	Staphylococcus aureus
2196	S1M10000020D03	Staphylococcus aureus
2197	S1M10000020D04	Staphylococcus aureus
2198	S1M10000020D06	Staphylococcus aureus
2199	S1M10000020D07	Staphylococcus aureus
2200	S1M10000020D08	Staphylococcus aureus
2201	S1M10000020D09	Staphylococcus aureus
2202	S1M10000020D12	Staphylococcus aureus
2203	S1M10000020E01	Staphylococcus aureus
2204	S1M10000020E03	Staphylococcus aureus
2205	S1M10000020E04	Staphylococcus aureus
2206	S1M10000020E06	Staphylococcus aureus
2207	S1M10000020E08	Staphylococcus aureus
2208	S1M10000020E11	Staphylococcus aureus
2209	S1M10000020E12	Staphylococcus aureus
2210	S1M10000020F01	Staphylococcus aureus
2211	S1M10000020F05	Staphylococcus aureus
2212	S1M10000020F06	Staphylococcus aureus
2213	51M10000020F07	Staphylococcus aureus
2214	S1M10000020F09	Staphylococcus aureus
2215	S1M10000020F11	Staphylococcus aureus
2216	S1M10000020F12	Staphylococcus aureus
2217	S1M10000020G01	Staphylococcus aureus
2218	S1M10000020G05	Staphylococcus aureus
2219	S1M10000020G07	Staphylococcus aureus
2220	S1M10000020G08	Staphylococcus aureus
2221	S1M10000020G09	Staphylococcus aureus
2222	S1M10000020G10	Staphylococcus aureus
2223	S1M10000020G11	Staphylococcus aureus
2224	S1M10000020G12	Staphylococcus aureus
2225	S1M10000020H01	Staphylococcus aureus
2226	S1M10000020H02	Staphylococcus aureus
2227	S1M10000020H04	Staphylococcus aureus
2228	S1M10000020H06	Staphylococcus aureus
2229	S1M10000020H08	Staphylococcus aureus
2230	S1M10000020H10	Staphylococcus aureus
2231	S1M10000020H11	Staphylococcus aureus
2232	S1M10000021A04	Staphylococcus aureus
2233	S1M10000021A05	Staphylococcus aureus
2234	S1M10000021A06	Staphylococcus aureus
2235	S1M10000021A07	Staphylococcus aureus
2236	S1M10000021A08	Staphylococcus aureus
2237	S1M10000021A09	Staphylococcus aureus
2238	S1M10000021A10	Staphylococcus aureus
2239	S1M10000021B05	Staphylococcus aureus
2240	S1M10000021B06	Staphylococcus aureus
2241	S1M10000021B07	Staphylococcus aureus
2242	S1M10000021B10	Staphylococcus aureus
2243	S1M10000021C04	Staphylococcus aureus
2244	S1M10000021C05	Staphylococcus aureus
2245	S1M10000021C07	Staphylococcus aureus
2246	S1M10000021C08	Staphylococcus aureus
2247	S1M10000021C10	Staphylococcus aureus
2248	S1M10000021C11	Staphylococcus aureus
2249	S1M10000021C12	Staphylococcus aureus
2250	S1M10000021D01	Staphylococcus aureus
2251	S1M10000021D03	Staphylococcus aureus
2252	S1M10000021D04	Staphylococcus aureus
2253	S1M10000021D06	Staphylococcus aureus
2254	S1M10000021D09	Staphylococcus aureus
2255	S1M10000021D10	Staphylococcus aureus
2256	S1M10000021E01	Staphylococcus aureus
2257	S1M10000021E02	Staphylococcus aureus
2258	S1M10000021E03	Staphylococcus aureus
2259	S1M10000021E05	Staphylococcus aureus
2260	S1M10000021E06	Staphylococcus aureus
2261	S1M10000021E09	Staphylococcus aureus
2262	S1M10000021E12	Staphylococcus aureus
2263	S1M10000021F02	Staphylococcus aureus
2264	S1M10000021F04	Staphylococcus aureus
2265	S1M10000021F05	Staphylococcus aureus
2266	S1M10000021F06	Staphylococcus aureus
2267	S1M10000021F07	Staphylococcus aureus
2268	S1M10000021F09	Staphylococcus aureus
2269	S1M10000021F11	Staphylococcus aureus
2270	S1M10000021G01	Staphylococcus aureus
2271	S1M10000021G03	Staphylococcus aureus
2272	S1M10000021G08	Staphylococcus aureus
2273	S1M10000021H04	Staphylococcus aureus
2274	S1M10000021H05	Staphylococcus aureus
2275	S1M10000021H07	Staphylococcus aureus
2276	S1M10000021H08	Staphylococcus aureus
2277	S1M10000021H11	Staphylococcus aureus
2278	S1M10000022A02	Staphylococcus aureus
2279	S1M10000022A03	Staphylococcus aureus
2280	S1M10000022A05	Staphylococcus aureus
2281	S1M10000022A08	Staphylococcus aureus
2282	S1M10000022A09	Staphylococcus aureus
2283	S1M10000022A12	Staphylococcus aureus
2284	S1M10000022B02	Staphylococcus aureus
2285	S1M10000022B03	Staphylococcus aureus
2286	S1M10000022B05	Staphylococcus aureus
2287	S1M10000022B06	Staphylococcus aureus
2288	S1M10000022B08	Staphylococcus aureus
2289	S1M10000022B09	Staphylococcus aureus
2290	S1M10000022B10	Staphylococcus aureus
2291	S1M10000022B11	Staphylococcus aureus
2292	S1M10000022B12	Staphylococcus aureus
2293	S1M10000022C02	Staphylococcus aureus
2294	S1M10000022C03	Staphylococcus aureus
2295	S1M10000022C04	Staphylococcus aureus
2296	S1M10000022C06	Staphylococcus aureus
2297	S1M10000022C07	Staphylococcus aureus
2298	S1M10000022C08	Staphylococcus aureus
2299	S1M10000022C11	Staphylococcus aureus
2300	S1M10000022D03	Staphylococcus aureus
2301	S1M10000022D05	Staphylococcus aureus
2302	S1M10000022D06	Staphylococcus aureus
2303	S1M10000022D07	Staphylococcus aureus
2304	S1M10000022D08	Staphylococcus aureus
2305	S1M10000022D09	Staphylococcus aureus
2306	S1M10000022D11	Staphylococcus aureus
2307	S1M10000022E01	Staphylococcus aureus
2308	S1M10000022E03	Staphylococcus aureus
2309	S1M10000022E05	Staphylococcus aureus
2310	S1M10000022E09	Staphylococcus aureus
2311	S1M10000022F04	Staphylococcus aureus
2312	S1M10000022F06	Staphylococcus aureus
2313	S1M10000022F07	Staphylococcus aureus
2314	S1M10000022F08	Staphylococcus aureus
2315	S1M10000022F11	Staphylococcus aureus
2316	S1M10000022G03	Staphylococcus aureus
2317	S1M10000022G04	Staphylococcus aureus
2318	S1M10000022G07	Staphylococcus aureus
2319	S1M10000022G08	Staphylococcus aureus
2320	S1M10000022G12	Staphylococcus aureus
2321	S1M10000022H03	Staphylococcus aureus
2322	S1M10000022H05	Staphylococcus aureus
2323	S1M10000022H06	Staphylococcus aureus
2324	S1M10000022H07	Staphylococcus aureus
2325	S1M10000022H08	Staphylococcus aureus
2326	S1M10000022H11	Staphylococcus aureus
2327	S1M10000023A05	Staphylococcus aureus
2328	S1M10000023A09	Staphylococcus aureus
2329	S1M10000023A11	Staphylococcus aureus
2330	S1M10000023A12	Staphylococcus aureus
2331	S1M10000023B01	Staphylococcus aureus
2332	S1M10000023B03	Staphylococcus aureus
2333	S1M10000023B07	Staphylococcus aureus
2334	S1M10000023B08	Staphylococcus aureus
2335	S1M10000023B09	Staphylococcus aureus
2336	S1M10000023B10	Staphylococcus aureus
2337	S1M10000023B11	Staphylococcus aureus
2338	S1M10000023B12	Staphylococcus aureus
2339	S1M10000023C02	Staphylococcus aureus
2340	S1M10000023C10	Staphylococcus aureus
2341	S1M10000023C11	Staphylococcus aureus
2342	S1M10000023C12	Staphylococcus aureus
2343	S1M10000023D01	Staphylococcus aureus
2344	S1M10000023D03	Staphylococcus aureus
2345	S1M10000023D04	Staphylococcus aureus
2346	S1M10000023D07	Staphylococcus aureus
2347	S1M10000023D08	Staphylococcus aureus
2348	S1M10000023D09	Staphylococcus aureus
2349	S1M10000023D10	Staphylococcus aureus
2350	S1M10000023D12	Staphylococcus aureus
2351	S1M10000023E01	Staphylococcus aureus
2352	S1M10000023E04	Staphylococcus aureus
2353	S1M10000023E07	Staphylococcus aureus
2354	S1M10000023E10	Staphylococcus aureus
2355	S1M10000023E11	Staphylococcus aureus
2356	S1M10000023F04	Staphylococcus aureus
2357	S1M10000023F07	Staphylococcus aureus
2358	S1M10000023F08	Staphylococcus aureus
2359	S1M10000023F10	Staphylococcus aureus
2360	S1M10000023F11	Staphylococcus aureus
2361	S1M10000023F12	Staphylococcus aureus
2362	S1M10000023G02	Staphylococcus aureus
2363	S1M10000023G03	Staphylococcus aureus
2364	S1M10000023G06	Staphylococcus aureus
2365	S1M10000023G07	Staphylococcus aureus
2366	S1M10000023G08	Staphylococcus aureus
2367	S1M10000023G09	Staphylococcus aureus
2368	S1M10000023G11	Staphylococcus aureus
2369	S1M10000023H02	Staphylococcus aureus
2370	S1M10000023H06	Staphylococcus aureus
2371	S1M10000023H07	Staphylococcus aureus
2372	S1M10000023H09	Staphylococcus aureus
2373	S1M10000023H10	Staphylococcus aureus
2374	S1M10000024A02	Staphylococcus aureus
2375	S1M10000024A04	Staphylococcus aureus
2376	S1M10000024A07	Staphylococcus aureus
2377	S1M10000024A08	Staphylococcus aureus
2378	S1M10000024A11	Staphylococcus aureus
2379	S1M10000024B05	Staphylococcus aureus
2380	S1M10000024B06	Staphylococcus aureus
2381	S1M10000024B08	Staphylococcus aureus
2382	S1M10000024B09	Staphylococcus aureus
2383	S1M10000024B10	Staphylococcus aureus
2384	S1M10000024C02	Staphylococcus aureus
2385	S1M10000024C04	Staphylococcus aureus
2386	S1M10000024C07	Staphylococcus aureus
2387	S1M10000024D02	Staphylococcus aureus
2388	S1M10000024D03	Staphylococcus aureus
2389	S1M10000024D10	Staphylococcus aureus
2390	S1M10000024D11	Staphylococcus aureus
2391	S1M10000024E03	Staphylococcus aureus
2392	S1M10000024E05	Staphylococcus aureus
2393	S1M10000024E06	Staphylococcus aureus
2394	S1M10000024E07	Staphylococcus aureus
2395	S1M10000024E08	Staphylococcus aureus
2396	S1M10000024F02	Staphylococcus aureus
2397	S1M10000024F03	Staphylococcus aureus
2398	S1M10000024F05	Staphylococcus aureus
2399	S1M10000024F08	Staphylococcus aureus
2400	S1M10000024F10	Staphylococcus aureus
2401	S1M10000024G05	Staphylococcus aureus
2402	S1M10000024G06	Staphylococcus aureus
2403	S1M10000024G07	Staphylococcus aureus
2404	S1M10000024G08	Staphylococcus aureus
2405	S1M10000024G10	Staphylococcus aureus
2406	S1M10000024G12	Staphylococcus aureus
2407	S1M10000024H02	Staphylococcus aureus
2408	S1M10000024H04	Staphylococcus aureus
2409	S1M10000024H07	Staphylococcus aureus
2410	S1M10000024H08	Staphylococcus aureus
2411	S1M10000025A03	Staphylococcus aureus
2412	S1M10000025A08	Staphylococcus aureus
2413	S1M10000025A09	Staphylococcus aureus
2414	S1M10000025A10	Staphylococcus aureus
2415	S1M10000025B01	Staphylococcus aureus
2416	S1M10000025B02	Staphylococcus aureus
2417	S1M10000025B03	Staphylococcus aureus
2418	S1M10000025B05	Staphylococcus aureus
2419	S1M10000025B06	Staphylococcus aureus
2420	S1M10000025B09	Staphylococcus aureus
2421	S1M10000025B12	Staphylococcus aureus
2422	S1M10000025C01	Staphylococcus aureus
2423	S1M10000025C03	Staphylococcus aureus
2424	S1M10000025C05	Staphylococcus aureus
2425	S1M10000025C09	Staphylococcus aureus
2426	S1M10000025C10	Staphylococcus aureus
2427	S1M10000025C11	Staphylococcus aureus
2428	S1M10000025D01	Staphylococcus aureus
2429	S1M10000025D03	Staphylococcus aureus
2430	S1M10000025D04	Staphylococcus aureus
2431	S1M10000025D06	Staphylococcus aureus
2432	S1M10000025D08	Staphylococcus aureus
2433	S1M10000025D09	Staphylococcus aureus
2434	S1M10000025D10	Staphylococcus aureus
2435	S1M10000025E01	Staphylococcus aureus
2436	S1M10000025E04	Staphylococcus aureus
2437	S1M10000025E09	Staphylococcus aureus
2438	S1M10000025E11	Staphylococcus aureus
2439	S1M10000025F03	Staphylococcus aureus
2440	S1M10000025F05	Staphylococcus aureus
2441	S1M10000025F08	Staphylococcus aureus
2442	S1M10000025F09	Staphylococcus aureus
2443	S1M1000002SF10	Staphylococcus aureus
2444	S1M1000002SF12	Staphylococcus aureus
2445	S1M10000025G04	Staphylococcus aureus
2446	S1M10000025G06	Staphylococcus aureus
2447	S1M10000025G10	Staphylococcus aureus
2448	S1M10000025H05	Staphylococcus aureus
2449	S1M10000025H06	Staphylococcus aureus
2450	S1M10000025H07	Staphylococcus aureus
2451	S1M10000025H10	Staphylococcus aureus
2452	S1M10000026A02	Staphylococcus aureus
2453	S1M10000026A04	Staphylococcus aureus
2454	S1M10000026A05	Staphylococcus aureus
2455	S1M10000026A06	Staphylococcus aureus
2456	S1M10000026A07	Staphylococcus aureus
2457	S1M10000026A08	Staphylococcus aureus
2458	S1M10000026A09	Staphylococcus aureus
2459	S1M10000026A10	Staphylococcus aureus
2460	S1M10000026A11	Staphylococcus aureus
2461	S1M10000026B02	Staphylococcus aureus
2462	S1M10000026B03	Staphylococcus aureus
2463	S1M10000026B05	Staphylococcus aureus
2464	S1M10000026B06	Staphylococcus aureus
2465	S1M10000026B07	Staphylococcus aureus
2466	S1M10000026B10	Staphylococcus aureus
2467	S1M10000026B11	Staphylococcus aureus
2468	S1M10000026B12	Staphylococcus aureus
2469	S1M10000026C01	Staphylococcus aureus
2470	S1M10000026C06	Staphylococcus aureus
2471	S1M10000026C07	Staphylococcus aureus
2472	S1M10000026C08	Staphylococcus aureus
2473	S1M10000026C11	Staphylococcus aureus
2474	S1M10000026C12	Staphylococcus aureus
2475	S1M10000026D04	Staphylococcus aureus
2476	S1M10000026D05	Staphylococcus aureus
2477	S1M10000026D06	Staphylococcus aureus
2478	S1M10000026D07	Staphylococcus aureus
2479	S1M10000026D08	Staphylococcus aureus
2480	S1M10000026D10	Staphylococcus aureus
2481	S1M10000026D12	Staphylococcus aureus
2482	S1M10000026E01	Staphylococcus aureus
2483	S1M10000026E07	Staphylococcus aureus
2484	S1M10000026E09	Staphylococcus aureus
2485	S1M10000026E10	Staphylococcus aureus
2486	S1M10000026E11	Staphylococcus aureus
2487	S1M10000026E12	Staphylococcus aureus
2488	S1M10000026F01	Staphylococcus aureus
2489	S1M10000026F03	Staphylococcus aureus
2490	S1M10000026F04	Staphylococcus aureus
2491	S1M10000026F05	Staphylococcus aureus
2492	S1M10000026F06	Staphylococcus aureus
2493	S1M10000026F07	Staphylococcus aureus
2494	S1M10000026F08	Staphylococcus aureus
2495	S1M10000026F09	Staphylococcus aureus
2496	S1M10000026F10	Staphylococcus aureus
2497	S1M10000026F11	Staphylococcus aureus
2498	S1M10000026F12	Staphylococcus aureus
2499	S1M10000026G01	Staphylococcus aureus
2500	S1M10000026G03	Staphylococcus aureus
2501	S1M10000026G04	Staphylococcus aureus
2502	S1M10000026G05	Staphylococcus aureus
2503	S1M10000026G06	Staphylococcus aureus
2504	S1M10000026G07	Staphylococcus aureus
2505	S1M10000026G09	Staphylococcus aureus
2506	S1M10000026G10	Staphylococcus aureus
2507	S1M10000026G12	Staphylococcus aureus
2508	S1M10000026H01	Staphylococcus aureus
2509	S1M10000026H02	Staphylococcus aureus
2510	S1M10000026H03	Staphylococcus aureus
2511	S1M10000026H04	Staphylococcus aureus
2512	S1M10000026H05	Staphylococcus aureus
2513	S1M10000026H07	Staphylococcus aureus
2514	S1M10000026H09	Staphylococcus aureus
2515	S1M10000026H10	Staphylococcus aureus
2516	S1M10000027A04	Staphylococcus aureus
2517	S1M10000027A05	Staphylococcus aureus
2518	S1M10000027A08	Staphylococcus aureus
2519	S1M10000027A11	Staphylococcus aureus
2520	S1M10000027B04	Staphylococcus aureus
2521	S1M10000027B06	Staphylococcus aureus
2522	S1M10000027B07	Staphylococcus aureus
2523	S1M10000027B08	Staphylococcus aureus
2524	S1M10000027B09	Staphylococcus aureus
2525	S1M10000027B11	Staphylococcus aureus
2526	S1M10000027C02	Staphylococcus aureus
2527	S1M10000027C04	Staphylococcus aureus
2528	S1M10000027C05	Staphylococcus aureus
2529	S1M10000027C06	Staphylococcus aureus
2530	S1M10000027C08	Staphylococcus aureus
2531	S1M10000027C09	Staphylococcus aureus
2532	S1M10000027D02	Staphylococcus aureus
2533	S1M10000027D03	Staphylococcus aureus
2534	S1M10000027D05	Staphylococcus aureus
2535	S1M10000027D06	Staphylococcus aureus
2536	S1M10000027D08	Staphylococcus aureus
2537	S1M10000027D09	Staphylococcus aureus
2538	S1M10000027D10	Staphylococcus aureus
2539	S1M10000027D11	Staphylococcus aureus
2540	S1M10000027E05	Staphylococcus aureus
2541	S1M10000027E06	Staphylococcus aureus
2542	S1M10000027E07	Staphylococcus aureus
2543	S1M10000027E08	Staphylococcus aureus
2544	S1M10000027E09	Staphylococcus aureus
2545	S1M10000027E11	Staphylococcus aureus
2546	S1M10000027F01	Staphylococcus aureus
2547	S1M10000027F02	Staphylococcus aureus
2548	S1M10000027F05	Staphylococcus aureus
2549	S1M10000027F06	Staphylococcus aureus
2550	S1M10000027F08	Staphylococcus aureus
2551	S1M10000027F09	Staphylococcus aureus
2552	S1M10000027G03	Staphylococcus aureus
2553	S1M10000027G04	Staphylococcus aureus
2554	S1M10000027G05	Staphylococcus aureus
2555	S1M10000027G06	Staphylococcus aureus
2556	S1M10000027G07	Staphylococcus aureus
2557	S1M10000027G09	Staphylococcus aureus
2558	S1M10000027G11	Staphylococcus aureus
2559	S1M10000027H02	Staphylococcus aureus
2560	S1M10000027H04	Staphylococcus aureus
2561	S1M10000027H05	Staphylococcus aureus
2562	S1M10000027H06	Staphylococcus aureus
2563	S1M10000027H07	Staphylococcus aureus
2564	S1M10000027H08	Staphylococcus aureus
2565	S1M10000027H09	Staphylococcus aureus
2566	S1M10000027H10	Staphylococcus aureus
2567	S1M10000027H11	Staphylococcus aureus
2568	S1M10000028A02	Staphylococcus aureus
2569	S1M10000028A04	Staphylococcus aureus
2570	S1M10000028A06	Staphylococcus aureus
2571	S1M10000028A08	Staphylococcus aureus
2572	S1M10000028B01	Staphylococcus aureus
2573	S1M10000028B02	Staphylococcus aureus
2574	S1M10000028B03	Staphylococcus aureus
2575	S1M10000028B04	Staphylococcus aureus
2576	S1M10000028B05	Staphylococcus aureus
2577	S1M10000028B06	Staphylococcus aureus
2578	S1M10000028B08	Staphylococcus aureus
2579	S1M10000028B09	Staphylococcus aureus
2580	S1M10000028C02	Staphylococcus aureus
2581	S1M10000028C04	Staphylococcus aureus
2582	S1M10000028C05	Staphylococcus aureus
2583	S1M10000028C06	Staphylococcus aureus
2584	S1M10000028C08	Staphylococcus aureus
2585	S1M10000028D03	Staphylococcus aureus
2586	S1M10000028D04	Staphylococcus aureus
2587	S1M10000028D06	Staphylococcus aureus
2588	S1M10000028D07	Staphylococcus aureus
2589	S1M10000028D08	Staphylococcus aureus
2590	S1M10000028D09	Staphylococcus aureus
2591	S1M10000028E01	Staphylococcus aureus
2592	S1M10000028E03	Staphylococcus aureus
2593	S1M10000028E08	Staphylococcus aureus
2594	S1M10000028F01	Staphylococcus aureus
2595	S1M10000028F03	Staphylococcus aureus
2596	S1M10000028F04	Staphylococcus aureus
2597	S1M10000028F05	Staphylococcus aureus
2598	S1M10000028F06	Staphylococcus aureus
2599	S1M10000028F07	Staphylococcus aureus
2600	S1M10000028G01	Staphylococcus aureus
2601	S1M10000028G02	Staphylococcus aureus
2602	S1M10000028G03	Staphylococcus aureus
2603	S1M10000028G04	Staphylococcus aureus
2604	S1M10000028G05	Staphylococcus aureus
2605	S1M10000028G06	Staphylococcus aureus
2606	S1M10000028G08	Staphylococcus aureus
2607	S1M10000028H03	Staphylococcus aureus
2608	S1M10000028H04	Staphylococcus aureus
2609	S1M10000028H05	Staphylococcus aureus
2610	S1M10000029A02	Staphylococcus aureus
2611	S1M10000029A04	Staphylococcus aureus
2612	S1M10000029A09	Staphylococcus aureus
2613	S1M10000029A10	Staphylococcus aureus
2614	S1M10000029A11	Staphylococcus aureus
2615	S1M10000029A12	Staphylococcus aureus
2616	S1M10000029B02	Staphylococcus aureus
2617	S1M10000029B03	Staphylococcus aureus
2618	S1M10000029B04	Staphylococcus aureus
2619	S1M10000029B05	Staphylococcus aureus
2620	S1M10000029B06	Staphylococcus aureus
2621	S1M10000029B08	Staphylococcus aureus
2622	S1M10000029B10	Staphylococcus aureus
2623	S1M10000029C02	Staphylococcus aureus
2624	S1M10000029C03	Staphylococcus aureus
2625	S1M10000029C05	Staphylococcus aureus
2626	S1M10000029C07	Staphylococcus aureus
2627	S1M10000029C09	Staphylococcus aureus
2628	S1M10000029C10	Staphylococcus aureus
2629	S1M10000029C12	Staphylococcus aureus
2630	S1M10000029D02	Staphylococcus aureus
2631	S1M10000029D05	Staphylococcus aureus
2632	S1M10000029D09	Staphylococcus aureus
2633	S1M10000029D10	Staphylococcus aureus
2634	S1M10000029D12	Staphylococcus aureus
2635	S1M10000029E02	Staphylococcus aureus
2636	S1M10000029E05	Staphylococcus aureus
2637	S1M10000029E10	Staphylococcus aureus
2638	S1M10000029E11	Staphylococcus aureus
2639	S1M10000029F01	Staphylococcus aureus
2640	S1M10000029F02	Staphylococcus aureus
2641	S1M10000029F04	Staphylococcus aureus
2642	S1M10000029F09	Staphylococcus aureus
2643	S1M10000029F10	Staphylococcus aureus
2644	S1M10000029F11	Staphylococcus aureus
2645	S1M10000029F12	Staphylococcus aureus
2646	S1M10000029G01	Staphylococcus aureus
2647	S1M10000029G02	Staphylococcus aureus
2648	S1M10000029G03	Staphylococcus aureus
2649	S1M10000029G05	Staphylococcus aureus
2650	S1M10000029G07	Staphylococcus aureus
2651	S1M10000029G08	Staphylococcus aureus
2652	S1M10000029G12	Staphylococcus aureus
2653	S1M10000029H01	Staphylococcus aureus
2654	S1M10000029H05	Staphylococcus aureus
2655	S1M10000029H06	Staphylococcus aureus
2656	S1M10000029H08	Staphylococcus aureus
2657	S1M10000029H09	Staphylococcus aureus
2658	S1M10000029H10	Staphylococcus aureus
2659	S1M10000030A02	Staphylococcus aureus
2660	S1M10000030A05	Staphylococcus aureus
2661	S1M10000030A09	Staphylococcus aureus
2662	S1M10000030A10	Staphylococcus aureus
2663	S1M10000030A11	Staphylococcus aureus
2664	S1M10000030B02	Staphylococcus aureus
2665	S1M10000030B05	Staphylococcus aureus
2666	S1M10000030B07	Staphylococcus aureus
2667	S1M10000030B09	Staphylococcus aureus
2668	S1M10000030C02	Staphylococcus aureus
2669	S1M10000030C03	Staphylococcus aureus
2670	S1M10000030C04	Staphylococcus aureus
2671	S1M10000030C05	Staphylococcus aureus
2672	S1M10000030C08	Staphylococcus aureus
2673	S1M10000030C09	Staphylococcus aureus
2674	S1M10000030C10	Staphylococcus aureus
2675	S1M10000030C12	Staphylococcus aureus
2676	S1M10000030D01	Staphylococcus aureus
2677	S1M10000030D02	Staphylococcus aureus
2678	S1M10000030D03	Staphylococcus aureus
2679	S1M10000030D05	Staphylococcus aureus
2680	S1M10000030D06	Staphylococcus aureus
2681	S1M10000030D07	Staphylococcus aureus
2682	S1M10000030D09	Staphylococcus aureus
2683	S1M10000030D10	Staphylococcus aureus
2684	S1M1000003OD11	Staphylococcus aureus
2685	S1M10000030E02	Staphylococcus aureus
2686	S1M10000030E06	Staphylococcus aureus
2687	S1M10000030E07	Staphylococcus aureus
2688	S1M10000030E11	Staphylococcus aureus
2689	S1M10000030E12	Staphylococcus aureus
2690	S1M10000030F01	Staphylococcus aureus
2691	S1M10000030F07	Staphylococcus aureus
2692	S1M10000030F08	Staphylococcus aureus
2693	S1M10000030F09	Staphylococcus aureus
2694	S1M10000030F10	Staphylococcus aureus
2695	S1M10000030G03	Staphylococcus aureus
2696	S1M10000030G05	Staphylococcus aureus
2697	S1M10000030G07	Staphylococcus aureus
2698	S1M10000030G08	Staphylococcus aureus
2699	S1M10000030G09	Staphylococcus aureus
2700	S1M10000030G10	Staphylococcus aureus
2701	S1M10000030G11	Staphylococcus aureus
2702	S1M10000030G12	Staphylococcus aureus
2703	S1M10000030H01	Staphylococcus aureus
2704	S1M10000030H02	Staphylococcus aureus
2705	S1M10000030H03	Staphylococcus aureus
2706	S1M10000030H05	Staphylococcus aureus
2707	S1M10000030H07	Staphylococcus aureus
2708	S1M10000030H09	Staphylococcus aureus
2709	S1M10000031A03	Staphylococcus aureus
2710	S1M10000031A08	Staphylococcus aureus
2711	S1M10000031A10	Staphylococcus aureus
2712	S1M10000031B01	Staphylococcus aureus
2713	S1M10000031B02	Staphylococcus aureus
2714	S1M10000031B04	Staphylococcus aureus
2715	S1M10000031B11	Staphylococcus aureus
2716	S1M10000031B12	Staphylococcus aureus
2717	S1M10000031C04	Staphylococcus aureus
2718	S1M10000031C07	Staphylococcus aureus
2719	S1M10000031C09	Staphylococcus aureus
2720	S1M10000031C11	Staphylococcus aureus
2721	S1M10000031D06	Staphylococcus aureus
2722	S1M10000031D07	Staphylococcus aureus
2723	S1M10000031DO8	Staphylococcus aureus
2724	S1M10000031D09	Staphylococcus aureus
2725	S1M10000031E02	Staphylococcus aureus
2726	S1M10000031E03	Staphylococcus aureus
2727	S1M10000031EO4	Staphylococcus aureus
2728	S1M10000031E07	Staphylococcus aureus
2729	S1M10000031E08	Staphylococcus aureus
2730	S1M10000031E10	Staphylococcus aureus
2731	S1M10000031E12	Staphylococcus aureus
2732	S1M10000031F02	Staphylococcus aureus
2733	S1M10000031F03	Staphylococcus aureus
2734	S1M10000031F04	Staphylococcus aureus
2735	S1M10000031F05	Staphylococcus aureus
2736	S1M10000031F08	Staphylococcus aureus
2737	S1M10000031F10	Staphylococcus aureus
2738	S1M10000031F11	Staphylococcus aureus
2739	S1M10000031F12	Staphylococcus aureus
2740	S1M10000031G02	Staphylococcus aureus
2741	S1M10000031G03	Staphylococcus aureus
2742	S1M10000031G04	Staphylococcus aureus
2743	S1M10000031G06	Staphylococcus aureus
2744	S1M10000031G09	Staphylococcus aureus
2745	S1M10000031G10	Staphylococcus aureus
2746	S1M10000031G11	Staphylococcus aureus
2747	S1M10000031H01	Staphylococcus aureus
2748	S1M10000031H02	Staphylococcus aureus
2749	S1M10000031H06	Staphylococcus aureus
2750	S1M10000031H09	Staphylococcus aureus
2751	S1M10000031H11	Staphylococcus aureus
2752	S1M10000032A03	Staphylococcus aureus
2753	S1M10000032A05	Staphylococcus aureus
2754	S1M10000032A06	Staphylococcus aureus
2755	S1M10000032A07	Staphylococcus aureus
2756	S1M10000032A08	Staphylococcus aureus
2757	S1M10000032A10	Staphylococcus aureus
2758	S1M10000032B01	Staphylococcus aureus
2759	S1M10000032B05	Staphylococcus aureus
2760	S1M10000032B07	Staphylococcus aureus
2761	S1M10000032B08	Staphylococcus aureus
2762	S1M10000032B11	Staphylococcus aureus
2763	S1M10000032B12	Staphylococcus aureus
2764	S1M10000032C01	Staphylococcus aureus
2765	S1M10000032C03	Staphylococcus aureus
2766	S1M10000032C04	Staphylococcus aureus
2767	S1M10000032C05	Staphylococcus aureus
2768	S1M10000032C09	Staphylococcus aureus
2769	S1M10000032C10	Staphylococcus aureus
2770	S1M10000032C11	Staphylococcus aureus
2771	S1M10000032C12	Staphylococcus aureus
2772	S1M10000032D03	Staphylococcus aureus
2773	S1M10000032D06	Staphylococcus aureus
2774	S1M10000032D07	Staphylococcus aureus
2775	S1M10000032D09	Staphylococcus aureus
2776	S1M10000032D11	Staphylococcus aureus
2777	S1M10000032E02	Staphylococcus aureus
2778	S1M10000032E03	Staphylococcus aureus
2779	S1M10000032E04	Staphylococcus aureus
2780	S1M10000032E06	Staphylococcus aureus
2781	S1M10000032E08	Staphylococcus aureus
2782	S1M10000032E09	Staphylococcus aureus
2783	S1M10000032E10	Staphylococcus aureus
2784	S1M10000032E11	Staphylococcus aureus
2785	S1M10000032E12	Staphylococcus aureus
2786	S1M10000032F01	Staphylococcus aureus
2787	S1M10000032F04	Staphylococcus aureus
2788	S1M10000032F05	Staphylococcus aureus
2789	S1M10000032F10	Staphylococcus aureus
2790	S1M10000032F11	Staphylococcus aureus
2791	S1M10000032F12	Staphylococcus aureus
2792	S1M10000032G02	Staphylococcus aureus
2793	S1M10000032G03	Staphylococcus aureus
2794	S1M10000032G04	Staphylococcus aureus
2795	S1M10000032G06	Staphylococcus aureus
2796	S1M10000032G08	Staphylococcus aureus
2797	S1M10000032G10	Staphylococcus aureus
2798	S1M10000032G12	Staphylococcus aureus
2799	S1M10000032H01	Staphylococcus aureus
2800	S1M10000032H04	Staphylococcus aureus
2801	S1M10000032H07	Staphylococcus aureus
2802	S1M10000032H09	Staphylococcus aureus
2803	S1M10000032H11	Staphylococcus aureus
2804	S1M10000033A02	Staphylococcus aureus
2805	S1M10000033A07	Staphylococcus aureus
2806	S1M10000033A08	Staphylococcus aureus
2807	S1M10000033A10	Staphylococcus aureus
2808	S1M10000033B02	Staphylococcus aureus
2809	S1M10000033B07	Staphylococcus aureus
2810	S1M10000033B08	Staphylococcus aureus
2811	S1M10000033B11	Staphylococcus aureus
2812	S1M10000033B12	Staphylococcus aureus
2813	S1M10000033C04	Staphylococcus aureus
2814	S1M10000033D02	Staphylococcus aureus
2815	S1M10000033D03	Staphylococcus aureus
2816	S1M10000033D04	Staphylococcus aureus
2817	S1M10000033D05	Staphylococcus aureus
2818	S1M10000033D06	Staphylococcus aureus
2819	S1M10000033D10	Staphylococcus aureus
2820	S1M10000033D12	Staphylococcus aureus
2821	S1M10000033E04	Staphylococcus aureus
2822	S1M10000033E10	Staphylococcus aureus
2823	S1M10000033E12	Staphylococcus aureus
2824	S1M10000033F02	Staphylococcus aureus
2825	S1M10000033F03	Staphylococcus aureus
2826	S1M10000033F06	Staphylococcus aureus
2827	S1M10000033F07	Staphylococcus aureus
2828	S1M10000033F09	Staphylococcus aureus
2829	S1M10000033F11	Staphylococcus aureus
2830	S1M10000033G05	Staphylococcus aureus
2831	S1M10000033G07	Staphylococcus aureus
2832	S1M10000033G09	Staphylococcus aureus
2833	S1M10000033G10	Staphylococcus aureus
2834	S1M10000033G11	Staphylococcus aureus
2835	S1M10000033G12	Staphylococcus aureus
2836	S1M10000033H01	Staphylococcus aureus
2837	S1M10000033H02	Staphylococcus aureus
2838	S1M10000033H03	Staphylococcus aureus
2839	S1M10000033H07	Staphylococcus aureus
2840	S1M10000033H08	Staphylococcus aureus
2841	S1M10000033H09	Staphylococcus aureus
2842	S1M10000033H10	Staphylococcus aureus
2843	S1M10000033H11	Staphylococcus aureus
2844	S1M10000034A02	Staphylococcus aureus
2845	S1M10000034A03	Staphylococcus aureus
2846	S1M10000034A04	Staphylococcus aureus
2847	S1M10000034A05	Staphylococcus aureus
2848	S1M10000034A08	Staphylococcus aureus
2849	S1M10000034A09	Staphylococcus aureus
2850	S1M10000034A11	Staphylococcus aureus
2851	S1M10000034A12	Staphylococcus aureus
2852	S1M10000034B03	Staphylococcus aureus
2853	S1M10000034B05	Staphylococcus aureus
2854	S1M10000034B06	Staphylococcus aureus
2855	S1M10000034B07	Staphylococcus aureus
2856	S1M10000034B08	Staphylococcus aureus
2857	S1M10000034B09	Staphylococcus aureus
2858	S1M10000034B10	Staphylococcus aureus
2859	S1M10000034B12	Staphylococcus aureus
2860	S1M10000034C02	Staphylococcus aureus
2861	S1M10000034C06	Staphylococcus aureus
2862	S1M10000034C07	Staphylococcus aureus
2863	S1M10000034C09	Staphylococcus aureus
2864	S1M10000034C12	Staphylococcus aureus
2865	S1M10000034D01	Staphylococcus aureus
2866	S1M10000034D05	Staphylococcus aureus
2867	S1M10000034D06	Staphylococcus aureus
2868	S1M10000034D07	Staphylococcus aureus
2869	S1M10000034D08	Staphylococcus aureus
2870	S1M10000034D10	Staphylococcus aureus
2871	S1M10000034D11	Staphylococcus aureus
2872	S1M10000034D12	Staphylococcus aureus
2873	S1M10000034E01	Staphylococcus aureus
2874	S1M10000034E02	Staphylococcus aureus
2875	S1M10000034E04	Staphylococcus aureus
2876	S1M10000034E05	Staphylococcus aureus
2877	S1M10000034E06	Staphylococcus aureus
2878	S1M10000034E07	Staphylococcus aureus
2879	S1M10000034E10	Staphylococcus aureus
2880	S1M10000034E11	Staphylococcus aureus
2881	S1M10000034E12	Staphylococcus aureus
2882	S1M10000034F01	Staphylococcus aureus
2883	S1M10000034F02	Staphylococcus aureus
2884	S1M10000034F03	Staphylococcus aureus
2885	S1M10000034F04	Staphylococcus aureus
2886	S1M10000034F05	Staphylococcus aureus
2887	S1M10000034F07	Staphylococcus aureus
2888	S1M10000034F08	Staphylococcus aureus
2889	S1M10000034F09	Staphylococcus aureus
2890	S1M10000034F10	Staphylococcus aureus
2891	S1M10000034F12	Staphylococcus aureus
2892	S1M10000034G02	Staphylococcus aureus
2893	S1M10000034G03	Staphylococcus aureus
2894	S1M10000034G06	Staphylococcus aureus
2895	S1M10000034G07	Staphylococcus aureus
2896	S1M10000034G08	Staphylococcus aureus
2897	S1M10000034G09	Staphylococcus aureus
2898	S1M10000034G11	Staphylococcus aureus
2899	S1M10000034G12	Staphylococcus aureus
2900	S1M10000034H01	Staphylococcus aureus
2901	S1M10000034H02	Staphylococcus aureus
2902	S1M10000034H03	Staphylococcus aureus
2903	S1M10000034H06	Staphylococcus aureus
2904	S1M10000034H07	Staphylococcus aureus
2905	S1M10000034H08	Staphylococcus aureus
2906	S1M10000034H09	Staphylococcus aureus
2907	S1M10000034H10	Staphylococcus aureus
2908	S1M10000035A03	Staphylococcus aureus
2909	S1M10000035A08	Staphylococcus aureus
2910	S1M10000035A09	Staphylococcus aureus
2911	S1M10000035A10	Staphylococcus aureus
2912	S1M10000035A11	Staphylococcus aureus
2913	S1M10000035A12	Staphylococcus aureus
2914	S1M10000035B01	Staphylococcus aureus
2915	S1M10000035B03	Staphylococcus aureus
2916	S1M10000035B04	Staphylococcus aureus
2917	S1M10000035B08	Staphylococcus aureus
2918	S1M10000035B11	Staphylococcus aureus
2919	S1M10000035C01	Staphylococcus aureus
2920	S1M10000035C02	Staphylococcus aureus
2921	S1M10000035C04	Staphylococcus aureus
2922	S1M10000035C06	Staphylococcus aureus
2923	S1M10000035C11	Staphylococcus aureus
2924	S1M10000035D01	Staphylococcus aureus
2925	S1M10000035D04	Staphylococcus aureus
2926	S1M10000035D06	Staphylococcus aureus
2927	S1M10000035D09	Staphylococcus aureus
2928	S1M10000035D12	Staphylococcus aureus
2929	S1M10000035E02	Staphylococcus aureus
2930	S1M10000035E03	Staphylococcus aureus
2931	S1M10000035E04	Staphylococcus aureus
2932	S1M10000035E08	Staphylococcus aureus
2933	S1M10000035E09	Staphylococcus aureus
2934	S1M10000035E12	Staphylococcus aureus
2935	S1M10000035F03	Staphylococcus aureus
2936	S1M10000035F04	Staphylococcus aureus
2937	S1M10000035F09	Staphylococcus aureus
2938	S1M10000035F12	Staphylococcus aureus
2939	S1M10000035G02	Staphylococcus aureus
2940	S1M10000035G09	Staphylococcus aureus
2941	S1M10000035G11	Staphylococcus aureus
2942	S1M10000035G12	Staphylococcus aureus
2943	S1M10000035H01	Staphylococcus aureus
2944	S1M10000035H07	Staphylococcus aureus
2945	S1M10000035H08	Staphylococcus aureus
2946	S1M10000035H09	Staphylococcus aureus
2947	S1M10000035H10	Staphylococcus aureus
2948	S1M10000035H11	Staphylococcus aureus
2949	S1M10000036A02	Staphylococcus aureus
2950	S1M10000036A03	Staphylococcus aureus
2951	S1M10000036A04	Staphylococcus aureus
2952	S1M10000036A05	Staphylococcus aureus
2953	S1M10000036A08	Staphylococcus aureus
2954	S1M10000036A11	Staphylococcus aureus
2955	S1M10000036A12	Staphylococcus aureus
2956	S1M10000036B04	Staphylococcus aureus
2957	S1M10000036B06	Staphylococcus aureus
2958	S1M10000036B07	Staphylococcus aureus
2959	S1M10000036B08	Staphylococcus aureus
2960	S1M10000036B11	Staphylococcus aureus
2961	S1M10000036B12	Staphylococcus aureus
2962	S1M10000036C01	Staphylococcus aureus
2963	S1M10000036C03	Staphylococcus aureus
2964	S1M10000036C04	Staphylococcus aureus
2965	S1M10000036C05	Staphylococcus aureus
2966	S1M10000036C06	Staphylococcus aureus
2967	S1M10000036C07	Staphylococcus aureus
2968	S1M10000036C09	Staphylococcus aureus
2969	S1M10000036C10	Staphylococcus aureus
2970	S1M10000036D02	Staphylococcus aureus
2971	S1M10000036D03	Staphylococcus aureus
2972	S1M10000036D06	Staphylococcus aureus
2973	S1M10000036D08	Staphylococcus aureus
2974	S1M10000036D10	Staphylococcus aureus
2975	S1M10000036D11	Staphylococcus aureus
2976	S1M10000036D12	Staphylococcus aureus
2977	S1M10000036E06	Staphylococcus aureus
2978	S1M10000036E08	Staphylococcus aureus
2979	S1M10000036E11	Staphylococcus aureus
2980	S1M10000036F06	Staphylococcus aureus
2981	S1M10000036F07	Staphylococcus aureus
2982	S1M10000036F08	Staphylococcus aureus
2983	S1M10000036F09	Staphylococcus aureus
2984	S1M10000036F10	Staphylococcus aureus
2985	S1M10000036F11	Staphylococcus aureus
2986	S1M10000036G03	Staphylococcus aureus
2987	S1M10000036G07	Staphylococcus aureus
2988	S1M10000036G08	Staphylococcus aureus
2989	S1M10000036G11	Staphylococcus aureus
2990	S1M10000036H01	Staphylococcus aureus
2991	S1M10000036H02	Staphylococcus aureus
2992	S1M10000036H03	Staphylococcus aureus
2993	S1M10000036H04	Staphylococcus aureus
2994	S1M10000036H05	Staphylococcus aureus
2995	S1M10000036H06	Staphylococcus aureus
2996	S1M10000036H08	Staphylococcus aureus
2997	S1M10000036H11	Staphylococcus aureus
2998	S1M10000037A02	Staphylococcus aureus
2999	S1M10000037A03	Staphylococcus aureus
3000	S1M10000037A06	Staphylococcus aureus
3001	S1M10000037A08	Staphylococcus aureus
3002	S1M10000037A09	Staphylococcus aureus
3003	S1M10000037A11	Staphylococcus aureus
3004	S1M10000037A12	Staphylococcus aureus
3005	S1M10000037B03	Staphylococcus aureus
3006	S1M10000037B04	Staphylococcus aureus
3007	S1M10000037B05	Staphylococcus aureus
3008	S1M10000037B06	Staphylococcus aureus
3009	S1M10000037B07	Staphylococcus aureus
3010	S1M10000037B08	Staphylococcus aureus
3011	S1M10000037B10	Staphylococcus aureus
3012	S1M10000037B11	Staphylococcus aureus
3013	S1M10000037B12	Staphylococcus aureus
3014	S1M10000037C05	Staphylococcus aureus
3015	S1M10000037C06	Staphylococcus aureus
3016	S1M10000037C07	Staphylococcus aureus
3017	S1M10000037C08	Staphylococcus aureus
3018	S1M10000037C09	Staphylococcus aureus
3019	S1M10000037C10	Staphylococcus aureus
3020	S1M10000037D04	Staphylococcus aureus
3021	S1M10000037D05	Staphylococcus aureus
3022	S1M10000037D06	Staphylococcus aureus
3023	S1M10000037D09	Staphylococcus aureus
3024	S1M10000037D12	Staphylococcus aureus
3025	S1M10000037E02	Staphylococcus aureus
3026	S1M10000037E03	Staphylococcus aureus
3027	S1M10000037E06	Staphylococcus aureus
3028	S1M10000037E08	Staphylococcus aureus
3029	S1M10000037E09	Staphylococcus aureus
3030	S1M10000037E10	Staphylococcus aureus
3031	S1M10000037E11	Staphylococcus aureus
3032	S1M10000037E12	Staphylococcus aureus
3033	S1M10000037F02	Staphylococcus aureus
3034	S1M10000037F03	Staphylococcus aureus
3035	S1M10000037F04	Staphylococcus aureus
3036	S1M10000037F05	Staphylococcus aureus
3037	S1M10000037F06	Staphylococcus aureus
3038	S1M10000037F07	Staphylococcus aureus
3039	S1M10000037F08	Staphylococcus aureus
3040	S1M10000037F09	Staphylococcus aureus
3041	S1M10000037F10	Staphylococcus aureus
3042	S1M10000037G01	Staphylococcus aureus
3043	S1M10000037G02	Staphylococcus aureus
3044	S1M10000037G03	Staphylococcus aureus
3045	S1M10000037G06	Staphylococcus aureus
3046	S1M10000037G07	Staphylococcus aureus
3047	S1M10000037G08	Staphylococcus aureus
3048	51M10000037G10	Staphylococcus aureus
3049	S1M10000037H02	Staphylococcus aureus
3050	S1M10000037H03	Staphylococcus aureus
3051	S1M10000037H05	Staphylococcus aureus
3052	S1M10000037H07	Staphylococcus aureus
3053	S1M10000037H08	Staphylococcus aureus
3054	S1M10000037H09	Staphylococcus aureus
3055	S1M10000037H11	Staphylococcus aureus
3056	S1M10000038A04	Staphylococcus aureus
3057	S1M10000038A07	Staphylococcus aureus
3058	S1M10000038A08	Staphylococcus aureus
3059	S1M10000038A09	Staphylococcus aureus
3060	S1M10000038A11	Staphylococcus aureus
3061	S1M10000038A12	Staphylococcus aureus
3062	S1M10000038B01	Staphylococcus aureus
3063	S1M10000038B03	Staphylococcus aureus
3064	S1M10000038B07	Staphylococcus aureus
3065	S1M10000038B08	Staphylococcus aureus
3066	S1M10000038B09	Staphylococcus aureus
3067	S1M10000038B12	Staphylococcus aureus
3068	S1M10000038C01	Staphylococcus aureus
3069	S1M10000038C02	Staphylococcus aureus
3070	S1M10000038C06	Staphylococcus aureus
3071	S1M10000038C08	Staphylococcus aureus
3072	S1M10000038C10	Staphylococcus aureus
3073	S1M10000038C11	Staphylococcus aureus
3074	S1M10000038C12	Staphylococcus aureus
3075	S1M10000038D02	Staphylococcus aureus
3076	S1M10000038D05	Staphylococcus aureus
3077	S1M10000038D07	Staphylococcus aureus
3078	S1M10000038D08	Staphylococcus aureus
3079	S1M10000038D09	Staphylococcus aureus
3080	S1M10000038D10	Staphylococcus aureus
3081	S1M10000038D11	Staphylococcus aureus
3082	S1M10000038D12	Staphylococcus aureus
3083	S1M10000038E01	Staphylococcus aureus
3084	S1M10000038E02	Staphylococcus aureus
3085	S1M10000038E03	Staphylococcus aureus
3086	S1M10000038E04	Staphylococcus aureus
3087	S1M10000038E05	Staphylococcus aureus
3088	S1M10000038E06	Staphylococcus aureus
3089	S1M10000038E07	Staphylococcus aureus
3090	S1M10000038E10	Staphylococcus aureus
3091	S1M10000038E12	Staphylococcus aureus
3092	S1M10000038F03	Staphylococcus aureus
3093	S1M10000038F04	Staphylococcus aureus
3094	S1M10000038F05	Staphylococcus aureus
3095	S1M10000038F06	Staphylococcus aureus
3096	S1M10000038F08	Staphylococcus aureus
3097	S1M10000038F09	Staphylococcus aureus
3098	S1M10000038F10	Staphylococcus aureus
3099	S1M10000038F11	Staphylococcus aureus
3100	S1M10000038F12	Staphylococcus aureus
3101	S1M10000038G01	Staphylococcus aureus
3102	S1M10000038G03	Staphylococcus aureus
3103	S1M10000038G04	Staphylococcus aureus
3104	S1M10000038G06	Staphylococcus aureus
3105	S1M10000038G08	Staphylococcus aureus
3106	S1M10000038G10	Staphylococcus aureus
3107	S1M10000038G11	Staphylococcus aureus
3108	S1M10000038G12	Staphylococcus aureus
3109	S1M10000038H03	Staphylococcus aureus
3110	S1M10000038H07	Staphylococcus aureus
3111	S1M10000038H09	Staphylococcus aureus
3112	S1M10000038H11	Staphylococcus aureus
3113	S1M10000039A02	Staphylococcus aureus
3114	S1M10000039A05	Staphylococcus aureus
3115	S1M10000039A07	Staphylococcus aureus
3116	S1M10000039A08	Staphylococcus aureus
3117	S1M10000039A11	Staphylococcus aureus
3118	S1M10000039A12	Staphylococcus aureus
3119	S1M10000039B02	Staphylococcus aureus
3120	S1M10000039B06	Staphylococcus aureus
3121	S1M10000039B07	Staphylococcus aureus
3122	S1M10000039B10	Staphylococcus aureus
3123	S1M10000039B12	Staphylococcus aureus
3124	S1M10000039C04	Staphylococcus aureus
3125	S1M10000039C06	Staphylococcus aureus
3126	S1M10000039C07	Staphylococcus aureus
3127	S1M10000039C08	Staphylococcus aureus
3128	S1M10000039C09	Staphylococcus aureus
3129	S1M10000039C10	Staphylococcus aureus
3130	S1M10000039C11	Staphylococcus aureus
3131	S1M10000039D02	Staphylococcus aureus
3132	S1M10000039D09	Staphylococcus aureus
3133	S1M10000039D10	Staphylococcus aureus
3134	S1M10000039E01	Staphylococcus aureus
3135	S1M10000039E08	Staphylococcus aureus
3136	S1M10000039E09	Staphylococcus aureus
3137	S1M10000039E10	Staphylococcus aureus
3138	S1M10000039E11	Staphylococcus aureus
3139	S1M10000039F02	Staphylococcus aureus
3140	S1M10000039F03	Staphylococcus aureus
3141	S1M10000039F05	Staphylococcus aureus
3142	S1M10000039F07	Staphylococcus aureus
3143	S1M10000039F08	Staphylococcus aureus
3144	S1M10000039F09	Staphylococcus aureus
3145	S1M10000039F10	Staphylococcus aureus
3146	S1M10000039F12	Staphylococcus aureus
3147	S1M10000039G03	Staphylococcus aureus
3148	S1M10000039G04	Staphylococcus aureus
3149	S1M10000039G07	Staphylococcus aureus
3150	S1M10000039G10	Staphylococcus aureus
3151	S1M10000039H02	Staphylococcus aureus
3152	S1M10000039H03	Staphylococcus aureus
3153	S1M10000039H04	Staphylococcus aureus
3154	S1M10000039H06	Staphylococcus aureus
3155	S1M10000039H07	Staphylococcus aureus
3156	S1M10000039H08	Staphylococcus aureus
3157	S1M10000040A04	Staphylococcus aureus
3158	S1M10000040A05	Staphylococcus aureus
3159	S1M10000040A07	Staphylococcus aureus
3160	S1M10000040A08	Staphylococcus aureus
3161	S1M10000040A10	Staphylococcus aureus
3162	S1M10000040A11	Staphylococcus aureus
3163	S1M10000040B01	Staphylococcus aureus
3164	S1M10000040B03	Staphylococcus aureus
3165	S1M10000040B07	Staphylococcus aureus
3166	S1M10000040B11	Staphylococcus aureus
3167	S1M10000040C03	Staphylococcus aureus
3168	S1M10000040C04	Staphylococcus aureus
3169	S1M10000040C05	Staphylococcus aureus
3170	S1M10000040C06	Staphylococcus aureus
3171	S1M10000040C07	Staphylococcus aureus
3172	S1M10000040C08	Staphylococcus aureus
3173	S1M10000040C10	Staphylococcus aureus
3174	S1M10000040C11	Staphylococcus aureus
3175	S1M10000040D01	Staphylococcus aureus
3176	S1M10000040D03	Staphylococcus aureus
3177	S1M10000040D08	Staphylococcus aureus
3178	S1M10000040D09	Staphylococcus aureus
3179	S1M10000040D11	Staphylococcus aureus
3180	S1M10000040E01	Staphylococcus aureus
3181	S1M10000040E02	Staphylococcus aureus
3182	S1M10000040E04	Staphylococcus aureus
3183	S1M10000040E05	Staphylococcus aureus
3184	S1M10000040E06	Staphylococcus aureus
3185	S1M10000040E07	Staphylococcus aureus
3186	S1M10000040E09	Staphylococcus aureus
3187	S1M10000040E10	Staphylococcus aureus
3188	S1M10000040E11	Staphylococcus aureus
3189	S1M10000040E12	Staphylococcus aureus
3190	S1M10000040F01	Staphylococcus aureus
3191	S1M10000040F02	Staphylococcus aureus
3192	S1M10000040F03	Staphylococcus aureus
3193	S1M10000040F04	Staphylococcus aureus
3194	S1M10000040F05	Staphylococcus aureus
3195	S1M10000040F06	Staphylococcus aureus
3196	S1M10000040F08	Staphylococcus aureus
3197	S1M10000040F09	Staphylococcus aureus
3198	S1M10000040F12	Staphylococcus aureus
3199	S1M10000040G01	Staphylococcus aureus
3200	S1M10000040G02	Staphylococcus aureus
3201	S1M10000040G04	Staphylococcus aureus
3202	S1M10000040G07	Staphylococcus aureus
3203	S1M10000040G08	Staphylococcus aureus
3204	S1M10000040G12	Staphylococcus aureus
3205	S1M10000040H02	Staphylococcus aureus
3206	S1M10000040H03	Staphylococcus aureus
3207	S1M10000040H04	Staphylococcus aureus
3208	S1M10000040H05	Staphylococcus aureus
3209	S1M10000040H07	Staphylococcus aureus
3210	S1M10000040H10	Staphylococcus aureus
3211	SIM10000041A03	Staphylococcus aureus
3212	S1M10000041B02	Staphylococcus aureus
3213	S1M10000041B03	Staphylococcus aureus
3214	S1M10000041B05	Staphylococcus aureus
3215	S1M10000041B06	Staphylococcus aureus
3216	S1M10000041B07	Staphylococcus aureus
3217	S1M10000041B12	Staphylococcus aureus
3218	S1M10000041C08	Staphylococcus aureus
3219	S1M10000041C10	Staphylococcus aureus
3220	S1M10000041C11	Staphylococcus aureus
3221	S1M10000041D06	Staphylococcus aureus
3222	S1M10000041D07	Staphylococcus aureus
3223	S1M10000041D08	Staphylococcus aureus
3224	S1M10000041D10	Staphylococcus aureus
3225	S1M10000041D12	Staphylococcus aureus
3226	S1M10000041E03	Staphylococcus aureus
3227	S1M10000041E06	Staphylococcus aureus
3228	S1M10000041E09	Staphylococcus aureus
3229	S1M10000041E12	Staphylococcus aureus
3230	S1M10000041F03	Staphylococcus aureus
3231	S1M10000041F11	Staphylococcus aureus
3232	S1M10000041F12	Staphylococcus aureus
3233	S1M10000041G01	Staphylococcus aureus
3234	S1M10000041G06	Staphylococcus aureus
3235	S1M10000041G08	Staphylococcus aureus
3236	S1M10000041G10	Staphylococcus aureus
3237	S1M10000041G11	Staphylococcus aureus
3238	S1M10000041H01	Staphylococcus aureus
3239	S1M10000041H04	Staphylococcus aureus
3240	S1M10000041H05	Staphylococcus aureus
3241	S1M10000041H07	Staphylococcus aureus
3242	S1M10000041H08	Staphylococcus aureus
3243	S1M10000041H09	Staphylococcus aureus
3244	S1M10000042A04	Staphylococcus aureus
3245	S1M10000042A05	Staphylococcus aureus
3246	S1M10000042A06	Staphylococcus aureus
3247	S1M10000042A07	Staphylococcus aureus
3248	S1M10000042A09	Staphylococcus aureus
3249	S1M10000042A11	Staphylococcus aureus
3250	S1M10000042A12	Staphylococcus aureus
3251	S1M10000042B02	Staphylococcus aureus
3252	S1M10000042B03	Staphylococcus aureus
3253	S1M10000042B06	Staphylococcus aureus
3254	S1M10000042B07	Staphylococcus aureus
3255	S1M10000042B08	Staphylococcus aureus
3256	S1M10000042B09	Staphylococcus aureus
3257	S1M10000042B10	Staphylococcus aureus
3258	S1M10000042B11	Staphylococcus aureus
3259	S1M10000042B12	Staphylococcus aureus
3260	S1M10000042C02	Staphylococcus aureus
3261	S1M10000042C06	Staphylococcus aureus
3262	S1M10000042C10	Staphylococcus aureus
3263	S1M10000042C11	Staphylococcus aureus
3264	S1M10000042D04	Staphylococcus aureus
3265	S1M10000042D07	Staphylococcus aureus
3266	S1M10000042D10	Staphylococcus aureus
3267	S1M10000042D11	Staphylococcus aureus
3268	S1M10000042E03	Staphylococcus aureus
3269	S1M10000042E06	Staphylococcus aureus
3270	S1M10000042E08	Staphylococcus aureus
3271	S1M10000042F01	Staphylococcus aureus
3272	S1M10000042F02	Staphylococcus aureus
3273	S1M10000042F05	Staphylococcus aureus
3274	S1M10000042F06	Staphylococcus aureus
3275	S1M10000042F08	Staphylococcus aureus
3276	S1M10000042F09	Staphylococcus aureus
3277	S1M10000042F10	Staphylococcus aureus
3278	S1M10000042F11	Staphylococcus aureus
3279	S1M10000042G01	Staphylococcus aureus
3280	S1M10000042G03	Staphylococcus aureus
3281	S1M10000042G08	Staphylococcus aureus
3282	S1M10000042G09	Staphylococcus aureus
3283	S1M10000042G12	Staphylococcus aureus
3284	S1M10000042H05	Staphylococcus aureus
3285	S1M10000042H07	Staphylococcus aureus
3286	S1M10000042H11	Staphylococcus aureus
3287	S1M10000043A02	Staphylococcus aureus
3288	S1M10000043A03	Staphylococcus aureus
3289	S1M10000043A04	Staphylococcus aureus
3290	S1M10000043A06	Staphylococcus aureus
3291	S1M10000043A07	Staphylococcus aureus
3292	S1M10000043A08	Staphylococcus aureus
3293	S1M10000043A10	Staphylococcus aureus
3294	S1M10000043A11	Staphylococcus aureus
3295	S1M10000043A12	Staphylococcus aureus
3296	S1M10000043B01	Staphylococcus aureus
3297	S1M10000043B02	Staphylococcus aureus
3298	S1M10000043B07	Staphylococcus aureus
3299	S1M10000043B08	Staphylococcus aureus
3300	S1M10000043B09	Staphylococcus aureus
3301	S1M10000043B10	Staphylococcus aureus
3302	S1M10000043B12	Staphylococcus aureus
3303	S1M10000043C02	Staphylococcus aureus
3304	S1M10000043C07	Staphylococcus aureus
3305	S1M10000043C11	Staphylococcus aureus
3306	S1M10000043C12	Staphylococcus aureus
3307	S1M10000043D01	Staphylococcus aureus
3308	S1M10000043D02	Staphylococcus aureus
3309	S1M10000043D04	Staphylococcus aureus
3310	S1M10000043D10	Staphylococcus aureus
3311	S1M10000043D12	Staphylococcus aureus
3312	S1M10000043E02	Staphylococcus aureus
3313	S1M10000043E03	Staphylococcus aureus
3314	S1M10000043E05	Staphylococcus aureus
3315	S1M10000043E07	Staphylococcus aureus
3316	S1M10000043E08	Staphylococcus aureus
3317	S1M10000043E10	Staphylococcus aureus
3318	S1M10000043E11	Staphylococcus aureus
3319	S1M10000043E12	Staphylococcus aureus
3320	S1M10000043F01	Staphylococcus aureus
3321	S1M10000043F05	Staphylococcus aureus
3322	S1M10000043F07	Staphylococcus aureus
3323	S1M10000043F08	Staphylococcus aureus
3324	S1M10000043F09	Staphylococcus aureus
3325	S1M10000043G01	Staphylococcus aureus
3326	S1M10000043G04	Staphylococcus aureus
3327	S1M10000043G05	Staphylococcus aureus
3328	S1M10000043G09	Staphylococcus aureus
3329	S1M10000043G10	Staphylococcus aureus
3330	S1M10000043H01	Staphylococcus aureus
3331	S1M10000043H03	Staphylococcus aureus
3332	S1M10000043H04	Staphylococcus aureus
3333	S1M10000043H05	Staphylococcus aureus
3334	S1M10000043H06	Staphylococcus aureus
3335	S1M10000043H09	Staphylococcus aureus
3336	S1M10000043H10	Staphylococcus aureus
3337	S1M10000043H11	Staphylococcus aureus
3338	S1M10000044A02	Staphylococcus aureus
3339	S1M10000044A06	Staphylococcus aureus
3340	S1M10000044A08	Staphylococcus aureus
3341	S1M10000044A09	Staphylococcus aureus
3342	S1M10000044A11	Staphylococcus aureus
3343	S1M10000044A12	Staphylococcus aureus
3344	S1M10000044B01	Staphylococcus aureus
3345	S1M10000044B02	Staphylococcus aureus
3346	S1M10000044B05	Staphylococcus aureus
3347	S1M10000044B06	Staphylococcus aureus
3348	S1M10000044B08	Staphylococcus aureus
3349	S1M10000044B11	Staphylococcus aureus
3350	S1M10000044B12	Staphylococcus aureus
3351	S1M10000044C04	Staphylococcus aureus
3352	S1M10000044C06	Staphylococcus aureus
3353	S1M10000044C07	Staphylococcus aureus
3354	S1M10000044C08	Staphylococcus aureus
3355	S1M10000044C11	Staphylococcus aureus
3356	S1M10000044C12	Staphylococcus aureus
3357	S1M10000044D01	Staphylococcus aureus
3358	S1M10000044D04	Staphylococcus aureus
3359	S1M10000044D06	Staphylococcus aureus
3360	S1M10000044D08	Staphylococcus aureus
3361	S1M10000044D09	Staphylococcus aureus
3362	S1M10000044D10	Staphylococcus aureus
3363	S1M10000044D11	Staphylococcus aureus
3364	S1M10000044D12	Staphylococcus aureus
3365	S1M10000044E01	Staphylococcus aureus
3366	S1M10000044E02	Staphylococcus aureus
3367	S1M10000044E06	Staphylococcus aureus
3368	S1M10000044E07	Staphylococcus aureus
3369	S1M10000044E09	Staphylococcus aureus
3370	S1M10000044E10	Staphylococcus aureus
3371	S1M10000044E11	Staphylococcus aureus
3372	S1M10000044F02	Staphylococcus aureus
3373	S1M10000044F06	Staphylococcus aureus
3374	S1M10000044F08	Staphylococcus aureus
3375	S1M10000044F10	Staphylococcus aureus
3376	S1M10000044G02	Staphylococcus aureus
3377	S1M10000044G05	Staphylococcus aureus
3378	S1M10000044G08	Staphylococcus aureus
3379	S1M10000044G10	Staphylococcus aureus
3380	S1M10000044G11	Staphylococcus aureus
3381	S1M10000044H06	Staphylococcus aureus
3382	S1M10000044H07	Staphylococcus aureus
3383	S1M10000044H08	Staphylococcus aureus
3384	S1M10000044H09	Staphylococcus aureus
3385	S1M10000044H10	Staphylococcus aureus
3386	S1M10000044H11	Staphylococcus aureus
3387	S1M10000045A02	Staphylococcus aureus
3388	S1M10000045A06	Staphylococcus aureus
3389	S1M10000045A07	Staphylococcus aureus
3390	S1M10000045A08	Staphylococcus aureus
3391	S1M10000045A12	Staphylococcus aureus
3392	S1M10000045B01	Staphylococcus aureus
3393	S1M10000045B02	Staphylococcus aureus
3394	S1M10000045B03	Staphylococcus aureus
3395	S1M10000045B07	Staphylococcus aureus
3396	S1M10000045B10	Staphylococcus aureus
3397	S1M10000045B11	Staphylococcus aureus
3398	S1M10000045B12	Staphylococcus aureus
3399	S1M10000045C02	Staphylococcus aureus
3400	S1M10000045C03	Staphylococcus aureus
3401	S1M10000045C04	Staphylococcus aureus
3402	S1M10000045C05	Staphylococcus aureus
3403	S1M10000045C07	Staphylococcus aureus
3404	S1M10000045C09	Staphylococcus aureus
3405	S1M10000045D01	Staphylococcus aureus
3406	S1M10000045D03	Staphylococcus aureus
3407	S1M10000045D07	Staphylococcus aureus
3408	S1M10000045D08	Staphylococcus aureus
3409	S1M10000045D09	Staphylococcus aureus
3410	S1M10000045D10	Staphylococcus aureus
3411	S1M10000045D11	Staphylococcus aureus
3412	S1M10000045D12	Staphylococcus aureus
3413	S1M10000045E04	Staphylococcus aureus
3414	S1M10000045E05	Staphylococcus aureus
3415	S1M10000045E08	Staphylococcus aureus
3416	S1M10000045E09	Staphylococcus aureus
3417	S1M10000045E10	Staphylococcus aureus
3418	S1M10000045E11	Staphylococcus aureus
3419	S1M10000045E12	Staphylococcus aureus
3420	S1M10000045F04	Staphylococcus aureus
3421	S1M10000045F05	Staphylococcus aureus
3422	S1M10000045F08	Staphylococcus aureus
3423	S1M10000045F11	Staphylococcus aureus
3424	S1M10000045F12	Staphylococcus aureus
3425	S1M10000045G03	Staphylococcus aureus
3426	S1M10000045G06	Staphylococcus aureus
3427	S1M10000045G07	Staphylococcus aureus
3428	S1M10000045G08	Staphylococcus aureus
3429	S1M10000045G10	Staphylococcus aureus
3430	S1M10000045G12	Staphylococcus aureus
3431	S1M10000045H06	Staphylococcus aureus
3432	S1M10000045H10	Staphylococcus aureus
3433	S1M10000045H11	Staphylococcus aureus
3434	S1M10000046A03	Staphylococcus aureus
3435	S1M10000046A04	Staphylococcus aureus
3436	S1M10000046A06	Staphylococcus aureus
3437	S1M10000046A08	Staphylococcus aureus
3438	S1M10000046A09	Staphylococcus aureus
3439	S1M10000046A11	Staphylococcus aureus
3440	S1M10000046A12	Staphylococcus aureus
3441	S1M10000046B01	Staphylococcus aureus
3442	S1M10000046B03	Staphylococcus aureus
3443	S1M10000046B04	Staphylococcus aureus
3444	S1M10000046B05	Staphylococcus aureus
3445	S1M10000046B07	Staphylococcus aureus
3446	S1M10000046B08	Staphylococcus aureus
3447	S1M10000046B09	Staphylococcus aureus
3448	S1M10000046B11	Staphylococcus aureus
3449	S1M10000046B12	Staphylococcus aureus
3450	S1M10000046C02	Staphylococcus aureus
3451	S1M10000046C04	Staphylococcus aureus
3452	S1M10000046C05	Staphylococcus aureus
3453	S1M10000046C06	Staphylococcus aureus
3454	S1M10000046C07	Staphylococcus aureus
3455	S1M10000046C08	Staphylococcus aureus
3456	S1M10000046C11	Staphylococcus aureus
3457	S1M10000046C12	Staphylococcus aureus
3458	S1M10000046D01	Staphylococcus aureus
3459	S1M10000046D02	Staphylococcus aureus
3460	S1M10000046D03	Staphylococcus aureus
3461	S1M10000046D04	Staphylococcus aureus
3462	S1M10000046D05	Staphylococcus aureus
3463	S1M10000046D08	Staphylococcus aureus
3464	S1M10000046D09	Staphylococcus aureus
3465	S1M10000046D10	Staphylococcus aureus
3466	S1M10000046D11	Staphylococcus aureus
3467	S1M10000046D12	Staphylococcus aureus
3468	S1M10000046E01	Staphylococcus aureus
3469	S1M10000046E02	Staphylococcus aureus
3470	S1M10000046E04	Staphylococcus aureus
3471	S1M10000046E07	Staphylococcus aureus
3472	S1M10000046E08	Staphylococcus aureus
3473	S1M10000046E10	Staphylococcus aureus
3474	S1M10000046F01	Staphylococcus aureus
3475	S1M10000046F02	Staphylococcus aureus
3476	S1M10000046F05	Staphylococcus aureus
3477	S1M10000046F06	Staphylococcus aureus
3478	S1M10000046F08	Staphylococcus aureus
3479	S1M10000046F09	Staphylococcus aureus
3480	S1M10000046F10	Staphylococcus aureus
3481	S1M10000046F12	Staphylococcus aureus
3482	S1M10000046G01	Staphylococcus aureus
3483	S1M10000046G02	Staphylococcus aureus
3484	S1M10000046G03	Staphylococcus aureus
3485	S1M10000046G04	Staphylococcus aureus
3486	S1M10000046G07	Staphylococcus aureus
3487	S1M10000046G09	Staphylococcus aureus
3488	S1M10000046G10	Staphylococcus aureus
3489	S1M10000046H01	Staphylococcus aureus
3490	S1M10000046H10	Staphylococcus aureus
3491	S1M10000047A03	Staphylococcus aureus
3492	S1M10000047A04	Staphylococcus aureus
3493	S1M10000047A05	Staphylococcus aureus
3494	S1M10000047A06	Staphylococcus aureus
3495	S1M10000047A07	Staphylococcus aureus
3496	S1M10000047A08	Staphylococcus aureus
3497	S1M10000047A09	Staphylococcus aureus
3498	S1M10000047A10	Staphylococcus aureus
3499	S1M10000047A11	Staphylococcus aureus
3500	S1M10000047A12	Staphylococcus aureus
3501	S1M10000047B02	Staphylococcus aureus
3502	S1M10000047B04	Staphylococcus aureus
3503	S1M10000047BOS	Staphylococcus aureus
3504	S1M10000047B06	Staphylococcus aureus
3505	S1M10000047B08	Staphylococcus aureus
3506	S1M10000047B09	Staphylococcus aureus
3507	S1M10000047B10	Staphylococcus aureus
3508	S1M10000047B12	Staphylococcus aureus
3509	S1M10000047C01	Staphylococcus aureus
3510	S1M10000047C02	Staphylococcus aureus
3511	S1M10000047C03	Staphylococcus aureus
3512	S1M10000047C04	Staphylococcus aureus
3513	S1M10000047C06	Staphylococcus aureus
3514	S1M10000047C08	Staphylococcus aureus
3515	S1M10000047C09	Staphylococcus aureus
3516	S1M10000047C11	Staphylococcus aureus
3517	S1M10000047C12	Staphylococcus aureus
3518	S1M10000047D02	Staphylococcus aureus
3519	S1M10000047D03	Staphylococcus aureus
3520	S1M10000047D04	Staphylococcus aureus
3521	S1M10000047D05	Staphylococcus aureus
3522	S1M10000047D09	Staphylococcus aureus
3523	S1M10000047D10	Staphylococcus aureus
3524	S1M10000047D11	Staphylococcus aureus
3525	S1M10000047D12	Staphylococcus aureus
3526	S1M10000047E01	Staphylococcus aureus
3527	S1M10000047E02	Staphylococcus aureus
3528	S1M10000047E03	Staphylococcus aureus
3529	S1M10000047E04	Staphylococcus aureus
3530	S1M10000047E05	Staphylococcus aureus
3531	S1M10000047E06	Staphylococcus aureus
3532	S1M10000047E08	Staphylococcus aureus
3533	S1M10000047E09	Staphylococcus aureus
3534	S1M10000047E10	Staphylococcus aureus
3535	S1M10000047E11	Staphylococcus aureus
3536	S1M10000047E12	Staphylococcus aureus
3537	S1M10000047F02	Staphylococcus aureus
3538	S1M10000047F03	Staphylococcus aureus
3539	S1M10000047F04	Staphylococcus aureus
3540	S1M10000047F05	Staphylococcus aureus
3541	S1M10000047F06	Staphylococcus aureus
3542	S1M10000047F07	Staphylococcus aureus
3543	S1M10000047F08	Staphylococcus aureus
3544	S1M10000047F09	Staphylococcus aureus
3545	S1M10000047F10	Staphylococcus aureus
3546	S1M10000047F11	Staphylococcus aureus
3547	S1M10000047F12	Staphylococcus aureus
3548	S1M10000047G01	Staphylococcus aureus
3549	S1M10000047G02	Staphylococcus aureus
3550	S1M10000047G04	Staphylococcus aureus
3551	S1M10000047G05	Staphylococcus aureus
3552	S1M10000047G06	Staphylococcus aureus
3553	S1M10000047G07	Staphylococcus aureus
3554	S1M10000047G08	Staphylococcus aureus
3555	S1M10000047G09	Staphylococcus aureus
3556	S1M10000047G10	Staphylococcus aureus
3557	S1M10000047H03	Staphylococcus aureus
3558	S1M10000047H04	Staphylococcus aureus
3559	S1M10000047H05	Staphylococcus aureus
3560	S1M10000047H06	Staphylococcus aureus
3561	S1M10000047H07	Staphylococcus aureus
3562	S1M10000047H08	Staphylococcus aureus
3563	S1M10000047H09	Staphylococcus aureus
3564	S1M10000047H11	Staphylococcus aureus
3565	S1M10000048A02	Staphylococcus aureus
3566	S1M10000048A03	Staphylococcus aureus
3567	S1M10000048A04	Staphylococcus aureus
3568	S1M10000048A05	Staphylococcus aureus
3569	S1M10000048A06	Staphylococcus aureus
3570	S1M10000048A07	Staphylococcus aureus
3571	S1M10000048A09	Staphylococcus aureus
3572	S1M10000048A10	Staphylococcus aureus
3573	S1M10000048A11	Staphylococcus aureus
3574	S1M10000048A12	Staphylococcus aureus
3575	S1M10000048B02	Staphylococcus aureus
3576	S1M10000048B05	Staphylococcus aureus
3577	S1M10000048B08	Staphylococcus aureus
3578	S1M10000048B10	Staphylococcus aureus
3579	S1M10000048B11	Staphylococcus aureus
3580	S1M10000048B12	Staphylococcus aureus
3581	S1M10000048C01	Staphylococcus aureus
3582	S1M10000048C02	Staphylococcus aureus
3583	S1M10000048C03	Staphylococcus aureus
3584	S1M10000048C05	Staphylococcus aureus
3585	S1M10000048C06	Staphylococcus aureus
3586	S1M10000048C07	Staphylococcus aureus
3587	S1M10000048C08	Staphylococcus aureus
3588	S1M10000048C09	Staphylococcus aureus
3589	S1M10000048C11	Staphylococcus aureus
3590	S1M10000048D02	Staphylococcus aureus
3591	S1M10000048D08	Staphylococcus aureus
3592	S1M10000048D09	Staphylococcus aureus
3593	S1M10000048D10	Staphylococcus aureus
3594	S1M10000048D12	Staphylococcus aureus
3595	S1M10000048E02	Staphylococcus aureus
3596	S1M10000048E03	Staphylococcus aureus
3597	S1M10000048E04	Staphylococcus aureus
3598	S1M10000048E06	Staphylococcus aureus
3599	S1M10000048E07	Staphylococcus aureus
3600	S1M10000048E08	Staphylococcus aureus
3601	S1M10000048E10	Staphylococcus aureus
3602	S1M10000048F02	Staphylococcus aureus
3603	S1M10000048F07	Staphylococcus aureus
3604	S1M10000048F08	Staphylococcus aureus
3605	S1M10000048F09	Staphylococcus aureus
3606	S1M10000048F11	Staphylococcus aureus
3607	S1M10000048F12	Staphylococcus aureus
3608	S1M10000048G02	Staphylococcus aureus
3609	S1M10000048G03	Staphylococcus aureus
3610	S1M10000048G04	Staphylococcus aureus
3611	S1M10000048G05	Staphylococcus aureus
3612	S1M10000048G07	Staphylococcus aureus
3613	S1M10000048G10	Staphylococcus aureus
3614	S1M10000048G11	Staphylococcus aureus
3615	S1M10000048H01	Staphylococcus aureus
3616	S1M10000048H02	Staphylococcus aureus
3617	S1M10000048H03	Staphylococcus aureus
3618	S1M10000048H04	Staphylococcus aureus
3619	S1M10000048H05	Staphylococcus aureus
3620	S1M10000048H07	Staphylococcus aureus
3621	S1M10000048H08	Staphylococcus aureus
3622	S1M10000048H09	Staphylococcus aureus
3623	S1M10000048H10	Staphylococcus aureus
3624	S1M10000048H11	Staphylococcus aureus
3625	S1M10000009E10	Staphylococcus aureus
3626	S1M10000001F01	Staphylococcus aureus
3627	S1M10000006B12	Staphylococcus aureus
3628	S1M10000003D09	Staphylococcus aureus
3629	S1M10000001D11	Staphylococcus aureus
3630	S1M10000003B07	Staphylococcus aureus
3631	S1M10000002A07	Staphylococcus aureus
3632	S1M10000003F11	Staphylococcus aureus
3633	S1M10000047C07	Staphylococcus aureus
3634	S1M10000013F10	Staphylococcus aureus
3635	S1M10000014D11	Staphylococcus aureus
3636	S1M10000015F05	Staphylococcus aureus
3637	S1M10000048D01	Staphylococcus aureus
3638	S1M10000011C03	Staphylococcus aureus
3639	S1M10000012F03	Staphylococcus aureus
3640	S1M10000002F07	Staphylococcus aureus
3641	S1M10000048G01	Staphylococcus aureus
3642	S1M10000009G12	Staphylococcus aureus
3643	S1M10000012D05	Staphylococcus aureus
3644	S1M10000014D07	Staphylococcus aureus
3645	S1M10000047C05	Staphylococcus aureus
3646	S1M10000018D08*	Staphylococcus aureus
3647	S1M10000047B01	Staphylococcus aureus
3648	S1M10000047H10	Staphylococcus aureus
3649	S1M10000001A04	Staphylococcus aureus
3650	S1M10000016E01	Staphylococcus aureus
3651	S1M10000017E12	Staphylococcus aureus
3652	S1M10000019B01	Staphylococcus aureus
3653	S1M10000048F03	Staphylococcus aureus
3654	S1M10000034A07	Staphylococcus aureus
3655	S1M10000023G01	Staphylococcus aureus
3656	S1M10000021G12	Staphylococcus aureus
3657	S1M10000024E04	Staphylococcus aureus
3658	S1M10000028H08	Staphylococcus aureus
3659	S1M10000022B07	Staphylococcus aureus
3660	S1M10000003A05	Staphylococcus aureus
3661	S1M10000003AO9	Staphylococcus aureus
3662	S1M10000003E01	Staphylococcus aureus
3663	S1M10000004C11	Staphylococcus aureus
3664	S1M10000007E08	Staphylococcus aureus
3665	S1M10000021G06	Staphylococcus aureus
3666	S1M10000024C06	Staphylococcus aureus
3667	S1M10000024D01	Staphylococcus aureus
3668	S1M10000027D07	Staphylococcus aureus
3669	S1M10000027E03	Staphylococcus aureus
3670	S1M10000027G01	Staphylococcus aureus
3671	S1M10000029A03	Staphylococcus aureus
3672	S1M10000032B10	Staphylococcus aureus
3673	S1M10000032C07	Staphylococcus aureus
3674	S1M10000038D04	Staphylococcus aureus
3675	S1M10000047D07	Staphylococcus aureus
3676	S1M10000048B03	Staphylococcus aureus
3677	S1M10000048B06	Staphylococcus aureus
3678	S1M10000048C10	Staphylococcus aureus
3679	S1M10000048F05	Staphylococcus aureus
3680	S4M10000001C01	Salmonella typhimurium
3681	S4M10000002B06	Salmonella typhimurium
3682	S4M10000002B09	Salmonella typhimurium
3683	S4M10000002G04	Salmonella typhimurium
3684	S4M10000002G08	Salmonella typhimurium
3685	S4M10000005G05	Salmonella typhimurium
3686	S4M10000005H02	Salmonella typhimurium
3687	S4M10000006A06	Salmonella typhimurium
3688	S4M10000006A08	Salmonella typhimurium
3689	S4M10000006C05	Salmonella typhimurium
3690	S4M10000006F08	Salmonella typhimurium
3691	S4M10000007G01	Salmonella typhimurium
3692	S4M10000008C08	Salmonella typhimurium
3693	S4M10000008H10	Salmonella typhimurium
3694	S4M10000009A05	Salmonella typhimurium
3695	S4M10000010B05	Salmonella typhimurium
3696	S4M10000010D04	Salmonella typhimurium
3697	S4M10000010H04	Salmonella typhimurium
3698	S4M10000011D08	Salmonella typhimurium
3699	S4M10000011E08	Salmonella typhimurium
3700	S4M10000012B06	Salmonella typhimurium
3701	S4M10000012B12	Salmonella typhimurium
3702	S4M10000012D02	Salmonella typhimurium
3703	S4M10000013H02	Salmonella typhimurium
3704	S4M10000014B05	Salmonella typhimurium
3705	S4M10000014D04	Salmonella typhimurium
3706	S4M10000014D07	Salmonella typhimurium
3707	S4M10000014H02	Salmonella typhimurium
3708	S4M10000015B11	Salmonella typhimurium
3709	S4M10000015E09	Salmonella typhimurium
3710	S4M10000016A02	Salmonella typhimurium
3711	S4M10000018D09	Salmonella typhimurium
3712	S4M10000018E10	Salmonella typhimurium
3713	S4M10000018F10	Salmonella typhimurium
3714	S4M10000018G03	Salmonella typhimurium
3715	S4M10000018H04	Salmonella typhimurium
3716	S4M10000019F05	Salmonella typhimurium
3717	S4M10000019G04	Salmonella typhimurium
3718	S4M10000019G05	Salmonella typhimurium
3719	S4M10000019H06	Salmonella typhimurium
3720	S4M10000020A04	Salmonella typhimurium
3721	S4M10000020F05	Salmonella typhimurium
3722	S4M10000020G10	Salmonella typhimurium
3723	S4M10000022D04	Salmonella typhimurium
3724	S4M10000022D12	Salmonella typhimurium
3725	S4M10000022E12	Salmonella typhimurium
3726	S4M10000022G07	Salmonella typhimurium
3727	S4M10000022H06	Salmonella typhimurium
3728	S4M10000023F01	Salmonella typhimurium
3729	S4M10000024B02	Salmonella typhimurium
3730	S4M10000024C06	Salmonella typhimurium
3731	S4M10000024C11	Salmonella typhimurium
3732	S4M10000024F08	Salmonella typhimurium
3733	S4M10000024G01	Salmonella typhimurium
3734	S4M10000024G04	Salmonella typhimurium
3735	S4M10000024G09	Salmonella typhimurium
3736	S4M10000024H02	Salmonella typhimurium
3737	S4M10000025A11	Salmonella typhimurium
3738	S4M10000025E02	Salmonella typhimurium
3739	S4M10000025E05	Salmonella typhimurium
3740	S4M10000025H07	Salmonella typhimurium
3741	S4M10000026C10	Salmonella typhimurium
3742	S4M10000026D04	Salmonella typhimurium
3743	S4M10000026E06	Salmonella typhimurium
3744	S4M10000026E12	Salmonella typhimurium
3745	S4M10000027C10	Salmonella typhimurium
3746	S4M10000027E02	Salmonella typhimurium
3747	S4M10000029B12	Salmonella typhimurium
3748	S4M10000029D12	Salmonella typhimurium
3749	S4M10000030D03	Salmonella typhimurium
3750	S4M10000030F07	Salmonella typhimurium
3751	S4M10000030G11	Salmonella typhimurium
3752	S4M10000032B12	Salmonella typhimurium
3753	S4M10000033F08	Salmonella typhimurium
3754	S4M10000033G05	Salmonella typhimurium
3755	S4M10000033G09	Salmonella typhimurium
3756	S4M10000034A02	Salmonella typhimurium
3757	S4M10000034A09	Salmonella typhimurium
3758	S4M10000034D06	Salmonella typhimurium
3759	S4M10000034H05	Salmonella typhimurium
3760	S4M10000034H09	Salmonella typhimurium
3761	S4M10000035B01	Salmonella typhimurium
3762	S4M10000035D01	Salmonella typhimurium
3763	S4M10000035D02	Salmonella typhimurium
3764	S4M10000035E03	Salmonella typhimurium
3765	S4M10000035F02	Salmonella typhimurium
3766	S4M10000035F09	Salmonella typhimurium
3767	S4M10000036D07	Salmonella typhimurium
3768	S4M10000036F07	Salmonella typhimurium
3769	S4M10000037A04	Salmonella typhimurium
3770	S4M10000037A10	Salmonella typhimurium
3771	S4M10000037E10	Salmonella typhimurium
3772	S4M10000037H09	Salmonella typhimurium
3773	S4M10000001H01	Salmonella typhimurium
3774	S4M10000002F06	Salmonella typhimurium
3775	S4M10000008D01	Salmonella typhimurium
3776	S4M10000009G11	Salmonella typhimurium
3777	S4M10000011F09	Salmonella typhimurium
3778	S4M10000020F08	Salmonella typhimurium
3779	S4M10000021E07	Salmonella typhimurium
3780	S4M10000022B05	Salmonella typhimurium
3781	S4M10000025H11	Salmonella typhimurium
3782	S4M10000026B10	Salmonella typhimurium
3783	S4M10000026E03	Salmonella typhimurium
3784	S4M10000029A03	Salmonella typhimurium
3785	S4M10000029C11	Salmonella typhimurium
3786	S4M10000030F06	Salmonella typhimurium
3787	S4M10000032F03	Salmonella typhimurium
3788	S4M10000032G01	Salmonella typhimurium
3789	S4M10000034C05	Salmonella typhimurium
3790	S4M10000034H04	Salmonella typhimurium
3791	S4M10000035A09	Salmonella typhimurium
3792	S4M10000035B06	Salmonella typhimurium
3793	S4M10000035F01	Salmonella typhimurium
3794	S4M10000037A08	Salmonella typhimurium
3795	S4M10000037E03	Salmonella typhimurium

[0879]

TABLE 1B
					full length
					ORF
	Clone		Gene Seq ID		Protein Seq
Clone name	Seq ID	PathoSeq Locus	(protein)	Genemarked gene	ID
E3M10000001A02	8	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000001A06	9	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000001B01	10	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000001B02	11	EFA100739	4888	EFA1c0022_orf_23p	10537
E3M10000001B02	11	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000001B02	11	EFA1025S1	5001	EFA1c0022_orf_25p	10539
E3M10000001B05	12	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000001B06	13	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000001B08	14	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000001B10	15	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000001C02	16	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000001C09	17	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000001D02	18	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000001D04	19	EFA100742	4891	EFA1c0022_orf_20p	10534
E3M10000001D04	19	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000001D04	19	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000001D05	20	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000001D05	20	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000001D09	21	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000001D09	21	EFA100211	4871	EFA1c0022_orf_10p	10523
B3M10000001E01	22	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000001E01	22	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000001E02	23	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000001E03	24	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000001E03	24	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000001E04	25	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000001E08	26	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000001E09	27	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000001E09	27	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000001F02	28	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000001F04	29	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000001F06	30	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000001F07	31	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000001G02	32	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000001G03	33	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000001G03	33	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000001G04	34	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000001G05	35	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000001H02	36	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000001H03	37	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000001H03	37	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000001H04	38	EFA100742	4891	EFA1c0022_orf_20p	10534
E3M10000001H04	38	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000001H04	38	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000004A04	39	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000004A04	39	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000004C03	40	EFA100478	4880	EFA1c0012_orf_2p	10486
E3M10000004D01	41	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000004D01	41	EFA101413	4938	#N/A	#N/A
E3M10000004D01	41	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000004D02	42	EFA102022	4974	EFA1c0044_orf_106p	10881
E3M10000004D02	42	EFA102023	4975	EFA1c0044_orf_107p	10882
E3M10000004D10	43	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000004D10	43	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000004E11	44	EFA101086	4910	EFA1c0240_orf_90p	10763
E3M10000004F08	45	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000004F08	45	EFA102551	5001	EFA1c0022_orf_25p	10539
B3M10000004F10	46	EFA101086	4910	EFA1c0040_orf_90p	10763
E3M10000004G01	47	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000004H11	48	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000004H11	48	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005A07	49	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000005B01	50	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000005B01	50	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000005B08	51	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000005B08	51	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005C01	52	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000005C03	53	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000005C04	54	EFA102186	4981	EFA1c0045_orf_94p	10949
E3M10000005C04	54	EFA102453	4993	EFA1c0045_orf_203p	10931
E3M10000005C04	54	EFA102728	5006	EFA1c0045_orf_93p	10948
E3M10000005D03	55	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000005D04	56	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000005D10	57	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000005D10	57	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005E01	58	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000005E01	58	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005E02	59	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000005E02	59	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005E03	60	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000005E08	61	EFA101403	4932	EFA1c0033_orf_54p	10662
E3M10000005F07	62	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000005F10	63	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000005F10	63	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005G05	64	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000005G05	64	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000005H04	65	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000006B03	66	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000006B03	66	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000006C01	67	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000006C01	67	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000006C12	68	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000006C12	68	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000006D03	69	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000006D03	69	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000006E11	70	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000006E11	70	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000006F04	71	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000006F04	71	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000006G04	72	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000006G04	72	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000006G12	73	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000006G12	73	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000006H09	74	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000007A02	75	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007A02	75	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000007B02	76	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007B02	76	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000007B03	77	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007B03	77	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000007C03	78	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000007C03	78	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000007C04	79	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000007D03	80	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007D03	80	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000007E05	81	EFA100742	4891	EFA1c0022_orf_20p	10534
E3M10000007E05	81	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000007E05	81	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000007F01	82	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007F01	82	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000007F06	83	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007F06	83	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000007G01	84	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000007G01	84	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000008C03	85	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000008C08	86	EFA101536	4946	EFA1c0042_orf_46p	10823
E3M10000008C09	87	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000008D08	88	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000008E02	89	EFA100783	4895	EFA1c0042_orf_141p	10811
E3M10000008G05	90	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000008G05	90	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000008G09	91	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000008G09	91	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000008H02	92	EFA101695	4954	EFA1c0031_orf_6p	10629
E3M10000009C07	93	EFA103508	5029	EFA1c0033_orf_95p	10672
E3M10000009C09	94	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000009D01	95	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000009E02	96	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000009E02	96	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000009E03	97	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000009E05	98	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000009G02	99	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000010C08	100	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000010D05	101	EFA100757	4894	EFA1c0044_orf_27p	10897
E3M10000010F01	102	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000010G05	103	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000010G07	104	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000010G09	105	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000010G10	106	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M1000200210H	107	EFA100194	4868	EFA1c0022_orf_26p	10540
E3M10000011A09	108	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000011B03	109	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000011B09	110	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000011C07	111	EFA101790	4959	EFA1c0042_orf_111p	10803
E3M10000011D03	112	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000011D03	112	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000011H02	113	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000011H05	114	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000012B01	115	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000012B02	116	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000012B07	117	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000012B07	117	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000012B07	117	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000012B08	118	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000012C01	119	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000012D10	120	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000012E08	121	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000012F05	122	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000012F06	123	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000012F07	124	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000012F07	124	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000012F10	125	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000012F10	125	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000012G02	126	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000012G07	127	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000012G07	127	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000013A06	128	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000013A07	129	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000013C05	130	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000013C05	130	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000013D02	131	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000013D08	132	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000013D10	133	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000013D10	133	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000013E02	134	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000013E08	135	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000013F05	136	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000013F12	137	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000013F12	137	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000013G10	138	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000013H03	139	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000013H05	140	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000013H10	141	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000014B12	142	EFA100739	4888	EFA1c0022_orf_23p	10537
E3M10000014B12	142	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000014B12	142	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000014E12	143	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000014E12	143	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000014G09	144	EFA100991	4905	EFA1c0035_orf_60p	10681
E3M10000014G09	144	EFA103033	5016	EFA1c0035_orf_60p	10681
E3M10000015B04	145	EFA100065	4863	EFA1c0042_orf_14p	10813
E3M10000015B12	146	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000015E12	147	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000015E12	147	EFA100211	4871	EFA1c0022_orf_10p	10523
E3M10000016A03	148	EFA101753	4957	EFA1c0022_orf_50p	10552
E3M10000016A04	149	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000016C11	150	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000016C11	150	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000016D03	151	EFA102774	5009	EFA1c0044_orf_25p	10896
E3M10000016F06	152	EFA102205	4983	EFA1c0041_orf_115p	10769
E3M10000016F10	153	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000016F10	153	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000016H05	154	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000016H10	155	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000017A09	156	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000017A09	156	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000017D09	157	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000018A07	158	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000018C02	159	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000018E01	160	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000018G09	161	EFA101583	4949	EFA1c0026_orf_23p	10593
E3M10000018H06	162	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000019B06	163	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000019D02	164	EFA102022	4974	EFA1c0044_orf_106p	10881
E3M10000019E03	165	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000019E03	165	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000019E04	166	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000020G04	167	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000020G04	167	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000020H05	168	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000021A08	169	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000021A08	169	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000021A11	170	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000021B10	171	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000021C03	172	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000021C04	173	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000021C08	174	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000021D04	175	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000021D04	175	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000021E10	176	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000021G04	177	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000021G10	178	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000021G11	179	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000021H11	180	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000022A04	181	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000022A11	182	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000022B04	183	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000022B05	184	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000022B05	184	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000022B07	185	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000022C05	186	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000022C05	186	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000022C06	187	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000022C09	188	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000022D04	189	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000022F05	190	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000022F06	191	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000022F06	191	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000022F08	192	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000022G02	193	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000022G12	194	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000023A03	195	EFA101413	4938	#N/A	#N/A
E3M10000023A06	196	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000023A07	197	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000023A09	198	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000023B02	199	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000023B02	199	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000023B06	200	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000023C03	201	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000023C03	201	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000023C04	202	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000023C06	203	EFA101413	4938	#N/A	#N/A
E3M10000023C08	204	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000023C09	205	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000023C09	205	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000023D02	206	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000023D04	207	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000023D10	208	EFA101413	4938	#N/A	#N/A
E3M10000023E04	209	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000023E07	210	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000023E09	211	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000023F02	212	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000023F10	213	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000023G02	214	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000023G04	215	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000023G10	216	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000023H08	217	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000024A03	218	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000024A04	219	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000024A08	220	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000024A08	220	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000024C06	221	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000025A06	222	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000025B01	223	EFA100194	4868	EFA1c0022_orf_26p	10540
E3M10000025B01	223	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000025B03	224	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000025B03	224	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000025B05	225	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000025B10	226	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000025C01	227	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000025C04	228	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000025C05	229	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000025C05	229	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000025C07	230	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000025C08	231	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000025C08	231	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000025C09	232	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000025C11	233	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000025D01	234	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000025D01	234	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000025D10	235	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000025E07	236	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000025E08	237	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000025E12	238	EFA102728	5006	EFA1c0045_orf_93p	10948
E3M10000025F04	239	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000025F04	239	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000025F06	240	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000025F06	240	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000025F06	240	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000025F08	241	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000025F09	242	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000025F10	243	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000025F11	244	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000025F12	245	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000025G02	246	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000025007	247	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000025G09	248	EFA102185	4980	EFA1c0045_orf_95p	10950
E3M10000027A02	249	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000027A07	250	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000027A09	251	EFA101413	4938	#N/A	#N/A
E3M10000027A09	251	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000027B07	252	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000027B08	253	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000027B09	254	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000027B09	254	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000027C02	255	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000027C03	256	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000027C08	257	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000027D03	258	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000027D03	258	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000027D05	259	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000027D08	260	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000027D10	261	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000027G01	262	EFA102186	4981	EFA1c0045_orf_94p	10949
E3M10000027G08	263	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000027H04	264	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000027H07	265	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000027H07	265	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000028A02	266	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000028A03	267	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000028A04	268	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000028A04	268	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000028A05	269	EFA101080	4909	#N/A	#N/A
E3M10000028A05	269	EFA102915	5014	EFA1c0032_orf_27p	10640
E3M10000028A06	270	EFA103210	5022	EFA1c0036_orf_119p	10688
E3M10000028A08	271	EFA101424	4943	EFA1c0041_orf_39p	10784
E3M10000028A08	271	EFA101425	4944	EFA1c0041_orf_40p	10785
E3M10000028B01	272	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000028B02	273	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000028B02	273	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000028B03	274	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000028B04	275	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000028B05	276	EFA101424	4943	EFA1c0041_orf_39p	10784
E3M10000028B05	276	EFA101425	4944	EFA1c0041_orf_40p	10785
E3M10000028B06	277	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000028B07	278	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000028B08	279	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000028C01	280	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000028C01	280	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000028C02	281	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000028C02	281	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000028C04	282	EFA101322	4927	EFA1c0030_orf_57p	10620
E3M10000028C05	283	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000028C06	284	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000028C07	285	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000028C08	286	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000028C08	286	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000028D01	287	EFA100194	4868	EFA1c0022_orf_26p	10540
E3M10000028D01	287	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000028D02	288	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000028D05	289	EFA101080	4909	#N/A	#N/A
E3M10000028D06	290	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000028D08	291	EFA103268	5023	EFA1c0010_orf_1p	10479
E3M10000028E01	292	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000028E04	293	EFA101370	4931	EFA1c0040_orf_103p	10738
E3M10000028E07	294	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000028F02	295	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000028F03	296	EFA100742	4891	EFA1c0022_orf_20p	10534
E3M10000028F03	296	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000028F03	296	EFA102554	5002	EFA1c0022_orf_19p	10532
E3M10000028F04	297	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000028F04	297	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000028F05	298	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000028F06	299	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000028F07	300	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000028G05	301	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000028G06	302	EFA100748	4892	EFA1c0011_orf_10p	10483
E3M10000028G07	303	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000028G07	303	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000028H04	304	EFA101409	4934	EFA1c0022_orf_11p	10524
E3M10000028H07	305	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000029A02	306	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000029A04	307	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000029A05	308	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000029A10	309	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000029A11	310	EFA101413	4938	#N/A	#N/A
E3M10000029B01	311	EFA103295	5024	EFA1c0032_orf_1p	10633
E3M10000029B02	312	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000029B05	313	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000029B06	314	EFA100914	4900	EFA1c0024_orf_9p	10579
E3M10000029B08	315	EFA102338	4987	EFA1c0032_orf_8p	10651
E3M10000029B11	316	EFA100397	4877	EFA1c0041_orf_148p	10773
E3M10000029B12	317	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000029C01	318	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000029C02	319	EFA102788	5011	EFA1c0033_orf_41p	10661
E3M10000029C03	320	EFA102253	4984	EFA1c0038_orf_85p	10727
E3M10000029C04	321	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000029C05	322	EFA100399	4878	EFA1c0041_orf_104p	10766
E3M10000029C06	323	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000029C06	323	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000029C07	324	EFA102352	4990	EFA1c0032_orf_21p	10635
E3M10000029C07	324	EFA102353	4991	EFA1c0032_orf_22p	10636
E3M10000029C08	325	EFA101868	4966	EFA1c0042_orf_69p	10829
E3M10000029C09	326	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000029C10	327	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000029C12	328	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000029D01	329	EFA101080	4909	#N/A	#N/A
E3M10000029D03	330	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000029D04	331	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000029D05	332	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000029D06	333	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000029D06	333	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000029D08	334	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000029D12	335	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000029E01	336	EFA101404	4933	EFA1c0033_orf_55p	10663
E3M10000029E02	337	EFA102051	4976	#N/A	#N/A
E3M10000029E03	338	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000029E05	339	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000029E07	340	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000029E08	341	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000029E09	342	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000029E12	343	EFA100397	4877	EFA1c0041_orf_148p	10773
E3M10000029F01	344	EFA100023	4862	EFA1c0017_orf_1p	10505
E3M10000029F05	345	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000029F06	346	EFA101795	4962	EFA1c0045_orf_165p	10922
E3M10000029F09	347	EFA100689	4886	EFA1c0038_orf_54p	10717
E3M10000029F10	348	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000029F11	349	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000029F12	350	EFA102282	4985	EFA1c0038_orf_89p	10729
E3M10000029G01	351	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000029G04	352	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000029G05	353	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000029G07	354	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000029G08	355	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000029G09	356	EFA102201	4982	#N/A	#N/A
E3M10000029G10	357	EFA101797	4963	EFA1c0045_orf_167p	10924
E3M10000029G11	358	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000029G12	359	EFA101541	4948	EFA1c0012_orf_5p	10488
E3M10000029H02	360	EFA101339	4928	EFA1c0040_orf_13p	10743
E3M10000029H02	360	EFA101340	4929	EFA1c0040_orf_15p	10745
E3M10000029H04	361	EFA102352	4990	EFA1c0032_orf_21p	10635
E3M10000029H04	361	EFA102353	4991	EFA1c0032_orf_22p	10636
E3M10000029H05	362	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000029H07	363	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000029H08	364	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000029H11	365	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000030A05	366	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000030A08	367	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000030A09	368	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000030A11	369	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000030B03	370	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000030B04	371	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000030B05	372	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000030B06	373	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000030B07	374	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000030B08	375	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000030B10	376	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000030B11	377	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000030B12	378	EFA102352	4990	EFA1c0032_orf_21p	10635
E3M10000030B12	378	EFA102353	4991	EFA1c0032_orf_22p	10636
E3M10000030C03	379	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000030C04	380	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000030C12	381	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000030D02	382	EFA102350	4988	EFA1c0032_orf_19p	10632
E3M10000030D05	383	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000030D08	384	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000030D09	385	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000030D10	386	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000030D12	387	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000030E01	388	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000030E01	388	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000030E02	389	EFA100329	4875	EFA1c0041_orf_35p	10782
E3M10000030E04	390	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000030E08	391	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000030E09	392	EFA103365	5026	EFA1c0022_orf_1p	10533
E3M10000030E10	393	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000030F01	394	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000030F04	395	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000030F06	396	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000030F07	397	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000030F10	398	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000030F12	399	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000030G01	400	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000030G03	401	EFA100023	4862	EFA1c0017_orf_1p	10505
E3M10000030G06	402	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000030G08	403	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000030G09	404	EFA103210	5022	EFA1c0036_orf_119p	10688
E3M10000030G12	405	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000030H03	406	EFA101258	4926	EFA1c0045_orf_160p	10918
E3M10000030H04	407	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000030H06	408	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000030H07	409	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000030H08	410	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000030H10	411	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000030H11	412	EFA100615	4881	EFA1c0016_orf_29p	10501
E3M10000031A02	413	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000031A06	414	EFA100970	4903	EFA1c0044_orf_98p	10906
E3M10000031A07	415	EFA102201	4982	#N/A	#N/A
E3M10000031A08	416	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000031B02	417	EFA100289	4872	EFA1c0042_orf_139p	10810
E3M10000031B03	418	EFA100426	4879	EFA1c0036_orf_59p	10702
E3M10000031B04	419	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000031B09	420	EFA102183	4979	EFA1c0045_orf_97p	10952
E3M10000031B10	421	EFA101253	4924	EFA1c0043_orf_178p	10852
E3M10000031B11	422	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000031B12	423	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000031C01	424	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000031C04	425	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000031C06	426	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000031C10	427	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000031C11	428	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000031C12	429	EFA100668	4885	EFA1c0035_orf_58p	10679
E3M10000031D03	430	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000031D04	431	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000031D08	432	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000031E03	433	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000031E09	434	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000031F02	435	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000031F02	435	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000031F04	436	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000031F07	437	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000031F09	438	EFA102764	5008	EFA1c0008_orf_3p	10478
E3M10000031F11	439	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000031F11	439	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000031G03	440	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000031G04	441	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000031G05	442	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000031G06	443	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000031G07	444	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000031G08	445	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000031G11	446	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000031H05	447	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000031H06	448	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000031H07	449	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000031H08	450	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000031H10	451	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000031H11	452	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000031H11	452	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000032A02	453	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000032A04	454	EFA101670	4950	EFA1c0019_orf_20p	10511
E3M10000032A06	455	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000032A07	456	EFA101670	4950	EFA1c0019_orf_20p	10511
E3M10000032A08	457	EFA100329	4875	EFA1c0041_orf_35p	10782
E3M10000032A09	458	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000032A10	459	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000032A11	460	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000032A11	460	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000032B03	461	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000032B04	462	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000032B07	463	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000032B08	464	EFA102698	5005	EFA1c0045_orf_115p	10909
E3M10000032B09	465	EFA102051	4976	#N/A	#N/A
E3M10000032B11	466	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000032B12	467	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000032C01	468	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000032C02	469	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000032C03	470	EFA103348	5025	EFA1c0043_orf_67p	10873
E3M10000032C04	471	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000032C06	472	EFA101150	4915	EFA1c0038_orf_57p	10719
E3M10000032C09	473	EFA100740	4889	EFA1c0022_orf_22p	10536
E3M10000032C11	474	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000032C12	475	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000032D01	476	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000032D02	477	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000032D03	478	EFA100399	4878	EFA1c0041_orf_104p	10766
E3M10000032D06	479	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000032D09	480	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000032D12	481	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000032E04	482	EFA101792	4961	EFA1c0042_orf_113p	10805
E3M10000032E04	482	EFA103786	5031	EFA1c0042_orf_114p	10806
E3M10000032E05	483	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000032E08	484	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000032E10	485	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000032E10	485	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000032E11	486	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000032E12	487	EFA102326	4986	#N/A	#N/A
E3M10000032F02	488	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000032F02	488	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000032F03	489	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000032F05	490	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000032F07	491	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000032F08	492	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000032F11	493	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000032F12	494	EFA102201	4982	#N/A	#N/A
E3M10000032G01	495	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000032G02	496	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000032G04	497	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000032G05	498	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000032G06	499	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000032G07	500	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000032H05	501	EFA100200	4869	EFA1c0041_orf_88p	10798
E3M10000032H06	502	EFA101833	4965	EFA1c0038_orf_62p	10720
E3M10000032H08	503	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000032H09	504	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000032H10	505	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000033A03	506	EFA101253	4924	EFA1c0043_orf_178p	10852
E3M10000033A04	507	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000033A05	508	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000033A06	509	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000033A07	510	EFA102774	5009	EFA1c0044_orf_25p	10896
E3M10000033A08	511	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000033A11	512	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000033B01	513	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000033B02	514	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000033B04	515	EFA101765	4958	EFA1c0025_orf_33p	10587
E3M10000033B05	516	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000033B06	517	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000033B08	518	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000033B09	519	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000033C01	520	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000033C02	521	EFA103174	5021	EFA1c0036_orf_120p	10689
E3M10000033C05	522	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000033C05	522	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000033C09	523	EFA100811	4898	EFA1c0022_orf_33p	10546
E3M10000033C10	524	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000033C10	524	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000033C11	525	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000033C12	526	EFA102389	4992	EFA1c0044_orf_83p	10904
E3M10000033D01	527	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000033D04	528	EFA101682	4951	EFA1c0041_orf_53p	10789
E3M10000033D05	529	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000033D06	530	EFA100641	4883	EFA1c0041_orf_57p	10793
E3M10000033D06	530	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000033D09	531	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000033D10	532	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000033D11	533	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000033E02	534	EFA101477	4945	EFA1c0043_orf_224p	10861
E3M10000033E03	535	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000033E03	535	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000033E04	536	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000033E05	537	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000033E07	538	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000033E08	539	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000033E09	540	EFA100617	4882	EFA1c0040_orf_93p	10764
E3M10000033E11	541	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000033F01	542	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000033F03	543	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000033F04	544	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000033F05	545	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000033F07	546	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000033F08	547	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000033F10	548	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000033F12	549	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000033F12	549	EFA102542	4999	EFA1c0028_orf_4p	10603
E3M10000033G01	550	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000033G02	551	EFA102813	5013	EFA1c0043_orf_9p	10878
E3M10000033G03	552	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000033G04	553	EFA102326	4986	#N/A	#N/A
E3M10000033G06	554	EFA101404	4933	EFA1c0033_orf_55p	10663
E3M10000033G07	555	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000033G08	556	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000033G09	557	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000033G12	558	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000033H02	559	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000033H04	560	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000033H05	561	EFA100741	4890	EFA1c0022_orf_21p	10535
E3M10000033H07	562	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000033H08	563	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000033H09	564	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000033H10	565	EFA101079	4908	#N/A	#N/A
E3M10000033H11	566	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000034A02	567	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000034A03	568	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000034A04	569	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000034B02	570	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000034B04	571	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000034C04	572	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000034D01	573	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000034D02	574	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000034E01	575	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000034E04	576	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000034F02	577	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000034F03	578	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000034F04	579	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000034G02	580	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000034G03	581	EFA100740	4889	EFA1c0022_orf_22p	10536
E3M10000034H02	582	EFA101257	4925	EFA1c0045_orf_159p	10917
E3M10000034H03	583	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000035A02	584	EFA103268	5023	EFA1c0010_orf_1p	10479
E3M10000035A04	585	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000035A05	586	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000035A06	587	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000035A08	588	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000035A09	589	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000035A11	590	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000035B01	591	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000035B03	592	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035B06	593	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000035B07	594	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000035B08	595	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000035B10	596	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000035B11	597	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000035B12	598	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000035C01	599	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035C03	600	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000035C04	601	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000035C05	602	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000035C06	603	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000035C07	604	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000035C08	605	EFA100741	4890	EFA1c0022_orf_21p	10535
E3M10000035C08	605	EFA100742	4891	EFA1c0022_orf_20p	10534
E3M10000035C09	606	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000035C11	607	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035C12	608	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035D02	609	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000035D03	610	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000035D04	611	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000035D05	612	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000035D10	613	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000035D11	614	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000035E03	615	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000035E04	616	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000035E05	617	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000035E07	618	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000035E08	619	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000035E09	620	EFA100312	4874	EFA1c0032_orf_28p	10641
E3M10000035E10	621	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000035E11	622	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000035E12	623	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035F01	624	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000035F02	625	EFA101925	4971	EFA1c0044_orf_19p	10893
E3M10000035F03	626	EFA100312	4874	EFA1c0032_orf_28p	10641
E3M10000035F06	627	EFA101080	4909	#N/A	#N/A
E3M10000035F07	628	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000035F08	629	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035F09	630	EFA101410	4935	EFA1c0022_orf_12p	10525
E3M10000035F09	630	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000035F11	631	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000035F12	632	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000035G02	633	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000035G02	633	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000035G04	634	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000035G05	635	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000035G08	636	EFA100642	4884	EFA1c00241_orf_56p	10792
E3M10000035G09	637	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000035G09	637	EFA103508	5029	EFA1c0033_orf_95p	10672
E3M10000035G10	638	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000035G11	639	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000035H03	640	EFA101080	4909	#N/A	#N/A
E3M10000035H06	641	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000035H09	642	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000035H11	643	EFA101257	4925	EFA1c0045_orf_159p	10917
E3M10000035H11	643	EFA101258	4926	EFA1c0045_orf_160p	10918
E3M10000036A03	644	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000036A04	645	EFA101416	4941	EFA1c0022_orf_17p	10530
B3M10000036A05	646	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000036A06	647	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000036A07	648	EFA103268	5023	EFA1c0010_orf_1p	10479
E3M10000036A08	649	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000036A09	650	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000036A10	651	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000036B01	652	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000036B03	653	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000036B06	654	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036B07	655	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000036B08	656	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000036B09	657	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000036B11	658	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000036B12	659	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036B12	659	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000036C01	660	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000036C03	661	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000036C06	662	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000036C07	663	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000036C08	664	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000036C09	665	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000036C10	666	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000036C11	667	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000036D03	668	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000036D04	669	EFA102201	4982	#N/A	#N/A
E3M10000036D06	670	EFA100740	4889	EFA1c0022_orf_22p	10536
E3M10000036D08	671	EFA101164	4921	EFA1c0022_orf_7p	10558
E3M10000036D09	672	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000036D10	673	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000036D11	674	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000036D12	675	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000036E01	676	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000036E04	677	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036E05	678	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000036E07	679	EFA101022	4906	EFA1c0043_orf_69p	10875
E3M10000036E08	680	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000036F03	681	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000036F04	682	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000036F05	683	EFA101792	4961	EFA1c0042_orf_113p	10805
E3M10000036F08	684	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000036F09	685	EFA101404	4933	EFA1c0033_orf_55p	10663
E3M10000036F10	686	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036F12	687	EFA101163	4920	EFA1c0022_orf_6p	10557
E3M10000036G01	688	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000036G01	688	EFA102551	5001	EFA1c0022_orf_25p	10539
E3M10000036G02	689	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000036G03	690	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000036G04	691	EFA102091	4977	EFA1c0010_orf_3p	10481
B3M10000036G06	692	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000036G10	693	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036H02	694	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000036H03	695	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000036H04	696	EFA103365	5026	EFA1c0022_orf_1p	10533
E3M10000036H05	697	EFA100194	4868	EFA1c0022_orf_26p	10540
E3M10000036H06	698	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036H07	699	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000036H08	700	EFA103210	5022	EFA1c0036_orf_119p	10688
E3M10000036H09	701	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000036H10	702	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000037A03	703	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000037A06	704	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000037A08	705	EFA103365	5026	EFA1c0022_orf_1p	10533
E3M10000037A09	706	EFA100756	4893	EFA1c0024_orf_39p	10575
E3M10000037A10	707	EFA103268	5023	EFA1c0010_orf_1p	10479
E3M10000037B02	708	EFA100641	4883	EFA1c0041_orf_57p	10793
E3M10000037B02	708	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000037B07	709	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000037B08	710	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000037B11	711	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000037C01	712	EFA101080	4909	#N/A	#N/A
E3M10000037C02	713	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000037C04	714	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000037C05	715	EFA102655	5003	EFA1c0039_orf_25p	10733
B3M10000037C07	716	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000037C07	716	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000037C11	717	EFA100615	4881	EFA1c0016_orf_29p	10501
E3M10000037C12	718	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000037D02	719	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000037D03	720	EFA100795	4896	EFA1c0043_orf_229p	10863
E3M10000037D03	720	EFA103081	5020	EFA1c0043_orf_28p	10862
E3M10000037D04	721	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000037D05	722	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000037D06	723	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000037D09	724	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000037D09	724	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000037D11	725	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000037E01	726	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000037E02	727	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000037E03	728	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000037E05	729	EFA101080	4909	#N/A	#N/A
E3M10000037E07	730	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000037E08	731	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000037E10	732	EFA101253	4924	EFA1c0043_orf_178p	10852
E3M10000037E12	733	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000037F01	734	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000037F02	735	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000037F06	736	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000037F07	737	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000037F12	738	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000037G01	739	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000037G02	740	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000037G03	741	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000037G05	742	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000037G06	743	EFA103295	5024	EFA1c0032_orf_1p	10633
E3M10000037G07	744	EFA101541	4948	EFA1c0012_orf_5p	10488
E3M10000037G08	745	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000037G10	746	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000037G11	747	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000037H02	748	EFA101413	4938	#N/A	#N/A
E3M10000037H05	749	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000037H07	750	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000037H10	751	EFA101080	4909	#N/A	#N/A
E3M10000037H11	752	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000038A02	753	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000038A03	754	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000038A05	755	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000038A06	756	EFA102549	5000	EFA1c0022_orf_24p	10538
E3M10000038A07	757	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000038A09	758	EFA102736	5007	EFA1c0022_orf_60p	10556
E3M10000038A10	759	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000038A11	760	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000038B02	761	EFA103210	5022	EFA1c0036_orf_119p	10688
E3M10000038B03	762	EFA102389	4992	EFA1c0044_orf_83p	10904
E3M10000038B04	763	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000038B05	764	EFA100795	4896	EFA1c0043_orf_229p	10863
E3M10000038B05	764	EFA103081	5020	EFA1c0043_orf_28p	10862
E3M10000038B07	765	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000038B08	766	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000038B09	767	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000038B11	768	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000038C02	769	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000038C03	770	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000038C05	771	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000038C07	772	EFA101963	4972	EFA1c0043_orf_162p	10848
E3M10000038C10	773	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000038C12	774	EFA101080	4909	#N/A	#N/A
E3M10000038D01	775	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000038D02	776	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000038D04	777	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000038D08	778	EFA101160	4917	EFA1c0022_orf_3p	10549
B3M10000038D10	779	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000038D11	780	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000038D12	781	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000038E02	782	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000038E03	783	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000038E04	784	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000038E05	785	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000038E07	786	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000038E08	787	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000038E11	788	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000038F02	789	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000038F04	790	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000038F05	791	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000038F05	791	EFA101161	4918	EFA1c0022_orf_4p	10551
E3M10000038F06	792	EFA103571	5030	EFA1c0044_orf_101p	10879
E3M10000038F07	793	EFA103210	5022	EFA1c0036_orf_119p	10688
E3M10000038F09	794	EFA102185	4980	EFA1c0045_orf_95p	10950
E3M10000038F10	795	EFA101080	4909	#N/A	#N/A
E3M10000038F11	796	EFA100740	4889	EFA1c0022_orf_22p	10536
E3M10000038G02	797	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000038G03	798	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000038G06	799	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000038G07	800	EFA102352	4990	EFA1c0032_orf_21p	10635
E3M10000038G07	800	EFA102353	4991	EFA1c0032_orf_22p	10636
E3M10000038G11	801	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000038H02	802	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000038H05	803	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000038H06	804	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000038H07	805	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000038H08	806	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000038H09	807	EFA102802	5012	EFA1c0043_orf_18p	10854
E3M10000038H10	808	EFA101541	4948	EFA1c0012_orf_5p	10488
E3M10000039A02	809	EFA101736	4955	EFA1c0041_orf_14p	10775
E3M10000039A02	809	EFA101737	4956	EFA1c0041_orf_15p	10778
E3M10000039A06	810	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000039A07	811	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000039A08	812	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000039A10	813	EFA101257	4925	EFA1c0045_orf_159p	10917
E3M10000039A11	814	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000039B01	815	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000039B03	816	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000039B04	817	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000039B04	817	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000039B06	818	EFA100870	4899	EFA1c0031_orf_36p	10627
E3M10000039B07	819	EFA102110	4978	EFA1c0042_orf_99p	10841
E3M10000039B08	820	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000039B09	821	EFA101792	4961	EFA1c0042_orf_113p	10805
E3M10000039B11	822	EFA101080	4909	#N/A	#N/A
E3M10000039C02	823	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000039C04	824	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000039C05	825	EFA100739	4888	EFA1c0022_orf_23p	10537
E3M10000039C06	826	EFA103504	5028	EFA1c0033_orf_94p	10671
E3M10000039C07	827	EFA101791	4960	EFA1c0042_orf_112p	10804
E3M10000039C07	827	EFA101792	4961	EFA1c0042_orf_113p	10805
E3M10000039C08	828	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000039C09	829	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000039C10	830	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000039D02	831	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000039D03	832	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000039D04	833	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000039D06	834	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000039E01	835	EFA102201	4982	#N/A	#N/A
E3M10000039E02	836	EFA101540	4947	EFA1c0012_orf_4p	10487
E3M10000039E03	837	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000039E05	838	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000039E07	839	EFA103295	5024	EFA1c0032_orf_1p	10633
E3M10000039E08	840	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000039F01	841	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000039F02	842	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000039F03	843	EFA102788	5011	EFA1c0033_orf_41p	10661
E3M10000039F03	843	EFA103375	5027	EFA1c0033_orf_40p	10660
E3M10000039F06	844	EFA100739	4888	EFA1c0022_orf_23p	10537
E3M10000039F07	845	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000039F08	846	EFA101162	4919	EFA1c0022_orf_5p	10555
E3M10000039G01	847	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000039G02	848	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000039G05	849	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000039G07	850	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000039G09	851	EFA102541	4998	EFA1c0028_orf_3p	10602
E3M10000039G10	852	EFA101682	4951	EFA1c0041_orf_53p	10789
E3M10000039H02	853	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000039H07	854	EFA101080	4909	#N/A	#N/A
E3M10000039H08	855	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000039H10	856	EFA101413	4938	#N/A	#N/A
E3M10000039H11	857	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000039H11	857	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000040A03	858	EFA101123	4913	EFA1c0040_orf_22p	10748
E3M10000040A05	859	EFA101080	4909	#N/A	#N/A
E3M10000040A07	860	EFA100157	4865	EFA1c0034_orf_63p	10673
E3M10000040A09	861	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000040A10	862	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000040A11	863	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000040B01	864	EFA102788	5011	EFA1c0033_orf_41p	10661
E3M10000040B02	865	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000040B05	866	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000040B05	866	EFA103268	5023	EFA1c0010_orf_1p	10479
E3M10000040B06	867	EFA102518	4997	EFA1c0032_orf_46p	10647
E3M10000040B08	868	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000040B09	869	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000040B10	870	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000040B11	871	EFA102764	5008	EFA1c0008_orf_3p	10478
E3M10000040B12	872	EFA100210	4870	EFA1c0022_orf_9p	10560
E3M10000040C02	873	EFA101080	4909	#N/A	#N/A
E3M10000040C05	874	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000040C06	875	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000040C07	876	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000040C08	877	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000040C09	878	EFA100165	4866	EFA1c0032_orf_23p	10637
E3M10000040C09	878	EFA102353	4991	EFA1c0032_orf_22p	10636
E3M10000040C10	879	EFA101686	4953	EFA1c0045_orf_63p	10940
B3M10000040C11	880	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000040C12	881	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000040D03	882	EFA102201	4982	#N/A	#N/A
E3M10000040D04	883	EFA101080	4909	#N/A	#N/A
E3M10000040D08	884	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000040D12	885	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000040E02	886	EFA102051	4976	#N/A	#N/A
E3M10000040E10	887	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000040E11	888	EFA103039	5018	EFA1c0043_orf_16p	10850
E3M10000040E12	889	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000040F01	890	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000040F03	891	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000040F08	892	EFA101080	4909	#N/A	#N/A
E3M10000040F09	893	EFA100919	4901	EFA1c0013_orf_12p	10491
E3M10000040F10	894	EFA102051	4976	#N/A	#N/A
E3M10000040G01	895	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000040G02	896	EFA101424	4943	EFA1c0041_orf_39p	10784
E3M10000040G02	896	EFA101425	4944	EFA1c0041_orf_40p	10785
E3M10000040G04	897	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000040G05	898	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000040G07	899	EFA101079	4908	#N/A	#N/A
E3M10000040G07	899	EFA101080	4909	#N/A	#N/A
E3M10000040G08	900	EFA102186	4981	EFA1c0045_orf_94p	10949
E3M10000040G09	901	EFA103021	5015	EFA1c0030_orf_16p	10612
E3M10000040G11	902	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000040H02	903	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000040H03	904	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000040H04	905	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000040H04	905	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000040H05	906	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000040H05	906	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000040H09	907	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000040H09	907	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000041A03	908	EFA100615	4881	EFA1c0016_orf_29p	10501
E3M10000041A05	909	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000041A08	910	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000041A09	911	EFA101354	4930	EFA1c0032_orf_69p	10648
E3M10000041A10	912	EFA10G001	4861	EFA1c0030_orf_3p	10618
E3M10000041A11	913	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000041A11	913	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000041B02	914	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000041B03	915	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000041B05	916	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000041B06	917	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000041B08	918	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000041B09	919	EFA101924	4970	EFA1c0044_orf_18p	10891
E3M10000041B09	919	EFA101925	4971	EFA1c0044_orf_19p	10893
E3M10000041B10	920	EFA101080	4909	#N/A	#N/A
E3M10000041B11	921	EFA101416	4941	EFA1c0022_orf_17p	10530
E3M10000041B11	921	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000041B12	922	EFA101411	4936	EFA1c0022_orf_13p	10526
E3M10000041C01	923	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000041C07	924	EFA100739	4888	EFA1c0022_orf_23p	10537
E3M10000041C08	925	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000041C09	926	EFA103365	5026	EFA1c0022_orf_1p	10533
E3M10000041C10	927	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000041C11	928	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000041C12	929	EFA100798	4897	EFA1c0042_orf_160p	10818
E3M10000041D02	930	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000041D03	931	EFA101060	4907	EFA1c0038_orf_73p	10722
E3M10000041D04	932	EFA100642	4884	EFA1c0041_orf_56p	10792
E3M10000041D04	932	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000041D05	933	EFA101080	4909	#N/A	#N/A
E3M10000041D06	934	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000041D08	935	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000041D09	936	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000041D10	937	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000041D11	938	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000041D12	939	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000041E02	940	EFA101797	4963	EFA1c0045_orf_167p	10924
E3M10000041E03	941	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000041E05	942	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000041E07	943	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000041E10	944	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000041E11	945	EFA100190	4867	EFA1c0010_orf_2p	10480
E3M10000041F03	946	EFA102503	4996	EFA1c0032_orf_32p	10643
E3M10000041F05	947	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000041F06	948	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000041F07	949	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000041F08	950	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000041F09	951	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000041F10	952	EFA101079	4908	#N/A	#N/A
E3M10000041F10	952	EFA101080	4909	#N/A	#N/A
E3M10000041F11	953	EFA101160	4917	EFA1c0022_orf_3p	10549
E3M10000041G02	954	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000041G03	955	EFA102253	4984	EFA1c0038_orf_85p	10727
E3M10000041G04	956	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000041G06	957	EFA100978	4904	EFA1c0022_orf_27p	10541
E3M10000041G07	958	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000041G08	959	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000041G09	960	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000041G10	961	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000041G12	962	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000041H04	963	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000041H05	964	EFA100329	4875	EFA1c0041_orf_35p	10782
E3M10000041H06	965	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000041H07	966	EFA103062	5019	EFA1c0030_orf_19p	10615
E3M10000041H08	967	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000041H09	968	EFA102788	5011	EFA1c0033_orf_41p	10661
E3M10000041H10	969	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000041H11	970	EFA102253	4984	EFA1c0038_orf_85p	10727
E3M10000042A03	971	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000042A03	971	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000042A08	972	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000042A10	973	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000042B01	974	EFA101404	4933	EFA1c0033_orf_55p	10663
E3M10000042B02	975	EFA100668	4885	EFA1c0035_orf_58p	10679
E3M10000042B04	976	EFA102186	4981	EFA1c0045_orf_94p	10949
E3M10000042B04	976	EFA102453	4993	EFA1c0045_orf_203p	10931
E3M10000042B08	977	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000042B09	978	EFA101797	4963	EFA1c0045_orf_167p	10924
E3M10000042B10	979	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000042B11	980	EFA101165	4922	EFA1c0022_orf_8p	10559
E3M10000042C02	981	EFA101150	4915	EFA1c0038_orf_57p	10719
E3M10000042C03	982	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000042C04	983	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000042C10	984	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000042C10	984	EFA100295	4873	EFA1c0021_orf_15p	10517
E3M10000042D01	985	EFA100615	4881	EFA1c0016_orf_29p	10501
E3M10000042D02	986	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000042D03	987	EFA100394	4876	EFA1c0034_orf_6p	10675
E3M10000042D06	988	EFA102091	4977	EFA1c0010_orf_3p	10481
E3M10000042D09	989	EFA101141	4914	EFA1c0030_orf_18p	10614
E3M10000042D11	990	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000042D12	991	EFA100795	4896	EFA1c0043_orf_229p	10863
E3M10000042E05	992	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000042E12	993	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000042F11	994	EFA101792	4961	EFA1c0042_orf_113p	10805
E3M10000042G01	995	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000042G05	996	EFA101685	4952	EFA1c0041_orf_55p	10791
E3M10000042G07	997	EFA101169	4923	EFA1c0024_orf_38p	10574
E3M10000042G08	998	EFA102780	5010	EFA1c0045_orf_101p	10908
E3M10000042G11	999	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000042G11	999	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000042G12	1000	EFA102501	4994	EFA1c0031_orf_35p	10626
E3M10000042H06	1001	EFA101799	4964	EFA1c0045_orf_169p	10926
E3M10000042H08	1002	EFA101120	4911	EFA1c0036_orf_113p	10687
E3M10000042H11	1003	EFA100668	4885	EFA1c0035_orf_58p	10679
E3M10000043A02	1004	EFA101799	4964	EFA1c0045_orf_169p	10926
E3M10000043A03	1005	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000043A05	1006	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000043A08	1007	EFA100689	4886	EFA1c0038_orf_54p	10717
E3M10000043A09	1008	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000043A09	1008	EFA101415	4940	EFA1c0022_orf_16p	10529
E3M10000043A10	1009	EFA101080	4909	#N/A	#N/A
E3M10000043A11	1010	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000043B01	1011	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000043B02	1012	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000043B03	1013	EFA103038	5017	EFA1c0030_orf_17p	10613
E3M10000043B06	1014	EFA101404	4933	EFA1c0033_orf_55p	10663
E3M10000043B08	1015	EFA101123	4913	EFA1c0040_orf_22p	10748
E3M10000043B09	1016	EFA101892	4969	EFA1c0017_orf_21p	10506
E3M10000043B10	1017	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000043B11	1018	EFA100704	4887	EFA1c0010_orf_4p	10482
E3M10000043B12	1019	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000043C01	1020	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000043C08	1021	EFA101412	4937	EFA1c0022_orf_14p	10527
E3M10000043C09	1022	EFA100151	4864	EFA1c0021_orf_14p	10516
E3M10000043D01	1023	EFA101417	4942	EFA1c0022_orf_18p	10531
E3M10000043D02	1024	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000043D09	1025	EFA102351	4989	EFA1c0032_orf_20p	10634
E3M10000043D10	1026	EFA101872	4967	EFA1c0042_orf_152p	10815
E3M10000043D10	1026	EFA101873	4968	EFA1c0042_orf_153p	10816
E3M10000043D12	1027	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000043E03	1028	EFA100397	4877	EFA1c0041_orf_148p	10773
E3M10000043E07	1029	EFA101339	4928	EFA1c0040_orf_13p	10743
E3M10000043E08	1030	EFA101872	4967	EFA1c0042_orf_152p	10815
E3M10000043E08	1030	EFA101873	4968	EFA1c0042_orf_153p	10816
E3M10000043E10	1031	EFA102656	5004	EFA1c0039_orf_26p	10734
E3M10000043E11	1032	EFA102813	5013	EFA1c0043_orf_9p	10878
E3M10000043F03	1033	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000043F04	1034	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000043F06	1035	EFA100615	4881	EFA1c0016_orf_29p	10501
E3M10000043F08	1036	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000043F10	1037	EFA101159	4916	EFA1c0022_orf_2p	10543
E3M10000043F12	1038	EFA101080	4909	#N/A	#N/A
E3M10000043G03	1039	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000043G04	1040	EFA102502	4995	EFA1c0031_orf_36p	10627
E3M10000043G05	1041	EFA101686	4953	EFA1c0045_orf_63p	10940
E3M10000043G07	1042	EFA100157	4865	EFA1c0034_orf_63p	10673
E3M10000043G08	1043	EFA101080	4909	#N/A	#N/A
E3M10000043G10	1044	EFA101792	4961	EFA1c0042_orf_113p	10805
E3M10000043G11	1045	EFA101080	4909	#N/A	#N/A
E3M10000043G12	1046	EFA101121	4912	EFA1c0036_orf_112p	10686
E3M10000043H02	1047	EFA101414	4939	EFA1c0022_orf_15p	10528
E3M10000043H05	1048	EFA101080	4909	#N/A	#N/A
E3M10000043H08	1049	EFA100615	4881	EFA1c0016_orf_29p	10501
E3M10000043H09	1050	EFA102006	4973	EFA1c0025_orf_17p	10580
E3M10000043H11	1051	EFA102655	5003	EFA1c0039_orf_25p	10733
E3M10000044C02	1052	EFA100955	4902	EFA1c0022_orf_28p	10542
E3M10000044E01	1053	EFA102091	4977	EFA1c0010_orf_3p	10481
K1M10000002F02	1054	KPN101750	5037	KPN1c1723_orf_1p	11652
K1M10000003C01	1055	KPN103882	5040	KPN1c2848_orf_1p	11716
K1M10000007F01	1057	KPN104183	5041	KPN1c1646_orf_2p	11650
K1M10000007F01	1057	KPN106659	5049	KPN1c1646_orf_1p	11649
K1M10000008C02	1058	KPN107626	5051	#N/A	#N/A
K1M10000008C10	1059	KPN101729	5036	KPN1c1566_orf_1p	11647
K1M10000008G10	1060	KPN106840	5050	KPN1c2087_orf_1p	11664
K1M10000009D04	1061	KPN107776	5052	KPN1c4041_orf_1p	11771
K1M10000013E04	1062	KPN105779	5047	KPN1c4012_orf_1p	11770
K1M10000020B02	1065	KPN101729	5036	KPN1c1566_orf_1p	11647
K1M10000022C10	1067	KPN100854	5033	KPN1c0845_orf_1p	11630
K1M10000030C07	1070	KPN104716	5045	KPN1c3094_orf_5p	11757
K1M10000030E07	1071	KPN104538	5044	KPN1c2918_orf_2p	11726
K1M10000032E11	1073	KPN101729	5036	KPN1c1566_orf_1p	11647
K1M10000033B02	1074	KPN101729	5036	KPN1c1566_orf_1p	11647
K1M10000033E01	1075	KPN100432	5032	KPN1c0331_orf_1p	11628
K1M10000036G08	1076	KPN106044	5048	#N/A	#N/A
K1M10000037D10	1077	KPN104281	5042	KPN1c3000_orf_3p	11742
K1M10000038H09	1078	KPN102057	5038	KPN1c1958_orf_1p	11661
K1M10000039H03	1079	KPN106840	5050	KPN1c2087_orf_1p	11664
K1M10000043D05	1081	KPN102638	5039	KPN1c2127_orf_1p	11667
K1M10000043H10	1082	KPN105722	5046	#N/A	#N/A
K1M10000044D08	1084	KPN104430	5043	#N/A	#N/A
K1M10000044G05	1086	KPN101026	5035	KPN1c0875_orf_1p	11631
K1M10000045A07	1087	KPN101022	5034	KPN1c1316_orf_3p	11642
K1M10000045D10	1088	KPN102638	5039	KPN1c2127_orf_1p	11667
P1M10000008C06	1092	PA2424	5107	#N/A	#N/A
P1M10000008G04	1093	PA0337	5060	#N/A	#N/A
P1M10000010C03	1094	PA4997	5202	#N/A	#N/A
P1M10000014H10	1095	PA4252	5168	#N/A	#N/A
P1M10000014H10	1095	PA4253	5169	#N/A	#N/A
P1M10000015C06	1096	PA0413	5064	#N/A	#N/A
P1M10000015C06	1096	PA0414	5065	#N/A	#N/A
P1M10000015C09	1097	PA3041	5124	#N/A	#N/A
P1M10000016C04	1098	PA2680	5117	#N/A	#N/A
P1M10000018B01	1099	PA4264	5177	#N/A	#N/A
P1M10000018C01	1100	PA4264	5177	#N/A	#N/A
P1M10000018E01	1101	PA4067	5151	#N/A	#N/A
P1M10000018G01	1102	PA4067	5151	#N/A	#N/A
P1M10000019F01	1103	PA4271	5180	#N/A	#N/A
P1M10000019F01	1103	PA4272	5181	#N/A	#N/A
P1M10000021G03	1104	PA4264	5177	#N/A	#N/A
P1M10000021G05	1105	PA4251	5167	#N/A	#N/A
P1M10000022D09	1106	PA5299	5211	#N/A	#N/A
P1M10000024D06	1107	PA3160	5130	#N/A	#N/A
P1M10000024E06	1108	PA4888	5200	#N/A	#N/A
P1M10000024H03	1109	PA2313	5105	#N/A	#N/A
P1M10000025A06	1110	PA2222	5104	#N/A	#N/A
P1M10000025G07	1111	PA3153	5128	#N/A	#N/A
P1M10000025H07	1112	PA3153	5128	#N/A	#N/A
P1M10000025H07	1112	PA3154	5129	#N/A	#N/A
P1M10000026E06	1113	PA0715	5074	#N/A	#N/A
P1M10000026F04	1114	PA2222	5104	#N/A	#N/A
P1M10000026G09	1115	PA3011	5122	#N/A	#N/A
P1M10000026H02	1116	PA3013	5123	#N/A	#N/A
P1M10000026H05	1117	PA3154	5129	#N/A	#N/A
P1M10000027A06	1118	PA4257	5172	#N/A	#N/A
P1M10000027B02	1119	PA3154	5129	#N/A	#N/A
P1M10000027G05	1120	PA2313	5105	#N/A	#N/A
P1M10000028A08	1121	PA0788	5075	#N/A	#N/A
P1M10000028B01	1122	PA4263	5176	#N/A	#N/A
P1M10000028E02	1123	PA2584	5112	#N/A	#N/A
P1M10000029A09	1124	PA3154	5129	#N/A	#N/A
P1M10000029G03	1125	PA1301	5083	#N/A	#N/A
P1M10000029H05	1126	PA0353	5061	#N/A	#N/A
P1M10000032F04	1127	PA0265	5058	#N/A	#N/A
P1M10000033A02	1128	PA3068	5126	#N/A	#N/A
P1M10000033B08	1129	PA4244	5160	#N/A	#N/A
P1M10000033E03	1130	PA3984	5147	#N/A	#N/A
P1M10000033F01	1131	PA1986	5095	#N/A	#N/A
P1M10000033G08	1132	PA2009	5096	#N/A	#N/A
P1M10000035A06	1133	PA4249	5165	#N/A	#N/A
P1M10000037B12	1134	PA4254	5170	#N/A	#N/A
P1M10000037G12	1135	PA5076	5204	#N/A	#N/A
P1M10000038B08	1136	PA4070	5152	#N/A	#N/A
P1M10000038C03	1137	PA3931	5146	#N/A	#N/A
P1M10000038C06	1138	PA2197	5103	#N/A	#N/A
P1M10000038F04	1139	PA5207	5208	#N/A	#N/A
P1M10000038G02	1140	PA4542	5192	#N/A	#N/A
P1M10000039G05	1141	PA3764	5141	#N/A	#N/A
P1M10000039G12	1142	PA5567	5220	#N/A	#N/A
P1M10000040C01	1143	PA4105	5154	#N/A	#N/A
P1M10000040C04	1144	PA1115	5081	#N/A	#N/A
P1M10000040D04	1145	PA0378	5062	#N/A	#N/A
P1M10000040D05	1146	PA5209	5209	#N/A	#N/A
P1M10000040E10	1147	PA2128	5100	#N/A	#N/A
P1M10000040H03	1148	PA1115	5081	#N/A	#N/A
P1M10000041A12	1149	PA4254	5170	#N/A	#N/A
P1M10000041B02	1150	PA2128	5100	#N/A	#N/A
P1M10000041E01	1151	PA2398	5106	#N/A	#N/A
P1M10000041F01	1152	PA4681	5196	#N/A	#N/A
P1M10000042B12	1153	PA0642	5072	#N/A	#N/A
P1M10000042E08	1154	PA4252	5168	#N/A	#N/A
P1M10000042E08	1154	PA4253	5169	#N/A	#N/A
P1M10000043A03	1155	PA3006	5121	#N/A	#N/A
P1M10000043D06	1156	PA3764	5141	#N/A	#N/A
P1M10000044F07	1157	PA4244	5160	#N/A	#N/A
P1M10000046B03	1158	PA1462	5087	#N/A	#N/A
P1M10000046C07	1159	PA2671	5116	#N/A	#N/A
P1M10000046C08	1160	PA0472	5069	#N/A	#N/A
P1M10000046C09	1161	PA3764	5141	#N/A	#N/A
P1M10000046G11	1162	PA1115	5081	#N/A	#N/A
P1M10000047B04	1163	PA3006	5121	#N/A	#N/A
P1M10000047E11	1164	PA2684	5118	#N/A	#N/A
P1M10000047F07	1165	PA4506	5190	#N/A	#N/A
P1M10000047G10	1166	PA4259	5174	#N/A	#N/A
P1M10000048A03	1167	PA4105	5154	#N/A	#N/A
P1M10000049E08	1168	PA4272	5181	#N/A	#N/A
P1M10000049G10	1169	PA4027	5149	#N/A	#N/A
P1M10000050G11	1170	PA4249	5165	#N/A	#N/A
P1M10000051D11	1171	PA1365	5085	#N/A	#N/A
P1M10000051F01	1172	PA1115	5081	#N/A	#N/A
P1M10000052C03	1173	PA0938	5078	#N/A	#N/A
P1M10000052C12	1174	PA5076	5204	#N/A	#N/A
P1M10000052E04	1175	PA1398	5086	#N/A	#N/A
P1M10000053B12	1176	PA5436	5215	#N/A	#N/A
P1M10000053C02	1177	PA0353	5061	#N/A	#N/A
P1M10000053E07	1178	PA4254	5170	#N/A	#N/A
P1M10000053F08	1179	PA1270	5082	#N/A	#N/A
P1M10000055A11	1180	PA5076	5204	#N/A	#N/A
P1M10000055C08	1181	PA1493	5088	#N/A	#N/A
P1M10000055E05	1182	PA5507	5219	#N/A	#N/A
P1M10000056C07	1183	PA1360	5084	#N/A	#N/A
P1M10000056F05	1184	PA4258	5173	#N/A	#N/A
P1M10000056F05	1184	PA4259	5174	#N/A	#N/A
P1M10000056F06	1185	PA2634	5114	#N/A	#N/A
P1M10000056G01	1186	PA5076	5204	#N/A	#N/A
P1M10000058B07	1187	PA5436	5215	#N/A	#N/A
P1M10000059B04	1188	PA4375	5186	#N/A	#N/A
P1M10000059B10	1189	PA4269	5179	#N/A	#N/A
P1M10000059B11	1190	PA0934	5077	#N/A	#N/A
P1M10000059D11	1191	PA4027	5149	#N/A	#N/A
P1M10000059H08	1192	PA4027	5149	#N/A	#N/A
P1M10000059H09	1193	PA4271	5180	#N/A	#N/A
P1M10000060E03	1194	PA0423	5067	#N/A	#N/A
P1M10000060H02	1195	PA0221	5057	#N/A	#N/A
P1M10000060H04	1196	PA4473	5189	#N/A	#N/A
P1M10000061B04	1197	PA2726	5119	#N/A	#N/A
P1M10000061E04	1198	PA4244	5160	#N/A	#N/A
P1M10000061F04	1199	PA3522	5136	#N/A	#N/A
P1M10000062A12	1200	PA4598	5194	#N/A	#N/A
P1M10000062C03	1201	PA0321	5059	#N/A	#N/A
P1M10000062C04	1202	PA4254	5170	#N/A	#N/A
P1M10000062C07	1203	PA4251	5167	#N/A	#N/A
P1M10000062C12	1204	PA5316	5212	#N/A	#N/A
P1M10000062D07	1205	PA4247	5163	#N/A	#N/A
P1M10000062D08	1206	PA0882	5076	#N/A	#N/A
P1M10000062E08	1207	PA4248	5164	#N/A	#N/A
P1M10000062E08	1207	PA4249	5165	#N/A	#N/A
P1M10000062F06	1208	PA0028	5053	#N/A	#N/A
P1M10000062G11	1209	PA4506	5190	#N/A	#N/A
P1M10000062H01	1210	PA3121	5127	#N/A	#N/A
P1M10000062H04	1211	PA4254	5170	#N/A	#N/A
P1M10000063F02	1212	PA2684	5118	#N/A	#N/A
P1M10000063G02	1213	PA4262	5175	#N/A	#N/A
P1M10000063H02	1214	PA4081	5153	#N/A	#N/A
P1M10000064A10	1215	PA4268	5178	#N/A	#N/A
P1M10000064C02	1216	PA0650	5073	#N/A	#N/A
P1M10000064C03	1217	PA5030	5203	#N/A	#N/A
P1M10000064D03	1218	PA0129	5055	#N/A	#N/A
P1M10000064E05	1219	PA4512	5191	#N/A	#N/A
P1M10000064G12	1220	PA2147	5101	#N/A	#N/A
P1M10000064H07	1221	PA1072	5080	#N/A	#N/A
P1M10000065A04	1222	PA3522	5136	#N/A	#N/A
P1M10000065B07	1223	PA4347	5184	#N/A	#N/A
P1M10000065C03	1224	PA4347	5184	#N/A	#N/A
P1M10000065C05	1225	PA0642	5072	#N/A	#N/A
P1M10000065D06	1226	PA4347	5184	#N/A	#N/A
P1M10000065F01	1227	PA2494	5111	#N/A	#N/A
P1M10000065G06	1228	PA0423	5067	#N/A	#N/A
P1M10000065H07	1229	PA1019	5079	#N/A	#N/A
P1M10000066A10	1230	PA4709	5197	#N/A	#N/A
P1M10000066A11	1231	PA2594	5113	#N/A	#N/A
P1M10000066F04	1232	PA4024	5148	#N/A	#N/A
P1M10000067A05	1233	PA3876	5144	#N/A	#N/A
P1M10000067A05	1233	PA3877	5145	#N/A	#N/A
P1M10000067A06	1234	PA0419	5066	#N/A	#N/A
P1M10000067A08	1235	PA0600	5071	#N/A	#N/A
P1M10000067C04	1236	PA3845	5142	#N/A	#N/A
P1M10000067C06	1237	PA4433	5188	#N/A	#N/A
P1M10000067D05	1238	PA3479	5134	#N/A	#N/A
P1M10000067F05	1239	PA3643	5137	#N/A	#N/A
P1M10000067G05	1240	PA5199	5207	#N/A	#N/A
P1M10000068A09	1241	PA0353	5061	#N/A	#N/A
P1M10000068D04	1242	PA5388	5213	#N/A	#N/A
P1M10000068F04	1243	PA4237	5158	#N/A	#N/A
P1M10000068F08	1244	PA5193	5206	#N/A	#N/A
P1M10000068G01	1245	PA3716	5140	#N/A	#N/A
P1M10000068H05	1246	PA4268	5178	#N/A	#N/A
P1M10000069D09	1247	PA4246	5162	#N/A	#N/A
P1M10000069G06	1248	PA4246	5162	#N/A	#N/A
P1M10000069H02	1249	PA4433	5188	#N/A	#N/A
P1M10000070A05	1250	PA2470	5109	#N/A	#N/A
P1M10000070B10	1251	PA5393	5214	#N/A	#N/A
P1M10000070C06	1252	PA4237	5158	#N/A	#N/A
P1M10000070D08	1253	PA4105	5154	#N/A	#N/A
P1M10000070E03	1254	PA4709	5197	#N/A	#N/A
P1M10000070G06	1255	PA3374	5133	#N/A	#N/A
P1M10000070G12	1256	PA3121	5127	#N/A	#N/A
P1M10000070H06	1257	PA3374	5133	#N/A	#N/A
P1M10000071A03	1258	PA4251	5167	#N/A	#N/A
P1M10000071C01	1259	PA4251	5167	#N/A	#N/A
P1M10000071E04	1260	PA3484	5135	#N/A	#N/A
P1M10000071F01	1261	PA0506	5070	#N/A	#N/A
P1M10000073A06	1262	PA4246	5162	#N/A	#N/A
P1M10000073B10	1263	PA5248	5210	#N/A	#N/A
P1M10000073D04	1264	PA1115	5081	#N/A	#N/A
P1M10000073D09	1265	PA1918	5094	#N/A	#N/A
P1M10000073G03	1266	PA5248	5210	#N/A	#N/A
P1M10000074B01	1267	PA4771	5199	#N/A	#N/A
P1M10000074B04	1268	PA1684	5091	#N/A	#N/A
P1M10000074E04	1269	PA0120	5054	#N/A	#N/A
P1M10000074E09	1270	PA3479	5134	#N/A	#N/A
P1M10000074F10	1271	PA1019	5079	#N/A	#N/A
P1M10000074G12	1272	PA4244	5160	#N/A	#N/A
P1M10000074G12	1272	PA4245	5161	#N/A	#N/A
P1M10000075A04	1273	PA3279	5131	#N/A	#N/A
P1M10000075A04	1273	PA3280	5132	#N/A	#N/A
P1M10000075B03	1274	PA4576	5193	#N/A	#N/A
P1M10000075F02	1275	PA4254	5170	#N/A	#N/A
P1M10000075G05	1276	PA3709	5139	#N/A	#N/A
P1M10000076D05	1277	PA1876	5093	#N/A	#N/A
P1M10000076D10	1278	PA1636	5090	#N/A	#N/A
P1M10000077A08	1279	PA3479	5134	#N/A	#N/A
P1M10000077C08	1280	PA1019	5079	#N/A	#N/A
P1M10000077E04	1281	PA3522	5136	#N/A	#N/A
P1M10000077H05	1282	PA4246	5162	#N/A	#N/A
P1M10000079A10	1283	PA4576	5193	#N/A	#N/A
P1M10000079B10	1284	PA4576	5193	#N/A	#N/A
P1M10000079C10	1285	PA4576	5193	#N/A	#N/A
P1M10000079D01	1286	PA1547	5089	#N/A	#N/A
P1M10000079D10	1287	PA5490	5217	#N/A	#N/A
P1M10000079F06	1288	PA3006	5121	#N/A	#N/A
P1M10000080B01	1289	PA3866	5143	#N/A	#N/A
P1M10000080B06	1290	PA4244	5160	#N/A	#N/A
P1M10000080B06	1290	PA4245	5161	#N/A	#N/A
P1M10000080C01	1291	PA0469	5068	#N/A	#N/A
P1M10000080C06	1292	PA4250	5166	#N/A	#N/A
P1M10000080E04	1293	PA4250	5166	#N/A	#N/A
P1M10000081D12	1294	PA3006	5121	#N/A	#N/A
P1M10000081G05	1295	PA4037	5150	#N/A	#N/A
P1M10000081H05	1296	PA4316	5182	#N/A	#N/A
P1M10000082A05	1297	PA0401	5063	#N/A	#N/A
P1M10000082B04	1298	PA3006	5121	#N/A	#N/A
P1M10000082C05	1299	PA4246	5162	#N/A	#N/A
P1M10000082D05	1300	PA4256	5171	#N/A	#N/A
P1M10000082E05	1301	PA4246	5162	#N/A	#N/A
P1M10000083A11	1302	PA3006	5121	#N/A	#N/A
P1M10000083B01	1303	PA4271	5180	#N/A	#N/A
P1M10000083B12	1304	PA4268	5178	#N/A	#N/A
P1M10000083C11	1305	PA4242	5159	#N/A	#N/A
P1M10000083C12	1306	PA3006	5121	#N/A	#N/A
P1M10000084A04	1307	PA4942	5201	#N/A	#N/A
P1M10000084D03	1308	PA3006	5121	#N/A	#N/A
P1M10000084E04	1309	PA5493	5218	#N/A	#N/A
P1M10000084B11	1310	PA2196	5102	#N/A	#N/A
P1M10000084F08	1311	PA4271	5180	#N/A	#N/A
P1M10000085D06	1312	PA3006	5121	#N/A	#N/A
P1M10000086A02	1313	PA4413	5187	#N/A	#N/A
P1M10000086B01	1314	PA4158	5157	#N/A	#N/A
P1M10000086D02	1315	PA2641	5115	#N/A	#N/A
P1M10000086E05	1316	PA3006	5121	#N/A	#N/A
P1M10000087A11	1317	PA4268	5178	#N/A	#N/A
P1M10000087C09	1318	PA2083	5097	#N/A	#N/A
P1M10000087E04	1319	PA4246	5162	#N/A	#N/A
P1M10000087F04	1320	PA0141	5056	#N/A	#N/A
P1M10000087F09	1321	PA4124	5155	#N/A	#N/A
P1M10000087F09	1321	PA4125	5156	#N/A	#N/A
P1M10000088A07	1322	PA2742	5120	#N/A	#N/A
P1M10000088D06	1323	PA2108	5099	#N/A	#N/A
P1M10000089C08	1324	PA3048	5125	#N/A	#N/A
P1M10000089D11	1325	PA4268	5178	#N/A	#N/A
P1M10000089G08	1326	PA2461	5108	#N/A	#N/A
P1M10000090B11	1327	PA3153	5128	#N/A	#N/A
P1M10000090F06	1328	PA2313	5105	#N/A	#N/A
P1M10000090F08	1329	PA4258	5173	#N/A	#N/A
P1M10000090F08	1329	PA4259	5174	#N/A	#N/A
P1M10000091D02	1330	PA3866	5143	#N/A	#N/A
P1M10000091E09	1331	PA5316	5212	#N/A	#N/A
P1M10000091G10	1332	PA2742	5120	#N/A	#N/A
P1M10000092B02	1333	PA2641	5115	#N/A	#N/A
P1M10000092B10	1334	PA4268	5178	#N/A	#N/A
P1M10000092D09	1335	PA2128	5100	#N/A	#N/A
P1M10000092E02	1336	PA4256	5171	#N/A	#N/A
P1M10000092F05	1337	PA0423	5067	#N/A	#N/A
P1M10000093A03	1338	PA5088	5205	#N/A	#N/A
P1M10000093B09	1339	PA3703	5138	#N/A	#N/A
P1M10000093C08	1340	PA1868	5092	#N/A	#N/A
P1M10000093E09	1341	PA4332	5183	#N/A	#N/A
P1M10000093F03	1342	PA2101	5098	#N/A	#N/A
P1M10000093H07	1343	PA4665	5195	#N/A	#N/A
P1M10000094F04	1344	PA4268	5178	#N/A	#N/A
P1M10000094H03	1345	PA4744	5198	#N/A	#N/A
P1M10000095C01	1346	PA2488	5110	#N/A	#N/A
P1M10000095C09	1347	PA5443	5216	#N/A	#N/A
P1M10000095E04	1348	PA4363	5185	#N/A	#N/A
P1M10000095G04	1349	PA4256	5171	#N/A	#N/A
P1M10000096E04	1350	PA0353	5061	#N/A	#N/A
P1M10000096E12	1351	PA4246	5162	#N/A	#N/A
S1M10000001A05	1354	SAU103232	5769	SAU1c0045_orf_341p	12697
S1M10000001A05	1354	SAU201508	5819	SAU2c0432_orf_19p	12947
S1M10000001A08	1355	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000001A09	1356	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000001A10	1357	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000001C06	1358	SAU102939	5747	#N/A	#N/A
S1M10000001D01	1359	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000001D02	1360	SAU100527	5285	SAU1c0037_orf_101p	12341
S1M10000001D02	1360	SAU100880	5346	SAU1c0037_orf_100p	12340
S1M10000001D06	1361	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000001D07	1362	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000001E02	1363	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000001E04	1364	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000001E04	1364	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000001E05	1365	SAU102939	5747	#N/A	#N/A
S1M10000001E09	1366	SAU201752	5832	SAU2c0436_orf_19p	12963
S1M10000001E10	1367	SAU103038	5757	#N/A	#N/A
S1M10000001E11	1368	SAU302513	5906	SAU3c1298_orf_1p	13085
S1M10000001F02	1369	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000001F04	1370	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000001F08	1371	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000001F09	1372	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000001F10	1373	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000001F11	1374	SAU102939	5747	#N/A	#N/A
S1M10000001G01	1375	SAU102939	5747	#N/A	#N/A
S1M10000001G07	1376	SAU102939	5747	#N/A	#N/A
S1M10000001G08	1377	SAU102939	5747	#N/A	#N/A
S1M10000001G10	1378	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000002A02	1379	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000002A09	1380	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000002A10	1381	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000002A10	1381	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000002A10	1381	SAU301148	5888	#N/A	#N/A
S1M10000002A12	1382	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000002A12	1382	SAU300455	5872	#N/A	#N/A
S1M10000002A12	1382	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000002B01	1383	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000002B03	1384	SAU101034	5371	SAU1c0044_orf_27p	12608
S1M10000002B04	1385	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000002B05	1386	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000002B06	1387	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000002B07	1388	SAU101389	5441	SAU1c0038_orf_54p	12387
S1M10000002B09	1389	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000002B09	1389	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000002B09	1389	SAU301148	5888	#N/A	#N/A
S1M10000002B11	1390	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000002C02	1391	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000002C02	1391	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000002C02	1391	SAU301148	5888	#N/A	#N/A
S1M10000002C09	1392	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000002C10	1393	SAU103077	5759	SAU1c0039_orf_44p	12408
S1M10000002C11	1394	SAU202267	5848	SAU2c0204_orf_2p	12727
S1M10000002C11	1394	SAU202781	5853	SAU2c0109_orf_2p	12718
S1M10000002C11	1394	SAU203001	5859	SAU2c0412_orf_15p	12894
S1M10000002C11	1394	SAU302698	5909	SAU3c1408_orf_2p	13114
S1M10000002C11	1394	SAU302699	5910	SAU3c1408_orf_3p	13115
S1M10000002C12	1395	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000002D01	1396	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000002D02	1397	SAU100741	5318	SAU1c0039_orf_48p	12409
S1M10000002D03	1398	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000002D05	1399	SAU202930	5856	SAU2c0396_orf_3p	12871
S1M10000002D07	1400	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000002D07	1400	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000002D08	1401	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000002D10	1402	SAU102939	5747	#N/A	#N/A
S1M10000002D12	1403	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000002E01	1404	SAU101616	5495	SAU1c0040_orf_32p	12432
S1M10000002E02	1405	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000002E07	1406	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000002E07	1406	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000002E07	1406	SAU301148	5888	#N/A	#N/A
S1M10000002E09	1407	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000002E11	1408	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000002E12	1409	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000002F01	1410	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000002F02	1411	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000002F04	1412	SAU102939	5747	#N/A	#N/A
S1M10000002F09	1413	SAU302513	5906	SAU3c1298_orf_1p	13085
S1M10000002F12	1414	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000002G01	1415	SAU102939	5747	#N/A	#N/A
S1M10000002G03	1416	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000002G05	1417	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000002G06	1418	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000002G07	1419	SAU103038	5757	#N/A	#N/A
S1M10000002G08	1420	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000002G09	1421	SAU102939	5747	#N/A	#N/A
S1M10000002G10	1422	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000002G11	1423	SAU102939	5747	#N/A	#N/A
S1M10000002G12	1424	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003A01	1425	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000003A01	1425	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000003A01	1425	SAU301148	5888	#N/A	#N/A
S1M10000003A02	1426	SAU101624	5497	SAU1c0040_orf_25p	12429
S1M10000003A03	1427	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000003A04	1428	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000003A06	1429	SAU101266	5408	SAU1c0042_orf_117p	12490
S1M10000003A07	1430	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003A08	1431	SAU102939	5747	#N/A	#N/A
S1M10000003A10	1432	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000003A11	1433	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000003B06	1434	SAU102007	5590	SAU1c0040_orf_108p	12428
S1M10000003B08	1435	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000003B09	1436	SAU100771	5325	SAU1c0043_orf_49p	12545
S1M10000003B12	1437	SAU302060	5905	SAU3c0879_orf_1p	13042
S1M10000003C06	1438	SAU102447	5672	SAU1c0045_orf_24p	12685
S1M10000003C07	1439	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000003C10	1440	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003C12	1441	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003D05	1442	SAU102939	5747	#N/A	#N/A
S1M10000003D06	1443	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000003D08	1444	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000003D10	1445	SAU102422	5666	SAU1c0030_orf_22p	12207
S1M10000003E07	1446	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000003E09	1447	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003E10	1448	SAU101674	5508	SAU1c0044_orf_226p	12594
S1M10000003E11	1449	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003F02	1450	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003F05	1451	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000003F06	1452	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000003F07	1453	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000003F08	1454	SAU102939	5747	#N/A	#N/A
S1M10000003F12	1455	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000003G03	1456	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000003G04	1457	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000003G04	1457	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000003G04	1457	SAU301148	5888	#N/A	#N/A
S1M10000003G08	1458	SAU102939	5747	#N/A	#N/A
S1M10000003G10	1459	SAU102939	5747	#N/A	#N/A
S1M10000004A04	1460	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000004A06	1461	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000004A07	1462	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000004A11	1463	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000004A12	1464	SAU102132	5605	SAU1c0027_orf_19p	12177
S1M10000004B03	1465	SAU102610	5714	SAU1c0041_orf_53p	12474
S1M10000004B04	1466	SAU102059	5597	SAU1c0034_orf_51p	1286
S1M10000004B06	1467	SAU102939	5747	#N/A	#N/A
S1M10000004B08	1468	SAU100272	5251	SAU1c0018_orf_7p	12141
S1M10000004B09	1469	SAU101476	5459	SAU1c0032_orf_69p	12254
S1M10000004B11	1470	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000004C01	1471	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000004C02	1472	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000004C02	1472	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000004C02	1472	SAU301148	5888	#N/A	#N/A
S1M10000004C03	1473	SAU102939	5747	#N/A	#N/A
S1M10000004C06	1474	SAU102883	5741	SAU1c0045_orf_38p	12702
S1M10000004C07	1475	SAU102939	5747	#N/A	#N/A
S1M10000004C08	1476	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000004C08	1476	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000004C09	1477	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000004C09	1477	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000004C09	1477	SAU301148	5888	#N/A	#N/A
S1M10000004C10	1478	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000004C10	1478	SAU101286	5413	SAU1c0034_orf_67p	12292
S1M10000004C10	1478	SAU302931	5913	SAU3c1507_orf_10p	13155
S1M10000004C12	1479	SAU102007	5590	SAU1c0040_orf_108p	12428
S1M10000004D01	1480	SAU101301	5416	SAU1c0044_orf_114p	12558
S1M10000004D01	1480	SAU101302	5417	SAU1c0044_orf_115p	12559
S1M10000004D03	1481	SAU102390	5657	SAU1c0033_orf_38p	12269
S1M10000004D03	1481	SAU201333	5810	SAU2c0418_orf_8p	12905
S1M10000004D04	1482	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000004D04	1482	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000004D06	1483	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000004D07	1484	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000004D07	1484	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000004D07	1484	SAU301148	5888	#N/A	#N/A
S1M10000004D08	1485	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000004D10	1486	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000004D12	1487	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000004D12	1487	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000004E03	1488	SAU101371	5435	SAU1c0033_orf_7p	12275
S1M10000004E04	1489	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000004E06	1490	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000004E07	1491	SAU101476	5459	SAU1c0032_orf_69p	12254
S1M10000004E11	1492	SAU102939	5747	#N/A	#N/A
S1M10000004E12	1493	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000004F01	1494	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000004F02	1495	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000004F06	1496	SAU201611	5825	SAU2c0440_orf_14p	12973
S1M10000004F07	1497	SAU102764	5734	SAU1c0044_orf_56p	12625
S1M10000004F08	1498	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000004F08	1498	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000004F09	1499	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000004F09	1499	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000004F09	1499	SAU301148	5888	#N/A	#N/A
S1M10000004F12	1500	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000004G01	1501	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000004G01	1501	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000004G01	1501	SAU301148	5888	#N/A	#N/A
S1M10000004G02	1502	SAU102939	5747	#N/A	#N/A
S1M10000004G03	1503	SAU102449	5674	SAU1c0045_orf_22p	12677
S1M10000004G05	1504	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000004G06	1505	SAU102939	5747	#N/A	#N/A
S1M10000004G07	1506	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000004G07	1506	SAU100965	5364	SAU1c0044_orf_57p	12642
S1M10000004G09	1507	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000004G12	1508	SAU100497	5280	SAU1c0018_orf_3p	12140
S1M10000005A01	1509	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000005A01	1509	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000005A01	1509	SAU301148	5888	#N/A	#N/A
S1M10000005A03	1510	SAU101090	5380	SAU1c0028_orf_8p	12191
S1M10000005A05	1511	SAU102939	5747	#N/A	#N/A
S1M10000005A06	1512	SAU102939	5747	#N/A	#N/A
S1M10000005A07	1513	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000005A08	1514	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000005A08	1514	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000005A08	1514	SAU301148	5888	#N/A	#N/A
S1M10000005A09	1515	SAU103038	5757	#N/A	#N/A
S1M10000005A10	1516	SAU101239	5402	SAU1c0044_orf_15p	12570
S1M10000005A10	1516	SAU101240	5403	SAU1c0044_orf_16p	12573
S1M10000005A11	1517	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000005B02	1518	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000005B04	1519	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000005B07	1520	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000005B07	1520	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000005B07	1520	SAU301148	5888	#N/A	#N/A
S1M10000005B08	1521	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000005B09	1522	SAU102422	5666	SAU1c0030_orf_22p	12207
S1M10000005B12	1523	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000005B12	1523	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000005C01	1524	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000005C01	1524	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000005C01	1524	SAU301148	5888	#N/A	#N/A
S1M10000005C05	1525	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000005C06	1526	SAU100885	5348	SAU1c0038_orf_38p	12376
S1M10000005C09	1527	SAU302513	5906	SAU3c1298_orf_1p	13085
S1M10000005C11	1528	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000005D01	1529	SAU103038	5757	#N/A	#N/A
S1M10000005D02	1530	SAU102007	5590	SAU1c0040_orf_108p	12428
S1M10000005D03	1531	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000005D04	1532	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000005D04	1532	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000005D05	1533	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000005D06	1534	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000005D06	1534	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000005D07	1535	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000005D08	1536	SAU101624	5497	SAU1c0040_orf_25p	12429
S1M10000005D09	1537	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000005D11	1538	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000005D12	1539	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000005E01	1540	SAU100542	5288	SAU1c0043_orf_210p	12532
S1M10000005E02	1541	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000005E05	1542	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000005E05	1542	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000005E05	1542	SAU301148	5888	#N/A	#N/A
S1M10000005E06	1543	SAU102939	5747	#N/A	#N/A
S1M10000005E07	1544	SAU102939	5747	#N/A	#N/A
S1M10000005E08	1545	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000005E08	1545	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000005E08	1545	SAU301148	5888	#N/A	#N/A
S1M10000005E10	1546	SAU102939	5747	#N/A	#N/A
S1M10000005E11	1547	SAU100381	5265	SAU1c0033_orf_9p	12276
S1M10000005E12	1548	SAU102939	5747	#N/A	#N/A
S1M10000005F02	1549	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000005F02	1549	SAU100965	5364	SAU1c0044_orf_87p	12642
S1M10000005F03	1550	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000005F03	1550	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000005F04	1551	SAU102044	5593	SAU1c0039_orf_65p	12414
S1M10000005F04	1551	SAU102046	5594	SAU1c0039_orf_66p	12415
S1M10000005F04	1551	SAU201961	5840	#N/A	#N/A
S1M10000006A03	1552	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006A03	1552	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006A03	1552	SAU301148	5888	#N/A	#N/A
S1M10000006A04	1553	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000006A05	1554	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000006A05	1554	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000006A07	1555	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000006A08	1556	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006A08	1556	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006A08	1556	SAU301148	5888	#N/A	#N/A
S1M10000006A10	1557	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006A10	1557	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006A10	1557	SAU301148	5888	#N/A	#N/A
S1M10000006A12	1558	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000006B02	1559	SAU100741	5318	SAU1c0039_orf_48p	12409
S1M10000006B03	1560	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000006B04	1561	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006B04	1561	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006B04	1561	SAU301148	5888	#N/A	#N/A
S1M10000006B07	1562	SAU102059	5597	SAU1c0034_orf_51p	1286
S1M10000006B10	1563	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000006B11	1564	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000006C02	1565	SAU102939	5747	#N/A	#N/A
S1M10000006C04	1566	SAU102287	5637	SAU1c0038_orf_7p	12398
S1M10000006C06	1567	SAU102486	5687	SAU1c0039_orf_93p	12420
S1M10000006C06	1567	SAU102487	5688	SAU1c0039_orf_92p	12419
S1M10000006C07	1568	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000006C08	1569	SAU102939	5747	#N/A	#N/A
S1M10000006C10	1570	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006C10	1570	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006C10	1570	SAU301148	5888	#N/A	#N/A
S1M10000006D03	1571	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000006D05	1572	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006D05	1572	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006D05	1572	SAU301148	5888	#N/A	#N/A
S1M10000006D06	1573	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006D06	1573	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006D06	1573	SAU301148	5888	#N/A	#N/A
S1M10000006D07	1574	SAU102936	5746	SAU1c0037_orf_57p	12356
S1M10000006D08	1575	SAU102939	5747	#N/A	#N/A
S1M10000006E02	1576	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006E02	1576	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006E02	1576	SAU301148	5888	#N/A	#N/A
S1M10000006E03	1577	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000006E04	1578	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000006E07	1579	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000006E07	1579	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000006E07	1579	SAU301148	5888	#N/A	#N/A
S1M10000006E08	1580	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000006F01	1581	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000006F02	1582	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000006F03	1583	SAU102294	5639	SAU1c0044_orf_288p	12610
S1M10000006F03	1583	SAU301080	5885	SAU3c1287_orf_1p	13083
S1M10000006F04	1584	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000006F06	1585	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000006G02	1586	SAU101833	5555	SAU1c0038_orf_34p	12373
S1M10000006G03	1587	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000006G05	1588	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000006G06	1589	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000006G07	1590	SAU101612	5493	SAU1c0044_orf_7p	12637
S1M10000006G07	1590	SAU202945	5857	SAU2c0394_orf_7p	12868
S1M10000006G09	1591	SAU102939	5747	#N/A	#N/A
S1M10000006G10	1592	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000006G11	1593	SAU101438	5450	SAU1c0038_orf_40p	12379
S1M10000007A02	1594	SAU102939	5747	#N/A	#N/A
S1M10000007A03	1595	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000007B02	1596	SAU102352	5650	SAU1c0040_orf_38p	12434
S1M10000007B02	1596	SAU202872	5854	SAU2c0393_orf_6p	12866
S1M10000007B11	1597	SAU101476	5459	SAU1c0032_orf_69p	12254
S1M10000007C02	1598	SAU102939	5747	#N/A	#N/A
S1M10000007C04	1599	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000007C05	1600	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000007C06	1601	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000007C07	1602	SAU101266	5408	SAU1c0042_orf_117p	12490
S1M10000007C08	1603	SAU101717	5513	SAU1c0016_orf_16p	12131
S1M10000007C09	1604	SAU102939	5747	4N/A	#N/A
S1M10000007D03	1605	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000007D03	1605	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000007D03	1605	SAU301148	5888	#N/A	#N/A
S1M10000007D06	1606	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000007D08	1607	SAU102939	5747	#N/A	#N/A
S1M10000007D10	1608	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000007D11	1609	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000007E04	1610	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000007E04	1610	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000007E04	1610	SAU301148	5888	#N/A	#N/A
S1M10000007E06	1611	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000007E07	1612	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000007F01	1613	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000007F02	1614	SAU101685	5512	SAU1c0023_orf_11p	12152
S1M10000007F04	1615	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000007F08	1616	SAU100794	5330	SAU1c0028_orf_53p	12189
S1M10000007F09	1617	SAU202930	5856	SAU2c0396_orf_3p	12871
S1M10000007F10	1618	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000007F11	1619	SAU102939	5747	#N/A	#N/A
S1M10000007F12	1620	SAU102939	5747	#N/A	#N/A
S1M10000007G02	1621	SAU101270	5410	SAU1c0037_orf_89p	12365
S1M10000007G03	1622	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000007G05	1623	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000007G07	1624	SAU102652	5725	SAU1c0045_orf_115p	12653
S1M10000007G08	1625	SAU103038	5757	#N/A	#N/A
S1M10000008A03	1626	SAU101476	5459	SAU1c0032_orf_69p	12254
S1M10000008A04	1627	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000008A05	1628	SAU102939	5747	#N/A	#N/A
S1M10000008A08	1629	SAU102905	5742	SAU1c0033_orf_45p	12273
S1M10000008A08	1629	SAU301869	5903	SAU3c1353_orf_1p	13093
S1M10000008A09	1630	SAU100741	5318	SAU1c0039_orf_48p	12409
S1M10000008A12	1631	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000008B03	1632	SAU103144	5761	SAU1c0045_orf_15p	12663
S1M10000008B04	1633	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000008B04	1633	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000008B04	1633	SAU301148	5888	#N/A	#N/A
S1M10000008B06	1634	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000008B08	1635	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000008B09	1636	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000008B10	1637	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000008C05	1638	SAU102939	5747	#N/A	#N/A
S1M10000008C06	1639	SAU102939	5747	#N/A	#N/A
S1M10000008C07	1640	SAU102939	5747	#N/A	#N/A
S1M10000008C08	1641	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000008C09	1642	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000008D05	1643	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000008D09	1644	SAU103038	5757	#N/A	#N/A
S1M10000008E05	1645	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000008E08	1646	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000008Eo9	1647	SAU101343	5425	SAU1c0044_orf_40p	12619
S1M10000008E10	1648	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000008F01	1649	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000008F01	1649	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000008F02	1650	SAU102007	5590	SAU1c0040_orf_108p	12428
S1M10000008F03	1651	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000008F06	1652	SAU100741	5318	SAU1c0039_orf_48p	12409
S1M10000008F08	1653	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000008F09	1654	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000008F09	1654	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000008F09	1654	SAU301148	5888	#N/A	#N/A
S1M10000008F10	1655	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000008F11	1656	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000008G02	1657	SAU201167	5803	SAU2c0407_orf_5p	12887
S1M10000008G03	1658	SAU101637	5500	SAU1c0029_orf_8p	12201
S1M10000008G05	1659	SAU102870	5738	SAU1c0026_orf_17p	12170
S1M10000009A02	1660	SAU101159	5387	SAU1c0036_orf_46p	12331
S1M10000009A04	1661	SAU102979	5750	SAU1c0043_orf_227p	12536
S1M10000009A07	1662	SAU101371	5435	SAU1c0033_orf_7p	12275
S1M10000009A08	1663	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000009A08	1663	SAU100659	5304	SAU1c0038_orf_60p	12390
S1M10000009A09	1664	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000009A10	1665	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000009A11	1666	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000009B01	1667	SAU201506	5818	SAU2c0432_orf_18p	12946
S1M10000009B02	1668	SAU101159	5387	SAU1c0036_orf_46p	12331
S1M10000009B03	1669	SAU201506	5818	SAU2c0432_orf_18p	12946
S1M10000009B04	1670	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000009B05	1671	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000009B06	1672	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000009B07	1673	SAU201952	5839	SAU2c0457_orf_10p	13020
S1M10000009B10	1674	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000009B10	1674	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000009B11	1675	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000009B12	1676	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000009C01	1677	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000009C01	1677	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000009C02	1678	SAU102418	5664	SAU1c0030_orf_18p	12205
S1M10000009C05	1679	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000009C06	1680	SAU102613	5715	SAU1c0041_orf_55p	12475
S1M10000009C07	1681	SAU102460	5678	SAU1c0026_orf_18p	12171
S1M10000009C08	1682	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000009C09	1683	SAU102129	5604	SAU1c0027_orf_17p	12176
S1M10000009C10	1684	SAU102336	5646	SAU1c0045_off_146p	12659
S1M10000009C11	1685	SAU102340	5647	SAU1c0045_orf_149p	12660
S1M10000009D01	1686	SAU102262	5627	SAU1c0032_orf_58p	12248
S1M10000009D02	1687	SAU100355	5263	SAU1c0023_orf_6p	12155
S1M10000009D03	1688	SAU102418	5664	SAU1c0030_orf_18p	12205
S1M10000009D04	1689	SAU102979	5750	SAU1c0043_orf_227p	12536
S1M10000009D05	1690	SAU100799	5331	SAU1c0045_orf_243p	12682
S1M10000009D07	1691	SAU200994	5802	SAU2c0428_orf_4p	12935
S1M10000009D09	1692	SAU101681	5510	SAU1c0044_orf_220p	12592
S1M10000009D09	1692	SAU101682	5511	SAU1c0044_orf_219p	12591
S1M10000009D11	1693	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000009D11	1693	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000009D11	1693	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000009E02	1694	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000009E02	1694	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000009E06	1695	SAU102059	5597	SAU1c0034_orf_51p	1286
S1M10000009E08	1696	SAU201539	5821	SAU2c0431_orf_15p	12943
S1M10000009E09	1697	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000009E11	1698	SAU101501	5541	#N/A	#N/A
S1M10000009E12	1699	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000009F01	1700	SAU101452	5455	SAU1c0045_orf_247p	12684
S1M10000009F02	1701	SAU101818	5553	SAU1c0038_orf_20p	12369
S1M10000009F03	1702	SAU101488	5463	SAU1c0025_orf_18p	12164
S1M10000009F05	1703	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000009F06	1704	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000009F07	1705	SAU102607	5712	SAU1c0041_orf_51p	12472
S1M10000009F07	1705	SAU102944	5749	SAU1c0041_orf_47p	12468
S1M10000009F09	1706	SAU202176	5846	SAU2c0412_orf_3p	12895
S1M10000009F09	1706	SAU302805	5911	SAU3c1458_orf_1p	13133
S1M10000009F10	1707	SAU102392	5658	SAU1c0033_orf_40p	12270
S1M10000009F10	1707	SAU201541	5822	SAU2c0431_orf_14p	12942
S1M10000009G02	1708	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000009G02	1708	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000009G03	1709	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000009G05	1710	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000009G06	1711	SAU102909	5743	SAU1c0036_orf_16p	12315
S1M10000009G07	1712	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000009G09	1713	SAU102693	5731	SAU1c0044_orf_58p	12627
S1M10000009G10	1714	SAU100646	5302	SAU1c0025_orf_5p	12168
S1M10000009G11	1715	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000009H01	1716	SAU201506	5818	SAU2c0432_orf_18p	12946
S1M10000009H02	1717	SAU102658	5726	SAU1c0045_orf_121p	12654
S1M10000009H03	1718	SAU201654	5829	SAU2c0442_orf_12p	12982
S1M10000009H05	1719	SAU100582	5292	SAU1c0042_orf_21p	12503
S1M10000009H05	1719	SAU102165	5610	SAU1c0041_orf_25p	12460
S1M10000009H05	1719	SAU201929	5838	SAU2c0451_orf_19p	13008
S1M10000009H07	1720	SAU102297	5640	SAU1c0045_orf_41p	12704
S1M10000009H09	1721	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000009H11	1722	SAU101801	5541	#N/A	#N/A
S1M10000011A02	1723	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000011A03	1724	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000011A04	1725	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000011A06	1726	SAU101574	5486	SAU1c0044_orf_213p	12588
S1M10000011A06	1726	SAU101575	5487	SAU1c0044_orf_214p	12589
S1M10000011B01	1727	SAU102881	5740	SAU1c0032_orf_4p	12242
S1M10000011B02	1728	SAU101541	5472	SAU1c0037_orf_128p	12344
S1M10000011B03	1729	SAU101849	5559	SAU1c0044_orf_148p	12567
S1M10000011B04	1730	SAU101574	5486	SAU1c0044_orf_213p	12588
S1M10000011B04	1730	SAU101575	5487	SAU1c0044_orf_214p	12589
S1M10000011B05	1731	SAU200934	5799	SAU2c0375_orf_9p	12842
S1M10000011C01	1732	SAU101447	5454	SAU1c0045_orf_244p	12683
S1M10000011C05	1733	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000011C05	1733	SAU202756	5852	SAU2c0470_orf_1p	13027
S1M10000011C06	1734	SAU102350	5649	SAU1c0040_orf_36p	12433
S1M10000011D01	1735	SAU101293	5414	SAU1c0044_orf_61p	12631
S1M10000011D02	1736	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000011D04	1737	SAU102280	5632	SAU1c0038_orf_3p	12378
S1M10000011D06	1738	SAU102942	5748	SAU1c0035_orf_103p	12296
S1M10000011E02	1739	SAU101966	5580	SAU1c0028_orf_41p	12186
S1M10000011E03	1740	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000011E04	1741	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000011F01	1742	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000011F03	1743	SAU102350	5649	SAU1c0040_orf_36p	12433
S1M10000011F04	1744	SAU101155	5385	SAU1c0036_orf_11p	12310
S1M10000011F06	1745	SAU101481	5460	SAU1c0015_orf_9p	12130
S1M10000011F06	1745	SAU101482	5461	SAU1c0015_orf_10p	12123
S1M10000011G01	1746	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000011G03	1747	SAU302626	5907	SAU3c1367_orf_3p	13105
S1M10000011G04	1748	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000011G05	1749	SAU102350	5649	SAU1c0040_orf_36p	12433
S1M10000011G06	1750	SAU102298	5641	SAU1c0045_orf_42p	12705
S1M10000011H01	1751	SAU201558	5823	SAU2c0434_orf_5p	12954
S1M10000011H03	1752	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000011H03	1752	SAU202756	5852	SAU2c0470_orf_1p	13027
S1M10000011H04	1753	SAU200934	5799	SAU2c0375_orf_9p	12842
S1M10000012A02	1754	SAU102533	5695	#N/A	#N/A
S1M10000012A02	1754	SAU102534	5696	#N/A	#N/A
S1M10000012A06	1755	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000012A08	1756	SAU101630	5498	SAU1c0039_orf_4p	12410
S1M10000012A08	1756	SAU300156	5867	SAU3c0609_orf_2p	13036
S1M10000012A09	1757	SAU102356	5652	SAU1c0040_orf_41p	12436
S1M10000012A10	1758	SAU101266	5408	SAU1c0042_orf_117p	12490
S1M10000012A11	1759	SAU100390	5267	#N/A	#N/A
S1M10000012A11	1759	SAU200028	5771	SAU2c0145_orf_1p	12721
S1M10000012B01	1760	SAU100751	5321	SAU1c0036_orf_59p	12335
S1M10000012B05	1761	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000012B06	1762	SAU102350	5649	SAU1c0040_orf_36p	12433
S1M10000012B07	1763	SAU101814	5551	SAU1c0032_orf_32p	12237
S1M10000012B07	1763	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000012B11	1764	SAU102551	5698	SAU1c0045_orf_206p	12672
S1M10000012C01	1765	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000012C03	1766	SAU100776	5327	SAU1c0041_orf_72p	12482
S1M10000012C04	1767	SAU100776	5327	SAU1c0041_orf_72p	12482
S1M10000012C05	1768	SAU201558	5823	SAU2c0434_orf_5p	12954
S1M10000012C06	1769	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000012C06	1769	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000012C11	1770	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000012C11	1770	SAU102881	5740	SAU1c0032_orf_4p	12242
S1M10000012C12	1771	SAU101781	5528	SAU1c0037_orf_43p	12353
S1M10000012D04	1772	SAU201952	5839	SAU2c0457_orf_10p	13020
S1M10000012D06	1773	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000012D07	1774	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000012D08	1775	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000012D09	1776	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000012D12	1777	SAU102620	5718	SAU1c0041_orf_62p	12479
S1M10000012D12	1777	SAU102621	5719	SAU1c0041_orf_63p	12480
S1M10000012D12	1777	SAU202006	5842	SAU2c0456_orf_20p	13018
S1M10000012E01	1778	SAU100733	5314	SAU1c0044_orf_254p	12602
S1M10000012E01	1778	SAU100734	5315	SAU1c0044_orf_255p	12603
S1M10000012E02	1779	SAU102485	5686	SAU1c0039_orf_95p	12421
S1M10000012E04	1780	SAU201486	5817	SAU2c0457_orf_34p	13023
S1M10000012E07	1781	SAU100390	5267	#N/A	#N/A
S1M10000012E07	1781	SAU200028	5771	SAU2c0145_orf_1p	12721
S1M10000012E08	1782	SAU101189	5392	SAU1c0033_orf_25p	12264
S1M10000012E12	1783	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000012E12	1783	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000012E12	1783	SAU301148	5888	#N/A	#N/A
S1M10000012F04	1784	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000012F07	1785	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000012F07	1785	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000012F08	1786	SAU101189	5392	SAU1c0033_orf_25p	12264
S1M10000012F09	1787	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000012F10	1788	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000012F11	1789	SAU101781	5528	SAU1c0037_orf_43p	12353
S1M10000012F12	1790	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000012F12	1790	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000012F12	1790	SAU301148	5888	#N/A	#N/A
S1M10000012G01	1791	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000012G02	1792	SAU301758	5900	SAU3c1508_orf_5p	13156
S1M10000012G03	1793	SAU201301	5809	SAU2c0416_orf_17p	12899
S1M10000012G06	1794	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000012G07	1795	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000012G07	1795	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000012G08	1796	SAU102593	5704	SAU1c0041_orf_39p	12463
S1M10000012G10	1797	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000012H05	1798	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000012H08	1799	SAU202186	5847	SAU2c0222_orf_1p	12731
S1M10000012H09	1800	SAU100227	5244	SAU1c0043_orf_188p	12525
S1M10000012H10	1801	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000012H10	1801	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000012H10	1801	SAU101751	5521	SAU1c0040_orf_86p	12448
S1M10000012H11	1802	SAU301118	5886	SAU3c1305_orf_3p	13086
S1M10000013A02	1803	SAU102674	5730	SAU1c0024_orf_12p	12156
S1M10000013A03	1804	SAU101006	5367	SAU1c0028_orf_59p	12190
S1M10000013A05	1805	SAU102450	5675	SAU1c0045_orf_21p	12675
S1M10000013A07	1806	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000013A08	1807	SAU101143	5383	SAU1c0042_orf_159p	12502
S1M10000013A09	1808	SAU101567	5481	SAU1c0022_orf_10p	12144
S1M10000013A09	1808	SAU200030	5772	SAU2c0282_orf_3p	12745
S1M10000013A10	1809	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000013A11	1810	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000013A12	1811	SAU100690	5309	#N/A	#N/A
S1M10000013B02	1812	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000013B03	1813	SAU201236	5808	SAU2c0409_orf_10p	12891
S1M10000013B04	1814	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000013B05	1815	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000013B06	1816	SAU100118	5229	SAU1c0015_orf_13p	12125
S1M10000013B07	1817	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000013B07	1817	SAU301148	5888	#N/A	#N/A
S1M10000013B09	1818	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000013B11	1819	SAU103042	5758	#N/A	#N/A
S1M10000013C03	1820	SAU101781	5528	SAU1c0037_orf_43p	12353
S1M10000013C05	1821	SAU101038	5372	SAU1c0043_orf_180p	12521
S1M10000013C07	1822	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000013C08	1823	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000013C09	1824	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000013C10	1825	SAU100736	5316	SAU1c0038_orf_64p	12391
S1M10000013C11	1826	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000013C12	1827	SAU103038	5757	#N/A	#N/A
S1M10000013D08	1828	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000013D09	1829	SAU102669	5728	SAU1c0024_orf_7p	12160
S1M10000013D09	1829	SAU302956	5915	SAU3c1513_orf_9p	13161
S1M10000013D11	1830	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000013E01	1831	SAU102674	5730	SAU1c0024_orf_12p	12156
S1M10000013E02	1832	SAU101184	5391	SAU1c0035_orf_80p	12305
S1M10000013E04	1833	SAU101802	5542	SAU1c0032_orf_22p	12227
S1M10000013E06	1834	SAU101833	5555	SAU1c0038_orf_34p	12373
S1M10000013E08	1835	SAU100831	5335	SAU1c0038_orf_93p	12403
S1M10000013E09	1836	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000013E10	1837	SAU101801	5541	#N/A	#N/A
S1M10000013F02	1838	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000013F03	1839	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000013F06	1840	SAU103038	5757	#N/A	#N/A
S1M10000013F07	1841	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000013F08	1842	SAU100961	5360	SAU1c0044_orf_83p	12638
S1M10000013F09	1843	SAU101398	5442	SAU1c0036_orf_33p	12324
S1M10000013F12	1844	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000013G01	1845	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000013G04	1846	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000013G05	1847	SAU102241	5617	SAU1c0043_orf_25p	12539
S1M10000013G05	1847	SAU102242	5618	SAU1c0043_orf_26p	12540
S1M10000013G06	1848	SAU102380	5654	SAU1c0033_orf_29p	12265
S1M10000013G07	1849	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000013G10	1850	SAU201539	5821	SAU2c0431_orf_15p	12943
S1M10000013G11	1851	SAU101890	5570	SAU1c0034_orf_29p	12280
S1M10000013G12	1852	SAU100843	5339	SAU1c0036_orf_40p	12328
S1M10000013H03	1853	SAU100690	5309	#N/A	#N/A
S1M10000013H04	1854	SAU102450	5675	SAU1c0045_orf_21p	12675
S1M10000013H05	1855	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000013H07	1856	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000013H09	1857	SAU100444	5275	SAU1c0038_orf_67p	12392
S1M10000013H09	1857	SAU200721	5791	SAU2c0339_orf_5p	12797
S1M10000013H10	1858	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000013H11	1859	SAU100690	5309	#N/A	#N/A
S1M10000014A02	1860	SAU200564	5784	SAU2c0324_orf_6p	12780
S1M10000014A03	1861	SAU101310	5418	SAU1c0044_orf_125p	12562
S1M10000014A05	1862	SAU101991	5582	SAU1c0040_orf_94p	12454
S1M10000014A07	1863	SAU101526	5470	SAU1c0027_orf_32p	12179
S1M10000014A08	1864	SAU103038	5757	#N/A	#N/A
S1M10000014A11	1865	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000014A12	1866	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000014B01	1867	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000014B02	1868	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000014B02	1868	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000014B03	1869	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000014B04	1870	SAU100778	5328	SAU1c0043_orf_140p	12514
S1M10000014B05	1871	SA1310476	5682	SAU1c0026_orf_33p	12175
S1M10000014B06	1872	SAU101199	5395	SAU1c0035_orf_62p	12302
S1M10000014B07	1873	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000014B08	1874	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000014B10	1875	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000014B11	1876	SAU102534	5696	#N/A	#N/A
S1M10000014B12	1877	SAU102534	5696	#N/A	#N/A
S1M10000014C01	1878	SAU101575	5487	SAU1c0044_orf_214p	12589
S1M10000014c05	1879	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000014C06	1880	SAU100305	5256	SAU1c0038_orf_77p	12397
S1M10000014C07	1881	SAU101801	5541	#N/A	#N/A
S1M10000014C09	1882	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000014C09	1882	SAU102881	5740	SAU1c0032_orf_4p	12242
S1M10000014C10	1883	SAU302901	5912	SAU3c1497_orf_8p	13146
S1M10000014C11	1884	SAU100514	5281	SAU1c0044_orf_57p	12626
S1M10000014C12	1885	SAU101814	5551	SAU1c0032_orf_32pf	12237
S1M10000014C12	1885	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000014D03	1886	SAU100885	5348	SAU1c0038_orf_38p	12376
S1M10000014D06	1887	SAU100305	5256	SAU1c0038_orf_77p	12397
S1M10000014D08	1888	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000014D09	1889	SAU100808	5332	SAU1c0037_orf_12p	12345
S1M10000014D10	1890	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000014E01	1891	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000014E01	1891	SAU101794	5535	#N/A	#N/A
S1M10000014E04	1892	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000014E05	1893	SAU101565	5480	SAU1c0022_orf_8p	12151
S1M10000014E07	1894	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000014E07	1894	SAU100659	5304	SAU1c0038_orf_60p	12390
S1M10000014E08	1895	SAU202176	5846	SAU2c0412_orf_3p	12895
S1M10000014E09	1896	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000014E09	1896	SAU300269	5869	#N/A	#N/A
S1M10000014E10	1897	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000014E12	1898	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000014E12	1898	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000014F02	1899	SAU100128	5231	#N/A	#N/A
S1M10000014F02	1899	SAU101549	5476	SAU1c0043_orf_64p	12549
S1M10000014F02	1899	SAU101576	5488	SAU1c0044_orf_105p	12554
S1M10000014F03	1900	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000014F03	1900	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000014F04	1901	SAU102449	5674	SAU1c0045_orf_22p	12677
S1M10000014F05	1902	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000014F08	1903	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000014F09	1904	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000014F09	1904	SAU300269	5869	#N/A	#N/A
S1M10000014F10	1905	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000014G02	1906	SAU102054	5596	SAU1c0039_orf_74p	12417
S1M10000014G04	1907	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000014G06	1908	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000014G07	1909	SAU201620	5827	#N/A	#N/A
S1M10000014G08	1910	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000014G12	1911	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000014H02	1912	SAU100242	5246	SAU1c0036_orf_5p	12336
S1M10000014H03	1913	SAU102264	5628	SAU1c0032_orf_60p	12250
S1M10000014H04	1914	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000014H05	1915	SAU102116	5602	SAU1c0027_orf_5p	12180
S1M10000014H06	1916	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000014H07	1917	SAU103038	5757	#N/A	#N/A
S1M10000014H08	1918	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000014H11	1919	SAU102534	5696	#N/A	#N/A
S1M10000015A02	1920	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000015A03	1921	SAU102388	5655	SAU1c0033_orf_35p	12267
S1M10000015A05	1922	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000015A06	1923	SAU101857	5560	SAU1c0044_orf_156p	12569
S1M10000015A09	1924	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000015A10	1925	SAU103038	5757	#N/A	#N/A
S1M10000015A11	1926	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000015A12	1927	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000015B02	1928	SAU102340	5647	SAU1c0045_orf_149p	12660
S1M10000015B05	1929	SAU103038	5757	#N/A	#N/A
S1M10000015B08	1930	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000015B08	1930	SAU101792	5533	SAU1c0032_orf_13p	12217
S1M10000015B09	1931	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000015B09	1931	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000015B09	1931	SAU302685	5908	SAU3c1403_orf_1p	13113
S1M10000015B10	1932	SAU102308	5642	SAU1c0045_orf_50p	12706
S1M10000015C01	1933	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000015C02	1934	SAU102340	5647	SAU1c0045_orf_149p	12660
S1M10000015C03	1935	SAU102390	5657	SAU1c0033_orf_38p	12269
S1M10000015C03	1935	SAU201333	5810	SAU2c0418_orf_8p	12905
S1M10000015C05	1936	SAU100690	5309	#N/A	#N/A
S1M10000015C06	1937	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000015C08	1938	SAU100133	5233	SAU1c0044_orf_170p	12574
S1M10000015C08	1938	SAU100323	5261	SAU1c0044_orf_171p	12575
S1M10000015C10	1939	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000015C12	1940	SAU100305	5256	SAU1c0038_orf_77p	12397
S1M10000015D02	1941	SAU100794	5330	SAU1c0028_orf_53p	12189
S1M10000015D03	1942	SAU102032	5591	SAU1c0029_orf_47p	12198
S1M10000015D04	1943	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000015D05	1944	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000015D06	1945	SAU100736	5316	SAU1c0038_orf_64p	12391
S1M10000015D12	1946	SAU101814	5551	SAU1c0032_orf_32p	12237
S1M10000015E02	1947	SAU102390	5657	SAU1c0033_orf_38p	12269
S1M10000015E02	1947	SAU201333	5810	SAU2c0418_orf_8p	12905
S1M10000015E03	1948	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000015E06	1949	SAU101320	5420	SAU1c0015_orf_16p	12128
S1M10000015E07	1950	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000015E09	1951	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000015E10	1952	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000015E11	1953	SAU102286	5636	SAU1c0038_orf_6p	12393
S1M10000015E11	1953	SAU102287	5637	SAU1c0038_orf_7p	12398
S1M10000015E12	1954	SAU102352	5650	SAU1c0040_orf_38p	12434
S1M10000015F01	1955	SAU100123	5230	SAU1c0043_orf_189p	12526
S1M10000015F01	1955	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000015F01	1955	SAU103159	5762	SAU1c0045_orf_204p	12670
S1M10000015F01	1955	SAU201827	5837	SAU2c0449_orf_21p	13002
S1M10000015F02	1956	SAU101561	5479	SAU1c0022_orf_4p	12149
S1M10000015F03	1957	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000015F04	1958	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000015F06	1959	SAU201385	5814	#N/A	#N/A
S1M10000015F07	1960	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000015F08	1961	SAU102102	5600	SAU1c0045_orf_340p	12696
S1M10000015F09	1962	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000015F09	1962	SAU101801	5541	#N/A	#N/A
S1M10000015F10	1963	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000015G01	1964	SAU102481	5685	SAU1c0039_orf_99p	12422
S1M10000015G02	1965	SAU200058	5773	SAU2c0134_orf_1p	12719
S1M10000015G02	1965	SAU200059	5774	SAU2c0134_orf_3p	12720
S1M10000015G03	1966	SAU101070	5376	SAU1c0034_orf_60p	12291
S1M10000015G04	1967	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000015G05	1968	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000015G06	1969	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000015G07	1970	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000015G08	1971	SAU101814	5551	SAU1c0032_orf_32p	12237
S1M10000015G09	1972	SAU102143	5607	SAU1c0041_orf_14p	12458
S1M10000015G09	1972	SAU102144	5608	SAU1c0041_orf_15p	12459
S1M10000015G10	1973	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000015G11	1974	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000015H04	1975	SAU101801	5541	#N/A	#N/A
S1M10000015H04	1975	SAU101802	5542	SAU1c0032_orf_22p	12227
S1M10000015H06	1976	SAU201385	5814	#N/A	#N/A
S1M10000016A03	1977	SAU101803	5543	SAU1c0032_orf_23p	1228
S1M10000016A03	1977	SAU101804	5544	#N/A	#N/A
S1M10000016A04	1978	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000016A04	1978	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000016A06	1979	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000016A07	1980	SAU100932	5356	SAU1c0044_orf_308p	12615
S1M10000016A09	1981	SAU101067	5375	SAU1c0034_orf_58p	12290
S1M10000016A09	1981	SAU300732	5877	SAU3c1116_orf_1p	13061
S1M10000016A10	1982	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000016A12	1983	SAU100522	5284	SAU1c0044_orf_249p	12599
S1M10000016B02	1984	SAU102449	5674	SAU1c0045_orf_22p	12677
S1M10000016B05	1985	SAU101320	5420	SAU1c0015_orf_16p	12128
S1M10000016B06	1986	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000016B06	1986	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000016B07	1987	SAU103077	5759	SAU1c0039_orf_44p	12408
S1M10000016B08	1988	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000016B09	1989	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000016B10	1990	SAU101006	5367	SAU1c0028_orf_59p	12190
S1M10000016B11	1991	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000016B12	1992	SAU101794	5535	#N/A	#N/A
S1M10000016B12	1992	SAU101795	5536	SAU1c0032_orf_15p	12219
S1M10000016C01	1993	SAU100845	5340	SAU1c0036_orf_41p	12329
S1M10000016C02	1994	SAU102049	5595	SAU1c0039_orf_68p	12416
S1M10000016C04	1995	SAU100921	5355	SAU1c0038_orf_76p	12396
S1M10000016C05	1996	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000016C06	1997	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000016C06	1997	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000016C06	1997	SAU301148	5888	#N/A	#N/A
S1M10000016C08	1998	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000016C09	1999	SAU102233	5616	SAU1c0043_orf_20p	12531
S1M10000016C10	2000	SAU201513	5820	SAU2c0432_orf_10p	12944
S1M10000016C10	2000	SAU203196	5861	SAU2c0432_orf_11p	12945
S1M10000016C11	2001	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000016C12	2002	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000016D01	2003	SAU102355	5651	SAU1c0040_orf_40p	12435
S1M10000016D02	2004	SAU200242	5777	SAU2c0250_orf_2p	12734
S1M10000016D04	2005	SAU100921	5355	SAU1c0038_orf_76p	12396
S1M10000016D05	2006	SAU100770	5324	#N/A	#N/A
S1M10000016D06	2007	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000016D08	2008	SAU101070	5376	SAU1c0034_orf_60p	12291
S1M10000016D09	2009	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000016D10	2010	SAU201513	5820	SAU2c0432_orf_10p	12944
S1M10000016D10	2010	SAU203196	5861	SAU2c0432_orf_11p	12945
S1M10000016D11	2011	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000016E04	2012	SAU101371	5435	SAU1c0033_orf_7p	12275
S1M10000016E05	2013	SAU101320	5420	SAU1c0015_orf_16p	12128
S1M10000016E06	2014	SAU102639	5724	#N/A	#N/A
S1M10000016E07	2015	SAU102636	5722	SAU1c0045_orf_101p	12650
S1MT0000016E07	2015	SAU102637	5723	SAU1c0045_orf_102p	12651
S1M10000016E08	2016	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000016E09	2017	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000016E10	2018	SAU102983	5751	SAU1c0045_orf_224p	12676
S1M10000016E11	2019	SAU102281	5633	SAU1c0038_orf_4p	12384
S1M10000016E12	2020	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000016F02	2021	SAU102113	5601	SAU1c0027_orf_2p	12178
S1M10000016F02	2021	SAU301223	5889	SAU3c1345_orf_3p	13090
S1M10000016F03	2022	SAU101864	5562	SAU1c0044_orf_163p	12572
S1M10000016F05	2023	SAU201168	5804	SAU2c0407_orf_8p	12889
S1M10000016F06	2024	SAU102407	5662	#N/A	#N/A
S1M10000016F08	2025	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000016F09	2026	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000016F11	2027	SAU102113	5601	SAU1c0027_orf_2p	12178
S1M10000016F11	2027	SAU301223	5889	SAU3c1345_orf_3p	13090
S1M10000016G01	2028	SAU102434	5669	SAU1c0045_orf_36p	12700
S1M10000016G03	2029	SAU101300	5415	SAU1c0044_orf_113p	12557
S1M10000016G03	2029	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000016G04	2030	SAU102450	5675	SAU1c0045_orf_21p	12675
S1M10000016G05	2031	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000016H03	2032	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000016H04	2033	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000016H08	2034	SAU101067	5375	SAU1c0034_orf_58p	12290
S1M10000016H08	2034	SAU300732	5877	SAU3c1116_orf_1p	13061
S1M10000016H10	2035	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000017A02	2036	SAU101866	5564	SAU1c0036_orf_21p	12319
S1M10000017A03	2037	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000017A03	2037	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000017A04	2038	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000017A08	2039	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000017A11	2040	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000017A12	2041	SAU301357	5893	SAU3c1394_orf_2p	13111
S1M10000017B02	2042	SAU102242	5618	SAU1c0043_orf_26p	12540
S1M10000017B05	2043	SAU302513	5906	SAU3c1298_orf_1p	13085
S1M10000017B07	2044	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000017B08	2045	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000017B09	2046	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000017B10	2047	SAU101754	5523	SAU1c0040_orf_84p	12446
S1M10000017B11	2048	SAU101754	5523	SAU1c0040_orf_84p	12446
S1M10000017B12	2049	SAU201375	5811	SAU2c0426_orf_4p	12926
S1M10000017C01	2050	SAU101224	5397	SAU1c0044_orf_98p	12647
S1M10000017C03	2051	SAU101910	5576	SAU1c0040_orf_76p	12440
S1M10000017C05	2052	SAU200657	5789	#N/A	#N/A
S1M10000017C08	2053	SAU101890	5570	SAU1c0034_orf_29p	12280
S1M10000017C09	2054	SAU101398	5442	SAU1c0036_orf_33p	12324
S1M10000017C10	2055	SAU102614	5716	SAU1c0041_orf_56p	12476
S1M10000017C10	2055	SAU102615	5717	SAU1c0041_orf_57p	12477
S1M10000017C11	2056	SAU101799	5539	SAU1c0032_orf_19p	12223
S1M10000017C11	2056	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000017C12	2057	SAU101782	5529	SAU1c0037_orf_44p	12354
S1M10000017C12	2057	SAU200994	5802	SAU2c0428_orf_4p	12935
S1M10000017D03	2058	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000017D09	2059	SAU101799	5539	SAU1c0032_orf_19p	12223
S1M10000017D09	2059	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000017D10	2060	SAU100633	5301	SAU1c0043_orf_147p	12515
S1M10000017E04	2061	SAU101801	5541	#N/A	#N/A
S1M10000017E05	2062	SAU102334	5645	SAU1c0045_orf_144p	12658
S1M10000017E08	2063	SAU101198	5394	SAU1c0035_orf_61p	12301
S1M10000017E11	2064	SAU102883	5741	SAU1c0045_orf_38p	12702
S1M10000017F01	2065	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000017F04	2066	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000017F04	2066	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000017F05	2067	SAU102541	5697	SAU1c0045_orf_195p	12668
S1M10000017F06	2068	SAU102356	5652	SAU1c0040_orf_41p	12436
S1M10000017F11	2069	SAU101463	5458	SAU1c0045_orf_232p	12679
S1M10000017G02	2070	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000017G05	2071	SAU102259	5624	SAU1c0032_orf_55p	12245
S1M10000017G06	2072	SAU200565	5785	SAU2c0324_orf_7p	12781
S1M10000018A03	2073	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000018A03	2073	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000018A04	2074	SAU102142	5606	SAU1c0041_orf_13p	12457
S1M10000018A05	2075	SAU100886	5349	SAU1c0018_orf_16p	12139
S1M10000018A05	2075	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000018A06	2076	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000018A08	2077	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000018A08	2077	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000018A09	2078	SAU102142	5606	SAU1c0041_orf_13p	12457
S1M10000018A10	2079	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000018A11	2080	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000018A11	2080	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000018B02	2081	SAU100886	5349	SAU1c0018_orf_16p	12139
S1M10000018B02	2081	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000018B03	2082	SAU101839	5556	SAU1c0042_orf_12p	12495
S1M10000018B05	2083	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000018B09	2084	SAU100836	5336	SAU1c0031_orf_13p	12212
S1M10000018B09	2084	SAU202731	5850	#N/A	#N/A
S1M10000018B10	2085	SAU100401	5268	SAU1c0044_orf_174p	12576
S1M10000018B10	2085	SAU300335	5870	#N/A	#N/A
S1M10000018B11	2086	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000018C01	2087	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000018C02	2088	SAU102447	5672	SAU1c0045_orf_24p	12685
S1M10000018C03	2089	SAU100778	5328	SAU1c0043_orf_140p	12514
S1M10000018C04	2090	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000018C05	2091	SAU103038	5757	#N/A	#N/A
S1M10000018C06	2092	SAU100684	5306	SAU1c0044_orf_68p	12632
S1M10000018C08	2093	SAU102256	5622	SAU1c0032_orf_52p	12243
S1M10000018C08	2093	SAU102257	5623	SAU1c0032_orf_53p	12244
S1M10000018C09	2094	SAU101065	5374	SAU1c0034_orf_56p	12289
S1M10000018C09	2094	SAU102068	5599	SAU1c0034_orf_55p	12288
S1M10000018C10	2095	SAU100112	5227	SAU1c0044_orf_70p	12634
S1M10000018C11	2096	SAU102663	5727	SAU1c0024_orf_2p	12158
S1M10000018C12	2097	SAU101948	5579	SAU1c0045_orf_69p	12709
S1M10000018D01	2098	SAU101452	5455	SAU1c0045_orf_247p	12684
S1M10000018D02	2099	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000018D02	2099	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000018D03	2100	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000018D04	2101	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000018D09	2102	SAU101067	5375	SAU1c0034_orf_58p	12290
S1M10000018D10	2103	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000018D11	2104	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000018D12	2105	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000018E01	2106	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000018E02	2107	SAU100265	5249	SAU1c0014_orf_11p	12122
S1M10000018E03	2108	SAU102420	5665	SAU1c0030_orf_20p	12206
S1M10000018E04	2109	SAU102035	5592	SAU1c0029_orf_50P	12199
S1M10000018E05	2110	SAU100596	5295	SAU1c0043_orf_63p	12548
S1M10000018E08	2111	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000018E09	2112	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000018E11	2113	SAU101799	5539	SAU1c0032_orf_19p	12223
S1M10000018E11	2113	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000018E12	2114	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000018F03	2115	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000018F04	2116	SAU102396	5660	SAU1c0033_orf_43p	12272
S1M10000018F04	2116	SAU301118	5886	SAU3c1305_orf_3p	13086
S1M10000018F07	2117	SAU102629	5720	SAU1c0041_orf_71p	12481
S1M10000018F09	2118	SAU101810	5549	SAU1c0032_orf_28p	12233
S1M10000018F09	2118	SAU300110	5865	SAU3c0533_orf_2p	13031
S1M10000018F10	2119	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000018F10	2119	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000018F12	2120	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000018G03	2121	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000018G05	2122	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000018G07	2123	SAU101727	5516	SAU1c0016_orf_6p	12133
S1M10000018G08	2124	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000018G08	2124	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000018G09	2125	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000018G09	2125	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000018G10	2126	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000018G10	2126	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000018G12	2127	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000018H01	2128	SAU101663	5506	SAU1c0033_orf_14p	12261
S1M10000018H02	2129	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000018H02	2129	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000018H07	2130	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000018H09	2131	SAU101622	5496	SAU1c0040_orf_27p	12430
S1M10000018H10	2132	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000019A02	2133	SAU103077	5759	SAU1c0039_orf_44p	12408
S1M10000019A03	2134	SAU102352	5650	SAU1c0400_orf_38p	12434
S1M10000019A05	2135	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000019A06	2136	SAU101311	5419	SAU1c0044_orf_126p	12563
S1M10000019A07	2137	SAU101727	5516	SAU1c0016_orf_6p	12133
S1M10000019A07	2137	SAU101728	5517	SAU1c0016_orf_5p	12132
S1M10000019A09	2138	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000019A11	2139	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000019A12	2140	SAU102693	5731	SAU1c0044_orf_58p	12627
S1M10000019A12	2140	SAU102694	5732	SAU1c0044_orf_59p	12628
S1M10000019B03	2141	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000019B04	2142	SAU100899	5351	SAU1c0034_orf_11p	12277
S1M10000019B04	2142	SAU100901	5352	SAU1c0034_orf_13p	12278
S1M10000019B07	2143	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000019B08	2144	SAU102422	5666	SAU1c0030_orf_22p	12207
S1M10000019B08	2144	SAU102423	5667	SAU1c0030_orf_23p	12208
S1M10000019B09	2145	SAU100182	5241	SAU1c0037_orf_82p	12362
S1M10000019B09	2145	SAU100251	5248	SAU1c0037_orf_83p	12363
S1M10000019B10	2146	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000019B11	2147	SAU100879	5345	SAU1c0041_orf_82p	12483
S1M10000019B12	2148	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000019C01	2149	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000019C04	2150	SAU103175	5764	SAU1c0045_orf_269p	12687
S1M10000019C04	2150	SAU301472	5897	SAU3c1431_orf_4p	13124
S1M10000019C05	2151	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000019C06	2152	SAU101790	5531	SAU1c0032_orf_11p	12215
S1M10000019C06	2152	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000019C07	2153	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000019C08	2154	SAU202126	5844	SAU2c0045_orf_1p	12714
S1M10000019C11	2155	SAU100301	5254	SAU1c0040_orf_91p	12452
S1M10000019C12	2156	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000019D01	2157	SAU102270	5631	SAU1c0032_orf_65p	12253
S1M10000019D02	2158	SAU101145	5384	SAU1c0035_orf_43p	12299
S1M10000019D04	2159	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000019D05	2160	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000019D06	2161	SAU102526	5692	SAU1c0045_orf_299p	12691
S1M10000019D07	2162	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000019D09	2163	SAU102639	5724	#N/A	#N/A
S1M10000019D12	2164	SAU101805	5545	SAU1c0032_orf_24p	12229
S1M10000019E01	2165	SAU100961	5360	SAU1c0044_orf_83p	12638
S1M10000019E01	2165	SAU100962	5361	SAU1c0044_orf_84p	12639
S1M10000019E02	2166	SAU101624	5497	SAU1c0040_orf_25p	12429
S1M10000019E07	2167	SAU102352	5650	SAU1c0040_orf_38p	12434
S1M10000019F01	2168	SAU102241	5617	SAU1c0043_orf_25p	12539
S1M10000019F05	2169	SAU101612	5493	SAU1c0044_orf_7p	12637
S1M10000019F05	2169	SAU202945	5857	SAU2c0394_orf_7p	12868
S1M10000019F06	2170	SAU101864	5562	SAU1c0044_orf_163p	12572
S1M10000019F08	2171	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000019F09	2172	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000019F11	2173	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000019G04	2174	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000019G07	2175	SAU100522	5284	SAU1c0044_orf_249p	12599
S1M10000019G09	2176	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000019G10	2177	SAU101235	5400	SAU1c0044_orf_11p	12561
S1M10000019G10	2177	SAU101236	5401	SAU1c0044_orf_12p	12564
S1M10000019G11	2178	SAU101802	5542	SAU1c0032_orf_22p	12227
S1M10000019H05	2179	SAU101802	5542	SAU1c0032_orf_22p	12227
S1M10000019H05	2179	SAU101803	5543	SAU1c0032_orf_23p	1228
S1M10000019H08	2180	SAU102449	5674	SAU1c0045_orf_22p	12677
S1M10000020A05	2181	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000020A06	2182	SAU101801	5541	#N/A	#N/A
S1M10000020A07	2183	SAU101567	5481	SAU1c0022_orf_10p	12144
S1M10000020A07	2183	SAU200030	5772	SAU2c0282_orf_3p	12745
S1M10000020A11	2184	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000020A12	2185	SAU101907	5574	SAU1c0040_orf_79p	12442
51M10000020B02	2186	SAU100475	5276	SAU1c0036_orf_61p	12337
S1M10000020B03	2187	SAU100059	5224	SAU1c0045_orf_10p	12652
S1M10000020B05	2188	SAU301133	5887	SAU3c1311_orf_3p	13087
S1M10000020B06	2189	SAU100747	5320	SAU1c0044_orf_235p	12597
S1M10000020B07	2190	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000020B09	2191	SAU101371	5435	SAU1c0033_orf_7p	12275
S1M10000020B12	2192	SAU102143	5607	SAU1c0041_orf_14p	12458
S1M10000020C09	2193	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000020C10	2194	SAU101799	5539	SAU1c0032_orf_19p	12223
S1M10000020C10	2194	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000020C11	2195	SAU101452	5455	SAU1c0045_orf_247p	12684
S1M10000020D03	2196	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000020D04	2197	SAU102481	5685	SAU1c0039_orf_99p	12422
S1M10000020D06	2198	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000020D07	2199	SAU100198	5243	SAU1c0009_orf_1p	12120
S1M10000020D08	2200	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000020D09	2201	SAU102939	5747	#N/A	#N/A
S1M10000020D12	2202	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000020E01	2203	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000020E03	2204	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000020E04	2205	SAU101805	5545	SAU1c0032_orf_24p	12229
S1M10000020E06	2206	SAU102162	5609	SAU1c0041_orf_27p	12462
S1M10000020E08	2207	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000020E11	2208	SAU101876	5567	SAU1c0025_orf_9p	12169
S1M10000020E12	2209	SAU200657	5789	#N/A	#N/A
S1M10000020F01	2210	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000020F05	2211	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000020F06	2212	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000020F06	2212	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000020F07	2213	SAU200731	5793	SAU2c0352_orf_2p	12808
S1M10000020F09	2214	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000020F11	2215	SAU101663	5506	SAU1c0033_orf_14p	12261
S1M10000020F11	2215	SAU101664	5507	SAU1c0033_orf_15p	12262
S1M10000020F12	2216	SAU100745	5319	SAU1c0044_orf_233p	12596
S1M10000020G01	2217	SAU102905	5742	SAU1c0033_orf_45p	12273
S1M10000020G05	2218	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000020G07	2219	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000020G08	2220	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000020G09	2221	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000020G10	2222	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000020G10	2222	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000020G11	2223	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000020G12	2224	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000020H01	2225	SAU202039	5843	SAU2c0452_orf_20p	13009
S1M10000020H02	2226	SAU101754	5523	SAU1c0040_orf_84p	12446
S1M10000020H04	2227	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000020H06	2228	SAU101541	5472	SAU1c0037_orf_128p	12344
S1M10000020H08	2229	SAU201558	5823	SAU2c0434_orf_5p	12954
S1M10000020H10	2230	SAU101754	5523	SAU1c0040_orf_84p	12446
S1M10000020H11	2231	SAU100053	5222	SAU1c0020_orf_1p	12143
S1M10000021A04	2232	SAU200752	5795	SAU2c0354_orf_5p	12809
S1M10000021A04	2232	SAU300975	5880	SAU3c1240_orf_3p	13075
S1M10000021A05	2233	SAU101408	5445	SAU1c0035_orf_93p	12308
S1M10000021A06	2234	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000021A07	2235	SAU100496	5279	SAU1c0041_orf_83p	12484
S1M10000021A07	2235	SAU301004	5882	SAU3c1255_orf_1p	13079
S1M10000021A08	2236	SAU101183	5390	SAU1c0035_orf_79p	12304
S1M10000021A09	2237	SAU102933	5744	SAU1c0039_orf_62p	12412
S1M10000021A09	2237	SAU201184	5805	SAU2c0351_orf_19p	12807
S1M10000021A10	2238	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000021B05	2239	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000021B05	2239	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000021B06	2240	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M1000001307	2241	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000021B10	2242	SAU101772	5526	SAU1c0037_orf_34p	12351
S1M10000021C04	2243	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000021C05	2244	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000021C07	2245	SAU202968	5858	SAU2c0407_orf_2p	12886
S1M10000021C08	2246	SAU102575	5700	SAU1c0044_orf_283p	12609
S1M10000021C10	2247	SAU101320	5420	SAU1c0015_orf_16p	12128
S1M10000021C11	2248	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000021C12	2249	SAU101726	5515	SAU1c0016_orf_7p	12134
S1M10000021D01	2250	SAU102503	5691	SAU1c0045_orf_274p	12690
S1M10000021D03	2251	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000021D03	2251	SAU101286	5413	SAU1c0034_orf_67p	12292
S1M10000021D04	2252	SAU100858	5341	SAU1c0038_orf_86p	12401
S1M10000021D04	2252	SAU100859	5342	SAU1c0038_orf_87p	12402
S1M10000021D06	2253	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000021D09	2254	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000021D10	2255	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000021E01	2256	SAU101655	5505	SAU1c0042_orf_125p	12494
S1M10000021E02	2257	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000021E02	2257	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000021E03	2258	SAU101857	5560	SAU1c0044_orf_156p	12569
S1M10000021E05	2259	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000021E06	2260	SAU102663	5727	SAU1c0024_orf_2p	12158
S1M10000021E09	2261	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000021E12	2262	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000021F02	2263	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000021F04	2264	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000021F04	2264	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000021F05	2265	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000021F06	2266	SAU101235	5400	SAU1c0044_orf_11p	12561
S1M10000021F07	2267	SAU101383	5438	SAU1c0022_orf_20p	12147
S1M10000021F09	2268	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000021F09	2268	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000021F11	2269	SAU101371	5435	SAU1c0033_orf_7p	12275
S1M10000021G01	2270	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000021G03	2271	SAU301357	5893	SAU3c1394_orf_2p	13111
S1M10000021G08	2272	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000021H04	2273	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000021H04	2273	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000021H05	2274	SAU300131	5866	SAU3c0560_orf_2p	13034
S1M10000021H07	2275	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000021H08	2276	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000021H11	2277	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000022A02	2278	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000022A02	2278	SAU301230	5890	SAU3c1347_orf_6p	13092
S1M10000022A03	2279	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000022A05	2280	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000022A08	2281	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000022A09	2282	SAU102939	5747	#N/A	#N/A
S1M10000022A12	2283	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000022B02	2284	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000022B02	2284	SAU301230	5890	SAU3c1347_orf_6p	13092
S1M10000022B03	2285	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000022B05	2286	SAU100920	5354	SAU1c0038_orf_75p	12395
S1M10000022B06	2287	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000022B08	2288	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000022B09	2289	SAU102939	5747	#N/A	#N/A
S1M10000022B10	2290	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000022B11	2291	SAU101726	5515	SAU1c0016_orf_7p	12134
S1M10000022B12	2292	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000022C02	2293	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000022C03	2294	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000022C04	2295	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000022C06	2296	SAU100246	5247	SAU1c0042_orf_130p	12496
S1M10000022C06	2296	SAU300998	5881	SAU3c1253_orf_3p	13077
S1M10000022C07	2297	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000022C08	2298	SAU100528	5286	SAU1c0042_orf_87p	12507
S1M10000022C08	2298	SAU103115	5760	SAU1c0042_orf_88p	12508
S1M10000022C11	2299	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000022D03	2300	SAU101805	5545	SAU1c0032_orf_24p	12229
S1M10000022D05	2301	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000022D06	2302	SAU100921	5355	SAU1c0038_orf_76p	12396
S1M10000022D07	2303	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000022D08	2304	SAU101189	5392	SAU1c0033_orf_25p	12264
S1M10000022D09	2305	SAU101726	5515	SAU1c0016_orf_7p	12134
S1M10000022D11	2306	SAU101447	5454	SAU1c0045_orf_244p	12683
S1M10000022E01	2307	SAU200601	5787	#N/A	#N/A
S1M10000022E03	2308	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000022E05	2309	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000022E09	2310	SAU101235	5400	SAU1c0044_orf_11p	12561
S1M10000022E09	2310	SAU101236	5401	SAU1c0044_orf_12p	12564
S1M10000022F04	2311	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000022F06	2312	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000022F07	2313	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000022F08	2314	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000022F11	2315	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000022G03	2316	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000022G04	2317	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000022G07	2318	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000022G08	2319	SAU100557	5291	SAU1c0044_orf_132p	12565
S1M10000022G12	2320	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000022H03	2321	SAU101006	5367	SAU1c0028_orf_59p	12190
S1M10000022H05	2322	SAU101814	5551	SAU1c0032_orf_32p	12237
S1M10000022H06	2323	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000022H07	2324	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000022H08	2325	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000022H11	2326	SAU101610	5492	SAU1c0044_orf_5p	12629
S1M10000023A05	2327	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000023A09	2328	SAU101340	5423	SAU1c0038_orf_82p	12400
S1M10000023A11	2329	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000023A12	2330	SAU101651	5502	SAU1c0042_orf_122p	12491
S1M10000023A12	2330	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000023B01	2331	SAU100886	5349	SAU1c0018_orf_16p	12139
S1M10000023B03	2332	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000023B03	2332	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000023B07	2333	SAU101857	5560	SAU1c0044_orf_156p	12569
S1M10000023B08	2334	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000023B08	2334	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000023B09	2335	SAU101340	5423	SAU1c0038_orf_82p	12400
S1M10000023B10	2336	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000023B11	2337	SAU102613	5715	SAU1c0041_orf_55p	12475
S1M10000023B12	2338	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000023B12	2338	SAU301148	5888	#N/A	#N/A
S1M10000023C02	2339	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000023C02	2339	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000023C10	2340	SAU102554	5699	SAU1c0045_orf_209p	12673
S1M10000023C11	2341	SAU102352	5650	SAU1c0040_orf_38p	12434
S1M10000023C12	2342	SAU100077	5226	SAU1c0043_orf_178p	12520
S1M10000023D01	2343	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000023D03	2344	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000023D04	2345	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000023D07	2346	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000023D08	2347	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000023D09	2348	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000023D10	2349	SAU100963	5362	SAU1c0044_orf_85p	12640
S1M10000023D12	2350	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000023E01	2351	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000023E04	2352	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000023E07	2353	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000023E10	2354	SAU203293	5862	SAU2c0441_orf_21p	12979
S1M10000023E11	2355	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000023F04	2356	SAU101736	5518	SAU1c0043_orf_166p	12519
S1M10000023F04	2356	SAU101737	5519	SAU1c0043_orf_165p	12518
S1M10000023F07	2357	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000023F08	2358	SAU102883	5741	SAU1c0045_orf_38p	12702
S1M10000023F10	2359	SAU102352	5650	SAU1c0040_orf_38p	12434
S1M10000023F11	2360	SAU100617	5300	SAU1c0035_orf_102p	12295
S1M10000023F12	2361	SAU102352	5650	SAU1c0040_orf_38p	12434
S1M10000023G02	2362	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000023G03	2363	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000023G06	2364	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000023G07	2365	SAU301054	5884	#N/A	#N/A
S1M10000023G08	2366	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000023G09	2367	SAU101968	5581	SAU1c0028_orf_43p	12187
S1M10000023G11	2368	SAU102613	5715	SAU1c0041_orf_55p	12475
S1M10000023H02	2369	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000023H06	2370	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000023H07	2371	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000023H09	2372	SAU101340	5423	SAU1c0038_orf_82p	12400
S1M10000023H10	2373	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000024A02	2374	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000024A04	2375	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000024A07	2376	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000024A08	2377	SAU101231	5399	SAU1c0035_orf_6p	12303
S1M10000024A11	2378	SAU103226	5768	SAU1c0045_orf_95p	12713
S1M10000024B05	2379	SAU102418	5664	SAU1c0030_orf_18p	12205
S1M10000024B06	2380	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000024B08	2381	SAU100601	5296	SAU1c0044_orf_313p	12616
S1M10000024B09	2382	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000024B10	2383	SAU101265	5407	#N/A	#N/A
S1M10000024C02	2384	SAU101197	5393	SAU1c0035_orf_60p	12300
S1M10000024C04	2385	SAU101862	5561	SAU1c0044_orf_161p	12571
S1M10000024C07	2386	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000024D02	2387	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000024D03	2388	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000024D10	2389	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000024D10	2389	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000024D11	2390	SAU101198	5394	SAU1c0035_orf_61p	12301
S1M10000024E03	2391	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000024E05	2392	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000024E05	2392	SAU101801	5541	#N/A	#N/A
S1M10000024E06	2393	SAU102418	5664	SAU1c0030_orf_18p	12205
S1M10000024E07	2394	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000024E08	2395	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000024F02	2396	SAU101447	5454	SAU1c0045_orf_244p	12683
S1M10000024F03	2397	SAU102992	5752	SAU1c0044_orf_60p	12630
S1M10000024F05	2398	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000024F08	2399	SAU101726	5515	SAU1c0016_orf_7p	12134
S1M10000024F10	2400	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000024G05	2401	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000024G05	2401	SAU101801	5541	#N/A	#N/A
S1M10000024G06	2402	SAU102418	5664	SAU1c0030_orf_18p	12205
S1M10000024G07	2403	SAU102334	5645	SAU1c0045_orf_144p	12658
S1M10000024G08	2404	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000024G10	2405	SAU202176	5846	SAU2c0412_orf_3p	12895
S1M10000024G12	2406	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000024H02	2407	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000024H04	2408	SAU100770	5324	#N/A	#N/A
S1M10000024H07	2409	SAU200725	5792	SAU2c0428_orf_20p	12933
S1M10000024H08	2410	SAU102002	5587	SAU1c0040_orf_103p	12425
S1M10000024H08	2410	SAU102003	5588	SAU1c0040_orf_104p	12426
S1M10000025A03	2411	SAU101247	5405	SAU1c0043_orf_136p	12512
S1M10000025A08	2412	SAU102766	5735	#N/A	#N/A
S1M10000025A08	2412	SAU201236	5808	SAU2c0409_orf_10p	12891
S1M10000025A08	2412	SAU300338	5871	#N/A	#N/A
S1M10000025A09	2413	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000025A10	2414	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000025A10	2414	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000025A10	2414	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000025B01	2415	SAU101655	5505	SAU1c0042_orf_125p	12494
S1M10000025B02	2416	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000025B03	2417	SAU101385	5439	SAU1c0038_orf_50p	12385
S1M10000025B05	2418	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000025B05	2418	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000025B05	2418	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000025B06	2419	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000025B09	2420	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000025B12	2421	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000025C01	2422	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000025C03	2423	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000025C05	2424	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000025C09	2425	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000025C09	2425	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000025C10	2426	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000025C11	2427	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000025D01	2428	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000025D03	2429	SAU101771	5525	SAU1c0037_orf_33p	12350
S1M10000025D03	2429	SAU101772	5526	SAU1c0037_orf_34p	12351
S1M10000025D04	2430	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000025D06	2431	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000025D08	2432	SAU102598	5705	SAU1c0041_orf_43p	12464
S1M10000025D08	2432	SAU102599	5706	SAU1c0041_orf_45p	12466
S1M10000025D08	2432	SAU103191	5765	SAU1c0041_orf_44p	12465
S1M10000025D09	2433	SAU100522	5284	SAU1c0044_orf_249p	12599
S1M10000025D10	2434	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000025D10	2434	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000025E01	2435	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000025E04	2436	SAU100389	5266	SAU1c0034_orf_14p	12279
S1M10000025E09	2437	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000025E11	2438	SAU102437	5670	SAU1c0045_orf_33p	12695
S1M10000025F03	2439	SAU102297	5640	SAU1c0045_orf_41p	12704
S1M10000025E05	2440	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000025F05	2440	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000025F08	2441	SAU200685	5790	SAU2c0344_orf_9p	12801
S1M10000025F09	2442	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000025F10	2443	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000025F12	2444	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000025F12	2444	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000025G04	2445	SAU300617	5874	SAU3c1046_orf_2p	13056
S1M10000025G06	2446	SAU300617	5874	SAU3c1046_orf_2p	13056
S1M10000025G10	2447	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000025H05	2448	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000025H06	2449	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000025H07	2450	SAU200752	5795	SAU2c0354_orf_5p	12809
S1M10000025H07	2450	SAU300975	5880	SAU3c1240_orf_3p	13075
S1M10000025H10	2451	SAU100590	5293	SAU1c0013_orf_5p	12121
S1M10000025H10	2451	SAU301268	5891	SAU3c1364_orf_2p	13102
S1M10000026A02	2452	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000026A04	2453	SAU102340	5647	SAU1c0045_orf_149p	12660
S1M10000026A05	2454	SAU200934	5799	SAU2c0375_orf_9p	12842
S1M10000026A06	2455	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000026A07	2456	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000026A08	2457	SAU100266	5250	SAU1c0032_orf_75p	12256
S1M10000026A09	2458	SAU102452	5676	SAU1c0045_orf_20p	12674
S1M10000026A09	2458	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000026A10	2459	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000026A11	2460	SAU102259	5624	SAU1c0032_orf_55p	12245
S1M10000026A11	2460	SAU102260	5625	SAU1c0032_orf_56p	12246
S1M10000026A11	2460	SAU102261	5626	SAU1c0032_orf_57p	12247
S1M10000026A11	2460	SAU300868	5879	#N/A	#N/A
S1M10000026B02	2461	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000026B03	2462	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000026B05	2463	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000026B06	2464	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000026B07	2465	SAU101341	5424	SAU1c0044_orf_38p	12618
S1M10000026B07	2465	SAU301275	5892	SAU3c1365_orf_2p	13103
S1M10000026B10	2466	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000026B11	2467	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000026B12	2468	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000026C01	2469	SAU100266	5250	SAU1c0032_orf_75p	12256
S1M10000026C06	2470	SAU101772	5526	SAU1c0037_orf_34p	12351
S1M10000026C07	2471	SAU101842	5557	SAU1c0042_orf_9p	12510
S1M10000026C08	2472	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000026C11	2473	SAU200657	5789	#N/A	#N/A
S1M10000026C12	2474	SAU101726	5515	SAU1c0016_orf_7p	12134
S1M10000026D04	2475	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000026D05	2476	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000026D06	2477	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000026D07	2478	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000026D08	2479	SAU100690	5309	#N/A	#N/A
S1M10000026D10	2480	SAU203296	5863	SAU2c0442_orf_18p	12983
S1M10000026D12	2481	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000026E01	2482	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000026E07	2483	SAU102939	5747	#N/A	#N/A
S1M10000026E09	2484	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000026E09	2484	SAU102002	5587	SAU1c0040_orf_103p	12425
S1M10000026E10	2485	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000026E11	2486	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000026E12	2487	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000026F01	2488	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000026F03	2489	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000026F03	2489	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000026F04	2490	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000026F05	2491	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000026F06	2492	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000026F07	2493	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000026F08	2494	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000026F09	2495	SAU102939	5747	#N/A	#N/A
S1M10000026F10	2496	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000026E11	2497	SAU102939	5747	#N/A	#N/A
S1M10000026F12	2498	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000026G01	2499	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000026G03	2500	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000026G04	2501	SAU100690	5309	#N/A	#N/A
S1M10000026G05	2502	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000026G06	2503	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000026G07	2504	SAU100886	5349	SAU1c0018_orf_16p	12139
S1M10000026G09	2505	SAU100542	5288	SAU1c0043_orf_210p	12532
S1M10000026G10	2506	SAU100613	5299	SAU1c0015_orf_14p	12126
S1M10000026G10	2506	SAU102812	5736	SAU1c0015_orf_15p	12127
S1M10000026G12	2507	SAU101551	5477	SAU1c0043_orf_67p	12550
S1M10000026H01	2508	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000026H02	2509	SAU102355	5651	SAU1c0040_orf_40p	12435
S1M10000026H03	2510	SAU101801	5541	#N/A	#N/A
S1M10000026H04	2511	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000026H04	2511	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000026H04	2511	SAU301148	5888	#N/A	#N/A
S1M10000026H05	2512	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000026H07	2513	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000026H07	2513	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000026H09	2514	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000026H09	2514	SAU301148	5888	#N/A	#N/A
S1M10000026H10	2515	SAU102479	5683	SAU1c0039_orf_101p	12405
S1M10000027A04	2516	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000027A05	2517	SAU101805	5545	SAU1c0032_orf_24p	12229
S1M10000027A08	2518	SAU101772	5526	SAU1c0037_orf_34p	12351
S1M10000027A11	2519	SAU101551	5477	SAU1c0043_orf_67p	12550
S1M10000027B04	2520	SAU102939	5747	#N/A	#N/A
S1M10000027B06	2521	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000027B07	2522	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000027B08	2523	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000027B09	2524	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000027B11	2525	SAU101265	5407	#N/A	#N/A
S1M10000027C02	2526	SAU101327	5421	SAU1c0044_orf_296p	12612
S1M10000027C04	2527	SAU201236	5808	SAU2c0409_orf_10p	12891
S1M10000027C05	2528	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000027C06	2529	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000027C08	2530	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000027C09	2531	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000027D02	2532	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000027D02	2532	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000027D03	2533	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000027D05	2534	SAU101554	5478	SAU1c0043_orf_70p	12551
S1M10000027D06	2535	SAU202708	5849	SAU2c0385_orf_1p	12855
S1M10000027D08	2536	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000027D09	2537	SAU203524	5864	SAU2c0435_orf_1p	12957
S1M10000027D10	2538	SAU102283	5634	SAU1c0006_orf_1p	12119
S1M10000027D11	2539	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000027E05	2540	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000027E05	2540	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000027E06	2541	SAU100690	5309	#N/A	#N/A
S1M10000027E07	2542	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000027E08	2543	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000027E09	2544	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000027E11	2545	SAU101551	5477	SAU1c0043_orf_67p	12550
S1M10000027F01	2546	SAU103038	5757	#N/A	4N/A
S1M10000027F02	2547	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000027F05	2548	SAU100882	5347	SAU1c0038_orf_35p	12374
S1M10000027F06	2549	SAU100690	5309	#N/A	#N/A
S1M10000027F08	2550	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000027F09	2551	SAU100858	5341	SAU1c0038_orf_86p	12401
S1M10000027G03	2552	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000027G04	2553	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000027G05	2554	SAU102526	5692	SAU1c0045_orf_299p	12691
S1M10000027G06	2555	SAU202708	5849	SAU2c0385_orf_1p	12855
S1M10000027G07	2556	SAU102265	5629	SAU1c0032_orf_61p	12251
S1M10000027G09	2557	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000027G11	2558	SAU102533	5695	#N/A	#N/A
S1M10000027G11	2558	SAU102534	5696	#N/A	#N/A
S1M10000027H02	2559	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000027H04	2560	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000027H05	2561	SAU102526	5692	SAU1c0045_orf_299p	12691
S1M10000027H06	2562	SAU100690	5309	#N/A	#N/A
S1M10000027H07	2563	SAU100542	5288	SAU1c0043_orf_210p	12532
S1M10000027H08	2564	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000027H09	2565	SAU101382	5437	SAU1c0022_orf_19p	12146
S1M10000027H10	2566	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000027H11	2567	SAU102533	5695	#N/A	#N/A
S1M10000027H11	2567	SAU102534	5696	#N/A	#N/A
S1M10000028A02	2568	SAU101085	5378	SAU1c0034_orf_42p	1284
S1M10000028A02	2568	SAU101086	5379	SAU1c0034_orf_43p	1285
S1M10000028A04	2569	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000028A06	2570	SAU100478	5277	SAU1c0044_orf_265p	12605
S1M10000028A06	2570	SAU100996	5366	SAU1c0044_orf_266p	12606
S1M10000028A08	2571	SAU102054	5596	SAU1c0039_orf_74p	12417
S1M10000028B01	2572	SAU101085	5378	SAU1c0034_orf_42p	12284
S1M10000028B01	2572	SAU101086	5379	SAU1c0034_orf_43p	12285
S1M10000028B02	2573	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000028B02	2573	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000028B03	2574	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000028B04	2575	SAU102764	5734	SAU1c0044_orf_56p	12625
S1M10000028B05	2576	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000028B06	2577	SAU201558	5823	SAU2c0434_orf_5p	12954
S1M10000028B08	2578	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000028B09	2579	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000028C02	2580	SAU203296	5863	SAU2c0442_orf_18p	12983
S1M10000028C04	2581	SAU101381	5436	SAU1c0022_orf_18p	12145
S1M10000028C05	2582	SAU100313	5259	SAU1c0045_orf_153p	12661
S1M10000028C05	2582	SAU100359	5264	SAU1c0032_orf_35p	12239
S1M10000028C05	2582	SAU200297	5778	SAU2c0274_orf_2p	12739
S1M10000028C06	2583	SAU103226	5768	SAU1c0045_orf_95p	12713
S1M10000028C08	2584	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000028D03	2585	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000028D04	2586	SAU101381	5436	SAU1c0022_orf_18p	12145
S1M10000028D06	2587	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000028D07	2588	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000028D08	2589	SAU100858	5341	SAU1c0038_orf_86p	12401
S1M10000028D09	2590	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000028E01	2591	SAU100062	5225	SAU1c0035_orf_98p	12309
S1M10000028E01	2591	SAU100231	5245	#N/A	#N/A
S1M10000028E03	2592	SAU100770	5324	#N/A	#N/A
S1M10000028E08	2593	SAU101865	5563	SAU1c0036_orf_20p	12318
S1M10000028F01	2594	SAU101085	5378	SAU1c0034_orf_42p	12284
S1M10000028F01	2594	SAU101086	5379	SAU1c0034_orf_43p	12285
S1M10000028F03	2595	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000028F04	2596	SAU100301	5254	SAU1c0040_orf_91p	12452
S1M10000028F04	2596	SAU100302	5255	SAU1c0040_orf_92p	12453
S1M10000028F05	2597	SAU100301	5254	SAU1c0040_orf_91p	12452
S1M10000028F05	2597	SAU100302	5255	SAU1c0040_orf_92p	12453
S1M10000028F06	2598	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000028F06	2598	SAU202756	5852	SAU2c0470_orf_1p	13027
S1M10000028F07	2599	SAU101006	5367	SAU1c0028_orf_59p	12190
S1M10000028G01	2600	SAU102554	5699	SAU1c0045_orf_209p	12673
S1M10000028G02	2601	SAU201236	5808	SAU2c0409_orf_10p	12891
S1M10000028G02	2601	SAU300338	5871	#N/A	#N/A
S1M10000028G03	2602	SAU101231	5399	SAU1c0035_orf_6p	12303
S1M10000028G04	2603	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000028G04	2603	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000028G05	2604	SAU100690	5309	#N/A	#N/A
S1M10000028G06	2605	SAU101865	5563	SAU1c0036_orf_20p	12318
S1M10000028G08	2606	SAU101341	5424	SAU1c0044_orf_38p	12618
S1M10000028G08	2606	SAU301275	5892	SAU3c1365_orf_2p	13103
S1M10000028H03	2607	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000028H04	2608	SAU103038	5757	#N/A	#N/A
S1M10000028H05	2609	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000029A02	2610	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000029A04	2611	SAU100489	5278	SAU1c0044_orf_133p	12566
S1M10000029A04	2611	SAU100557	5291	SAU1c0044_orf_132p	12565
S1M10000029A09	2612	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000029A10	2613	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000029A11	2614	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000029A12	2615	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000029B02	2616	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000029B03	2617	SAU201225	5807	SAU2c0412_orf_5p	12896
S1M10000029B04	2618	SAU201621	5828	SAU2c0437_orf_4p	12966
S1M10000029B05	2619	SAU100355	5263	SAU1c0023_orf_6p	12155
S1M10000029B06	2620	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000029B08	2621	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000029B10	2622	SAU101891	5571	SAU1c0034_orf_30p	12281
S1M10000029C02	2623	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000029C03	2624	SAU100690	5309	#N/A	#N/A
S1M10000029C05	2625	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000029C07	2626	SAU102222	5613	SAU1c0043_orf_12p	12511
S1M10000029C09	2627	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000029C10	2628	SAU101995	5583	SAU1c0040_orf_98p	12455
S1M10000029C12	2629	SAU100859	5342	SAU1c0038_orf_87p	12402
S1M10000029D02	2630	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000029D05	2631	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000029D09	2632	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000029D10	2633	SAU101891	5571	SAU1c0034_orf_30p	12281
S1M10000029D12	2634	SAU100056	5223	SAU1c0044_orf_176p	12577
S1M10000029E02	2635	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000029E05	2636	SAU100522	5284	SAU1c0044_orf_249p	12599
S1M10000029E10	2637	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000029E11	2638	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000029F01	2639	SAU101803	5543	SAU1c0032_orf_23p	1228
S1M10000029F01	2639	SAU101804	5544	#N/A	#N/A
S1M10000029F02	2640	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000029F02	2640	SAU101286	5413	SAU1c0034_orf_67p	12292
S1M10000029F04	2641	SAU102639	5724	#N/A	#N/A
S1M10000029F09	2642	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000029F09	2642	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000029F10	2643	SAU102621	5719	SAU1c0041_orf_63p	12480
S1M10000029F11	2644	SAU102883	5741	SAU1c0045_orf_38p	12702
S1M10000029F12	2645	SAU102603	5709	SAU1c0041_orf_48p	12469
S1M10000029F12	2645	SAU102609	5713	SAU1c0041_orf_52p	12473
S1M10000029G01	2646	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000029002	2647	SAU101622	5496	SAU1c0040_orf_27p	12430
S1M10000029G03	2648	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000029G05	2649	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000029G07	2650	SAU101622	5496	SAU1c0040_orf_27p	12430
S1M10000029G08	2651	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000029G12	2652	SAU101270	5410	SAU1c0037_orf_89p	12365
S1M10000029H01	2653	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000029H05	2654	SAU102613	5715	SAU1c0041_orf_55p	12475
S1M10000029H06	2655	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000029H08	2656	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000029H09	2657	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000029H10	2658	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000030A02	2659	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000030A05	2660	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000030A09	2661	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000030A10	2662	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000030A10	2662	SAU202882	5855	SAU2c0381_orf_3p	12848
S1M10000030A11	2663	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000030B02	2664	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000030B05	2665	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000030B07	2666	SAU101180	5389	SAU1c0045_orf_126p	12656
S1M10000030B09	2667	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000030C02	2668	SAU102531	5694	SAU1c0045_orf_186p	12667
S1M10000030C03	2669	SAU102629	5720	SAU1c0041_orf_71p	12481
S1M10000030C04	2670	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000030C05	2671	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000030C08	2672	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000030C09	2673	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000030C10	2674	SAU301592	5898	SAU3c1467_orf_2p	13137
S1M10000030C12	2675	SAU100961	5360	SAU1c0044_orf_83p	12638
S1M10000030C12	2675	SAU100962	5361	SAU1c0044_orf_84p	12639
S1M10000030D01	2676	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000030D02	2677	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000030D03	2678	SAU100731	5313	SAU1c0044_orf_252p	12601
S1M10000030D05	2679	SAU102222	5613	SAU1c0043_orf_12p	12511
S1M10000030D06	2680	SAU102392	5658	SAU1c0033_orf_40p	12270
S1M10000030D06	2680	SAU201541	5822	SAU2c0431_orf_14p	12942
S1M10000030D07	2681	SAU102392	5658	SAU1c0033_orf_40p	12270
S1M10000030D07	2681	SAU201541	5822	SAU2c0431_orf_14p	12942
S1M10000029F09	2642	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000029F09	2642	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000029F10	2643	SAU102621	5719	SAU1c0041_orf_63p	12480
S1M10000029F11	2644	SAU102883	5741	SAU1c0045_orf_38p	12702
S1M10000029F12	2645	SAU102603	5709	SAU1c0041_orf_48p	12469
S1M10000029F12	2645	SAU102609	5713	SAU1c0041_orf_52p	12473
S1M10000029G01	2646	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000029G02	2647	SAU101622	5496	SAU1c0040_orf_27p	12430
S1M10000029G03	2648	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000029G05	2649	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000029G07	2650	SAU101622	5496	SAU1c0040_orf_27p	12430
S1M10000029G08	2651	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000029G12	2652	SAU101270	5410	SAU1c0037_orf_89p	12365
S1M10000029H01	2653	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000029H05	2654	SAU102613	5715	SAU1c0041_orf_55p	12475
S1M10000029H06	2655	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000029H08	2656	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000029H09	2657	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000029H10	2658	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000030A02	2659	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000030A05	2660	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000030A09	2661	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000030A10	2662	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000030A10	2662	SAU202882	5855	SAU2c0381_orf_3p	12848
S1M10000030A11	2663	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000030B02	2664	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000030B05	2665	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000030B07	2666	SAU101180	5389	SAU1c0045_orf_126p	12656
S1M10000030B09	2667	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000030C02	2668	SAU102531	5694	SAU1c0045_orf_186p	12667
S1M10000030C03	2669	SAU102629	5720	SAU1c0041_orf_71p	12481
S1M10000030C04	2670	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000030C05	2671	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000030C08	2672	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000030C09	2673	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000030C10	2674	SAU301592	5898	SAU3c1467_orf_2p	13137
S1M10000030C12	2675	SAU100961	5360	SAU1c0044_orf_83p	12638
S1M10000030C12	2675	SAU100962	5361	SAU1c0044_orf_84p	12639
S1M10000030D01	2676	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000030D02	2677	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000030D03	2678	SAU100731	5313	SAU1c0044_orf_252p	12601
S1M10000030D05	2679	SAU102222	5613	SAU1c0043_orf_12p	12511
S1M10000030D06	2680	SAU102392	5658	SAU1c0033_orf_40p	12270
S1M10000030D06	2680	SAU201541	5822	SAU2c0431_orf_14p	12942
S1M10000030D07	2681	SAU102392	5658	SAU1c0033_orf_40p	12270
S1M10000030D07	2681	SAU201541	5822	SAU2c0431_orf_14p	12942
S1M10000030D09	2682	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000030D10	2683	SAU100313	5259	SAU1c0045_orf_153p	12661
S1M10000030D10	2683	SAU100359	5264	SAU1c0032_orf_35p	12239
S1M10000030D11	2684	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000030E02	2685	SAU100731	5313	SAU1c0044_orf_252p	12601
S1M10000030E06	2686	SAU102909	5743	SAU1c0036_orf_16p	12315
S1M10000030E07	2687	SAU102939	5747	#N/A	#N/A
S1M10000030E11	2688	SAU101790	5531	SAU1c0032_orf_11p	12215
S1M10000030E12	2689	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000030F01	2690	SAU100731	5313	SAU1c0044_orf_252p	12601
S1M10000030F07	2691	SAU102939	5747	#N/A	#N/A
S1M10000030F08	2692	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000030F08	2692	SAU101801	5541	#N/A	#N/A
S1M10000030F09	2693	SAU101266	5408	SAU1c0042_orf_117p	12490
S1M10000030F10	2694	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000030G03	2695	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000030G05	2696	SAU102246	5619	SAU1c0043_orf_30p	12542
S1M10000030G05	2696	SAU102247	5620	SAU1c0043_orf_31p	12543
S1M10000030G07	2697	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000030G08	2698	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000030G09	2699	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000030G10	2700	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000030G11	2701	SAU101529	5471	SAU1c0043_orf_39p	12544
S1M10000030G12	2702	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000030H01	2703	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000030H02	2704	SAU200392	5780	SAU2c0298_orf_3p	12755
S1M10000030H03	2705	SAU102162	5609	SAU1c0041_orf_27p	12462
S1M10000030H05	2706	SAU102380	5654	SAU1c0033_orf_29p	12265
S1M10000030H07	2707	SAU100123	5230	SAU1c0043_orf_189p	12526
S1M10000030H07	2707	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000030H07	2707	SAU103159	5762	SAU1c0045_orf_204p	12670
S1M10000030H07	2707	SAU201827	5837	SAU2c0449_orf_21p	13002
S1M10000030H09	2708	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000031A03	2709	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000031A08	2710	SAU101641	5501	SAU1c0029_orf_12p	12193
S1M10000031A10	2711	SAU102242	5618	SAU1c0043_orf_26p	12540
S1M10000031B01	2712	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000031B02	2713	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000031B04	2714	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000031B11	2715	SAU101262	5406	SAU1c0042_orf_113p	12488
S1M10000031B12	2716	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000031C04	2717	SAU100062	5225	SAU1c0035_orf_98p	12309
S1M10000031C04	2717	SAU100231	5245	#N/A	#N/A
S1M10000031C07	2718	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000031C09	2719	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000031C11	2720	SAU102935	5745	#N/A	#N/A
S1M10000031D06	2721	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000031D07	2722	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000031D08	2723	SAU101891	5571	SAU1c0034_orf_30p	12281
S1M10000031D09	2724	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000031E02	2725	SAU101350	5429	SAU1c0042_orf_109p	12487
S1M10000031E03	2726	SAU101267	5409	SAU1c0037_orf_86p	12364
S1M10000031E03	2726	SAU300719	5876	SAU3c1108_orf_3p	13059
S1M10000031E04	2727	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000031E07	2728	SAU102449	5674	SAU1c0045_orf_22p	12677
S1M10000031E08	2729	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000031E10	2730	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000031E12	2731	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000031F02	2732	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000031F02	2732	SAU101801	5541	#N/A	4N/A
S1M10000031F03	2733	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000031F04	2734	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000031F04	2734	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000031F05	2735	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000031F08	2736	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000031F10	2737	SAU102593	5704	SAU1c0041_orf_39p	12463
S1M10000031F11	2738	SAU102469	5679	SAU1c0026_orf_25p	12172
S1M10000031F12	2739	SAU102593	5704	SAU1c0041_orf_39p	12463
S1M10000031002	2740	SAU101797	5537	SAU1c0032_orf_17p	12221
S1M10000031003	2741	SAU101679	5509	SAU1c0044_orf_222p	12593
S1M10000031G04	2742	SAU103198	5766	#N/A	#N/A
S1M10000031006	2743	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000031G09	2744	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000031G10	2745	SAU100077	5226	SAU1c0043_orf_178p	12520
S1M10000031G11	2746	SAU100118	5229	SAU1c0015_orf_13p	12125
S1M10000031H01	2747	SAU103144	5761	SAU1c0045_orf_15p	12663
S1M10000031H02	2748	SAU100886	5349	SAU1c0018_orf_16p	12139
S1M10000031H06	2749	SAU100690	5309	#N/A	#N/A
S1M10000031H09	2750	SAU201743	5831	#N/A	#N/A
S1M10000031H11	2751	SAU100077	5226	SAU1c0043_orf_178p	12520
S1M10000032A03	2752	SAU202039	5843	SAU2c0452_orf_20p	13009
S1M10000032A05	2753	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000032A06	2754	SAU100610	5298	SAU1c0034_orf_71p	12294
S1M10000032A07	2755	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000032A08	2756	SAU102142	5606	SAU1c0041_orf_13p	12457
S1M10000032A08	2756	SAU102143	5607	SAU1c0041_orf_14p	12458
S1M10000032A10	2757	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000032B01	2758	SAU301898	5904	SAU3c1079_orf_1p	13057
S1M10000032B05	2759	SAU102607	5712	SAU1c0041_orf_51p	12472
S1M10000032B05	2759	SAU102944	5749	SAU1c0041_orf_47p	12468
S1M10000032B07	2760	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000032B08	2761	SAU100175	5240	SAU1c0044_orf_204p	12582
S1M10000032B11	2762	SAU100944	5357	SAU1c0042_orf_5p	12505
S1M10000032B12	2763	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000032C01	2764	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000032C03	2765	SAU102241	5617	SAU1c0043_orf_25p	12539
S1M10000032C04	2766	SAU102241	5617	SAU1c0043_orf_25p	12539
S1M10000032C05	2767	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000032C09	2768	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000032C10	2769	SAU201615	5826	SAU2c0440_orf_10p	12972
S1M10000032C11	2770	SAU102863	5737	#N/A	#N/A
S1M10000032C12	2771	SAU102863	5737	#N/A	#N/A
S1M10000032D03	2772	SAU100613	5299	SAU1c0015_orf_14p	12126
S1M10000032D06	2773	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000032D07	2774	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000032D09	2775	SAU100128	5231	#N/A	#N/A
S1M10000032D09	2775	SAU101549	5476	SAU1c0043_orf_64p	12549
S1M10000032D09	2775	SAU101576	5488	SAU1c0044_orf_105p	12554
S1M10000032D11	2776	SAU100128	5231	#N/A	#N/A
S1M10000032D11	2776	SAU101549	5476	SAU1c0043_orf_64p	12549
S1M10000032D11	2776	SAU101576	5488	SAU1c0044_orf_105p	12554
S1M10000032E02	2777	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000032E03	2778	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000032E04	2779	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000032E06	2780	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000032E08	2781	SAU102281	5633	SAU1c0038_orf_4p	12384
S1M10000032E09	2782	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000032E10	2783	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000032E11	2784	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000032E12	2785	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000032F01	2786	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000032F01	2786	SAU102002	5587	SAU1c0040_orf_103p	12425
S1M10000032F04	2787	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000032F05	2788	SAU101339	5422	SAU1c0038_orf_81p	12399
S1M10000032F10	2789	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000032F10	2789	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000032F11	2790	SAU101189	5392	SAU1c0033_orf_25p	12264
S1M10000032F12	2791	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000032G02	2792	SAU100710	5311	SAU1c0043_orf_54p	12546
S1M10000032G02	2792	SAU200628	5788	SAU2c0334_orf_4p	12790
S1M10000032G03	2793	SAU100813	5334	SAU1c0036_orf_29p	12322
S1M10000032G04	2794	SAU101904	5573	SAU1c0044_orf_36p	12617
S1M10000032G06	2795	SAU101509	5469	SAU1c0039_orf_81p	12418
S1M10000032G08	2796	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000032G10	2797	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000032G12	2798	SAU101084	5377	SAU1c0034_orf_41p	12283
S1M10000032H01	2799	SAU101445	5452	SAU1c0038_orf_47p	12382
S1M10000032H01	2799	SAU101446	5453	SAU1c0038_orf_48p	12383
S1M10000032H04	2800	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000032H07	2801	SAU101797	5537	SAU1c0032_orf_17p	12221
S1M10000032H07	2801	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000032H09	2802	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000032H11	2803	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000032H11	2803	SAU301148	5888	#N/A	#N/A
S1M100000323A0	2804	SAU201775	5835	SAU2c0446_orf_4p	12996
S1M100000323A0	2804	SAU301080	5885	SAU3c1287_orf_1p	13083
S1M10000033A07	2805	SAU200949	5800	SAU2c0380_orf_11p	12846
S1M10000033A08	2806	SAU101231	5399	SAU1c0035_orf_6p	12303
S1M10000033A10	2807	SAU202039	5843	SAU2c0452_orf_20p	13009
S1M10000033B02	2808	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000033B07	2809	SAU102044	5593	SAU1c0039_orf_65p	12414
S1M10000033B08	2810	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000033B11	2811	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000033B11	2811	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000033B12	2812	SAU101104	5382	SAU1c0029_orf_20p	12195
S1M10000033B12	2812	SAU103010	5753	SAU1c0029_orf_19p	12194
S1M10000033C04	2813	SAU102933	5744	SAU1c0039_orf_62p	12412
S1M10000033D02	2814	SAU102333	5644	SAU1c0045_orf_143p	12657
S1M10000033D03	2815	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000033D04	2816	SAU100745	5319	SAU1c0044_orf_233p	12596
S1M10000033D05	2817	5AV100301	5254	SAU1c0040_orf_91p	12452
S1M10000033D06	2818	SAU102113	5601	SAU1c0027_orf_2p	12178
S1M10000033D10	2819	SAU100813	5334	SAU1c0036_orf_29p	12322
S1M10000033D12	2820	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000033E04	2821	SAU102318	5643	SAU1c0045_orf_60p	12707
S1M10000033E10	2822	SAU100162	5239	SAU1c0044_orf_206p	12583
S1M10000033E12	2823	SAU100770	5324	#N/A	#N/A
S1M10000033F02	2824	SAU101724	5514	SAU1c0016_orf_9p	12136
S1M10000033F03	2825	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000033F06	2826	SAU102449	5674	SAU1c0045_orf_22p	12677
S1M10000033F07	2827	SAU102044	5593	SAU1c0039_orf_65p	12414
S1M10000033F09	2828	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000033F11	2829	SAU100689	5308	SAU1c0036_orf_2p	12323
S1M10000033G05	2830	SAU101904	5573	SAU1c0044_orf_36p	12617
S1M10000033G07	2831	SAU101824	5554	SAU1c0038_orf_26p	12371
S1M10000033G09	2832	SAU102380	5654	SAU1c0033_orf_29p	12265
S1M10000033G10	2833	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000033G10	2833	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000033G11	2834	SAU101968	5581	SAU1c0028_orf_43p	12187
S1M10000033G12	2835	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000033H01	2836	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000033H02	2837	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000033H03	2838	SAU101833	5555	SAU1c0038_orf_34p	12373
S1M10000033H07	2839	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000033H08	2840	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000033H09	2841	SAU100710	5311	SAU1c0043_orf_54p	12546
S1M10000033H10	2842	SAU100690	5309	#N/A	#N/A
S1M10000033H11	2843	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000034A02	2844	SAU101197	5393	SAU1c0035_orf_60p	12300
S1M10000034A03	2845	SAU102939	5747	#N/A	#N/A
S1M10000034A04	2846	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000034A05	2847	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000034A08	2848	SAU101020	5368	SAU1c0045_orf_86p	12710
S1M10000034A09	2849	SAU100773	5326	SAU1c0038_orf_39p	12377
S1M10000034A11	2850	SAU102389	5656	SAU1c0033_orf_36p	12268
S1M10000034A12	2851	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000034B03	2852	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000034B05	2853	SAU101630	5498	SAU1c0039_orf_4p	12410
S1M10000034B06	2854	SAU102607	5712	SAU1c0041_orf_51p	12472
S1M10000034B06	2854	SAU102944	5749	SAU1c0041_orf_47p	12468
S1M10000034B07	2855	SAU100077	5226	SAU1c0043_orf_178p	12520
S1M10000034B08	2856	SAU101341	5424	SAU1c0044_orf_38p	12618
S1M10000034B09	2857	SAU101909	5575	SAU1c0040_orf_77p	12441
S1M10000034B10	2858	SAU101882	5569	SAU1c0025_orf_15p	12163
S1M10000034B12	2859	SAU200593	5786	SAU2c0327_orf_1p	12784
S1M10000034C02	2860	SAU100557	5291	SAU1c0044_orf_132p	12565
S1M10000034C06	2861	SAU200157	5776	#N/A	#N/A
S1M10000034C07	2862	SAU101343	5425	SAU1c0044_orf_40p	12619
S1M10000034C09	2863	SAU102281	5633	SAU1c0038_orf_4p	12384
S1M10000034C12	2864	SAU100859	5342	SAU1c0038_orf_87p	12402
S1M10000034D01	2865	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000034D05	2866	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000034D06	2867	SAU200157	5776	#N/A	#N/A
S1M10000034D07	2868	SAU100745	5319	SAU1c0044_orf_233p	12596
S1M10000034D08	2869	SAU102284	5635	SAU1c0038_orf_5p	12389
S1M10000034D08	2869	SAU201469	5816	SAU2c0438_orf_6p	12967
S1M10000034D10	2870	SAU102474	5681	SAU1c0026_orf_31p	12174
S1M10000034D11	2871	SAU101881	5568	SAU1c0025_orf_14p	12162
S1M10000034D12	2872	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000034E01	2873	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000034E02	2874	SAU100557	5291	SAU1c0044_orf_132p	12565
S1M10000034E04	2875	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000034E05	2876	SAU100738	5317	SAU1c0044_orf_52p	12624
S1M10000034E06	2877	SAU100347	5262	SAU1c0036_orf_56p	12334
S1M10000034E06	2877	SAU100443	5274	SAU1c0036_orf_55p	12333
S1M10000034E07	2878	SAU100617	5300	SAU1c0035_orf_102p	12295
S1M10000034E10	2879	SAU102401	5661	SAU1c0030_orf_4p	12209
S1M10000034E11	2880	SAU101881	5568	SAU1c0025_orf_14p	12162
S1M10000034E12	2881	SAU200960	5801	SAU2c0377_orf_5p	12843
S1M10000034F01	2882	SAU202731	5850	#N/A	#N/A
S1M10000034F02	2883	SAU201621	5828	SAU2c0437_orf_4p	12966
S1M10000034F03	2884	SAU201971	5841	SAU2c0455_orf_17p	13015
S1M10000034F03	2884	SAU301363	5894	#N/A	#N/A
S1M10000034F04	2885	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000034F05	2886	SAU101630	5498	SAU1c0039_orf_4p	12410
S1M10000034F07	2887	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000034F08	2888	SAU202736	5851	SAU2c0426_orf_7p	12927
S1M10000034F09	2889	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000034F10	2890	SAU102350	5649	SAU1c0040_orf_36p	12433
S1M10000034F12	2891	SAU100522	5284	SAU1c0044_orf_249p	12599
S1M10000034G02	2892	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000034G03	2893	SAU101198	5394	SAU1c0035_orf_61p	12301
S1M10000034G06	2894	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000034G07	2895	SAU102380	5654	SAU1c0033_orf_29p	12265
S1M10000034G08	2896	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000034G09	2897	SAU102294	5639	SAU1c0044_orf_288p	12610
S1M10000034G09	2897	SAU201775	5835	SAU2c0446_orf_4p	12996
S1M10000034G11	2898	SAU200558	5782	SAU2c0322_orf_5p	12777
S1M10000034G12	2899	SAU100557	5291	SAU1c0044_orf_132p	12565
S1M10000034H01	2900	SAU101293	5414	SAU1c0044_orf_61p	12631
S1M10000034H02	2901	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000034H03	2902	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000034H06	2903	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000034H07	2904	SAU100077	5226	SAU1c0043_orf_178p	12520
S1M10000034H08	2905	SAU200740	5794	SAU2c0340_orf_3p	12798
S1M10000034H09	2906	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000034H10	2907	SAU102422	5666	SAU1c0030_orf_22p	12207
S1M10000035A03	2908	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000035A08	2909	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000035A09	2910	SAU101350	5429	SAU1c0042_orf_109p	12487
S1M10000035A09	2910	SAU101351	5430	SAU1c0042_orf_108p	12486
S1M10000035A10	2911	SAU203296	5863	SAU2c0442_orf_18p	12983
S1M10000035A11	2912	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000035A12	2913	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000035A12	2913	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000035A12	2913	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000035B01	2914	SAU102584	5702	SAU1c0043_orf_239p	12537
S1M10000035B03	2915	SAU102246	5619	SAU1c0043_orf_30p	12542
S1M10000035B04	2916	SAU102246	5619	SAU1c0043_orf_30p	12542
S1M10000035B08	2917	SAU103232	5769	SAU1c0045_orf_341p	12697
S1M10000035B11	2918	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000035C01	2919	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000035C02	2920	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000035C04	2921	SAU100214	5228	SAU1c0043_orf_225p	12535
S1M10000035C06	2922	SAU101497	5468	SAU1c0037_orf_66p	12361
S1M10000035C11	2923	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000035D01	2924	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000035D04	2925	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000035D06	2926	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000035D09	2927	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000035D12	2928	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000035E02	2929	SAU102883	5741	SAU1c0045_orf_38p	12702
S1M10000035E03	2930	SAU102447	5672	SAU1c0045_orf_24p	12685
S1M10000035E04	2931	SAU103025	5755	SAU1c00229_orf_9p	12202
S1M10000035E08	2932	SAU100690	5309	#N/A	#N/A
S1M10000035E09	2933	SAU101197	5393	SAU1c0035_orf_60p	12300
S1M10000035E12	2934	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000035F03	2935	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000035E03	2935	SAU202882	5855	SAU2c0381_orf_3p	12848
S1M10000035F04	2936	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000035F09	2937	SAU203296	5863	SAU2c0442_orf_18p	12983
S1M10000035F12	2938	SAU101427	5447	SAU1c0042_orf_144p	12500
S1M10000035F12	2938	SAU103204	5767	SAU1c0042_orf_143p	12499
S1M10000035G02	2939	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000035G09	2940	SAU203296	5863	SAU2c0442_orf_18p	12983
S1M10000035G11	2941	SAU101344	5426	SAU1c0044_orf_41p	12620
S1M10000035G12	2942	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000035H01	2943	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000035H07	2944	SAU100313	5259	SAU1c0045_orf_153p	12661
S1M10000035H07	2944	SAU100359	5264	SAU1c0032_orf_35p	12239
S1M10000035H07	2944	SAU200297	5778	SAU2c0274_orf_2p	12739
S1M10000035H08	2945	SAU101772	5526	SAU1c0037_orf_34p	12351
S1M10000035H09	2946	SAU100496	5279	SAU1c0041_orf_83p	12484
S1M10000035H09	2946	SAU301004	5882	SAU3c1255_orf_1p	13079
S1M10000035H10	2947	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000035H11	2948	SAU101344	5426	SAU1c0044_orf_41p	12620
S1M10000036A02	2949	SAU102447	5672	SAU1c0045_orf_24p	12685
S1M10000036A03	2950	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000036A04	2951	SAU200994	5802	SAU2c0428_orf_4p	12935
S1M10000036A05	2952	SAU101810	5549	SAU1c0032_orf_28p	12233
S1M10000036A05	2952	SAU101811	5550	SAU1c0032_orf_29p	12234
S1M10000036A05	2952	SAU300110	5865	SAU3c0533_orf_2p	13031
S1M10000036A08	2953	SAU101220	5396	SAU1c0044_orf_94p	12645
S1M10000036A11	2954	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000036A12	2955	SAU100813	5334	SAU1c0036_orf_29p	12322
S1M10000036B04	2956	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000036B04	2956	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000036B06	2957	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000036B07	2958	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000036B08	2959	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000036B11	2960	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000036B12	2961	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000036C01	2962	SAU100242	5246	SAU1c0036_orf_5p	12336
S1M10000036C03	2963	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000036C04	2964	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000036C05	2965	SAU100497	5280	SAU1c0018_orf_3p	12140
S1M10000036C06	2966	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000036C07	2967	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000036C07	2967	SAU101801	5541	#N/A	#N/A
S1M10000036C09	2968	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000036C09	2968	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000036C09	2968	SAU302685	5908	SAU3c1403_orf_1p	13113
S1M10000036C10	2969	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000036C10	2969	SAU101751	5521	SAU1c0040_orf_86p	12448
S1M10000036D02	2970	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000036D03	2971	SAU103038	5757	#N/A	#N/A
S1M10000036D06	2972	SAU103024	5754	SAU1c0029_orf_6p	12200
S1M10000036D08	2973	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000036D10	2974	SAU102933	5744	SAU1c0039_orf_62p	12412
S1M10000036D11	2975	SAU101197	5393	SAU1c0035_orf_60p	12300
S1M10000036D11	2975	SAU101198	5394	SAU1c0035_orf_61p	12301
S1M10000036D12	2976	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000036E06	2977	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000036E06	2977	SAU202756	5852	SAU2c0470_orf_1p	13027
S1M10000036E08	2978	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000036E11	2979	SAU101343	5425	SAU1c0044_orf_40p	12619
S1M10000036F06	2980	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000036F07	2981	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000036F08	2982	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000036F09	2983	SAU100532	5287	SAU1c0044_orf_198p	12580
S1M10000036F10	2984	SAU101586	5489	SAU1c0044_orf_242p	12598
S1M10000036F11	2985	SAU201506	5818	SAU2c0432_orf_18p	12946
S1M10000036G03	2986	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000036G07	2987	SAU102355	5651	SAU1c0040_orf_40p	12435
S1M10000036G08	2988	SAU102336	5646	SAU1c0045_orf_146p	12659
S1M10000036G11	2989	SAU101340	5423	SAU1c0038_orf_82p	12400
S1M10000036H01	2990	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000036H02	2991	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000036H03	2992	SAU102909	5743	SAU1c0036_orf_16p	12315
S1M10000036H04	2993	SAU102909	5743	SAU1c0036_orf_16p	12315
S1M10000036H05	2994	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000036H06	2995	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000036H08	2996	SAU102909	5743	SAU1c0036_orf_16p	12315
S1M10000036H11	2997	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000037A02	2998	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000037A02	2998	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000037A03	2999	SAU100128	5231	#N/A	#N/A
S1M10000037A03	2999	SAU101549	5476	SAU1c0043_orf_64p	12549
S1M10000037A03	2999	SAU101576	5488	SAU1c0044_orf_105p	12554
S1M10000037A06	3000	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000037A08	3001	SAU102669	5728	SAU1c0024_orf_7p	12160
S1M10000037A09	3002	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000037A09	3002	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000037A11	3003	SAU101436	5449	SAU1c0028_orf_23p	12183
S1M10000037A12	3004	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000037B03	3005	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000037B04	3006	SAU100767	5323	SAU1c0044_orf_192p	12579
S1M10000037B05	3007	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000037B06	3008	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000037B06	3008	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000037B07	3009	SAU101915	5577	SAU1c0040_orf_72p	12439
S1M10000037B08	3010	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000037B10	3011	SAU101346	5427	SAU1c0044_orf_43p	12621
S1M10000037B11	3012	SAU101399	5443	SAU1c0036_orf_34p	12325
S1M10000037B12	3013	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000037C05	3014	SAU101482	5461	SAU1c0015_orf_10p	12123
S1M10000037C06	3015	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000037C07	3016	SAU101641	5501	SAU1c0029_orf_12p	12193
S1M10000037C08	3017	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000037C09	3018	SAU101818	5553	SAU1c0038_orf_20p	12369
S1M10000037C10	3019	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000037D04	3020	SAU102283	5634	SAU1c0006_orf_1p	12119
S1M10000037D05	3021	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000037D06	3022	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000037D09	3023	SAU102246	5619	SAU1c0043_orf_30p	12542
S1M10000037D12	3024	SAU101999	5585	SAU1c0040_orf_101p	12423
S1M10000037E02	3025	SAU102447	5672	SAU1c0045_orf_24p	12685
S1M10000037E02	3025	SAU102448	5673	SAU1c0045_orf_23p	12681
S1M10000037E03	3026	SAU100813	5334	SAU1c0036_orf_29p	12322
S1M10000037E06	3027	SAU100921	5355	SAU1c0038_orf_76p	12396
S1M10000037E08	3028	SAU100139	5234	SAU1c0032_orf_6p	12255
S1M10000037E08	3028	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000037E09	3029	SAU102049	5595	SAU1c0039_orf_68p	12416
S1M10000037E10	3030	SAU101444	5451	SAU1c0038_orf_46p	12381
S1M10000037E11	3031	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000037E12	3032	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000037F02	3033	SAU100776	5327	SAU1c0041_orf_72p	12482
S1M10000037F03	3034	SAU101339	5422	SAU1c0038_orf_81p	12399
S1M10000037F04	3035	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000037F05	3036	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000037F06	3037	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000037F06	3037	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000037F07	3038	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000037F07	3038	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000037F08	3039	SAU203001	5859	SAU2c0412_orf_15p	12894
S1M10000037F08	3039	SAU203007	5860	SAU2c0412_orf_10p	12893
S1M10000037F09	3040	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000037F10	3041	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000037G01	3042	SAU102502	5690	SAU1c0045_orf_273p	12689
S1M10000037G01	3042	SAU102503	5691	SAU1c0045_orf_274p	12690
S1M10000037G02	3043	SAU100658	5303	SAU1c0038_orf_59p	12388
S1M10000037G03	3044	SAU101344	5426	SAU1c0044_orf_41p	12620
S1M10000037G06	3045	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000037G07	3046	SAU103038	5757	#N/A	#N/A
S1M10000037G08	3047	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000037G10	3048	SAU100062	5225	SAU1c0035_orf_98p	12309
S1M10000037H02	3049	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000037H03	3050	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000037H05	3051	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000037H07	3052	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000037H08	3053	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000037H09	3054	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000037H11	3055	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000038A04	3056	SAU101275	5412	SAU1c0044_orf_257p	12604
S1M10000038A07	3057	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000038A08	3058	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000038A09	3059	SAU100307	5257	SAU1c0036_orf_134p	12313
S1M10000038A11	3060	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000038A12	3061	SAU101799	5539	SAU1c0032_orf_19p	12223
S1M10000038B01	3062	SAU101483	5462	SAu1c0015_orf_11p	12124
S1M10000038B03	3063	SAU101360	5431	SAU1c0044_orf_109p	12555
S1M10000038B07	3064	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000038B08	3065	SAU100308	5258	SAU1c0036_orf_133p	12312
S1M10000038B09	3066	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000038B09	3066	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000038B12	3067	SAU102764	5734	SAU1c0044_orf_56p	12625
S1M10000038C01	3068	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000038C02	3069	SAU200657	5789	#N/A	#N/A
S1M10000038C06	3070	SAU101320	5420	SAU1c0015_orf_16p	12128
S1M10000038C08	3071	SAU102132	5605	SAU1c0027_orf_19p	12177
S1M10000038C10	3072	SAU101346	5427	SAU1c0044_orf_43p	12621
S1M10000038C10	3072	SAU101347	5428	SAU1c0044_orf_44p	12622
S1M10000038C11	3073	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000038C12	3074	SAU101792	5533	SAU1c0032_orf_13p	12217
S1M10000038D02	3075	SAU101842	5557	SAU1c0042_orf_9p	12510
S1M10000038D05	3076	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000038D07	3077	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000038D08	3078	SAU101341	5424	SAU1c0044_orf_38p	12618
S1M10000038D08	3078	SAU301275	5892	SAU3c1365_orf_2p	13103
S1M10000038D09	3079	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000038D10	3080	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000038D11	3081	SAU101300	5415	SAU1c0044_orf_113p	12557
S1M10000038D11	3081	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000038D12	3082	SAU100752	5322	SAU1c0043_orf_183p	12524
S1M10000038D12	3082	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000038E01	3083	SAU101814	5551	SAU1c0032_orf_32p	12237
S1M10000038E02	3084	SAU101842	5557	SAU1c0042_orf_9p	12510
S1M10000038E03	3085	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000038E04	3086	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000038E05	3087	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000038E06	3088	SAU102231	5614	SAU1c0043_orf_18p	12527
S1M10000038E06	3088	SAU102232	5615	SAU1c0043_orf_19p	12530
S1M10000038E07	3089	SAU200593	5786	SAU2c0327_orf_1p	12784
S1M10000038E10	3090	SAU201558	5823	SAU2c0434_orf_5p	12954
S1M10000038E12	3091	SAU100838	5337	SAU1c0031_orf_12p	12211
S1M10000038E12	3091	SAU100839	5338	SAU1c0031_orf_11p	12210
S1M10000038F03	3092	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000038F04	3093	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000038F04	3093	SAU100965	5364	SAU1c0044_orf_87p	12642
S1M10000038F05	3094	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000038F05	3094	SAU100965	5364	SAU1c0044_orf_87p	12642
S1M10000038F06	3095	SAU101189	5392	SAU1c0033_orf_25p	12264
S1M10000038F08	3096	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000038F09	3097	SAU201666	5830	SAU2c0442_orf_11p	12981
S1M10000038F10	3098	SAU101197	5393	SAU1c0035_orf_60p	12300
S1M10000038F11	3099	SAU100747	5320	SAU1c0044_orf_235p	12597
S1M10000038F12	3100	SAU202039	5843	SAU2c0452_orf_20p	13009
S1M10000038G01	3101	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000038G03	3102	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000038G04	3103	SAU100475	5276	SAU1c0036_orf_61p	12337
S1M10000038G06	3104	SAU101189	5392	SAU1c0033_orf_25p	12264
S1M10000038G08	3105	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000038G10	3106	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000038G11	3107	SAU100123	5230	SAU1c0043_orf_189p	12526
S1M10000038G11	3107	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000038G12	3108	SAU101184	5391	SAU1c0035_orf_80p	12305
S1M10000038H03	3109	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000038H07	3110	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000038H09	3111	SAU102340	5647	SAU1c0045_orf_149p	12660
S1M10000038H11	3112	SAU101452	5455	SAU1c0045_orf_247p	12684
S1M10000039A02	3113	SAU100496	5279	SAU1c0041_orf_83p	12484
S1M10000039A02	3113	SAU301004	5882	SAU3c1255_orf_1p	13079
S1M10000039A05	3114	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000039A05	3114	SAU100965	5364	SAU1c0044_orf_87p	12642
S1M10000039A07	3115	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000039A08	3116	SAU100522	5284	SAU1c0044_orf_249p	12599
S1M10000039A11	3117	SAU100613	5299	SAU1c0015_orf_14p	12126
S1M10000039A12	3118	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000039B02	3119	SAU101455	5456	SAU1c0045_orf_250p	12686
S1M10000039B02	3119	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000039B06	3120	SAU102350	5649	SAU1c0040_orf_36p	12433
S1M10000039B07	3121	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000039B10	3122	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000039B12	3123	SAU301118	5886	SAU3c1305_orf_3p	13086
S1M10000039C04	3124	SAU102252	5621	SAU1c0032_orf_48p	12241
S1M10000039C06	3125	SAU100633	5301	SAU1c0043_orf_147p	12515
S1M10000039C07	3126	SAU200657	5789	#N/A	#N/A
S1M10000039C08	3127	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000039C09	3128	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000039C10	3129	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000039C11	3130	SAU200657	5789	#N/A	#N/A
S1M10000039D02	3131	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000039D09	3132	SAU102294	5639	SAU1c0044_orf_288p	12610
S1M10000039D09	3132	SAU301080	5885	SAU3c1287_orf_1p	13083
S1M10000039D10	3133	SAU100323	5261	SAU1c0044_orf_171p	12575
S1M10000039E01	3134	SAU102264	5628	SAU1c0032_orf_60p	12250
S1M10000039E08	3135	SAU100412	5269	SAU1c0029_orf_38p	12197
S1M10000039E09	3136	SAU100056	5223	SAU1c0044_orf_176p	12577
S1M10000039E10	3137	SAU102394	5659	SAU1c0033_orf_41p	12271
S1M10000039E10	3137	SAU301118	5886	SAU3c1305_orf_3p	13086
S1M10000039E11	3138	SAU102473	5680	SAU1c0026_orf_30p	12173
S1M10000039F02	3139	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000039F03	3140	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000039F05	3141	SAU100118	5229	SAU1c0015_orf_13p	12125
S1M10000039F07	3142	SAU102531	5694	SAU1c0045_orf_186p	12667
S1M10000039F08	3143	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000039F09	3144	SAU200157	5776	#N/A	#N/A
S1M10000039F10	3145	SAU100059	5224	SAU1c0045_orf_10p	12652
S1M10000039F12	3146	SAU101565	5480	SAU1c0022_orf_8p	12151
S1M10000039G03	3147	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000039G04	3148	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000039G07	3149	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000039G07	3149	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000039G10	3150	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000039H02	3151	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000039H02	3151	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000039H03	3152	SAU100313	5259	SAU1c0045_orf_153p	12661
S1M10000039H03	3152	SAU100359	5264	SAU1c0032_orf_35p	12239
S1M10000039H03	3152	SAU200297	5778	SAU2c0274_orf_2p	12739
S1M10000039H04	3153	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000039H06	3154	SAU102283	5634	SAU1c0006_orf_1p	12119
S1M10000039H07	3155	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000039H07	3155	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000039H08	3156	SAU102440	5671	SAU1c0045_orf_30p	12692
S1M10000040A04	3157	SAU100040	5221	SAU1c0043_orf_217p	12533
S1M10000040A05	3158	SAU102671	5729	SAU1c0024_orf_9p	12161
S1M10000040A07	3159	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000040A08	3160	SAU200157	5776	#N/A	#N/A
S1M10000040A10	3161	SAU103038	5757	#N/A	#N/A
S1M10000040A11	3162	SAU101801	5541	#N/A	#N/A
S1M10000040B01	3163	SAU101461	5457	SAU1c0045_orf_234p	12680
S1M10000040B03	3164	SAU102102	5600	SAU1c0045_orf_340p	12696
S1M10000040B07	3165	SAU101432	5448	SAU1c0028_orf_27p	12184
S1M10000040B11	3166	SAU101198	5394	SAU1c0035_orf_61p	12301
S1M10000040C03	3167	SAU201971	5841	SAU2c0455_orf_17p	13015
S1M10000040C03	3167	SAU301363	5894	#N/A	#N/A
S1M10000040C04	3168	SAU102551	5698	SAU1c0045_orf_206p	12672
S1M10000040C05	3169	SAU102534	5696	#N/A	#N/A
S1M10000040C06	3170	SAU101247	5405	SAU1c0043_orf_136p	12512
S1M10000040C07	3171	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000040C08	3172	SAU101197	5393	SAU1c0035_orf_60p	12300
S1M10000040C10	3173	SAU201810	5836	SAU2c0308_orf_2p	12769
S1M10000040C10	3173	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000040C10	3173	SAU301148	5888	#N/A	#N/A
S1M10000040C11	3174	SAU101869	5566	SAU1c0036_orf_24p	12321
S1M10000040D01	3175	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000040D01	3175	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000040D03	3176	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000040D03	3176	SAU102201	5612	SAU1c0045_orf_169p	12666
S1M10000040D08	3177	SAU100633	5301	SAU1c0043_orf_147p	12515
S1M10000040D09	3178	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000040D11	3179	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000040E01	3180	SAU100916	5353	SAU1c0038_orf_71p	12394
S1M10000040E02	3181	SAU101845	5558	SAU1c0042_orf_7p	12506
S1M10000040E04	3182	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000040E05	3183	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000040E06	3184	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000040E07	3185	SAU101006	5367	SAU1c0028_orf_59p	12190
S1M10000040E09	3186	SAU102605	5710	SAU1c0041_orf_49p	12470
S1M10000040E10	3187	SAU100714	5312	SAU1c0044_orf_74p	12635
S1M10000040E11	3188	SAU101226	5398	SAU1c0035_orf_2p	12298
S1M10000040E12	3189	SAU102503	5691	SAU1c0045_orf_274p	12690
S1M10000040E12	3189	SAU201380	5812	SAU2c0426_orf_11p	12922
S1M10000040F01	3190	SAU101226	5398	SAU1c0035_orf_2p	12298
S1M10000040F02	3191	SAU101614	5494	SAU1c0044_orf_9p	12649
S1M10000040F03	3192	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000040F04	3193	SAU100123	5230	SAU1c0043_orf_189p	12526
S1M10000040F04	3193	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000040F04	3193	SAU103159	5762	SAU1c0045_orf_204p	12670
S1M10000040F04	3193	SAU201827	5837	SAU2c0449_orf_21p	13002
S1M10000040F05	3194	SAU102232	5615	SAU1c0043_orf_19p	12530
S1M10000040F06	3195	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000040F08	3196	SAU300713	5875	SAU3c1104_orf_1p	13058
S1M10000040F09	3197	SAU101610	5492	SAU1c0044_orf_5p	12629
S1M10000040F12	3198	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000040G01	3199	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000040G02	3200	SAU200561	5783	SAU2c0324_orf_3p	12779
S1M10000040G02	3200	SAU301773	5901	SAU3c1509_orf_2p	13157
S1M10000040G04	3201	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000040G07	3202	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000040G08	3203	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000040G12	3204	SAU101421	5446	SAU1c0042_orf_138p	12498
S1M10000040H02	3205	SAU100773	5326	SAU1c0038_orf_39p	12377
S1M10000040H03	3206	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000040H04	3207	SAU200914	5796	SAU2c0373_orf_2p	12837
S1M10000040H05	3208	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000040H07	3209	SAU100921	5355	SAU1c0038_orf_76p	12396
S1M10000040H10	3210	SAU202039	5843	SAU2c0452_orf_20p	13009
S1M10000041A03	3211	SAU102054	5596	SAU1c0039_orf_74p	12417
S1M10000041B02	3212	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000041B03	3213	SAU101592	5490	SAU1c0039_orf_37p	12406
S1M10000041B05	3214	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000041B06	3215	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000041B07	3216	SAU101145	5384	SAU1c0035_orf_43p	12299
S1M10000041B12	3217	SAU102725	5733	SAU1c0036_orf_68p	12338
S1M10000041C08	3218	SAU102607	5712	SAU1c0041_orf_51p	12472
S1M10000041C08	3218	SAU102944	5749	SAU1c0041_orf_47p	12468
S1M10000041C10	3219	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000041C11	3220	SAU101570	5482	SAU1c0044_orf_209p	12584
S1M10000041D06	3221	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000041D07	3222	SAU102639	5724	#N/A	#N/A
S1M10000041D08	3223	SAU200030	5772	SAU2c0282_orf_3p	12745
S1M10000041D10	3224	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000041D12	3225	SAU102658	5726	SAU1c0045_orf_121p	12654
S1M10000041E03	3226	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000041E06	3227	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000041E09	3228	SAU201236	5808	SAU2c0409_orf_10p	12891
S1M10000041E12	3229	SAU100952	5358	SAU1c0043_orf_182p	12523
S1M10000041F03	3230	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000041F03	3230	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000041F11	3231	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000041E12	3232	SAU102480	5684	SAU1c0039_orf_100p	12404
S1M10000041F12	3232	SAU102481	5685	SAU1c0039_orf_99p	12422
S1M10000041G01	3233	SAU100532	5287	SAU1c0044_orf_198p	12580
S1M10000041G06	3234	SAU102345	5648	SAU1c0045_orf_125p	12655
S1M10000041G08	3235	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000041G10	3236	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000041G11	3237	SAU101802	5542	SAU1c0032_orf_22p	12227
S1M10000041H01	3238	SAU101198	5394	SAU1c0035_orf_61p	12301
S1M10000041H04	3239	SAU100497	5280	SAU1c0018_orf_3p	12140
S1M10000041H05	3240	SAU100242	5246	SAU1c0036_orf_5p	12336
S1M10000041H07	3241	SAU102486	5687	SAU1c0039_orf_93p	12420
S1M10000041H07	3241	SAU102487	5688	SAU1c0039_orf_92p	12419
S1M10000041H08	3242	SAU301133	5887	SAU3c1311_orf_3p	13087
S1M10000041H09	3243	SAU103169	5763	SAU1c0045_orf_230p	12678
S1M10000042A04	3244	SAU201236	5808	SAU2c0409_orf_10p	12891
S1M10000042A05	3245	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000042A06	3246	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000042A07	3247	SAU100633	5301	SAU1c0043_orf_147p	12515
S1M10000042A09	3248	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000042A11	3249	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000042A12	3250	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000042B02	3251	SAU202736	5851	SAU2c0426_orf_7p	12927
S1M10000042B03	3252	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000042B06	3253	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000042B07	3254	SAU101343	5425	SAU1c0044_orf_40p	12619
S1M10000042B08	3255	SAU100443	5274	SAU1c0036_orf_55p	12333
S1M10000042B09	3256	SAU101802	5542	SAU1c0032_orf_22p	12227
S1M10000042B10	3257	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000042B10	3257	SAU102527	5693	SAU1c0032_orf_9p	12260
S1M10000042B11	3258	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000042B12	3259	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000042C02	3260	SAU100617	5300	SAU1c0035_orf_102p	12295
S1M10000042C06	3261	SAU102032	5591	SAU1c0029_orf_47p	12198
S1M10000042C10	3262	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000042C11	3263	SAU103037	5756	SAU1c0044_orf_303p	12613
S1M10000042D04	3264	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000042D07	3265	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000042D10	3266	SAU203296	5863	SAU2c0442_orf_18p	12983
S1M10000042D11	3267	SAU102663	5727	SAU1c0024_orf_2p	12158
S1M10000042E03	3268	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000042E06	3269	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000042E08	3270	SAU103198	5766	#N/A	#N/A
S1M10000042F01	3271	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000042F02	3272	SAU101891	5571	SAU1c0034_orf_30p	12281
S1M10000042F05	3273	SAU101652	5503	SAU1c0042_orf_123p	12492
S1M10000042F06	3274	SAU100773	5326	SAU1c0038_orf_39p	12377
S1M10000042F08	3275	SAU100162	5239	SAU1c0044_orf_206p	12583
S1M10000042F09	3276	SAU100246	5247	SAU1c0042_orf_130p	12496
S1M10000042F09	3276	SAU300998	5881	SAU3c1253_orf_3p	13077
S1M10000042F10	3277	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000042F11	3278	SAU101653	5504	SAU1c0042_orf_124p	12493
S1M10000042G01	3279	SAU100140	5235	SAU1c0032_orf_7p	12258
S1M10000042G03	3280	SAU101220	5396	SAU1c0044_orf_94p	12645
S1M10000042G08	3281	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000042G09	3282	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000042G12	3283	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000042H05	3284	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000042H07	3285	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000042H11	3286	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000043A02	3287	SAU203001	5859	SAU2c0412_orf_15p	12894
S1M10000043A03	3288	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000043A04	3289	SAU200088	5775	SAU2c0159_orf_1p	12724
S1M10000043A06	3290	SAU100077	5226	SAU1c0043_orf_178p	12520
S1M10000043A07	3291	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000043A08	3292	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000043A10	3293	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000043A11	3294	SAU100865	5343	SAU1c0044_orf_99p	12648
S1M10000043A12	3295	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000043B01	3296	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000043B02	3297	SAU100059	5224	SAU1c0045_orf_10p	12652
S1M10000043B07	3298	SAU101922	5578	SAU1c0040_orf_66p	12438
S1M10000043B07	3298	SAU200345	5779	SAU2c0292_orf_3p	12751
S1M10000043B08	3299	SAU100313	5259	SAU1c0045_orf_153p	12661
S1M10000043B08	3299	SAU100359	5264	SAU1c0032_orf_35p	12239
S1M10000043B08	3299	SAU200297	5778	SAU2c0274_orf_2p	12739
S1M10000043B09	3300	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000043B10	3301	SAU100436	5273	SAU1c0023_orf_20p	12154
S1M10000043B12	3302	SAU102142	5606	SAU1c0041_orf_13p	12457
S1M10000043C02	3303	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000043C07	3304	SAU101784	5530	SAU1c0037_orf_46p	12355
S1M10000043C11	3305	SAU201403	5815	SAU2c0423_orf_3p	12913
S1M10000043C12	3306	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000043D01	3307	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000043D02	3308	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000043D04	3309	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000043D10	3310	SAU102631	5721	SAU1c0045_orf_94p	12712
S1M10000043D12	3311	SAU100496	5279	SAU1c0041_orf_83p	12484
S1M10000043D12	3311	SAU301004	5882	SAU3c1255_orf_1p	13079
S1M10000043E02	3312	SAU100793	5329	SAU1c0028_orf_52p	12188
S1M10000043E02	3312	SAU301433	5895	SAU3c1420_orf_2p	13118
S1M10000043E03	3313	SAU102032	5591	SAU1c0029_orf_47p	12198
S1M10000043E05	3314	SAU102067	5598	SAU1c0034_orf_54p	12287
S1M10000043E07	3315	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000043E08	3316	SAU101344	5426	SAU1c0044_orf_41p	12620
S1M10000043E10	3317	SAU100186	5242	SAU1c0036_orf_19p	12317
S1M10000043E11	3318	SAU102498	5689	SAU1c0045_orf_270p	12688
S1M10000043E11	3318	SAU201381	5813	SAU2c0426_orf_16p	12923
S1M10000043E12	3319	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000043F01	3320	SAU101797	5537	SAU1c0032_orf_17p	12221
S1M10000043F01	3320	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000043F05	3321	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000043F07	3322	SAU102447	5672	SAU1c0045_orf_24p	12685
S1M10000043F07	3322	SAU102448	5673	SAU1c0045_orf_23p	12681
S1M10000043F08	3323	SAU101344	5426	SAU1c0044_orf_41p	12620
S1M10000043F09	3324	SAU101801	5541	#N/A	#N/A
S1M10000043G01	3325	SAU100059	5224	SAU1c0045_orf_10p	12652
S1M10000043G04	3326	SAU102423	5667	SAU1c0030_orf_23p	12208
S1M10000043G05	3327	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000043G09	3328	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000043G09	3328	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000043G10	3329	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000043H01	3330	SAU101797	5537	SAU1c0032_orf_17p	12221
S1M10000043H01	3330	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000043H03	3331	SAU101803	5543	SAU1c0032_orf_23p	12228
S1M10000043H03	3331	SAU101804	5544	#N/A	#N/A
S1M10000043H04	3332	SAU100128	5231	#N/A	#N/A
S1M10000043H04	3332	SAU101549	5476	SAU1c0043_orf_64p	12549
S1M10000043H04	3332	SAU101576	5488	SAU1c0044_orf_105p	12554
S1M10000043H05	3333	SAU200058	5773	SAU2c0134_orf_1p	12719
S1M10000043H05	3333	SAU200059	5774	SAU2c0134_orf_3p	12720
S1M10000043H06	3334	SAU102417	5663	SAU1c0030_orf_17p	12204
S1M10000043H06	3334	SAU102863	5737	#N/A	#N/A
S1M10000043H09	3335	SAU302950	5914	SAU3c1512_orf_12p	13160
S1M10000043H10	3336	SAU101024	5369	SAU1c0045_orf_90p	12711
S1M10000043H11	3337	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000044A02	3338	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000044A06	3339	SAU101777	5527	SAU1c0037_orf_39p	12352
S1M10000044A08	3340	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000044A09	3341	SAU102292	5638	SAU1c0038_orf_10p	12368
S1M10000044A11	3342	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000044A12	3343	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000044B01	3344	SAU102268	5630	SAU1c0032_orf_63p	12252
S1M10000044B02	3345	SAU101968	5581	SAU1c0028_orf_43p	12187
S1M10000044B05	3346	SAU100690	5309	#N/A	#N/A
S1M10000044B06	3347	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000044B06	3347	SAU102881	5740	SAU1c0032_orf_4p	12242
S1M10000044B08	3348	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000044B11	3349	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000044B12	3350	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000044C04	3351	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000044C06	3352	SAU101614	5494	SAU1c0044_orf_9p	12649
S1M10000044C07	3353	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000044C07	3353	SAU100965	5364	SAU1c0044_orf_87p	12642
S1M10000044C08	3354	SAU102909	5743	SAU1c0036_orf_16p	12315
S1M10000044C11	3355	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000044C12	3356	SAU102280	5632	SAU1c0038_orf_3p	12378
S1M10000044D01	3357	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000044D01	3357	SAU102880	5739	SAU1c0032_orf_1p	12224
S1M10000044D04	3358	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000044D06	3359	SAU101300	5415	SAU1c0044_orf_113p	12557
S1M10000044D06	3359	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000044D08	3360	SAU102270	5631	SAU1c0032_orf_65p	12253
S1M10000044D09	3361	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000044D10	3362	SAU201197	5806	SAU2c0429_orf_2p	12938
S1M10000044D11	3363	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000044D12	3364	SAU102231	5614	SAU1c0043_orf_18p	12527
S1M10000044D12	3364	SAU102232	5615	SAU1c0043_orf_19p	12530
S1M10000044E01	3365	SAU101371	5435	SAU1c0033_orf_7p	12275
S1M10000044E02	3366	SAU102283	5634	SAU1c0006_orf_1p	12119
S1M10000044E06	3367	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000044E07	3368	SAU301829	5902	SAU3c1515_orf_7p	13162
S1M10000044E09	3369	SAU101320	5420	SAU1c0015_orf_16p	12128
S1M10000044E10	3370	SAU100497	5280	SAU1c0018_orf_3p	12140
S1M10000044E11	3371	SAU101270	5410	SAU1c0037_orf_89p	12365
S1M10000044E02	3372	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000044F06	3373	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000044F08	3374	SAU101262	5406	SAU1c0042_orf_113p	12488
S1M10000044F10	3375	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000044F10	3375	SAU202882	5855	SAU2c0381_orf_3p	12848
S1M10000044G02	3376	SAU102933	5744	SAU1c0039_orf_62p	12412
S1M10000044G05	3377	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000044G08	3378	SAU102601	5707	SAU1c0041_orf_46p	12467
S1M10000044G08	3378	SAU102606	5711	SAU1c0041_orf_50p	12471
S1M10000044G10	3379	SAU101092	5381	SAU1c0028_orf_9p	12192
S1M10000044G10	3379	SAU202882	5855	SAU2c0381_orf_3p	12848
S1M10000044G11	3380	SAU101546	5475	SAU1c0037_orf_133p	12349
S1M10000044H06	3381	SAU100964	5363	SAU1c0044_orf_86p	12641
S1M10000044H06	3381	SAU100965	5364	SAU1c0044_orf_87p	12642
S1M10000044H07	3382	SAU100595	5294	SAU1c0043_orf_62p	12547
S1M10000044H08	3383	SAU101543	5473	SAU1c0037_orf_130p	12346
S1M10000044H09	3384	SAU100886	5349	SAU1c0018_orf_16p	12139
S1M10000044H09	3384	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000044H10	3385	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000044H11	3386	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000045A02	3387	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000045A06	3388	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000045A07	3389	SAU102378	5653	SAU1c0040_orf_61p	12437
S1M10000045A08	3390	SAU102336	5646	SAU1c0045_orf_146p	12659
S1M10000045A12	3391	SAU201765	5833	SAU2c0309_orf_5p	12770
S1M10000045B01	3392	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000045B02	3393	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000045B03	3394	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000045B07	3395	SAU101803	5543	SAU1c0032_orf_23p	12228
S1M10000045B10	3396	SAU200468	5781	SAU2c0429_orf_19p	12937
S1M10000045B11	3397	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000045B12	3398	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000045C02	3399	SAU100690	5309	#N/A	#N/A
S1M10000045C03	3400	SAU100887	5350	SAU1c0018_orf_15p	12138
S1M10000045C04	3401	SAU102286	5636	SAU1c0038_orf_6p	12393
S1M10000045C04	3401	SAU102287	5637	SAU1c0038_orf_7p	12398
S1M10000045C05	3402	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000045C07	3403	SAU101573	5485	SAU1c0044_orf_212p	12587
S1M10000045C09	3404	SAU101744	5520	SAU1c0037_orf_94p	12367
S1M10000045C09	3404	SAU300191	5868	SAU3c0672_orf_1p	13037
S1M10000045D01	3405	SAU101893	5572	SAU1c0034_orf_32p	12282
S1M10000045D03	3406	SAU101599	5491	SAU1c0041_orf_5p	12478
S1M10000045D07	3407	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000045D08	3408	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000045D09	3409	SAU101572	5484	SAU1c0044_orf_211p	12586
S1M10000045D10	3410	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000045D11	3411	SAU101492	5465	SAU1c0025_orf_21p	12166
S1M10000045D11	3411	SAU101493	5466	SAU1c0025_orf_22p	12167
S1M10000045D12	3412	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000045D12	3412	SAU101801	5541	#N/A	#N/A
S1M10000045E04	3413	SAU102132	5605	SAU1c0027_orf_19p	12177
S1M10000045E05	3414	SAU101491	5464	SAU1c0025_orf_20p	12165
S1M10000045E08	3415	SAU201752	5832	SAU2c0436_orf_19p	12963
S1M10000045E09	3416	SAU101794	5535	#N/A	#N/A
S1M10000045E10	3417	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000045E11	3418	SAU100970	5365	SAU1c0043_orf_197p	12529
S1M10000045E12	3419	SAU100547	5290	SAU1c0032_orf_3p	12240
S1M10000045F04	3420	SAU102241	5617	SAU1c0043_orf_25p	12539
S1M10000045F05	3421	SAU100114	5228	SAU1c0043_orf_225p	12535
S1M10000045F08	3422	SAU200657	5789	#N/A	#N/A
S1M10000045F11	3423	SAU102117	5603	SAU1c0027_orf_6p	12181
S1M10000045F12	3424	SAU101806	5546	SAU1c0032_orf_25p	12230
S1M10000045G03	3425	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000045G06	3426	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000045G07	3427	SAU101561	5479	SAU1c0022_orf_4p	12149
S1M10000045G08	3428	SAU100690	5309	#N/A	#N/A
S1M10000045G10	3429	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000045G12	3430	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000045H06	3431	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000045H10	3432	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000045H11	3433	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000046A03	3434	SAU202731	5850	#N/A	#N/A
S1M10000046A04	3435	SAU100062	5225	SAU1c0035_orf_98p	12309
S1M10000046A04	3435	SAU100231	5245	#N/A	#N/A
S1M10000046A06	3436	SAU101383	5438	SAU1c0022_orf_20p	12147
S1M10000046A08	3437	SAU200994	5802	SAU2c0428_orf_4p	12935
S1M10000046A09	3438	SAU100315	5260	SAU1c0037_orf_62p	12358
S1M10000046A11	3439	SAU100432	5271	SAU1c0040_orf_88p	12450
S1M10000046A11	3439	SAU100433	5272	SAU1c0040_orf_87p	12449
S1M10000046A12	3440	SAU101814	5551	SAU1c0032_orf_32p	12237
S1M10000046B01	3441	SAU102334	5645	SAU1c0045_orf_144p	12658
S1M10000046B03	3442	SAU101039	5373	SAU1c0043_orf_181p	12522
S1M10000046B04	3443	SAU101797	5537	SAU1c0032_orf_17p	12221
S1M10000046B05	3444	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000046B07	3445	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000046B08	3446	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000046B09	3447	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000046B11	3448	SAU102541	5697	SAU1c0045_orf_195p	12668
S1M10000046B12	3449	SAU101400	5444	SAU1c0036_orf_35p	12326
S1M10000046C02	3450	SAU200601	5787	#N/A	#N/A
S1M10000046C04	3451	SAU100118	5229	SAU1c0015_orf_13p	12125
S1M10000046C05	3452	SAU101159	5387	SAU1c0036_orf_46p	12331
S1M10000046C06	3453	SAU102585	5703	SAU1c0044_orf_289p	12611
S1M10000046C06	3453	SAU201773	5834	SAU2c0446_orf_4p	12996
S1M10000046C07	3454	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000046C08	3455	SAU100414	5270	SAU1c0022_orf_24p	12148
S1M10000046C11	3456	SAU102144	5608	SAU1c0041_orf_15p	12459
S1M10000046C12	3457	SAU100313	5259	SAU1c0045_orf_153p	12661
S1M10000046C12	3457	SAU100359	5264	SAU1c0032_orf_35p	12239
S1M10000046D01	3458	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000046D02	3459	SAU102144	5608	SAU1c0041_orf_15p	12459
S1M10000046D03	3460	SAU101857	5560	SAU1c0044_orf_156p	12569
S1M10000046D04	3461	SAU102433	5668	SAU1c0045_orf_37p	12701
S1M10000046D05	3462	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000046D08	3463	SAU101495	5467	SAU1c0037_orf_65p	12360
S1M10000046D09	3464	SAU100679	5305	SAU1c0018_orf_14p	12137
S1M10000046D10	3465	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000046D11	3466	SAU100496	5279	SAU1c0041_orf_83p	12484
S1M10000046D11	3466	SAU301004	5882	SAU3c1255_orf_1p	13079
S1M10000046D12	3467	SAU100496	5279	SAU1c0041_orf_83p	12484
S1M10000046D12	3467	SAU301004	5882	SAU3c1255_orf_1p	13079
S1M10000046E01	3468	SAU101610	5492	SAU1c0044_orf_5p	12629
S1M10000046E02	3469	SAU101857	5560	SAU1c0044_orf_156p	12569
S1M10000046E04	3470	SAU101800	5540	SAU1c0032_orf_20p	12225
S1M10000046E04	3470	SAU101801	5541	#N/A	#N/A
S1M10000046E07	3471	SAU100521	5283	SAU1c0044_orf_250p	12600
S1M10000046E08	3472	SAU102283	5634	SAU1c0006_orf_1p	12119
S1M10000046E10	3473	SAU102283	5634	SAU1c0006_orf_1p	12119
S1M10000046F01	3474	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000046F02	3475	SAU100546	5289	SAU1c0032_orf_2p	12235
S1M10000046F02	3475	SAU102880	5739	SAU1c0032_orf_1p	12224
S1M10000046F05	3476	SAU102671	5729	SAU1c0024_orf_9p	12161
S1M10000046F06	3477	SAU100702	5310	SAU1c0029_orf_34p	12196
S1M10000046F06	3477	SAU300825	5878	SAU3c1171_orf_1p	13068
S1M10000046F08	3478	SAU102297	5640	SAU1c0045_orf_41p	12704
S1M10000046F09	3479	SAU100517	5282	#N/A	#N/A
S1M10000046F10	3480	SAU102059	5597	SAU1c0034_orf_51p	12286
S1M10000046F12	3481	SAU101365	5432	SAU1c0044_orf_112p	12556
S1M10000046G01	3482	SAU200752	5795	SAU2c0354_orf_5p	12809
S1M10000046G01	3482	SAU300975	5880	SAU3c1240_orf_3p	13075
S1M10000046G02	3483	SAU101571	5483	SAU1c0044_orf_210p	12585
S1M10000046G03	3484	SAU100773	5326	SAU1c0038_orf_39p	12377
S1M10000046G04	3485	SAU100436	5273	SAU1c0023_orf_20p	12154
S1M10000046G07	3486	SAU101866	5564	SAU1c0036_orf_21p	12319
S1M10000046G09	3487	SAU102663	5727	SAU1c0024_orf_2p	12158
S1M10000046G10	3488	SAU101756	5524	SAU1c0040_orf_82p	12445
S1M10000046H01	3489	SAU101445	5452	SAU1c0038_orf_47p	12382
S1M10000046H01	3489	SAU101446	5453	SAU1c0038_orf_48p	12383
S1M10000046H10	3490	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000047A03	3491	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000047A04	3492	SAU300572	5873	SAU3c1019_orf_1p	13051
S1M10000047A05	3493	SAU101805	5545	SAU1c0032_orf_24p	12229
S1M10000047A06	3494	SAU201775	5835	SAU2c0446_orf_4p	12996
S1M10000047A06	3494	SAU301030	5883	SAU3c1268_orf_1p	13080
S1M10000047A07	3495	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000047A08	3496	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000047A09	3497	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000047A10	3498	SAU100751	5321	SAU1c0036_orf_59p	12335
S1M10000047A11	3499	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000047A12	3500	SAU100300	5253	SAU1c0040_orf_90p	12451
S1M10000047B02	3501	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000047B04	3502	SAU101366	5433	SAU1c0033_orf_2p	12266
S1M10000047B05	3503	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000047B06	3504	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000047B08	3505	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000047B09	3506	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000047B10	3507	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000047B12	3508	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000047C01	3509	SAU100275	5252	SAU1c0036_orf_15p	12314
S1M10000047C02	3510	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000047C03	3511	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000047C04	3512	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000047C06	3513	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000047C08	3514	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000047C09	3515	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000047C11	3516	SAU201775	5835	SAU2c0446_orf_4p	12996
S1M10000047C11	3516	SAU301030	5883	SAU3c1268_orf_1p	13080
S1M10000047C12	3517	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000047D02	3518	SAU101387	5440	SAU1c0038_orf_52p	12386
S1M10000047D03	3519	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000047D04	3520	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000047D05	3521	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000047D09	3522	SAU100921	5355	SAU1c0038_orf_76p	12396
S1M10000047D10	3523	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000047D11	3524	SAU103038	5757	#N/A	#N/A
S1M10000047D12	3525	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000047E01	3526	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000047E02	3527	SAU100131	5232	SAU1c0043_orf_156p	12517
S1M10000047E03	3528	SAU102452	5676	SAU1c0045_orf_20p	12674
S1M10000047E04	3529	SAU101996	5584	SAU1c0040_orf_99p	12456
S1M10000047E05	3530	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000047E06	3531	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000047E08	3532	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000047E09	3533	SAU100810	5333	SAU1c0037_orf_11p	12343
S1M10000047E10	3534	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000047E11	3535	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000047E12	3536	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000047F02	3537	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000047F03	3538	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000047F04	3539	SAU300572	5873	SAU3c1019_orf_1p	13051
S1M10000047F05	3540	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000047F06	3541	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000047F07	3542	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000047F08	3543	SAU101242	5404	SAU1c0044_orf_18p	12578
S1M10000047F09	3544	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000047F10	3545	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000047F11	3546	SAU101805	5545	SAU1c0032_orf_24p	12229
S1M10000047F12	3547	SAU101808	5548	SAU1c0032_orf_27p	12232
S1M10000047G01	3548	SAU101369	5434	SAU1c0033_orf_5p	12274
S1M10000047G02	3549	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000047G04	3550	SAU101341	5424	SAU1c0044_orf_38p	12618
S1M10000047G05	3551	SAU100684	5306	SAU1c0044_orf_68p	12632
S1M10000047G05	3551	SAU100685	5307	SAU1c0044_orf_69p	12633
S1M10000047G06	3552	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000047G07	3553	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000047G08	3554	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000047G09	3555	SAU100810	5333	SAU1c0037_orf_11p	12343
S1M10000047G10	3556	SAU102607	5712	SAU1c0041_orf_51p	12472
S1M10000047H03	3557	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000047H04	3558	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000047H05	3559	SAU102452	5676	SAU1c0045_orf_20p	12674
S1M10000047H06	3560	SAU103038	5757	#N/A	#N/A
S1M10000047H07	3561	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000047H08	3562	SAU101798	5538	SAU1c0032_orf_18p	12222
S1M10000047H09	3563	SAU102578	5701	SAU1c0039_orf_61p	12411
S1M10000047H11	3564	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000048A02	3565	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000048A03	3566	SAU100866	5344	SAU1c0044_orf_100p	12553
S1M10000048A04	3567	SAU103038	5757	#N/A	#N/A
S1M10000048A05	3568	SAU101868	5565	SAU1c0036_orf_23p	12320
S1M10000048A06	3569	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000048A07	3570	SAU101156	5386	SAU1c0036_orf_12p	12311
S1M10000048A09	3571	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000048A10	3572	SAU201571	5824	SAU2c0447_orf_17p	12997
S1M10000048A11	3573	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000048A12	3574	SAU101271	5411	SAU1c0037_orf_90p	12366
S1M10000048B02	3575	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000048B05	3576	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000048B08	3577	SAU102452	5676	SAU1c0045_orf_20p	12674
S1M10000048B10	3578	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000048B11	3579	SAU103038	5757	#N/A	#N/A
S1M10000048B12	3580	SAU200916	5797	SAU2c0373_orf_4p	12838
S1M10000048B12	3580	SAU301620	5899	SAU3c1478_orf_2p	13140
S1M10000048C01	3581	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000048C02	3582	SAU301465	5896	SAU3c1429_orf_4p	13121
S1M10000048C03	3583	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000048C05	3584	SAU300998	5881	SAU3c1253_orf_3p	13077
S1M10000048C06	3585	SAU100684	5306	SAU1c0044_orf_68p	12632
S1M10000048C06	3585	SAU100685	5307	SAU1c0044_orf_69p	12633
S1M10000048C07	3586	SAU102452	5676	SAU1c0045_orf_20p	12674
S1M10000048C08	3587	SAU101632	5499	SAU1c0039_orf_3p	12407
S1M10000048C09	3588	SAU101907	5574	SAU1c0040_orf_79p	12442
S1M10000048C11	3589	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000048D02	3590	SAU100123	5230	SAU1c0043_orf_189p	12526
S1M10000048D02	3590	SAU102001	5586	SAU1c0040_orf_102p	12424
S1M10000048D02	3590	SAU103159	5762	SAU1c0045_orf_204p	12670
S1M10000048D02	3590	SAU201827	5837	SAU2c0449_orf_21p	13002
S1M10000048D08	3591	SAU300572	5873	SAU3c1019_orf_1p	13051
S1M10000048D09	3592	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000048D10	3593	SAU302950	5914	SAU3c1512_orf_12p	13160
S1M10000048D12	3594	SAU102599	5706	SAU1c0041_orf_45p	12466
S1M10000048D12	3594	SAU103191	5765	SAU1c00241_orf_44p	12465
S1M10000048E02	3595	SAU101028	5370	SAU1c0043_orf_7p	12552
S1M10000048E03	3596	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000048E04	3597	SAU101545	5474	SAU1c0037_orf_132p	12348
S1M10000048E06	3598	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000048E07	3599	SAU100959	5359	SAU1c0042_orf_102p	12485
S1M10000048E08	3600	SAU101807	5547	SAU1c0032_orf_26p	12231
S1M10000048E10	3601	SAU302950	5914	SAU3c1512_orf_12p	13160
S1M10000048F02	3602	SAU101387	5440	SAU1c0038_orf_52p	12386
S1M10000048F07	3603	SAU101175	5388	SAU1c0031_orf_1p	12213
S1M10000048F08	3604	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000048F09	3605	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000048F11	3606	SAU202174	5845	SAU2c0412_orf_3p	12895
S1M10000048F11	3606	SAU301148	5888	#N/A	#N/A
S1M10000048F12	3607	SAU103038	5757	#N/A	#N/A
S1M10000048G02	3608	SAU102453	5677	SAU1c0045_orf_19p	12669
S1M10000048G03	3609	SAU200928	5798	SAU2c0365_orf_5p	12815
S1M10000048G04	3610	SAU102602	5708	SAU1c0032_orf_5p	12249
S1M10000048G05	3611	SAU101752	5522	SAU1c0040_orf_85p	12447
S1M10000048G07	3612	SAU102006	5589	SAU1c0040_orf_107p	12427
S1M10000048G07	3612	SAU102007	5590	SAU1c0040_orf_108p	12428
S1M10000048G10	3613	SAU101793	5534	SAU1c0032_orf_14p	12218
S1M10000048G11	3614	SAU200006	5770	SAU2c0157_orf_1p	12723
S1M10000048H01	3615	SAU100608	5297	SAU1c0034_orf_69p	12293
S1M10000048H02	3616	SAU100158	5238	SAU1c0040_orf_80p	12443
S1M10000048H03	3617	SAU101815	5552	SAU1c0032_orf_33p	12238
S1M10000048H04	3618	SAU102200	5611	SAU1c0045_orf_168p	12665
S1M10000048H05	3619	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000048H07	3620	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000048H08	3621	SAU100141	5236	SAU1c0032_orf_8p	12259
S1M10000048H09	3622	SAU100157	5237	SAU1c0040_orf_81p	12444
S1M10000048H10	3623	SAU101791	5532	SAU1c0032_orf_12p	12216
S1M10000048H11	3624	SAU101271	5411	SAU1c0037_orf_90p	12366
K1M10000037D10	1077	ECO100078	10023	#N/A	#N/A
K1M10000002F02	1054	ECO100252	10052	#N/A	#N/A
K1M10000007F01	1057	ECO100397	10064	#N/A	#N/A
K1M10000007F01	1057	ECO100398	10065	#N/A	#N/A
K1M10000004F06	1056	ECO100990	10120	#N/A	#N/A
K1M10000019D06	1064	ECO100990	10120	#N/A	#N/A
K1M10000030C07	1070	ECO102108	10214	#N/A	#N/A
K1M10000044G05	1086	ECO102262	10228	#N/A	#N/A
K1M10000036G08	1076	ECO102447	10247	#N/A	#N/A
K1M10000033E01	1075	ECO102539	10258	#N/A	#N/A
K1M10000043D05	1081	ECO102620	10266	#N/A	#N/A
K1M10000045D10	1088	ECO102620	10266	#N/A	#N/A
K1M10000003C01	1055	ECO103101	10315	#N/A	#N/A
K1M10000030E07	1071	ECO104120	10462	#N/A	#N/A
K1M10000045A07	1087	ECO104268	10475	#N/A	#N/A
S4M10000020F05	3721	ECO100449	#N/A	#N/A	#N/A
S4M10000026D04	3742	ECO100676	#N/A	#N/A	#N/A
S4M10000014D07	3706	ECO100757	#N/A	#N/A	#N/A
S4M10000015B11	3708	ECO100757	#N/A	#N/A	#N/A
S4M10000016A02	3710	ECO100757	#N/A	#N/A	#N/A
S4M10000022E12	3725	ECO100757	#N/A	#N/A	#N/A
S4M10000026E12	3744	ECO100757	#N/A	#N/A	#N/A
S4M10000035E03	3764	ECO100757	#N/A	#N/A	#N/A
S4M10000008H10	3693	ECO100758	10101	#N/A	#N/A
S4M10000014B05	3704	ECO100758	10101	#N/A	#N/A
S4M10000014D07	3706	ECO100758	10101	#N/A	#N/A
S4M10000015B11	3708	ECO100758	10101	#N/A	#N/A
S4M10000015E09	3709	ECO100758	10101	#N/A	#N/A
S4M10000016A02	3710	ECO100758	10101	#N/A	#N/A
S4M10000022E12	3725	ECO100758	10101	#N/A	#N/A
S4M10000029B12	3747	ECO100758	10101	#N/A	#N/A
S4M10000020G10	3722	ECO100796	10105	#N/A	#N/A
S4M10000023F01	3728	ECO101916	#N/A	#N/A	#N/A
S4M10000014H02	3707	ECO102028	#N/A	#N/A	#N/A
S4M10000012B06	3700	ECO102066	#N/A	#N/A	#N/A
S4M10000035D01	3762	ECO102066	#N/A	#N/A	#N/A
S4M10000024C06	3730	ECO102189	10224	#N/A	#N/A
S4M10000006C05	3689	ECO102282	#N/A	#N/A	#N/A
S4M10000037H09	3772	ECO102296	#N/A	#N/A	#N/A
S4M10000030G11	3751	ECO102302	#N/A	#N/A	#N/A
S4M10000026C10	3741	ECO102416	10245	#N/A	#N/A
34M10000026E06	3743	ECO102416	10245	#N/A	#N/A
S4M10000036F07	3768	ECO102416	10245	#N/A	#N/A
S4M10000034A02	3756	ECO102526	#N/A	#N/A	#N/A
S4M10000006F08	3690	ECO102541	10259	#N/A	#N/A
S4M10000002G08	3684	ECO102730	#N/A	#N/A	#N/A
S4M10000026C10	3741	ECO102870	#N/A	#N/A	#N/A
S4M10000026E06	3743	ECO102870	#N/A	#N/A	#N/A
S4M10000036F07	3768	ECO102870	#N/A	#N/A	#N/A
S4M10000034H05	3759	ECO102900	#N/A	#N/A	#N/A
S4M10000006A08	3688	ECO102944	#N/A	#N/A	#N/A
S4M10000014D04	3705	ECO102986	10301	#N/A	#N/A
S4M10000022D12	3724	ECO103238	10354	#N/A	#N/A
S4M10000033F08	3753	ECO103238	10354	#N/A	#N/A
S4M10000033G09	3755	ECO103238	10354	#N/A	#N/A
S4M10000001C01	3680	ECO103265	10365	#N/A	#N/A
S4M10000024B02	3729	ECO103280	#N/A	#N/A	#N/A
S4M10000020A04	3720	ECO103461	#N/A	#N/A	#N/A
S4M10000002B06	3681	ECO103666	#N/A	#N/A	#N/A
S4M10000019H06	3719	ECO103738	#N/A	#N/A	#N/A
S4M10000024H02	3736	ECO103738	#N/A	#N/A	#N/A
S4M10000030F07	3750	ECO103738	#N/A	#N/A	#N/A
S4M10000034H09	3760	ECO103738	#N/A	#N/A	#N/A
S4M10000032B12	3752	ECO103935	#N/A	#N/A	#N/A
S4M10000002B09	3682	ECO103936	#N/A	#N/A	#N/A
S4M10000037A10	3770	ECO103951	#N/A	#N/A	#N/A
S4M10000018D09	3711	ECO104080	#N/A	#N/A	#N/A
S4M10000035F09	3766	EFA101301	#N/A	EFA1c0040_orf_173p	#N/A
S4M10000035F09	3766	EFA102170	#N/A	EFA1c0040_orf_121p	#N/A
S4M10000001C01	3680	EFA103268	#N/A	EFA1c0010_orf_1p	10479
S4M10000036F07	3768	HPY200334	#N/A	#N/A	#N/A
S4M10000001C01	3680	HPY201116	11570	#N/A	#N/A
S4M10000037A10	3770	KPN100467	#N/A	KPN1c0583_orf_2p	#N/A
S4M10000030G11	3751	KPN101078	#N/A	KPN1c1190_orf_1p	#N/A
S4M10000024B02	3729	KPN101160	#N/A	KPN1c1224_orf_1p	#N/A
S4M10000032B12	3752	KPN101846	#N/A	KPN1c1681_orf_2p	#N/A
S4M10000006C05	3689	KPN102011	#N/A	KPN1c1862_orf_4p	#N/A
S4M10000035B01	3761	KPN102014	#N/A	KPN1c1786_orf_1p	11654
S4M10000012B06	3700	KPN102524	#N/A	#N/A	#N/A
S4M10000035D01	3762	KPN102524	#N/A	#N/A	#N/A
S4M10000002G04	3683	KPN102558	#N/A	KPN1c1982_orf_3p	#N/A
S4M10000002G08	3684	KPN102558	#N/A	KPN1c1982_orf_3p	#N/A
S4M10000008H10	3693	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000014B05	3704	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000014D07	3706	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000015B11	3708	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000015E09	3709	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000016A02	3710	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000022E12	3725	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000026E12	3744	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000035E03	3764	KPN103640	#N/A	KPN1c2761_orf_1p	#N/A
S4M10000008H10	3693	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000014B05	3704	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000014D07	3706	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000015B11	3708	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000015E09	3709	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000016A02	3710	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000022E12	3725	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000029B12	3747	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000035E03	3764	KPN103641	#N/A	KPN1c2761_orf_2p	11705
S4M10000026C10	3741	KPN103871	#N/A	KPN1c2844_orf_2p	#N/A
S4M10000026E06	3743	KPN103871	#N/A	KPN1c2844_orf_2p	#N/A
S4M10000036F07	3768	KPN103871	#N/A	KPN1c2844_orf_2p	#N/A
S4M10000019H06	3719	KPN104321	#N/A	KPN1c3011_orf_1p	#N/A
S4M10000024H02	3736	KPN104321	#N/A	KPN1c3011_orf_1p	#N/A
S4M10000030E07	3750	KPN104321	#N/A	KPN1c3011_orf_1p	#N/A
S4M10000034H09	3760	KPN104321	#N/A	KPN1c3011_orf_1p	#N/A
S4M10000035F02	3765	KPN104321	#N/A	KPN1c3011_orf_1p	#N/A
S4M10000002B06	3681	KPN104608	#N/A	KPN1c3070_orf_3p	#N/A
S4M10000018D09	3711	KPN105957	#N/A	KPN1c3587_orf_1p	#N/A
S4M10000024C06	3730	KPN106468	#N/A	KPN1c1186_orf_1p	11638
S4M10000009A05	3694	KPN106681	#N/A	#N/A	#N/A
S4M10000010D04	3696	KPN106681	#N/A	#N/A	#N/A
S4M10000011E08	3699	KPN106681	#N/A	#N/A	#N/A
S4M10000020A04	3720	KPN106813	#N/A	KPN1c2010_orf_1p	#N/A
S4M10000005G05	3685	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000006F08	3690	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000007G01	3691	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000008C08	3692	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000018E10	3712	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000018E10	3713	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000019G04	3717	KPN106840	#N/A	KPN1c2087_orf_1p	11664
S4M10000001C01	3680	SAU101756	#N/A	SAU1c0040_orf_82p	12445
S4M10000001C01	3680	SAU200931	#N/A	SAU2c0151_orf_1p	12722
S4M10000001C01	3680	SPN102008	#N/A	SPN1c0007_orf_92p	#N/A
S4M10000001C01	3680	SPN202419	#N/A	SPN2c0592_orf_1p	#N/A
S4M10000019H06	3719	STY000068	#N/A	STYc00048_orf_26p	#N/A
S4M10000024H02	3736	STY000068	#N/A	STYc00048_orf_26p	#N/A
S4M10000030F07	3750	STY000068	#N/A	STYc00048_orf_26p	#N/A
S4M10000034H09	3760	STY000068	#N/A	STYc00048_orf_26p	#N/A
S4M10000035F02	3765	STY000068	#N/A	STYc00048_orf_26p	#N/A
S4M10000026C10	3741	STY000225	#N/A	STYc00041_orf_40p	13740
S4M10000026E06	3743	STY000225	#N/A	STYc00041_orf_40p	13740
S4M10000036F07	3768	STY000225	#N/A	STYc00041_orf_40p	13740
S4M10000026D04	3742	STY000244	#N/A	STYc00041_orf_11p	#N/A
S4M10000034H05	3759	STY000244	#N/A	STYc00041_orf_11p	#N/A
S4M10000027E02	3746	STY000409	#N/A	STYc00053_orf_110p	#N/A
S4M10000025E02	3738	STY000498	#N/A	STYc00072_orf_46p	#N/A
S4M10000034A02	3756	STY000498	#N/A	STYc00072_orf_46p	#N/A
S4M10000034D06	3758	STY000625	#N/A	STYc00062_orf_63p	13784
S4M10000014D04	3705	STY000737	#N/A	STYc00054_orf_108p	13759
S4M10000013H02	3703	STY000753	#N/A	STYc00054_orf_91p	#N/A
S4M10000006A08	3688	STY000817	#N/A	STYc00054_orf_145p	#N/A
S4M10000036D07	3767	STY000817	#N/A	STYc00054_orf_145p	#N/A
S4M10000018D09	3711	STY000848	#N/A	STYc00101_orf_23p	#N/A
S4M10000014H02	3707	STY000968	#N/A	STYc00086_orf_86p	#N/A
S4M10000024G04	3734	STY000986	#N/A	#N/A	#N/A
S4M10000025H07	3740	STY000986	#N/A	#N/A	#N/A
S4M10000029D12	3748	STY000986	#N/A	#N/A	#N/A
S4M10000037A10	3770	STY001009	#N/A	STYc00080_orf_144p	#N/A
S4M10000035F09	3766	STY001185	#N/A	STYc00098_orf_2p	#N/A
S4M10000026D04	3742	STY001220	#N/A	STYc00123_orf_17p	#N/A
S4M10000022H06	3727	STY001285	#N/A	#N/A	#N/A
S4M10000030D03	3749	STY001285	#N/A	#N/A	#N/A
S4M10000037E10	3771	STY001363	#N/A	STYc00034_orf_126p	#N/A
S4M10000002B06	3681	STY001380	#N/A	STYc00119_orf_3p	#N/A
S4M10000011D08	3698	STY001534	#N/A	#N/A	#N/A
S4M10000024C11	3731	STY001582	#N/A	#N/A	#N/A
S4M10000025A11	3737	STY001582	#N/A	#N/A	#N/A
S4M10000035F09	3766	STY001619	#N/A	#N/A	#N/A
S4M10000022D12	3724	STY001777	#N/A	STYc00187_orf_4p	13970
S4M10000033F08	3753	STY001777	#N/A	STYc00187_orf_4p	13970
S4M10000033G09	3755	STY001777	#N/A	STYc00187_orf_4p	13970
S4M10000001C01	3680	STY001790	#N/A	STYc00187_orf_14p	13967
S4M10000026C10	3741	STY001853	#N/A	STYc00180_orf_22p	#N/A
S4M10000026E06	3743	STY001853	#N/A	STYc00180_orf_22p	#N/A
S4M10000036F07	3768	STY001853	#N/A	STYc00180_orf_22p	#N/A
S4M10000020A04	3720	STY002064	#N/A	STYc00074_orf_163p	#N/A
S4M10000020A04	3720	STY002066	#N/A	#N/A	#N/A
S4M10000024B02	3729	STY002145	#N/A	STYc00074_orf_17p	#N/A
S4M10000010B05	3695	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000012B12	3701	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000022D04	3723	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000022G07	3726	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000024G01	3733	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000024G09	3735	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000025E05	3739	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000027C10	3745	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000034A09	3757	STY002525	#N/A	STYc00114_orf_159p	#N/A
S4M10000037H09	3772	STY002590	#N/A	STYc00114_orf_104p	#N/A
S4M10000002G04	3683	STY002623	#N/A	STYc00114_orf_90p	#N/A
S4M10000002G08	3684	STY002623	#N/A	STYc00114_orf_90p	#N/A
S4M10000033G05	3754	STY002638	#N/A	STYc00114_orf_15p	13870
S4M10000006A06	3687	STY002672	#N/A	STYc00114_orf_136p	#N/A
S4M10000010H04	3697	STY002711	#N/A	STYc00223_orf_1p	#N/A
S4M10000005H02	3686	STY002738	#N/A	STYc00223_orf_17p	#N/A
S4M10000012B06	3700	STY002826	#N/A	STYc00152_orf_12p	#N/A
S4M10000035D01	3762	STY002826	#N/A	STYc00152_orf_12p	#N/A
S4M10000018G03	3714	STY002889	#N/A	#N/A	#N/A
S4M10000018H04	3715	STY002889	#N/A	#N/A	#N/A
S4M10000019F05	3716	STY002889	#N/A	#N/A	#N/A
S4M10000019G05	3718	STY002889	#N/A	#N/A	#N/A
S4M10000037E10	3771	STY002959	#N/A	STYc00215_orf_11p	14011
S4M10000002B09	3682	STY003082	#N/A	STYc00238_orf_12p	#N/A
S4M10000032B12	3752	STY003084	#N/A	STYc00238_orf_13p	#N/A
S4M10000024C06	3730	STY003375	#N/A	STYc00183_orf_19p	13957
S4M10000012D02	3702	STY003377	#N/A	#N/A	#N/A
S4M10000030G11	3751	STY003384	#N/A	STYc00183_orf_130p	#N/A
S4M10000006F08	3690	STY003460	#N/A	STYc00339_orf_20p	14087
S4M10000024F08	3732	STY003664	#N/A	#N/A	#N/A
S4M10000020G10	3722	STY004048	#N/A	STYc00207_orf_161p	13999
S4M10000008H10	3693	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000014B05	3704	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000015E09	3709	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000016A02	3710	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000022E12	3725	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000029B12	3747	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000035E03	3764	STY004152	#N/A	STYc00207_orf_194p	14003
S4M10000008H10	3693	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000014B05	3704	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000014D07	3706	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000015B11	3708	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000015E09	3709	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000016A02	3710	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000022E12	3725	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000026E12	3744	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000035E03	3764	STY004154	#N/A	STYc00207_orf_195p	#N/A
S4M10000005G05	3685	STY004239	#N/A	#N/A	#N/A
S4M10000007G01	3691	STY004239	#N/A	#N/A	#N/A
S4M10000008C08	3692	STY004239	#N/A	#N/A	#N/A
S4M10000018E10	3712	STY004239	#N/A	#N/A	#N/A
S4M10000018F10	3713	STY004239	#N/A	#N/A	#N/A
S4M10000019G04	3717	STY004239	#N/A	#N/A	#N/A
S4M10000037A04	3769	STY005016	#N/A	#N/A	#N/A
K1M10000007F01	1057	SAU100968	#N/A	SAU1c0044_orf_90p	12643
K1M10000007E01	1057	SAU201145	#N/A	SAU2c0405_orf_7p	12884
K1M10000007F01	1057	SPN101971	#N/A	SPN1c0209_orf_54p	#N/A
K1M10000007F01	1057	SPN201024	#N/A	SPN2c0417_orf_4p	#N/A
K1M10000003C01	1055	STY000773	#N/A	STYc00054_orf_16p	13764
K1M10000023E09	1068	STY000886	#N/A	#N/A	#N/A
K1M10000023E10	1069	STY000886	#N/A	#N/A	#N/A
K1M10000007F01	1057	STY001430	#N/A	STYc00148_orf_11p	13915
K1M10000007F01	1057	STY001433	#N/A	STYc00148_orf_12p	13916
K1M10000036G08	1076	STY001867	#N/A	STYc00180_orf_50p	13948
K1M10000030C07	1070	STY002768	#N/A	#N/A	#N/A
K1M10000037D10	1077	STY002995	#N/A	STYc00215_orf_67p	14018
K1M10000044G05	1086	STY003357	#N/A	STYc00183_orf_91p	13963

[0880]

	TABLE IC
	PathoSeq Gene Locus	Nucleotide SeqID	Protein SeqID
	EFA100001	3806	4861
	EFA100023	3807	4862
	EFA100065	3808	4863
	EFA100151	3809	4864
	EFA100157	3810	4865
	EFA100165	3811	4866
	EFA100190	3812	4867
	EFA100194	3813	4868
	EFA100200	3814	4869
	EFA100210	3815	4870
	EFA100211	3816	4871
	EFA100289	3817	4872
	EFA100295	3818	4873
	EFA100312	3819	4874
	EFA100329	3820	4875
	EFA100394	3821	4876
	EFA100397	3822	4877
	EFA100399	3823	4878
	EFA100426	3824	4879
	EFA100478	3825	4880
	EFA100615	3826	4881
	EFA100617	3827	4882
	EFA100641	3828	4883
	EFA100642	3829	4884
	EFA100668	3830	4885
	EFA100689	3831	4886
	EFA100704	3832	4887
	EFA100739	3833	4888
	EFA100740	3834	4889
	EFA100741	3835	4890
	EFA100742	3836	4891
	EFA100748	3837	4892
	EFA100756	3838	4893
	EFA100757	3839	4894
	EFA100783	3840	4895
	EFA100795	3841	4896
	EFA100798	3842	4897
	EFA100811	3843	4898
	EFA100870	3844	4899
	EFA100914	3845	4900
	EFA100919	3846	4901
	EFA100955	3847	4902
	EFA100970	3848	4903
	EFA100978	3849	4904
	EFA100991	3850	4905
	EFA101022	3851	4906
	EFA101060	3852	4907
	EFA101079	3853	4908
	EFA101080	3854	4909
	EFA101086	3855	4910
	EFA101120	3856	4911
	EFA101121	3857	4912
	EFA101123	3858	4913
	EFA101141	3859	4914
	EFA101150	3860	4915
	EFA101159	3861	4916
	EFA101160	3862	4917
	EFA101161	3863	4918
	EFA101162	3864	4919
	EFA101163	3865	4920
	EFA101164	3866	4921
	EFA101165	3867	4922
	EFA101169	3868	4923
	EFA101253	3869	4924
	EFA101257	3870	4925
	EFA101258	3871	4926
	EFA101322	3872	4927
	EFA101339	3873	4928
	EFA101340	3874	4929
	EFA101354	3875	4930
	EFA101370	3876	4931
	EFA101403	3877	4932
	EFA101404	3878	4933
	EFA101409	3879	4934
	EFA101410	3880	4935
	EFA101411	3881	4936
	EFA101412	3882	4937
	EFA101413	3883	4938
	EFA101414	3884	4939
	EFA101415	3885	4940
	EFA101416	3886	4941
	EFA101417	3887	4942
	EFA101424	3888	4943
	EFA101425	3889	4944
	EFA101477	3890	4945
	EFA101536	3891	4946
	EFA101540	3892	4947
	EFA101541	3893	4948
	EFA101583	3894	4949
	EFA101670	3895	4950
	EFA101682	3896	4951
	EFA101685	3897	4952
	EFA101686	3898	4953
	EFA101695	3899	4954
	EFA101736	3900	4955
	EFA101737	3901	4956
	EFA101753	3902	4957
	EFA101765	3903	4958
	EFA101790	3904	4959
	EFA101791	3905	4960
	EFA101792	3906	4961
	EFA101795	3907	4962
	EFA101797	3908	4963
	EFA101799	3909	4964
	EFA101833	3910	4965
	EFA101868	3911	4966
	EFA101872	3912	4967
	EFA101873	3913	4968
	EFA101892	3914	4969
	EFA101924	3915	4970
	EFA101925	3916	4971
	EFA101963	3917	4972
	EFA102006	3918	4973
	EFA102022	3919	4974
	EFA102023	3920	4975
	EFA102051	3921	4976
	EFA102091	3922	4977
	EFA102110	3923	4978
	EFA102183	3924	4979
	EFA102185	3925	4980
	EFA102186	3926	4981
	EFA102201	3927	4982
	EFA102205	3928	4983
	EFA102253	3929	4984
	EFA102282	3930	4985
	EFA102326	3931	4986
	EFA102338	3932	4987
	EFA102350	3933	4988
	EFA102351	3934	4989
	EFA102352	3935	4990
	EFA102353	3936	4991
	EFA102389	3937	4992
	EFA102453	3938	4993
	EFA102501	3939	4994
	EFA102502	3940	4995
	EFA102503	3941	4996
	EFA102518	3942	4997
	EFA102541	3943	4998
	EFA102542	3944	4999
	EFA102549	3945	5000
	EFA102551	3946	5001
	EFA102554	3947	5002
	EFA102655	3948	5003
	EFA102656	3949	5004
	EFA102698	3950	5005
	EFA102728	3951	5006
	EFA102736	3952	5007
	EFA102764	3953	5008
	EFA102774	3954	5009
	EFA102780	3955	5010
	EFA102788	3956	5011
	EFA102802	3957	5012
	EFA102813	3958	5013
	EFA102915	3959	5014
	EFA103021	3960	5015
	EFA103033	3961	5016
	EFA103038	3962	5017
	EFA103039	3963	5018
	EFA103062	3964	5019
	EFA103081	3965	5020
	EFA103174	3966	5021
	EFA103210	3967	5022
	EFA103268	3968	5023
	EFA103295	3969	5024
	EFA103348	3970	5025
	EFA103365	3971	5026
	EFA103375	3972	5027
	EFA103504	3973	5028
	EFA103508	3974	5029
	EFA103571	3975	5030
	EFA103786	3976	5031
	KPN100432	3977	5032
	KPN100854	3978	5033
	KPN101022	3979	5034
	KPN101026	3980	5035
	KPN101729	3981	5036
	KPN101750	3982	5037
	KPN102057	3983	5038
	KPN102638	3984	5039
	KPN103882	3985	5040
	KPN104183	3986	5041
	KPN104281	3987	5042
	KPN104430	3988	5043
	KPN104538	3989	5044
	KPN104716	3990	5045
	KPN105722	3991	5046
	KPN105779	3992	5047
	KPN106044	3993	5048
	KPN106659	3994	5049
	KPN106840	3995	5050
	KPN107626	3996	5051
	KPN107776	3997	5052
	PA0028	3998	5053
	PA0120	3999	5054
	PA0129	4000	5055
	PA0141	4001	5056
	PA0221	4002	5057
	PA0265	4003	5058
	PA0321	4004	5059
	PA0337	4005	5060
	PA0353	4006	5061
	PA0378	4007	5062
	PA0401	4008	5063
	PA0413	4009	5064
	PA0414	4010	5065
	PA0419	4011	5066
	PA0423	4012	5067
	PA0469	4013	5068
	PA0472	4014	5069
	PA0506	4015	5070
	PA0600	4016	5071
	PA0642	4017	5072
	PA0650	4018	5073
	PA0715	4019	5074
	PA0788	4020	5075
	PA0882	4021	5076
	PA0934	4022	5077
	PA0938	4023	5078
	PA1019	4024	5079
	PA1072	4025	5080
	PA1115	4026	5081
	PA1270	4027	5082
	PA1301	4028	5083
	PA1360	4029	5084
	PA1365	4030	5085
	PA1398	4031	5086
	PA1462	4032	5087
	PA1493	4033	5088
	PA1547	4034	5089
	PA1636	4035	5090
	PA1684	4036	5091
	PA1868	4037	5092
	PA1876	4038	5093
	PA1918	4039	5094
	PA1986	4040	5095
	PA2009	4041	5096
	PA2083	4042	5097
	PA2101	4043	5098
	PA2108	4044	5099
	PA2128	4045	5100
	PA2147	4046	5101
	PA2196	4047	5102
	PA2197	4048	5103
	PA2222	4049	5104
	PA2313	4050	5105
	PA2398	4051	5106
	PA2424	4052	5107
	PA2461	4053	5108
	PA2470	4054	5109
	PA2488	4055	5110
	PA2494	4056	5111
	PA2584	4057	5112
	PA2594	4058	5113
	PA2634	4059	5114
	PA2641	4060	5115
	PA2671	4061	5116
	PA2680	4062	5117
	PA2684	4063	5118
	PA2726	4064	5119
	PA2742	4065	5120
	PA3006	4066	5121
	PA3011	4067	5122
	PA3013	4068	5123
	PA3041	4069	5124
	PA3048	4070	5125
	PA3068	4071	5126
	PA3121	4072	5127
	PA3153	4073	5128
	PA3154	4074	5129
	PA3160	4075	5130
	PA3279	4076	5131
	PA3280	4077	5132
	PA3374	4078	5133
	PA3479	4079	5134
	PA3484	4080	5135
	PA3522	4081	5136
	PA3643	4082	5137
	PA3703	4083	5138
	PA3709	4084	5139
	PA3716	4085	5140
	PA3764	4086	5141
	PA3845	4087	5142
	PA3866	4088	5143
	PA3876	4089	5144
	PA3877	4090	5145
	PA3931	4091	5146
	PA3984	4092	5147
	PA4024	4093	5148
	PA4027	4094	5149
	PA4037	4095	5150
	PA4067	4096	5151
	PA4070	4097	5152
	PA4081	4098	5153
	PA4105	4099	5154
	PA4124	4100	5155
	PA4125	4101	5156
	PA4158	4102	5157
	PA4237	4103	5158
	PA4242	4104	5159
	PA4244	4105	5160
	PA4245	4106	5161
	PA4246	4107	5162
	PA4247	4108	5163
	PA4248	4109	5164
	PA4249	4110	5165
	PA4250	4111	5166
	PA4251	4112	5167
	PA4252	4113	5168
	PA4253	4114	5169
	PA4254	4115	5170
	PA4256	4116	5171
	PA4257	4117	5172
	PA4258	4118	5173
	PA4259	4119	5174
	PA4262	4120	5175
	PA4263	4121	5176
	PA4264	4122	5177
	PA4268	4123	5178
	PA4269	4124	5179
	PA4271	4125	5180
	PA4272	4126	5181
	PA4316	4127	5182
	PA4332	4128	5183
	PA4347	4129	5184
	PA4363	4130	5185
	PA4375	4131	5186
	PA4413	4132	5187
	PA4433	4133	5188
	PA4473	4134	5189
	PA4506	4135	5190
	PA4512	4136	5191
	PA4542	4137	5192
	PA4576	4138	5193
	PA4598	4139	5194
	PA4665	4140	5195
	PA4681	4141	5196
	PA4709	4142	5197
	PA4744	4143	5198
	PA4771	4144	5199
	PA4888	4145	5200
	PA4942	4146	5201
	PA4997	4147	5202
	PA5030	4148	5203
	PA5076	4149	5204
	PA5088	4150	5205
	PA5193	4151	5206
	PA5199	4152	5207
	PA5207	4153	5208
	PA5209	4154	5209
	PA5248	4155	5210
	PA5299	4156	5211
	PA5316	4157	5212
	PA5388	4158	5213
	PA5393	4159	5214
	PA5436	4160	5215
	PA5443	4161	5216
	PA5490	4162	5217
	PA5493	4163	5218
	PA5507	4164	5219
	PA5567	4165	5220
	SAU100040	4166	5221
	SAU100053	4167	5222
	SAU100056	4168	5223
	SAU100059	4169	5224
	SAU100062	4170	5225
	SAU100077	4171	5226
	SAU100112	4172	5227
	SAU100114	4173	5228
	SAU100118	4174	5229
	SAU100123	4175	5230
	SAU100128	4176	5231
	SAU100131	4177	5232
	SAU100133	4178	5233
	SAU100139	4179	5234
	SAU100140	4180	5235
	SAU100141	4181	5236
	SAU100157	4182	5237
	SAU100158	4183	5238
	SAU100162	4184	5239
	SAU100175	4185	5240
	SAU100182	4186	5241
	SAU100186	4187	5242
	SAU100198	4188	5243
	SAU100227	4189	5244
	SAU100231	4190	5245
	SAU100242	4191	5246
	SAU100246	4192	5247
	SAU100251	4193	5248
	SAU100265	4194	5249
	SAU100266	4195	5250
	SAU100272	4196	5251
	SAU100275	4197	5252
	SAU100300	4198	5253
	SAU100301	4199	5254
	SAU100302	4200	5255
	SAU100305	4201	5256
	SAU100307	4202	5257
	SAU100308	4203	5258
	SAU100313	4204	5259
	SAU100315	4205	5260
	SAU100323	4206	5261
	SAU100347	4207	5262
	SAU100355	4208	5263
	SAU100359	4209	5264
	SAU100381	4210	5265
	SAU100389	4211	5266
	SAU100390	4212	5267
	SAU100401	4213	5268
	SAU100412	4214	5269
	SAU100414	4215	5270
	SAU100432	4216	5271
	SAU100433	4217	5272
	SAU100436	4218	5273
	SAU100443	4219	5274
	SAU100444	4220	5275
	SAU100475	4221	5276
	SAU100478	4222	5277
	SAU100489	4223	5278
	SAU100496	4224	5279
	SAU100497	4225	5280
	SAU100514	4226	5281
	SAU100517	4227	5282
	SAU100521	4228	5283
	SAU100522	4229	5284
	SAU100527	4230	5285
	SAU100528	4231	5286
	SAU100532	4232	5287
	SAU100542	4233	5288
	SAU100546	4234	5289
	SAU100547	4235	5290
	SAU100557	4236	5291
	SAU100582	4237	5292
	SAU100590	4238	5293
	SAU100595	4239	5294
	SAU100596	4240	5295
	SAU100601	4241	5296
	SAU100608	4242	5297
	SAU100610	4243	5298
	SAU100613	4244	5299
	SAU100617	4245	5300
	SAU100633	4246	5301
	SAU100646	4247	5302
	SAU100658	4248	5303
	SAU100659	4249	5304
	SAU100679	4250	5305
	SAU100684	4251	5306
	SAU100685	4252	5307
	SAU100689	4253	5308
	SAU100690	4254	5309
	SAU100702	4255	5310
	SAU100710	4256	5311
	SAU100714	4257	5312
	SAU100731	4258	5313
	SAU100733	4259	5314
	SAU100734	4260	5315
	SAU100736	4261	5316
	SAU100738	4262	5317
	SAU100741	4263	5318
	SAU100745	4264	5319
	SAU100747	4265	5320
	SAU100751	4266	5321
	SAU100752	4267	5322
	SAU100767	4268	5323
	SAU100770	4269	5324
	SAU100771	4270	5325
	SAU100773	4271	5326
	SAU100776	4272	5327
	SAU100778	4273	5328
	SAU100793	4274	5329
	SAU100794	4275	5330
	SAU100799	4276	5331
	SAU100808	4277	5332
	SAU100810	4278	5333
	SAU100813	4279	5334
	SAU100831	4280	5335
	SAU100836	4281	5336
	SAU100838	4282	5337
	SAU100839	4283	5338
	SAU100843	4284	5339
	SAU100845	4285	5340
	SAU100858	4286	5341
	SAU100859	4287	5342
	SAU100865	4288	5343
	SAU100866	4289	5344
	SAU100879	4290	5345
	SAU100880	4291	5346
	SAU100882	4292	5347
	SAU100885	4293	5348
	SAU100886	4294	5349
	SAU100887	4295	5350
	SAU100899	4296	5351
	SAU100901	4297	5352
	SAU100916	4298	5353
	SAU100920	4299	5354
	SAU100921	4300	5355
	SAU100932	4301	5356
	SAU100944	4302	5357
	SAU100952	4303	5358
	SAU100959	4304	5359
	SAU100961	4305	5360
	SAU100962	4306	5361
	SAU100963	4307	5362
	SAU100964	4308	5363
	SAU100965	4309	5364
	SAU100970	4310	5365
	SAU100996	4311	5366
	SAU101006	4312	5367
	SAU101020	4313	5368
	SAU101024	4314	5369
	SAU101028	4315	5370
	SAU101034	4316	5371
	SAU101038	4317	5372
	SAU101039	4318	5373
	SAU101065	4319	5374
	SAU101067	4320	5375
	SAU101070	4321	5376
	SAU101084	4322	5377
	SAU101085	4323	5378
	SAU101086	4324	5379
	SAU101090	4325	5380
	SAU101092	4326	5381
	SAU101104	4327	5382
	SAU101143	4328	5383
	SAU101145	4329	5384
	SAU101155	4330	5385
	SAU101156	4331	5386
	SAU101159	4332	5387
	SAU101175	4333	5388
	SAU101180	4334	5389
	SAU101183	4335	5390
	SAU101184	4336	5391
	SAU101189	4337	5392
	SAU101197	4338	5393
	SAU101198	4339	5394
	SAU101199	4340	5395
	SAU101220	4341	5396
	SAU101224	4342	5397
	SAU101226	4343	5398
	SAU101231	4344	5399
	SAU101235	4345	5400
	SAU101236	4346	5401
	SAU101239	4347	5402
	SAU101240	4348	5403
	SAU101242	4349	5404
	SAU101247	4350	5405
	SAU101262	4351	5406
	SAU101265	4352	5407
	SAU101266	4353	5408
	SAU101267	4354	5409
	SAU101270	4355	5410
	SAU101271	4356	5411
	SAU101275	4357	5412
	SAU101286	4358	5413
	SAU101293	4359	5414
	SAU101300	4360	5415
	SAU101301	4361	5416
	SAU101302	4362	5417
	SAU101310	4363	5418
	SAU101311	4364	5419
	SAU101320	4365	5420
	SAU101327	4366	5421
	SAU101339	4367	5422
	SAU101340	4368	5423
	SAU101341	4369	5424
	SAU101343	4370	5425
	SAU101344	4371	5426
	SAU101346	4372	5427
	SAU101347	4373	5428
	SAU101350	4374	5429
	SAU101351	4375	5430
	SAU101360	4376	5431
	SAU101365	4377	5432
	SAU101366	4378	5433
	SAU101369	4379	5434
	SAU101371	4380	5435
	SAU101381	4381	5436
	SAU101382	4382	5437
	SAU101383	4383	5438
	SAU101385	4384	5439
	SAU101387	4385	5440
	SAU101389	4386	5441
	SAU101398	4387	5442
	SAU101399	4388	5443
	SAU101400	4389	5444
	SAU101408	4390	5445
	SAU101421	4391	5446
	SAU101427	4392	5447
	SAU101432	4393	5448
	SAU101436	4394	5449
	SAU101438	4395	5450
	SAU101444	4396	5451
	SAU101445	4397	5452
	SAU101446	4398	5453
	SAU101447	4399	5454
	SAU101452	4400	5455
	SAU101455	4401	5456
	SAU101461	4402	5457
	SAU101463	4403	5458
	SAU101476	4404	5459
	SAU101481	4405	5460
	SAU101482	4406	5461
	SAU101483	4407	5462
	SAU101488	4408	5463
	SAU101491	4409	5464
	SAU101492	4410	5465
	SAU101493	4411	5466
	SAU101495	4412	5467
	SAU101497	4413	5468
	SAU101509	4414	5469
	SAU101526	4415	5470
	SAU101529	4416	5471
	SAU101541	4417	5472
	SAU101543	4418	5473
	SAU101545	4419	5474
	SAU101546	4420	5475
	SAU101549	4421	5476
	SAU101551	4422	5477
	SAU101554	4423	5478
	SAU101561	4424	5479
	SAU101565	4425	5480
	SAU101567	4426	5481
	SAU101570	4427	5482
	SAU101571	4428	5483
	SAU101572	4429	5484
	SAU101573	4430	5485
	SAU101574	4431	5486
	SAU101575	4432	5487
	SAU101576	4433	5488
	SAU101586	4434	5489
	SAU101592	4435	5490
	SAU101599	4436	5491
	SAU101610	4437	5492
	SAU101612	4438	5493
	SAU101614	4439	5494
	SAU101616	4440	5495
	SAU101622	4441	5496
	SAU101624	4442	5497
	SAU101630	4443	5498
	SAU101632	4444	5499
	SAU101637	4445	5500
	SAU101641	4446	5501
	SAU101651	4447	5502
	SAU101652	4448	5503
	SAU101653	4449	5504
	SAU101655	4450	5505
	SAU101663	4451	5506
	SAU101664	4452	5507
	SAU101674	4453	5508
	SAU101679	4454	5509
	SAU101681	4455	5510
	SAU101682	4456	5511
	SAU101685	4457	5512
	SAU101717	4458	5513
	SAU101724	4459	5514
	SAU101726	4460	5515
	SAU101727	4461	5516
	SAU101728	4462	5517
	SAU101736	4463	5518
	SAU101737	4464	5519
	SAU101744	4465	5520
	SAU101751	4466	5521
	SAU101752	4467	5522
	SAU101754	4468	5523
	SAU101756	4469	5524
	SAU101771	4470	5525
	SAU101772	4471	5526
	SAU101777	4472	5527
	SAU101781	4473	5528
	SAU101782	4474	5529
	SAU101784	4475	5530
	SAU101790	4476	5531
	SAU101791	4477	5532
	SAU101792	4478	5533
	SAU101793	4479	5534
	SAU101794	4480	5535
	SAU101795	4481	5536
	SAU101797	4482	5537
	SAU101798	4483	5538
	SAU101799	4484	5539
	SAU101800	4485	5540
	SAU101801	4486	5541
	SAU101802	4487	5542
	SAU101803	4488	5543
	SAU101804	4489	5544
	SAU101805	4490	5545
	SAU101806	4491	5546
	SAU101807	4492	5547
	SAU101808	4493	5548
	SAU101810	4494	5549
	SAU101811	4495	5550
	SAU101814	4496	5551
	SAU101815	4497	5552
	SAU101818	4498	5553
	SAU101824	4499	5554
	SAU101833	4500	5555
	SAU101839	4501	5556
	SAU101842	4502	5557
	SAU101845	4503	5558
	SAU101849	4504	5559
	SAU101857	4505	5560
	SAU101862	4506	5561
	SAU101864	4507	5562
	SAU101865	4508	5563
	SAU101866	4509	5564
	SAU101868	4510	5565
	SAU101869	4511	5566
	SAU101876	4512	5567
	SAU101881	4513	5568
	SAU101882	4514	5569
	SAU101890	4515	5570
	SAU101891	4516	5571
	SAU101893	4517	5572
	SAU101904	4518	5573
	SAU101907	4519	5574
	SAU101909	4520	5575
	SAU101910	4521	5576
	SAU101915	4522	5577
	SAU101922	4523	5578
	SAU101948	4524	5579
	SAU101966	4525	5580
	SAU101968	4526	5581
	SAU101991	4527	5582
	SAU101995	4528	5583
	SAU101996	4529	5584
	SAU101999	4530	5585
	SAU102001	4531	5586
	SAU102002	4532	5587
	SAU102003	4533	5588
	SAU102006	4534	5589
	SAU102007	4535	5590
	SAU102032	4536	5591
	SAU102035	4537	5592
	SAU102044	4538	5593
	SAU102046	4539	5594
	SAU102049	4540	5595
	SAU102054	4541	5596
	SAU102059	4542	5597
	SAU102067	4543	5598
	SAU102068	4544	5599
	SAU102102	4545	5600
	SAU102113	4546	5601
	SAU102116	4547	5602
	SAU102117	4548	5603
	SAU102129	4549	5604
	SAU102132	4550	5605
	SAU102142	4551	5606
	SAU102143	4552	5607
	SAU102144	4553	5608
	SAU102162	4554	5609
	SAU102165	4555	5610
	SAU102200	4556	5611
	SAU102201	4557	5612
	SAU102222	4558	5613
	SAU102231	4559	5614
	SAU102232	4560	5615
	SAU102233	4561	5616
	SAU102241	4562	5617
	SAU102242	4563	5618
	SAU102246	4564	5619
	SAU102247	4565	5620
	SAU102252	4566	5621
	SAU102256	4567	5622
	SAU102257	4568	5623
	SAU102259	4569	5624
	SAU102260	4570	5625
	SAU102261	4571	5626
	SAU102262	4572	5627
	SAU102264	4573	5628
	SAU102265	4574	5629
	SAU102268	4575	5630
	SAU102270	4576	5631
	SAU102280	4577	5632
	SAU102281	4578	5633
	SAU102283	4579	5634
	SAU102284	4580	5635
	SAU102286	4581	5636
	SAU102287	4582	5637
	SAU102292	4583	5638
	SAU102294	4584	5639
	SAU102297	4585	5640
	SAU102298	4586	5641
	SAU102308	4587	5642
	SAU102318	4588	5643
	SAU102333	4589	5644
	SAU102334	4590	5645
	SAU102336	4591	5646
	SAU102340	4592	5647
	SAU102345	4593	5648
	SAU102350	4594	5649
	SAU102352	4595	5650
	SAU102355	4596	5651
	SAU102356	4597	5652
	SAU102378	4598	5653
	SAU102380	4599	5654
	SAU102388	4600	5655
	SAU102389	4601	5656
	SAU102390	4602	5657
	SAU102392	4603	5658
	SAU102394	4604	5659
	SAU102396	4605	5660
	SAU102401	4606	5661
	SAU102407	4607	5662
	SAU102417	4608	5663
	SAU102418	4609	5664
	SAU102420	4610	5665
	SAU102422	4611	5666
	SAU102423	4612	5667
	SAU102433	4613	5668
	SAU102434	4614	5669
	SAU102437	4615	5670
	SAU102440	4616	5671
	SAU102447	4617	5672
	SAU102448	4618	5673
	SAU102449	4619	5674
	SAU102450	4620	5675
	SAU102452	4621	5676
	SAU102453	4622	5677
	SAU102460	4623	5678
	SAU102469	4624	5679
	SAU102473	4625	5680
	SAU102474	4626	5681
	SAU102476	4627	5682
	SAU102479	4628	5683
	SAU102480	4629	5684
	SAU102481	4630	5685
	SAU102485	4631	5686
	SAU102486	4632	5687
	SAU102487	4633	5688
	SAU102498	4634	5689
	SAU102502	4635	5690
	SAU102503	4636	5691
	SAU102526	4637	5692
	SAU102527	4638	5693
	SAU102531	4639	5694
	SAU102533	4640	5695
	SAU102534	4641	5696
	SAU102541	4642	5697
	SAU102551	4643	5698
	SAU102554	4644	5699
	SAU102575	4645	5700
	SAU102578	4646	5701
	SAU102584	4647	5702
	SAU102585	4648	5703
	SAU102593	4649	5704
	SAU102598	4650	5705
	SAU102599	4651	5706
	SAU102601	4652	5707
	SAU102602	4653	5708
	SAU102603	4654	5709
	SAU102605	4655	5710
	SAU102606	4656	5711
	SAU102607	4657	5712
	SAU102609	4658	5713
	SAU102610	4659	5714
	SAU102613	4660	5715
	SAU102614	4661	5716
	SAU102615	4662	5717
	SAU102620	4663	5718
	SAU102621	4664	5719
	SAU102629	4665	5720
	SAU102631	4666	5721
	SAU102636	4667	5722
	SAU102637	4668	5723
	SAU102639	4669	5724
	SAU102652	4670	5725
	SAU102658	4671	5726
	SAU102663	4672	5727
	SAU102669	4673	5728
	SAU102671	4674	5729
	SAU102674	4675	5730
	SAU102693	4676	5731
	SAU102694	4677	5732
	SAU102725	4678	5733
	SAU102764	4679	5734
	SAU102766	4680	5735
	SAU102812	4681	5736
	SAU102863	4682	5737
	SAU102870	4683	5738
	SAU102880	4684	5739
	SAU102881	4685	5740
	SAU102883	4686	5741
	SAU102905	4687	5742
	SAU102909	4688	5743
	SAU102933	4689	5744
	SAU102935	4690	5745
	SAU102936	4691	5746
	SAU102939	4692	5747
	SAU102942	4693	5748
	SAU102944	4694	5749
	SAU102979	4695	5750
	SAU102983	4696	5751
	SAU102992	4697	5752
	SAU103010	4698	5753
	SAU103024	4699	5754
	SAU103025	4700	5755
	SAU103037	4701	5756
	SAU103038	4702	5757
	SAU103042	4703	5758
	SAU103077	4704	5759
	SAU103115	4705	5760
	SAU103144	4706	5761
	SAU103159	4707	5762
	SAU103169	4708	5763
	SAU103175	4709	5764
	SAU103191	4710	5765
	SAU103198	4711	5766
	SAU103204	4712	5767
	SAU103226	4713	5768
	SAU103232	4714	5769
	SAU200006	4715	5770
	SAU200028	4716	5771
	SAU200030	4717	5772
	SAU200058	4718	5773
	SAU200059	4719	5774
	SAU200088	4720	5775
	SAU200157	4721	5776
	SAU200242	4722	5777
	SAU200297	4723	5778
	SAU200345	4724	5779
	SAU200392	4725	5780
	SAU200468	4726	5781
	SAU200558	4727	5782
	SAU200561	4728	5783
	SAU200564	4729	5784
	SAU200565	4730	5785
	SAU200593	4731	5786
	SAU200601	4732	5787
	SAU200628	4733	5788
	SAU200657	4734	5789
	SAU200685	4735	5790
	SAU200721	4736	5791
	SAU200725	4737	5792
	SAU200731	4738	5793
	SAU200740	4739	5794
	SAU200752	4740	5795
	SAU200914	4741	5796
	SAU200916	4742	5797
	SAU200928	4743	5798
	SAU200934	4744	5799
	SAU200949	4745	5800
	SAU200960	4746	5801
	SAU200994	4747	5802
	SAU201167	4748	5803
	SAU201168	4749	5804
	SAU201184	4750	5805
	SAU201197	4751	5806
	SAU201225	4752	5807
	SAU201236	4753	5808
	SAU201301	4754	5809
	SAU201333	4755	5810
	SAU201375	4756	5811
	SAU201380	4757	5812
	SAU201381	4758	5813
	SAU201385	4759	5814
	SAU201403	4760	5815
	SAU201469	4761	5816
	SAU201486	4762	5817
	SAU201506	4763	5818
	SAU201508	4764	5819
	SAU201513	4765	5820
	SAU201539	4766	5821
	SAU201541	4767	5822
	SAU201558	4768	5823
	SAU201571	4769	5824
	SAU201611	4770	5825
	SAU201615	4771	5826
	SAU201620	4772	5827
	SAU201621	4773	5828
	SAU201654	4774	5829
	SAU201666	4775	5830
	SAU201743	4776	5831
	SAU201752	4777	5832
	SAU201765	4778	5833
	SAU201773	4779	5834
	SAU201775	4780	5835
	SAU201810	4781	5836
	SAU201827	4782	5837
	SAU201929	4783	5838
	SAU201952	4784	5839
	SAU201961	4785	5840
	SAU201971	4786	5841
	SAU202006	4787	5842
	SAU202039	4788	5843
	SAU202126	4789	5844
	SAU202174	4790	5845
	SAU202176	4791	5846
	SAU202186	4792	5847
	SAU202267	4793	5848
	SAU202708	4794	5849
	SAU202731	4795	5850
	SAU202736	4796	5851
	SAU202756	4797	5852
	SAU202781	4798	5853
	SAU202872	4799	5854
	SAU202882	4800	5855
	SAU202930	4801	5856
	SAU202945	4802	5857
	SAU202968	4803	5858
	SAU203001	4804	5859
	SAU203007	4805	5860
	SAU203196	4806	5861
	SAU203293	4807	5862
	SAU203296	4808	5863
	SAU203524	4809	5864
	SAU300110	4810	5865
	SAU300131	4811	5866
	SAU300156	4812	5867
	SAU300191	4813	5868
	SAU300269	4814	5869
	SAU300335	4815	5870
	SAU300338	4816	5871
	SAU300455	4817	5872
	SAU300572	4818	5873
	SAU300617	4819	5874
	SAU300713	4820	5875
	SAU300719	4821	5876
	SAU300732	4822	5877
	SAU300825	4823	5878
	SAU300868	4824	5879
	SAU300975	4825	5880
	SAU300998	4826	5881
	SAU301004	4827	5882
	SAU301030	4828	5883
	SAU301054	4829	5884
	SAU301080	4830	5885
	SAU301118	4831	5886
	SAU301133	4832	5887
	SAU301148	4833	5888
	SAU301223	4834	5889
	SAU301230	4835	5890
	SAU301268	4836	5891
	SAU301275	4837	5892
	SAU301357	4838	5893
	SAU301363	4839	5894
	SAU301433	4840	5895
	SAU301465	4841	5896
	SAU301472	4842	5897
	SAU301592	4843	5898
	SAU301620	4844	5899
	SAU301758	4845	5900
	SAU301773	4846	5901
	SAU301829	4847	5902
	SAU301869	4848	5903
	SAU301898	4849	5904
	SAU302060	4850	5905
	SAU302513	4851	5906
	SAU302626	4852	5907
	SAU302685	4853	5908
	SAU302698	4854	5909
	SAU302699	4855	5910
	SAU302805	4856	5911
	SAU302901	4857	5912
	SAU302931	4858	5913
	SAU302950	4859	5914
	SAU302956	4860	5915

[0881]

Claims

1. A purified or isolated nucleic acid sequence comprising a nucleotide sequence consisting essentially of one of SEQ ID NOs: 8-3795, wherein expression of said nucleic acid inhibits proliferation of a cell.

2. A purified or isolated nucleic acid comprising a fragment of one of SEQ ID NOs.: 8-3795, said fragment selected from the group consisting of fragments comprising at least 10, at least 20, at least 25, at least 30, at least 50 and more than 50 consecutive nucleotides of one of SEQ ID NOs: 8-3795.

3. A purified or isolated antisense nucleic acid comprising a nucleotide sequence complementary to at least a portion of an intragenic sequence, intergenic sequence, sequences spanning at least a portion of two or more genes, 5′ noncoding region, or 3′ noncoding region within an operon comprising a proliferation-required gene whose activity or expression is inhibited by an antisense nucleic acid comprising the nucleotide sequence of one of SEQ ID NOs.: 8-3795.

4. A purified or isolated nucleic acid comprising a nucleotide sequence having at least 70% identity to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 8-3795, the nucleotide sequences complementary to SEQ ID NOs.: 8-3795 and the sequences complementary to fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 8-3795 as determined using BLASTN version 2.0 with the default parameters.

5. A vector comprising a promoter operably linked to a nucleic acid encoding a polypeptide whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of any one of SEQ ID NOs.: 8-3795.

6. A purified or isolated polypeptide comprising a polypeptide whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of any one of SEQ ID NOs.: 8-3795, or a fragment selected from the group consisting of fragments comprising at least 5, at least 10, at least 20, at least 30, at least 40, at least 50, at least 60 or more than 60 consecutive amino acids of one of the said polypeptides.

7. A purified or isolated polypeptide comprising a polypeptide having at least 25% amino acid identity to a polypeptide whose expression is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, or at least 25% amino acid identity to a fragment comprising at least 10, at least 20, at least 30, at least 40, at least 50, at least 60 or more than 60 consecutive amino acids of a polypeptide whose expression is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 as determined using FASTA version 3.0t78 with the default parameters.

8. A method of producing a polypeptide, comprising introducing a vector comprising a promoter operably linked to a nucleic acid comprising a nucleotide sequence encoding a polypeptide whose expression is inhibited by an antisense nucleic acid comprising one of SEQ ID NOs.: 8-3795 into a cell.

9. A method of inhibiting proliferation of a cell in an individual comprising inhibiting the activity or reducing the amount of a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or inhibiting the activity or reducing the amount of a nucleic acid encoding said gene product.

10. A method for identifying a compound which influences the activity of a gene product required for proliferation, said gene product comprising a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising: contacting said gene product with a candidate compound; and determining whether said compound influences the activity of said gene product.

11. A method for identifying a compound or nucleic acid having the ability to reduce the activity or level of a gene product required for proliferation, said gene product comprising a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising: (a) contacting a target gene or RNA encoding said gene product with a candidate compound or nucleic acid; and (b) measuring an activity of said target.

12. A method for identifying a compound which reduces the activity or level of a gene product required for proliferation of a cell, wherein the activity or expression of said gene product is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising the steps of: (a) providing a sublethal level of an antisense nucleic acid comprising a nucleotide sequence complementary to a nucleic acid comprising a nucleotide sequence encoding said gene product in a cell to reduce the activity or amount of said gene product in said cell, thereby producing a sensitized cell; (b) contacting said sensitized cell with a compound; and (c) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

13. A method for inhibiting cellular proliferation comprising introducing an effective amount of a compound with activity against a gene whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a compound with activity against the product of said gene into a population of cells expressing said gene.

14. A composition comprising an effective concentration of an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, or a proliferation-inhibiting portion thereof in a pharmaceutically acceptable carrier.

15. A method for inhibiting the activity or expression of a gene in an operon required for proliferation wherein the activity or expression of at least one gene in said operon is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising contacting a cell in a cell population with an antisense nucleic acid complementary to at least a portion of said operon.

16. A method for identifying a gene which is required for proliferation of a cell comprising: (a) contacting a cell with an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, wherein said cell is a cell other than the organism from which said nucleic acid was obtained; (b) determining whether said nucleic acid inhibits proliferation of said cell; and (c) identifying the gene in said cell which encodes the mRNA which is complementary to said antisense nucleic acid or a portion thereof.

17. A method for identifying a compound having the ability to inhibit proliferation of a cell comprising: (a) identifying a homolog of a gene or gene product whose activity or level is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 in a test cell, wherein said test cell is not the cell from which said nucleic acid was obtained; (b) identifying an inhibitory nucleic acid sequence which inhibits the activity of said homolog in said test cell; (c) contacting said test cell with a sublethal level of said inhibitory nucleic acid, thus sensitizing said cell; (d) contacting the sensitized cell of step (c) with a compound; and (e) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not contain said inhibitory nucleic acid.

18. A method of identifying a compound having the ability to inhibit proliferation comprising: (a) contacting a test cell with a sublethal level of a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 or a portion thereof which inhibits the proliferation of the cell from which said nucleic acid was obtained, thus sensitizing said test cell; (b) contacting the sensitized test cell of step (a) with a compound; and (c) determining the degree to which said compound inhibits proliferation of said sensitized test cell relative to a cell which does not contain said nucleic acid.

19. A method for identifying a compound having activity against a biological pathway required for proliferation comprising: (a) sensitizing a cell by providing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding a gene product required for proliferation, wherein the activity or expression of said gene product is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, in said cell to reduce the activity or amount of said gene product; (b) contacting the sensitized cell with a compound; and (c) determining the degree to which said compound inhibits the growth of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

20. A method for identifying a compound having the ability to inhibit cellular proliferation comprising: (a) contacting a cell with an agent which reduces the activity or level of a gene product required for proliferation of said cell, wherein said gene product is a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795; (b) contacting said cell with a compound; and (c) determining whether said compound reduces proliferation of said contacted cell by acting on said gene product.

21. A method for identifying the biological pathway in which a proliferation-required gene or its gene product lies, wherein said gene or gene product comprises a gene or gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795, said method comprising: (a) providing a sublethal level of an antisense nucleic acid which inhibits the activity of said proliferation-required gene or gene product in a test cell; (b) contacting said test cell with a compound known to inhibit growth or proliferation of a cell, wherein the biological pathway on which said compound acts is known; and (c) determining the degree to which said proliferation of said test cell is inhibited relative to a cell which was not contacted with said compound.

22. A method for determining the biological pathway on which a test compound acts comprising: (a) providing a sublethal level of an antisense nucleic acid complementary to a proliferation-required nucleic acid in a first cell, wherein the activity or expression of said proliferation-required nucleic acid is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795 and wherein the biological pathway in which said proliferation-required nucleic acid or a protein encoded by said proliferation-required nucleic acid lies is known, (b) contacting said first cell with said test compound; and (c) determining the degree to which said test compound inhibits proliferation of said first cell relative to a cell which does not contain said antisense nucleic acid.

23. A purified or isolated nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795.

24. A compound which interacts with a gene or gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of one of SEQ ID NOs.: 8-3795 to inhibit proliferation.

25. A compound which interacts with a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence of one of SEQ ID NOs.: 8-3795 to inhibit proliferation.

26. A method for manufacturing an antibiotic comprising the steps of: screening one or more candidate compounds to identify a compound that reduces the activity or level of a gene product required for proliferation, said gene product comprising a gene product whose activity or expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795; and manufacturing the compound so identified.

27. A purified or isolated nucleic acid comprising a nucleic acid having at least 70% nucleotide sequence identity to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012, the nucleotide sequences complementary to SEQ ID NOs.:3796-3800, 3806-4860, 5916-10012, and the nucleotide sequences complementary to fragments comprising at least 25 consecutive nucleotides of SEQ ID NOs.: 3796-3800, 3806-4860, 5916-10012 as determined using BLASTN version 2.0 with the default parameters.

28. A method of inhibiting proliferation of a cell comprising inhibiting the activity or reducing the amount of a gene product in said cell or inhibiting the activity or reducing the amount of a nucleic acid encoding said gene product in said cell, wherein said gene product is selected from the group consisting of a gene product having having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid which hybridizes to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid which hybridizes to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 8-3795.

29. A method for identifying a compound which influences the activity of a gene product required for proliferation comprising: contacting a candidate compound with a gene product selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; and determining whether said candidate compound influences the activity of said gene product.

30. A method for identifying a compound or nucleic acid having the ability to reduce the activity or level of a gene product required for proliferation comprising: (a) providing a target that is a gene or RNA, wherein said target comprises a nucleic acid that encodes a gene product selected from the group consisting of a gene product having having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleic acid identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; (b) contacting said target with a candidate compound or nucleic acid; and (c) measuring an activity of said target.

31. A method for identifying a compound which reduces the activity or level of a gene product required for proliferation of a cell comprising: (a) providing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding said gene product in a cell to reduce the activity or amount of said gene product in said cell, thereby producing a sensitized cell, wherein said gene product is selected from the group consisting of a gene product having having at least 70% nucleic acid identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; (b) contacting said sensitized cell with a compound; and (c) determining the degree to which said compound inhibits the growth of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

32. A method for inhibiting cellular proliferation comprising introducing a compound with activity against a gene product or a compound with activity against a gene encoding said gene product into a population of cells expressing said gene product, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

33. A preparation comprising an effective concentration of an antisense nucleic acid in a pharmaceutically acceptable carrier wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid comprising a sequence having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a proliferation-inhibiting portion thereof, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions.

34. A method for inhibiting the activity or expression of a gene in an operon which encodes a gene product required for proliferation comprising contacting a cell in a cell population with an antisense nucleic acid comprising at least a proliferation-inhibiting portion of said operon in an antisense orientation, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

35. A method for identifying a gene which is required for proliferation of a cell comprising: (a) contacting a cell with an antisense nucleic acid selected from the group consisting of a nucleic acid at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795 or a proliferation-inhibiting portion thereof, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, wherein said cell is a cell other than the organism from which said nucleic acid was obtained; (b) determining whether said nucleic acid inhibits proliferation of said cell; and (c) identifying the gene in said cell which encodes the mRNA which is complementary to said antisense nucleic acid or a portion thereof.

36. A method for identifying a compound having the ability to inhibit proliferation of a cell comprising: (a) identifying a homolog of a gene or gene product whose activity or level is inhibited by an antisense nucleic acid in a test cell, wherein said test cell is not the microorgaism from which the antisense nucleic acid was obtained, wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions; (b) identifying an inhibitory nucleic acid sequence which inhibits the activity of said homolog in said test cell; (c) contacting said test cell with a sublethal level of said inhibitory nucleic acid, thus sensitizing said cell; (d) contacting the sensitized cell of step (c) with a compound; and (e) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not express said inhibitory nucleic acid.

37. A method of identifying a compound having the ability to inhibit proliferation comprising: (a) sensitizing a test cell by contacting said test cell with a sublethal level of an antisense nucleic acid, wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs. 8-3795 or a portion thereof which inhibits the proliferation of the cell from which said nucleic acid was obtained, a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditionst; (b) contacting the sensitized test cell of step (a) with a compound; and (c) determining the degree to which said compound inhibits proliferation of said sensitized test cell relative to a cell which does not contain said antisense nucleic acid.

38. A method for identifying a compound having activity against a biological pathway required for proliferation comprising: (a) sensitizing a cell by providing a sublethal level of an antisense nucleic acid complementary to a nucleic acid encoding a gene product required for proliferation, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; (b) contacting the sensitized cell with a compound; and (c) determining the extent to which said compound inhibits the growth of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

39. A method for identifying a compound having the ability to inhibit cellular proliferation comprising: (a) contacting a cell with an agent which reduces the activity or level of a gene product required for proliferation of said cell, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; (b) contacting said cell with a compound; and (c) determining the degree to which said compound reduces proliferation of said contacted cell relative to a cell which was not contacted with said agent.

40. A method for identifying the biological pathway in which a proliferation-required gene product or a gene encoding a proliferation-required gene product lies comprising: (a) providing a sublethal level of an antisense nucleic acid which inhibits the activity or reduces the level of said gene encoding a proliferation-required gene product or said said proliferation-required gene product in a test cell, wherein said proliferation-required gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; (b) contacting said test cell with a compound known to inhibit growth or proliferation of a cell, wherein the biological pathway on which said compound acts is known; and (c) determining the degree to which said compound inhibits proliferation of said test cell relative to a cell which does not contain said antisense nucleic acid.

41. A method for determining the biological pathway on which a test compound acts comprising: (a) providing a sublethal level of an antisense nucleic acid complementary to a proliferation-required nucleic acid in a cell, thereby producing a sensitized cell, wherein said antisense nucleic acid is selected from the group consisting of a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795 or a proliferation-inhibiting portion thereof,a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, and a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions and wherein the biological pathway in which said proliferation-required nucleic acid or a protein encoded by said proliferation-required polypeptide lies is known, (b) contacting said cell with said test compound; and (c) determining the degree to which said compound inhibits proliferation of said sensitized cell relative to a cell which does not contain said antisense nucleic acid.

42. A compound which inhibits proliferation by interacting with a gene encoding a gene product required for proliferation or with a gene product required for proliferation, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an anti sense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.

43. A method for manufacturing an antibiotic comprising the steps of: screening one or more candidate compounds to identify a compound that reduces the activity or level of a gene product required for proliferation wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795; and manufacturing the compound so identified.

44. A method for inhibiting proliferation of a cell in a subject comprising administering an effective amount of a compound that reduces the activity or level of a gene product required for proliferation of said cell, wherein said gene product is selected from the group consisting of a gene product having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid having at least 70% nucleotide sequence identity as determined using BLASTN version 2.0 with the default parameters to a nucleic acid encoding a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs:8-3795, a gene product having at least 25% amino acid identity as determined using FASTA version 3.0t78 with the default parameters to a gene product whose expression is inhibited by an antisense nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs.: 8-3795, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under stringent conditions, a gene product encoded by a nucleic acid comprising a nucleotide sequence which hybridizes to a nucleic acid selected from the group consisting of SEQ ID NOs.: 8-3795 under moderate conditions, and a gene product whose activity may be complemented by the gene product whose activity is inhibited by a nucleic acid selected from the group consisting of SEQ ID NOs: 8-3795.